<SEC-DOCUMENT>0001628280-22-021350.txt : 20220805
<SEC-HEADER>0001628280-22-021350.hdr.sgml : 20220805
<ACCEPTANCE-DATETIME>20220805160513
ACCESSION NUMBER:		0001628280-22-021350
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		62
CONFORMED PERIOD OF REPORT:	20220630
FILED AS OF DATE:		20220805
DATE AS OF CHANGE:		20220805

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PROCEPT BioRobotics Corp
		CENTRAL INDEX KEY:			0001588978
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				260199180
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40797
		FILM NUMBER:		221140745

	BUSINESS ADDRESS:	
		STREET 1:		900 ISLAND DRIVE
		CITY:			REDWOOD CITY
		STATE:			CA
		ZIP:			94065
		BUSINESS PHONE:		650-232-7200

	MAIL ADDRESS:	
		STREET 1:		900 ISLAND DRIVE
		CITY:			REDWOOD CITY
		STATE:			CA
		ZIP:			94065
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>prct-20220630.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:311bf6b2-ae92-4a64-91ca-35c82a3f09ce,g:4b68a96a-367b-4d30-a7c4-4a5adc893ec2,d:bb2df456afff4355bae87af9d1240625--><html xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:prct="http://www.procept-biorobotics.com/20220630" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns="http://www.w3.org/1999/xhtml" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>prct-20220630</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80L2ZyYWc6NjI0MzlmZjQ2YTQ2NDNlZjhlMzNmMTczOWY2YzQ1YzIvdGFibGU6YTIwMjNmYWU4OGZjNGRkZGI4MDE3MDJhNDczODk0ODIvdGFibGVyYW5nZTphMjAyM2ZhZTg4ZmM0ZGRkYjgwMTcwMmE0NzM4OTQ4Ml8wLTEtMS0xLTcwMjY1_ef4fff61-9406-4b10-882f-d86b167c4745">0001588978</ix:nonNumeric><ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80L2ZyYWc6NjI0MzlmZjQ2YTQ2NDNlZjhlMzNmMTczOWY2YzQ1YzIvdGFibGU6YTIwMjNmYWU4OGZjNGRkZGI4MDE3MDJhNDczODk0ODIvdGFibGVyYW5nZTphMjAyM2ZhZTg4ZmM0ZGRkYjgwMTcwMmE0NzM4OTQ4Ml8xLTEtMS0xLTcwMjY1_398de845-af58-4ca2-be8e-02e176392ea3">12/31</ix:nonNumeric><ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80L2ZyYWc6NjI0MzlmZjQ2YTQ2NDNlZjhlMzNmMTczOWY2YzQ1YzIvdGFibGU6YTIwMjNmYWU4OGZjNGRkZGI4MDE3MDJhNDczODk0ODIvdGFibGVyYW5nZTphMjAyM2ZhZTg4ZmM0ZGRkYjgwMTcwMmE0NzM4OTQ4Ml8yLTEtMS0xLTcwMjY1_47ca55f7-d5cf-4f05-87b5-5659eea77779">2022</ix:nonNumeric><ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80L2ZyYWc6NjI0MzlmZjQ2YTQ2NDNlZjhlMzNmMTczOWY2YzQ1YzIvdGFibGU6YTIwMjNmYWU4OGZjNGRkZGI4MDE3MDJhNDczODk0ODIvdGFibGVyYW5nZTphMjAyM2ZhZTg4ZmM0ZGRkYjgwMTcwMmE0NzM4OTQ4Ml8zLTEtMS0xLTcwMjY1_8a931e70-434f-4f2a-bd41-9f71c594f40b">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80L2ZyYWc6NjI0MzlmZjQ2YTQ2NDNlZjhlMzNmMTczOWY2YzQ1YzIvdGFibGU6YTIwMjNmYWU4OGZjNGRkZGI4MDE3MDJhNDczODk0ODIvdGFibGVyYW5nZTphMjAyM2ZhZTg4ZmM0ZGRkYjgwMTcwMmE0NzM4OTQ4Ml80LTEtMS0xLTcwMjY1_5c305ce1-5efc-46ff-883b-1957cd385970">Q2</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="prct-20220630.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5244b61f062c425cb72b630f1ffc25d3_I20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i6225d555eeba47689e5b7d633c1f277f_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i96161312b8e749cc9c7f6f759945011c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i9640280ee02a463885b62fb60246cfec_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4eeb8d5fbaa443cfb4b403f6bf784110_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9585d1c54a684663894a7893b7489c39_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2247db1a4a2640a299b416b33a688b7c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1defffe1f1964d89826a5865f9c988a5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f83ee6a840d4fcf9011375d58625785_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01886b412db145e0a0a2fe5ced6a37b3_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e567fde435a43809f3e7db528da3c7d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5536a0a58c9e43a89b71f9c8d5fde9db_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib49ef5b808cc4ce58c5c2146e6a4a872_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idbe9cd2e7c184e5f9f1b6182c72c33bc_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a5f8472ee434d169dea6396cc0d2243_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8e0d0a6ea974a85bc5c95e8ea39af53_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d726aec89c84cdfacf0dd37b1b7db33_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3c71862037247eaab3a9d37ea5de5f9_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3fc05616d7449288a6f5900e51f12cd_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if60434966ba04e68bb10f89d746d9c71_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id69d7c117e41411bb58321abe66da977_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e81cc1babd944fca585586deb7d643a_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i627bfed199d449d8b9f34ce309b5b446_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24963d2b7ff64b7ea5ae30aef83c1ab2_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b4d8b1368e44cf78783a263b8dad765_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a939982b2f54db8a27e8f371521eb89_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icbfd320e5dd848119b7bdb3871172b7a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14cbbd3f6b274b5b9fb32f03421ac7b6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i282fabdbdaff4996a0ac69a7bc75b9b8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5288075d3e6407caf4a41af1e03bf62_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1f38e11fe9a410499fe555213ca38f8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28c750db7e8b493c961a7d62d4a754ad_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7fe5f544032b4ef4a2f76f6a6f973e06_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ee47d851f3042aaaf707d3b82004294_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea9c042e07264772b04308a25e550340_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b181e472b094adbad522e89a97c3965_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94b26e0dbca84b9b8524e15573d9bf33_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac576b608667443aad04c57beda563ac_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9bc468ed15de4a9d97e08aa2fbe09c34_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied0b777dba264312b4d74af5c79a0cb3_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6966f0a91417487ba500b6d3df3fcc46_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8722cf471d0a4e458baade237a5960c6_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i727054a48db344dc84054f19179656ea_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38e5e80513f848e596aad02407f696f7_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia737ca5e401d4e1898b0e48e1bb51d05_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a06654ca8fc49a0aaed81f85663e69f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2228949c5a34355af819610f5c3e6c7_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67e7f282b71d4074a19bfe3304779fce_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9dfc04e8f5654c70a7bd05c9b50882c4_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8591f6f61272452cb59c7b8fd943a9f0_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i054a395a39bb4b049e783cf126b64e4c_D20210901-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76637c8aeec140d2b14464b0d2e859c4_D20210901-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie390a471379b4ab1bcab0d1678411d3a_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic71fc6b5bde14a3db707e62f0fc13d18_D20210901-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia464c84a1d294b1a90b1144fd82c6978_D20210901-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50623cf37fe345b787005f8045a73bbf_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">prct:SeriesERedeemableConvertiblePreferredStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i271be39716a24ae3a1220dde2c194490_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0624c3f7a1a24f1cbf5381ed78fa8773_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28d56366abcb4c1ba6762562d89f11be_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03e5fbb904174fc6a95ec0686a05e446_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib662e1ac7c4f4fc09ed63ee4ad3d6920_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06c709bf479e43c389950311b1d0360b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71decfbc977f40ac8eb9c51a9d97ccbe_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idbcba339097743d39f83b2c7a95fa80c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ec894abcc4c490b980330e1351b89bd_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i9261f6f74d684c688cfaeac2f36b5a12_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9d53416940548b886aec19be0a44a4e_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1c2312756cd4f6e99858bfda9b5b1dc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4a5962583214d618c2bce6e91e2bc49_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49866073e1f44cf1b38b071917bc10c4_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b5a6a38e4a04bd580825d3c7c3c7b97_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56ff5a0cd9ad480ca54975bb361ad2e2_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida5e5f1bb1d542c9b2cd7ccf481a8af2_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie19c67cd74ed40aabeb9098c4f2fb478_D20190301-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e254378ff134e9681a4249bcc83e5fc_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prct:LoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="installment"><xbrli:measure>prct:installment</xbrli:measure></xbrli:unit><xbrli:context id="i10156edb55894acbb210fec9c3468287_D20190901-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prct:LoanFacilityTrancheOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b01acac5e6143eaba1f435139069823_D20200301-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prct:LoanFacilityTrancheTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4b1440f6de14019a797df774eb5f464_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prct:LoanFacilityTrancheThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c2a33ef0d514076961c5e1590bfa66c_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prct:LoanFacilityTrancheThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6777b1709ddc4642b6a8f38a6e6be39d_D20210101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prct:LoanFacilityTrancheThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33d2d97450ea42cea69aeef3e9ea7937_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prct:LoanFacilityTrancheFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia16ecc55dbd348ecaaaaaa7c92629f98_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prct:LoanFacilityTrancheFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9256f6c0b3ab484d973170c275d30dd6_I20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prct:LoanFacilityTrancheTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2530161d85e4792bd363ce72e96e9b9_I20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prct:LoanFacilityTrancheTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i861bb40fd82c4a378c9527bee4405c32_D20210101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prct:LoanFacilityTrancheTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia47c0681a1b8412cb1f3e5eb400ad5fc_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prct:LoanFacilityTrancheFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3bba515e9a0d4545bb068c2fe7296bf1_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prct:LoanFacilityTrancheFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if00ac5ae82404ee98272aabd9c6a9606_D20210901-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prct:LoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i683101ff096c40c2a24cbd6236452190_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prct:LoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1c06405d72a4f48a81ffc14a560fce7_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prct:LoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id06260efb84542fcbe48470c87f30c7c_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prct:LoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19e8bd64054f475ea78f283d6415e474_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2afc20bf0a74c8497a36a93f40390d4_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prct:LoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68b9bf6c49b34ddb9f9cdf4df2a9cde7_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prct:LoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa96468d217b44f29426837ed43cb27e_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">prct:A2021EquityIncentiveAwardPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98ec9d7c3e23460eb44d3b79a24f38f8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73c3f9942c10418c97d1df582f8b37c7_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f17d9fd3b0f45df96c50d9c3c83002b_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7eabbab66fc246509ee375373f59a3c8_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00f54e9cbe804bb38c30969068ff45d3_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5734f87cb59c4ab99ff5087249c3e6bc_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48c0e4524ffe4c1fa1c1d659ea30bc91_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97a15a5737b34117975db805d85bb267_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic60a1a1821b14d1d8d6ac4fff874549d_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17afe0c0dcba45159077ed56cad20253_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">prct:A2021EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8d4c78e6b0f482fae70548a9459a7f1_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">prct:A2021EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c8e42000a7c49b7b20f5345c42d7b26_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">prct:A2021EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i277b8f845b9c4fe49bd226a094fd599c_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibfcaafa17e4746279efe3c570e6f9fbb_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie094c47c8e41442d8f48b3161b3255d9_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3846b5796b46497498e5a63b411da5f9_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i164ec0a968a3490c8e5ca191f4a7e36b_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie06546dec3a04d87b10442e18708fbee_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i028690643f5b41a3bf4ab56e7150dcfd_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30ea9dc52b724da0aac81e7933fd37f3_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90bfc90968d64d2f95bb4f0aab2fabef_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f12acefea06470fbd1ff183c033427c_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0f804f4efc44311ad8c409d09969458_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7eaf117796f144da98cb336ef5d2a3c6_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16c6e66d4ce6495b8d9d4fb2a81130ec_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia13da9ea227f4e738ed2a4ade74a841d_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idaefefa698af4a6bb691e2fb7f0a6944_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">prct:RedeemableConvertiblePreferredStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i140935dcf8204cbf959d52cbd44911ae_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">prct:RedeemableConvertiblePreferredStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01badfb698334a429a1be2da49cd7a91_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1372789c7d3948d3b8aca78f2d9b92dd_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i124d9db5d45e4effa8c6d68140756087_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10a1fb79429d4c70978ced6bf017f60f_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49e74c53b47042178251b4824d6b4122_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">prct:A2021EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34fe12d789d3432680d4d84cc2fdfe4f_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">prct:A2021EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae550cb350ab4aa093330a1aa67fbb59_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prct:SystemSalesAndRentalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc3548f9c5af4248b89810935e741c81_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prct:SystemSalesAndRentalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i354124ad73aa4d359530dedf6cc892ff_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prct:SystemSalesAndRentalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i034be609d4174ca28c7931f45c17137f_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prct:SystemSalesAndRentalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93f054b306ba42db85eac45b5398e920_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prct:HandPiecesAndOtherConsumablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a3ab372268f4d07ac5a6cef9de6d000_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prct:HandPiecesAndOtherConsumablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0f3737d0aba4fb9a4cb003b37c4a03c_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prct:HandPiecesAndOtherConsumablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34e859a6c83448509ff840a825f98408_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prct:HandPiecesAndOtherConsumablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa95f8ea20be433eafa6a8ca0854a1ab_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prct:ServiceRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i103aeef9defe4b0387c733d075b32506_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prct:ServiceRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7323a463430b427eade72651460a0dda_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prct:ServiceRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c8cc8b31066433d9ab97e1244ff31b5_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prct:ServiceRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56197f81b18f4fdd9144c91fbf486356_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84cfac7405214cd68837a7cd08d45162_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iebbce8d97e394404821074c8c3cbf98b_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b6d991467f646b192fb0bf7523d7fe3_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0697cd6105f4abf9c831356c1473b25_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prct:SystemSalesAndRentalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prct:OutsideTheUnitedStatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i837cadc9f10943b7b8afdee6a7838bae_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prct:SystemSalesAndRentalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prct:OutsideTheUnitedStatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d7b2d1422fa47d7b08d486dff9d320a_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prct:SystemSalesAndRentalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prct:OutsideTheUnitedStatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb609047c8a640abaa29cd36b1d98737_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prct:SystemSalesAndRentalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prct:OutsideTheUnitedStatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i841d3dd4b3a54b2f94fa7066f3cea1e5_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prct:HandPiecesAndOtherConsumablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prct:OutsideTheUnitedStatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9832ef4d4be47168e465fd04aaf5f66_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prct:HandPiecesAndOtherConsumablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prct:OutsideTheUnitedStatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc2c8df366d747ccaf7c4700fcfa6b6b_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prct:HandPiecesAndOtherConsumablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prct:OutsideTheUnitedStatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d3b3cc27d31469897df4789948762e2_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prct:HandPiecesAndOtherConsumablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prct:OutsideTheUnitedStatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib25e541235774f03a985292fa15ef08c_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prct:OutsideTheUnitedStatesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prct:ServiceRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id619c937117e495295cff348cd8098f9_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prct:OutsideTheUnitedStatesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prct:ServiceRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8b4017be8a44b8c871ccec3eb53803d_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prct:OutsideTheUnitedStatesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prct:ServiceRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ffaf08378e1423a947bf449998d53e6_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prct:OutsideTheUnitedStatesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prct:ServiceRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b75e831ee944df685fe171431077c73_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prct:OutsideTheUnitedStatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9f1dced786449a0ba9d25bcd7dda9de_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prct:OutsideTheUnitedStatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if17ffbed1df54f99a2e086997e1e3fec_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prct:OutsideTheUnitedStatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b6405459f5948bfb4f2a67be3632426_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prct:OutsideTheUnitedStatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b602262223d4640893e5dd50f271572_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">prct:Customer1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i126dea3f4e7745c5ae15e412fd7a688c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">prct:Customer1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4fcecdc96c7946a6917102a9bc187595_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06b7903ecea34c54885ee96df8bd17f7_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24596b41408a4ffea6e70203801645e4_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i178c15123386454db3b2a62f93f77161_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i969ef2b7ba3b4291a15d9307f31bf736_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prct:OutsideTheUnitedStatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id766d70acd42417684ab4d19ff0aaba3_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prct:OutsideTheUnitedStatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie317f3d85145457ebb62b991028c5dbc_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prct:OutsideTheUnitedStatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74d4cb137b6049418262544587636450_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prct:OutsideTheUnitedStatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id73017efcdff4610924f905608444615_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="building"><xbrli:measure>prct:building</xbrli:measure></xbrli:unit><xbrli:unit id="sqft"><xbrli:measure>utr:sqft</xbrli:measure></xbrli:unit><xbrli:context id="ic8e9593d6af940928b18f5797d0ae114_D20211231-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001588978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-31</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="renewaloption"><xbrli:measure>prct:renewalOption</xbrli:measure></xbrli:unit></ix:resources></ix:header></div><div id="ibb2df456afff4355bae87af9d1240625_1"></div><div style="min-height:36pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xL2ZyYWc6NjFiMmFlN2VmZGY0NDU1ODkxMDNkMzFkNzVhOGFmYjcvdGV4dHJlZ2lvbjo2MWIyYWU3ZWZkZjQ0NTU4OTEwM2QzMWQ3NWE4YWZiN18xOTc5_3af53476-37aa-4913-8a42-3837ac41e1b4">10-Q</ix:nonNumeric> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Mark One)</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.706%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xL2ZyYWc6NjFiMmFlN2VmZGY0NDU1ODkxMDNkMzFkNzVhOGFmYjcvdGFibGU6ZmJjMGNmYmExMWY4NDA0YTk5NjlkNDkyNjhiN2I3ZjcvdGFibGVyYW5nZTpmYmMwY2ZiYTExZjg0MDRhOTk2OWQ0OTI2OGI3YjdmN18wLTAtMS0xLTcwMjY1_05e0e3b4-3164-4669-b211-fa419fccccfb">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xL2ZyYWc6NjFiMmFlN2VmZGY0NDU1ODkxMDNkMzFkNzVhOGFmYjcvdGV4dHJlZ2lvbjo2MWIyYWU3ZWZkZjQ0NTU4OTEwM2QzMWQ3NWE4YWZiN18xMzQ_5d6f64e3-a322-4bdf-83fb-9d4086ee2940">June&#160;30, 2022</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OR</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.706%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xL2ZyYWc6NjFiMmFlN2VmZGY0NDU1ODkxMDNkMzFkNzVhOGFmYjcvdGFibGU6MjYwNTRjZjYzODc0NGNhYTkxNmQzOGQ2NDZjYjBmNTYvdGFibGVyYW5nZToyNjA1NGNmNjM4NzQ0Y2FhOTE2ZDM4ZDY0NmNiMGY1Nl8wLTAtMS0xLTcwMjY1_98c773b9-d664-4520-ba43-97eb696c353e">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from &#160;                        to  </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission file number <ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xL2ZyYWc6NjFiMmFlN2VmZGY0NDU1ODkxMDNkMzFkNzVhOGFmYjcvdGV4dHJlZ2lvbjo2MWIyYWU3ZWZkZjQ0NTU4OTEwM2QzMWQ3NWE4YWZiN18xOTcy_9a9e1c69-ecc6-4233-afe1-1fbd5b4a3646">001-40797</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xL2ZyYWc6NjFiMmFlN2VmZGY0NDU1ODkxMDNkMzFkNzVhOGFmYjcvdGV4dHJlZ2lvbjo2MWIyYWU3ZWZkZjQ0NTU4OTEwM2QzMWQ3NWE4YWZiN18xOTcz_032477f4-dc3a-421e-882d-312dfd9b156c">PROCEPT BioRobotics Corporation</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.485%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xL2ZyYWc6NjFiMmFlN2VmZGY0NDU1ODkxMDNkMzFkNzVhOGFmYjcvdGFibGU6Y2Q4M2YyNzEyZDc5NGEyMDk4OGM1ZDkwZWMzYjMwYTIvdGFibGVyYW5nZTpjZDgzZjI3MTJkNzk0YTIwOTg4YzVkOTBlYzNiMzBhMl8wLTAtMS0xLTcwMjY1_607f3639-224a-4da3-9bca-ce6e1200faba">Delaware</ix:nonNumeric></span></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xL2ZyYWc6NjFiMmFlN2VmZGY0NDU1ODkxMDNkMzFkNzVhOGFmYjcvdGFibGU6Y2Q4M2YyNzEyZDc5NGEyMDk4OGM1ZDkwZWMzYjMwYTIvdGFibGVyYW5nZTpjZDgzZjI3MTJkNzk0YTIwOTg4YzVkOTBlYzNiMzBhMl8wLTMtMS0xLTcwMjY1_4c6e58aa-65cd-4a95-af64-268e3c5e9d27">26-0199180</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(I.R.S. Employer Identification No.)</span></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xL2ZyYWc6NjFiMmFlN2VmZGY0NDU1ODkxMDNkMzFkNzVhOGFmYjcvdGFibGU6Y2Q4M2YyNzEyZDc5NGEyMDk4OGM1ZDkwZWMzYjMwYTIvdGFibGVyYW5nZTpjZDgzZjI3MTJkNzk0YTIwOTg4YzVkOTBlYzNiMzBhMl8zLTAtMS0xLTcwMjY1_338bffcf-8b54-43d3-9142-9e8cebec83e8">900 Island Drive</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xL2ZyYWc6NjFiMmFlN2VmZGY0NDU1ODkxMDNkMzFkNzVhOGFmYjcvdGFibGU6Y2Q4M2YyNzEyZDc5NGEyMDk4OGM1ZDkwZWMzYjMwYTIvdGFibGVyYW5nZTpjZDgzZjI3MTJkNzk0YTIwOTg4YzVkOTBlYzNiMzBhMl8zLTEtMS0xLTcwMjY1_d79444cb-74bd-49a6-b72a-d9500dda7cab">Redwood City</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xL2ZyYWc6NjFiMmFlN2VmZGY0NDU1ODkxMDNkMzFkNzVhOGFmYjcvdGFibGU6Y2Q4M2YyNzEyZDc5NGEyMDk4OGM1ZDkwZWMzYjMwYTIvdGFibGVyYW5nZTpjZDgzZjI3MTJkNzk0YTIwOTg4YzVkOTBlYzNiMzBhMl8zLTItMS0xLTcwMjY1_8616a1ac-d669-4536-94c5-ff9fd262e048">CA</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xL2ZyYWc6NjFiMmFlN2VmZGY0NDU1ODkxMDNkMzFkNzVhOGFmYjcvdGFibGU6Y2Q4M2YyNzEyZDc5NGEyMDk4OGM1ZDkwZWMzYjMwYTIvdGFibGVyYW5nZTpjZDgzZjI3MTJkNzk0YTIwOTg4YzVkOTBlYzNiMzBhMl8zLTMtMS0xLTcwMjY1_469cc424-383b-48b6-b0b2-2deaec2fa2f2">94065</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address of Principal Executive Offices)</span></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Zip Code)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xL2ZyYWc6NjFiMmFlN2VmZGY0NDU1ODkxMDNkMzFkNzVhOGFmYjcvdGV4dHJlZ2lvbjo2MWIyYWU3ZWZkZjQ0NTU4OTEwM2QzMWQ3NWE4YWZiN18xOTgx_ff0f9ce7-c4ae-4d6e-960c-c437a19ee099">650</ix:nonNumeric>) <ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xL2ZyYWc6NjFiMmFlN2VmZGY0NDU1ODkxMDNkMzFkNzVhOGFmYjcvdGV4dHJlZ2lvbjo2MWIyYWU3ZWZkZjQ0NTU4OTEwM2QzMWQ3NWE4YWZiN18xOTc1_40bbb563-a622-49b4-b7d1-709d7f9e27f3">232-7200</ix:nonNumeric> </span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant's telephone number, including area code)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act: </span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.955%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.707%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xL2ZyYWc6NjFiMmFlN2VmZGY0NDU1ODkxMDNkMzFkNzVhOGFmYjcvdGFibGU6Yzc5NmQzNGE0MDE1NDg3MWE2YjI5NWZkODJlNTM3YzEvdGFibGVyYW5nZTpjNzk2ZDM0YTQwMTU0ODcxYTZiMjk1ZmQ4MmU1MzdjMV8xLTAtMS0xLTcwMjY1_b4d88d57-dda7-494a-a609-0d6e6af6059d">Common stock, $0.00001 par value per share</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xL2ZyYWc6NjFiMmFlN2VmZGY0NDU1ODkxMDNkMzFkNzVhOGFmYjcvdGFibGU6Yzc5NmQzNGE0MDE1NDg3MWE2YjI5NWZkODJlNTM3YzEvdGFibGVyYW5nZTpjNzk2ZDM0YTQwMTU0ODcxYTZiMjk1ZmQ4MmU1MzdjMV8xLTEtMS0xLTcwMjY1_b321cdd8-b9c9-481f-a10d-35936f9bf54c">PRCT</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xL2ZyYWc6NjFiMmFlN2VmZGY0NDU1ODkxMDNkMzFkNzVhOGFmYjcvdGFibGU6Yzc5NmQzNGE0MDE1NDg3MWE2YjI5NWZkODJlNTM3YzEvdGFibGVyYW5nZTpjNzk2ZDM0YTQwMTU0ODcxYTZiMjk1ZmQ4MmU1MzdjMV8xLTItMS0xLTcwMjY1_8da5c1f1-346d-4b6c-8b6c-f1e4f27d0556">Nasdaq Global Market</ix:nonNumeric></span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports); and (2) has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xL2ZyYWc6NjFiMmFlN2VmZGY0NDU1ODkxMDNkMzFkNzVhOGFmYjcvdGV4dHJlZ2lvbjo2MWIyYWU3ZWZkZjQ0NTU4OTEwM2QzMWQ3NWE4YWZiN18xOTgy_fe07d2ba-375b-4a58-b5e6-146bcb1bc2cc">Yes</ix:nonNumeric>&#160; &#9746;   No &#9744; </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically and posted on its corporate web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xL2ZyYWc6NjFiMmFlN2VmZGY0NDU1ODkxMDNkMzFkNzVhOGFmYjcvdGV4dHJlZ2lvbjo2MWIyYWU3ZWZkZjQ0NTU4OTEwM2QzMWQ3NWE4YWZiN18xOTc2_6acdede3-31bf-46c2-8b11-38022f123ffd">Yes</ix:nonNumeric>&#160;&#160;&#9746;&#160;&#160;&#160;No&#160;&#160;&#9744;&#160;</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer&#8221; and &#8220;smaller reporting company&#8221; in Rule 12b-2 of the Exchange Act. (Check one):</span></div><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:75.277%"><tr><td style="width:1.0%"></td><td style="width:31.925%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.213%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.633%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Large accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xL2ZyYWc6NjFiMmFlN2VmZGY0NDU1ODkxMDNkMzFkNzVhOGFmYjcvdGFibGU6Mjk2YTBkZDU1NzZhNDE4NDg0NzIxZjU5NTFmOWZiZjQvdGFibGVyYW5nZToyOTZhMGRkNTU3NmE0MTg0ODQ3MjFmNTk1MWY5ZmJmNF8xLTAtMS0xLTcwMjY1_5cab031a-ea61-4f72-a9ee-0c85eba3db6d">Non-accelerated filer</ix:nonNumeric>&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="dei:EntitySmallBusiness" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xL2ZyYWc6NjFiMmFlN2VmZGY0NDU1ODkxMDNkMzFkNzVhOGFmYjcvdGFibGU6Mjk2YTBkZDU1NzZhNDE4NDg0NzIxZjU5NTFmOWZiZjQvdGFibGVyYW5nZToyOTZhMGRkNTU3NmE0MTg0ODQ3MjFmNTk1MWY5ZmJmNF8xLTMtMS0xLTcwMjY1_d2b46026-a152-404d-9681-4b62c3ebd064">&#9746;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xL2ZyYWc6NjFiMmFlN2VmZGY0NDU1ODkxMDNkMzFkNzVhOGFmYjcvdGFibGU6Mjk2YTBkZDU1NzZhNDE4NDg0NzIxZjU5NTFmOWZiZjQvdGFibGVyYW5nZToyOTZhMGRkNTU3NmE0MTg0ODQ3MjFmNTk1MWY5ZmJmNF8yLTMtMS0xLTcwMjY1_efc6ae47-d4cd-4b1a-8b48-7067a419ce5c">&#9746;</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="dei:EntityExTransitionPeriod" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xL2ZyYWc6NjFiMmFlN2VmZGY0NDU1ODkxMDNkMzFkNzVhOGFmYjcvdGV4dHJlZ2lvbjo2MWIyYWU3ZWZkZjQ0NTU4OTEwM2QzMWQ3NWE4YWZiN18xOTc3_4ea4b270-e485-4738-b9d8-8241113736f8">&#9744;</ix:nonNumeric></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). &#160;&#160;&#160;&#160;Yes&#160;&#160;&#160;<ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xL2ZyYWc6NjFiMmFlN2VmZGY0NDU1ODkxMDNkMzFkNzVhOGFmYjcvdGV4dHJlZ2lvbjo2MWIyYWU3ZWZkZjQ0NTU4OTEwM2QzMWQ3NWE4YWZiN18xOTc4_1a70f48b-92f4-4f36-85d0-28fbe3b1b686">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160;&#160;No&#160;&#160;&#9746;</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The registrant had outstanding <ix:nonFraction unitRef="shares" contextRef="i5244b61f062c425cb72b630f1ffc25d3_I20220731" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xL2ZyYWc6NjFiMmFlN2VmZGY0NDU1ODkxMDNkMzFkNzVhOGFmYjcvdGV4dHJlZ2lvbjo2MWIyYWU3ZWZkZjQ0NTU4OTEwM2QzMWQ3NWE4YWZiN18xOTM2_8486343d-73cc-4daa-b9f4-f39b4e1c7450">44,592,286</ix:nonFraction> shares of common stock as of July 31, 2022.</span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div></div><div id="ibb2df456afff4355bae87af9d1240625_7"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROCEPT BioRobotics Corporation </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Form 10-Q &#8211; QUARTERLY REPORT </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Quarter Ended June&#160;30, 2022</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.714%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.675%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.311%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibb2df456afff4355bae87af9d1240625_13">Part I. Financial Information</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibb2df456afff4355bae87af9d1240625_16">Item 1.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibb2df456afff4355bae87af9d1240625_16">Condensed Consolidated Financial Statements (unaudited)</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibb2df456afff4355bae87af9d1240625_19">4</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibb2df456afff4355bae87af9d1240625_19">Condensed Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibb2df456afff4355bae87af9d1240625_19">4</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibb2df456afff4355bae87af9d1240625_22">Condensed Consolidated Statements of Operations and Comprehensive Loss</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibb2df456afff4355bae87af9d1240625_22">5</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibb2df456afff4355bae87af9d1240625_25">Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders&#8217; Equity (Deficit</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibb2df456afff4355bae87af9d1240625_25">6</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibb2df456afff4355bae87af9d1240625_25">Condensed Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibb2df456afff4355bae87af9d1240625_28">8</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibb2df456afff4355bae87af9d1240625_31">Notes to Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibb2df456afff4355bae87af9d1240625_31">9</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibb2df456afff4355bae87af9d1240625_61">Item 2.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibb2df456afff4355bae87af9d1240625_61">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibb2df456afff4355bae87af9d1240625_61">20</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibb2df456afff4355bae87af9d1240625_94">Item 3.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibb2df456afff4355bae87af9d1240625_94">Quantitative and Qualitative Disclosure About Market Risk</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibb2df456afff4355bae87af9d1240625_94">31</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibb2df456afff4355bae87af9d1240625_97">Item 4.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibb2df456afff4355bae87af9d1240625_97">Controls and Procedures</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibb2df456afff4355bae87af9d1240625_97">31</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibb2df456afff4355bae87af9d1240625_100">Part II. Other Information</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibb2df456afff4355bae87af9d1240625_103">Item 1.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibb2df456afff4355bae87af9d1240625_103">Legal Proceedings</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibb2df456afff4355bae87af9d1240625_103">33</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibb2df456afff4355bae87af9d1240625_106">Item 1A.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibb2df456afff4355bae87af9d1240625_106">Risk Factors</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibb2df456afff4355bae87af9d1240625_106">33</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibb2df456afff4355bae87af9d1240625_109">Item 2.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibb2df456afff4355bae87af9d1240625_109">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibb2df456afff4355bae87af9d1240625_109">33</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibb2df456afff4355bae87af9d1240625_109">Item 3.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibb2df456afff4355bae87af9d1240625_109">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibb2df456afff4355bae87af9d1240625_109">33</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibb2df456afff4355bae87af9d1240625_109">Item 4.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibb2df456afff4355bae87af9d1240625_109">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibb2df456afff4355bae87af9d1240625_109">33</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibb2df456afff4355bae87af9d1240625_109">Item 5.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibb2df456afff4355bae87af9d1240625_109">Other Information</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibb2df456afff4355bae87af9d1240625_109">33</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibb2df456afff4355bae87af9d1240625_121">Item 6.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibb2df456afff4355bae87af9d1240625_121">Exhibits</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibb2df456afff4355bae87af9d1240625_121">34</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibb2df456afff4355bae87af9d1240625_124">Signatures</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="ibb2df456afff4355bae87af9d1240625_10"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-bottom:9pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">                This Quarterly Report on Form 10-Q contains forward-looking statements. All statements other than statements of historical facts contained in this Quarterly Report are forward-looking statements. In some cases, you can identify forward-looking statements by terms such as &#8220;may,&#8221; &#8220;can&#8221;, &#8220;will,&#8221; &#8220;would,&#8221; &#8220;should,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;could,&#8221; &#8220;intend,&#8221; &#8220;target,&#8221; &#8220;project,&#8221; &#8220;contemplate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;predict,&#8221; &#8220;potential,&#8221; or &#8220;continue&#8221; or the negative of these terms or other similar expressions, although not all forward-looking statements contain these words. All statements other than statements of historical facts contained in this Quarterly Report, including without limitation statements regarding our business model and strategic plans for our products, technologies and business, including our implementation thereof, the impact on our business, financial condition and results of operations from the ongoing and global COVID-19 pandemic, or any other pandemic, epidemic or outbreak of an infectious disease in the United States or worldwide, the timing of and our ability to obtain and maintain regulatory approvals, our commercialization, marketing and manufacturing capabilities and strategy, our expectations about the commercial success and market acceptance of our products, the sufficiency of our cash, cash equivalents and short-term investments, and the plans and objectives of management for future operations and capital expenditures are forward-looking statements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">                The forward-looking statements in this Quarterly Report are only predictions and are based largely on our current expectations and projections about future events and trends that we believe may affect our financial condition, results of operations, business strategy, short-term and long-term business operations and objectives, and financial needs. These forward-looking statements speak only as of the date of this Quarterly Report and are subject to a number of known and unknown risks, uncertainties, and assumptions, including those described under the sections in this Quarterly Report entitled &#8220;Risk Factors&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and elsewhere in this Quarterly Report. Moreover, we operate in a very competitive and rapidly changing environment. New risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties, and assumptions, the future events and trends discussed in this Quarterly Report may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">                Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, you should not rely upon these forward-looking statements as predictions of future events. The events and circumstances reflected in the forward-looking statements may not be achieved or occur. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, performance, or achievements. Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise. We intend the forward-looking statements contained in this Quarterly Report to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and Section 21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;).</span></div><div style="margin-bottom:9pt;text-align:center"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="ibb2df456afff4355bae87af9d1240625_13"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-bottom:9pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div id="ibb2df456afff4355bae87af9d1240625_16"></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div id="ibb2df456afff4355bae87af9d1240625_19"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROCEPT BioRobotics Corporation</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except per share data)</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="margin-bottom:9pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNS0xLTEtMS03MDI2NQ_9296c4e4-8b8a-4f02-99ca-34b488c2721b">269,806</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNS0zLTEtMS03MDI2NQ_c182f508-e1ae-483a-8797-8f5ccab68eaf">304,320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNi0xLTEtMS03MDI2NQ_f6b8da85-66e0-4ea2-a4c3-d65b5cc3b9dd">10,894</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNi0zLTEtMS03MDI2NQ_5f457925-c24c-42b4-a710-a6520e18eccc">4,464</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNy0xLTEtMS03MDI2NQ_413311c2-85e0-46d4-a95a-050bf364a151">13,777</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNy0zLTEtMS03MDI2NQ_170e6b21-c5c6-49f3-9549-fd546e4b03a9">13,147</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfOC0xLTEtMS03MDI2NQ_021bd6c2-f792-4800-b550-07257b89fbfc">3,860</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfOC0zLTEtMS03MDI2NQ_20a6493e-7a2e-499c-bef4-8edabdb16617">4,242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfOS0xLTEtMS03MDI2NQ_fde3c172-d34e-4e00-a897-7d3f2fdd9ba0">298,337</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfOS0zLTEtMS03MDI2NQ_7d8715dd-7571-40c9-949a-fbbdec331a02">326,173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMTAtMS0xLTEtNzAyNjU_50366c0d-fa2e-4943-b929-f84d7552e6e8">3,814</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMTAtMy0xLTEtNzAyNjU_f6219d35-ae11-46a2-ace9-d7b4c342820f">777</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMTEtMS0xLTEtNzAyNjU_fa13d38d-8803-4892-912d-9acedd692399">4,397</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMTEtMy0xLTEtNzAyNjU_2b18e6eb-14c1-4a13-abb0-e5b97ac77b8c">5,045</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease right-of-use assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMTItMS0xLTEtNzAyNjU_c7ac8f8b-bb17-45e9-96d7-fd4b46aa3dbd">2,463</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMTItMy0xLTEtNzAyNjU_2e51967a-7a7c-4477-ac2d-f0518a851ba6">3,279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMTMtMS0xLTEtNzAyNjU_b774b6e5-ec2a-45fe-b290-20d31f006cca">1,614</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231" decimals="-3" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMTMtMy0xLTEtNzAyNjU_65801247-407c-40f8-b668-0686b5ac0fd8">1,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMTQtMS0xLTEtNzM3MTk_8a8769f3-8b43-4ba9-9a47-59a92c64e2ee">302</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMTQtMy0xLTEtNzM3MTc_32dbde0b-fea6-48dc-aa19-b222dfa784cf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMTUtMS0xLTEtNzAyNjU_37916014-cbe9-4a8b-9675-eebefc159c57">310,927</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMTUtMy0xLTEtNzAyNjU_58b28615-8f1f-4297-ac56-34d493ebf6db">337,024</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liabilities and Stockholders' Equity</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMTgtMS0xLTEtNzAyNjU_7606a82e-2a22-4d14-b452-ba898fe6d5be">3,342</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMTgtMy0xLTEtNzAyNjU_770fc02b-56d5-40b0-8c8e-868df6fb2af3">2,029</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="us-gaap:AccruedSalariesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMTktMS0xLTEtNzAyNjU_8bd42c68-d431-42d8-8b18-890557a560d2">6,906</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231" decimals="-3" name="us-gaap:AccruedSalariesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMTktMy0xLTEtNzAyNjU_1f32e072-1266-460b-b5e1-e18edcb745d7">6,475</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMjAtMS0xLTEtNzAyNjU_efc9de71-6310-41bf-b5f3-5683e2f8690a">1,863</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMjAtMy0xLTEtNzAyNjU_a51507ea-623d-4f5a-8a4d-c942a3fcb560">1,025</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease &#8211; current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMjItMS0xLTEtNzAyNjU_8da7a16c-d19a-45bd-9876-0bc27229eac0">2,258</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMjItMy0xLTEtNzAyNjU_a5eb1e3f-b70b-4e93-8d27-b968f191b5b3">2,105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMjQtMS0xLTEtNzAyNjU_03b46e8d-9b81-41c3-8887-8ee3e6d0776c">4,264</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMjQtMy0xLTEtNzAyNjU_c55bc481-6846-4a3c-8bf3-7733e45d604f">4,608</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMjUtMS0xLTEtNzAyNjU_85785637-3505-4c0c-86b7-87fbe4f7c384">18,633</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMjUtMy0xLTEtNzAyNjU_94dc9740-1168-4885-8f48-aae601c6a0e8">16,242</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Note payable &#8211; non-current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMjYtMS0xLTEtNzAyNjU_5b9579fc-e7e7-4029-bf4f-530fa1c92240">50,507</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMjYtMy0xLTEtNzAyNjU_2238d332-1cb7-4e8e-a72a-4d5895481563">50,004</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease &#8211; non-current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMjctMS0xLTEtNzAyNjU_fa1fc968-e683-4352-a7f7-06ee6f435128">829</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMjctMy0xLTEtNzAyNjU_6afc5e6d-f883-4480-b458-933b4c38bf20">1,991</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loan facility derivative liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="us-gaap:DerivativeLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMjgtMS0xLTEtNzAyNjU_4d1d861f-eadc-4529-b303-3c787cc1b4b0">1,570</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231" decimals="-3" name="us-gaap:DerivativeLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMjgtMy0xLTEtNzAyNjU_f1cb828b-5b3d-4a0a-be3d-c607e308ae86">1,496</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMzAtMS0xLTEtNzAyNjU_a3d01ecb-9887-4ffd-811e-b853a7199192">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMzAtMy0xLTEtNzAyNjU_1ed37ae3-bb6b-437b-a232-3d64d6f92476">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMzEtMS0xLTEtNzAyNjU_fe1cf0ad-58ad-47dd-981e-af56763ffce5">71,739</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMzEtMy0xLTEtNzAyNjU_d88cb429-8d7c-456c-b253-32344aa4d964">69,933</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commitments and contingencies (see Note 11)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMzItMS0xLTEtNzAyNjU_b8ff2f79-40a9-48d7-9f99-c8f826f302b0"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMzItMy0xLTEtNzAyNjU_d0c269df-d35b-4853-bf4a-127026e94e0f"></ix:nonFraction></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMzgtMC0xLTEtNzAyNjUvdGV4dHJlZ2lvbjo3NTlkYTdjYzg4NGI0MTQ2YTc4M2VmNzJhNDIyZWMwOF8yMQ_72efb2df-7534-4046-81c9-6621b10b8a7a"><ix:nonFraction unitRef="usdPerShare" contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMzgtMC0xLTEtNzAyNjUvdGV4dHJlZ2lvbjo3NTlkYTdjYzg4NGI0MTQ2YTc4M2VmNzJhNDIyZWMwOF8yMQ_b26c848d-cfc2-4d97-8c0d-84e83c2830b1">0.00001</ix:nonFraction></ix:nonFraction> par value;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Authorized shares: <ix:nonFraction unitRef="shares" contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMzktMC0xLTEtNzAyNjUvdGV4dHJlZ2lvbjozNTU3NzE1ZTVjMjI0N2IwOTExZGUxYmEwMTdhYjI3Nl8yMw_23a774f3-262a-49be-8f31-97e5a7f933e2"><ix:nonFraction unitRef="shares" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMzktMC0xLTEtNzAyNjUvdGV4dHJlZ2lvbjozNTU3NzE1ZTVjMjI0N2IwOTExZGUxYmEwMTdhYjI3Nl8yMw_42a38fc6-5bf5-4d07-992c-89f894d9c78f">10,000</ix:nonFraction></ix:nonFraction> at June&#160;30, 2022 and December&#160;31, 2021</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:33pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issued and outstanding shares: <ix:nonFraction unitRef="shares" contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNDAtMC0xLTEtNzAyNjUvdGV4dHJlZ2lvbjpkNDE2ODhkNmJhMGE0OTQxOTBiYjgwZjE2MDgyZDUxNl8zNQ_3c007f0a-6136-4bed-9958-12520ca669f5"><ix:nonFraction unitRef="shares" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNDAtMC0xLTEtNzAyNjUvdGV4dHJlZ2lvbjpkNDE2ODhkNmJhMGE0OTQxOTBiYjgwZjE2MDgyZDUxNl8zNQ_6b69a422-fa46-4ca7-9d97-68b301babbc1"><ix:nonFraction unitRef="shares" contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNDAtMC0xLTEtNzAyNjUvdGV4dHJlZ2lvbjpkNDE2ODhkNmJhMGE0OTQxOTBiYjgwZjE2MDgyZDUxNl8zNQ_bdd275b6-0e4f-4ec1-852c-fc5a7be0c30f"><ix:nonFraction unitRef="shares" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNDAtMC0xLTEtNzAyNjUvdGV4dHJlZ2lvbjpkNDE2ODhkNmJhMGE0OTQxOTBiYjgwZjE2MDgyZDUxNl8zNQ_fbb4dee5-1039-4508-93b8-a70e039b8f2d">none</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> at June&#160;30, 2022 and December&#160;31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNDAtMS0xLTEtNzAyNjU_da56874a-8947-48ad-b2a2-965f272900e7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNDAtMy0xLTEtNzAyNjU_4c879951-aa2d-4248-ab10-5ebaaee95e2a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNDEtMC0xLTEtNzAyNjUvdGV4dHJlZ2lvbjozYjRiZDNhOWZkOTk0YWMzODUxYzY3OTFkNTU2ZWQ5M18xOA_47caacac-6050-4fcd-9dce-14ad23034392"><ix:nonFraction unitRef="usdPerShare" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNDEtMC0xLTEtNzAyNjUvdGV4dHJlZ2lvbjozYjRiZDNhOWZkOTk0YWMzODUxYzY3OTFkNTU2ZWQ5M18xOA_5f3c6f7b-cf9e-41fb-b515-28e25b1158a3">0.00001</ix:nonFraction></ix:nonFraction> par value;</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Authorized shares: <ix:nonFraction unitRef="shares" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNDItMC0xLTEtNzAyNjUvdGV4dHJlZ2lvbjozYjBjOWZkOWZhYzM0MjNiYTY5MTRkMGNhNWUyYjc5YV8yMw_01d221fe-9f60-494e-b3c1-aed245e5de0e"><ix:nonFraction unitRef="shares" contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNDItMC0xLTEtNzAyNjUvdGV4dHJlZ2lvbjozYjBjOWZkOWZhYzM0MjNiYTY5MTRkMGNhNWUyYjc5YV8yMw_c5f3f683-828e-410e-8b36-02c36d8468f7">300,000</ix:nonFraction></ix:nonFraction> at June&#160;30, 2022 and December&#160;31, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issued and outstanding shares: <ix:nonFraction unitRef="shares" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNDMtMC0xLTEtNzAyNjUvdGV4dHJlZ2lvbjoyNWNkOWM0OTI3NTA0MGM3ODk5MDQyODhkYzBmMWYzM18zNQ_ba7363c0-0f27-488e-8729-7bdfc0737916"><ix:nonFraction unitRef="shares" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNDMtMC0xLTEtNzAyNjUvdGV4dHJlZ2lvbjoyNWNkOWM0OTI3NTA0MGM3ODk5MDQyODhkYzBmMWYzM18zNQ_db3fa824-d7ee-4e3a-b836-d673b36a84f4">44,538</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNDMtMC0xLTEtNzAyNjUvdGV4dHJlZ2lvbjoyNWNkOWM0OTI3NTA0MGM3ODk5MDQyODhkYzBmMWYzM180Mg_16708785-a482-4b7e-951b-28d3c7a64524"><ix:nonFraction unitRef="shares" contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNDMtMC0xLTEtNzAyNjUvdGV4dHJlZ2lvbjoyNWNkOWM0OTI3NTA0MGM3ODk5MDQyODhkYzBmMWYzM180Mg_719d2b25-e946-4323-92b7-62d9081fc433">43,676</ix:nonFraction></ix:nonFraction> at June&#160;30, 2022 and December&#160;31, 2021, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNDMtMS0xLTEtNzAyNjU_a1a6461f-408f-4d7f-9d67-a5d9d6d79d4c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNDMtMy0xLTEtNzAyNjU_abae91aa-d6da-443f-a7c2-5a59176bd715">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNDQtMS0xLTEtNzAyNjU_abe2bca7-229e-449c-bfcd-e9e4ed25bc7d">537,046</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNDQtMy0xLTEtNzAyNjU_fb96cd37-190e-47b5-aedf-0d163583fe02">528,666</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNDUtMS0xLTEtNzAyNjU_b393c640-ef43-4af8-912c-98c2029d1b59">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNDUtMy0xLTEtNzAyNjU_cb3e5deb-1efe-4d74-9215-accebbcf890d">54</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNDYtMS0xLTEtNzAyNjU_664252a8-0861-4f26-9ef8-2af1d3348d29">297,890</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNDYtMy0xLTEtNzAyNjU_7361e6be-8513-4ee0-9b48-adcff11411b9">261,521</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNDctMS0xLTEtNzAyNjU_7ea5009b-c02d-405d-9c79-5db7dc62144b">239,188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNDctMy0xLTEtNzAyNjU_bf317005-5830-4d7f-976a-f3ba7596f970">267,091</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNDgtMS0xLTEtNzAyNjU_173895dc-f9a7-4d3a-9112-ac325e444f2d">310,927</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNDgtMy0xLTEtNzAyNjU_19c3b112-2828-4ef7-b6fa-1f8a03d17a36">337,024</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements. </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="ibb2df456afff4355bae87af9d1240625_22"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROCEPT BioRobotics Corporation</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except per share data)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMy0xLTEtMS03MDI2NQ_38d02606-f4ca-4ff5-aa9d-49f7ccbd2429">16,691</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMy0zLTEtMS03MDI2NQ_83aa9075-bd45-4c60-ba0a-4ba2baaad9ba">8,476</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMy01LTEtMS03MDI2NQ_7a7665da-b0bd-4c61-888b-c4a237456f90">30,888</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMy03LTEtMS03MDI2NQ_3ffdeec1-d38e-4217-8174-87adacfb3afb">15,668</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfNC0xLTEtMS03MDI2NQ_4326534f-b06b-466e-a8bc-c3e171d4cafe">8,205</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfNC0zLTEtMS03MDI2NQ_fb148d27-81e8-4161-99e5-913c2bd06e0a">4,893</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfNC01LTEtMS03MDI2NQ_b045ad61-2f75-42b0-b4b0-d3d7482086cb">14,710</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfNC03LTEtMS03MDI2NQ_dee37060-b457-4943-b525-ba2e86ae39cd">8,558</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfNS0xLTEtMS03MDI2NQ_cf4a511a-3cbb-471b-bc8f-689dd10bfe5a">8,486</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfNS0zLTEtMS03MDI2NQ_41edc136-a24c-4020-8c29-e8f1a05bdf79">3,583</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfNS01LTEtMS03MDI2NQ_ae2af8c4-759b-4f32-9965-1954b63a2cf0">16,178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfNS03LTEtMS03MDI2NQ_b7bb89e0-28bb-48ac-97b1-11397a327543">7,110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfNy0xLTEtMS03MDI2NQ_0cc23686-dcd4-408c-b1d0-34e8f4742a8c">6,706</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfNy0zLTEtMS03MDI2NQ_b0269cb8-e055-4fd5-aceb-1328593484b5">4,476</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfNy01LTEtMS03MDI2NQ_aec87159-c10a-46ad-8d79-96280351a8f5">11,717</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfNy03LTEtMS03MDI2NQ_de05e74d-ab42-4d7f-87f7-0ff0596c2692">8,998</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfOC0xLTEtMS03MDI2NQ_0e97e354-3227-4ce9-8ac0-2416282c2f08">19,655</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfOC0zLTEtMS03MDI2NQ_488582b5-ca80-4e11-97f6-c4418337c449">12,299</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfOC01LTEtMS03MDI2NQ_6c4a377e-fae6-4fda-a638-7bdf152d89f4">38,040</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfOC03LTEtMS03MDI2NQ_139d2bd8-5a15-482f-8a6c-5a955a473136">22,648</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfOS0xLTEtMS03MDI2NQ_0f692937-716c-45ff-bbc3-993c67d539c6">26,361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfOS0zLTEtMS03MDI2NQ_c1f6d9f7-c3f5-455d-86c7-ee32e5d6d2b9">16,775</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfOS01LTEtMS03MDI2NQ_182122dc-c432-4c9f-b28b-e9ab5c46e607">49,757</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfOS03LTEtMS03MDI2NQ_4bcde7ed-fd5b-44b7-a37d-b0b3b1f3e501">31,646</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTAtMS0xLTEtNzAyNjU_89591113-f57e-4fa9-b24a-480959ee41cc">17,875</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTAtMy0xLTEtNzAyNjU_e737395b-6826-42be-bf54-eaaa2b338cfa">13,192</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTAtNS0xLTEtNzAyNjU_086e633d-8e1a-4090-a096-7805f81a359d">33,579</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTAtNy0xLTEtNzAyNjU_30ac1419-7195-46e9-bde4-738a74cf89d2">24,536</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTEtMS0xLTEtNzAyNjU_19b49b68-3afa-418f-809b-998545d4413e">1,441</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTEtMy0xLTEtNzAyNjU_91263a00-811d-45fc-96d0-773999996db7">1,436</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTEtNS0xLTEtNzAyNjU_428c6db9-e750-4b69-91c4-5fbc06d86c98">2,862</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTEtNy0xLTEtNzAyNjU_eac76267-605f-4fc2-a35c-9ba227211b72">2,900</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630" decimals="-3" name="prct:InterestAndOtherIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTItMS0xLTEtNzAyNjU_c96e35db-6a58-4718-9e84-2629de014f20">132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630" decimals="-3" name="prct:InterestAndOtherIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTItMy0xLTEtNzAyNjU_349c3211-a61a-444f-9b12-58b09cbf316c">48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" decimals="-3" name="prct:InterestAndOtherIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTItNS0xLTEtNzAyNjU_b611c75c-c69c-4212-beff-957d73237378">72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630" decimals="-3" name="prct:InterestAndOtherIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTItNy0xLTEtNzAyNjU_51445451-b0f8-43f6-9137-20154b3358be">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTMtMS0xLTEtNzAyNjU_91d90ed2-fc99-4f47-8a40-b45c1fc16cf2"><ix:nonFraction unitRef="usd" contextRef="i4eeb8d5fbaa443cfb4b403f6bf784110_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTMtMS0xLTEtNzAyNjU_e78c383b-eeb7-4cad-854f-9704ee3c0144">19,184</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTMtMy0xLTEtNzAyNjU_ffe67fac-e0e9-43f6-ac6f-d999dd0b9b21">14,580</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTMtNS0xLTEtNzAyNjU_81839024-b6fd-4fbf-a9c7-59a0ee237f7c">36,369</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTMtNy0xLTEtNzAyNjU_76597fa9-f7e1-4198-9844-82dc4325e151">27,402</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share, basic and diluted</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTQtMS0xLTEtNzAyNjU_a66ef6ea-5f36-4dba-8fca-8caf1d6a3155"><ix:nonFraction unitRef="usdPerShare" contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTQtMS0xLTEtNzAyNjU_e3f896e7-cc04-48db-85f4-a38a78e7caea">0.43</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTQtMy0xLTEtNzAyNjU_8199ac9f-19ae-4c99-8ebf-6f7c4f00162e"><ix:nonFraction unitRef="usdPerShare" contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTQtMy0xLTEtNzAyNjU_972260d4-4ee1-48cd-bd02-04cf91767c60">2.60</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTQtNS0xLTEtNzAyNjU_45a2bb4d-1575-4a16-9b59-ff61c5f7206d"><ix:nonFraction unitRef="usdPerShare" contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTQtNS0xLTEtNzAyNjU_8e87b738-7f24-476f-b586-d16883f38e51">0.82</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTQtNy0xLTEtNzAyNjU_45792bbf-c4f9-4460-a8a2-ab6354b498b5"><ix:nonFraction unitRef="usdPerShare" contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTQtNy0xLTEtNzAyNjU_5017b47b-d6b4-44e3-8c83-cc7e589de302">5.25</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares used to</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">compute net loss per share attributable to</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">common shareholders, basic and diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTctMS0xLTEtNzAyNjU_65f36532-fa22-441b-a78e-be19a1f1cb7a"><ix:nonFraction unitRef="shares" contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTctMS0xLTEtNzAyNjU_b12930c7-8fb3-42a7-a478-b07082351f3d">44,324</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTctMy0xLTEtNzAyNjU_2caf95eb-bf27-45b3-9325-19432e3642f5"><ix:nonFraction unitRef="shares" contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTctMy0xLTEtNzAyNjU_8606a51f-480a-4f62-87a3-64072fc20934">5,597</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTctNS0xLTEtNzAyNjU_12c40465-6fa1-4805-bb0e-09cdafb643ce"><ix:nonFraction unitRef="shares" contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTctNS0xLTEtNzAyNjU_76734d8a-db16-4bfd-8258-053b769bb979">44,091</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTctNy0xLTEtNzAyNjU_47f3cacd-b344-4608-acfd-d6ed519a2c32"><ix:nonFraction unitRef="shares" contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTctNy0xLTEtNzAyNjU_67d7feb5-abc3-492c-ad2b-8ef4074114cf">5,216</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain (loss) on cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTktMS0xLTEtNzAyNjU_f0142852-1395-44fa-a538-e595d323a780">85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTktMy0xLTEtNzAyNjU_39546480-9a97-4602-b40d-fa4f618e465a">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTktNS0xLTEtNzAyNjU_bbfa17f7-13a9-4ad8-9c24-7dea077cfcff">87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTktNy0xLTEtNzAyNjU_3dcb7826-fcf3-41e2-8ade-2c4c2a00e123">25</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMjAtMS0xLTEtNzAyNjU_cc94ce8e-b77b-4121-a72d-65de0286e25d">19,099</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMjAtMy0xLTEtNzAyNjU_cb978065-59d5-4f77-a2e8-b155ba453333">14,589</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMjAtNS0xLTEtNzAyNjU_f871bc66-0b81-44e9-8b7d-90ca0740af31">36,282</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMjAtNy0xLTEtNzAyNjU_d797ed9f-c1c9-4b1a-bc6e-7bf9c27a004d">27,427</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="ibb2df456afff4355bae87af9d1240625_25"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROCEPT BioRobotics Corporation</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&#8217; EQUITY (DEFICIT) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)  </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)  </span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.705%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.844%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.844%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.262%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.844%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.844%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.381%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.043%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.770%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.129%"></td><td style="width:0.1%"></td></tr><tr style="height:27pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Redeemable<br/>Convertible<br/>Preferred Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Stockholders'<br/>Equity<br/>(Deficit)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231" decimals="-3" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMi0xLTEtMS03MDI2NQ_5ea86bd5-b4ea-4f04-924b-3a433e3a9de3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMi0zLTEtMS03MDI2NQ_af06cebf-a711-4cd3-a732-c14e764c6cce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9585d1c54a684663894a7893b7489c39_I20211231" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMi02LTEtMS03MDI2NQ_2d852064-77ca-4cda-bb43-a278a1f280dd">43,676</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9585d1c54a684663894a7893b7489c39_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMi04LTEtMS03MDI2NQ_ef58509d-c103-464d-9fac-ea02b30bfa60">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2247db1a4a2640a299b416b33a688b7c_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMi0xMC0xLTEtNzAyNjU_78f147eb-9bcb-4df7-9e3d-d9cbf1f177c8">528,666</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1defffe1f1964d89826a5865f9c988a5_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMi0xMi0xLTEtNzAyNjU_e2c81c9b-5fb9-4785-9285-c97f9be5b826">54</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4f83ee6a840d4fcf9011375d58625785_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMi0xNC0xLTEtNzAyNjU_3e200035-c1dd-4d3d-b7b0-062ba19d983f">261,521</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMi0xNi0xLTEtNzAyNjU_998dc614-367a-4c79-9655-d8324f29ebc3">267,091</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance upon exercise of options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i01886b412db145e0a0a2fe5ced6a37b3_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMy02LTEtMS03MDI2NQ_b2245320-cf0c-4bb2-bcac-46aea4a9e107">401</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e567fde435a43809f3e7db528da3c7d_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMy0xMC0xLTEtNzAyNjU_b148999f-dbd8-460c-9752-7d0f22d0846f">1,291</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5536a0a58c9e43a89b71f9c8d5fde9db_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMy0xNi0xLTEtNzAyNjU_f6082ef4-e05f-41fb-9f8e-3510eb52490b">1,291</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e567fde435a43809f3e7db528da3c7d_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfNC0xMC0xLTEtNzAyNjU_a8135c1e-67da-40e9-8ed7-b46cc81b517b">1,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5536a0a58c9e43a89b71f9c8d5fde9db_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfNC0xNi0xLTEtNzAyNjU_c4c31b69-8337-4356-ae5e-9f6abd23b7fa">1,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain on cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib49ef5b808cc4ce58c5c2146e6a4a872_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfNS0xMi0xLTEtNzAyNjU_45b7aa5d-e8f1-4b39-87bc-63e26a23eb68">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5536a0a58c9e43a89b71f9c8d5fde9db_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfNS0xNi0xLTEtNzAyNjU_2d6d7655-8441-458e-a6e0-d5e89214e1cf">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idbe9cd2e7c184e5f9f1b6182c72c33bc_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfNi0xNC0xLTEtNzAyNjU_89a1829e-04e0-451a-ac32-dd27a0ca5664">17,185</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5536a0a58c9e43a89b71f9c8d5fde9db_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfNi0xNi0xLTEtNzAyNjU_d0331936-575e-4049-9474-f5a9e93b4fd9">17,185</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4a5f8472ee434d169dea6396cc0d2243_I20220331" decimals="-3" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMTYtMS0xLTEtNzAyNjU_1199769e-308a-4a96-ad9a-0974634ba19b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a5f8472ee434d169dea6396cc0d2243_I20220331" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMTYtMy0xLTEtNzAyNjU_fe8f1b90-2b5c-4de4-b8c0-237a88478ed7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic8e0d0a6ea974a85bc5c95e8ea39af53_I20220331" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMTYtNi0xLTEtNzAyNjU_e530b129-f1a8-4fb5-b323-ea0a246567aa">44,077</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8e0d0a6ea974a85bc5c95e8ea39af53_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMTYtOC0xLTEtNzAyNjU_ce5fd89b-fdc2-49fb-8b97-ad8e0c8f38d0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d726aec89c84cdfacf0dd37b1b7db33_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMTYtMTAtMS0xLTcwMjY1_7623538b-419c-49f3-b12f-7034507257c3">531,509</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie3c71862037247eaab3a9d37ea5de5f9_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMTYtMTItMS0xLTcwMjY1_b1af74e6-d58c-4cb9-8491-d56ec32a510c">53</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3fc05616d7449288a6f5900e51f12cd_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMTYtMTQtMS0xLTcwMjY1_e2fc3d5e-ea38-47a7-b606-e685fc17129e">278,706</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a5f8472ee434d169dea6396cc0d2243_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMTYtMTYtMS0xLTcwMjY1_34b84b10-2f63-4571-9fb1-439ac8d6584c">252,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance upon exercise of options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if60434966ba04e68bb10f89d746d9c71_D20220401-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMTItNi0xLTEtNzA2MzI_974c47f7-c32d-44a9-9a43-78b6fe682a7b">400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id69d7c117e41411bb58321abe66da977_D20220401-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMTItMTAtMS0xLTcwNjMy_66aa6a4f-e46b-416b-ac8a-6cc55b145981">1,572</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMTItMTYtMS0xLTcwNjMy_6d7c7bf5-695d-47c1-b2b2-5cb728dad7ab">1,572</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued under employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if60434966ba04e68bb10f89d746d9c71_D20220401-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMTMtNi0xLTEtNzQ3MzA_4dab4047-ac74-42ab-a375-b347bbd640e8">61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id69d7c117e41411bb58321abe66da977_D20220401-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMTMtMTAtMS0xLTc0NzMw_e6695b0f-044a-4a9b-8987-006ed1d65ab3">1,289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMTMtMTYtMS0xLTc0NzMw_4968ba88-1383-4e6c-90d1-d7ac4e8a6123">1,289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id69d7c117e41411bb58321abe66da977_D20220401-20220630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMTMtMTAtMS0xLTcwNjMy_9a6ad399-90c4-40d5-941f-f8223d36fa8d">2,676</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMTMtMTYtMS0xLTcwNjMy_da8c8c5a-19d5-490d-97ed-48f1a3b5a828">2,676</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain on cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e81cc1babd944fca585586deb7d643a_D20220401-20220630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMTctMTItMS0xLTcwMjY1_dadb3e43-065c-4c62-95ba-aac674b9e050">85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMTctMTYtMS0xLTcwMjY1_47f8dc22-01b3-4344-9af9-aebf3d803c53">85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4eeb8d5fbaa443cfb4b403f6bf784110_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMTgtMTQtMS0xLTcwMjY1_9576bcd6-5111-4c95-9c35-5f96b4b295cd">19,184</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMTgtMTYtMS0xLTcwMjY1_43085164-18a0-4339-b6e6-0a4fc642dd13">19,184</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMTktMS0xLTEtNzAyNjU_c81ec783-565a-4a91-99a4-c86577ed92a5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMTktMy0xLTEtNzAyNjU_cbdabefc-4c2d-4afe-a1e4-27cbbabc1711">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i627bfed199d449d8b9f34ce309b5b446_I20220630" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMTktNi0xLTEtNzAyNjU_b5daaff5-f8a0-4ac4-9b76-d261bd30feba">44,538</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i627bfed199d449d8b9f34ce309b5b446_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMTktOC0xLTEtNzAyNjU_657c33b8-4f0c-42d0-94a3-890354d0e108">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24963d2b7ff64b7ea5ae30aef83c1ab2_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMTktMTAtMS0xLTcwMjY1_026d9e7a-cb98-41e5-9dd6-cf1e771ea362">537,046</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4d8b1368e44cf78783a263b8dad765_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMTktMTItMS0xLTcwMjY1_1e8d2bd2-fc2e-4104-a1f5-489f8fdf2cb4">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a939982b2f54db8a27e8f371521eb89_I20220630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMTktMTQtMS0xLTcwMjY1_08d186da-d6ab-40aa-93e5-4b2e855f94e2">297,890</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMTktMTYtMS0xLTcwMjY1_62d9c745-be13-4794-9421-2af1ab1b06c9">239,188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="margin-bottom:9pt;text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROCEPT BioRobotics Corporation</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&#8217; EQUITY (DEFICIT) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)  </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited) </span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.705%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.844%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.844%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.262%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.844%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.844%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.381%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.043%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.770%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.129%"></td><td style="width:0.1%"></td></tr><tr style="height:27pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Redeemable<br/>Convertible<br/>Preferred Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Stockholders'<br/>Equity<br/>(Deficit)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icbfd320e5dd848119b7bdb3871172b7a_I20201231" decimals="-3" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMi0xLTEtMS03MDY0MQ_18c08f87-af14-41a6-8bfa-780a751adfd9">25,402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbfd320e5dd848119b7bdb3871172b7a_I20201231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMi0zLTEtMS03MDY0MQ_3de8be86-cec3-433d-bd0f-eeb0fc70e5cd">243,854</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i14cbbd3f6b274b5b9fb32f03421ac7b6_I20201231" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMi02LTEtMS03MDY0MQ_8297824c-3612-465f-ac53-68c28a57f572">4,713</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14cbbd3f6b274b5b9fb32f03421ac7b6_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMi04LTEtMS03MDY0MQ_6b3b2394-35ab-4402-8b92-3ba31a0bba20">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i282fabdbdaff4996a0ac69a7bc75b9b8_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMi0xMC0xLTEtNzA2NDE_5cf5a0c6-73c6-4cf7-80cf-19832e8865fc">18,788</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5288075d3e6407caf4a41af1e03bf62_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMi0xMi0xLTEtNzA2NDE_76e24612-ae6e-4a62-96de-2f4f9ea4abaf">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic1f38e11fe9a410499fe555213ca38f8_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMi0xNC0xLTEtNzA2NDE_194733be-28c8-46f6-b4df-17a81ab22469">201,668</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icbfd320e5dd848119b7bdb3871172b7a_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMi0xNi0xLTEtNzA2NDE_22b62c96-ccff-4ba9-959c-77e68d9b89d8">182,894</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance upon exercise of options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i28c750db7e8b493c961a7d62d4a754ad_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMy02LTEtMS03MDY0MQ_21d57cb8-dc5e-411b-babc-b681e4c13fdd"><ix:nonFraction unitRef="shares" contextRef="i28c750db7e8b493c961a7d62d4a754ad_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMy02LTEtMS03MDY0MQ_e7feec4c-489e-4d80-9048-18ae3bb0e00f">504</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5f544032b4ef4a2f76f6a6f973e06_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMy0xMC0xLTEtNzA2NDE_0de7cc78-555f-4294-aa3c-0c608c7f7daa"><ix:nonFraction unitRef="usd" contextRef="i7fe5f544032b4ef4a2f76f6a6f973e06_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMy0xMC0xLTEtNzA2NDE_a20a176c-cc16-4586-8dfe-b7fc1c460fb5">1,225</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee47d851f3042aaaf707d3b82004294_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMy0xNi0xLTEtNzA2NDE_146e532c-8a12-4a70-ab2e-1ceafb89023d"><ix:nonFraction unitRef="usd" contextRef="i5ee47d851f3042aaaf707d3b82004294_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMy0xNi0xLTEtNzA2NDE_31d3f15b-6434-4060-986f-19fdc54c90d7">1,225</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5f544032b4ef4a2f76f6a6f973e06_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfNC0xMC0xLTEtNzA2NDE_2d7efedb-f749-4cc2-a1e2-0da9b179a77b"><ix:nonFraction unitRef="usd" contextRef="i7fe5f544032b4ef4a2f76f6a6f973e06_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfNC0xMC0xLTEtNzA2NDE_403e4cd4-0ba0-4fdc-b1bf-76fe0a87a638">650</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee47d851f3042aaaf707d3b82004294_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfNC0xNi0xLTEtNzA2NDE_07b7aac0-6e42-4fc7-8df7-5d5069fd058d"><ix:nonFraction unitRef="usd" contextRef="i5ee47d851f3042aaaf707d3b82004294_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfNC0xNi0xLTEtNzA2NDE_15eaa27d-eac8-431a-927d-9fad5f148108">650</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized loss on cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iea9c042e07264772b04308a25e550340_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfNS0xMi0xLTEtNzA2NDE_1b17c774-79fa-42a6-a1b2-096b8bceb2ae"><ix:nonFraction unitRef="usd" contextRef="iea9c042e07264772b04308a25e550340_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfNS0xMi0xLTEtNzA2NDE_a2e2db64-6552-4ee0-8430-695c5926786b">16</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ee47d851f3042aaaf707d3b82004294_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfNS0xNi0xLTEtNzA2NDE_074b3406-f636-4f55-ad79-0cda8c4fb39a"><ix:nonFraction unitRef="usd" contextRef="i5ee47d851f3042aaaf707d3b82004294_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfNS0xNi0xLTEtNzA2NDE_380ef97d-7aa9-49ab-be61-a110d29aa8d9">16</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b181e472b094adbad522e89a97c3965_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfNi0xNC0xLTEtNzA2NDE_00e294bd-11f5-42a7-8c94-b5355b2b3d4c"><ix:nonFraction unitRef="usd" contextRef="i7b181e472b094adbad522e89a97c3965_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfNi0xNC0xLTEtNzA2NDE_c02ba51e-dac8-471d-9a8f-c15ce6cda549">12,822</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ee47d851f3042aaaf707d3b82004294_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfNi0xNi0xLTEtNzA2NDE_cb9dc1e5-2329-436b-8c1f-e59bb80d669a"><ix:nonFraction unitRef="usd" contextRef="i5ee47d851f3042aaaf707d3b82004294_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfNi0xNi0xLTEtNzA2NDE_f4a4e2f1-1946-4c33-8206-3d5f9e8b0594">12,822</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i94b26e0dbca84b9b8524e15573d9bf33_I20210331" decimals="-3" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMTEtMS0xLTEtNzA2NDE_0744c57f-6780-4d1d-9169-c53cc6ca3c62">25,402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94b26e0dbca84b9b8524e15573d9bf33_I20210331" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMTEtMy0xLTEtNzA2NDE_93052095-76b5-446d-9502-3201e3345963">243,854</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iac576b608667443aad04c57beda563ac_I20210331" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMTEtNi0xLTEtNzA2NDE_1f3a2704-8e64-4db4-be11-3b36bca7b458">5,217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac576b608667443aad04c57beda563ac_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMTEtOC0xLTEtNzA2NDE_2242fa93-6a2d-4733-8530-dd931406816d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc468ed15de4a9d97e08aa2fbe09c34_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMTEtMTAtMS0xLTcwNjQx_2cd069bd-ead1-4632-ae60-5cc7a59fc1d2">20,663</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied0b777dba264312b4d74af5c79a0cb3_I20210331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMTEtMTItMS0xLTcwNjQx_1a601ea7-60e8-42e7-9556-4987b51bc04c">30</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6966f0a91417487ba500b6d3df3fcc46_I20210331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMTEtMTQtMS0xLTcwNjQx_ab91de7c-b82f-40f5-a808-0c54327044f3">214,490</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94b26e0dbca84b9b8524e15573d9bf33_I20210331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMTEtMTYtMS0xLTcwNjQx_504dfb3e-032f-4417-b6aa-ef6748295a86">193,857</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of preferred stock, net of issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630" decimals="-3" name="prct:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMTItMS0xLTEtNzA5ODQ_b9424985-08d2-4526-9b7d-77a4257c26bc">4,448</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630" decimals="-3" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMTItMy0xLTEtNzA5ODQ_ea75dcb9-f852-4c15-8f5e-ba60dfd77fea">84,710</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance upon exercise of options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8722cf471d0a4e458baade237a5960c6_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMTItNi0xLTEtNzA2NDE_5b095172-fe01-4c02-abb7-5c9edbc2efae">575</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i727054a48db344dc84054f19179656ea_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMTItMTAtMS0xLTcwNjQx_237b9a17-de09-4861-aa9f-2e0ad4235267">1,415</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMTItMTYtMS0xLTcwNjQx_de612158-558c-4f50-928e-c45c904d21a2">1,415</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i727054a48db344dc84054f19179656ea_D20210401-20210630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMTMtMTAtMS0xLTcwNjQx_b027704f-6376-49ff-b632-792f91eec4b5">725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMTMtMTYtMS0xLTcwNjQx_260c4ac5-bae0-4733-afbd-d00b416503a0">725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized loss on cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i38e5e80513f848e596aad02407f696f7_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMTQtMTItMS0xLTcwNjQx_ad2e211d-885f-474d-86e4-05efba42aa1f">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMTQtMTYtMS0xLTcwNjQx_4405eb56-f77f-4660-8f93-f6c1eb653aff">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia737ca5e401d4e1898b0e48e1bb51d05_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMTUtMTQtMS0xLTcwNjQx_04719ff5-8d96-4472-9f1d-39a375799bc5">14,580</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMTUtMTYtMS0xLTcwNjQx_c1b7be8a-8d8b-4340-8a6f-600edec4d3e5">14,580</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0a06654ca8fc49a0aaed81f85663e69f_I20210630" decimals="-3" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMTYtMS0xLTEtNzA2NDE_9ef395d3-e3b2-4325-a8e1-ac5689d83823">29,850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a06654ca8fc49a0aaed81f85663e69f_I20210630" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMTYtMy0xLTEtNzA2NDE_d8f5a1b8-e2dc-4a20-a2dd-cc6fb52c7459">328,564</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic2228949c5a34355af819610f5c3e6c7_I20210630" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMTYtNi0xLTEtNzA2NDE_96eae6a0-4368-42fd-989e-b582f89c6dbd">5,792</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2228949c5a34355af819610f5c3e6c7_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMTYtOC0xLTEtNzA2NDE_85c87891-015c-4a03-ac78-2df9e9f9bdcd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67e7f282b71d4074a19bfe3304779fce_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMTYtMTAtMS0xLTcwNjQx_98a215f4-bfc9-4960-b25c-3e21c80faf75">22,803</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9dfc04e8f5654c70a7bd05c9b50882c4_I20210630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMTYtMTItMS0xLTcwNjQx_c6634834-7f92-4311-bde4-3b7724777da5">39</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8591f6f61272452cb59c7b8fd943a9f0_I20210630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMTYtMTQtMS0xLTcwNjQx_e0f28684-0629-4946-b49c-3eba5cb4fd23">229,070</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0a06654ca8fc49a0aaed81f85663e69f_I20210630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMTYtMTYtMS0xLTcwNjQx_f5f67fa2-ecca-4306-af46-bfcc4390e6fa">206,306</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="ibb2df456afff4355bae87af9d1240625_28"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:9pt"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROCEPT BioRobotics Corporation</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited) </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Six Months Ended June 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfNC0xLTEtMS03MDI2NQ_e3fa9342-9e50-45b8-b617-4e0b4dbe40a8">36,369</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfNC0zLTEtMS03MDI2NQ_8b25b6da-f3a8-4d4a-b7b6-94097822d5d5">27,402</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Adjustments to reconcile net loss to cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfNi0xLTEtMS03MDI2NQ_95c39d9c-d262-4717-bb83-befdb997267d">1,475</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfNi0zLTEtMS03MDI2NQ_f8927ca8-ebf4-42e6-b332-b65faa6a8594">1,765</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfNy0xLTEtMS03MDI2NQ_d246b2d8-fb26-4086-bd19-18f59723b69b">4,228</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfNy0zLTEtMS03MDI2NQ_6c5426f3-2bb1-4a42-a588-29c7e6e2fb5d">1,375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Change in fair value of redeemable convertible preferred stock warrants and derivative liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" decimals="-3" name="prct:FairValueAdjustmentOfWarrantsAndGainLossOnDerivativeInstrumentsNetPretax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfOC0xLTEtMS03MDI2NQ_360cdad2-941d-4d1e-93f4-770cb25cc4bb">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630" decimals="-3" sign="-" name="prct:FairValueAdjustmentOfWarrantsAndGainLossOnDerivativeInstrumentsNetPretax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfOC0zLTEtMS03MDI2NQ_d81b514c-c54a-4044-bf83-c07e80855417">43</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Non-cash lease adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" decimals="-3" name="prct:NonCashLeaseAccretionExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfOS0xLTEtMS03MDI2NQ_2743975e-73bc-4ce5-9097-ef9d38a5b415">193</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630" decimals="-3" name="prct:NonCashLeaseAccretionExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfOS0zLTEtMS03MDI2NQ_7af64c14-165d-4b6f-915f-6dc059f3b0b7">158</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMTQtMS0xLTEtNzAyNjU_a1894560-d55b-4c60-8ba9-ec8d75679a89">6,430</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMTQtMy0xLTEtNzAyNjU_fc98d0fc-ee1a-409a-a7e2-2656261f35e6">3,591</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMTUtMS0xLTEtNzAyNjU_414d3831-1899-400e-80e8-e8ea867acce9">684</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMTUtMy0xLTEtNzAyNjU_56d1ab28-3695-429a-8c82-e6d9e71c1165">2,761</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMTYtMS0xLTEtNzAyNjU_328b3274-47b4-4ae4-9237-7c2901f2181e">471</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMTYtMy0xLTEtNzAyNjU_f10150ef-89fd-44c0-9391-5001c80e84af">1,412</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMTctMS0xLTEtNzM3MzI_b933b67c-aba9-40f3-8201-36c4318b64cd">302</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMTctMy0xLTEtNzM3MjY_37315116-39c8-4615-a3a5-6e1f36301add">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMTctMS0xLTEtNzAyNjU_03ff3de6-2ca4-419d-b2c8-a2803c9818b0">947</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMTctMy0xLTEtNzAyNjU_adafcf09-0ea5-47f8-a93e-3b30f9cc67cd">2,120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accrued compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedSalaries" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMTgtMS0xLTEtNzAyNjU_e734e683-8079-4d15-bd0d-5a52702b93a7">431</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedSalaries" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMTgtMy0xLTEtNzAyNjU_baf0d167-3172-4d2d-87cf-f6f0ede10cdf">653</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accrued interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" decimals="-3" name="us-gaap:IncreaseDecreaseInInterestPayableNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMTktMS0xLTEtNzAyNjU_84829479-3748-4cf9-8e4e-096873f7a1d5">503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630" decimals="-3" name="us-gaap:IncreaseDecreaseInInterestPayableNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMTktMy0xLTEtNzAyNjU_96a64f4a-2cb2-4412-8123-a5411b16935d">532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMjAtMS0xLTEtNzAyNjU_3b991b17-734c-401f-96ac-938c08fe447e">838</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMjAtMy0xLTEtNzAyNjU_cba222ce-efa2-4036-8c22-119b54749acd">431</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMjItMS0xLTEtNzAyNjU_56fe7261-e65c-4079-a626-afbdf57a9ceb">346</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMjItMy0xLTEtNzAyNjU_0892fc03-ab66-403d-b655-3031230451f0">1,690</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net cash used in operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMjMtMS0xLTEtNzAyNjU_a9cd7df8-5893-4410-9430-0a2a5268b314">35,357</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMjMtMy0xLTEtNzAyNjU_b3fb231a-959e-4200-8547-05b234c88c15">28,107</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMjgtMS0xLTEtNzAyNjU_4c36f5e3-7a59-4a6d-bcd6-673b1c1ef193">273</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMjgtMy0xLTEtNzAyNjU_9de83458-1944-4169-bac7-bbe9207ad1ad">149</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMjktMS0xLTEtNzAyNjU_58d77fb4-0b94-4fd4-99ca-c8d9c489784e">273</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMjktMy0xLTEtNzAyNjU_38a1cc63-cd8a-4eed-b053-d1fe6bc90450">149</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Proceeds from issuance of Series G preferred stock, net of issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMzItMS0xLTEtNzQ5ODU_fff480c6-56a8-4072-854b-b1ae434da25c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMzEtMy0xLTEtNzM3MDk_0f027edf-5290-4a5c-a77e-6b068c7e8ecc">84,710</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Proceeds from issuance of common stock under employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMzMtMS0xLTEtNzQ4ODc_96a8d5b0-54bc-4641-bdf3-d363e97dbd6c">1,289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMzMtMy0xLTEtNzQ4ODA_6b16f21c-eb06-4634-89a3-d6d891aba926">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Proceeds from issuance of common stock from the exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMzEtMS0xLTEtNzAyNjU_e915e2cf-986c-4f33-aca2-f9cfebee09b6">2,864</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMzEtMy0xLTEtNzAyNjU_bb1480f9-b5b9-4aa4-9381-a600af77e938">2,640</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMzctMS0xLTEtNzAyNjU_df6ddb4b-1d37-404e-a37a-4d5b1c7e69b8">4,153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMzctMy0xLTEtNzAyNjU_42e02fbc-6a17-41df-98c7-deb100b59ff8">87,350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net (decrease) increase in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMzgtMS0xLTEtNzAyNjU_e366cd3a-39b2-4bf8-98ac-3863300c85e9">31,477</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMzgtMy0xLTEtNzAyNjU_a89bd3af-3040-4877-b94b-031eac1172d1">59,094</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Cash, cash equivalents and restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Beginning of the period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfNDAtMS0xLTEtNzAyNjU_3ebfe7f7-034a-4702-8a34-e9dfc5624df2">305,097</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icbfd320e5dd848119b7bdb3871172b7a_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfNDAtMy0xLTEtNzAyNjU_dd4fb9d9-7e68-40f3-914b-08f167bdefdc">100,907</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">End of the period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfNDEtMS0xLTEtNzAyNjU_0d866545-3688-4cb2-a2c7-5049f54dc13f">273,620</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0a06654ca8fc49a0aaed81f85663e69f_I20210630" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfNDEtMy0xLTEtNzAyNjU_949882b0-28b7-4f6c-9f47-6decd2acf400">160,001</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reconciliation of cash, cash equivalents and restricted cash to balance sheets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfNDMtMS0xLTEtNzAyNjU_5599f259-af1e-47b1-88f9-c617296f724d">269,806</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0a06654ca8fc49a0aaed81f85663e69f_I20210630" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfNDMtMy0xLTEtNzAyNjU_8b61e354-8e4c-439b-abfe-35c02f1d8388">159,224</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfNDQtMS0xLTEtNzAyNjU_5f91fb71-3b44-496b-a44e-f42c8a311b84">3,814</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0a06654ca8fc49a0aaed81f85663e69f_I20210630" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfNDQtMy0xLTEtNzAyNjU_9aeebbb9-6f80-4811-b14d-d87391f6116f">777</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash, cash equivalents and restricted cash in balance sheets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfNDUtMS0xLTEtNzAyNjU_339a16b3-0549-40ac-b87d-98aed89669e9">273,620</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0a06654ca8fc49a0aaed81f85663e69f_I20210630" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfNDUtMy0xLTEtNzAyNjU_f679b267-d71e-41d5-a7d3-b2c1eb934cf2">160,001</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Supplemental cash flow information</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest paid</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfNDctMS0xLTEtNzAyNjU_b1649e05-ff30-4fbf-b019-d2b77cd0e52c">2,369</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfNDctMy0xLTEtNzAyNjU_0ed3fe72-10ca-4eca-8f68-e0722cb3401d">2,369</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Non-cash investing and financing activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Transfer of evaluation units from inventory to property and equipment, net</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" decimals="-3" name="prct:TransferFromInventoryToPropertyAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfNTAtMS0xLTEtNzAyNjU_57baead7-e1c1-402f-a573-3edf007d031a">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630" decimals="-3" sign="-" name="prct:TransferFromInventoryToPropertyAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfNTAtMy0xLTEtNzAyNjU_89480da0-f5c8-49f0-b25e-5f286c5649da">439</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Property and equipment included in accounts payable and other current liabilities</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfNTEtMS0xLTEtNzAyNjU_8ec3f19a-1290-4c37-98e2-29ed68dd1b1c">566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfNTEtMy0xLTEtNzAyNjU_242b64e9-83d2-4fa4-9b1d-8a57805f14be">226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deferred offering costs included in accounts payable and other current liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" decimals="-3" name="prct:DeferredOfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfNTItMS0xLTEtNzA4NTg_10b3114f-a9c9-4509-b707-61145a9f5aac"><ix:nonFraction unitRef="usd" contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" decimals="-3" name="prct:DeferredOfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfNTItMS0xLTEtNzA4NTg_21cf0104-6a60-487e-9f45-572b90e3290e">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630" decimals="-3" name="prct:DeferredOfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfNTItMy0xLTEtNzA4NTc_6767a99d-e2ce-4d93-8e45-c0d6f7e93d3a">856</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements. </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="ibb2df456afff4355bae87af9d1240625_31"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROCEPT BioRobotics Corporation</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited) </span></div><div id="ibb2df456afff4355bae87af9d1240625_34"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8zNC9mcmFnOjYzZDBjYjE3MDdhNjRjMTdiYWZlYTY1ZjEwYTZmZDEzL3RleHRyZWdpb246NjNkMGNiMTcwN2E2NGMxN2JhZmVhNjVmMTBhNmZkMTNfMjg3Mg_ba7234aa-3a88-49b2-8af9-311905dd7fc6" continuedAt="i4b9eab5bbac843aa9aa022337ccc6830" escape="true">Organization </ix:nonNumeric></span></div><ix:continuation id="i4b9eab5bbac843aa9aa022337ccc6830" continuedAt="i55ee31125482428dbab4666c46240016"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Description of Business </span></div><div style="margin-bottom:9pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PROCEPT BioRobotics Corporation (the &#8220;Company&#8221;) is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. BPH is the most common prostate disease and impacts approximately 40 million men in the United States. The AquaBeam Robotic System employs a single-use disposable handpiece to deliver the Company&#8217;s proprietary Aquablation therapy, which combines real-time, multi-dimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. The Company designed its AquaBeam Robotic System to enable consistent and reproducible BPH surgery outcomes. The Company received U.S. Food and Drug Administration clearance in December 2017 to market its AquaBeam Robotic System.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity</span></div><div style="margin-bottom:9pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, the Company had cash and cash equivalents of $<ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8zNC9mcmFnOjYzZDBjYjE3MDdhNjRjMTdiYWZlYTY1ZjEwYTZmZDEzL3RleHRyZWdpb246NjNkMGNiMTcwN2E2NGMxN2JhZmVhNjVmMTBhNmZkMTNfMTE2OA_2143e067-60af-41d6-8f13-d839b7d15029">269.8</ix:nonFraction> million, and an accumulated deficit of $<ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-5" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8zNC9mcmFnOjYzZDBjYjE3MDdhNjRjMTdiYWZlYTY1ZjEwYTZmZDEzL3RleHRyZWdpb246NjNkMGNiMTcwN2E2NGMxN2JhZmVhNjVmMTBhNmZkMTNfMTIyMw_002bd278-8b43-4557-a8ae-e02bef148a2b">297.9</ix:nonFraction> million. In September 2021, the Company completed its initial public offering (&#8220;IPO&#8221;) for net proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="i054a395a39bb4b049e783cf126b64e4c_D20210901-20210930" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8zNC9mcmFnOjYzZDBjYjE3MDdhNjRjMTdiYWZlYTY1ZjEwYTZmZDEzL3RleHRyZWdpb246NjNkMGNiMTcwN2E2NGMxN2JhZmVhNjVmMTBhNmZkMTNfMTM1OQ_5433d853-6eba-4d52-b193-c933dccaaaaa">172.4</ix:nonFraction> million, after deducting underwriting discounts and commissions and offering expenses. Since its inception, the Company has financed its operations with a combination of debt and equity financing arrangements. The Company expects its cash and cash equivalents, revenue and available debt financing arrangements will be sufficient to fund its operations through at least the next twelve months from the issuance date of these financial statements. The Company has not achieved positive cash flow from operations to date and expects to continue incurring losses for the foreseeable future as it focuses on growing its business.</span></div></ix:continuation><div style="margin-bottom:9pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i55ee31125482428dbab4666c46240016">The COVID-19 pandemic and the resulting economic downturn are affecting business conditions in the industry in which the Company operates. In response to the pandemic, many state and local governments in the United States issued orders that temporarily precluded elective medical procedures in order to conserve scarce health system resources. The Company has taken necessary precautions to safeguard its employees, patients, customers, and other stakeholders from the COVID-19 pandemic, while maintaining business continuity to support its patients, customers and employees. The timing, extent and continuation of any increase in procedures, and any corresponding increase in sales of the Company&#8217;s products, and whether there could be a future decrease in the current level of procedures as a result of the COVID-19 pandemic or otherwise, remain uncertain and are subject to a variety of factors.</ix:continuation> </span></div><div id="ibb2df456afff4355bae87af9d1240625_37"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8zNy9mcmFnOjk0ZWQ0ZDVhNWYzZDRhMmFiOTNjY2ViMzc3YzViZWE1L3RleHRyZWdpb246OTRlZDRkNWE1ZjNkNGEyYWI5M2NjZWIzNzdjNWJlYTVfMzc0ODY_b790bfe9-3d9f-4860-883d-a3182955df03" continuedAt="i4e038c7a18fe4761aaac711e0d262164" escape="true">Summary of Significant Accounting Policies </ix:nonNumeric></span></div><ix:continuation id="i4e038c7a18fe4761aaac711e0d262164" continuedAt="i0e11e6a3de5a48e5b2dcd81d32ddb0b1"><ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8zNy9mcmFnOjk0ZWQ0ZDVhNWYzZDRhMmFiOTNjY2ViMzc3YzViZWE1L3RleHRyZWdpb246OTRlZDRkNWE1ZjNkNGEyYWI5M2NjZWIzNzdjNWJlYTVfMzc0ODI_bfaaa8db-4070-4348-8f01-8d08779d4752" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation </span></div><div style="margin-bottom:9pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements have been presented in accordance with U.S. generally accepted accounting principles (&#8220;U.S. GAAP&#8221;) and pursuant to the rules and regulations of the United States Securities and Exchange Commission (&#8220;SEC&#8221;). These condensed consolidated financial statements include the accounts of the Company and its consolidated subsidiaries. All intercompany balances and transactions have been eliminated upon consolidation. The Company operates as one reportable segment.</span></div></ix:nonNumeric><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unaudited Interim Financial Statements </span></div><div style="margin-bottom:9pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying balance sheet as of June&#160;30, 2022, the statements of operations and comprehensive loss for the three and six months ended June 30, 2022 and 2021, and cash flows for the six months ended June 30, 2022 and 2021, and the statements of redeemable convertible preferred stock and stockholders&#8217; equity (deficit) as of June&#160;30, 2022 and 2021, are unaudited. The financial data and other information disclosed in these notes to the financial statements related to June&#160;30, 2022, and the three and six months ended June 30, 2022 and 2021, are also unaudited. </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span><br/></span></div></div><ix:continuation id="i0e11e6a3de5a48e5b2dcd81d32ddb0b1" continuedAt="i2e466a9ce451498fb3e7573daae7c14e"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying balance sheet as of December&#160;31, 2021 have been derived from the audited consolidated financial statements included in the Company&#8217;s Annual Report on Form 10-K (&#8220;Annual Report&#8221;) filed with the Securities and Exchange Commission.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited interim financial statements have been prepared on the same basis as the annual financial statements and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments, necessary to a fair statement of the Company&#8217;s financial position as of June&#160;30, 2022, and the results of its operations and cash flows for the three and six months ended June 30, 2022 and 2021. The results for the three and six months ended June 30, 2022, are not necessarily indicative of results to be expected for the year ending December&#160;31, 2022, or for any other interim period or for any future year and should be read in conjunction with the annual consolidated financial statements included in the Company&#8217;s Annual Report.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8zNy9mcmFnOjk0ZWQ0ZDVhNWYzZDRhMmFiOTNjY2ViMzc3YzViZWE1L3RleHRyZWdpb246OTRlZDRkNWE1ZjNkNGEyYWI5M2NjZWIzNzdjNWJlYTVfMzc0OTQ_2ac0738f-5a3a-46fa-9961-1fa9a847899b" continuedAt="i03f9caaaf5754b2890d422336934cf50" escape="true">Use of Estimates </ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i03f9caaaf5754b2890d422336934cf50">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts and disclosures reported in the condensed consolidated financial statements. Management uses significant judgment when making estimates related to its common stock valuation in periods before the Company&#8217;s IPO and related stock-based compensation expense, right-of-use lease asset, lease liability, and loan facility derivative liability, as well as certain accrued liabilities. Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results could differ from those estimates.</ix:continuation> </span></div><ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="us-gaap:StockholdersEquityPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8zNy9mcmFnOjk0ZWQ0ZDVhNWYzZDRhMmFiOTNjY2ViMzc3YzViZWE1L3RleHRyZWdpb246OTRlZDRkNWE1ZjNkNGEyYWI5M2NjZWIzNzdjNWJlYTVfMzc1MDE_a69562dc-4d85-4716-b8f1-05a003c89612" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Initial Public Offering</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2021, the Company completed its IPO by issuing <ix:nonFraction unitRef="shares" contextRef="i054a395a39bb4b049e783cf126b64e4c_D20210901-20210930" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8zNy9mcmFnOjk0ZWQ0ZDVhNWYzZDRhMmFiOTNjY2ViMzc3YzViZWE1L3RleHRyZWdpb246OTRlZDRkNWE1ZjNkNGEyYWI5M2NjZWIzNzdjNWJlYTVfMTU3Mw_9e825ae8-1641-4b07-9ba6-0c80afaddb53">6,556,000</ix:nonFraction> shares of common stock, and the exercise of the underwriters option for <ix:nonFraction unitRef="shares" contextRef="i76637c8aeec140d2b14464b0d2e859c4_D20210901-20210930" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8zNy9mcmFnOjk0ZWQ0ZDVhNWYzZDRhMmFiOTNjY2ViMzc3YzViZWE1L3RleHRyZWdpb246OTRlZDRkNWE1ZjNkNGEyYWI5M2NjZWIzNzdjNWJlYTVfMTY0OA_05d1ccc8-61ea-4829-a509-e8fe46d7913b">983,400</ix:nonFraction> shares, at an offering price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ie390a471379b4ab1bcab0d1678411d3a_I20210930" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8zNy9mcmFnOjk0ZWQ0ZDVhNWYzZDRhMmFiOTNjY2ViMzc3YzViZWE1L3RleHRyZWdpb246OTRlZDRkNWE1ZjNkNGEyYWI5M2NjZWIzNzdjNWJlYTVfMTY4Mw_d8535c2f-a2b0-4136-a49f-ed3b0a719d53">25.00</ix:nonFraction> per share, for total net proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="i054a395a39bb4b049e783cf126b64e4c_D20210901-20210930" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8zNy9mcmFnOjk0ZWQ0ZDVhNWYzZDRhMmFiOTNjY2ViMzc3YzViZWE1L3RleHRyZWdpb246OTRlZDRkNWE1ZjNkNGEyYWI5M2NjZWIzNzdjNWJlYTVfMTczNw_5433d853-6eba-4d52-b193-c933dccaaaaa">172.4</ix:nonFraction> million, after deducting underwriting discounts and commissions of $<ix:nonFraction unitRef="usd" contextRef="ic71fc6b5bde14a3db707e62f0fc13d18_D20210901-20210930" decimals="-5" name="us-gaap:PaymentsForUnderwritingExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8zNy9mcmFnOjk0ZWQ0ZDVhNWYzZDRhMmFiOTNjY2ViMzc3YzViZWE1L3RleHRyZWdpb246OTRlZDRkNWE1ZjNkNGEyYWI5M2NjZWIzNzdjNWJlYTVfMTc5OQ_14ec219d-5708-4b6b-a762-bbd04a668c43">13.2</ix:nonFraction> million and offering expenses of $<ix:nonFraction unitRef="usd" contextRef="ic71fc6b5bde14a3db707e62f0fc13d18_D20210901-20210930" decimals="-5" name="us-gaap:PaymentsOfStockIssuanceCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8zNy9mcmFnOjk0ZWQ0ZDVhNWYzZDRhMmFiOTNjY2ViMzc3YzViZWE1L3RleHRyZWdpb246OTRlZDRkNWE1ZjNkNGEyYWI5M2NjZWIzNzdjNWJlYTVfMTgyNw_ee73f0a1-ba57-4f1b-9892-d09dba1716f4">2.9</ix:nonFraction> million. Offering costs are capitalized, and consist of fees and expenses incurred in connection with the sale of common stock in its IPO, including legal, accounting, printing and other IPO-related costs. Upon completion of its IPO, these deferred offering costs were reclassified to stockholders&#8217; equity and recorded against the proceeds from the offering. In addition, all <ix:nonFraction unitRef="shares" contextRef="ie390a471379b4ab1bcab0d1678411d3a_I20210930" decimals="INF" name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8zNy9mcmFnOjk0ZWQ0ZDVhNWYzZDRhMmFiOTNjY2ViMzc3YzViZWE1L3RleHRyZWdpb246OTRlZDRkNWE1ZjNkNGEyYWI5M2NjZWIzNzdjNWJlYTVfMjE5OA_a7746372-f170-45be-ba83-74b088b7a390"><ix:nonFraction unitRef="shares" contextRef="ie390a471379b4ab1bcab0d1678411d3a_I20210930" decimals="INF" name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8zNy9mcmFnOjk0ZWQ0ZDVhNWYzZDRhMmFiOTNjY2ViMzc3YzViZWE1L3RleHRyZWdpb246OTRlZDRkNWE1ZjNkNGEyYWI5M2NjZWIzNzdjNWJlYTVfMjE5OA_be4c7d6f-0ed7-40a7-8a6e-b14a791ecf67">29,912,264</ix:nonFraction></ix:nonFraction> shares of its then-outstanding redeemable convertible preferred stock automatically converted into <ix:nonFraction unitRef="shares" contextRef="ie390a471379b4ab1bcab0d1678411d3a_I20210930" decimals="INF" name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8zNy9mcmFnOjk0ZWQ0ZDVhNWYzZDRhMmFiOTNjY2ViMzc3YzViZWE1L3RleHRyZWdpb246OTRlZDRkNWE1ZjNkNGEyYWI5M2NjZWIzNzdjNWJlYTVfMjMwMA_a7746372-f170-45be-ba83-74b088b7a390"><ix:nonFraction unitRef="shares" contextRef="ie390a471379b4ab1bcab0d1678411d3a_I20210930" decimals="INF" name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8zNy9mcmFnOjk0ZWQ0ZDVhNWYzZDRhMmFiOTNjY2ViMzc3YzViZWE1L3RleHRyZWdpb246OTRlZDRkNWE1ZjNkNGEyYWI5M2NjZWIzNzdjNWJlYTVfMjMwMA_be4c7d6f-0ed7-40a7-8a6e-b14a791ecf67">29,912,264</ix:nonFraction></ix:nonFraction> shares of common stock and it reclassified $<ix:nonFraction unitRef="usd" contextRef="ia464c84a1d294b1a90b1144fd82c6978_D20210901-20210930" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8zNy9mcmFnOjk0ZWQ0ZDVhNWYzZDRhMmFiOTNjY2ViMzc3YzViZWE1L3RleHRyZWdpb246OTRlZDRkNWE1ZjNkNGEyYWI5M2NjZWIzNzdjNWJlYTVfMjM0Ng_6a50ec45-4e8f-493a-89be-fa30606e809b">329.5</ix:nonFraction> million of redeemable convertible preferred stock to additional paid-in capital on its condensed consolidated balance sheet.  Also, upon the completion of the Company&#8217;s IPO, the Company&#8217;s <ix:nonFraction unitRef="shares" contextRef="i50623cf37fe345b787005f8045a73bbf_D20210101-20210930" decimals="INF" name="prct:TemporaryEquityStockIssuedDuringPeriodSharesWarrantExercises" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8zNy9mcmFnOjk0ZWQ0ZDVhNWYzZDRhMmFiOTNjY2ViMzc3YzViZWE1L3RleHRyZWdpb246OTRlZDRkNWE1ZjNkNGEyYWI5M2NjZWIzNzdjNWJlYTVfMjc0ODc3OTE0NDk4OA_5b21fa2c-a0d1-495a-810e-c40f9d7b8b1b">62,454</ix:nonFraction> redeemable convertible preferred stock warrants were exercised and the remaining unexercised warrants expired.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="prct:JobsActAccountingElectionPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8zNy9mcmFnOjk0ZWQ0ZDVhNWYzZDRhMmFiOTNjY2ViMzc3YzViZWE1L3RleHRyZWdpb246OTRlZDRkNWE1ZjNkNGEyYWI5M2NjZWIzNzdjNWJlYTVfMjE5OTAyMzM2MjY4OA_990a9101-08f0-40df-82c3-236045a87508" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">JOBS Act Accounting Election</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is an emerging growth company, as defined in the JOBS Act. Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act until such time as those standards apply to private companies. The Company has elected to avail itself of this exemption and, therefore, for new or revised accounting standards applicable to public companies, the Company will be subject to an extended transition period until those standards would otherwise apply to private companies.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8zNy9mcmFnOjk0ZWQ0ZDVhNWYzZDRhMmFiOTNjY2ViMzc3YzViZWE1L3RleHRyZWdpb246OTRlZDRkNWE1ZjNkNGEyYWI5M2NjZWIzNzdjNWJlYTVfMzc1MDI_688f6fb9-ce01-4ca4-a874-17ac9a56facd" continuedAt="ifeb9af6bb17b464e800b0c9fbad7a077" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2020-4, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (&#8220;ASU 2020-4&#8221;). The amendments in ASU 2020-4 provide optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. These amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. The expedients and exceptions provided do not apply to contract modifications made and hedging relationships entered into or evaluated after December 31, 2022, except for hedging relationships existing as of December 31, 2022, that an entity has elected certain optional expedients for and that are retained through the end of the hedging relationship. </span></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span><br/></span></div></div><ix:continuation id="i2e466a9ce451498fb3e7573daae7c14e"><ix:continuation id="ifeb9af6bb17b464e800b0c9fbad7a077"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These amendments are effective for all entities as of March 12, 2020 through December 31, 2022. The Company is currently evaluating the impact of the adoption of this ASU on its consolidated financial statements.</span></div><div style="margin-bottom:9pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments&#8212;Credit Losses (Topic 326) Measurement of Credit Losses on Financial Instruments (&#8220;ASU 2016-13&#8221;), which requires an entity to utilize a new impairment model known as the current expected credit loss (&#8220;CECL&#8221;) model to estimate its lifetime &#8220;expected credit loss&#8221; and record an allowance that, when deducted from the amortized cost basis of the financial assets and certain other instruments, including but not limited to available-for-sale debt securities. Credit losses relating to available-for-sale debt securities will be recorded through an allowance for credit losses rather than as a direct write-down to the security. ASU 2016-13 requires a cumulative effect adjustment to the balance sheet as of the beginning of the first reporting period in which the guidance is effective. In November 2019, the FASB issued ASU 2019-10, Financial Instruments&#8212;Credit Losses (Topic 326), Derivatives and Hedging (Topic 815) and Leases (Topic 842): Effective Dates, which defers the effective date of ASU 2016-13 to fiscal years beginning after December 15, 2022 for all entities except SEC reporting companies that are not smaller reporting companies. ASU 2016-13 will be effective for the Company beginning January 1, 2023. The Company is currently evaluating the impact of the adoption of this ASU on its consolidated financial statements.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Accounting Policies</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Property and Equipment </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation and amortization for property and equipment are determined using the straight-line method over the estimated useful lives of the respective assets, generally three to five years. As of June 30, 2022, the Company no longer reclassifies inventory used at customer sites for evaluation purposes to property and equipment due to change in customary business practices.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June 30, 2022, with the exception of the accounting policy above, there have been no material changes to the Company&#8217;s significant accounting policies as described in its 2021 Annual Report or the first quarter 2022 Quarterly Report that have had a material impact on the Company&#8217;s condensed consolidated financial statements and related notes.</span></div></ix:continuation></ix:continuation><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:24.5pt"><span><br/></span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div style="margin-bottom:9pt;text-indent:24.5pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:24.5pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" xsi:nil="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8zNy9mcmFnOjk0ZWQ0ZDVhNWYzZDRhMmFiOTNjY2ViMzc3YzViZWE1L3RleHRyZWdpb246OTRlZDRkNWE1ZjNkNGEyYWI5M2NjZWIzNzdjNWJlYTVfMzc0ODE_01abfb44-b275-4bd5-8f12-019810cba2b1" escape="true"></ix:nonNumeric><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><div id="ibb2df456afff4355bae87af9d1240625_652"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-bottom:9pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90ZXh0cmVnaW9uOjFmYTI3OTlkMjlmNzQ4NTViNjdlNzZlNzMwMTYyMDVhXzg3OTYwOTMwMjYxMTM_e0af470b-81bd-45a2-b0b3-af899f995f51" continuedAt="i0383408fbf3d4c41b14865a29b2a91b8" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><ix:continuation id="i0383408fbf3d4c41b14865a29b2a91b8"><ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90ZXh0cmVnaW9uOjFmYTI3OTlkMjlmNzQ4NTViNjdlNzZlNzMwMTYyMDVhXzg3OTYwOTMwMjYxMTQ_c743ea38-767a-40a7-a6b1-0b3fa5e2aa53" escape="true"><div style="margin-bottom:9pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of assets and liabilities measured at fair value on a recurring basis (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.194%"><tr><td style="width:1.0%"></td><td style="width:45.248%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.865%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.396%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.865%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.396%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.865%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.396%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.869%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i271be39716a24ae3a1220dde2c194490_I20220630" decimals="-3" name="us-gaap:Cash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTo1YzFmNTE4ZTRlZDY0Y2MyOGFjOTAxMTAwOTJjMjM1Zi90YWJsZXJhbmdlOjVjMWY1MThlNGVkNjRjYzI4YWM5MDExMDA5MmMyMzVmXzQtMS0xLTEtNzEyMTc_7a81d56e-b26b-4b80-9e2c-e1d6520b53c3">3,810</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0624c3f7a1a24f1cbf5381ed78fa8773_I20220630" decimals="-3" name="us-gaap:Cash" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTo1YzFmNTE4ZTRlZDY0Y2MyOGFjOTAxMTAwOTJjMjM1Zi90YWJsZXJhbmdlOjVjMWY1MThlNGVkNjRjYzI4YWM5MDExMDA5MmMyMzVmXzQtMy0xLTEtNzEyMTc_2adb6a2e-6936-4cdc-a421-1a1b96a445c9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28d56366abcb4c1ba6762562d89f11be_I20220630" decimals="-3" name="us-gaap:Cash" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTo1YzFmNTE4ZTRlZDY0Y2MyOGFjOTAxMTAwOTJjMjM1Zi90YWJsZXJhbmdlOjVjMWY1MThlNGVkNjRjYzI4YWM5MDExMDA5MmMyMzVmXzQtNS0xLTEtNzEyMTc_db2a1493-7493-4b52-9d42-3d4d551555e7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03e5fbb904174fc6a95ec0686a05e446_I20220630" decimals="-3" name="us-gaap:Cash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTo1YzFmNTE4ZTRlZDY0Y2MyOGFjOTAxMTAwOTJjMjM1Zi90YWJsZXJhbmdlOjVjMWY1MThlNGVkNjRjYzI4YWM5MDExMDA5MmMyMzVmXzQtNy0xLTEtNzEyMTc_90ca7df3-63fb-4c4b-b410-8d4c3d881e93">3,810</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i271be39716a24ae3a1220dde2c194490_I20220630" decimals="-3" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTo1YzFmNTE4ZTRlZDY0Y2MyOGFjOTAxMTAwOTJjMjM1Zi90YWJsZXJhbmdlOjVjMWY1MThlNGVkNjRjYzI4YWM5MDExMDA5MmMyMzVmXzUtMS0xLTEtNzEyMTc_ca268236-cf05-4aaf-98da-def5573707d5">265,996</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0624c3f7a1a24f1cbf5381ed78fa8773_I20220630" decimals="-3" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTo1YzFmNTE4ZTRlZDY0Y2MyOGFjOTAxMTAwOTJjMjM1Zi90YWJsZXJhbmdlOjVjMWY1MThlNGVkNjRjYzI4YWM5MDExMDA5MmMyMzVmXzUtMy0xLTEtNzEyMTc_03aa4919-7468-49a3-b185-0a4c8e330ec5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28d56366abcb4c1ba6762562d89f11be_I20220630" decimals="-3" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTo1YzFmNTE4ZTRlZDY0Y2MyOGFjOTAxMTAwOTJjMjM1Zi90YWJsZXJhbmdlOjVjMWY1MThlNGVkNjRjYzI4YWM5MDExMDA5MmMyMzVmXzUtNS0xLTEtNzEyMTc_9d8fc30f-213c-4c51-ac4e-b1b2fee846e1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03e5fbb904174fc6a95ec0686a05e446_I20220630" decimals="-3" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTo1YzFmNTE4ZTRlZDY0Y2MyOGFjOTAxMTAwOTJjMjM1Zi90YWJsZXJhbmdlOjVjMWY1MThlNGVkNjRjYzI4YWM5MDExMDA5MmMyMzVmXzUtNy0xLTEtNzEyMTc_122d9278-4c4f-431f-b48f-1cc4b0a10035">265,996</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash and cash equivalents</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i271be39716a24ae3a1220dde2c194490_I20220630" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTo1YzFmNTE4ZTRlZDY0Y2MyOGFjOTAxMTAwOTJjMjM1Zi90YWJsZXJhbmdlOjVjMWY1MThlNGVkNjRjYzI4YWM5MDExMDA5MmMyMzVmXzYtMS0xLTEtNzEyMTc_61c0ed0f-7f7a-42e6-9908-1d55f268b939">269,806</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0624c3f7a1a24f1cbf5381ed78fa8773_I20220630" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTo1YzFmNTE4ZTRlZDY0Y2MyOGFjOTAxMTAwOTJjMjM1Zi90YWJsZXJhbmdlOjVjMWY1MThlNGVkNjRjYzI4YWM5MDExMDA5MmMyMzVmXzYtMy0xLTEtNzEyMTc_16cd84e5-fd8e-4adf-93cf-a68e042b8fd1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28d56366abcb4c1ba6762562d89f11be_I20220630" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTo1YzFmNTE4ZTRlZDY0Y2MyOGFjOTAxMTAwOTJjMjM1Zi90YWJsZXJhbmdlOjVjMWY1MThlNGVkNjRjYzI4YWM5MDExMDA5MmMyMzVmXzYtNS0xLTEtNzEyMTc_27dcf86f-00db-4e34-84b9-78cf6163557d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03e5fbb904174fc6a95ec0686a05e446_I20220630" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTo1YzFmNTE4ZTRlZDY0Y2MyOGFjOTAxMTAwOTJjMjM1Zi90YWJsZXJhbmdlOjVjMWY1MThlNGVkNjRjYzI4YWM5MDExMDA5MmMyMzVmXzYtNy0xLTEtNzEyMTc_61a45146-d69e-4720-a115-fa13e22eb859">269,806</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loan facility derivative liability</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i271be39716a24ae3a1220dde2c194490_I20220630" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTo1YzFmNTE4ZTRlZDY0Y2MyOGFjOTAxMTAwOTJjMjM1Zi90YWJsZXJhbmdlOjVjMWY1MThlNGVkNjRjYzI4YWM5MDExMDA5MmMyMzVmXzktMS0xLTEtNzEyMTc_89dce56c-2e58-4729-858a-3e4d889a95cc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0624c3f7a1a24f1cbf5381ed78fa8773_I20220630" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTo1YzFmNTE4ZTRlZDY0Y2MyOGFjOTAxMTAwOTJjMjM1Zi90YWJsZXJhbmdlOjVjMWY1MThlNGVkNjRjYzI4YWM5MDExMDA5MmMyMzVmXzktMy0xLTEtNzEyMTc_16597bf5-445c-45c8-9a04-371062e7672e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28d56366abcb4c1ba6762562d89f11be_I20220630" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTo1YzFmNTE4ZTRlZDY0Y2MyOGFjOTAxMTAwOTJjMjM1Zi90YWJsZXJhbmdlOjVjMWY1MThlNGVkNjRjYzI4YWM5MDExMDA5MmMyMzVmXzktNS0xLTEtNzEyMTc_edf87591-751b-4528-bbf0-3d9676c2a04c">1,570</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03e5fbb904174fc6a95ec0686a05e446_I20220630" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTo1YzFmNTE4ZTRlZDY0Y2MyOGFjOTAxMTAwOTJjMjM1Zi90YWJsZXJhbmdlOjVjMWY1MThlNGVkNjRjYzI4YWM5MDExMDA5MmMyMzVmXzktNy0xLTEtNzEyMTc_824eb70d-4c91-48f2-8828-e6bf00a9b493">1,570</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.194%"><tr><td style="width:1.0%"></td><td style="width:45.248%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.865%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.396%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.865%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.396%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.865%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.396%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.869%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib662e1ac7c4f4fc09ed63ee4ad3d6920_I20211231" decimals="-3" name="us-gaap:Cash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTowNWRiMTkyMzEyMDA0NjNlYTAxNjQ2ZWVhMDlkMGI0OS90YWJsZXJhbmdlOjA1ZGIxOTIzMTIwMDQ2M2VhMDE2NDZlZWEwOWQwYjQ5XzQtMS0xLTEtNzIzNzE_4e483dc2-ca92-4b2a-9dc1-79b6c7a211b8">13,621</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06c709bf479e43c389950311b1d0360b_I20211231" decimals="-3" name="us-gaap:Cash" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTowNWRiMTkyMzEyMDA0NjNlYTAxNjQ2ZWVhMDlkMGI0OS90YWJsZXJhbmdlOjA1ZGIxOTIzMTIwMDQ2M2VhMDE2NDZlZWEwOWQwYjQ5XzQtMy0xLTEtNzIzNzE_25234404-99a3-48e4-a4fc-17682c873cd3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71decfbc977f40ac8eb9c51a9d97ccbe_I20211231" decimals="-3" name="us-gaap:Cash" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTowNWRiMTkyMzEyMDA0NjNlYTAxNjQ2ZWVhMDlkMGI0OS90YWJsZXJhbmdlOjA1ZGIxOTIzMTIwMDQ2M2VhMDE2NDZlZWEwOWQwYjQ5XzQtNS0xLTEtNzIzNzE_63cce9cd-9cce-4544-91cf-3837a767a477">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbcba339097743d39f83b2c7a95fa80c_I20211231" decimals="-3" name="us-gaap:Cash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTowNWRiMTkyMzEyMDA0NjNlYTAxNjQ2ZWVhMDlkMGI0OS90YWJsZXJhbmdlOjA1ZGIxOTIzMTIwMDQ2M2VhMDE2NDZlZWEwOWQwYjQ5XzQtNy0xLTEtNzIzNzE_38ae79e0-a369-403e-bfdf-5779cb391a91">13,621</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib662e1ac7c4f4fc09ed63ee4ad3d6920_I20211231" decimals="-3" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTowNWRiMTkyMzEyMDA0NjNlYTAxNjQ2ZWVhMDlkMGI0OS90YWJsZXJhbmdlOjA1ZGIxOTIzMTIwMDQ2M2VhMDE2NDZlZWEwOWQwYjQ5XzUtMS0xLTEtNzIzNzE_04c73706-c349-497d-a68b-b62251dc6ded">290,699</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06c709bf479e43c389950311b1d0360b_I20211231" decimals="-3" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTowNWRiMTkyMzEyMDA0NjNlYTAxNjQ2ZWVhMDlkMGI0OS90YWJsZXJhbmdlOjA1ZGIxOTIzMTIwMDQ2M2VhMDE2NDZlZWEwOWQwYjQ5XzUtMy0xLTEtNzIzNzE_b1551b9d-c71f-4a99-b991-2f9eb1be822b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71decfbc977f40ac8eb9c51a9d97ccbe_I20211231" decimals="-3" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTowNWRiMTkyMzEyMDA0NjNlYTAxNjQ2ZWVhMDlkMGI0OS90YWJsZXJhbmdlOjA1ZGIxOTIzMTIwMDQ2M2VhMDE2NDZlZWEwOWQwYjQ5XzUtNS0xLTEtNzIzNzE_0fbe7d98-5e0d-4533-b3fd-e86548549777">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbcba339097743d39f83b2c7a95fa80c_I20211231" decimals="-3" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTowNWRiMTkyMzEyMDA0NjNlYTAxNjQ2ZWVhMDlkMGI0OS90YWJsZXJhbmdlOjA1ZGIxOTIzMTIwMDQ2M2VhMDE2NDZlZWEwOWQwYjQ5XzUtNy0xLTEtNzIzNzE_e78a57f6-9f51-4c77-a4fe-64b0d0058bfe">290,699</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash and cash equivalents</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib662e1ac7c4f4fc09ed63ee4ad3d6920_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTowNWRiMTkyMzEyMDA0NjNlYTAxNjQ2ZWVhMDlkMGI0OS90YWJsZXJhbmdlOjA1ZGIxOTIzMTIwMDQ2M2VhMDE2NDZlZWEwOWQwYjQ5XzYtMS0xLTEtNzIzNzE_bc7685a8-39e5-4667-b055-43c8e0772507">304,320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06c709bf479e43c389950311b1d0360b_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTowNWRiMTkyMzEyMDA0NjNlYTAxNjQ2ZWVhMDlkMGI0OS90YWJsZXJhbmdlOjA1ZGIxOTIzMTIwMDQ2M2VhMDE2NDZlZWEwOWQwYjQ5XzYtMy0xLTEtNzIzNzE_71aaf50a-a4bd-45ae-99b9-dc71b4dbd5d8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71decfbc977f40ac8eb9c51a9d97ccbe_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTowNWRiMTkyMzEyMDA0NjNlYTAxNjQ2ZWVhMDlkMGI0OS90YWJsZXJhbmdlOjA1ZGIxOTIzMTIwMDQ2M2VhMDE2NDZlZWEwOWQwYjQ5XzYtNS0xLTEtNzIzNzE_90777a4a-7bf9-4cb9-9c84-9d97ba4bbf50">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbcba339097743d39f83b2c7a95fa80c_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTowNWRiMTkyMzEyMDA0NjNlYTAxNjQ2ZWVhMDlkMGI0OS90YWJsZXJhbmdlOjA1ZGIxOTIzMTIwMDQ2M2VhMDE2NDZlZWEwOWQwYjQ5XzYtNy0xLTEtNzIzNzE_9ea27873-7671-4160-ac56-32d3d9d7c19a">304,320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loan facility derivative liability</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib662e1ac7c4f4fc09ed63ee4ad3d6920_I20211231" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTowNWRiMTkyMzEyMDA0NjNlYTAxNjQ2ZWVhMDlkMGI0OS90YWJsZXJhbmdlOjA1ZGIxOTIzMTIwMDQ2M2VhMDE2NDZlZWEwOWQwYjQ5XzktMS0xLTEtNzIzNzU_c685fcff-44b8-49bf-9e60-ee4654eb498c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06c709bf479e43c389950311b1d0360b_I20211231" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTowNWRiMTkyMzEyMDA0NjNlYTAxNjQ2ZWVhMDlkMGI0OS90YWJsZXJhbmdlOjA1ZGIxOTIzMTIwMDQ2M2VhMDE2NDZlZWEwOWQwYjQ5XzktMy0xLTEtNzIzNzU_0b35ff25-be43-441a-a804-a35389ffb2bc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71decfbc977f40ac8eb9c51a9d97ccbe_I20211231" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTowNWRiMTkyMzEyMDA0NjNlYTAxNjQ2ZWVhMDlkMGI0OS90YWJsZXJhbmdlOjA1ZGIxOTIzMTIwMDQ2M2VhMDE2NDZlZWEwOWQwYjQ5XzktNS0xLTEtNzIzNzU_f806dc1d-06dd-4966-82fa-46124bce5530">1,496</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbcba339097743d39f83b2c7a95fa80c_I20211231" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTowNWRiMTkyMzEyMDA0NjNlYTAxNjQ2ZWVhMDlkMGI0OS90YWJsZXJhbmdlOjA1ZGIxOTIzMTIwMDQ2M2VhMDE2NDZlZWEwOWQwYjQ5XzktNy0xLTEtNzIzNzU_643dfae6-be92-46b6-be3b-c274c2983525">1,496</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents consist primarily of money market funds and treasury securities. </span></div><div style="margin-bottom:9pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no transfers in and out of Level 3 during the three and six months ended June 30, 2022 and year ended December&#160;31, 2021. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the loan facility derivative liability was determined using a discounted cash flow calculation discounted at <ix:nonFraction unitRef="number" contextRef="i2ec894abcc4c490b980330e1351b89bd_I20220630" decimals="INF" name="us-gaap:LongTermDebtMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90ZXh0cmVnaW9uOjFmYTI3OTlkMjlmNzQ4NTViNjdlNzZlNzMwMTYyMDVhXzI3NDg3NzkwNzE1MTU_0b7a0e65-d0a7-40df-b6be-5ac1530904e8">10</ix:nonFraction>%. </span></div><ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90ZXh0cmVnaW9uOjFmYTI3OTlkMjlmNzQ4NTViNjdlNzZlNzMwMTYyMDVhXzg3OTYwOTMwMjYxMTU_6fc69fa5-8731-42ab-b18d-73e8c2ebdb29" escape="true"><div style="margin-bottom:9pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth a summary of the changes in the estimated fair value of the Company&#8217;s loan facility derivative liability, classified as Level 3 (in thousands): </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.750%"><tr><td style="width:1.0%"></td><td style="width:45.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.392%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.392%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.392%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.794%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9261f6f74d684c688cfaeac2f36b5a12_I20220331" decimals="-3" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTpkYTZhODdhM2Q4ODM0NWEyOTMyM2ZlNTU2NzI2MGU0Yi90YWJsZXJhbmdlOmRhNmE4N2EzZDg4MzQ1YTI5MzIzZmU1NTY3MjYwZTRiXzMtMS0xLTEtNzEyMjc_dcaafdb3-34b8-4bac-84f5-902ab1d65ad7">1,533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9d53416940548b886aec19be0a44a4e_I20210331" decimals="-3" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTpkYTZhODdhM2Q4ODM0NWEyOTMyM2ZlNTU2NzI2MGU0Yi90YWJsZXJhbmdlOmRhNmE4N2EzZDg4MzQ1YTI5MzIzZmU1NTY3MjYwZTRiXzMtMy0xLTEtNzEyMjc_78650459-7d77-4212-94c4-895f6a1c335a">1,825</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbcba339097743d39f83b2c7a95fa80c_I20211231" decimals="-3" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTpkYTZhODdhM2Q4ODM0NWEyOTMyM2ZlNTU2NzI2MGU0Yi90YWJsZXJhbmdlOmRhNmE4N2EzZDg4MzQ1YTI5MzIzZmU1NTY3MjYwZTRiXzMtNS0xLTEtNzIzMTU_5fa6ce1d-473d-4c2e-9031-3c8469f7287a">1,496</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1c2312756cd4f6e99858bfda9b5b1dc_I20201231" decimals="-3" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTpkYTZhODdhM2Q4ODM0NWEyOTMyM2ZlNTU2NzI2MGU0Yi90YWJsZXJhbmdlOmRhNmE4N2EzZDg4MzQ1YTI5MzIzZmU1NTY3MjYwZTRiXzMtNy0xLTEtNzIzMTU_83f4cbc2-e3b4-45c9-a3cb-bd6329118a51">1,782</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4a5962583214d618c2bce6e91e2bc49_D20220401-20220630" decimals="-3" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTpkYTZhODdhM2Q4ODM0NWEyOTMyM2ZlNTU2NzI2MGU0Yi90YWJsZXJhbmdlOmRhNmE4N2EzZDg4MzQ1YTI5MzIzZmU1NTY3MjYwZTRiXzQtMS0xLTEtNzEyMjc_5cc8d423-34ad-4516-a8c2-4ea1f4a6ce33">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49866073e1f44cf1b38b071917bc10c4_D20210401-20210630" decimals="-3" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTpkYTZhODdhM2Q4ODM0NWEyOTMyM2ZlNTU2NzI2MGU0Yi90YWJsZXJhbmdlOmRhNmE4N2EzZDg4MzQ1YTI5MzIzZmU1NTY3MjYwZTRiXzQtMy0xLTEtNzEyMjc_ba29d121-f5cc-4127-a60f-33c3ececd268">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b5a6a38e4a04bd580825d3c7c3c7b97_D20220101-20220630" decimals="-3" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTpkYTZhODdhM2Q4ODM0NWEyOTMyM2ZlNTU2NzI2MGU0Yi90YWJsZXJhbmdlOmRhNmE4N2EzZDg4MzQ1YTI5MzIzZmU1NTY3MjYwZTRiXzQtNS0xLTEtNzIzMTU_4609fc61-8346-47d4-991f-d62a70bb3072">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56ff5a0cd9ad480ca54975bb361ad2e2_D20210101-20210630" decimals="-3" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTpkYTZhODdhM2Q4ODM0NWEyOTMyM2ZlNTU2NzI2MGU0Yi90YWJsZXJhbmdlOmRhNmE4N2EzZDg4MzQ1YTI5MzIzZmU1NTY3MjYwZTRiXzQtNy0xLTEtNzIzMTU_d44abcaa-3603-4df3-87f8-c1d2533b69af">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4a5962583214d618c2bce6e91e2bc49_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTpkYTZhODdhM2Q4ODM0NWEyOTMyM2ZlNTU2NzI2MGU0Yi90YWJsZXJhbmdlOmRhNmE4N2EzZDg4MzQ1YTI5MzIzZmU1NTY3MjYwZTRiXzUtMS0xLTEtNzEyMjc_d7195ddf-7463-4f46-8c41-8f85f7ae2e4c">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i49866073e1f44cf1b38b071917bc10c4_D20210401-20210630" decimals="-3" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTpkYTZhODdhM2Q4ODM0NWEyOTMyM2ZlNTU2NzI2MGU0Yi90YWJsZXJhbmdlOmRhNmE4N2EzZDg4MzQ1YTI5MzIzZmU1NTY3MjYwZTRiXzUtMy0xLTEtNzEyMjc_cbf28e71-e17a-4f17-aa18-986d641d7c42">38</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b5a6a38e4a04bd580825d3c7c3c7b97_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTpkYTZhODdhM2Q4ODM0NWEyOTMyM2ZlNTU2NzI2MGU0Yi90YWJsZXJhbmdlOmRhNmE4N2EzZDg4MzQ1YTI5MzIzZmU1NTY3MjYwZTRiXzUtNS0xLTEtNzIzMTU_93acfead-d1e5-4f79-9606-620f2619e8ef">74</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56ff5a0cd9ad480ca54975bb361ad2e2_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTpkYTZhODdhM2Q4ODM0NWEyOTMyM2ZlNTU2NzI2MGU0Yi90YWJsZXJhbmdlOmRhNmE4N2EzZDg4MzQ1YTI5MzIzZmU1NTY3MjYwZTRiXzUtNy0xLTEtNzIzMTU_1b0400b0-226a-443d-a9e0-81ba28a65568">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of the period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03e5fbb904174fc6a95ec0686a05e446_I20220630" decimals="-3" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTpkYTZhODdhM2Q4ODM0NWEyOTMyM2ZlNTU2NzI2MGU0Yi90YWJsZXJhbmdlOmRhNmE4N2EzZDg4MzQ1YTI5MzIzZmU1NTY3MjYwZTRiXzctMS0xLTEtNzEyMjc_ed306ab1-1b27-4056-82b6-f352d9db6ce5">1,570</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida5e5f1bb1d542c9b2cd7ccf481a8af2_I20210630" decimals="-3" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTpkYTZhODdhM2Q4ODM0NWEyOTMyM2ZlNTU2NzI2MGU0Yi90YWJsZXJhbmdlOmRhNmE4N2EzZDg4MzQ1YTI5MzIzZmU1NTY3MjYwZTRiXzctMy0xLTEtNzEyMjc_7295ab86-b9b1-419c-9ee1-43fadf7fbe69">1,787</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03e5fbb904174fc6a95ec0686a05e446_I20220630" decimals="-3" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTpkYTZhODdhM2Q4ODM0NWEyOTMyM2ZlNTU2NzI2MGU0Yi90YWJsZXJhbmdlOmRhNmE4N2EzZDg4MzQ1YTI5MzIzZmU1NTY3MjYwZTRiXzctNS0xLTEtNzIzMTU_d6958737-b6cf-4b05-a5e9-cfeb0ac00f2c">1,570</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida5e5f1bb1d542c9b2cd7ccf481a8af2_I20210630" decimals="-3" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTpkYTZhODdhM2Q4ODM0NWEyOTMyM2ZlNTU2NzI2MGU0Yi90YWJsZXJhbmdlOmRhNmE4N2EzZDg4MzQ1YTI5MzIzZmU1NTY3MjYwZTRiXzctNy0xLTEtNzIzMTU_6cbdb289-2613-49b9-bf43-394ba40e0436">1,787</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><div id="ibb2df456afff4355bae87af9d1240625_40"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="us-gaap:InventoryDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80MC9mcmFnOjZjNTZlY2ZjNDFiZDQ1MTdhMzU0ZDA4NjhiZjIwMmY4L3RleHRyZWdpb246NmM1NmVjZmM0MWJkNDUxN2EzNTRkMDg2OGJmMjAyZjhfNDI0_55959934-567a-48bc-aa11-0ba72fd26509" continuedAt="i19fa0a59908b4fe2a1647b43ec0f8531" escape="true">Inventory</ix:nonNumeric></span></div><ix:continuation id="i19fa0a59908b4fe2a1647b43ec0f8531"><ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80MC9mcmFnOjZjNTZlY2ZjNDFiZDQ1MTdhMzU0ZDA4NjhiZjIwMmY4L3RleHRyZWdpb246NmM1NmVjZmM0MWJkNDUxN2EzNTRkMDg2OGJmMjAyZjhfNDI1_c7d231eb-a392-4ce9-827e-cf013b35a65e" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory consists of the following (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="us-gaap:InventoryRawMaterials" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80MC9mcmFnOjZjNTZlY2ZjNDFiZDQ1MTdhMzU0ZDA4NjhiZjIwMmY4L3RhYmxlOjJlNWJkMWM1ZWY0ODQ3Mjk5MWU1MGVhNzBlZjg1ZGVjL3RhYmxlcmFuZ2U6MmU1YmQxYzVlZjQ4NDcyOTkxZTUwZWE3MGVmODVkZWNfMy0xLTEtMS03MDI2NQ_a0949e74-f3dc-436d-8a89-b529622a385f">5,329</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231" decimals="-3" name="us-gaap:InventoryRawMaterials" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80MC9mcmFnOjZjNTZlY2ZjNDFiZDQ1MTdhMzU0ZDA4NjhiZjIwMmY4L3RhYmxlOjJlNWJkMWM1ZWY0ODQ3Mjk5MWU1MGVhNzBlZjg1ZGVjL3RhYmxlcmFuZ2U6MmU1YmQxYzVlZjQ4NDcyOTkxZTUwZWE3MGVmODVkZWNfMy0zLTEtMS03MDI2NQ_d35f9561-b94c-47f3-b24f-82cbc2242dc0">6,740</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="us-gaap:InventoryWorkInProcess" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80MC9mcmFnOjZjNTZlY2ZjNDFiZDQ1MTdhMzU0ZDA4NjhiZjIwMmY4L3RhYmxlOjJlNWJkMWM1ZWY0ODQ3Mjk5MWU1MGVhNzBlZjg1ZGVjL3RhYmxlcmFuZ2U6MmU1YmQxYzVlZjQ4NDcyOTkxZTUwZWE3MGVmODVkZWNfNC0xLTEtMS03MDI2NQ_4a992dc7-8bd0-4266-812a-62460c37954c">1,025</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231" decimals="-3" name="us-gaap:InventoryWorkInProcess" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80MC9mcmFnOjZjNTZlY2ZjNDFiZDQ1MTdhMzU0ZDA4NjhiZjIwMmY4L3RhYmxlOjJlNWJkMWM1ZWY0ODQ3Mjk5MWU1MGVhNzBlZjg1ZGVjL3RhYmxlcmFuZ2U6MmU1YmQxYzVlZjQ4NDcyOTkxZTUwZWE3MGVmODVkZWNfNC0zLTEtMS03MDI2NQ_26c15947-faf9-466c-afff-9c0fe702319e">905</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="us-gaap:InventoryFinishedGoods" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80MC9mcmFnOjZjNTZlY2ZjNDFiZDQ1MTdhMzU0ZDA4NjhiZjIwMmY4L3RhYmxlOjJlNWJkMWM1ZWY0ODQ3Mjk5MWU1MGVhNzBlZjg1ZGVjL3RhYmxlcmFuZ2U6MmU1YmQxYzVlZjQ4NDcyOTkxZTUwZWE3MGVmODVkZWNfNS0xLTEtMS03MDI2NQ_a2148859-aeeb-4237-957d-a70dd36e772c">7,423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231" decimals="-3" name="us-gaap:InventoryFinishedGoods" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80MC9mcmFnOjZjNTZlY2ZjNDFiZDQ1MTdhMzU0ZDA4NjhiZjIwMmY4L3RhYmxlOjJlNWJkMWM1ZWY0ODQ3Mjk5MWU1MGVhNzBlZjg1ZGVjL3RhYmxlcmFuZ2U6MmU1YmQxYzVlZjQ4NDcyOTkxZTUwZWE3MGVmODVkZWNfNS0zLTEtMS03MDI2NQ_db1eb403-f4a0-441e-aa76-5f5655dc2375">5,502</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80MC9mcmFnOjZjNTZlY2ZjNDFiZDQ1MTdhMzU0ZDA4NjhiZjIwMmY4L3RhYmxlOjJlNWJkMWM1ZWY0ODQ3Mjk5MWU1MGVhNzBlZjg1ZGVjL3RhYmxlcmFuZ2U6MmU1YmQxYzVlZjQ4NDcyOTkxZTUwZWE3MGVmODVkZWNfNi0xLTEtMS03MDI2NQ_bc127c17-2f1d-4a34-8a0b-31a15c875271">13,777</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80MC9mcmFnOjZjNTZlY2ZjNDFiZDQ1MTdhMzU0ZDA4NjhiZjIwMmY4L3RhYmxlOjJlNWJkMWM1ZWY0ODQ3Mjk5MWU1MGVhNzBlZjg1ZGVjL3RhYmxlcmFuZ2U6MmU1YmQxYzVlZjQ4NDcyOTkxZTUwZWE3MGVmODVkZWNfNi0zLTEtMS03MDI2NQ_25384c2a-9fb3-4959-a912-9d56c16c5a10">13,147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:9pt"><span><br/></span></div><div id="ibb2df456afff4355bae87af9d1240625_43"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="us-gaap:IntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80My9mcmFnOjYzZTE5MDliYTU0OTQzOWE5OTc1YTE1ZmQ1YjU1ZGM4L3RleHRyZWdpb246NjNlMTkwOWJhNTQ5NDM5YTk5NzVhMTVmZDViNTVkYzhfMTU0OA_2fa5aa88-44c0-4cb3-8cae-4ceb851dda17" continuedAt="i6dee8d7b6444454ab01527b466f3b7ed" escape="true">Intangible Assets </ix:nonNumeric></span></div><ix:continuation id="i6dee8d7b6444454ab01527b466f3b7ed"><div style="margin-bottom:9pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2019, the Company entered into a license agreement with HydroCision, Inc. This agreement grants the Company an exclusive, perpetual, irrevocable, worldwide, fully paid-up license to develop, manufacture and commercialize products in the field of urology using the patented technology and know-how controlled by HydroCision as of the effective date and as well as new patented technology developed by HydroCision that cover certain activities and improvements that relate to the use of fluid jet technology in connection with the licensed products during the period commencing on the effective date and ending on the earlier of the date that the Company ceases to use HydroCision&#8217;s existing contract manufacturers and the third anniversary of the effective date. Also included is the right to utilize HydroCision&#8217;s contract manufacturers, if desired. The consideration paid was a one-time upfront payment of $<ix:nonFraction unitRef="usd" contextRef="ie19c67cd74ed40aabeb9098c4f2fb478_D20190301-20190331" decimals="-5" name="us-gaap:PaymentsToAcquireIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80My9mcmFnOjYzZTE5MDliYTU0OTQzOWE5OTc1YTE1ZmQ1YjU1ZGM4L3RleHRyZWdpb246NjNlMTkwOWJhNTQ5NDM5YTk5NzVhMTVmZDViNTVkYzhfOTQz_b2fb0e85-0a50-41e3-bd01-4fe9cf0b930f">2.5</ix:nonFraction> million, as well as allowing HydroCision (a reciprocal license) to use any new patented technology and know-how developed by the Company relating to the HydroCision patented technology and know-how in the field of urology for HydroCision use outside the field of urology. HydroCision will pay for any patent maintenance fees on HydroCision&#8217;s licensed patents. As of June&#160;30, 2022 and December&#160;31, 2021, accumulated amortization was $<ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80My9mcmFnOjYzZTE5MDliYTU0OTQzOWE5OTc1YTE1ZmQ1YjU1ZGM4L3RleHRyZWdpb246NjNlMTkwOWJhNTQ5NDM5YTk5NzVhMTVmZDViNTVkYzhfMTM0NA_0c50c5b2-449e-4135-bc2e-a979d231b691">0.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80My9mcmFnOjYzZTE5MDliYTU0OTQzOWE5OTc1YTE1ZmQ1YjU1ZGM4L3RleHRyZWdpb246NjNlMTkwOWJhNTQ5NDM5YTk5NzVhMTVmZDViNTVkYzhfMTM1MQ_2246c6d5-b4e3-4e6a-9ca5-d6921ac691d6">0.8</ix:nonFraction> million, respectively, and the net carrying amount is expected to be amortized at a rate of $<ix:nonFraction unitRef="usd" contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231" decimals="-5" name="prct:FiniteLivedIntangibleAssetExpectedAnnualAmortizationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80My9mcmFnOjYzZTE5MDliYTU0OTQzOWE5OTc1YTE1ZmQ1YjU1ZGM4L3RleHRyZWdpb246NjNlMTkwOWJhNTQ5NDM5YTk5NzVhMTVmZDViNTVkYzhfMTQzOA_f74d799f-1fb9-43c0-8974-14cc380c3f70">0.3</ix:nonFraction> million per year until fully amortized.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense for intangible assets was $<ix:nonFraction unitRef="usd" contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80My9mcmFnOjYzZTE5MDliYTU0OTQzOWE5OTc1YTE1ZmQ1YjU1ZGM4L3RleHRyZWdpb246NjNlMTkwOWJhNTQ5NDM5YTk5NzVhMTVmZDViNTVkYzhfOTM0NTg0ODgzNzY2Mw_8056540d-d1c4-4316-9826-5b8bf626c111"><ix:nonFraction unitRef="usd" contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80My9mcmFnOjYzZTE5MDliYTU0OTQzOWE5OTc1YTE1ZmQ1YjU1ZGM4L3RleHRyZWdpb246NjNlMTkwOWJhNTQ5NDM5YTk5NzVhMTVmZDViNTVkYzhfOTM0NTg0ODgzNzY2Mw_8fef072b-1977-4685-aba8-e2006c3083b6">0.1</ix:nonFraction></ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80My9mcmFnOjYzZTE5MDliYTU0OTQzOWE5OTc1YTE1ZmQ1YjU1ZGM4L3RleHRyZWdpb246NjNlMTkwOWJhNTQ5NDM5YTk5NzVhMTVmZDViNTVkYzhfOTM0NTg0ODgzNzY5Ng_0cb44966-db8b-40f1-8787-5d04c993f957"><ix:nonFraction unitRef="usd" contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80My9mcmFnOjYzZTE5MDliYTU0OTQzOWE5OTc1YTE1ZmQ1YjU1ZGM4L3RleHRyZWdpb246NjNlMTkwOWJhNTQ5NDM5YTk5NzVhMTVmZDViNTVkYzhfOTM0NTg0ODgzNzY5Ng_1d316f01-87d9-4f68-b757-e569b818f5d4">0.1</ix:nonFraction></ix:nonFraction> million for the three and six months ended June 30, 2022 and 2021.</span></div></ix:continuation><div id="ibb2df456afff4355bae87af9d1240625_46"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfNDAwOA_12393036-695d-4904-946f-8d3d094e3dc0" continuedAt="i752e0338a4e84eb9ac7845f7f3d33e6e" escape="true"><ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="us-gaap:DerivativesAndFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfNjU5NzA2OTc3MjM5OQ_cbf4eeda-c9dc-478d-a680-d538a266ad87" continuedAt="ie5bf3b5a062247da82e73183fdb823af" escape="true">Loan Facility and Derivative Liability</ix:nonNumeric></ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i752e0338a4e84eb9ac7845f7f3d33e6e" continuedAt="if2bc5824fe6e407580173ba65c01eacd"><ix:continuation id="ie5bf3b5a062247da82e73183fdb823af" continuedAt="ie313c52ad9b048d6907638724bdcaa5b">In September 2019, the Company entered into a loan facility for up to $<ix:nonFraction unitRef="usd" contextRef="i1e254378ff134e9681a4249bcc83e5fc_I20190930" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfOTM_6bb78aa4-2dcc-45bd-882e-c783e4c3bfd0">75.0</ix:nonFraction> million available in <ix:nonFraction unitRef="installment" contextRef="i1e254378ff134e9681a4249bcc83e5fc_I20190930" decimals="INF" name="prct:LineOfCreditFacilityNumberOfInstallments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfMTA5_fbf30033-3218-472e-a0e1-00a3003fa218">four</ix:nonFraction> installments. The Company borrowed $<ix:nonFraction unitRef="usd" contextRef="i10156edb55894acbb210fec9c3468287_D20190901-20190930" decimals="-5" name="us-gaap:ProceedsFromLongTermLinesOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfMTQ3_dfc6b2df-3c5a-4727-a567-a0c8e114772e">25.0</ix:nonFraction> million in September 2019. An additional $<ix:nonFraction unitRef="usd" contextRef="i0b01acac5e6143eaba1f435139069823_D20200301-20200331" decimals="-5" name="us-gaap:ProceedsFromLongTermLinesOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfMTgz_41e54911-702e-494e-a072-460b4d205320">25.0</ix:nonFraction> million was borrowed in March 2020. The third installment of $<ix:nonFraction unitRef="usd" contextRef="ib4b1440f6de14019a797df774eb5f464_I20210331" decimals="-5" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfMjM5_2fc9d59b-4942-4c3b-8291-a259b8369b04">10.0</ix:nonFraction> million was originally available for draw through March 31, 2021 contingent upon achieving $<ix:nonFraction unitRef="usd" contextRef="i3c2a33ef0d514076961c5e1590bfa66c_D20210101-20210630" decimals="-5" name="prct:LineOfCreditFacilityCovenantComplianceContingentTrailingSixTwelveMonthRevenueTarget" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfMzI1_40c29f20-9b05-456a-9e0b-a350ed2789bb">20.0</ix:nonFraction> million in trailing six months revenue. In January 2021, the third installment was amended to be available for draw through June 30, 2021 contingent upon achieving $<ix:nonFraction unitRef="usd" contextRef="i6777b1709ddc4642b6a8f38a6e6be39d_D20210101-20210131" decimals="-5" name="prct:LineOfCreditFacilityCovenantComplianceContingentTrailingSixTwelveMonthRevenueTarget" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfNDgz_1a347504-e99a-4dac-9e60-278806c4eafb">6.4</ix:nonFraction> million trailing six months revenue. The remaining $<ix:nonFraction unitRef="usd" contextRef="i33d2d97450ea42cea69aeef3e9ea7937_I20210630" decimals="-5" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfNTI4_b6f0f067-83dd-46ec-a55c-24c496137151">15.0</ix:nonFraction> million was originally available for draw through June 30, 2021 and is contingent upon achieving $<ix:nonFraction unitRef="usd" contextRef="ia16ecc55dbd348ecaaaaaa7c92629f98_D20210101-20210630" decimals="-5" name="prct:LineOfCreditFacilityCovenantComplianceContingentTrailingSixTwelveMonthRevenueTarget" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfNjIw_05bff03a-d723-4f09-beb6-6cbc45913d1e">25.0</ix:nonFraction>&#160;million in trailing six months revenue. In January 2021, this installment was amended to be available for draw through June 30, 2022. The facility bears an interest rate of the greater of (i) <ix:nonFraction unitRef="number" contextRef="i9256f6c0b3ab484d973170c275d30dd6_I20210131" decimals="INF" name="us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfNzg3_725f1028-ab4b-4381-8d91-d77e53c74ba3">9.37</ix:nonFraction>% and (ii) <ix:nonFraction unitRef="number" contextRef="ia2530161d85e4792bd363ce72e96e9b9_I20210131" decimals="INF" name="us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfNjU5NzA2OTc3MjM5Mw_ac900af3-5ea9-4b38-9161-b3cef8ac25ca">7.17</ix:nonFraction>% plus 30 day LIBOR. The initial term of the facility is <ix:nonNumeric contextRef="i861bb40fd82c4a378c9527bee4405c32_D20210101-20210131" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfNDAwOQ_d84fba94-c867-4754-ae89-2a7dde6ba83f">60</ix:nonNumeric> months with interest-only payments each month for <ix:nonNumeric contextRef="i861bb40fd82c4a378c9527bee4405c32_D20210101-20210131" name="prct:DebtInstrumentInterestOnlyPeriod" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfNDAxMA_f4ac91f5-51d5-4ed0-ad39-f3a8d4e56741">24</ix:nonNumeric> months followed by <ix:nonNumeric contextRef="i861bb40fd82c4a378c9527bee4405c32_D20210101-20210131" name="prct:DebtInstrumentPrincipalAndInterestPeriod" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfNDAxNA_9a86baa3-b670-4bd0-82a2-fa8215cf424b">36</ix:nonNumeric> months amortization of principal and interest. In January 2021, the interest-only period was amended to <ix:nonNumeric contextRef="i6777b1709ddc4642b6a8f38a6e6be39d_D20210101-20210131" name="prct:DebtInstrumentInterestOnlyPeriod" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfNDAxNQ_02d0093d-67c4-4c7d-9438-bbfcb7d179ee">36</ix:nonNumeric> months followed by <ix:nonNumeric contextRef="i6777b1709ddc4642b6a8f38a6e6be39d_D20210101-20210131" name="prct:DebtInstrumentPrincipalAndInterestPeriod" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfNDAxNg_a9229fed-2799-4792-a72b-5c9a0582d85b">24</ix:nonNumeric> months amortization (principal and interest) beginning October 1, 2022 since the amended trailing six months target revenue of $<ix:nonFraction unitRef="usd" contextRef="i6777b1709ddc4642b6a8f38a6e6be39d_D20210101-20210131" decimals="-5" name="prct:LineOfCreditFacilityCovenantComplianceContingentTrailingSixTwelveMonthRevenueTarget" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfMTIxMg_d268d0ea-488e-4f3d-84a0-b22290abf70f">6.4</ix:nonFraction> million was achieved, and accordingly, the current portion of the amount due was reclassified to non-current. Upon drawing the final $<ix:nonFraction unitRef="usd" contextRef="ia47c0681a1b8412cb1f3e5eb400ad5fc_I20220630" decimals="-5" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfMTM0MA_a5bc32c1-9048-43cc-b92e-8608bff06f04">15.0</ix:nonFraction> million tranche, the interest-only period was extended <ix:nonNumeric contextRef="i3bba515e9a0d4545bb068c2fe7296bf1_D20220101-20220630" name="prct:DebtInstrumentContingentBorrowingExtendedInterestOnlyPeriod" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfNDAxMQ_ef8f93c4-1194-404f-8121-da60b486ebef">12</ix:nonNumeric> months followed by <ix:nonNumeric contextRef="i3bba515e9a0d4545bb068c2fe7296bf1_D20220101-20220630" name="prct:DebtInstrumentContingentBorrowingExtendedPrincipalAndInterestPeriod" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfNDAxMg_33775792-359e-471d-a526-60d2fa8a554a">24</ix:nonNumeric> months amortization of principal and interest. Upon the completion of the Company raising over $<ix:nonFraction unitRef="usd" contextRef="if00ac5ae82404ee98272aabd9c6a9606_D20210901-20210930" decimals="-5" name="prct:DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfMTUwNQ_19923278-9ff0-4238-a496-2bddbfa0455c">50.0</ix:nonFraction> million in its IPO in September 2021, interest-only payments were extended an additional <ix:nonNumeric contextRef="if00ac5ae82404ee98272aabd9c6a9606_D20210901-20210930" name="prct:DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmountAchievedExtendedInterestOnlyPeriod" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfNDAwNQ_b4cccc6e-4b21-4754-b3d0-2351cbfd517d">12</ix:nonNumeric> months followed by <ix:nonNumeric contextRef="if00ac5ae82404ee98272aabd9c6a9606_D20210901-20210930" name="prct:DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmountAchievedExtendedPrincipalAndInterestPeriod" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfNDAwNg_49a59d95-e62c-447d-8bce-5ab15c32c4cf">12</ix:nonNumeric> months amortization of principal and interest. Substantially all assets of the Company are pledged as collateral. Commencing with the earlier of June 30, 2021 and the month following the funding of either the third or final installment, the Company is required to achieve revenues for the previous six months ended equal to the greater of (1) <ix:nonFraction unitRef="number" contextRef="i683101ff096c40c2a24cbd6236452190_I20210630" decimals="INF" name="prct:DebtInstrumentCovenantComplianceRevenueForecastForCommensuratePeriodPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfMTk1Ng_918e0328-7703-45b7-ad44-db916ce18e5f">70</ix:nonFraction>% of the forecast for the commensurate period, (2) $<ix:nonFraction unitRef="usd" contextRef="i683101ff096c40c2a24cbd6236452190_I20210630" decimals="-5" name="prct:DebtInstrumentCovenantComplianceRevenueForecastAmountFirstTwoInstallmentsOnly" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfMjAwOA_7e079d51-e970-42d0-80a9-39d9fbf03a6e">15.0</ix:nonFraction> million if </ix:continuation></ix:continuation></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span><br/></span></div></div><ix:continuation id="if2bc5824fe6e407580173ba65c01eacd" continuedAt="idf2832accc584425b0d57efe5f7f419b"><ix:continuation id="ie313c52ad9b048d6907638724bdcaa5b" continuedAt="i783bb79fa95240d98b23ea0033b1ddef"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">neither third or final installments have been drawn, (3) $<ix:nonFraction unitRef="usd" contextRef="i683101ff096c40c2a24cbd6236452190_I20210630" decimals="-5" name="prct:DebtInstrumentCovenantComplianceRevenueForecastAmountFirstThreeInstallmentsOnly" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfMjA3MQ_49045d63-9ba1-465a-93e1-032637cd4c29">20.0</ix:nonFraction> million if the third but not final installment has been drawn and (4) $<ix:nonFraction unitRef="usd" contextRef="i683101ff096c40c2a24cbd6236452190_I20210630" decimals="-5" name="prct:DebtInstrumentCovenantComplianceRevenueForecastAmountAllInstallmentsDrawn" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfMjEzNg_26c4cf16-9105-4f4e-b19e-af396538ca49">25.0</ix:nonFraction> million if both the third and final installments have been drawn.  </span></div><div style="margin-bottom:9pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The loan facility includes certain fees payable to the lender recorded as a loan discount that are accrued and amortized to interest expense during the loan term. A <ix:nonFraction unitRef="number" contextRef="ib1c06405d72a4f48a81ffc14a560fce7_I20220630" decimals="INF" name="prct:LineOfCreditFacilityFinalPaymentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfMjM2NA_87d0906b-2816-4835-a39d-ffab936fefd7">6</ix:nonFraction>% final payment fee of each funded tranche is payable at the earlier of prepayment or loan maturity and a <ix:nonFraction unitRef="number" contextRef="id06260efb84542fcbe48470c87f30c7c_D20220101-20220630" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfMjQ3MQ_9b1380e7-6ffe-43b1-8358-d331e85bac70">0.25</ix:nonFraction>% facility fee paid at each funded tranche. A prepayment fee was originally payable if the loan is paid before maturity in the amount of <ix:nonFraction unitRef="number" contextRef="ib1c06405d72a4f48a81ffc14a560fce7_I20220630" decimals="INF" name="prct:LineOfCreditFacilityEarlyRepaymentFeeFirstTwelveMonthPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfMjYwOQ_d28c193b-d0a3-44db-bcf8-0a21867ab9bb">3</ix:nonFraction>% of loans outstanding if paid in full during first 12 months, <ix:nonFraction unitRef="number" contextRef="ib1c06405d72a4f48a81ffc14a560fce7_I20220630" decimals="INF" name="prct:LineOfCreditFacilityEarlyRepaymentFeeSecondTwelveMonthPeriodPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfMjY3Mw_9693eb04-e308-405a-bbd1-bd6f6bc10819">2</ix:nonFraction>% if loan is paid in full during second twelve months, or <ix:nonFraction unitRef="number" contextRef="ib1c06405d72a4f48a81ffc14a560fce7_I20220630" decimals="INF" name="prct:LineOfCreditFacilityEarlyRepaymentFeeTwentyFourMonthsThruMaturityPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfMjcyOA_8fe4aa38-745f-484f-89c3-c9f2f46e6703">1</ix:nonFraction>% if loan is paid in full thereafter before maturity. In January 2021, the prepayment fee was removed as part of the amendments. In addition, the Company would pay the lender&#8217;s loan initiation fees and a fee upon the earlier occurrence of a defined liquidity event, including but not limited to, a merger or sale of the Company&#8217;s assets or voting stock, or achieving a $<ix:nonFraction unitRef="usd" contextRef="id06260efb84542fcbe48470c87f30c7c_D20220101-20220630" decimals="-6" name="prct:LineOfCreditFacilityCovenantComplianceContingentTrailingTwelveMonthRevenueTarget" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfMzA5OQ_76cefc1d-e696-4a2a-914f-d1b8e6eeb121">200</ix:nonFraction> million trailing twelve months revenue target, in each case, by September 2029</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success fees are calculated at the time of the liquidity event occurrence to be $<ix:nonFraction unitRef="usd" contextRef="ib1c06405d72a4f48a81ffc14a560fce7_I20220630" decimals="-5" name="prct:LineOfCreditFacilityCovenantTermsLiquidityOccurrenceOneInstallmentDrawn" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfMzI1NA_5e96bd46-144d-4932-aec7-e32b0ea593d2">1.0</ix:nonFraction> million if only the first installment has been drawn, $<ix:nonFraction unitRef="usd" contextRef="ib1c06405d72a4f48a81ffc14a560fce7_I20220630" decimals="-5" name="prct:LineOfCreditFacilityCovenantTermsLiquidityOccurrenceTwoInstallmentsDrawn" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfMzMwMw_31bf5def-018e-49b1-8b03-ee577e5b3243">2.0</ix:nonFraction> million if the first two installments have been drawn, $<ix:nonFraction unitRef="usd" contextRef="ib1c06405d72a4f48a81ffc14a560fce7_I20220630" decimals="-5" name="prct:LineOfCreditFacilityCovenantTermsLiquidityOccurrenceThreeInstallmentsDrawn" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfMzM1Mw_ad694229-3d2f-43ba-a5ca-d94f5e901144">2.4</ix:nonFraction> million if the first three installments have been drawn, or $<ix:nonFraction unitRef="usd" contextRef="ib1c06405d72a4f48a81ffc14a560fce7_I20220630" decimals="-5" name="prct:LineOfCreditFacilityCovenantTermsLiquidityOccurrenceFourInstallmentsDrawn" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfMzQwOA_35b64f86-2784-4bcb-aefa-ca15551a116d">3.0</ix:nonFraction> million if all four installments have been drawn, in each case, upon the occurrence of the defined liquidity event. As of June&#160;30, 2022, the Company has drawn on the first two installments. The Company determined that this obligation to pay success fees represents freestanding financial instruments. </span></div><div style="margin-bottom:9pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amendments in January 2021 were accounted for as a debt modification under ASC 470-50-40 as the changes in the debt terms are not considered substantial, and thus <ix:nonFraction unitRef="usd" contextRef="i19e8bd64054f475ea78f283d6415e474_D20210101-20211231" decimals="INF" name="prct:LineOfCreditFacilityGainLossOnAmendmentOfDebtTerms" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfMzg2MA_bb66c231-6a03-471f-978c-5ced04519851">no</ix:nonFraction> gain or loss was recorded and a new effective interest rate was established based on the carrying value of the loan and the revised cash flows.</span></div></ix:continuation></ix:continuation><div style="margin-bottom:9pt;text-indent:24.5pt"><ix:continuation id="idf2832accc584425b0d57efe5f7f419b" continuedAt="ia2f0c6cfc69042c9b08df109514c933a"><ix:continuation id="i783bb79fa95240d98b23ea0033b1ddef" continuedAt="i56a300092ed24bd28ed533a7c4289f87"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Company&#8217;s loan facility, the Company is obligated to pay a fee upon the earlier occurrence of a defined liquidity event, including but not limited to, a merger or sale of its assets or voting stock, or achieving a $<ix:nonFraction unitRef="usd" contextRef="ie2afc20bf0a74c8497a36a93f40390d4_D20220101-20220630" decimals="-5" name="prct:LineOfCreditFacilityCovenantComplianceContingentTrailingTwelveMonthRevenueTarget" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfMjc0ODc3OTA3MzczNA_904dcc18-8cbf-4cc1-8ba9-0430013a97b4">200.0</ix:nonFraction>&#160;million trailing twelve months revenue target, in each case, by September 2029</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">. </span></ix:continuation></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ia2f0c6cfc69042c9b08df109514c933a"><ix:continuation id="i56a300092ed24bd28ed533a7c4289f87">The fee is calculated at the time of the liquidity event occurrence to be $<ix:nonFraction unitRef="usd" contextRef="i68b9bf6c49b34ddb9f9cdf4df2a9cde7_I20220630" decimals="-5" name="prct:LineOfCreditFacilityCovenantTermsLiquidityOccurrenceOneInstallmentDrawn" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfMjc0ODc3OTA3Mzg4NA_e6a9150c-1d23-4b9b-824c-3f5bf673ee30">1.0</ix:nonFraction>&#160;million if only the first installment has been drawn, $<ix:nonFraction unitRef="usd" contextRef="i68b9bf6c49b34ddb9f9cdf4df2a9cde7_I20220630" decimals="-5" name="prct:LineOfCreditFacilityCovenantTermsLiquidityOccurrenceTwoInstallmentsDrawn" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfMjc0ODc3OTA3MzkzNA_f127809d-f540-4a74-885f-1054dcf680a6">2.0</ix:nonFraction> million if the first two installments have been drawn, $<ix:nonFraction unitRef="usd" contextRef="i68b9bf6c49b34ddb9f9cdf4df2a9cde7_I20220630" decimals="-5" name="prct:LineOfCreditFacilityCovenantTermsLiquidityOccurrenceThreeInstallmentsDrawn" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfMjc0ODc3OTA3Mzk4NQ_eb09fbb2-2f0a-45d8-8f82-c9a924355d65">2.4</ix:nonFraction> million if the first three installments have been drawn, or $<ix:nonFraction unitRef="usd" contextRef="i68b9bf6c49b34ddb9f9cdf4df2a9cde7_I20220630" decimals="-5" name="prct:LineOfCreditFacilityCovenantTermsLiquidityOccurrenceFourInstallmentsDrawn" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfMjc0ODc3OTA3NDA0MQ_aebe9f25-fa48-437b-8cc1-7f7f43271688">3.0</ix:nonFraction> million if all four installments have been drawn, in each case, upon the occurrence of the liquidity event. As of June&#160;30, 2022, the Company has drawn on the first two installments. The Company has determined this fee is a freestanding derivative instrument. The initial $<ix:nonFraction unitRef="usd" contextRef="i68b9bf6c49b34ddb9f9cdf4df2a9cde7_I20220630" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfMjc0ODc3OTA3NDI5MA_6b638070-44e5-4f1d-8798-5af42b73e56f">1.4</ix:nonFraction> million fair value of this loan facility derivative was recorded as a debt discount and liability on the date of issuance in connection with obtaining additional financing as applicable and will be revalued every reporting period until the earlier occurrence of a defined liquidity event or achieving a revenue target by September 2029 or termination of such fee arrangement.</ix:continuation></ix:continuation>  </span></div><div style="margin-bottom:9pt;text-indent:24.5pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><div id="ibb2df456afff4355bae87af9d1240625_49"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RleHRyZWdpb246YmIwZTNiYzI1ODYxNDUxOTliMWM1ZWZiN2U2YWM3YjNfNDk4_8d40bc61-e66f-4649-a066-6844c5fb5231" continuedAt="i80346b3b355746a2a74e6c5a939e4811" escape="true">Stock-Based Compensation</ix:nonNumeric></span></div><ix:continuation id="i80346b3b355746a2a74e6c5a939e4811" continuedAt="i3324375832a54aef96ad10ab75a16016"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had <ix:nonFraction unitRef="shares" contextRef="ifa96468d217b44f29426837ed43cb27e_I20220630" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RleHRyZWdpb246YmIwZTNiYzI1ODYxNDUxOTliMWM1ZWZiN2U2YWM3YjNfMjc0ODc3OTA4MTUxMg_4b788c39-2e71-416a-8fed-e10f996e5791">4.5</ix:nonFraction>&#160;million shares available for grant as of June 30, 2022 under the 2021 Equity Incentive Award Plan. The Company ceased making awards under the 2008 Stock Plan upon the effective date of the Company&#8217;s IPO.</span></div><ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RleHRyZWdpb246YmIwZTNiYzI1ODYxNDUxOTliMWM1ZWZiN2U2YWM3YjNfODc5NjA5MzAyODI4Ng_f16bf758-b403-4bfe-8bf2-a0f984b8e1f4" escape="true"><div style="margin-bottom:9pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the Company&#8217;s stock option activity and related information are as follows (shares in thousands): </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding, beginning of period</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i98ec9d7c3e23460eb44d3b79a24f38f8_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjJiY2E4MjE2MGFmZDRlZmRhNTIwMzFkMjdhMGFlODdiL3RhYmxlcmFuZ2U6MmJjYTgyMTYwYWZkNGVmZGE1MjAzMWQyN2EwYWU4N2JfNC0xLTEtMS03MTQ4Ng_20095078-ab91-4cfb-b5c5-05112718bb23">6,365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i98ec9d7c3e23460eb44d3b79a24f38f8_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjJiY2E4MjE2MGFmZDRlZmRhNTIwMzFkMjdhMGFlODdiL3RhYmxlcmFuZ2U6MmJjYTgyMTYwYWZkNGVmZGE1MjAzMWQyN2EwYWU4N2JfNC0zLTEtMS03MTQ4Ng_9c89d86f-b907-49e2-831e-186adbb2348b">5.34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i73c3f9942c10418c97d1df582f8b37c7_D20220101-20220630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjJiY2E4MjE2MGFmZDRlZmRhNTIwMzFkMjdhMGFlODdiL3RhYmxlcmFuZ2U6MmJjYTgyMTYwYWZkNGVmZGE1MjAzMWQyN2EwYWU4N2JfNS0xLTEtMS03MTQ4Ng_1f35fefb-3294-4316-9f75-b81ac7b7ccd7">254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i73c3f9942c10418c97d1df582f8b37c7_D20220101-20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjJiY2E4MjE2MGFmZDRlZmRhNTIwMzFkMjdhMGFlODdiL3RhYmxlcmFuZ2U6MmJjYTgyMTYwYWZkNGVmZGE1MjAzMWQyN2EwYWU4N2JfNS0zLTEtMS03MTQ4Ng_8c1c5d0d-1669-48b6-9e7e-fb4da5e4604b">35.58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i73c3f9942c10418c97d1df582f8b37c7_D20220101-20220630" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjJiY2E4MjE2MGFmZDRlZmRhNTIwMzFkMjdhMGFlODdiL3RhYmxlcmFuZ2U6MmJjYTgyMTYwYWZkNGVmZGE1MjAzMWQyN2EwYWU4N2JfNi0xLTEtMS03MTQ4Ng_c0669320-04e3-4a75-b95b-5aafa8c38cd6">802</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i73c3f9942c10418c97d1df582f8b37c7_D20220101-20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjJiY2E4MjE2MGFmZDRlZmRhNTIwMzFkMjdhMGFlODdiL3RhYmxlcmFuZ2U6MmJjYTgyMTYwYWZkNGVmZGE1MjAzMWQyN2EwYWU4N2JfNi0zLTEtMS03MTQ4Ng_551c0eae-b5a6-47d7-aa9e-d1e84f6b52cb">3.57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i73c3f9942c10418c97d1df582f8b37c7_D20220101-20220630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjJiY2E4MjE2MGFmZDRlZmRhNTIwMzFkMjdhMGFlODdiL3RhYmxlcmFuZ2U6MmJjYTgyMTYwYWZkNGVmZGE1MjAzMWQyN2EwYWU4N2JfNy0xLTEtMS03MTQ4Ng_46c7d224-ba38-445e-bca7-5c779e88345a">151</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i73c3f9942c10418c97d1df582f8b37c7_D20220101-20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjJiY2E4MjE2MGFmZDRlZmRhNTIwMzFkMjdhMGFlODdiL3RhYmxlcmFuZ2U6MmJjYTgyMTYwYWZkNGVmZGE1MjAzMWQyN2EwYWU4N2JfNy0zLTEtMS03MTQ4Ng_a9c81159-b06a-4419-9f55-809d5570ee0e">7.09</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding, end of period</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1f17d9fd3b0f45df96c50d9c3c83002b_I20220630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjJiY2E4MjE2MGFmZDRlZmRhNTIwMzFkMjdhMGFlODdiL3RhYmxlcmFuZ2U6MmJjYTgyMTYwYWZkNGVmZGE1MjAzMWQyN2EwYWU4N2JfOC0xLTEtMS03MTQ4Ng_effdf7ea-8dd5-4ef1-9231-66a223c726c0">5,666</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1f17d9fd3b0f45df96c50d9c3c83002b_I20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjJiY2E4MjE2MGFmZDRlZmRhNTIwMzFkMjdhMGFlODdiL3RhYmxlcmFuZ2U6MmJjYTgyMTYwYWZkNGVmZGE1MjAzMWQyN2EwYWU4N2JfOC0zLTEtMS03MTQ4Ng_adf664c0-e211-41ed-85db-526d8debeec1">6.90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1f17d9fd3b0f45df96c50d9c3c83002b_I20220630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjJiY2E4MjE2MGFmZDRlZmRhNTIwMzFkMjdhMGFlODdiL3RhYmxlcmFuZ2U6MmJjYTgyMTYwYWZkNGVmZGE1MjAzMWQyN2EwYWU4N2JfOS0xLTEtMS03MTQ4Ng_26c212d3-b2b4-4a3d-bf96-d77b3c4c5029">5,666</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1f17d9fd3b0f45df96c50d9c3c83002b_I20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjJiY2E4MjE2MGFmZDRlZmRhNTIwMzFkMjdhMGFlODdiL3RhYmxlcmFuZ2U6MmJjYTgyMTYwYWZkNGVmZGE1MjAzMWQyN2EwYWU4N2JfOS0zLTEtMS03MTQ4Ng_7d5049a6-8624-4008-ba9d-161f92de2bec">6.90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1f17d9fd3b0f45df96c50d9c3c83002b_I20220630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjJiY2E4MjE2MGFmZDRlZmRhNTIwMzFkMjdhMGFlODdiL3RhYmxlcmFuZ2U6MmJjYTgyMTYwYWZkNGVmZGE1MjAzMWQyN2EwYWU4N2JfMTAtMS0xLTEtNzE0ODY_cbd37ea6-b91c-4a07-ac70-d47817993d8f">2,933</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1f17d9fd3b0f45df96c50d9c3c83002b_I20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjJiY2E4MjE2MGFmZDRlZmRhNTIwMzFkMjdhMGFlODdiL3RhYmxlcmFuZ2U6MmJjYTgyMTYwYWZkNGVmZGE1MjAzMWQyN2EwYWU4N2JfMTAtMy0xLTEtNzE0ODY_0d137cf2-5fb8-465f-98a0-b7520b712230">4.63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022 and December&#160;31, 2021, the aggregate pre-tax intrinsic value of options outstanding and exercisable was $<ix:nonFraction unitRef="usd" contextRef="i1f17d9fd3b0f45df96c50d9c3c83002b_I20220630" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RleHRyZWdpb246YmIwZTNiYzI1ODYxNDUxOTliMWM1ZWZiN2U2YWM3YjNfMjc0ODc3OTA3MDY5OQ_2ad4d252-6b45-4cad-aa84-e31306184684">82.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i98ec9d7c3e23460eb44d3b79a24f38f8_I20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RleHRyZWdpb246YmIwZTNiYzI1ODYxNDUxOTliMWM1ZWZiN2U2YWM3YjNfMjc0ODc3OTA3MDcwNw_1c2444ce-19c5-47a6-9a95-b7b1bee04be5">64.3</ix:nonFraction> million, respectively, and the aggregate pre-tax intrinsic value options outstanding were $<ix:nonFraction unitRef="usd" contextRef="i1f17d9fd3b0f45df96c50d9c3c83002b_I20220630" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RleHRyZWdpb246YmIwZTNiYzI1ODYxNDUxOTliMWM1ZWZiN2U2YWM3YjNfMjc0ODc3OTA3MDc1NQ_fe11a9f5-877e-4eb5-a222-aeda3999d194">147.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i98ec9d7c3e23460eb44d3b79a24f38f8_I20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RleHRyZWdpb246YmIwZTNiYzI1ODYxNDUxOTliMWM1ZWZiN2U2YWM3YjNfMjc0ODc3OTA3MDc2Mw_6e912663-0b92-4432-8282-d7f64f1665b1">125.7</ix:nonFraction> million, respectively. The aggregate pre-tax intrinsic value of options exercised was $<ix:nonFraction unitRef="usd" contextRef="i73c3f9942c10418c97d1df582f8b37c7_D20220101-20220630" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RleHRyZWdpb246YmIwZTNiYzI1ODYxNDUxOTliMWM1ZWZiN2U2YWM3YjNfMjc0ODc3OTA3MDg0NQ_00ef5f3a-f30e-486f-a4ac-97ef208dfd5f">21.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i7eabbab66fc246509ee375373f59a3c8_D20210101-20210630" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RleHRyZWdpb246YmIwZTNiYzI1ODYxNDUxOTliMWM1ZWZiN2U2YWM3YjNfMjc0ODc3OTA3MDg1Mw_ad0c3ad0-c9cb-4aaf-bb44-67dd959eea1e">3.4</ix:nonFraction> million during the six months ended June&#160;30, 2022 and 2021, respectively. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2022, there was a total of $<ix:nonFraction unitRef="usd" contextRef="i73c3f9942c10418c97d1df582f8b37c7_D20220101-20220630" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RleHRyZWdpb246YmIwZTNiYzI1ODYxNDUxOTliMWM1ZWZiN2U2YWM3YjNfOTM0NTg0ODg0MzA0Ng_e16d7be5-2157-486c-8960-4d4610132162">11.4</ix:nonFraction> million of unrecognized stock-based compensation expense related to stock options.</span></div><ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RleHRyZWdpb246YmIwZTNiYzI1ODYxNDUxOTliMWM1ZWZiN2U2YWM3YjNfNjU5NzA2OTc3ODg4OA_2c4734e6-3283-4c29-a3b6-afdc01a3cfe1" continuedAt="i0773926cbb2743c88039703b8d31600e" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the options granted to employees or directors was estimated as of the grant date using the Black-Scholes model assuming the weighted-average assumptions listed in the following table: </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (years)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i00f54e9cbe804bb38c30969068ff45d3_D20220401-20220630" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOmM3NGM4MzYxNDQ2NDQ0ZjZhZTJjMzY2ODVjNjRiZjViL3RhYmxlcmFuZ2U6Yzc0YzgzNjE0NDY0NDRmNmFlMmMzNjY4NWM2NGJmNWJfMy0xLTEtMS03MjY5MA_5dbe2cc6-982b-496b-b863-146aab0c62bf">5.8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5734f87cb59c4ab99ff5087249c3e6bc_D20210401-20210630" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOmM3NGM4MzYxNDQ2NDQ0ZjZhZTJjMzY2ODVjNjRiZjViL3RhYmxlcmFuZ2U6Yzc0YzgzNjE0NDY0NDRmNmFlMmMzNjY4NWM2NGJmNWJfMy0zLTEtMS03MjY5MA_9795ab42-2f22-4669-9945-c9bd71c60147">6.0</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i73c3f9942c10418c97d1df582f8b37c7_D20220101-20220630" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOmM3NGM4MzYxNDQ2NDQ0ZjZhZTJjMzY2ODVjNjRiZjViL3RhYmxlcmFuZ2U6Yzc0YzgzNjE0NDY0NDRmNmFlMmMzNjY4NWM2NGJmNWJfMy01LTEtMS03Mjc3NQ_bc69e36e-3309-4e3a-abc6-847037b5067f">5.9</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7eabbab66fc246509ee375373f59a3c8_D20210101-20210630" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOmM3NGM4MzYxNDQ2NDQ0ZjZhZTJjMzY2ODVjNjRiZjViL3RhYmxlcmFuZ2U6Yzc0YzgzNjE0NDY0NDRmNmFlMmMzNjY4NWM2NGJmNWJfMy03LTEtMS03Mjc3NQ_050f5688-0db2-4b26-9e62-d56fd1eaf442">6.0</ix:nonNumeric></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i00f54e9cbe804bb38c30969068ff45d3_D20220401-20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOmM3NGM4MzYxNDQ2NDQ0ZjZhZTJjMzY2ODVjNjRiZjViL3RhYmxlcmFuZ2U6Yzc0YzgzNjE0NDY0NDRmNmFlMmMzNjY4NWM2NGJmNWJfNC0xLTEtMS03MjY5MA_378299c6-8b33-4c36-ad2e-33b3037021fc">56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5734f87cb59c4ab99ff5087249c3e6bc_D20210401-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOmM3NGM4MzYxNDQ2NDQ0ZjZhZTJjMzY2ODVjNjRiZjViL3RhYmxlcmFuZ2U6Yzc0YzgzNjE0NDY0NDRmNmFlMmMzNjY4NWM2NGJmNWJfNC0zLTEtMS03MjY5MA_bb0ca9a1-95b2-4e1f-87d2-2f9d8ea2a656">52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i73c3f9942c10418c97d1df582f8b37c7_D20220101-20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOmM3NGM4MzYxNDQ2NDQ0ZjZhZTJjMzY2ODVjNjRiZjViL3RhYmxlcmFuZ2U6Yzc0YzgzNjE0NDY0NDRmNmFlMmMzNjY4NWM2NGJmNWJfNC01LTEtMS03Mjc3NQ_769e793b-34f2-4e8b-9713-1ab29bfaefad">55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7eabbab66fc246509ee375373f59a3c8_D20210101-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOmM3NGM4MzYxNDQ2NDQ0ZjZhZTJjMzY2ODVjNjRiZjViL3RhYmxlcmFuZ2U6Yzc0YzgzNjE0NDY0NDRmNmFlMmMzNjY4NWM2NGJmNWJfNC03LTEtMS03Mjc3NQ_2d7b410d-7043-4a7c-8faf-b596b804070b">49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i00f54e9cbe804bb38c30969068ff45d3_D20220401-20220630" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOmM3NGM4MzYxNDQ2NDQ0ZjZhZTJjMzY2ODVjNjRiZjViL3RhYmxlcmFuZ2U6Yzc0YzgzNjE0NDY0NDRmNmFlMmMzNjY4NWM2NGJmNWJfNS0xLTEtMS03MjY5MA_8334b2bc-f17c-4244-ad6e-5675a5b76721">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5734f87cb59c4ab99ff5087249c3e6bc_D20210401-20210630" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOmM3NGM4MzYxNDQ2NDQ0ZjZhZTJjMzY2ODVjNjRiZjViL3RhYmxlcmFuZ2U6Yzc0YzgzNjE0NDY0NDRmNmFlMmMzNjY4NWM2NGJmNWJfNS0zLTEtMS03MjY5MA_f2c412b7-0d58-443a-9f28-2115f2e2c17f">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i73c3f9942c10418c97d1df582f8b37c7_D20220101-20220630" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOmM3NGM4MzYxNDQ2NDQ0ZjZhZTJjMzY2ODVjNjRiZjViL3RhYmxlcmFuZ2U6Yzc0YzgzNjE0NDY0NDRmNmFlMmMzNjY4NWM2NGJmNWJfNS01LTEtMS03Mjc3NQ_088f382d-d31a-45af-9b12-892ccfb97e36">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7eabbab66fc246509ee375373f59a3c8_D20210101-20210630" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOmM3NGM4MzYxNDQ2NDQ0ZjZhZTJjMzY2ODVjNjRiZjViL3RhYmxlcmFuZ2U6Yzc0YzgzNjE0NDY0NDRmNmFlMmMzNjY4NWM2NGJmNWJfNS03LTEtMS03Mjc3NQ_bb679333-671d-4284-81cf-fa771f826f6a">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend rate </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i00f54e9cbe804bb38c30969068ff45d3_D20220401-20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOmM3NGM4MzYxNDQ2NDQ0ZjZhZTJjMzY2ODVjNjRiZjViL3RhYmxlcmFuZ2U6Yzc0YzgzNjE0NDY0NDRmNmFlMmMzNjY4NWM2NGJmNWJfNi0xLTEtMS03MjY5MA_d2b79c1b-3659-43e9-b2cf-f3698ed24c09">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5734f87cb59c4ab99ff5087249c3e6bc_D20210401-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOmM3NGM4MzYxNDQ2NDQ0ZjZhZTJjMzY2ODVjNjRiZjViL3RhYmxlcmFuZ2U6Yzc0YzgzNjE0NDY0NDRmNmFlMmMzNjY4NWM2NGJmNWJfNi0zLTEtMS03MjY5MA_9067e8da-ce20-48c0-a3e2-27cb530671ce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i73c3f9942c10418c97d1df582f8b37c7_D20220101-20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOmM3NGM4MzYxNDQ2NDQ0ZjZhZTJjMzY2ODVjNjRiZjViL3RhYmxlcmFuZ2U6Yzc0YzgzNjE0NDY0NDRmNmFlMmMzNjY4NWM2NGJmNWJfNi01LTEtMS03Mjc3NQ_fdfb1875-a22e-48ee-84f2-1117806ee773">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7eabbab66fc246509ee375373f59a3c8_D20210101-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOmM3NGM4MzYxNDQ2NDQ0ZjZhZTJjMzY2ODVjNjRiZjViL3RhYmxlcmFuZ2U6Yzc0YzgzNjE0NDY0NDRmNmFlMmMzNjY4NWM2NGJmNWJfNi03LTEtMS03Mjc3NQ_c8e4f863-9fc4-482e-b186-d26ff26d145f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i00f54e9cbe804bb38c30969068ff45d3_D20220401-20220630" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOmM3NGM4MzYxNDQ2NDQ0ZjZhZTJjMzY2ODVjNjRiZjViL3RhYmxlcmFuZ2U6Yzc0YzgzNjE0NDY0NDRmNmFlMmMzNjY4NWM2NGJmNWJfNy0xLTEtMS03MjY5MA_af46e522-30e8-4f2f-9552-08462537fb86">20.07</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5734f87cb59c4ab99ff5087249c3e6bc_D20210401-20210630" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOmM3NGM4MzYxNDQ2NDQ0ZjZhZTJjMzY2ODVjNjRiZjViL3RhYmxlcmFuZ2U6Yzc0YzgzNjE0NDY0NDRmNmFlMmMzNjY4NWM2NGJmNWJfNy0zLTEtMS03MjY5MA_ba4ffb24-a73c-45fc-b597-8b5a725e4475">3.59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i73c3f9942c10418c97d1df582f8b37c7_D20220101-20220630" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOmM3NGM4MzYxNDQ2NDQ0ZjZhZTJjMzY2ODVjNjRiZjViL3RhYmxlcmFuZ2U6Yzc0YzgzNjE0NDY0NDRmNmFlMmMzNjY4NWM2NGJmNWJfNy01LTEtMS03Mjc3NQ_12f1de09-ae01-4105-a449-97769610871e">19.15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7eabbab66fc246509ee375373f59a3c8_D20210101-20210630" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOmM3NGM4MzYxNDQ2NDQ0ZjZhZTJjMzY2ODVjNjRiZjViL3RhYmxlcmFuZ2U6Yzc0YzgzNjE0NDY0NDRmNmFlMmMzNjY4NWM2NGJmNWJfNy03LTEtMS03Mjc3NQ_17a1d241-c93c-480f-ab6e-0c8ff2628e3b">3.14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Units</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="us-gaap:ScheduleOfOtherShareBasedCompensationActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RleHRyZWdpb246YmIwZTNiYzI1ODYxNDUxOTliMWM1ZWZiN2U2YWM3YjNfODc5NjA5MzAyODI4Nw_b2b51fc6-331d-481b-ba20-48f8b7b5fa8a" continuedAt="i7b13bd80d1fc473394289778be6a5a72" escape="true">A summary of the Company&#8217;s restricted stock unit (&#8220;RSU&#8221;) activity and related information are as follows (restricted stock units in thousands): </ix:nonNumeric></span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span><br/></span></div></div><ix:continuation id="i3324375832a54aef96ad10ab75a16016"><div style="margin-bottom:9pt"><ix:continuation id="i7b13bd80d1fc473394289778be6a5a72"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding, beginning of period</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i48c0e4524ffe4c1fa1c1d659ea30bc91_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjIwNDFiYjU3MWE3NjQyOWY5ZGI1YTcwYmNhZDJkNzliL3RhYmxlcmFuZ2U6MjA0MWJiNTcxYTc2NDI5ZjlkYjVhNzBiY2FkMmQ3OWJfNC0xLTEtMS03MTQ4Ng_027838ea-90cf-4482-82eb-71c516f75f58">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i48c0e4524ffe4c1fa1c1d659ea30bc91_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjIwNDFiYjU3MWE3NjQyOWY5ZGI1YTcwYmNhZDJkNzliL3RhYmxlcmFuZ2U6MjA0MWJiNTcxYTc2NDI5ZjlkYjVhNzBiY2FkMmQ3OWJfNC0zLTEtMS03MTQ4Ng_39c577f7-0ae0-4d40-8392-3cdd465feae4">34.78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Awarded</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i97a15a5737b34117975db805d85bb267_D20220101-20220630" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjIwNDFiYjU3MWE3NjQyOWY5ZGI1YTcwYmNhZDJkNzliL3RhYmxlcmFuZ2U6MjA0MWJiNTcxYTc2NDI5ZjlkYjVhNzBiY2FkMmQ3OWJfNS0xLTEtMS03MTQ4Ng_6db1be7d-488b-41ec-91ca-bd8da6a47cf3">538</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i97a15a5737b34117975db805d85bb267_D20220101-20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjIwNDFiYjU3MWE3NjQyOWY5ZGI1YTcwYmNhZDJkNzliL3RhYmxlcmFuZ2U6MjA0MWJiNTcxYTc2NDI5ZjlkYjVhNzBiY2FkMmQ3OWJfNS0zLTEtMS03MTQ4Ng_328fe883-d577-4c41-8e79-2b720144977f">34.14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i97a15a5737b34117975db805d85bb267_D20220101-20220630" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjIwNDFiYjU3MWE3NjQyOWY5ZGI1YTcwYmNhZDJkNzliL3RhYmxlcmFuZ2U6MjA0MWJiNTcxYTc2NDI5ZjlkYjVhNzBiY2FkMmQ3OWJfNy0xLTEtMS03MTQ4Ng_2b9253fd-90a3-4f72-8164-4eb0968c2166">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i97a15a5737b34117975db805d85bb267_D20220101-20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjIwNDFiYjU3MWE3NjQyOWY5ZGI1YTcwYmNhZDJkNzliL3RhYmxlcmFuZ2U6MjA0MWJiNTcxYTc2NDI5ZjlkYjVhNzBiY2FkMmQ3OWJfNy0zLTEtMS03MTQ4Ng_7419c8ba-ad35-4514-9595-0591371f28c7">31.76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding, end of period</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic60a1a1821b14d1d8d6ac4fff874549d_I20220630" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjIwNDFiYjU3MWE3NjQyOWY5ZGI1YTcwYmNhZDJkNzliL3RhYmxlcmFuZ2U6MjA0MWJiNTcxYTc2NDI5ZjlkYjVhNzBiY2FkMmQ3OWJfOC0xLTEtMS03MTQ4Ng_1f1adfcf-bce1-4649-bfa7-73fd7669cab8">559</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic60a1a1821b14d1d8d6ac4fff874549d_I20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjIwNDFiYjU3MWE3NjQyOWY5ZGI1YTcwYmNhZDJkNzliL3RhYmxlcmFuZ2U6MjA0MWJiNTcxYTc2NDI5ZjlkYjVhNzBiY2FkMmQ3OWJfOC0zLTEtMS03MTQ4Ng_1af444fb-fb44-4fd9-9c0b-43d24ce4865e">34.22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2022, there was a total of $<ix:nonFraction unitRef="usd" contextRef="i97a15a5737b34117975db805d85bb267_D20220101-20220630" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RleHRyZWdpb246YmIwZTNiYzI1ODYxNDUxOTliMWM1ZWZiN2U2YWM3YjNfOTM0NTg0ODg0MzA1MQ_82f3c188-3a32-4e6e-9add-376e1e4eaf75">17.8</ix:nonFraction> million of unrecognized stock-based compensation expense related to RSUs.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2022, there was approximately $<ix:nonFraction unitRef="usd" contextRef="i17afe0c0dcba45159077ed56cad20253_I20220630" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RleHRyZWdpb246YmIwZTNiYzI1ODYxNDUxOTliMWM1ZWZiN2U2YWM3YjNfMjc0ODc3OTA4MTc5NA_c0f42acd-d9a6-46e6-a492-ff064da9e3a4">0.7</ix:nonFraction>&#160;million of unrecognized cost related to employee stock purchases under the Employee Stock Purchase Plan (&#8220;ESPP&#8221;). This cost is expected to be recognized over a weighted average period of <ix:nonNumeric contextRef="ib8d4c78e6b0f482fae70548a9459a7f1_D20220101-20220630" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RleHRyZWdpb246YmIwZTNiYzI1ODYxNDUxOTliMWM1ZWZiN2U2YWM3YjNfNjU5NzA2OTc3OTA0Mg_246d5e83-fda5-4422-8e4e-9fc197e202ce">0.5</ix:nonNumeric> years. As of June 30, 2022, a total of <ix:nonFraction unitRef="shares" contextRef="i17afe0c0dcba45159077ed56cad20253_I20220630" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RleHRyZWdpb246YmIwZTNiYzI1ODYxNDUxOTliMWM1ZWZiN2U2YWM3YjNfMjc0ODc3OTA4MTgxOA_8300f0a6-2d90-4918-b66e-426602d57748">0.8</ix:nonFraction>&#160;million shares were available for issuance under the ESPP.</span></div><ix:continuation id="i0773926cbb2743c88039703b8d31600e"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the awards granted under the ESPP for the six months ended June 30, 2022 to employees was estimated as of the grant date using the Black-Scholes model assuming the weighted-average assumptions listed in the following table: </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.316%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (years)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9c8e42000a7c49b7b20f5345c42d7b26_D20220401-20220630" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOmRhZGU5MzY2YzM0NTQxNjJhN2I2Njk0MjE3ODBiZGU4L3RhYmxlcmFuZ2U6ZGFkZTkzNjZjMzQ1NDE2MmE3YjY2OTQyMTc4MGJkZThfMy0xLTEtMS03Mjc5Nw_fcc57f93-ab92-485f-876f-615b13547645">0.8</ix:nonNumeric></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9c8e42000a7c49b7b20f5345c42d7b26_D20220401-20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOmRhZGU5MzY2YzM0NTQxNjJhN2I2Njk0MjE3ODBiZGU4L3RhYmxlcmFuZ2U6ZGFkZTkzNjZjMzQ1NDE2MmE3YjY2OTQyMTc4MGJkZThfNC0xLTEtMS03Mjc5Nw_e045e20d-3ff6-4e2c-87c5-a458cfbf480d">57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9c8e42000a7c49b7b20f5345c42d7b26_D20220401-20220630" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOmRhZGU5MzY2YzM0NTQxNjJhN2I2Njk0MjE3ODBiZGU4L3RhYmxlcmFuZ2U6ZGFkZTkzNjZjMzQ1NDE2MmE3YjY2OTQyMTc4MGJkZThfNS0xLTEtMS03Mjc5Nw_b54f8f5b-6f45-4eab-8eb5-76ff680a8405">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend rate </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9c8e42000a7c49b7b20f5345c42d7b26_D20220401-20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOmRhZGU5MzY2YzM0NTQxNjJhN2I2Njk0MjE3ODBiZGU4L3RhYmxlcmFuZ2U6ZGFkZTkzNjZjMzQ1NDE2MmE3YjY2OTQyMTc4MGJkZThfNi0xLTEtMS03Mjc5Nw_f5d0a174-6472-4741-bda8-c139bfaee749">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average fair value</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9c8e42000a7c49b7b20f5345c42d7b26_D20220401-20220630" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOmRhZGU5MzY2YzM0NTQxNjJhN2I2Njk0MjE3ODBiZGU4L3RhYmxlcmFuZ2U6ZGFkZTkzNjZjMzQ1NDE2MmE3YjY2OTQyMTc4MGJkZThfNy0xLTEtMS03Mjc5Nw_14c9fcd7-41aa-4f5f-b15d-58880c94ab28">12.25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation><ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RleHRyZWdpb246YmIwZTNiYzI1ODYxNDUxOTliMWM1ZWZiN2U2YWM3YjNfODc5NjA5MzAyODI4OA_028b0cb6-474c-4718-a338-9d7e89ab5352" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total stock-based compensation recognized, before taxes, are as follows (in thousands): </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.684%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i277b8f845b9c4fe49bd226a094fd599c_D20220401-20220630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjIxNWI5ZWFlODZiMjQ5Mzc4N2M4YmJmMTJlMTAwNDU3L3RhYmxlcmFuZ2U6MjE1YjllYWU4NmIyNDkzNzg3YzhiYmYxMmUxMDA0NTdfMy0xLTEtMS03MTUwNA_063077c7-44cc-4d72-be6d-ad0de5ed9ff2">252</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfcaafa17e4746279efe3c570e6f9fbb_D20210401-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjIxNWI5ZWFlODZiMjQ5Mzc4N2M4YmJmMTJlMTAwNDU3L3RhYmxlcmFuZ2U6MjE1YjllYWU4NmIyNDkzNzg3YzhiYmYxMmUxMDA0NTdfMy0zLTEtMS03MTUwNA_28f04b9d-7686-4bbe-a686-36a3e594dbad">51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie094c47c8e41442d8f48b3161b3255d9_D20210101-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjIxNWI5ZWFlODZiMjQ5Mzc4N2M4YmJmMTJlMTAwNDU3L3RhYmxlcmFuZ2U6MjE1YjllYWU4NmIyNDkzNzg3YzhiYmYxMmUxMDA0NTdfMy01LTEtMS03MjgzNA_a2979434-3856-498f-aa8a-72d4c9b2e7e2">375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3846b5796b46497498e5a63b411da5f9_D20220101-20220630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjIxNWI5ZWFlODZiMjQ5Mzc4N2M4YmJmMTJlMTAwNDU3L3RhYmxlcmFuZ2U6MjE1YjllYWU4NmIyNDkzNzg3YzhiYmYxMmUxMDA0NTdfMy03LTEtMS03MjgzNA_b9c36c60-c109-46fb-b163-9cd233b08012">74</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i164ec0a968a3490c8e5ca191f4a7e36b_D20220401-20220630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjIxNWI5ZWFlODZiMjQ5Mzc4N2M4YmJmMTJlMTAwNDU3L3RhYmxlcmFuZ2U6MjE1YjllYWU4NmIyNDkzNzg3YzhiYmYxMmUxMDA0NTdfNC0xLTEtMS03MTUwNA_bb399525-3a02-4d99-a5c2-d0d703df9efb">553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie06546dec3a04d87b10442e18708fbee_D20210401-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjIxNWI5ZWFlODZiMjQ5Mzc4N2M4YmJmMTJlMTAwNDU3L3RhYmxlcmFuZ2U6MjE1YjllYWU4NmIyNDkzNzg3YzhiYmYxMmUxMDA0NTdfNC0zLTEtMS03MTUwNA_a3b8f734-7f9b-45ed-8502-e104307eb569">155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i028690643f5b41a3bf4ab56e7150dcfd_D20210101-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjIxNWI5ZWFlODZiMjQ5Mzc4N2M4YmJmMTJlMTAwNDU3L3RhYmxlcmFuZ2U6MjE1YjllYWU4NmIyNDkzNzg3YzhiYmYxMmUxMDA0NTdfNC01LTEtMS03MjgzNA_c6c9c399-3a9f-4217-ac05-1cc57307c204">853</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30ea9dc52b724da0aac81e7933fd37f3_D20220101-20220630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjIxNWI5ZWFlODZiMjQ5Mzc4N2M4YmJmMTJlMTAwNDU3L3RhYmxlcmFuZ2U6MjE1YjllYWU4NmIyNDkzNzg3YzhiYmYxMmUxMDA0NTdfNC03LTEtMS03MjgzNA_20a833f5-6d3f-4f67-8105-6ff3195e028e">307</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90bfc90968d64d2f95bb4f0aab2fabef_D20220401-20220630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjIxNWI5ZWFlODZiMjQ5Mzc4N2M4YmJmMTJlMTAwNDU3L3RhYmxlcmFuZ2U6MjE1YjllYWU4NmIyNDkzNzg3YzhiYmYxMmUxMDA0NTdfNS0xLTEtMS03MTUwNA_94a82d2e-f2f1-451f-82ef-1c30abfd4191">1,871</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f12acefea06470fbd1ff183c033427c_D20210401-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjIxNWI5ZWFlODZiMjQ5Mzc4N2M4YmJmMTJlMTAwNDU3L3RhYmxlcmFuZ2U6MjE1YjllYWU4NmIyNDkzNzg3YzhiYmYxMmUxMDA0NTdfNS0zLTEtMS03MTUwNA_2fcf2d7f-a40d-48ae-b2fa-14760655ce41">519</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0f804f4efc44311ad8c409d09969458_D20210101-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjIxNWI5ZWFlODZiMjQ5Mzc4N2M4YmJmMTJlMTAwNDU3L3RhYmxlcmFuZ2U6MjE1YjllYWU4NmIyNDkzNzg3YzhiYmYxMmUxMDA0NTdfNS01LTEtMS03MjgzNA_d14dfd60-90ac-467a-b1b4-0a4e762730d2">3,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7eaf117796f144da98cb336ef5d2a3c6_D20220101-20220630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjIxNWI5ZWFlODZiMjQ5Mzc4N2M4YmJmMTJlMTAwNDU3L3RhYmxlcmFuZ2U6MjE1YjllYWU4NmIyNDkzNzg3YzhiYmYxMmUxMDA0NTdfNS03LTEtMS03MjgzNA_2c58c580-bee2-4043-8d2d-1ed3da7bf273">994</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjIxNWI5ZWFlODZiMjQ5Mzc4N2M4YmJmMTJlMTAwNDU3L3RhYmxlcmFuZ2U6MjE1YjllYWU4NmIyNDkzNzg3YzhiYmYxMmUxMDA0NTdfNi0xLTEtMS03MTUwNA_f8e6ecc5-c2ee-4a42-a411-b72d4fea9c29">2,676</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjIxNWI5ZWFlODZiMjQ5Mzc4N2M4YmJmMTJlMTAwNDU3L3RhYmxlcmFuZ2U6MjE1YjllYWU4NmIyNDkzNzg3YzhiYmYxMmUxMDA0NTdfNi0zLTEtMS03MTUwNA_e342561e-6ca7-422a-afd6-6798f4cbe8d2">725</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjIxNWI5ZWFlODZiMjQ5Mzc4N2M4YmJmMTJlMTAwNDU3L3RhYmxlcmFuZ2U6MjE1YjllYWU4NmIyNDkzNzg3YzhiYmYxMmUxMDA0NTdfNi01LTEtMS03MjgzNA_52fad106-b10d-4f2e-8baf-393f13e3bd03">4,228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjIxNWI5ZWFlODZiMjQ5Mzc4N2M4YmJmMTJlMTAwNDU3L3RhYmxlcmFuZ2U6MjE1YjllYWU4NmIyNDkzNzg3YzhiYmYxMmUxMDA0NTdfNi03LTEtMS03MjgzNA_984f85e8-ca99-4d12-9253-c35626dda568">1,375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><div id="ibb2df456afff4355bae87af9d1240625_52"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RleHRyZWdpb246MDZiY2U3MTkzN2QxNDI0YTkxMDlhYzZjYmEyZjQxMWVfNDYz_e2944664-c2b8-4a89-b8be-3070e8172afe" continuedAt="iab663662875248f2a06208400696e4de" escape="true">Net Loss Per Share</ix:nonNumeric></span></div><ix:continuation id="iab663662875248f2a06208400696e4de"><div style="margin-bottom:9pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the completion of the Company&#8217;s IPO in September 2021, all <ix:nonFraction unitRef="shares" contextRef="ie390a471379b4ab1bcab0d1678411d3a_I20210930" decimals="INF" name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RleHRyZWdpb246MDZiY2U3MTkzN2QxNDI0YTkxMDlhYzZjYmEyZjQxMWVfMjc0ODc3OTA3MDQ3OQ_a7746372-f170-45be-ba83-74b088b7a390"><ix:nonFraction unitRef="shares" contextRef="ie390a471379b4ab1bcab0d1678411d3a_I20210930" decimals="INF" name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RleHRyZWdpb246MDZiY2U3MTkzN2QxNDI0YTkxMDlhYzZjYmEyZjQxMWVfMjc0ODc3OTA3MDQ3OQ_be4c7d6f-0ed7-40a7-8a6e-b14a791ecf67">29,912,264</ix:nonFraction></ix:nonFraction> shares of its then-outstanding redeemable convertible preferred stock automatically converted into <ix:nonFraction unitRef="shares" contextRef="ie390a471379b4ab1bcab0d1678411d3a_I20210930" decimals="INF" name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RleHRyZWdpb246MDZiY2U3MTkzN2QxNDI0YTkxMDlhYzZjYmEyZjQxMWVfMjc0ODc3OTA3MDU4Mg_a7746372-f170-45be-ba83-74b088b7a390"><ix:nonFraction unitRef="shares" contextRef="ie390a471379b4ab1bcab0d1678411d3a_I20210930" decimals="INF" name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RleHRyZWdpb246MDZiY2U3MTkzN2QxNDI0YTkxMDlhYzZjYmEyZjQxMWVfMjc0ODc3OTA3MDU4Mg_be4c7d6f-0ed7-40a7-8a6e-b14a791ecf67">29,912,264</ix:nonFraction></ix:nonFraction> shares of common stock.</span></div><ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="us-gaap:ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RleHRyZWdpb246MDZiY2U3MTkzN2QxNDI0YTkxMDlhYzZjYmEyZjQxMWVfODc5NjA5MzAyMzczNw_195039ee-c4e5-48af-b4de-1d9393aca24b" escape="true"><ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="us-gaap:ScheduleOfEarningsPerShareBasicByCommonClassTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RleHRyZWdpb246MDZiY2U3MTkzN2QxNDI0YTkxMDlhYzZjYmEyZjQxMWVfODc5NjA5MzAyMzczNw_b10c1c8b-18ef-486d-a2ca-cb76aa3e3768" escape="true"><div style="margin-bottom:9pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss per share was determined as follows (in thousands): </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.684%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjhiNzE4NjA2ZDA1NTQyMTU4ZDQzZjM1M2ZkMWI1NzFiL3RhYmxlcmFuZ2U6OGI3MTg2MDZkMDU1NDIxNThkNDNmMzUzZmQxYjU3MWJfMy0xLTEtMS03MTUzNw_871817a3-a850-42a3-93cb-d2e4d18c2d8f">19,184</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjhiNzE4NjA2ZDA1NTQyMTU4ZDQzZjM1M2ZkMWI1NzFiL3RhYmxlcmFuZ2U6OGI3MTg2MDZkMDU1NDIxNThkNDNmMzUzZmQxYjU3MWJfMy0zLTEtMS03MTUzNw_f042ced7-6f09-4c88-8f56-19072f9830d7">14,580</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjhiNzE4NjA2ZDA1NTQyMTU4ZDQzZjM1M2ZkMWI1NzFiL3RhYmxlcmFuZ2U6OGI3MTg2MDZkMDU1NDIxNThkNDNmMzUzZmQxYjU3MWJfMy01LTEtMS03MzAxNA_3912ccdf-349d-4e63-aea3-6a2e13f852cd">36,369</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjhiNzE4NjA2ZDA1NTQyMTU4ZDQzZjM1M2ZkMWI1NzFiL3RhYmxlcmFuZ2U6OGI3MTg2MDZkMDU1NDIxNThkNDNmMzUzZmQxYjU3MWJfMy03LTEtMS03MzAxNA_f7c0bfd8-31ba-457e-b7d8-9de45d41d020">27,402</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common stock outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjhiNzE4NjA2ZDA1NTQyMTU4ZDQzZjM1M2ZkMWI1NzFiL3RhYmxlcmFuZ2U6OGI3MTg2MDZkMDU1NDIxNThkNDNmMzUzZmQxYjU3MWJfNC0xLTEtMS03MTUzNw_c1fe3667-a14c-405c-88ff-65cea064158b"><ix:nonFraction unitRef="shares" contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjhiNzE4NjA2ZDA1NTQyMTU4ZDQzZjM1M2ZkMWI1NzFiL3RhYmxlcmFuZ2U6OGI3MTg2MDZkMDU1NDIxNThkNDNmMzUzZmQxYjU3MWJfNC0xLTEtMS03MTUzNw_d8b58e26-feaa-4fab-9596-dd85a7a8131b">44,324</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjhiNzE4NjA2ZDA1NTQyMTU4ZDQzZjM1M2ZkMWI1NzFiL3RhYmxlcmFuZ2U6OGI3MTg2MDZkMDU1NDIxNThkNDNmMzUzZmQxYjU3MWJfNC0zLTEtMS03MTUzNw_80c7b1e4-f080-4fb8-87c5-3c7fb24e5db7"><ix:nonFraction unitRef="shares" contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjhiNzE4NjA2ZDA1NTQyMTU4ZDQzZjM1M2ZkMWI1NzFiL3RhYmxlcmFuZ2U6OGI3MTg2MDZkMDU1NDIxNThkNDNmMzUzZmQxYjU3MWJfNC0zLTEtMS03MTUzNw_c19dd207-19d0-40a2-9e99-c961b67dfc6d">5,597</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjhiNzE4NjA2ZDA1NTQyMTU4ZDQzZjM1M2ZkMWI1NzFiL3RhYmxlcmFuZ2U6OGI3MTg2MDZkMDU1NDIxNThkNDNmMzUzZmQxYjU3MWJfNC01LTEtMS03MzExNg_49191a23-6772-46a3-9b2f-c9a0f9f061fc"><ix:nonFraction unitRef="shares" contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjhiNzE4NjA2ZDA1NTQyMTU4ZDQzZjM1M2ZkMWI1NzFiL3RhYmxlcmFuZ2U6OGI3MTg2MDZkMDU1NDIxNThkNDNmMzUzZmQxYjU3MWJfNC01LTEtMS03MzExNg_b17c71a7-f774-495d-91a9-4ab6682ce8c8">44,091</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjhiNzE4NjA2ZDA1NTQyMTU4ZDQzZjM1M2ZkMWI1NzFiL3RhYmxlcmFuZ2U6OGI3MTg2MDZkMDU1NDIxNThkNDNmMzUzZmQxYjU3MWJfNC03LTEtMS03MzExNg_024de2bf-30cd-46ba-8e80-a70020f0850c"><ix:nonFraction unitRef="shares" contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjhiNzE4NjA2ZDA1NTQyMTU4ZDQzZjM1M2ZkMWI1NzFiL3RhYmxlcmFuZ2U6OGI3MTg2MDZkMDU1NDIxNThkNDNmMzUzZmQxYjU3MWJfNC03LTEtMS03MzExNg_176704e1-b4d3-4e18-a760-2d516b48f3c8">5,216</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share, basic and diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjhiNzE4NjA2ZDA1NTQyMTU4ZDQzZjM1M2ZkMWI1NzFiL3RhYmxlcmFuZ2U6OGI3MTg2MDZkMDU1NDIxNThkNDNmMzUzZmQxYjU3MWJfNS0xLTEtMS03MTUzNw_21edf69d-0ab2-4d60-b9b5-f1c8c81380bc"><ix:nonFraction unitRef="usdPerShare" contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjhiNzE4NjA2ZDA1NTQyMTU4ZDQzZjM1M2ZkMWI1NzFiL3RhYmxlcmFuZ2U6OGI3MTg2MDZkMDU1NDIxNThkNDNmMzUzZmQxYjU3MWJfNS0xLTEtMS03MTUzNw_237c89ea-bfe8-4d95-ab26-48f21728efa0">0.43</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjhiNzE4NjA2ZDA1NTQyMTU4ZDQzZjM1M2ZkMWI1NzFiL3RhYmxlcmFuZ2U6OGI3MTg2MDZkMDU1NDIxNThkNDNmMzUzZmQxYjU3MWJfNS0zLTEtMS03MTUzNw_2fcae088-bc43-46bc-9d1e-fcf22ba2cfe9"><ix:nonFraction unitRef="usdPerShare" contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjhiNzE4NjA2ZDA1NTQyMTU4ZDQzZjM1M2ZkMWI1NzFiL3RhYmxlcmFuZ2U6OGI3MTg2MDZkMDU1NDIxNThkNDNmMzUzZmQxYjU3MWJfNS0zLTEtMS03MTUzNw_6edc0d90-f8ff-4c18-8cb2-4a0ab2c98c1e">2.60</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjhiNzE4NjA2ZDA1NTQyMTU4ZDQzZjM1M2ZkMWI1NzFiL3RhYmxlcmFuZ2U6OGI3MTg2MDZkMDU1NDIxNThkNDNmMzUzZmQxYjU3MWJfNS01LTEtMS03MzAyMQ_0d2a47e5-0d6c-457e-b938-54d1bba7af8c"><ix:nonFraction unitRef="usdPerShare" contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjhiNzE4NjA2ZDA1NTQyMTU4ZDQzZjM1M2ZkMWI1NzFiL3RhYmxlcmFuZ2U6OGI3MTg2MDZkMDU1NDIxNThkNDNmMzUzZmQxYjU3MWJfNS01LTEtMS03MzAyMQ_e1efac9e-6c8b-4370-a80f-375513b5e5e6">0.82</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjhiNzE4NjA2ZDA1NTQyMTU4ZDQzZjM1M2ZkMWI1NzFiL3RhYmxlcmFuZ2U6OGI3MTg2MDZkMDU1NDIxNThkNDNmMzUzZmQxYjU3MWJfNS03LTEtMS03MzAyMQ_252c63d4-b601-4b3c-a79f-9dea85a01181"><ix:nonFraction unitRef="usdPerShare" contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjhiNzE4NjA2ZDA1NTQyMTU4ZDQzZjM1M2ZkMWI1NzFiL3RhYmxlcmFuZ2U6OGI3MTg2MDZkMDU1NDIxNThkNDNmMzUzZmQxYjU3MWJfNS03LTEtMS03MzAyMQ_25de0304-ac87-4cb3-aa09-ec214339b92c">5.25</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RleHRyZWdpb246MDZiY2U3MTkzN2QxNDI0YTkxMDlhYzZjYmEyZjQxMWVfODc5NjA5MzAyMzczOA_e56a6957-7615-4f2c-8078-e83445cbd2f2" escape="true"><div style="margin-bottom:9pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following potentially dilutive securities outstanding have been excluded from the computations of weighted-average shares outstanding because such securities have an antidilutive impact due to losses reported (in common stock equivalent shares, in thousands): </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of June 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable convertible preferred stock outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i16c6e66d4ce6495b8d9d4fb2a81130ec_D20220101-20220630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjAwM2NmYTA1Y2JiNjQzMWFiMmM5YTVhZGEwODYwMGIyL3RhYmxlcmFuZ2U6MDAzY2ZhMDVjYmI2NDMxYWIyYzlhNWFkYTA4NjAwYjJfMy0xLTEtMS03MTUzNw_e81361b7-ef5c-4735-b6a7-9f294f2d56dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia13da9ea227f4e738ed2a4ade74a841d_D20210101-20210630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjAwM2NmYTA1Y2JiNjQzMWFiMmM5YTVhZGEwODYwMGIyL3RhYmxlcmFuZ2U6MDAzY2ZhMDVjYmI2NDMxYWIyYzlhNWFkYTA4NjAwYjJfMy0zLTEtMS03MTUzNw_bf93d8a9-094b-4c41-99ea-eae32a7df0e2">29,850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable convertible preferred stock warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idaefefa698af4a6bb691e2fb7f0a6944_D20220101-20220630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjAwM2NmYTA1Y2JiNjQzMWFiMmM5YTVhZGEwODYwMGIyL3RhYmxlcmFuZ2U6MDAzY2ZhMDVjYmI2NDMxYWIyYzlhNWFkYTA4NjAwYjJfNC0xLTEtMS03MTUzNw_24841bb5-5df8-43d6-a4b5-1be6584c2032">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i140935dcf8204cbf959d52cbd44911ae_D20210101-20210630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjAwM2NmYTA1Y2JiNjQzMWFiMmM5YTVhZGEwODYwMGIyL3RhYmxlcmFuZ2U6MDAzY2ZhMDVjYmI2NDMxYWIyYzlhNWFkYTA4NjAwYjJfNC0zLTEtMS03MTUzNw_c41ed12c-0a3e-4c2e-9f24-fcb965968203">72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i01badfb698334a429a1be2da49cd7a91_D20220101-20220630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjAwM2NmYTA1Y2JiNjQzMWFiMmM5YTVhZGEwODYwMGIyL3RhYmxlcmFuZ2U6MDAzY2ZhMDVjYmI2NDMxYWIyYzlhNWFkYTA4NjAwYjJfNi0xLTEtMS03MTUzNw_43e9fe6e-980c-4e97-a0af-e32a29447554">5,666</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1372789c7d3948d3b8aca78f2d9b92dd_D20210101-20210630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjAwM2NmYTA1Y2JiNjQzMWFiMmM5YTVhZGEwODYwMGIyL3RhYmxlcmFuZ2U6MDAzY2ZhMDVjYmI2NDMxYWIyYzlhNWFkYTA4NjAwYjJfNi0zLTEtMS03MTUzNw_20c60216-d89e-448e-92d3-70a6e2ab4bca">6,621</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i124d9db5d45e4effa8c6d68140756087_D20220101-20220630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjAwM2NmYTA1Y2JiNjQzMWFiMmM5YTVhZGEwODYwMGIyL3RhYmxlcmFuZ2U6MDAzY2ZhMDVjYmI2NDMxYWIyYzlhNWFkYTA4NjAwYjJfNy0xLTEtMS03MTUzNw_5304ae3b-df1b-482e-b93f-d5051087bf69">559</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i10a1fb79429d4c70978ced6bf017f60f_D20210101-20210630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjAwM2NmYTA1Y2JiNjQzMWFiMmM5YTVhZGEwODYwMGIyL3RhYmxlcmFuZ2U6MDAzY2ZhMDVjYmI2NDMxYWIyYzlhNWFkYTA4NjAwYjJfNy0zLTEtMS03MTUzNw_e51128ef-ab4b-4014-a5c3-4b739e02d859">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i49e74c53b47042178251b4824d6b4122_D20220101-20220630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjAwM2NmYTA1Y2JiNjQzMWFiMmM5YTVhZGEwODYwMGIyL3RhYmxlcmFuZ2U6MDAzY2ZhMDVjYmI2NDMxYWIyYzlhNWFkYTA4NjAwYjJfOC0xLTEtMS03MTUzNw_b5875f7b-5fce-4752-af0e-80a3e84465fa">61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i34fe12d789d3432680d4d84cc2fdfe4f_D20210101-20210630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjAwM2NmYTA1Y2JiNjQzMWFiMmM5YTVhZGEwODYwMGIyL3RhYmxlcmFuZ2U6MDAzY2ZhMDVjYmI2NDMxYWIyYzlhNWFkYTA4NjAwYjJfOC0zLTEtMS03MTUzNw_5b0c6d0e-ab25-4c14-841d-659b95006567">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjAwM2NmYTA1Y2JiNjQzMWFiMmM5YTVhZGEwODYwMGIyL3RhYmxlcmFuZ2U6MDAzY2ZhMDVjYmI2NDMxYWIyYzlhNWFkYTA4NjAwYjJfOS0xLTEtMS03MTUzNw_61f07685-d5af-4969-b7d2-cf1c91978575">6,286</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjAwM2NmYTA1Y2JiNjQzMWFiMmM5YTVhZGEwODYwMGIyL3RhYmxlcmFuZ2U6MDAzY2ZhMDVjYmI2NDMxYWIyYzlhNWFkYTA4NjAwYjJfOS0zLTEtMS03MTUzNw_0d2e9cf8-53c0-42f5-a48a-123d686c9ca3">36,543</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:9pt"><span><br/></span></div><div id="ibb2df456afff4355bae87af9d1240625_55"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RleHRyZWdpb246MTY0MzE4NWVmNjI4NDI1N2E1N2I1MDEwYjA5YWIwZDBfNzQzMA_06b3d1d7-8b42-4efa-93d2-0cb7577516a6" continuedAt="iff7dfd7946034a058138d956d0aa0a3e" escape="true">Revenue</ix:nonNumeric></span></div><ix:continuation id="iff7dfd7946034a058138d956d0aa0a3e"><ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RleHRyZWdpb246MTY0MzE4NWVmNjI4NDI1N2E1N2I1MDEwYjA5YWIwZDBfODc5NjA5MzAzNzEwOQ_20ffde5f-4f40-4480-bf54-b502fa3ff063" escape="true"><ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RleHRyZWdpb246MTY0MzE4NWVmNjI4NDI1N2E1N2I1MDEwYjA5YWIwZDBfODc5NjA5MzAzNzEwOQ_eb67f7d1-5804-4cd2-864e-80435f85cb85" continuedAt="ib57e3c513abc40ba878c5386242c342e" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents revenue disaggregated by type and geography (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.684%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">System sales and rentals</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae550cb350ab4aa093330a1aa67fbb59_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfNC0xLTEtMS03MTU1Ng_50e1377f-092c-4d5a-a1e3-511a76a87a23">8,516</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc3548f9c5af4248b89810935e741c81_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfNC0zLTEtMS03MTU1Ng_50ae5ac7-93d5-457f-883e-63b390a5e4ad">4,770</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i354124ad73aa4d359530dedf6cc892ff_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfMy01LTEtMS03NDk5Ng_46b661a6-f321-42cf-b403-080856933da6">16,270</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i034be609d4174ca28c7931f45c17137f_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfMy03LTEtMS03NDk5Ng_41f61bd0-fe3b-417b-ba7b-126c5d459559">9,330</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Handpieces and other consumables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93f054b306ba42db85eac45b5398e920_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfNS0xLTEtMS03MTU1Ng_77681a72-1345-4218-93b5-9564e9ab07e7">5,723</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a3ab372268f4d07ac5a6cef9de6d000_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfNS0zLTEtMS03MTU1Ng_a0fa790e-dd7a-40ff-8ebd-b23281f4be2d">1,653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0f3737d0aba4fb9a4cb003b37c4a03c_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfNC01LTEtMS03NDk5Ng_6e0b562a-f474-4fb3-92cc-65901796c70b">10,167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34e859a6c83448509ff840a825f98408_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfNC03LTEtMS03NDk5Ng_475c9f9f-3d0f-4a2c-9184-c82454247c7e">3,274</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa95f8ea20be433eafa6a8ca0854a1ab_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfNi0xLTEtMS03MTU1Ng_61df5fe5-7d51-4058-9da6-a883678e3f86">567</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i103aeef9defe4b0387c733d075b32506_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfNi0zLTEtMS03MTU1Ng_27b4336a-cec7-400f-ba85-eb56aeeef1f2">137</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7323a463430b427eade72651460a0dda_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfNS01LTEtMS03NDk5Ng_23e3b52e-2c4f-4340-80de-952d0b416621">929</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8cc8b31066433d9ab97e1244ff31b5_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfNS03LTEtMS03NDk5Ng_742fe878-1212-47c8-bbe4-752967848abb">209</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total U.S. revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56197f81b18f4fdd9144c91fbf486356_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfNy0xLTEtMS03MTU1Ng_6ab92ad5-aef6-4563-ac2b-421724ca056c">14,806</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84cfac7405214cd68837a7cd08d45162_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfNy0zLTEtMS03MTU1Ng_a29d3f9b-8748-4129-9825-5183ff1802b4">6,560</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebbce8d97e394404821074c8c3cbf98b_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfNi01LTEtMS03NDk5Ng_fd6439e7-4fd6-48c9-af7c-8f04f4c7cb52">27,366</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b6d991467f646b192fb0bf7523d7fe3_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfNi03LTEtMS03NDk5Ng_a72ca281-70ff-4ddd-adad-b754b0515674">12,813</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outside of U.S.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">System sales and rentals</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0697cd6105f4abf9c831356c1473b25_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfOS0xLTEtMS03MTU1Ng_80819347-04f8-4e54-9d58-3bd8281285f9">869</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i837cadc9f10943b7b8afdee6a7838bae_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfOS0zLTEtMS03MTU1Ng_199f2eb2-a694-4cfb-8437-9d9daf579b7f">973</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d7b2d1422fa47d7b08d486dff9d320a_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfOC01LTEtMS03NDk5Ng_98a7091e-a4e0-4e5b-8d1b-e75a6f03bd9f">1,610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb609047c8a640abaa29cd36b1d98737_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfOC03LTEtMS03NDk5Ng_22df346a-9633-42bc-a3cf-4659d617bfb8">1,244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Handpieces and other consumables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841d3dd4b3a54b2f94fa7066f3cea1e5_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfMTAtMS0xLTEtNzE1NTY_9b2ba30d-6b10-45dc-aabb-d7ae0a958fcc">832</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9832ef4d4be47168e465fd04aaf5f66_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfMTAtMy0xLTEtNzE1NTY_f4f5b33b-1757-4ea5-8c1c-1845c4066957">890</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc2c8df366d747ccaf7c4700fcfa6b6b_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfOS01LTEtMS03NDk5Ng_366acf76-71a2-44dd-9da2-33ae22cb18fa">1,578</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d3b3cc27d31469897df4789948762e2_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfOS03LTEtMS03NDk5Ng_f376a8ff-ad6b-41d4-9f41-7443688135c4">1,493</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib25e541235774f03a985292fa15ef08c_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfMTEtMS0xLTEtNzE1NTY_ba927a83-1462-44c4-9fdd-c91826d08e86">184</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id619c937117e495295cff348cd8098f9_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfMTEtMy0xLTEtNzE1NTY_f8d667e3-777b-47a9-95ce-43222bfc4273">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8b4017be8a44b8c871ccec3eb53803d_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfMTAtNS0xLTEtNzQ5OTY_88a823f7-dac5-4bcc-a520-d2979d46d2d3">334</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ffaf08378e1423a947bf449998d53e6_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfMTAtNy0xLTEtNzQ5OTY_186ff9ae-06ff-40b7-a734-668338b5647c">118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total outside of U.S. revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b75e831ee944df685fe171431077c73_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfMTItMS0xLTEtNzE1NTY_d3d76978-6385-47e0-8bb1-d9878f6f5ab6">1,885</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9f1dced786449a0ba9d25bcd7dda9de_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfMTItMy0xLTEtNzE1NTY_10114ea5-b5a5-428b-bf34-77f7df452185">1,916</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if17ffbed1df54f99a2e086997e1e3fec_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfMTEtNS0xLTEtNzQ5OTY_d27588f4-e584-48f6-92d7-b015c13b80bc">3,522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b6405459f5948bfb4f2a67be3632426_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfMTEtNy0xLTEtNzQ5OTY_8d3b13b3-bab3-40a4-8be9-8daabffd45d4">2,855</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfMTMtMS0xLTEtNzE1NTY_feb07ba1-b9ab-4cc0-aca3-33807d7f3608">16,691</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfMTMtMy0xLTEtNzE1NTY_d832e31f-9dff-47ee-b759-0635d4bccf66">8,476</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfMTItNS0xLTEtNzQ5OTY_89b4bb48-b0e2-4804-b2b8-eafc49b082bd">30,888</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfMTItNy0xLTEtNzQ5OTY_77ccd770-978a-4f6d-8b7e-1278e1f22f2d">15,668</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric></ix:continuation><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><div id="ibb2df456afff4355bae87af9d1240625_58"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="us-gaap:ConcentrationRiskDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81OC9mcmFnOmFhZjdhMjRkZGE3MDRlZmI5YmI3YWExMzQ5M2QwZDkyL3RleHRyZWdpb246YWFmN2EyNGRkYTcwNGVmYjliYjdhYTEzNDkzZDBkOTJfMjg0Ng_452600b5-0100-4f68-99a8-d45813610e07" continuedAt="i3b625dceb89347bb8286d8a34f230c8e" escape="true"><ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81OC9mcmFnOmFhZjdhMjRkZGE3MDRlZmI5YmI3YWExMzQ5M2QwZDkyL3RleHRyZWdpb246YWFmN2EyNGRkYTcwNGVmYjliYjdhYTEzNDkzZDBkOTJfNjU5NzA2OTc3MzUyNQ_86c4f378-6222-4343-8a2a-d7505b542d4b" continuedAt="id0087890e7b24761af63ae08037cfcef" escape="true">Segment, Geographical, and Customer Concentration</ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="i3b625dceb89347bb8286d8a34f230c8e"><ix:continuation id="id0087890e7b24761af63ae08037cfcef"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates as a single operating segment. The Company&#8217;s chief operating decision maker, its Chief Executive Officer, reviews financial information on an aggregate basis for the purposes of allocating resources and evaluating financial performance. The Company&#8217;s long-lived assets are primarily based in the United States.</span></div><div style="margin-bottom:9pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No customers accounted for more than 10% of revenue during the three and six months ended June 30, 2022 and 2021.</span></div><div style="margin-bottom:9pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No customers accounted for more than <ix:nonFraction unitRef="number" contextRef="i4b602262223d4640893e5dd50f271572_D20220101-20220630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81OC9mcmFnOmFhZjdhMjRkZGE3MDRlZmI5YmI3YWExMzQ5M2QwZDkyL3RleHRyZWdpb246YWFmN2EyNGRkYTcwNGVmYjliYjdhYTEzNDkzZDBkOTJfNjU5NzA2OTc3MzE5Ng_d3b376e8-bbf1-48ec-a994-e07de44a2c3b">10</ix:nonFraction>% of accounts receivable at June&#160;30, 2022. One customer accounted for <ix:nonFraction unitRef="number" contextRef="i126dea3f4e7745c5ae15e412fd7a688c_D20210101-20211231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81OC9mcmFnOmFhZjdhMjRkZGE3MDRlZmI5YmI3YWExMzQ5M2QwZDkyL3RleHRyZWdpb246YWFmN2EyNGRkYTcwNGVmYjliYjdhYTEzNDkzZDBkOTJfMjc0ODc3OTA3MjU2Mg_33254af5-3a85-4b11-9e58-b7a7518d611f">11</ix:nonFraction>% of accounts receivable at  December&#160;31, 2021.</span></div><ix:continuation id="ib57e3c513abc40ba878c5386242c342e"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s revenue by geographical location is as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4fcecdc96c7946a6917102a9bc187595_D20220401-20220630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81OC9mcmFnOmFhZjdhMjRkZGE3MDRlZmI5YmI3YWExMzQ5M2QwZDkyL3RhYmxlOjYyMTI2NDk4OGMzMjQwMTM4NWVhZWYwY2UzYTQwNTU0L3RhYmxlcmFuZ2U6NjIxMjY0OTg4YzMyNDAxMzg1ZWFlZjBjZTNhNDA1NTRfMy0xLTEtMS03NDk3MA_a0820456-a431-455b-8e58-4dfb0edd88e2">89</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i06b7903ecea34c54885ee96df8bd17f7_D20210401-20210630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81OC9mcmFnOmFhZjdhMjRkZGE3MDRlZmI5YmI3YWExMzQ5M2QwZDkyL3RhYmxlOjYyMTI2NDk4OGMzMjQwMTM4NWVhZWYwY2UzYTQwNTU0L3RhYmxlcmFuZ2U6NjIxMjY0OTg4YzMyNDAxMzg1ZWFlZjBjZTNhNDA1NTRfMy0zLTEtMS03NDk3MA_a649853b-a083-4eb6-87e4-500fc9cab9bd">77</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i24596b41408a4ffea6e70203801645e4_D20220101-20220630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81OC9mcmFnOmFhZjdhMjRkZGE3MDRlZmI5YmI3YWExMzQ5M2QwZDkyL3RhYmxlOjYyMTI2NDk4OGMzMjQwMTM4NWVhZWYwY2UzYTQwNTU0L3RhYmxlcmFuZ2U6NjIxMjY0OTg4YzMyNDAxMzg1ZWFlZjBjZTNhNDA1NTRfMy01LTEtMS03NDk3MA_0e9ce6c2-faa1-4c32-82ff-c8e4d18150d1">89</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i178c15123386454db3b2a62f93f77161_D20210101-20210630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81OC9mcmFnOmFhZjdhMjRkZGE3MDRlZmI5YmI3YWExMzQ5M2QwZDkyL3RhYmxlOjYyMTI2NDk4OGMzMjQwMTM4NWVhZWYwY2UzYTQwNTU0L3RhYmxlcmFuZ2U6NjIxMjY0OTg4YzMyNDAxMzg1ZWFlZjBjZTNhNDA1NTRfMy03LTEtMS03NDk3MA_a154b315-8612-4397-be36-bde3a45895d6">82</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outside the United States</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i969ef2b7ba3b4291a15d9307f31bf736_D20220401-20220630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81OC9mcmFnOmFhZjdhMjRkZGE3MDRlZmI5YmI3YWExMzQ5M2QwZDkyL3RhYmxlOjYyMTI2NDk4OGMzMjQwMTM4NWVhZWYwY2UzYTQwNTU0L3RhYmxlcmFuZ2U6NjIxMjY0OTg4YzMyNDAxMzg1ZWFlZjBjZTNhNDA1NTRfNC0xLTEtMS03NDk3MA_485abdff-c08e-4d7b-a525-3388be0d2d2b">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id766d70acd42417684ab4d19ff0aaba3_D20210401-20210630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81OC9mcmFnOmFhZjdhMjRkZGE3MDRlZmI5YmI3YWExMzQ5M2QwZDkyL3RhYmxlOjYyMTI2NDk4OGMzMjQwMTM4NWVhZWYwY2UzYTQwNTU0L3RhYmxlcmFuZ2U6NjIxMjY0OTg4YzMyNDAxMzg1ZWFlZjBjZTNhNDA1NTRfNC0zLTEtMS03NDk3MA_d3eca336-401e-4b23-b459-c609f3d4fe61">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie317f3d85145457ebb62b991028c5dbc_D20220101-20220630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81OC9mcmFnOmFhZjdhMjRkZGE3MDRlZmI5YmI3YWExMzQ5M2QwZDkyL3RhYmxlOjYyMTI2NDk4OGMzMjQwMTM4NWVhZWYwY2UzYTQwNTU0L3RhYmxlcmFuZ2U6NjIxMjY0OTg4YzMyNDAxMzg1ZWFlZjBjZTNhNDA1NTRfNC01LTEtMS03NDk3MA_88b13906-e64d-4c42-aca5-9f2aaf8abd6e">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i74d4cb137b6049418262544587636450_D20210101-20210630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81OC9mcmFnOmFhZjdhMjRkZGE3MDRlZmI5YmI3YWExMzQ5M2QwZDkyL3RhYmxlOjYyMTI2NDk4OGMzMjQwMTM4NWVhZWYwY2UzYTQwNTU0L3RhYmxlcmFuZ2U6NjIxMjY0OTg4YzMyNDAxMzg1ZWFlZjBjZTNhNDA1NTRfNC03LTEtMS03NDk3MA_9aa36a9f-5be4-4dd9-b911-444e0c116f27">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation></ix:continuation></ix:continuation><div style="margin-bottom:9pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><div id="ibb2df456afff4355bae87af9d1240625_667"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-bottom:9pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90ZXh0cmVnaW9uOmY3NzA3NzM4ZGNjMDQzNWJiNzAxMjdmMGE3ZWZjYjEzXzg3OTYwOTMwMjYxNzE_5d5f8b1a-bf7d-4b3b-bb5a-7d1227a334f1" continuedAt="i229cf79a06d742ffbd366e83a179fb23" escape="true"><ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90ZXh0cmVnaW9uOmY3NzA3NzM4ZGNjMDQzNWJiNzAxMjdmMGE3ZWZjYjEzXzg3OTYwOTMwMjYxNzE_6357a1a0-0a00-4c54-8164-3167ae8be832" continuedAt="ied6270f0af594eb5afab369fa9bf843a" escape="true">Commitments and Contingencies</ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="i229cf79a06d742ffbd366e83a179fb23"><ix:continuation id="ied6270f0af594eb5afab369fa9bf843a"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Guarantees and Indemnifications  </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the Company enters into agreements that contain a variety of representations and provide for general indemnification. The Company&#8217;s exposure under these agreements is unknown because it involves claims that may be made against the Company in the future. To date, the Company has not paid any claims or been required to defend any action related to its indemnification obligations. As of June&#160;30, 2022 and December&#160;31, 2021, the Company does not have any material indemnification claims that were probable or reasonably possible and consequently has not recorded related liabilities. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Facility Lease </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2013, the Company entered into a lease agreement for its current facility located in Redwood City, California. In 2018, the Company expanded the lease space and extended the lease agreement through October 2023. The lease agreement provides for an escalation of rent payments each year and the Company records rent expense on a straight-line basis over the term of the lease.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rent expense recognized under the lease, including additional rent charges for utilities, parking, maintenance, and real estate taxes, was $<ix:nonFraction unitRef="usd" contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630" decimals="-5" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90ZXh0cmVnaW9uOmY3NzA3NzM4ZGNjMDQzNWJiNzAxMjdmMGE3ZWZjYjEzXzk4OTU2MDQ2NTQ2NjI_0fe96ed4-27dd-4bb7-8454-4eea1a34a7a9"><ix:nonFraction unitRef="usd" contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630" decimals="-5" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90ZXh0cmVnaW9uOmY3NzA3NzM4ZGNjMDQzNWJiNzAxMjdmMGE3ZWZjYjEzXzk4OTU2MDQ2NTQ2NjI_b6e24881-64e7-4f6a-b898-529a2df44b9a">0.7</ix:nonFraction></ix:nonFraction>&#160;million for both the three months ended June 30, 2022 and 2021, respectively, and $<ix:nonFraction unitRef="usd" contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" decimals="-5" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90ZXh0cmVnaW9uOmY3NzA3NzM4ZGNjMDQzNWJiNzAxMjdmMGE3ZWZjYjEzXzk4OTU2MDQ2NTQ2NzA_0c7e2246-0d9c-4854-a4c4-5fe191f34bec">1.4</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630" decimals="-5" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90ZXh0cmVnaW9uOmY3NzA3NzM4ZGNjMDQzNWJiNzAxMjdmMGE3ZWZjYjEzXzk4OTU2MDQ2NTQ2Nzg_ab197ae3-c528-405b-ab7d-1c30bfa5ca6e">1.3</ix:nonFraction>&#160;million for the  six months ended June 30, 2022 and 2021, respectively.</span></div><div style="margin-bottom:9pt"><ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90ZXh0cmVnaW9uOmY3NzA3NzM4ZGNjMDQzNWJiNzAxMjdmMGE3ZWZjYjEzXzg3OTYwOTMwMjYxNzI_866dff97-bb0b-41bd-b846-d0c381616000" escape="true"><ix:nonNumeric contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90ZXh0cmVnaW9uOmY3NzA3NzM4ZGNjMDQzNWJiNzAxMjdmMGE3ZWZjYjEzXzg3OTYwOTMwMjYxNzI_acb6d04a-28e2-4259-bedb-049e0ef2df0c" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.666%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of June&#160;30, 2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Minimum Lease Payments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Debt Repayments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90YWJsZToyODQ0NjgzZDUwNzc0MjJmODI1MDdjNzk5MjFjYmNiOS90YWJsZXJhbmdlOjI4NDQ2ODNkNTA3NzQyMmY4MjUwN2M3OTkyMWNiY2I5XzEtMS0xLTEtNzE2MDY_1980a0ea-410f-4d85-a001-e3c43c2c3020">1,238</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90YWJsZToyODQ0NjgzZDUwNzc0MjJmODI1MDdjNzk5MjFjYmNiOS90YWJsZXJhbmdlOjI4NDQ2ODNkNTA3NzQyMmY4MjUwN2M3OTkyMWNiY2I5XzEtMy0xLTEtNzE2MDY_c1d26a3c-1a93-4803-a3da-3998cdf2040c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="prct:OperatingLeaseLiabilityAndLongTermDebtMaturityRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90YWJsZToyODQ0NjgzZDUwNzc0MjJmODI1MDdjNzk5MjFjYmNiOS90YWJsZXJhbmdlOjI4NDQ2ODNkNTA3NzQyMmY4MjUwN2M3OTkyMWNiY2I5XzEtNS0xLTEtNzE2MDY_eefcba78-463c-4af4-b2aa-f8a076425837">1,238</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90YWJsZToyODQ0NjgzZDUwNzc0MjJmODI1MDdjNzk5MjFjYmNiOS90YWJsZXJhbmdlOjI4NDQ2ODNkNTA3NzQyMmY4MjUwN2M3OTkyMWNiY2I5XzItMS0xLTEtNzE2MDY_d7a9cbc7-4362-4287-a5a1-30a01562a407">2,092</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90YWJsZToyODQ0NjgzZDUwNzc0MjJmODI1MDdjNzk5MjFjYmNiOS90YWJsZXJhbmdlOjI4NDQ2ODNkNTA3NzQyMmY4MjUwN2M3OTkyMWNiY2I5XzItMy0xLTEtNzE2MDY_2ad4c098-e67c-43d0-bc56-2ebfc5442c04">12,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="prct:OperatingLeaseLiabilityAndLongTermDebtMaturityYearOne" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90YWJsZToyODQ0NjgzZDUwNzc0MjJmODI1MDdjNzk5MjFjYmNiOS90YWJsZXJhbmdlOjI4NDQ2ODNkNTA3NzQyMmY4MjUwN2M3OTkyMWNiY2I5XzItNS0xLTEtNzE2MDY_ee745ff7-7266-4e6f-beca-4729350d439f">14,592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90YWJsZToyODQ0NjgzZDUwNzc0MjJmODI1MDdjNzk5MjFjYmNiOS90YWJsZXJhbmdlOjI4NDQ2ODNkNTA3NzQyMmY4MjUwN2M3OTkyMWNiY2I5XzMtMS0xLTEtNzE2MDY_670073d3-bd67-4d22-b16c-3859785ff359">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90YWJsZToyODQ0NjgzZDUwNzc0MjJmODI1MDdjNzk5MjFjYmNiOS90YWJsZXJhbmdlOjI4NDQ2ODNkNTA3NzQyMmY4MjUwN2M3OTkyMWNiY2I5XzMtMy0xLTEtNzE2MDY_dc07ce02-c114-4ac4-8149-1b2024d83115">37,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="prct:OperatingLeaseLiabilityAndLongTermDebtMaturityYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90YWJsZToyODQ0NjgzZDUwNzc0MjJmODI1MDdjNzk5MjFjYmNiOS90YWJsZXJhbmdlOjI4NDQ2ODNkNTA3NzQyMmY4MjUwN2M3OTkyMWNiY2I5XzMtNS0xLTEtNzE2MDY_253e293e-bf0b-45ff-a03a-e6d10ce4022d">37,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total minimum payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90YWJsZToyODQ0NjgzZDUwNzc0MjJmODI1MDdjNzk5MjFjYmNiOS90YWJsZXJhbmdlOjI4NDQ2ODNkNTA3NzQyMmY4MjUwN2M3OTkyMWNiY2I5XzYtMS0xLTEtNzE2MDY_67520135-a542-4c42-a682-ba7e1c0d7f57">3,330</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90YWJsZToyODQ0NjgzZDUwNzc0MjJmODI1MDdjNzk5MjFjYmNiOS90YWJsZXJhbmdlOjI4NDQ2ODNkNTA3NzQyMmY4MjUwN2M3OTkyMWNiY2I5XzYtMy0xLTEtNzE2MDY_3410fab4-0deb-4b7d-ab0b-11c5b0cf30f9">50,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="prct:OperatingLeaseLiabilityAndLongTermDebtMaturityGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90YWJsZToyODQ0NjgzZDUwNzc0MjJmODI1MDdjNzk5MjFjYmNiOS90YWJsZXJhbmdlOjI4NDQ2ODNkNTA3NzQyMmY4MjUwN2M3OTkyMWNiY2I5XzYtNS0xLTEtNzE2MDY_b79c93ff-d897-4140-b8b8-8e05e6ef1258">53,330</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amount representing interest/unamortized debt discount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90YWJsZToyODQ0NjgzZDUwNzc0MjJmODI1MDdjNzk5MjFjYmNiOS90YWJsZXJhbmdlOjI4NDQ2ODNkNTA3NzQyMmY4MjUwN2M3OTkyMWNiY2I5XzctMS0xLTEtNzE2MDY_340a9414-6d0c-4189-8817-0aea20869deb">243</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90YWJsZToyODQ0NjgzZDUwNzc0MjJmODI1MDdjNzk5MjFjYmNiOS90YWJsZXJhbmdlOjI4NDQ2ODNkNTA3NzQyMmY4MjUwN2M3OTkyMWNiY2I5XzctMy0xLTEtNzE2MDY_eeb3ec72-8e0a-41ec-8f1e-ebcc289565f5">507</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" sign="-" name="prct:OperatingLeaseLiabilityAndLongTermDebtMaturityUnamortizedDebtDiscount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90YWJsZToyODQ0NjgzZDUwNzc0MjJmODI1MDdjNzk5MjFjYmNiOS90YWJsZXJhbmdlOjI4NDQ2ODNkNTA3NzQyMmY4MjUwN2M3OTkyMWNiY2I5XzctNS0xLTEtNzE2MDY_f1294319-905e-430c-a46c-656108fbf809">264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of future payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90YWJsZToyODQ0NjgzZDUwNzc0MjJmODI1MDdjNzk5MjFjYmNiOS90YWJsZXJhbmdlOjI4NDQ2ODNkNTA3NzQyMmY4MjUwN2M3OTkyMWNiY2I5XzgtMS0xLTEtNzE2MDY_b3b5008a-6fed-4a0b-afff-61b032bd994e">3,087</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90YWJsZToyODQ0NjgzZDUwNzc0MjJmODI1MDdjNzk5MjFjYmNiOS90YWJsZXJhbmdlOjI4NDQ2ODNkNTA3NzQyMmY4MjUwN2M3OTkyMWNiY2I5XzgtMy0xLTEtNzE2MDY_9f6c92be-47c3-4d15-b4ed-245ad96bc963">50,507</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="prct:OperatingLeaseLiabilityAndLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90YWJsZToyODQ0NjgzZDUwNzc0MjJmODI1MDdjNzk5MjFjYmNiOS90YWJsZXJhbmdlOjI4NDQ2ODNkNTA3NzQyMmY4MjUwN2M3OTkyMWNiY2I5XzgtNS0xLTEtNzE2MDY_95d183dc-8c96-4298-87c3-e86fd04b1cbd">53,594</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90YWJsZToyODQ0NjgzZDUwNzc0MjJmODI1MDdjNzk5MjFjYmNiOS90YWJsZXJhbmdlOjI4NDQ2ODNkNTA3NzQyMmY4MjUwN2M3OTkyMWNiY2I5XzktMS0xLTEtNzE2MDY_0eb72c57-85c6-49f5-bb2a-2e1c9ba7351f">2,258</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90YWJsZToyODQ0NjgzZDUwNzc0MjJmODI1MDdjNzk5MjFjYmNiOS90YWJsZXJhbmdlOjI4NDQ2ODNkNTA3NzQyMmY4MjUwN2M3OTkyMWNiY2I5XzktMy0xLTEtNzE2MDY_72c2e2f3-ba22-461b-963b-31929a2e2bc1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="prct:OperatingLeaseLiabilityAndLongTermDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90YWJsZToyODQ0NjgzZDUwNzc0MjJmODI1MDdjNzk5MjFjYmNiOS90YWJsZXJhbmdlOjI4NDQ2ODNkNTA3NzQyMmY4MjUwN2M3OTkyMWNiY2I5XzktNS0xLTEtNzE2MDY_2b1cd728-3ee8-434e-a143-edb2f41b490a">2,258</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current portion</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90YWJsZToyODQ0NjgzZDUwNzc0MjJmODI1MDdjNzk5MjFjYmNiOS90YWJsZXJhbmdlOjI4NDQ2ODNkNTA3NzQyMmY4MjUwN2M3OTkyMWNiY2I5XzEwLTEtMS0xLTcxNjA2_d3cb8f26-f320-48df-b8c2-7ba3566eeafb">829</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90YWJsZToyODQ0NjgzZDUwNzc0MjJmODI1MDdjNzk5MjFjYmNiOS90YWJsZXJhbmdlOjI4NDQ2ODNkNTA3NzQyMmY4MjUwN2M3OTkyMWNiY2I5XzEwLTMtMS0xLTcxNjA2_b6a724ef-c2f5-40dc-875a-30a8a7b03afe">50,507</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630" decimals="-3" name="prct:OperatingLeaseLiabilityAndLongTermDebtExcludingCurrentMaturities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90YWJsZToyODQ0NjgzZDUwNzc0MjJmODI1MDdjNzk5MjFjYmNiOS90YWJsZXJhbmdlOjI4NDQ2ODNkNTA3NzQyMmY4MjUwN2M3OTkyMWNiY2I5XzEwLTUtMS0xLTcxNjA2_2a60854a-5174-44f2-87e1-10227399fcc3">51,336</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:nonNumeric></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022 and December&#160;31, 2021, the Company&#8217;s security deposit is in the form of, and recorded as, restricted cash. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, the Company entered into a lease for <ix:nonFraction unitRef="building" contextRef="id73017efcdff4610924f905608444615_I20211231" decimals="INF" name="prct:OperatingLeaseNumberOfBuildings" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90ZXh0cmVnaW9uOmY3NzA3NzM4ZGNjMDQzNWJiNzAxMjdmMGE3ZWZjYjEzXzkzNDU4NDg4NDEwMjc_5f0bc918-6756-435c-92f4-8877bdb37878">two</ix:nonFraction> existing buildings, comprising approximately <ix:nonFraction unitRef="sqft" contextRef="id73017efcdff4610924f905608444615_I20211231" decimals="0" name="prct:OperatingLeaseNumberOfSquareFeet" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90ZXh0cmVnaW9uOmY3NzA3NzM4ZGNjMDQzNWJiNzAxMjdmMGE3ZWZjYjEzXzkzNDU4NDg4NDEwNzY_6ff2c060-8134-408b-8d75-702260d7b3c2">158,221</ix:nonFraction> square feet of space, located in San Jose, California.  The lease commenced in July 2022, and will continue for 122 months following thereafter, with <ix:nonFraction unitRef="renewaloption" contextRef="ic8e9593d6af940928b18f5797d0ae114_D20211231-20211231" decimals="INF" name="prct:LesseeOperatingLeaseNumberOfRenewalOptions" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90ZXh0cmVnaW9uOmY3NzA3NzM4ZGNjMDQzNWJiNzAxMjdmMGE3ZWZjYjEzXzkzNDU4NDg4NDEyMzA_102a04b5-44b4-4c84-b0fb-edbbebc27820">two</ix:nonFraction> five year options to extend the term of the lease. The Lease provides for annual base rent of $<ix:nonFraction unitRef="usd" contextRef="id73017efcdff4610924f905608444615_I20211231" decimals="-5" name="prct:OperatingLeaseAnnualBaseRentYearOne" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90ZXh0cmVnaW9uOmY3NzA3NzM4ZGNjMDQzNWJiNzAxMjdmMGE3ZWZjYjEzXzkzNDU4NDg4NDEzMjc_ade2578b-bf20-4c3b-836a-f8cf1c87f777">4.3</ix:nonFraction> million for the first year, which increases on a yearly basis up to $<ix:nonFraction unitRef="usd" contextRef="id73017efcdff4610924f905608444615_I20211231" decimals="-5" name="prct:OperatingLeaseAnnualBaseRentYearTen" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90ZXh0cmVnaW9uOmY3NzA3NzM4ZGNjMDQzNWJiNzAxMjdmMGE3ZWZjYjEzXzkzNDU4NDg4NDEzODk_29fda2d3-a81c-4af5-9eb9-642206cc35f6">5.5</ix:nonFraction> million for the tenth year, for an aggregate of $<ix:nonFraction unitRef="usd" contextRef="id73017efcdff4610924f905608444615_I20211231" decimals="-5" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90ZXh0cmVnaW9uOmY3NzA3NzM4ZGNjMDQzNWJiNzAxMjdmMGE3ZWZjYjEzXzkzNDU4NDg4NDE0MzE_87b7ff9d-da96-49f3-a0ea-965aff5544ef">49.2</ix:nonFraction> million. Under the terms of the lease, the Company will receive an allowance of up to $<ix:nonFraction unitRef="usd" contextRef="id73017efcdff4610924f905608444615_I20211231" decimals="-5" name="prct:LesseeOperatingLeaseReceivableAllowanceForTenantImprovements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90ZXh0cmVnaW9uOmY3NzA3NzM4ZGNjMDQzNWJiNzAxMjdmMGE3ZWZjYjEzXzkzNDU4NDg4NDE1MTM_5474f1d9-9d7c-4855-807f-c0e25b8ed905">7.9</ix:nonFraction> million from the landlord to be applied to the Company&#8217;s construction of tenant improvements following the landlord&#8217;s delivery of the <ix:nonFraction unitRef="building" contextRef="id73017efcdff4610924f905608444615_I20211231" decimals="INF" name="prct:OperatingLeaseNumberOfBuildings" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90ZXh0cmVnaW9uOmY3NzA3NzM4ZGNjMDQzNWJiNzAxMjdmMGE3ZWZjYjEzXzkzNDU4NDg4NDE2NDM_32eceadd-013e-4f58-9d90-dddb36169a94">two</ix:nonFraction> buildings to the Company.  The Company is currently assessing the accounting impact of the lease on its consolidated financial statements.</span></div></ix:continuation></ix:continuation><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div id="ibb2df456afff4355bae87af9d1240625_677"></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><div id="ibb2df456afff4355bae87af9d1240625_61"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2. MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following discussion and analysis of our financial condition and results of operations together with our financial statements and related notes included elsewhere in this report. In addition to historical financial information, the following discussion and analysis contains forward-looking statements that involve risks, uncertainties and assumptions. Our actual results and timing of selected events may differ materially from those anticipated in these forward-looking statements as a result of many factors, including those discussed in the section titled &#8220;Risk Factors&#8221; and elsewhere in this report. Please also see the section titled &#8220;Cautionary Note Regarding Forward-Looking Statements.&#8221;</span></div><div id="ibb2df456afff4355bae87af9d1240625_64"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. We develop, manufacture and sell the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. BPH is the most common prostate disease and impacts approximately 40 million men in the United States. The AquaBeam Robotic System employs a single-use disposable handpiece to deliver our proprietary Aquablation therapy, which combines real-time, multi-dimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. We designed our AquaBeam Robotic System to enable consistent and reproducible BPH surgery outcomes. We believe that Aquablation therapy represents a paradigm shift in the surgical treatment of BPH by addressing compromises associated with alternative surgical interventions. We designed Aquablation therapy to deliver effective, safe and durable outcomes for males suffering from lower urinary tract symptoms, or LUTS, due to BPH that are independent of prostate size and shape or surgeon experience. We have developed a significant and growing body of clinical evidence, which includes nine clinical studies and over 100 peer-reviewed publications, supporting the benefits and clinical advantages of Aquablation therapy. As of June&#160;30, 2022, we had an install base of 176 AquaBeam Robotic Systems globally, including 114 in the United States.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our U.S. pivotal trial, the WATER study, is the only FDA pivotal study randomized against transurethral resection of prostate, or TURP, which is the historical standard of care for the surgical treatment of BPH. In this study, Aquablation therapy demonstrated superior safety and non-inferior efficacy compared to TURP across prostate sizes between 30 ml and 80 ml, and superior efficacy in a subset of patients with prostates larger than 50 ml. We have established strong relationships with key opinion leaders, or KOLs, within the urology community and collaborated with key urological societies in global markets. This support has been instrumental in facilitating broader acceptance and adoption of Aquablation therapy. As a result of our strong KOL network and our compelling clinical evidence, Aquablation therapy has been added to clinical guidelines of various professional associations, including the American Urological Association. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, we sell our products to hospitals. We are initially targeting 860 high-volume hospitals that perform, on average, more than 200 resective procedures annually and account for approximately 70% of all hospital-based resective procedures. Over time, we will gradually expand our focus to also include mid- and low-volume hospitals. These customers in turn bill various third-party payors, such as commercial payors and government agencies, for treatment payment of each patient. Effective in 2021, all local Medicare Administrative Contractors, or MACs, which represent 100% of eligible Medicare patients, issued final positive local coverage determinations to provide Medicare beneficiaries with access to Aquablation therapy in all 50 states. We also have favorable coverage decisions from several large commercial payors. We plan to leverage these recent successes in our active discussions with all commercial payors to establish additional positive national and regional coverage policies. Outside of the United States, we have ongoing efforts in key markets to expand established coverage and improve payment which we believe will expand patient access to Aquablation therapy.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We manufacture the AquaBeam Robotic System, the handpiece, integrated scope and other accessories at our facility in Redwood City, California. This includes supporting the supply chain distribution and logistics of the various components. Components, sub-assemblies and services required to manufacture our products are purchased from numerous global suppliers. Each AquaBeam Robotic System is shipped to our customers with a third-party </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">manufactured ultrasound system and probe. We utilize a well-known third-party logistics provider located in the United States and the Netherlands to ship our products to our customers globally. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generated revenue of $30.9 million and incurred a net loss of $36.4 million for the six months ended June 30, 2022, compared to revenue of $15.7 million and a net loss of $27.4 million for the six months ended June 30, 2021. As of June&#160;30, 2022, we had cash and cash equivalents of $269.8 million and an accumulated deficit of $297.9 million.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We completed our IPO in September 2021, which raised $172.4 million, net of issuance costs. Previously, our primary sources of capital have been from private placements of redeemable convertible preferred securities and debt financing agreements. As of June&#160;30, 2022, we have raised $337.1 million from private placements of redeemable convertible preferred securities from our investors. We expect our expenses will increase for the foreseeable future, in particular as we continue to make substantial investments in sales and marketing, operations and research and development. Moreover, we expect to incur additional expenses as a result of operating as a public company, including legal, accounting, insurance, compliance with the rules and regulations of the SEC and those of any stock exchange on which our securities are traded, investor relations, and other administrative and professional services expenses. Based on our operating plan, we currently believe that our existing cash and cash equivalents, anticipated revenue and available debt financing arrangements will be sufficient to meet our capital requirements and fund our operations through at least the next twelve months from the issuance date of the financial statements. If these sources are insufficient to satisfy our liquidity requirements, we may seek to sell additional public equity or debt securities or obtain an additional credit facility. The sale of equity and convertible debt securities may result in dilution to our stockholders and, in the case of preferred equity securities or convertible debt, those securities could provide for rights, preferences or privileges senior to those of our common stock. Debt financing, if available, may involve covenants restricting our operations or our ability to incur additional debt. Any debt financing or additional equity that we raise may contain terms that are not favorable to us or our stockholders. Additional financing may not be available at all, or in amounts or on terms unacceptable to us. If we are unable to obtain additional financing, we may be required to delay the development, commercialization and marketing of our products. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Factors Affecting Our Performance</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe there are several important factors that have impacted and that we expect will impact our operating performance and results of operations for the foreseeable future. While these factors may present significant opportunities for us, they also pose significant risks and challenges that we must address. See the section titled &#8220;Risk Factors&#8221; for more information. These factors include:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Grow our install base of AquaBeam Robotic Systems:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As of June&#160;30, 2022, we had an install base of 176 AquaBeam Robotic Systems globally, including 114 in the United States. In the United States, we are initially focused on driving adoption of Aquablation therapy among urologists that perform hospital-based resective BPH surgery. We are initially targeting 860 high-volume hospitals that we estimate perform, on average, more than 200 resective procedures annually and account for approximately 70% of all hospital-based resective procedures. To penetrate these hospitals, we will continue to increase our direct team of capital sales representatives, who are focused on driving system placement within hospitals by engaging with key surgeons and decision makers to educate them about the compelling value proposition of Aquablation therapy. As we increase our install base of AquaBeam Robotic systems our revenue will increase as a result of the system sale and resulting utilization.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Increase system utilization:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our revenue is significantly impacted by the utilization of our AquaBeam robotic system. Once we place a system within a hospital our objective is to establish Aquablation therapy as the surgical treatment of choice for BPH. Within each hospital we are initially focused on targeting urologists who perform medium-to-high volumes of resective procedures and converting their resective cases to Aquablation therapy. To accomplish this, we will continue expanding our team of highly trained Aquablation representatives and clinical specialists who are focused on driving system utilization within the hospital, providing education and training support and ensuring excellent user experiences. As urologists gain experience with Aquablation therapy we will leverage their experiences to capture more surgical volumes and establish Aquablation therapy as the surgical standard of care. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Reimbursement and coverage decisions by third-party payors.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Healthcare providers in the United States generally rely on third-party payors, principally federal Medicare, state Medicaid and private health insurance plans, to cover all or part of the cost of procedures using our AquaBeam Robotic System. The revenue we are able to generate from sales of our products depends in large part on the availability of sufficient reimbursement from such payors. Effective in 2021, all local MACs, representing 100% of eligible Medicare patients, issued final positive local coverage determinations to provide Medicare beneficiaries with access to Aquablation therapy in all 50 states. We believe that these favorable coverage decisions have been a catalyst for hospital adoption of our AquaBeam Robotic System. We believe our strong body of clinical evidence and support from key societies, supplemented by the momentum from Medicare coverage, have led to favorable coverage decisions from several large commercial payors. We plan to leverage these recent successes in our active discussions with commercial payors to establish additional positive national and regional coverage policies. We believe that additional commercial payor coverage will contribute to increasing utilization of our system over time. Outside of the United States, we have ongoing efforts in key markets to expand established coverage and further improve patient access to Aquablation therapy.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Cost of sales.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The results of our operations will depend, in part, on our ability to increase our gross margins by more effectively managing our costs to produce our AquaBeam Robotic System and single-use disposable handpieces, and to scale our manufacturing operations efficiently. We anticipate that as we expand our sales and marketing efforts and drive further sales growth, our purchasing costs on a per unit basis may decrease, and in turn improve our gross margin. As our commercial operations continue to grow, we expect to continue to realize operating leverage through increased scale efficiencies. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Investment in research and development to drive continuous improvements and innovation.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We are currently developing additional and next generation technologies to support and improve Aquablation therapy to further satisfy the evolving needs of surgeons and their patients as well as to further enhance the usability and scalability of the AquaBeam Robotic System. We also plan to leverage our treatment data and software development capabilities to integrate artificial intelligence and machine learning to enable computer-assisted anatomy recognition and improved treatment planning and personalization. Our future growth is dependent on these continuous improvements which require significant resources and investment.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impact of the COVID-19 Pandemic</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 outbreak and the consequential economic disruptions have negatively impacted and may continue to negatively impact our operations, revenue and overall financial condition. In response to the pandemic, numerous state&#160;and local jurisdictions imposed, and others in the future may impose, &#8220;shelter-in-place&#8221; orders, quarantines, executive orders, and similar government orders and restrictions for their residents to control the spread of&#160;COVID-19. Starting in mid-March 2020, the governor of California, where our headquarters are located, issued &#8220;shelter-in-place&#8221; or &#8220;stay at home&#8221; orders restricting non-essential activities, travel, and business operations, subject to certain exceptions for necessary activities.&#160;Such orders or restrictions have resulted in our headquarters closing, slowdowns and delays, travel restrictions, and cancellation of training and other events, among other effects, thereby negatively impacting our operations. Additionally, in the United States, governmental authorities have recommended, and in certain cases required, that elective, specialty and other procedures and appointments be suspended or canceled to avoid non-essential patient exposure to medical environments and potential infection with COVID-19 and to focus limited resources and personnel capacity toward the treatment of&#160;COVID-19.&#160;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> These measures and challenges have decreased the number of BPH procedures generally, and consequently could have slowed adoption of our AquaBeam therapy and may have impacted our ability to sell our AquaBeam Robotic System. We believe the number of our systems sold has been impacted as health care organizations globally have prioritized the treatment of patients with COVID-19, and as health care organizations continue to experience consequential economic disruptions from the COVID-19 pandemic such as budget shortfalls and staffing shortages. Numerous procedures have been and in certain jurisdictions in which we operate are continuing to be cancelled or delayed as a result of local public health measures and hospital policies. We have also experienced disruptions, and may experience future disruptions, including: delays in sales personnel becoming fully trained and productive; difficulties and delays in physician outreach and training physicians to use our AquaBeam Robotic System; </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">restrictions on personnel to travel; delays in follow-ups of our clinical studies; challenges with maintaining adequate supply from third-party manufacturers of components and finished goods and distribution providers; and access to physicians for training and case support.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While many restrictions associated with COVID-19 have more recently been relaxed, the longevity and extent of the various COVID-19 pandemic remains uncertain, including due to the emergence and impact of the COVID-19 variants and continued economic disruptions. These measures and challenges may continue for the duration of the pandemic and may negatively impact our revenue growth while the pandemic continues. </span></div><div id="ibb2df456afff4355bae87af9d1240625_67"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Components of Our Results of Operations </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generate our revenue primarily from the capital portion of our business, which includes sales and rentals of our AquaBeam Robotic System, and from the recurring revenue associated with sales of our single-use disposable handpieces that are used during each surgery performed with our system. Other revenue is derived primarily from service and repair and extended service contracts with our existing customers. We expect our revenue to increase in absolute dollars for the foreseeable future as we continue to focus on driving adoption of Aquablation therapy, and increased system utilization, though it may fluctuate from quarter to quarter.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents revenue by significant geographical locations for the periods indicated:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outside the United States</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that both our U.S. and international revenue will increase in the near term as we continue to expand the install base of AquaBeam Robotic Systems and increase the units sold of our single-use disposable handpieces. We expect our increase in revenues in absolute dollars to be larger in the United States.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Sales and Gross Margin </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of sales consists primarily of material costs, direct labor and manufacturing overhead costs, warranty and service costs, and other direct costs such as shipping costs. A significant portion of our cost of sales currently consists of manufacturing overhead costs. These overhead costs include compensation for personnel, including stock-based compensation, facilities, equipment and operations supervision, quality assurance and material procurement. We expect our cost of sales to increase in absolute dollars for the foreseeable future primarily as, and to the extent, our revenue grows, or we make additional investments in our manufacturing capabilities, though it may fluctuate from period to period. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We calculate gross margin percentage as gross profit divided by revenue. Our gross margin has been and will continue to be affected by a variety of factors, primarily, product and geographic mix and the resulting average selling prices, production volumes, manufacturing costs and product yields, and to a lesser extent the implementation of cost reduction strategies. We expect our gross margin to increase over the long term as our production volume increases and as we spread the fixed portion of our manufacturing overhead costs over a larger number of units produced, thereby significantly reducing our per unit manufacturing costs, though it may fluctuate from quarter to quarter. Our gross margins can fluctuate due to geographic mix. To the extent we sell more systems and handpieces in the United States, we expect our margins will increase due to the higher average selling prices as compared to sales outside of the United States.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expenses</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development, or R&amp;D, expenses consist primarily of engineering, product development, regulatory affairs, consulting services, materials, depreciation and other costs associated with products and technologies being developed. These expenses include employee and non-employee compensation, including stock-based compensation, supplies, materials, quality assurance expenses, consulting, related travel expenses and facilities expenses. We expect our R&amp;D expenses to increase in absolute dollars for the foreseeable future as we continue to develop, enhance and commercialize new products and technologies, though it may fluctuate from quarter to quarter. However, we expect our R&amp;D expenses as a percentage of revenue to vary over time depending on the level and timing of initiating new product development efforts. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, General and Administrative </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative, or SG&amp;A, expenses consist primarily of compensation for personnel, including stock-based compensation, related to selling, marketing, clinical affairs, professional education, finance, information technology, and human resource functions. SG&amp;A expenses also include commissions, training, travel expenses, promotional activities, conferences, trade shows, professional services fees, audit fees, legal fees, insurance costs and general corporate expenses including allocated facilities-related expenses. Clinical expenses include clinical trial design, clinical site reimbursement, data management and travel expenses. We expect our SG&amp;A expenses to increase in absolute dollars for the foreseeable future as we expand our commercial infrastructure and incur additional fees associated with operating as a public company, including legal, accounting, insurance, compliance with the rules and regulations of the SEC and those of any stock exchange on which our securities are traded, investor relations, and other administrative and professional services expenses, though it may fluctuate from quarter to quarter. However, over time, we expect our SG&amp;A expenses to decrease as a percentage of revenue. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest and Other Income, Net </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Expense</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense consists primarily of interest expense from our note payable.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest and Other Income, Net</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest and other income, net, consists primarily of interest income from our cash and cash equivalents balances, and fair value adjustments from our redeemable convertible preferred stock warrant liabilities and our loan facility derivative liability.  </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div id="ibb2df456afff4355bae87af9d1240625_70"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables show our results of operations for the three and six months ended June 30, 2022 and 2021:</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except percentages)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,691&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,476&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,215&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,205&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,893&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,312&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,486&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,583&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,903&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Gross margin</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,706&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,476&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,230&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,299&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,356&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,361&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,775&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,586&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,875)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,192)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,683)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,441)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,436)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,184)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,580)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,604)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except percentages)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,888&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,668&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,710&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,558&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,178&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,110&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,068&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Gross margin</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,717&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,998&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,719&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,040&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,648&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,392&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,757&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,646&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,111&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,579)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,536)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,043)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,862)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,900)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,369)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,402)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,967)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comparison of Three and Six Months Ended June 30, 2022 and 2021 </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except percentages)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">System sales and rentals</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,385&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,743&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,642&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Handpieces and other consumables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,555&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,543&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,012&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">751&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">561&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,691&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,476&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,215&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except percentages)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">System sales and rentals</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,880&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,574&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,306&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Handpieces and other consumables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,745&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,767&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,978&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,263&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">936&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,888&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,668&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,220&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue increased $8.2 million, or 97%, to $16.7 million during the three months ended June 30, 2022, compared to $8.5 million during the three months ended June 30, 2021, and increased $15.2 million or 97% to $30.9 million during the six months ended June 30, 2022, compared to $15.7 million during the six months ended June 30, 2021. The growth in revenue was primarily attributable to an increase of $8.2 million and $14.6 million in revenues derived from the United States for the three and six months ended June 30, 2022, respectively, resulting from higher sales volumes of both our AquaBeam Robotic System and our single-use disposable handpieces, and from the expansion of insurance coverage and the increase in personnel in our sales and marketing organizations. In addition, sales of both our AquaBeam Robotic System and our single-use disposable handpieces outside of the United States had an immaterial decrease in sales volume during the three months ended June 30, 2022, and increased by $0.7 million in sales volume during the six months ended June 30, 2022. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of Sales and Gross Margin </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of sales increased $3.3 million, or 68%, to $8.2 million during the three months ended June 30, 2022, compared to $4.9 million during the three months ended June 30, 2021, and increased $6.2 million or 72%, to $14.7 million during the six months ended June 30, 2022, compared to $8.6 million during the six months ended June 30, 2021. The increase in cost of sales was primarily attributable to the growth in the number of units sold.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross margin increased to 51% during the three months ended June 30, 2022, compared to 42% for the three months ended June 30, 2021, and increased to 52% during the six months ended June 30, 2022 compared to 45% during the six months ended June 30, 2021. The increase in gross margin was primarily attributable to the growth in unit sales, which allowed us to spread the fixed portion of our manufacturing overhead costs over more production units. Additionally, we realized higher average selling prices in the United States on both our AquaBeam Robotic System and our single-use disposable handpieces.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Expenses </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses (&#8220;R&amp;D&#8221;) increased $2.2 million, or 50%, to $6.7 million during the three months ended June 30, 2022, compared to $4.5 million during the three months ended June 30, 2021, and increased $2.7 million or 30%, to $11.7 million during the six months ended June 30, 2022, compared to $9.0 million during the six months ended June 30, 2021. The increase in R&amp;D expenses was primarily due to employee-related expenses of our R&amp;D organization. These expenses support ongoing product improvements and the development of additional and next generation technologies. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, General and Administrative Expenses </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general, and administrative expenses (SG&amp;A) increased $7.4 million, or 60%, to $19.7 million during the three months ended June 30, 2022, compared to $12.3 million during the three months ended June 30, 2021, and increased $15.4 million or 68% , to $38.0 million during the six months ended June 30, 2022, compared to $22.6 million. The increase in SG&amp;A expenses was primarily due to employee-related expenses of our sales and marketing organization and reimbursement and administrative organizations as we expanded our infrastructure to drive and support our growth in revenue.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Expense </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense was consistent during the three and six months ended June 30, 2022 and 2021. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest and Other Income, Net </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest and other income, net, was consistent during the three and six months ended June 30, 2022 and 2021. </span></div><div id="ibb2df456afff4355bae87af9d1240625_73"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We completed our IPO in September 2021, which raised $172.4 million, net of issuance costs. Previously, our primary sources of capital have been from private placements of redeemable convertible preferred securities and debt financing agreements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, we had cash and cash equivalents of $269.8 million, an accumulated deficit of $297.9 million, and $50.5 million outstanding on our loan facility. We expect our expenses will increase for the foreseeable future, in particular as we continue to make substantial investments in sales and marketing, operations and research and development. Moreover, we expect to incur additional expenses as a result of operating as a public company, including legal, accounting, insurance, compliance with the rules and regulations of the SEC and those of any stock exchange on which our securities are traded, investor relations, and other administrative and professional services expenses. Our future funding requirements will depend on many factors, including:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the degree and rate of market acceptance of our products and Aquablation therapy;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the scope and timing of investment in our sales force and expansion of our commercial organization;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact on our business from the ongoing and global COVID-19 pandemic and the end of the COVID-19 pandemic, or any other pandemic, epidemic or outbreak of an infectious disease;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the scope, rate of progress and cost of our current or future clinical trials and registries;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost of our research and development activities;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost and timing of additional regulatory clearances or approvals;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs associated with any product recall that may occur;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs associated with the manufacturing of our products at increased production levels;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs of attaining, defending and enforcing our intellectual property rights;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">whether we acquire third-party companies, products or technologies;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the terms and timing of any other collaborative, licensing and other arrangements that we may establish;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the emergence of competing technologies or other adverse market developments; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the rate at which we expand internationally.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on our operating plan, we currently believe that our existing cash and cash equivalents, anticipated revenue and available debt financing arrangements will be sufficient to meet our capital requirements and fund our operations through at least the next twelve months from the issuance date of the financial statements. We have based this estimate on assumptions that may prove to be wrong, and we may need to utilize additional available capital resources. If these sources are insufficient to satisfy our liquidity requirements, we may seek to sell additional public equity or debt securities or obtain an additional credit facility. The sale of equity and convertible debt securities may result in dilution to our stockholders and, in the case of preferred equity securities or convertible debt, those securities could provide for rights, preferences or privileges senior to those of our common stock. Debt financing, if available, may involve covenants restricting our operations or our ability to incur additional debt. Any debt financing or additional equity that we raise may contain terms that are not favorable to us or our stockholders. Additional financing may not be available at all, or in amounts or on terms unacceptable to us. If we are unable to obtain additional financing, we may be required to delay the development, commercialization and marketing of our products. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indebtedness</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2019, we entered into a loan facility that initially made up to a total of $75.0 million available in four installments. We borrowed $25.0 million in September 2019 and an additional $25.0 million in March 2020. The third installment is for $10.0 million and was originally available for draw through March 31, 2021 contingent upon our achieving $20.0 million trailing six months revenue in any month before March 31, 2021. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The remaining $15.0 million was originally available for draw through June 30, 2021 contingent upon achieving $25.0 million in trailing six months revenue. In January 2021, the third installment was amended to be available for draw through March 31, 2022 contingent upon our achieving $6.4 million trailing six months revenue prior to June 30, 2021, and the fourth installment was amended to be available for draw though June 30, 2022, which is now no longer available. The facility bears an interest rate of the greater of (i) 9.37% and (ii) 7.17% plus 30-day LIBOR. The facility includes customary negative covenants that, among other things, restrict our ability to incur indebtedness or enter into certain change of control transactions. It also contains customary events of default that would result in the termination of the commitments under the facility and permit the lender to accelerate payment on outstanding borrowings. As of June&#160;30, 2022, we were in compliance with all covenants under the facility. The initial term of the facility is 60 months with interest-only payments, with the repayment of principal being amortized over a period of: 36 months, if we fail to achieve the revenue target for the third installment, 24 months if we achieve the revenue target for the third installment but have not raised at least $50.0 million in an initial public offering, or 12 months if we achieve the revenue target for the third installment and raise at least $50.0 million in an initial public offering. Upon completion of raising over $50.0 million in our IPO in September 2021, interest-only payments was extended an additional 12 months followed by 12 months amortization of principal and interest. We pledged substantially all of our assets as collateral for the loan. Commencing with the quarter ended June 30, 2021, we are required to achieve revenue for the previous six months ended equal to 70% of the forecast for the commensurate quarterly period. Additionally, in connection with the loan facility, we are obligated to pay a fee upon the earlier occurrence of a defined liquidity event, including but not limited to, a merger or sale of our assets or voting stock, or our achieving a $200.0 million trailing twelve months revenue target, in each case, by September 2029. The fee is calculated at the time of the liquidity event occurrence to be $1.0 million if only the first installment has been drawn, $2.0 million if the first two installments have been drawn, $2.4 million if the first three installments have been drawn, or $3.0 million if all four installments have been drawn, in each case, upon the occurrence of the liquidity event. As of June&#160;30, 2022, we have drawn on the first two installments. As of June&#160;30, 2022, we had $50.0 million outstanding under the loan facility.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><div id="ibb2df456afff4355bae87af9d1240625_76"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Flows </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our cash flows for the periods presented:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash (used in) provided by:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,357)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,107)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(273)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(149)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net (decrease) increase in cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,477)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,094&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div id="ibb2df456afff4355bae87af9d1240625_79"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Cash Used in Operating Activities </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June 30, 2022, net cash used in operating activities was $35.4 million, consisting primarily of a net loss of $36.4 million and an increase in net operating assets of $4.6 million, partially offset by non-cash charges of $5.6 million. The cash used in operations was primarily due to our net loss due to the increase in operating expenses to support our commercialization and development activities. The expansion of our commercialization resulted in an increase in accounts receivable and inventory. Non-cash charges consisted primarily of stock-based compensation and depreciation. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June 30, 2021, net cash used in operating activities was $28.1 million, consisting primarily of a net loss of $27.4 million and an increase in net operating assets of $4.2 million, partially offset by non-cash charges of $3.5 million. The cash used in operations was primarily due to our net loss due to the increase in operating expenses to support our commercialization and development activities. The expansion of our commercialization resulted in an increase in accounts receivable, inventory and prepaid expenses, partially offset by an increase in accounts payable. Non-cash charges consisted primarily of depreciation and stock-based compensation. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Cash Used in by Investing Activities </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June 30, 2022, net cash used in investing activities was $0.3 million, consisting of purchases of property and equipment. During the six months ended June 30, 2021, net cash used in investing activities was  $0.1 million, consisting of purchases of property and equipment. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Cash Provided by Financing Activities </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June 30, 2022, net cash provided by financing activities was $4.2 million, consisting of proceeds from exercises of stock options. During the six months ended June 30, 2021, net cash provided by financing activities was $87.4 million, consisting of proceeds from issuance of Series G preferred stock, net of issuance costs and proceeds from exercises of stock options.</span></div><div id="ibb2df456afff4355bae87af9d1240625_82"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contractual Commitments and Contingencies</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information included in Note 11 to the condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q is incorporated herein by reference.</span></div><div id="ibb2df456afff4355bae87af9d1240625_85"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not have during the periods presented, and we do not currently have any off-balance sheet arrangements, such as structured finance, special purpose entities or variable interest entities. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><div id="ibb2df456afff4355bae87af9d1240625_88"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Estimates </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management&#8217;s discussion and analysis of our financial condition and results of operations is based on our financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles. The preparation of these financial statements requires us to make estimates and assumptions for the reported amounts of assets, liabilities, revenue, expenses and related disclosures. Our estimates are based on our historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions and any such differences may be material. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The significant accounting policies and estimates used in preparation of the unaudited condensed consolidated financial statements are described in our audited consolidated financial statements as of and for the year ended December 31, 2021, and the notes thereto, which are included in our Annual Report on Form 10-K dated March 22, 2022, or Annual Report, and in &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; included in our Annual Report. with the exception of the accounting policy change described in Part I, Item I, Note 2, there have been no material changes to our significant accounting policies during the three months ended June&#160;30, 2022. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">JOBS Act Accounting Election and Smaller Reporting Company Status</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are an &#8220;emerging growth company,&#8221; as defined in the JOBS Act. Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act until such time as those standards apply to private companies. We have elected to use this extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date that we (i) are no longer an emerging growth company or (ii) affirmatively and irrevocably opt out of the extended transition period provided in the JOBS Act. As a result, our consolidated financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also a &#8220;smaller reporting company&#8221; as defined in the Exchange Act. We may continue to be a smaller reporting company even after we are no longer an emerging growth company. We may take advantage of certain of the scaled disclosures available to smaller reporting companies and will be able to take advantage of these scaled disclosures for so long as our voting and non-voting common stock held by non-affiliates is less than $250.0 million measured on the last business day of our second fiscal quarter, or our annual revenue is less than $100.0 million during the most recently completed fiscal year and our voting and non-voting common stock held by non-affiliates is less than $700.0 million measured on the last business day of our second fiscal quarter.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On the last business day of our second quarter in 2022, the aggregate market value of our shares held by non-affiliate stockholders exceeded $700 million. As a result, as of December 31, 2022, we will be considered a large accelerated filer as defined in Rule 12b-2 under the Exchange Act, and we will cease to be an emerging growth company as defined in the JOBS Act. We will no longer be exempt from the auditor attestation requirements of Section 404(b) of the Sarbanes-Oxley Act, and our independent registered public accounting firm will evaluate and report on the effectiveness of internal control over financial reporting.</span></div><div id="ibb2df456afff4355bae87af9d1240625_91"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information included in Note 2 to the condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q is incorporated herein by reference.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><div id="ibb2df456afff4355bae87af9d1240625_94"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Quantitative and Qualitative Disclosures About Market Risk </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents of $269.8 million as of June&#160;30, 2022, consisted of securities carried at quoted market prices with an original maturity of three months or less and therefore there is minimal risk associated with fluctuating interest rates. We do not currently use or plan to use financial derivatives in our investment portfolio. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, as described above under the subsection titled &#8220;Indebtedness,&#8221; amounts outstanding under our loan facility bear interest at a floating rate equal to 7.17% plus the greater of 2.2% or 30-day LIBOR. As a result, we are exposed to risks from changes in interest rates. We do not believe that a hypothetical 100 basis point increase or decrease in interest rates or 30-day LIBOR would have had a material impact on our financial statements included elsewhere in this Quarterly Report on Form 10-Q. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Risk </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain our cash and cash equivalents with multiple financial institutions in the United States, and our current deposits are in excess of insured limits. We have reviewed the financial statements of these institutions and believe it has sufficient assets and liquidity to conduct its operations in the ordinary course of business with little or no credit risk to us. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our accounts receivable primarily relate to revenue from the sale or rental of our products. No customers accounted for more than 10% of accounts receivable at June&#160;30, 2022. One customer accounted for 11% of accounts receivable at December&#160;31, 2021. We believe that credit risk in our accounts receivable is mitigated by our credit evaluation process, relatively short collection terms and diversity of our customer base.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Risk </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A portion of our net sales and expenses are denominated in foreign currencies, most notably the Euro. Future fluctuations in the value of the U.S. Dollar may affect the price competitiveness of our products outside the United States. For direct sales outside the United States, we sell in both U.S. Dollars and local currencies, which could expose us to additional foreign currency risks, including changes in currency exchange rates. Our operating expenses in countries outside the United States, are payable in foreign currencies and therefore expose us to currency risk. We do not believe that a hypothetical 10% increase or decrease in the relative value of the U.S. dollar to other currencies would have had a material impact on our financial statements included elsewhere in this Quarterly Report on Form 10-Q.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not currently maintain a program to hedge exposures to non-U.S. dollar currencies.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Effects of Inflation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inflation generally affects us by increasing our cost of labor and research and development contract costs. We do not believe that inflation had a material effect on our financial statements included elsewhere in this Quarterly Report on Form 10-Q.</span></div><div id="ibb2df456afff4355bae87af9d1240625_97"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Controls and Procedures</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, with the participation of our Chief Executive Officer and our Chief Financial Officer, have evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on that evaluation, our Chief Executive Officer and our Chief Financial Officer have concluded that, as of June 30, 2022, our disclosure controls and procedures were effective at the reasonable assurance level.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Limitations on Effectiveness of Disclosure Controls and Procedures</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In designing and evaluating our disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply judgment in evaluating the benefits of possible controls and procedures relative to their costs.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter ended June 30, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><div id="ibb2df456afff4355bae87af9d1240625_100"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OTHER INFORMATION</span></div><div id="ibb2df456afff4355bae87af9d1240625_103"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Legal Proceeding</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are not subject to any material legal proceedings.</span></div><div id="ibb2df456afff4355bae87af9d1240625_106"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A. Risk Factors</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business, financial condition and operating results are affected by a number of factors, whether currently known or unknown, including risks specific to us or the healthcare industry as well as risks that affect businesses in general. In addition to the information set forth in this Quarterly Report on Form 10-Q, you should consider carefully the factors discussed in Part I, Item 1A, &#8220;Risk Factors&#8221; in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021, filed with the SEC on March 22, 2022. The risks and uncertainties disclosed in such Annual Report and in this Quarterly Report could materially adversely affect our business, financial condition, cash flows or results of operations and thus our stock price. During the three months ended June 30, 2022, there were no material changes to our previously disclosed risk factors. Besides risk factors disclosed in the Annual Report and this Quarterly Report, additional risks and uncertainties not currently known or we currently deem to be immaterial may also materially adversely affect our business, financial condition or results of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These risk factors may be important to understanding other statements in this Quarterly Report and should be read in conjunction with the unaudited condensed consolidated financial statements and related notes in Part I, Item 1, &#8220;Financial Statements&#8221; and Part I, Item 2, &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; of this Quarterly Report. Because of such risk factors, as well as other factors affecting our financial condition and operating results, past financial performance should not be considered to be a reliable indicator of future performance, and investors should not use historical trends to anticipate results or trends in future periods.</span></div><div id="ibb2df456afff4355bae87af9d1240625_109"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="ibb2df456afff4355bae87af9d1240625_112"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Defaults Upon Senior Securities</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="ibb2df456afff4355bae87af9d1240625_115"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Mine Safety Disclosures</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="ibb2df456afff4355bae87af9d1240625_118"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5. Other Information</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><div id="ibb2df456afff4355bae87af9d1240625_121"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span><br/></span></div></div><div style="-sec-extract:summary;margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;6. Exhibits </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following exhibits are filed or furnished as a part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.982%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.352%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:74.452%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.714%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit Description</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001588978/000162828021018923/exhibit31-closing8xk.htm">Amended and Restated Certificate of Incorporation</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (incorporated by reference to Exhibit 3.1 to the registrant&#8217;s Current Report on Form 8-K filed on September 21, 2021)</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001588978/000162828021018923/exhibit32-closing8xk.htm">Amended and Restated Bylaws</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (incorporated by reference to Exhibit 3.2 to the registrant&#8217;s Current Report on Form 8-K filed on September 21, 2021)</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex311soxcertificationrzadn.htm">Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex312soxcertificationkwate.htm">Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex321soxcertificationrzadn.htm">Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex322soxcertificationkwate.htm">Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Inline XBRL Instance Document &#8211; the instance document does not appear in the Interactive Data file because its XBRL tags are embedded within the Inline XBRL document.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Inline XBRL Taxonomy Extension Schema Document.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Inline XBRL Taxonomy Extension Calculation Linkbase Document.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Inline XBRL Taxonomy Extension Definition Linkbase Document.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Inline XBRL Taxonomy Extension Label Linkbase Document.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Inline XBRL Taxonomy Extension Presentation Linkbase Document.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">__________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14pt">Filed herewith.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">**&#160;&#160;&#160;&#160;Furnished herewith.&#160;&#160;&#160;&#160;</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><div id="ibb2df456afff4355bae87af9d1240625_124"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated: August&#160;5, 2022</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.291%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.292%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PROCEPT BIOROBOTICS CORPORATION</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Reza Zadno</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reza Zadno, Ph.D.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(principal executive officer)</span></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Kevin Waters</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kevin Waters</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EVP, Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(principal financial and accounting officer)</span></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>ex311soxcertificationrzadn.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i9e7ac950582e411f9b56e40e795c986d_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Exhibit 31.1</font></div><div style="margin-top:18pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,</font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">I, Reza Zadno, Ph.D., certify that&#58;</font></div><div style="margin-top:12pt;padding-left:24.5pt;text-indent:-24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:17pt">I have reviewed this Quarterly Report on Form&#160;10-Q of PROCEPT BioRobotics Corporation&#59;</font></div><div style="margin-top:12pt;padding-left:24.5pt;text-indent:-24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:17pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:24.5pt;text-indent:-24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:17pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:24.5pt;text-indent:-24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:17pt">The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;padding-left:49pt;text-indent:-24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(a)&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59; </font></div><div style="margin-top:12pt;padding-left:49pt;text-indent:-24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(b)&#160;&#160;&#160;&#160;&#91;omitted&#93;&#59;</font></div><div style="margin-top:12pt;padding-left:49pt;text-indent:-24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(c)&#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:49pt;text-indent:-24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(d)&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:24.5pt;text-indent:-24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:17pt">The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;padding-left:49pt;text-indent:-24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(a)&#160;&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;padding-left:49pt;text-indent:-24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(b)&#160;&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div style="padding-left:24.5pt;text-indent:-24.5pt"><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.880%"><tr><td style="width:1.0%"></td><td style="width:44.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.726%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.893%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.491%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Date&#58; August&#160;5, 2022</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">By&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#47;s&#47; Reza Zadno</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Reza Zadno, Ph.D.</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Chief Executive Officer </font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(Principal Executive Officer)</font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>ex312soxcertificationkwate.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="icdb491ea92f540a89c50da324798fc4f_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Exhibit 31.2</font></div><div style="margin-top:18pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,</font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">I, Kevin Waters, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:24.5pt;text-indent:-24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:17pt">I have reviewed this Quarterly Report on Form&#160;10-Q of PROCEPT BioRobotics Corporation&#59;</font></div><div style="margin-top:12pt;padding-left:24.5pt;text-indent:-24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:17pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:24.5pt;text-indent:-24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:17pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:24.5pt;text-indent:-24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:17pt">The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;padding-left:49pt;text-indent:-24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(a)&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:12pt;padding-left:49pt;text-indent:-24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(b)&#160;&#160;&#160;&#160;&#91;omitted&#93;&#59;</font></div><div style="margin-top:12pt;padding-left:49pt;text-indent:-24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(c)&#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:49pt;text-indent:-24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(d)&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:24.5pt;text-indent:-24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:17pt">The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;padding-left:49pt;text-indent:-24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(a)&#160;&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;padding-left:49pt;text-indent:-24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(b)&#160;&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div style="padding-left:24.5pt;text-indent:-24.5pt"><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.880%"><tr><td style="width:1.0%"></td><td style="width:44.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.726%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.893%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.491%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Date&#58; August&#160;5, 2022</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">By&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#47;s&#47; Kevin Waters</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Kevin Waters</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Chief Financial Officer </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(Principal Financial Officer and </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Principal Accounting Officer)</font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>ex321soxcertificationrzadn.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="id071678278394df3a9e77201ac4a0a6b_1"></div><div style="min-height:47.64pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Exhibit 32.1</font></div><div style="margin-top:18pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with the Quarterly Report of PROCEPT BioRobotics Corporation (the &#8220;Company&#8221;) on Form 10-Q for the period ending June&#160;30, 2022 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="margin-top:12pt;padding-left:49pt;text-indent:-24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(1)&#160;&#160;&#160;&#160;The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:12pt;padding-left:49pt;text-indent:-24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(2)&#160;&#160;&#160;&#160;The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.</font></div><div style="padding-left:24.5pt;text-indent:-24.5pt"><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.429%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Date&#58; August&#160;5, 2022</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">By&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#47;s&#47; Reza Zadno</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Reza Zadno, Ph.D.</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Chief Executive Officer </font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(Principal Executive Officer)</font></div></td></tr></table></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. &#167; 1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.</font></div><div><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>ex322soxcertificationkwate.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="iacd47b4018d14e0c8833f76887201c66_1"></div><div style="min-height:47.64pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Exhibit 32.2</font></div><div style="margin-top:18pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with the Quarterly Report of PROCEPT BioRobotics Corporation (the &#8220;Company&#8221;) on Form 10-Q for the period ending June&#160;30, 2022 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="margin-top:12pt;padding-left:49pt;text-indent:-24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(1)&#160;&#160;&#160;&#160;The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:12pt;padding-left:49pt;text-indent:-24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(2)&#160;&#160;&#160;&#160;The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.</font></div><div style="padding-left:24.5pt;text-indent:-24.5pt"><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.429%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Date&#58; August&#160;5, 2022</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">By&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#47;s&#47; Kevin Waters</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Kevin Waters</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Chief Financial Officer </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(Principal Financial Officer and </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Principal Accounting Officer)</font></div></td></tr></table></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. &#167; 1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>prct-20220630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:311bf6b2-ae92-4a64-91ca-35c82a3f09ce,g:4b68a96a-367b-4d30-a7c4-4a5adc893ec2-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:prct="http://www.procept-biorobotics.com/20220630" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.procept-biorobotics.com/20220630">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="prct-20220630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="prct-20220630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="prct-20220630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="prct-20220630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Coverpage" roleURI="http://www.procept-biorobotics.com/role/Coverpage">
        <link:definition>0001001 - Document - Cover page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheets" roleURI="http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets">
        <link:definition>1001002 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsParentheticals" roleURI="http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheetsParentheticals">
        <link:definition>1002003 - Statement - Condensed Consolidated Balance Sheets - Parentheticals</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofOperationsandComprehensiveLoss" roleURI="http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss">
        <link:definition>1003004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit" roleURI="http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit">
        <link:definition>1004005 - Statement - Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlows" roleURI="http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows">
        <link:definition>1005006 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Organization" roleURI="http://www.procept-biorobotics.com/role/Organization">
        <link:definition>2101101 - Disclosure - Organization</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationDetails" roleURI="http://www.procept-biorobotics.com/role/OrganizationDetails">
        <link:definition>2402401 - Disclosure - Organization (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://www.procept-biorobotics.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>2103102 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.procept-biorobotics.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>2204201 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesNarrativeDetails" roleURI="http://www.procept-biorobotics.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>2405402 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.procept-biorobotics.com/role/FairValueMeasurements">
        <link:definition>2106103 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.procept-biorobotics.com/role/FairValueMeasurementsTables">
        <link:definition>2307301 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsNarrativeDetails" roleURI="http://www.procept-biorobotics.com/role/FairValueMeasurementsNarrativeDetails">
        <link:definition>2408403 - Disclosure - Fair Value Measurements - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsFairValueDetails" roleURI="http://www.procept-biorobotics.com/role/FairValueMeasurementsFairValueDetails">
        <link:definition>2409404 - Disclosure - Fair Value Measurements - Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsFairValueInputsLevel3FairValueMeasurementsRecurringDetails" roleURI="http://www.procept-biorobotics.com/role/FairValueMeasurementsFairValueInputsLevel3FairValueMeasurementsRecurringDetails">
        <link:definition>2410405 - Disclosure - Fair Value Measurements - Fair Value, Inputs, Level 3 - Fair Value, Measurements, Recurring (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Inventory" roleURI="http://www.procept-biorobotics.com/role/Inventory">
        <link:definition>2111104 - Disclosure - Inventory</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoryTables" roleURI="http://www.procept-biorobotics.com/role/InventoryTables">
        <link:definition>2312302 - Disclosure - Inventory (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoryInventoryDetails" roleURI="http://www.procept-biorobotics.com/role/InventoryInventoryDetails">
        <link:definition>2413406 - Disclosure - Inventory - Inventory (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssets" roleURI="http://www.procept-biorobotics.com/role/IntangibleAssets">
        <link:definition>2114105 - Disclosure - Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsDetails" roleURI="http://www.procept-biorobotics.com/role/IntangibleAssetsDetails">
        <link:definition>2415407 - Disclosure - Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LoanFacilityandDerivativeLiability" roleURI="http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiability">
        <link:definition>2116106 - Disclosure - Loan Facility and Derivative Liability</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LoanFacilityandDerivativeLiabilityDetails" roleURI="http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiabilityDetails">
        <link:definition>2417408 - Disclosure - Loan Facility and Derivative Liability (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensation" roleURI="http://www.procept-biorobotics.com/role/StockBasedCompensation">
        <link:definition>2118107 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationTables" roleURI="http://www.procept-biorobotics.com/role/StockBasedCompensationTables">
        <link:definition>2319303 - Disclosure - Stock-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationNarrativeDetails" roleURI="http://www.procept-biorobotics.com/role/StockBasedCompensationNarrativeDetails">
        <link:definition>2420409 - Disclosure - Stock-Based Compensation - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationSummaryofStockOptionActivityDetails" roleURI="http://www.procept-biorobotics.com/role/StockBasedCompensationSummaryofStockOptionActivityDetails">
        <link:definition>2421410 - Disclosure - Stock-Based Compensation - Summary of Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationFairValueAssumptionsDetails" roleURI="http://www.procept-biorobotics.com/role/StockBasedCompensationFairValueAssumptionsDetails">
        <link:definition>2422411 - Disclosure - Stock-Based Compensation - Fair Value Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationRestrictedStockUnitDetails" roleURI="http://www.procept-biorobotics.com/role/StockBasedCompensationRestrictedStockUnitDetails">
        <link:definition>2423412 - Disclosure - Stock-Based Compensation - Restricted Stock Unit (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationStockbasedCompensationDetails" roleURI="http://www.procept-biorobotics.com/role/StockBasedCompensationStockbasedCompensationDetails">
        <link:definition>2424413 - Disclosure - Stock-Based Compensation - Stock-based Compensation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShare" roleURI="http://www.procept-biorobotics.com/role/NetLossPerShare">
        <link:definition>2125108 - Disclosure - Net Loss Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareTables" roleURI="http://www.procept-biorobotics.com/role/NetLossPerShareTables">
        <link:definition>2326304 - Disclosure - Net Loss Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareNarrativeDetails" roleURI="http://www.procept-biorobotics.com/role/NetLossPerShareNarrativeDetails">
        <link:definition>2427414 - Disclosure - Net Loss Per Share - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareNetlosspershareDetails" roleURI="http://www.procept-biorobotics.com/role/NetLossPerShareNetlosspershareDetails">
        <link:definition>2428415 - Disclosure - Net Loss Per Share - Net loss per share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerSharePotentiallyDilutiveSecuritiesDetails" roleURI="http://www.procept-biorobotics.com/role/NetLossPerSharePotentiallyDilutiveSecuritiesDetails">
        <link:definition>2429416 - Disclosure - Net Loss Per Share - Potentially Dilutive Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Revenue" roleURI="http://www.procept-biorobotics.com/role/Revenue">
        <link:definition>2130109 - Disclosure - Revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueTables" roleURI="http://www.procept-biorobotics.com/role/RevenueTables">
        <link:definition>2331305 - Disclosure - Revenue (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueDetails" roleURI="http://www.procept-biorobotics.com/role/RevenueDetails">
        <link:definition>2432417 - Disclosure - Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentGeographicalandCustomerConcentration" roleURI="http://www.procept-biorobotics.com/role/SegmentGeographicalandCustomerConcentration">
        <link:definition>2133110 - Disclosure - Segment, Geographical, and Customer Concentration</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentGeographicalandCustomerConcentrationTables" roleURI="http://www.procept-biorobotics.com/role/SegmentGeographicalandCustomerConcentrationTables">
        <link:definition>2334306 - Disclosure - Segment, Geographical, and Customer Concentration (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentGeographicalandCustomerConcentrationDetails" roleURI="http://www.procept-biorobotics.com/role/SegmentGeographicalandCustomerConcentrationDetails">
        <link:definition>2435418 - Disclosure - Segment, Geographical, and Customer Concentration (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.procept-biorobotics.com/role/CommitmentsandContingencies">
        <link:definition>2136111 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesTables" roleURI="http://www.procept-biorobotics.com/role/CommitmentsandContingenciesTables">
        <link:definition>2337307 - Disclosure - Commitments and Contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesNarrativeDetails" roleURI="http://www.procept-biorobotics.com/role/CommitmentsandContingenciesNarrativeDetails">
        <link:definition>2438419 - Disclosure - Commitments and Contingencies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesFutureMinimumLeasePaymentsandLongTermDebtMaturitiesDetails" roleURI="http://www.procept-biorobotics.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsandLongTermDebtMaturitiesDetails">
        <link:definition>2439420 - Disclosure - Commitments and Contingencies - Future Minimum Lease Payments and Long-Term Debt Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="prct_DebtInstrumentCovenantComplianceRevenueForecastAmountFirstThreeInstallmentsOnly" abstract="false" name="DebtInstrumentCovenantComplianceRevenueForecastAmountFirstThreeInstallmentsOnly" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prct_DebtInstrumentCovenantComplianceRevenueForecastAmountAllInstallmentsDrawn" abstract="false" name="DebtInstrumentCovenantComplianceRevenueForecastAmountAllInstallmentsDrawn" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prct_A2021EquityIncentiveAwardPlanMember" abstract="true" name="A2021EquityIncentiveAwardPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prct_DebtInstrumentCovenantComplianceRevenueForecastForCommensuratePeriodPercent" abstract="false" name="DebtInstrumentCovenantComplianceRevenueForecastForCommensuratePeriodPercent" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="prct_TemporaryEquityStockIssuedDuringPeriodSharesWarrantExercises" abstract="false" name="TemporaryEquityStockIssuedDuringPeriodSharesWarrantExercises" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="prct_LoanFacilityTrancheFourMember" abstract="true" name="LoanFacilityTrancheFourMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prct_A2021EmployeeStockPurchasePlanMember" abstract="true" name="A2021EmployeeStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prct_OperatingLeaseLiabilityAndLongTermDebtMaturityGross" abstract="false" name="OperatingLeaseLiabilityAndLongTermDebtMaturityGross" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prct_JobsActAccountingElectionPolicyTextBlock" abstract="false" name="JobsActAccountingElectionPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="prct_LoanFacilityTrancheTwoMember" abstract="true" name="LoanFacilityTrancheTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prct_LoanFacilityTrancheOneMember" abstract="true" name="LoanFacilityTrancheOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prct_HandPiecesAndOtherConsumablesMember" abstract="true" name="HandPiecesAndOtherConsumablesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prct_SystemSalesAndRentalsMember" abstract="true" name="SystemSalesAndRentalsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmountAchievedExtendedPrincipalAndInterestPeriod" abstract="false" name="DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmountAchievedExtendedPrincipalAndInterestPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmount" abstract="false" name="DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prct_LoanFacilityMember" abstract="true" name="LoanFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prct_DebtInstrumentInterestOnlyPeriod" abstract="false" name="DebtInstrumentInterestOnlyPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="prct_LineOfCreditFacilityEarlyRepaymentFeeSecondTwelveMonthPeriodPercent" abstract="false" name="LineOfCreditFacilityEarlyRepaymentFeeSecondTwelveMonthPeriodPercent" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="prct_FiniteLivedIntangibleAssetExpectedAnnualAmortizationExpense" abstract="false" name="FiniteLivedIntangibleAssetExpectedAnnualAmortizationExpense" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prct_OperatingLeaseLiabilityAndLongTermDebtCurrent" abstract="false" name="OperatingLeaseLiabilityAndLongTermDebtCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prct_LineOfCreditFacilityNumberOfInstallments" abstract="false" name="LineOfCreditFacilityNumberOfInstallments" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="prct_DeferredOfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction" abstract="false" name="DeferredOfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prct_OperatingLeaseNumberOfBuildings" abstract="false" name="OperatingLeaseNumberOfBuildings" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceFourInstallmentsDrawn" abstract="false" name="LineOfCreditFacilityCovenantTermsLiquidityOccurrenceFourInstallmentsDrawn" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prct_OperatingLeaseNumberOfSquareFeet" abstract="false" name="OperatingLeaseNumberOfSquareFeet" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="prct_TransferFromInventoryToPropertyAndEquipmentNet" abstract="false" name="TransferFromInventoryToPropertyAndEquipmentNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prct_LesseeOperatingLeaseNumberOfRenewalOptions" abstract="false" name="LesseeOperatingLeaseNumberOfRenewalOptions" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="prct_DebtInstrumentContingentBorrowingExtendedInterestOnlyPeriod" abstract="false" name="DebtInstrumentContingentBorrowingExtendedInterestOnlyPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="prct_OperatingLeaseLiabilityAndLongTermDebtMaturityYearOne" abstract="false" name="OperatingLeaseLiabilityAndLongTermDebtMaturityYearOne" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prct_DebtInstrumentContingentBorrowingExtendedPrincipalAndInterestPeriod" abstract="false" name="DebtInstrumentContingentBorrowingExtendedPrincipalAndInterestPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="prct_OperatingLeaseAnnualBaseRentYearOne" abstract="false" name="OperatingLeaseAnnualBaseRentYearOne" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prct_OperatingLeaseLiabilityAndLongTermDebt" abstract="false" name="OperatingLeaseLiabilityAndLongTermDebt" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prct_OperatingLeaseLiabilityAndLongTermDebtMaturityAbstract" abstract="true" name="OperatingLeaseLiabilityAndLongTermDebtMaturityAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="prct_LineOfCreditFacilityGainLossOnAmendmentOfDebtTerms" abstract="false" name="LineOfCreditFacilityGainLossOnAmendmentOfDebtTerms" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prct_DebtInstrumentCovenantComplianceRevenueForecastAmountFirstTwoInstallmentsOnly" abstract="false" name="DebtInstrumentCovenantComplianceRevenueForecastAmountFirstTwoInstallmentsOnly" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prct_LineOfCreditFacilityEarlyRepaymentFeeFirstTwelveMonthPercent" abstract="false" name="LineOfCreditFacilityEarlyRepaymentFeeFirstTwelveMonthPercent" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="prct_InitialPublicOfferingAbstract" abstract="true" name="InitialPublicOfferingAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="prct_OperatingLeaseLiabilityAndLongTermDebtMaturityUnamortizedDebtDiscount" abstract="false" name="OperatingLeaseLiabilityAndLongTermDebtMaturityUnamortizedDebtDiscount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prct_OutsideTheUnitedStatesMember" abstract="true" name="OutsideTheUnitedStatesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prct_LineOfCreditFacilityFinalPaymentFeePercentage" abstract="false" name="LineOfCreditFacilityFinalPaymentFeePercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="prct_LineOfCreditFacilityCovenantComplianceContingentTrailingTwelveMonthRevenueTarget" abstract="false" name="LineOfCreditFacilityCovenantComplianceContingentTrailingTwelveMonthRevenueTarget" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prct_FairValueAdjustmentOfWarrantsAndGainLossOnDerivativeInstrumentsNetPretax" abstract="false" name="FairValueAdjustmentOfWarrantsAndGainLossOnDerivativeInstrumentsNetPretax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prct_NonCashLeaseAccretionExpense" abstract="false" name="NonCashLeaseAccretionExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prct_SeriesERedeemableConvertiblePreferredStockWarrantsMember" abstract="true" name="SeriesERedeemableConvertiblePreferredStockWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prct_ServiceRevenueMember" abstract="true" name="ServiceRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prct_OperatingLeaseLiabilityAndLongTermDebtExcludingCurrentMaturities" abstract="false" name="OperatingLeaseLiabilityAndLongTermDebtExcludingCurrentMaturities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceOneInstallmentDrawn" abstract="false" name="LineOfCreditFacilityCovenantTermsLiquidityOccurrenceOneInstallmentDrawn" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceTwoInstallmentsDrawn" abstract="false" name="LineOfCreditFacilityCovenantTermsLiquidityOccurrenceTwoInstallmentsDrawn" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prct_LoanFacilityTrancheThreeMember" abstract="true" name="LoanFacilityTrancheThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prct_InterestAndOtherIncomeExpense" abstract="false" name="InterestAndOtherIncomeExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prct_LineOfCreditFacilityEarlyRepaymentFeeTwentyFourMonthsThruMaturityPercent" abstract="false" name="LineOfCreditFacilityEarlyRepaymentFeeTwentyFourMonthsThruMaturityPercent" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="prct_Customer1Member" abstract="true" name="Customer1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prct_LesseeOperatingLeaseReceivableAllowanceForTenantImprovements" abstract="false" name="LesseeOperatingLeaseReceivableAllowanceForTenantImprovements" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prct_OperatingLeaseAnnualBaseRentYearTen" abstract="false" name="OperatingLeaseAnnualBaseRentYearTen" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prct_LineOfCreditFacilityCovenantComplianceContingentTrailingSixTwelveMonthRevenueTarget" abstract="false" name="LineOfCreditFacilityCovenantComplianceContingentTrailingSixTwelveMonthRevenueTarget" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prct_OperatingLeaseLiabilityAndLongTermDebtMaturityYearTwo" abstract="false" name="OperatingLeaseLiabilityAndLongTermDebtMaturityYearTwo" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmountAchievedExtendedInterestOnlyPeriod" abstract="false" name="DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmountAchievedExtendedInterestOnlyPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="prct_RedeemableConvertiblePreferredStockWarrantsMember" abstract="true" name="RedeemableConvertiblePreferredStockWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prct_OperatingLeaseLiabilityAndLongTermDebtMaturityRemainderOfFiscalYear" abstract="false" name="OperatingLeaseLiabilityAndLongTermDebtMaturityRemainderOfFiscalYear" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceThreeInstallmentsDrawn" abstract="false" name="LineOfCreditFacilityCovenantTermsLiquidityOccurrenceThreeInstallmentsDrawn" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prct_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" abstract="false" name="TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="prct_DebtInstrumentPrincipalAndInterestPeriod" abstract="false" name="DebtInstrumentPrincipalAndInterestPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>prct-20220630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:311bf6b2-ae92-4a64-91ca-35c82a3f09ce,g:4b68a96a-367b-4d30-a7c4-4a5adc893ec2-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="prct-20220630.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_4f2c5126-f206-414b-bad9-ea55c3498608" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_61a70f95-df15-4c95-82ce-634d23281bde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_4f2c5126-f206-414b-bad9-ea55c3498608" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_61a70f95-df15-4c95-82ce-634d23281bde" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_4966964f-2f18-4a4a-874f-f0a0b1e3e998" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_4f2c5126-f206-414b-bad9-ea55c3498608" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_4966964f-2f18-4a4a-874f-f0a0b1e3e998" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_914cac23-cadb-46c4-a7fc-2e371b653f05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_4f2c5126-f206-414b-bad9-ea55c3498608" xlink:to="loc_us-gaap_AssetsCurrent_914cac23-cadb-46c4-a7fc-2e371b653f05" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_b2784a61-4a17-451a-a4d9-005889fb398b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_4f2c5126-f206-414b-bad9-ea55c3498608" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_b2784a61-4a17-451a-a4d9-005889fb398b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_42fc169d-0d54-407c-8f0e-fd7927dde259" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_4f2c5126-f206-414b-bad9-ea55c3498608" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_42fc169d-0d54-407c-8f0e-fd7927dde259" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_b9e8776b-b92d-477f-ad68-7cc93b02771c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_4f2c5126-f206-414b-bad9-ea55c3498608" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_b9e8776b-b92d-477f-ad68-7cc93b02771c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_614761d3-6925-4f21-9ffe-9b7aa437bf97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_b5e80e2d-cde9-431c-9976-11373dfd32b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_614761d3-6925-4f21-9ffe-9b7aa437bf97" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_b5e80e2d-cde9-431c-9976-11373dfd32b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_69f59c56-3d48-4c36-8405-b68577b81951" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_614761d3-6925-4f21-9ffe-9b7aa437bf97" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_69f59c56-3d48-4c36-8405-b68577b81951" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_aa618d4d-38d1-4133-8b20-8bc66a29dba8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_614761d3-6925-4f21-9ffe-9b7aa437bf97" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_aa618d4d-38d1-4133-8b20-8bc66a29dba8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_a1c0eb0f-4e6a-42ee-b320-9b01a5af22f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_614761d3-6925-4f21-9ffe-9b7aa437bf97" xlink:to="loc_us-gaap_LiabilitiesCurrent_a1c0eb0f-4e6a-42ee-b320-9b01a5af22f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent_ef96ab61-34bd-4efe-924d-fbc6279610e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_614761d3-6925-4f21-9ffe-9b7aa437bf97" xlink:to="loc_us-gaap_DerivativeLiabilitiesNoncurrent_ef96ab61-34bd-4efe-924d-fbc6279610e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_4baaaeb0-c927-4468-8b9f-cc8e53fc0b5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_969c30da-efe1-41fe-86e7-4eb1be5ca129" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_4baaaeb0-c927-4468-8b9f-cc8e53fc0b5a" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_969c30da-efe1-41fe-86e7-4eb1be5ca129" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_c2430d45-36bc-4246-ade3-2fc9f627aec2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_4baaaeb0-c927-4468-8b9f-cc8e53fc0b5a" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_c2430d45-36bc-4246-ade3-2fc9f627aec2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_b64ed50d-7712-4a91-8b00-4aa9200d19b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_4baaaeb0-c927-4468-8b9f-cc8e53fc0b5a" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_b64ed50d-7712-4a91-8b00-4aa9200d19b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalariesCurrent_414088f1-7a11-4204-8bf2-df17c2409455" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedSalariesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_4baaaeb0-c927-4468-8b9f-cc8e53fc0b5a" xlink:to="loc_us-gaap_AccruedSalariesCurrent_414088f1-7a11-4204-8bf2-df17c2409455" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_88433403-f727-4ccc-8de5-2e6147811990" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_4baaaeb0-c927-4468-8b9f-cc8e53fc0b5a" xlink:to="loc_us-gaap_AccountsPayableCurrent_88433403-f727-4ccc-8de5-2e6147811990" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_5b988b3c-9047-471b-b63a-86dc354685a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_230c8645-831c-492a-bfc5-3738f1fe3ff4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_5b988b3c-9047-471b-b63a-86dc354685a5" xlink:to="loc_us-gaap_StockholdersEquity_230c8645-831c-492a-bfc5-3738f1fe3ff4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_09ce2e8f-86ee-44c6-a09b-3b2f54a11977" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_5b988b3c-9047-471b-b63a-86dc354685a5" xlink:to="loc_us-gaap_Liabilities_09ce2e8f-86ee-44c6-a09b-3b2f54a11977" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_9bf3cb19-c427-4778-829e-0cf8905efcf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_5b988b3c-9047-471b-b63a-86dc354685a5" xlink:to="loc_us-gaap_CommitmentsAndContingencies_9bf3cb19-c427-4778-829e-0cf8905efcf4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_750408de-6895-4ece-b27d-5ba5b98ad188" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_e2bef031-4b99-45a3-95fb-2937739ba68f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_750408de-6895-4ece-b27d-5ba5b98ad188" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_e2bef031-4b99-45a3-95fb-2937739ba68f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_9689a28d-8e0a-4c13-977b-1c41bc38277d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_750408de-6895-4ece-b27d-5ba5b98ad188" xlink:to="loc_us-gaap_InventoryNet_9689a28d-8e0a-4c13-977b-1c41bc38277d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_bcbaad15-1bbd-4882-a856-c4bf36442cf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_750408de-6895-4ece-b27d-5ba5b98ad188" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_bcbaad15-1bbd-4882-a856-c4bf36442cf9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9222f0ce-b285-4570-b950-3c3e6d59bb3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_750408de-6895-4ece-b27d-5ba5b98ad188" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9222f0ce-b285-4570-b950-3c3e6d59bb3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_5ecf4c31-99ea-4920-ae81-04b0d685522a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_3bbd7aa0-595c-48ad-8e86-ff0e20d72773" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_5ecf4c31-99ea-4920-ae81-04b0d685522a" xlink:to="loc_us-gaap_AdditionalPaidInCapital_3bbd7aa0-595c-48ad-8e86-ff0e20d72773" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_1a75c15b-8ec2-45f5-a697-3f4933245523" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_5ecf4c31-99ea-4920-ae81-04b0d685522a" xlink:to="loc_us-gaap_PreferredStockValue_1a75c15b-8ec2-45f5-a697-3f4933245523" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_4f45b390-a0ec-4d44-8ffa-64e304ff1146" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_5ecf4c31-99ea-4920-ae81-04b0d685522a" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_4f45b390-a0ec-4d44-8ffa-64e304ff1146" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_98cee0c6-60af-4385-90dc-24b07521b1fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_5ecf4c31-99ea-4920-ae81-04b0d685522a" xlink:to="loc_us-gaap_CommonStockValue_98cee0c6-60af-4385-90dc-24b07521b1fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6db7ecd4-789a-426f-aadf-a354c85d9e5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_5ecf4c31-99ea-4920-ae81-04b0d685522a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6db7ecd4-789a-426f-aadf-a354c85d9e5d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="simple" xlink:href="prct-20220630.xsd#CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"/>
  <link:calculationLink xlink:role="http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_7782ebc6-dd91-4831-bb9d-9d3282863006" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_9f80c060-38c3-402d-ac5b-450ef6787adf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_7782ebc6-dd91-4831-bb9d-9d3282863006" xlink:to="loc_us-gaap_CostOfRevenue_9f80c060-38c3-402d-ac5b-450ef6787adf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5565e83a-0de5-436c-b504-b0fa9ab3708e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_7782ebc6-dd91-4831-bb9d-9d3282863006" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5565e83a-0de5-436c-b504-b0fa9ab3708e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_39ed975d-a5b8-4545-a779-93bd77cc4c31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_5a57c1ff-f532-474a-bed7-0baa286a95c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_39ed975d-a5b8-4545-a779-93bd77cc4c31" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_5a57c1ff-f532-474a-bed7-0baa286a95c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_378c0280-7fd0-4c88-b3c3-6a5c684c9f72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_39ed975d-a5b8-4545-a779-93bd77cc4c31" xlink:to="loc_us-gaap_NetIncomeLoss_378c0280-7fd0-4c88-b3c3-6a5c684c9f72" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_59cb1f31-6ad9-4b7f-b8f5-1a8848cddafa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_95a5b3bf-c6ba-41d4-bc7b-ddb275de9610" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_59cb1f31-6ad9-4b7f-b8f5-1a8848cddafa" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_95a5b3bf-c6ba-41d4-bc7b-ddb275de9610" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_9ef1ea27-0bab-4a20-9b03-cefa1d8e0bf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_59cb1f31-6ad9-4b7f-b8f5-1a8848cddafa" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_9ef1ea27-0bab-4a20-9b03-cefa1d8e0bf7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_df248025-7f7a-4040-87c1-c50455857397" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_ed326473-198f-4873-8b1d-f646f99169d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_df248025-7f7a-4040-87c1-c50455857397" xlink:to="loc_us-gaap_OperatingIncomeLoss_ed326473-198f-4873-8b1d-f646f99169d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_ae37b57f-2efa-436d-b98f-33f306594c65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_df248025-7f7a-4040-87c1-c50455857397" xlink:to="loc_us-gaap_InterestExpense_ae37b57f-2efa-436d-b98f-33f306594c65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_InterestAndOtherIncomeExpense_fc601c3d-d361-44ed-892a-df07a07c5644" xlink:href="prct-20220630.xsd#prct_InterestAndOtherIncomeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_df248025-7f7a-4040-87c1-c50455857397" xlink:to="loc_prct_InterestAndOtherIncomeExpense_fc601c3d-d361-44ed-892a-df07a07c5644" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_c517f5a4-9b80-4c1e-8bac-d315375b2033" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_71e31413-8da1-4e04-b679-8b56c94c357f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_c517f5a4-9b80-4c1e-8bac-d315375b2033" xlink:to="loc_us-gaap_OperatingExpenses_71e31413-8da1-4e04-b679-8b56c94c357f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_f01bf235-2e8a-453c-909d-548739ed1bef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_c517f5a4-9b80-4c1e-8bac-d315375b2033" xlink:to="loc_us-gaap_GrossProfit_f01bf235-2e8a-453c-909d-548739ed1bef" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="prct-20220630.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_197634ee-ecc6-420f-910c-eee3cefda54a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_1daecc55-9e07-41c1-8eb2-b5aa01546637" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_197634ee-ecc6-420f-910c-eee3cefda54a" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_1daecc55-9e07-41c1-8eb2-b5aa01546637" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_983f1128-874e-4d4e-bd05-71f717a382b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_197634ee-ecc6-420f-910c-eee3cefda54a" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_983f1128-874e-4d4e-bd05-71f717a382b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_5b61a0ab-c99f-419a-998a-69fd7c7f3af6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_197634ee-ecc6-420f-910c-eee3cefda54a" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_5b61a0ab-c99f-419a-998a-69fd7c7f3af6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5842aa10-c62f-441c-9580-e273a5f958de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_6372fb88-e12c-4d51-b439-dd21ff636a44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5842aa10-c62f-441c-9580-e273a5f958de" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_6372fb88-e12c-4d51-b439-dd21ff636a44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_FairValueAdjustmentOfWarrantsAndGainLossOnDerivativeInstrumentsNetPretax_0770c8bb-9b4a-41dd-8e93-2e37dd40af41" xlink:href="prct-20220630.xsd#prct_FairValueAdjustmentOfWarrantsAndGainLossOnDerivativeInstrumentsNetPretax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5842aa10-c62f-441c-9580-e273a5f958de" xlink:to="loc_prct_FairValueAdjustmentOfWarrantsAndGainLossOnDerivativeInstrumentsNetPretax_0770c8bb-9b4a-41dd-8e93-2e37dd40af41" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_a55a7414-778a-4b5e-b735-9b4fcc531eea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5842aa10-c62f-441c-9580-e273a5f958de" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_a55a7414-778a-4b5e-b735-9b4fcc531eea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedSalaries_74cc6e8c-fc22-436d-bd50-add29df0a98e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedSalaries"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5842aa10-c62f-441c-9580-e273a5f958de" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedSalaries_74cc6e8c-fc22-436d-bd50-add29df0a98e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_a509ac84-c947-417b-8cab-c12ec8f1450c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5842aa10-c62f-441c-9580-e273a5f958de" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_a509ac84-c947-417b-8cab-c12ec8f1450c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_3e24aef2-4dde-436d-84ff-0d6a9b1f7d76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5842aa10-c62f-441c-9580-e273a5f958de" xlink:to="loc_us-gaap_NetIncomeLoss_3e24aef2-4dde-436d-84ff-0d6a9b1f7d76" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_8cfec46f-4e2f-4ee0-a502-99fea1d8aeba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5842aa10-c62f-441c-9580-e273a5f958de" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_8cfec46f-4e2f-4ee0-a502-99fea1d8aeba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_NonCashLeaseAccretionExpense_c8a55ea5-3aae-4ce6-b781-c511d2b196e2" xlink:href="prct-20220630.xsd#prct_NonCashLeaseAccretionExpense"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5842aa10-c62f-441c-9580-e273a5f958de" xlink:to="loc_prct_NonCashLeaseAccretionExpense_c8a55ea5-3aae-4ce6-b781-c511d2b196e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_184ac56a-e12e-47a5-9fa2-e37c213a0ad7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5842aa10-c62f-441c-9580-e273a5f958de" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_184ac56a-e12e-47a5-9fa2-e37c213a0ad7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInterestPayableNet_fdbe92e3-ce9e-48e1-8d9a-511f666b9b26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInterestPayableNet"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5842aa10-c62f-441c-9580-e273a5f958de" xlink:to="loc_us-gaap_IncreaseDecreaseInInterestPayableNet_fdbe92e3-ce9e-48e1-8d9a-511f666b9b26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_b1fdf3f9-df66-4c70-a9b3-99b60640f953" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5842aa10-c62f-441c-9580-e273a5f958de" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_b1fdf3f9-df66-4c70-a9b3-99b60640f953" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_f7533c66-aec6-47e5-86f7-d54df6c4632a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5842aa10-c62f-441c-9580-e273a5f958de" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_f7533c66-aec6-47e5-86f7-d54df6c4632a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_ce4cbc42-a050-4209-a77e-19ff2bbd87f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5842aa10-c62f-441c-9580-e273a5f958de" xlink:to="loc_us-gaap_ShareBasedCompensation_ce4cbc42-a050-4209-a77e-19ff2bbd87f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_4183010b-e87d-45a0-81f6-b0c959027e81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5842aa10-c62f-441c-9580-e273a5f958de" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_4183010b-e87d-45a0-81f6-b0c959027e81" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c9786485-6262-4404-b2c9-09b8cc935f8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b1bb39f7-983e-41b8-88db-67c8624b4728" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c9786485-6262-4404-b2c9-09b8cc935f8a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b1bb39f7-983e-41b8-88db-67c8624b4728" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_cea97acf-345a-436a-9fc0-8392ec6cdd1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c9786485-6262-4404-b2c9-09b8cc935f8a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_cea97acf-345a-436a-9fc0-8392ec6cdd1a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6be3bdd9-a855-40a6-8181-cbc27c54ff6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c9786485-6262-4404-b2c9-09b8cc935f8a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6be3bdd9-a855-40a6-8181-cbc27c54ff6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2863765e-546e-4a08-a9c3-941be1ac86cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_3495b333-f4f4-4731-8cb6-29c48e4a0119" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2863765e-546e-4a08-a9c3-941be1ac86cb" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_3495b333-f4f4-4731-8cb6-29c48e4a0119" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2b67566e-8533-4637-af1b-a90d78a1c652" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2863765e-546e-4a08-a9c3-941be1ac86cb" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2b67566e-8533-4637-af1b-a90d78a1c652" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d0bb4597-2f7c-4e5b-b824-ef123a49a4aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_518f48e0-29c1-4f4d-a69a-e5f64b1a7bc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d0bb4597-2f7c-4e5b-b824-ef123a49a4aa" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_518f48e0-29c1-4f4d-a69a-e5f64b1a7bc4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/InventoryInventoryDetails" xlink:type="simple" xlink:href="prct-20220630.xsd#InventoryInventoryDetails"/>
  <link:calculationLink xlink:role="http://www.procept-biorobotics.com/role/InventoryInventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_45d29854-8c11-4b94-8123-2b8f3f2b1efd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess_1ee5e6c7-590c-4fc3-beb7-d5a05492c74b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_45d29854-8c11-4b94-8123-2b8f3f2b1efd" xlink:to="loc_us-gaap_InventoryWorkInProcess_1ee5e6c7-590c-4fc3-beb7-d5a05492c74b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials_608e9b6b-2333-4a84-aaae-60ed39634421" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterials"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_45d29854-8c11-4b94-8123-2b8f3f2b1efd" xlink:to="loc_us-gaap_InventoryRawMaterials_608e9b6b-2333-4a84-aaae-60ed39634421" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_dfea3cc8-efeb-4a9a-9eb6-9055db55587f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_45d29854-8c11-4b94-8123-2b8f3f2b1efd" xlink:to="loc_us-gaap_InventoryFinishedGoods_dfea3cc8-efeb-4a9a-9eb6-9055db55587f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsandLongTermDebtMaturitiesDetails" xlink:type="simple" xlink:href="prct-20220630.xsd#CommitmentsandContingenciesFutureMinimumLeasePaymentsandLongTermDebtMaturitiesDetails"/>
  <link:calculationLink xlink:role="http://www.procept-biorobotics.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsandLongTermDebtMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityGross_7c2fdc5f-8c88-4772-b3b6-8704e97c6613" xlink:href="prct-20220630.xsd#prct_OperatingLeaseLiabilityAndLongTermDebtMaturityGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityRemainderOfFiscalYear_028d0957-f618-4cf6-9a13-f32be68e473c" xlink:href="prct-20220630.xsd#prct_OperatingLeaseLiabilityAndLongTermDebtMaturityRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityGross_7c2fdc5f-8c88-4772-b3b6-8704e97c6613" xlink:to="loc_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityRemainderOfFiscalYear_028d0957-f618-4cf6-9a13-f32be68e473c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityYearTwo_9131f36b-1099-4e4c-9c9b-f787a793b965" xlink:href="prct-20220630.xsd#prct_OperatingLeaseLiabilityAndLongTermDebtMaturityYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityGross_7c2fdc5f-8c88-4772-b3b6-8704e97c6613" xlink:to="loc_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityYearTwo_9131f36b-1099-4e4c-9c9b-f787a793b965" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityYearOne_ca27b282-e6ca-4f19-b68a-7075f15f922f" xlink:href="prct-20220630.xsd#prct_OperatingLeaseLiabilityAndLongTermDebtMaturityYearOne"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityGross_7c2fdc5f-8c88-4772-b3b6-8704e97c6613" xlink:to="loc_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityYearOne_ca27b282-e6ca-4f19-b68a-7075f15f922f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_OperatingLeaseLiabilityAndLongTermDebt_ad34347e-7c72-46f8-9347-0f70bd0de8c9" xlink:href="prct-20220630.xsd#prct_OperatingLeaseLiabilityAndLongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_OperatingLeaseLiabilityAndLongTermDebtCurrent_17b95221-995c-4f20-a9a4-53161facd41d" xlink:href="prct-20220630.xsd#prct_OperatingLeaseLiabilityAndLongTermDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prct_OperatingLeaseLiabilityAndLongTermDebt_ad34347e-7c72-46f8-9347-0f70bd0de8c9" xlink:to="loc_prct_OperatingLeaseLiabilityAndLongTermDebtCurrent_17b95221-995c-4f20-a9a4-53161facd41d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_OperatingLeaseLiabilityAndLongTermDebtExcludingCurrentMaturities_8b97ac52-74db-4494-99b7-faa983959c69" xlink:href="prct-20220630.xsd#prct_OperatingLeaseLiabilityAndLongTermDebtExcludingCurrentMaturities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prct_OperatingLeaseLiabilityAndLongTermDebt_ad34347e-7c72-46f8-9347-0f70bd0de8c9" xlink:to="loc_prct_OperatingLeaseLiabilityAndLongTermDebtExcludingCurrentMaturities_8b97ac52-74db-4494-99b7-faa983959c69" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_6c1c713f-efcb-422e-8e25-e197217c1fa3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_c428baec-ae9c-440f-bcde-f58430449432" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_6c1c713f-efcb-422e-8e25-e197217c1fa3" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_c428baec-ae9c-440f-bcde-f58430449432" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_b24036fd-e3b8-4054-a6c4-9af29139b8bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_6c1c713f-efcb-422e-8e25-e197217c1fa3" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_b24036fd-e3b8-4054-a6c4-9af29139b8bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_73bbe100-400f-4371-9d85-7417ba4a654d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_6c1c713f-efcb-422e-8e25-e197217c1fa3" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_73bbe100-400f-4371-9d85-7417ba4a654d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_d44b6cde-c458-4465-aaae-189af5596d39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_ae2ac6af-96d3-4ee4-96b2-1cccacfd0c17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_d44b6cde-c458-4465-aaae-189af5596d39" xlink:to="loc_us-gaap_LongTermDebtCurrent_ae2ac6af-96d3-4ee4-96b2-1cccacfd0c17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_a380b53d-c851-47ec-8ce7-6650b95d92cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_d44b6cde-c458-4465-aaae-189af5596d39" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_a380b53d-c851-47ec-8ce7-6650b95d92cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_89b77c0e-8946-4fc7-b84c-a8d0ed1d5dec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_024e2198-96d1-430b-a80f-bf6716996c2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_89b77c0e-8946-4fc7-b84c-a8d0ed1d5dec" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_024e2198-96d1-430b-a80f-bf6716996c2d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_210750a5-a63f-47f4-a9e9-d9432ea5ac62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_89b77c0e-8946-4fc7-b84c-a8d0ed1d5dec" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_210750a5-a63f-47f4-a9e9-d9432ea5ac62" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_bee74f34-e896-4ead-aa10-acda781a1f2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_b35cbfd8-8a30-40d4-a1e4-2ae2d50c4a0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_bee74f34-e896-4ead-aa10-acda781a1f2e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_b35cbfd8-8a30-40d4-a1e4-2ae2d50c4a0e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_b333974f-f365-4179-80b6-4d91066ada0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_bee74f34-e896-4ead-aa10-acda781a1f2e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_b333974f-f365-4179-80b6-4d91066ada0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0177345e-a22e-4a91-bf23-feab9cc325be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_bee74f34-e896-4ead-aa10-acda781a1f2e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0177345e-a22e-4a91-bf23-feab9cc325be" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>prct-20220630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:311bf6b2-ae92-4a64-91ca-35c82a3f09ce,g:4b68a96a-367b-4d30-a7c4-4a5adc893ec2-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit" xlink:type="simple" xlink:href="prct-20220630.xsd#CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"/>
  <link:definitionLink xlink:role="http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit" xlink:type="extended" id="i47437d2ab87d462393c6430bad9ba407_CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_407e4304-27ee-4adc-9b30-32c1c0a3f455" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_92dddc71-0360-4668-a7c3-394dec28b32d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_407e4304-27ee-4adc-9b30-32c1c0a3f455" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_92dddc71-0360-4668-a7c3-394dec28b32d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_d0c0ebe6-b2dd-44cd-b88c-afb7ed3b4584" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_92dddc71-0360-4668-a7c3-394dec28b32d" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_d0c0ebe6-b2dd-44cd-b88c-afb7ed3b4584" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_66b39dc0-20e6-46b8-bf39-2d35d959636b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_92dddc71-0360-4668-a7c3-394dec28b32d" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_66b39dc0-20e6-46b8-bf39-2d35d959636b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_faa189db-bf92-44f7-8d17-c458723f5be2" xlink:href="prct-20220630.xsd#prct_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_92dddc71-0360-4668-a7c3-394dec28b32d" xlink:to="loc_prct_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_faa189db-bf92-44f7-8d17-c458723f5be2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_632f4a79-05e2-4d27-83e6-80960c291350" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_92dddc71-0360-4668-a7c3-394dec28b32d" xlink:to="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_632f4a79-05e2-4d27-83e6-80960c291350" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_3a7e27c6-a098-46bd-8192-0dec0ac16624" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_c6a317ad-5a25-446f-a615-2b7b46c0bd48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_37154f0d-a23e-44fd-b253-afca999febb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_407e4304-27ee-4adc-9b30-32c1c0a3f455" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_37154f0d-a23e-44fd-b253-afca999febb0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_5cd29bed-c54f-4b23-ac12-85e7468993ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_37154f0d-a23e-44fd-b253-afca999febb0" xlink:to="loc_us-gaap_SharesOutstanding_5cd29bed-c54f-4b23-ac12-85e7468993ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_68b9ef70-1f35-489c-b9d2-a28a9e6b6960" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_37154f0d-a23e-44fd-b253-afca999febb0" xlink:to="loc_us-gaap_StockholdersEquity_68b9ef70-1f35-489c-b9d2-a28a9e6b6960" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2a9b4445-bb1f-4f20-a777-b057f3932236" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_37154f0d-a23e-44fd-b253-afca999febb0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2a9b4445-bb1f-4f20-a777-b057f3932236" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_463c7378-4d35-45b7-82dc-204936b4dff3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_37154f0d-a23e-44fd-b253-afca999febb0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_463c7378-4d35-45b7-82dc-204936b4dff3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_354a0e34-e276-48dc-9269-e2bc9d0dd485" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_37154f0d-a23e-44fd-b253-afca999febb0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_354a0e34-e276-48dc-9269-e2bc9d0dd485" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_50d645a4-462f-47c8-bfd0-27fd3a2180d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_37154f0d-a23e-44fd-b253-afca999febb0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_50d645a4-462f-47c8-bfd0-27fd3a2180d0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition_e0371510-508b-4f29-8e21-045522dad6bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_37154f0d-a23e-44fd-b253-afca999febb0" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition_e0371510-508b-4f29-8e21-045522dad6bd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_d573cccb-6e88-4942-87b0-5ee9fe2cca1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_37154f0d-a23e-44fd-b253-afca999febb0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_d573cccb-6e88-4942-87b0-5ee9fe2cca1e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e85d4675-2623-456e-8f23-531853329a21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_37154f0d-a23e-44fd-b253-afca999febb0" xlink:to="loc_us-gaap_NetIncomeLoss_e85d4675-2623-456e-8f23-531853329a21" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_c2f171db-92ec-4c89-9205-17fd5d0b1760" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_de552706-885f-43f5-809e-f60b5779ffdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_59e5a092-28d6-41f5-9bf6-29bab5bdf958" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_407e4304-27ee-4adc-9b30-32c1c0a3f455" xlink:to="loc_us-gaap_StatementTable_59e5a092-28d6-41f5-9bf6-29bab5bdf958" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_938011f9-015c-4ee7-94f7-7e5fc99dd526" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_59e5a092-28d6-41f5-9bf6-29bab5bdf958" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_938011f9-015c-4ee7-94f7-7e5fc99dd526" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_938011f9-015c-4ee7-94f7-7e5fc99dd526_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_938011f9-015c-4ee7-94f7-7e5fc99dd526" xlink:to="loc_us-gaap_EquityComponentDomain_938011f9-015c-4ee7-94f7-7e5fc99dd526_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_445651ed-e618-4633-ace7-47d0f3fb2c55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_938011f9-015c-4ee7-94f7-7e5fc99dd526" xlink:to="loc_us-gaap_EquityComponentDomain_445651ed-e618-4633-ace7-47d0f3fb2c55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_67aee783-f544-4fda-8c74-9fa921211584" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_445651ed-e618-4633-ace7-47d0f3fb2c55" xlink:to="loc_us-gaap_CommonStockMember_67aee783-f544-4fda-8c74-9fa921211584" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_a2eab1a0-f5c4-48cb-b0d9-b35fd81d0a00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_445651ed-e618-4633-ace7-47d0f3fb2c55" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_a2eab1a0-f5c4-48cb-b0d9-b35fd81d0a00" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2c928d77-5564-4c7c-8ead-748716323535" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_445651ed-e618-4633-ace7-47d0f3fb2c55" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2c928d77-5564-4c7c-8ead-748716323535" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_3a7dba85-823e-4625-a58e-d872a1613348" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_445651ed-e618-4633-ace7-47d0f3fb2c55" xlink:to="loc_us-gaap_RetainedEarningsMember_3a7dba85-823e-4625-a58e-d872a1613348" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/OrganizationDetails" xlink:type="simple" xlink:href="prct-20220630.xsd#OrganizationDetails"/>
  <link:definitionLink xlink:role="http://www.procept-biorobotics.com/role/OrganizationDetails" xlink:type="extended" id="i2da13a85eff3460aa29ca1fe27e115cd_OrganizationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_09831ab7-f6e7-4b1d-9846-6008e9303091" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_31462219-20c2-45d7-83a7-30c626371ebe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_09831ab7-f6e7-4b1d-9846-6008e9303091" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_31462219-20c2-45d7-83a7-30c626371ebe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_60667959-741f-4f51-94be-66e4cdde5155" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_09831ab7-f6e7-4b1d-9846-6008e9303091" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_60667959-741f-4f51-94be-66e4cdde5155" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_InitialPublicOfferingAbstract_a9bcd8a3-ece3-469a-93be-e91e4762333f" xlink:href="prct-20220630.xsd#prct_InitialPublicOfferingAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_09831ab7-f6e7-4b1d-9846-6008e9303091" xlink:to="loc_prct_InitialPublicOfferingAbstract_a9bcd8a3-ece3-469a-93be-e91e4762333f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_d38aea2d-9f95-4be2-bb81-0e9cae269095" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prct_InitialPublicOfferingAbstract_a9bcd8a3-ece3-469a-93be-e91e4762333f" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_d38aea2d-9f95-4be2-bb81-0e9cae269095" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_97d3b636-96fc-4610-b6fb-0ca51afc0c49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_09831ab7-f6e7-4b1d-9846-6008e9303091" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_97d3b636-96fc-4610-b6fb-0ca51afc0c49" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_2311e054-faed-4140-8993-56fb126797ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_97d3b636-96fc-4610-b6fb-0ca51afc0c49" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_2311e054-faed-4140-8993-56fb126797ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2311e054-faed-4140-8993-56fb126797ca_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_2311e054-faed-4140-8993-56fb126797ca" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2311e054-faed-4140-8993-56fb126797ca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_ee100b44-ce04-43d8-83ad-9b9c96521e18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_2311e054-faed-4140-8993-56fb126797ca" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_ee100b44-ce04-43d8-83ad-9b9c96521e18" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_7a52823b-e8f1-4ddf-ac77-b6ea27e41c47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_ee100b44-ce04-43d8-83ad-9b9c96521e18" xlink:to="loc_us-gaap_IPOMember_7a52823b-e8f1-4ddf-ac77-b6ea27e41c47" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_a697868e-8268-4616-9cdd-6e7556d17431" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_97d3b636-96fc-4610-b6fb-0ca51afc0c49" xlink:to="loc_us-gaap_StatementClassOfStockAxis_a697868e-8268-4616-9cdd-6e7556d17431" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_a697868e-8268-4616-9cdd-6e7556d17431_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_a697868e-8268-4616-9cdd-6e7556d17431" xlink:to="loc_us-gaap_ClassOfStockDomain_a697868e-8268-4616-9cdd-6e7556d17431_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_b113826f-d3a2-4662-87c2-74b53812d813" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_a697868e-8268-4616-9cdd-6e7556d17431" xlink:to="loc_us-gaap_ClassOfStockDomain_b113826f-d3a2-4662-87c2-74b53812d813" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_692ae456-09f4-4358-a285-9826afc7b6d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_b113826f-d3a2-4662-87c2-74b53812d813" xlink:to="loc_us-gaap_CommonStockMember_692ae456-09f4-4358-a285-9826afc7b6d9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="prct-20220630.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.procept-biorobotics.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" id="i792e02ca010a467dac172cc312f72428_SummaryofSignificantAccountingPoliciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_460fe6f5-b41e-4615-b995-a35f1d7c478c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_d66e3489-6a22-4fe1-8fea-25e6700374b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_460fe6f5-b41e-4615-b995-a35f1d7c478c" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_d66e3489-6a22-4fe1-8fea-25e6700374b2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_86fc4c55-b3e4-454b-81a5-f2b9bc3c0c72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_460fe6f5-b41e-4615-b995-a35f1d7c478c" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_86fc4c55-b3e4-454b-81a5-f2b9bc3c0c72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_4caa47ce-9ab0-49bf-8b5b-8e6957b89ed6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_460fe6f5-b41e-4615-b995-a35f1d7c478c" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_4caa47ce-9ab0-49bf-8b5b-8e6957b89ed6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForUnderwritingExpense_0eb7b004-234c-4f05-9f17-b8df2bdd0d1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForUnderwritingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_460fe6f5-b41e-4615-b995-a35f1d7c478c" xlink:to="loc_us-gaap_PaymentsForUnderwritingExpense_0eb7b004-234c-4f05-9f17-b8df2bdd0d1a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_72f5fc52-2e82-4e44-83d5-6ffe3fb27ef2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_460fe6f5-b41e-4615-b995-a35f1d7c478c" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_72f5fc52-2e82-4e44-83d5-6ffe3fb27ef2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_2e5e863e-d102-43de-8bbe-d5e5d89bfeb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_460fe6f5-b41e-4615-b995-a35f1d7c478c" xlink:to="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_2e5e863e-d102-43de-8bbe-d5e5d89bfeb6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_a048f388-b541-4e33-801c-22f18b569ae8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_460fe6f5-b41e-4615-b995-a35f1d7c478c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_a048f388-b541-4e33-801c-22f18b569ae8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_TemporaryEquityStockIssuedDuringPeriodSharesWarrantExercises_d00b6cdc-45f8-49c7-8107-2cc9c081f3ed" xlink:href="prct-20220630.xsd#prct_TemporaryEquityStockIssuedDuringPeriodSharesWarrantExercises"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_460fe6f5-b41e-4615-b995-a35f1d7c478c" xlink:to="loc_prct_TemporaryEquityStockIssuedDuringPeriodSharesWarrantExercises_d00b6cdc-45f8-49c7-8107-2cc9c081f3ed" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_6a559e27-d518-4ad3-bf55-16cd4d376502" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_460fe6f5-b41e-4615-b995-a35f1d7c478c" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_6a559e27-d518-4ad3-bf55-16cd4d376502" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_e9725fdf-e8fb-453d-b44d-97c7eb56f08b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_6a559e27-d518-4ad3-bf55-16cd4d376502" xlink:to="loc_us-gaap_StatementClassOfStockAxis_e9725fdf-e8fb-453d-b44d-97c7eb56f08b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_e9725fdf-e8fb-453d-b44d-97c7eb56f08b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_e9725fdf-e8fb-453d-b44d-97c7eb56f08b" xlink:to="loc_us-gaap_ClassOfStockDomain_e9725fdf-e8fb-453d-b44d-97c7eb56f08b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_f1e7ca39-dbbf-443c-abcc-560c2eded199" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_e9725fdf-e8fb-453d-b44d-97c7eb56f08b" xlink:to="loc_us-gaap_ClassOfStockDomain_f1e7ca39-dbbf-443c-abcc-560c2eded199" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_c2c65944-5a0d-48e3-9e4d-0b575cb5bcb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_f1e7ca39-dbbf-443c-abcc-560c2eded199" xlink:to="loc_us-gaap_CommonStockMember_c2c65944-5a0d-48e3-9e4d-0b575cb5bcb3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_de574732-0c81-4ce7-9b91-4204f85d7963" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_6a559e27-d518-4ad3-bf55-16cd4d376502" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_de574732-0c81-4ce7-9b91-4204f85d7963" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_de574732-0c81-4ce7-9b91-4204f85d7963_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_de574732-0c81-4ce7-9b91-4204f85d7963" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_de574732-0c81-4ce7-9b91-4204f85d7963_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_753ae603-ae34-417f-bf97-c029abd8cd55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_de574732-0c81-4ce7-9b91-4204f85d7963" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_753ae603-ae34-417f-bf97-c029abd8cd55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_d437e7b2-9fea-47a5-b315-0c18c39b2c8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_753ae603-ae34-417f-bf97-c029abd8cd55" xlink:to="loc_us-gaap_IPOMember_d437e7b2-9fea-47a5-b315-0c18c39b2c8e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember_4b603b75-05f4-4591-b88e-7df905907631" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_753ae603-ae34-417f-bf97-c029abd8cd55" xlink:to="loc_us-gaap_OverAllotmentOptionMember_4b603b75-05f4-4591-b88e-7df905907631" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_aba0ef69-8458-4aee-bad4-d1c371c02190" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_6a559e27-d518-4ad3-bf55-16cd4d376502" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_aba0ef69-8458-4aee-bad4-d1c371c02190" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_aba0ef69-8458-4aee-bad4-d1c371c02190_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_aba0ef69-8458-4aee-bad4-d1c371c02190" xlink:to="loc_us-gaap_EquityComponentDomain_aba0ef69-8458-4aee-bad4-d1c371c02190_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_35a30e83-6369-4282-9706-c261d62d308a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_aba0ef69-8458-4aee-bad4-d1c371c02190" xlink:to="loc_us-gaap_EquityComponentDomain_35a30e83-6369-4282-9706-c261d62d308a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_ce6ca11a-3137-4a5d-b121-208e4933b149" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_35a30e83-6369-4282-9706-c261d62d308a" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_ce6ca11a-3137-4a5d-b121-208e4933b149" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_dac7746c-e020-4c77-9a76-1b2f75e53210" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_35a30e83-6369-4282-9706-c261d62d308a" xlink:to="loc_us-gaap_WarrantMember_dac7746c-e020-4c77-9a76-1b2f75e53210" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_6e204b95-ecb5-44d2-a416-c533ba14321e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_6a559e27-d518-4ad3-bf55-16cd4d376502" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_6e204b95-ecb5-44d2-a416-c533ba14321e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_6e204b95-ecb5-44d2-a416-c533ba14321e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_6e204b95-ecb5-44d2-a416-c533ba14321e" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_6e204b95-ecb5-44d2-a416-c533ba14321e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_a376a2c0-ff3c-420c-b239-fbca7193eb46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_6e204b95-ecb5-44d2-a416-c533ba14321e" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_a376a2c0-ff3c-420c-b239-fbca7193eb46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_SeriesERedeemableConvertiblePreferredStockWarrantsMember_b803db44-4074-450d-95b9-d309a8f3a9df" xlink:href="prct-20220630.xsd#prct_SeriesERedeemableConvertiblePreferredStockWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_a376a2c0-ff3c-420c-b239-fbca7193eb46" xlink:to="loc_prct_SeriesERedeemableConvertiblePreferredStockWarrantsMember_b803db44-4074-450d-95b9-d309a8f3a9df" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="prct-20220630.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.procept-biorobotics.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended" id="i6a98da9bd0264f23b51e167de09816b3_FairValueMeasurementsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_59c233f4-a26c-4730-9216-93d74ca37cc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMeasurementInput_4d65a22c-061d-4170-972a-9774eb591158" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_59c233f4-a26c-4730-9216-93d74ca37cc6" xlink:to="loc_us-gaap_LongTermDebtMeasurementInput_4d65a22c-061d-4170-972a-9774eb591158" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_0a896142-79a8-48c6-abe1-96fe1e878407" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_59c233f4-a26c-4730-9216-93d74ca37cc6" xlink:to="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_0a896142-79a8-48c6-abe1-96fe1e878407" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_395f35fe-64df-4d3e-9363-862ead7d5ad8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_0a896142-79a8-48c6-abe1-96fe1e878407" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_395f35fe-64df-4d3e-9363-862ead7d5ad8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_395f35fe-64df-4d3e-9363-862ead7d5ad8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_395f35fe-64df-4d3e-9363-862ead7d5ad8" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_395f35fe-64df-4d3e-9363-862ead7d5ad8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d9ad6b18-cc43-42bf-b492-74810558b415" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_395f35fe-64df-4d3e-9363-862ead7d5ad8" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d9ad6b18-cc43-42bf-b492-74810558b415" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_6f6a2153-d8c5-4fe9-8f80-975c8f9ed013" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d9ad6b18-cc43-42bf-b492-74810558b415" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_6f6a2153-d8c5-4fe9-8f80-975c8f9ed013" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_de36e115-cd3d-48f3-97e1-c3aa0fc2ec5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_0a896142-79a8-48c6-abe1-96fe1e878407" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_de36e115-cd3d-48f3-97e1-c3aa0fc2ec5b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_de36e115-cd3d-48f3-97e1-c3aa0fc2ec5b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_de36e115-cd3d-48f3-97e1-c3aa0fc2ec5b" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_de36e115-cd3d-48f3-97e1-c3aa0fc2ec5b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_807f1f1a-bf54-4d87-b62f-814d9263e209" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_de36e115-cd3d-48f3-97e1-c3aa0fc2ec5b" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_807f1f1a-bf54-4d87-b62f-814d9263e209" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_ee70d7b2-f64a-4123-90a3-9dbae90f4797" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_807f1f1a-bf54-4d87-b62f-814d9263e209" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_ee70d7b2-f64a-4123-90a3-9dbae90f4797" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_e325e786-d9e6-4eb9-b81f-f7d9f2ee38ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_0a896142-79a8-48c6-abe1-96fe1e878407" xlink:to="loc_us-gaap_ValuationTechniqueAxis_e325e786-d9e6-4eb9-b81f-f7d9f2ee38ed" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_e325e786-d9e6-4eb9-b81f-f7d9f2ee38ed_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationTechniqueAxis_e325e786-d9e6-4eb9-b81f-f7d9f2ee38ed" xlink:to="loc_us-gaap_ValuationTechniqueDomain_e325e786-d9e6-4eb9-b81f-f7d9f2ee38ed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_5d95defa-5bf4-4cab-ad61-bbf922528913" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationTechniqueAxis_e325e786-d9e6-4eb9-b81f-f7d9f2ee38ed" xlink:to="loc_us-gaap_ValuationTechniqueDomain_5d95defa-5bf4-4cab-ad61-bbf922528913" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_62efad37-7cd8-46de-a59b-2819cb6fe27b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationTechniqueDomain_5d95defa-5bf4-4cab-ad61-bbf922528913" xlink:to="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_62efad37-7cd8-46de-a59b-2819cb6fe27b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/FairValueMeasurementsFairValueDetails" xlink:type="simple" xlink:href="prct-20220630.xsd#FairValueMeasurementsFairValueDetails"/>
  <link:definitionLink xlink:role="http://www.procept-biorobotics.com/role/FairValueMeasurementsFairValueDetails" xlink:type="extended" id="if4f09b7ca08d461eb33c2e0557d1ea63_FairValueMeasurementsFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_aacf5721-930c-4fca-833a-28ec2f2a56bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash_cd706965-b1e5-4d63-9673-9b3ae7a7cdcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Cash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_aacf5721-930c-4fca-833a-28ec2f2a56bb" xlink:to="loc_us-gaap_Cash_cd706965-b1e5-4d63-9673-9b3ae7a7cdcf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_49b45594-3eec-4fac-98cf-188c43034c4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_aacf5721-930c-4fca-833a-28ec2f2a56bb" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_49b45594-3eec-4fac-98cf-188c43034c4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2c42e753-c190-4ef1-8058-9032380957e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_aacf5721-930c-4fca-833a-28ec2f2a56bb" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2c42e753-c190-4ef1-8058-9032380957e3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_eeb3ef66-2b9b-49ea-9df0-b5e3820fb672" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_aacf5721-930c-4fca-833a-28ec2f2a56bb" xlink:to="loc_us-gaap_DerivativeLiabilities_eeb3ef66-2b9b-49ea-9df0-b5e3820fb672" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_fe780ce0-21ac-44a5-b8f0-56159ff6f802" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_aacf5721-930c-4fca-833a-28ec2f2a56bb" xlink:to="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_fe780ce0-21ac-44a5-b8f0-56159ff6f802" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_db7668aa-0f67-4327-aafc-dabc996d32ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_fe780ce0-21ac-44a5-b8f0-56159ff6f802" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_db7668aa-0f67-4327-aafc-dabc996d32ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_db7668aa-0f67-4327-aafc-dabc996d32ab_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_db7668aa-0f67-4327-aafc-dabc996d32ab" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_db7668aa-0f67-4327-aafc-dabc996d32ab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_df122141-2e3c-4fe1-9a79-3581f3b3d8fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_db7668aa-0f67-4327-aafc-dabc996d32ab" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_df122141-2e3c-4fe1-9a79-3581f3b3d8fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_4f5427ba-025d-4ede-bc3d-a7c3fb10945a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_df122141-2e3c-4fe1-9a79-3581f3b3d8fd" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_4f5427ba-025d-4ede-bc3d-a7c3fb10945a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_5b3079a2-4cfb-40e0-b2a3-41fc436d8ab9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_df122141-2e3c-4fe1-9a79-3581f3b3d8fd" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_5b3079a2-4cfb-40e0-b2a3-41fc436d8ab9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_200a64b2-f573-4562-9dcd-51fd6ffa8dc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_df122141-2e3c-4fe1-9a79-3581f3b3d8fd" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_200a64b2-f573-4562-9dcd-51fd6ffa8dc7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c6f49191-a3b8-4c7d-a908-b2a2487f64df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_fe780ce0-21ac-44a5-b8f0-56159ff6f802" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c6f49191-a3b8-4c7d-a908-b2a2487f64df" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_c6f49191-a3b8-4c7d-a908-b2a2487f64df_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c6f49191-a3b8-4c7d-a908-b2a2487f64df" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_c6f49191-a3b8-4c7d-a908-b2a2487f64df_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_dbdcd668-f295-4bbc-adfd-2d02aff725de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c6f49191-a3b8-4c7d-a908-b2a2487f64df" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_dbdcd668-f295-4bbc-adfd-2d02aff725de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_627a8255-3c6e-42d7-af36-8c368286b48a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_dbdcd668-f295-4bbc-adfd-2d02aff725de" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_627a8255-3c6e-42d7-af36-8c368286b48a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/FairValueMeasurementsFairValueInputsLevel3FairValueMeasurementsRecurringDetails" xlink:type="simple" xlink:href="prct-20220630.xsd#FairValueMeasurementsFairValueInputsLevel3FairValueMeasurementsRecurringDetails"/>
  <link:definitionLink xlink:role="http://www.procept-biorobotics.com/role/FairValueMeasurementsFairValueInputsLevel3FairValueMeasurementsRecurringDetails" xlink:type="extended" id="icca42c2359214769bb4119eea1541798_FairValueMeasurementsFairValueInputsLevel3FairValueMeasurementsRecurringDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_637e30f1-3457-4580-b7a2-c2669cbcb01b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_ee08393b-fb97-4cf9-b863-d1cedeb7b169" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_637e30f1-3457-4580-b7a2-c2669cbcb01b" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_ee08393b-fb97-4cf9-b863-d1cedeb7b169" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_31e0cde2-fc65-4360-85b0-023debc24bf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_ee08393b-fb97-4cf9-b863-d1cedeb7b169" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_31e0cde2-fc65-4360-85b0-023debc24bf9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues_bc8d157a-a95c-496c-8b4d-291c5161223a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_ee08393b-fb97-4cf9-b863-d1cedeb7b169" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues_bc8d157a-a95c-496c-8b4d-291c5161223a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings_3e939dc0-ea31-4570-a4ab-83728a1c7512" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_ee08393b-fb97-4cf9-b863-d1cedeb7b169" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings_3e939dc0-ea31-4570-a4ab-83728a1c7512" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_b51f4c95-a4a7-47de-8982-ad9349bf720e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_736c7568-076a-4692-b47b-5ac4c1026d09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_637e30f1-3457-4580-b7a2-c2669cbcb01b" xlink:to="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_736c7568-076a-4692-b47b-5ac4c1026d09" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_097db3fe-69bb-464b-addf-643cdebccb4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_736c7568-076a-4692-b47b-5ac4c1026d09" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_097db3fe-69bb-464b-addf-643cdebccb4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_097db3fe-69bb-464b-addf-643cdebccb4b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_097db3fe-69bb-464b-addf-643cdebccb4b" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_097db3fe-69bb-464b-addf-643cdebccb4b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_66e09fd1-f95b-473f-9225-c2ee3fd44d83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_097db3fe-69bb-464b-addf-643cdebccb4b" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_66e09fd1-f95b-473f-9225-c2ee3fd44d83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_6ffe426f-a479-469e-b7a3-af8593e8972a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_66e09fd1-f95b-473f-9225-c2ee3fd44d83" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_6ffe426f-a479-469e-b7a3-af8593e8972a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiabilityDetails" xlink:type="simple" xlink:href="prct-20220630.xsd#LoanFacilityandDerivativeLiabilityDetails"/>
  <link:definitionLink xlink:role="http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiabilityDetails" xlink:type="extended" id="i7b3c63f4906344c4a29bbfe9c059234c_LoanFacilityandDerivativeLiabilityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_dd43303a-e3ab-4523-a233-488426393dac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_dd43303a-e3ab-4523-a233-488426393dac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_LineOfCreditFacilityNumberOfInstallments_1be7a390-d046-4bf4-84c4-91823ac95ffc" xlink:href="prct-20220630.xsd#prct_LineOfCreditFacilityNumberOfInstallments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_prct_LineOfCreditFacilityNumberOfInstallments_1be7a390-d046-4bf4-84c4-91823ac95ffc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_2a193d91-2195-4690-b28d-43a6e03788f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_2a193d91-2195-4690-b28d-43a6e03788f5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_61df8790-e5c0-4bfe-9a7c-60bc040ff7b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_61df8790-e5c0-4bfe-9a7c-60bc040ff7b3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_LineOfCreditFacilityCovenantComplianceContingentTrailingSixTwelveMonthRevenueTarget_ea5e712a-30f2-4458-95f0-0d3f930d2e5e" xlink:href="prct-20220630.xsd#prct_LineOfCreditFacilityCovenantComplianceContingentTrailingSixTwelveMonthRevenueTarget"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_prct_LineOfCreditFacilityCovenantComplianceContingentTrailingSixTwelveMonthRevenueTarget_ea5e712a-30f2-4458-95f0-0d3f930d2e5e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_2609a080-8833-40f3-84f0-365f8339a785" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_2609a080-8833-40f3-84f0-365f8339a785" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_ec4da406-a010-4aeb-87ed-b2fd55ebfa41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_us-gaap_DebtInstrumentTerm_ec4da406-a010-4aeb-87ed-b2fd55ebfa41" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_DebtInstrumentInterestOnlyPeriod_fdec8cae-c146-4cae-9467-cf7e6c5db488" xlink:href="prct-20220630.xsd#prct_DebtInstrumentInterestOnlyPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_prct_DebtInstrumentInterestOnlyPeriod_fdec8cae-c146-4cae-9467-cf7e6c5db488" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_DebtInstrumentPrincipalAndInterestPeriod_c56a3c53-78eb-4c93-8037-8b7f3e74a273" xlink:href="prct-20220630.xsd#prct_DebtInstrumentPrincipalAndInterestPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_prct_DebtInstrumentPrincipalAndInterestPeriod_c56a3c53-78eb-4c93-8037-8b7f3e74a273" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_DebtInstrumentContingentBorrowingExtendedInterestOnlyPeriod_05177679-71c2-45e5-a35a-b496782f181d" xlink:href="prct-20220630.xsd#prct_DebtInstrumentContingentBorrowingExtendedInterestOnlyPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_prct_DebtInstrumentContingentBorrowingExtendedInterestOnlyPeriod_05177679-71c2-45e5-a35a-b496782f181d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_DebtInstrumentContingentBorrowingExtendedPrincipalAndInterestPeriod_e70cbd89-eeef-44d2-9289-25b0051dbe3d" xlink:href="prct-20220630.xsd#prct_DebtInstrumentContingentBorrowingExtendedPrincipalAndInterestPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_prct_DebtInstrumentContingentBorrowingExtendedPrincipalAndInterestPeriod_e70cbd89-eeef-44d2-9289-25b0051dbe3d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmount_bdcd135d-df6b-43d0-8e7c-a969c93c84cc" xlink:href="prct-20220630.xsd#prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmount_bdcd135d-df6b-43d0-8e7c-a969c93c84cc" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmountAchievedExtendedInterestOnlyPeriod_099d80d7-3108-4060-bfa9-8d3c53cef86c" xlink:href="prct-20220630.xsd#prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmountAchievedExtendedInterestOnlyPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmountAchievedExtendedInterestOnlyPeriod_099d80d7-3108-4060-bfa9-8d3c53cef86c" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmountAchievedExtendedPrincipalAndInterestPeriod_7cca3b8b-a016-45fd-ad48-b1d2c889235d" xlink:href="prct-20220630.xsd#prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmountAchievedExtendedPrincipalAndInterestPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmountAchievedExtendedPrincipalAndInterestPeriod_7cca3b8b-a016-45fd-ad48-b1d2c889235d" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_DebtInstrumentCovenantComplianceRevenueForecastForCommensuratePeriodPercent_a322c222-ca0a-4995-b425-a3d3c828223e" xlink:href="prct-20220630.xsd#prct_DebtInstrumentCovenantComplianceRevenueForecastForCommensuratePeriodPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_prct_DebtInstrumentCovenantComplianceRevenueForecastForCommensuratePeriodPercent_a322c222-ca0a-4995-b425-a3d3c828223e" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_DebtInstrumentCovenantComplianceRevenueForecastAmountFirstTwoInstallmentsOnly_d7a44f74-5ae3-41e4-a52a-8a7b5fa40eb2" xlink:href="prct-20220630.xsd#prct_DebtInstrumentCovenantComplianceRevenueForecastAmountFirstTwoInstallmentsOnly"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_prct_DebtInstrumentCovenantComplianceRevenueForecastAmountFirstTwoInstallmentsOnly_d7a44f74-5ae3-41e4-a52a-8a7b5fa40eb2" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_DebtInstrumentCovenantComplianceRevenueForecastAmountFirstThreeInstallmentsOnly_8d9b0546-7d7a-4f31-b4c9-18bd78024e06" xlink:href="prct-20220630.xsd#prct_DebtInstrumentCovenantComplianceRevenueForecastAmountFirstThreeInstallmentsOnly"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_prct_DebtInstrumentCovenantComplianceRevenueForecastAmountFirstThreeInstallmentsOnly_8d9b0546-7d7a-4f31-b4c9-18bd78024e06" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_DebtInstrumentCovenantComplianceRevenueForecastAmountAllInstallmentsDrawn_3515466d-5536-4c20-93ca-d90c64444c92" xlink:href="prct-20220630.xsd#prct_DebtInstrumentCovenantComplianceRevenueForecastAmountAllInstallmentsDrawn"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_prct_DebtInstrumentCovenantComplianceRevenueForecastAmountAllInstallmentsDrawn_3515466d-5536-4c20-93ca-d90c64444c92" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_LineOfCreditFacilityFinalPaymentFeePercentage_95862087-459c-41d6-8cdc-f4749c330114" xlink:href="prct-20220630.xsd#prct_LineOfCreditFacilityFinalPaymentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_prct_LineOfCreditFacilityFinalPaymentFeePercentage_95862087-459c-41d6-8cdc-f4749c330114" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_f40787f0-2788-4886-bb87-24c8a1042e99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_f40787f0-2788-4886-bb87-24c8a1042e99" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_LineOfCreditFacilityEarlyRepaymentFeeFirstTwelveMonthPercent_d2eefb93-5f90-41c2-8cd9-469502c3b766" xlink:href="prct-20220630.xsd#prct_LineOfCreditFacilityEarlyRepaymentFeeFirstTwelveMonthPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_prct_LineOfCreditFacilityEarlyRepaymentFeeFirstTwelveMonthPercent_d2eefb93-5f90-41c2-8cd9-469502c3b766" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_LineOfCreditFacilityEarlyRepaymentFeeSecondTwelveMonthPeriodPercent_c6604748-0853-477f-83e2-011078c881bb" xlink:href="prct-20220630.xsd#prct_LineOfCreditFacilityEarlyRepaymentFeeSecondTwelveMonthPeriodPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_prct_LineOfCreditFacilityEarlyRepaymentFeeSecondTwelveMonthPeriodPercent_c6604748-0853-477f-83e2-011078c881bb" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_LineOfCreditFacilityEarlyRepaymentFeeTwentyFourMonthsThruMaturityPercent_510e69d6-64be-4b48-ab28-39a4f52e6d19" xlink:href="prct-20220630.xsd#prct_LineOfCreditFacilityEarlyRepaymentFeeTwentyFourMonthsThruMaturityPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_prct_LineOfCreditFacilityEarlyRepaymentFeeTwentyFourMonthsThruMaturityPercent_510e69d6-64be-4b48-ab28-39a4f52e6d19" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_LineOfCreditFacilityCovenantComplianceContingentTrailingTwelveMonthRevenueTarget_a4a3e24b-eb84-48d8-b06c-b51093d22933" xlink:href="prct-20220630.xsd#prct_LineOfCreditFacilityCovenantComplianceContingentTrailingTwelveMonthRevenueTarget"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_prct_LineOfCreditFacilityCovenantComplianceContingentTrailingTwelveMonthRevenueTarget_a4a3e24b-eb84-48d8-b06c-b51093d22933" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceOneInstallmentDrawn_a0f462df-44d8-4ab9-8019-877c1fb8f241" xlink:href="prct-20220630.xsd#prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceOneInstallmentDrawn"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceOneInstallmentDrawn_a0f462df-44d8-4ab9-8019-877c1fb8f241" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceTwoInstallmentsDrawn_c97bba57-3d29-4422-9443-3600e2a3dec7" xlink:href="prct-20220630.xsd#prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceTwoInstallmentsDrawn"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceTwoInstallmentsDrawn_c97bba57-3d29-4422-9443-3600e2a3dec7" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceThreeInstallmentsDrawn_5068ca09-05d5-495c-8c08-77381f557ca8" xlink:href="prct-20220630.xsd#prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceThreeInstallmentsDrawn"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceThreeInstallmentsDrawn_5068ca09-05d5-495c-8c08-77381f557ca8" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceFourInstallmentsDrawn_22d464c0-8ab4-4a3d-98fd-0961d3077403" xlink:href="prct-20220630.xsd#prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceFourInstallmentsDrawn"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceFourInstallmentsDrawn_22d464c0-8ab4-4a3d-98fd-0961d3077403" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_LineOfCreditFacilityGainLossOnAmendmentOfDebtTerms_10eff209-deca-403c-87a9-655b20f38c94" xlink:href="prct-20220630.xsd#prct_LineOfCreditFacilityGainLossOnAmendmentOfDebtTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_prct_LineOfCreditFacilityGainLossOnAmendmentOfDebtTerms_10eff209-deca-403c-87a9-655b20f38c94" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_20e19ff0-fe20-41a7-b496-357bf86acdb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_20e19ff0-fe20-41a7-b496-357bf86acdb8" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_afe178d2-908f-464a-8fe3-48672f58f339" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_afe178d2-908f-464a-8fe3-48672f58f339" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_062a56b4-3125-4de1-963a-f6545cf16bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_afe178d2-908f-464a-8fe3-48672f58f339" xlink:to="loc_us-gaap_DebtInstrumentAxis_062a56b4-3125-4de1-963a-f6545cf16bd0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_062a56b4-3125-4de1-963a-f6545cf16bd0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_062a56b4-3125-4de1-963a-f6545cf16bd0" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_062a56b4-3125-4de1-963a-f6545cf16bd0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c27c2585-ec7e-4f79-9dac-10b4fbd28ba9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_062a56b4-3125-4de1-963a-f6545cf16bd0" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c27c2585-ec7e-4f79-9dac-10b4fbd28ba9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_LoanFacilityMember_66d042c5-4f7f-4c13-b097-e7d2b646001f" xlink:href="prct-20220630.xsd#prct_LoanFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c27c2585-ec7e-4f79-9dac-10b4fbd28ba9" xlink:to="loc_prct_LoanFacilityMember_66d042c5-4f7f-4c13-b097-e7d2b646001f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_LoanFacilityTrancheOneMember_0b01461b-b661-42db-9375-2cdcec3b8fae" xlink:href="prct-20220630.xsd#prct_LoanFacilityTrancheOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prct_LoanFacilityMember_66d042c5-4f7f-4c13-b097-e7d2b646001f" xlink:to="loc_prct_LoanFacilityTrancheOneMember_0b01461b-b661-42db-9375-2cdcec3b8fae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_LoanFacilityTrancheTwoMember_5a5fe3b9-b5f4-4860-9b55-714f4a8773e7" xlink:href="prct-20220630.xsd#prct_LoanFacilityTrancheTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prct_LoanFacilityMember_66d042c5-4f7f-4c13-b097-e7d2b646001f" xlink:to="loc_prct_LoanFacilityTrancheTwoMember_5a5fe3b9-b5f4-4860-9b55-714f4a8773e7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_LoanFacilityTrancheThreeMember_12c6efc8-8ecc-41ce-b834-53896f5bd3f3" xlink:href="prct-20220630.xsd#prct_LoanFacilityTrancheThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prct_LoanFacilityMember_66d042c5-4f7f-4c13-b097-e7d2b646001f" xlink:to="loc_prct_LoanFacilityTrancheThreeMember_12c6efc8-8ecc-41ce-b834-53896f5bd3f3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_LoanFacilityTrancheFourMember_dc9e4deb-e609-4070-8989-731d2fbbd968" xlink:href="prct-20220630.xsd#prct_LoanFacilityTrancheFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prct_LoanFacilityMember_66d042c5-4f7f-4c13-b097-e7d2b646001f" xlink:to="loc_prct_LoanFacilityTrancheFourMember_dc9e4deb-e609-4070-8989-731d2fbbd968" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_b3a02581-f4cc-4d89-b102-671dfb29115d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_afe178d2-908f-464a-8fe3-48672f58f339" xlink:to="loc_us-gaap_CreditFacilityAxis_b3a02581-f4cc-4d89-b102-671dfb29115d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_b3a02581-f4cc-4d89-b102-671dfb29115d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_b3a02581-f4cc-4d89-b102-671dfb29115d" xlink:to="loc_us-gaap_CreditFacilityDomain_b3a02581-f4cc-4d89-b102-671dfb29115d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_fdacafcf-c98b-4359-a224-2237b4d02473" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_b3a02581-f4cc-4d89-b102-671dfb29115d" xlink:to="loc_us-gaap_CreditFacilityDomain_fdacafcf-c98b-4359-a224-2237b4d02473" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_73d2d502-6d38-4add-bbe3-8a5b09751be5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_fdacafcf-c98b-4359-a224-2237b4d02473" xlink:to="loc_us-gaap_LineOfCreditMember_73d2d502-6d38-4add-bbe3-8a5b09751be5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_2954681d-fb41-4c86-b97d-f9c6c6a1da2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_afe178d2-908f-464a-8fe3-48672f58f339" xlink:to="loc_us-gaap_VariableRateAxis_2954681d-fb41-4c86-b97d-f9c6c6a1da2c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_2954681d-fb41-4c86-b97d-f9c6c6a1da2c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_2954681d-fb41-4c86-b97d-f9c6c6a1da2c" xlink:to="loc_us-gaap_VariableRateDomain_2954681d-fb41-4c86-b97d-f9c6c6a1da2c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_3353b57c-0ae1-4a89-aa1a-b7501fdf2ffd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_2954681d-fb41-4c86-b97d-f9c6c6a1da2c" xlink:to="loc_us-gaap_VariableRateDomain_3353b57c-0ae1-4a89-aa1a-b7501fdf2ffd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_86a8ca73-abbc-4067-9ef9-3a12abb345d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_3353b57c-0ae1-4a89-aa1a-b7501fdf2ffd" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_86a8ca73-abbc-4067-9ef9-3a12abb345d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_9ba3eaa6-d71b-486f-99fc-c9e662766a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_afe178d2-908f-464a-8fe3-48672f58f339" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_9ba3eaa6-d71b-486f-99fc-c9e662766a1f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9ba3eaa6-d71b-486f-99fc-c9e662766a1f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9ba3eaa6-d71b-486f-99fc-c9e662766a1f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9ba3eaa6-d71b-486f-99fc-c9e662766a1f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b4019566-99fb-488d-b8b5-b65edcedc263" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9ba3eaa6-d71b-486f-99fc-c9e662766a1f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b4019566-99fb-488d-b8b5-b65edcedc263" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_96a6e80d-d9d4-4862-b682-d7e170139fc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b4019566-99fb-488d-b8b5-b65edcedc263" xlink:to="loc_us-gaap_LineOfCreditMember_96a6e80d-d9d4-4862-b682-d7e170139fc2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/StockBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="prct-20220630.xsd#StockBasedCompensationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.procept-biorobotics.com/role/StockBasedCompensationNarrativeDetails" xlink:type="extended" id="ib69f2bd883a74ebdac50432735975b2f_StockBasedCompensationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_43576de2-4705-4d91-87a9-0d73e0485471" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_1f426a45-5c39-4511-a11e-43aee02b3d3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_43576de2-4705-4d91-87a9-0d73e0485471" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_1f426a45-5c39-4511-a11e-43aee02b3d3d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_bd1d9b86-281f-4990-adcc-a7011f8ff72b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_43576de2-4705-4d91-87a9-0d73e0485471" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_bd1d9b86-281f-4990-adcc-a7011f8ff72b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_28d50620-4d7a-4d50-a346-ceb69d8151a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_43576de2-4705-4d91-87a9-0d73e0485471" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_28d50620-4d7a-4d50-a346-ceb69d8151a1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_02c402b9-0b03-47d2-8d1b-02ff039a43a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_43576de2-4705-4d91-87a9-0d73e0485471" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_02c402b9-0b03-47d2-8d1b-02ff039a43a6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_13b39a7c-f512-42b6-a42e-7b3ad40f144c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_43576de2-4705-4d91-87a9-0d73e0485471" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_13b39a7c-f512-42b6-a42e-7b3ad40f144c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_fd7e7aaa-31ed-49c5-b5f1-a12d14570d94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_43576de2-4705-4d91-87a9-0d73e0485471" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_fd7e7aaa-31ed-49c5-b5f1-a12d14570d94" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_0d7016cd-2172-4cc3-9841-9b8285384812" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_43576de2-4705-4d91-87a9-0d73e0485471" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_0d7016cd-2172-4cc3-9841-9b8285384812" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_efd5597d-9535-47eb-a03f-8d0ded539d3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_43576de2-4705-4d91-87a9-0d73e0485471" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_efd5597d-9535-47eb-a03f-8d0ded539d3d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_b1a23d84-086a-49e0-9f69-7f072b06581b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_efd5597d-9535-47eb-a03f-8d0ded539d3d" xlink:to="loc_us-gaap_AwardTypeAxis_b1a23d84-086a-49e0-9f69-7f072b06581b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b1a23d84-086a-49e0-9f69-7f072b06581b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_b1a23d84-086a-49e0-9f69-7f072b06581b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b1a23d84-086a-49e0-9f69-7f072b06581b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_039d5350-5eef-4649-8ef3-86e76ee4a163" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_b1a23d84-086a-49e0-9f69-7f072b06581b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_039d5350-5eef-4649-8ef3-86e76ee4a163" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_2e539c46-1921-4898-aae5-79f2c313e438" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_039d5350-5eef-4649-8ef3-86e76ee4a163" xlink:to="loc_us-gaap_EmployeeStockOptionMember_2e539c46-1921-4898-aae5-79f2c313e438" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_18a67055-db8b-4830-9edd-e62f8320f96c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_039d5350-5eef-4649-8ef3-86e76ee4a163" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_18a67055-db8b-4830-9edd-e62f8320f96c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_7837052e-580d-40c8-b225-64c6da0f25d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_efd5597d-9535-47eb-a03f-8d0ded539d3d" xlink:to="loc_us-gaap_PlanNameAxis_7837052e-580d-40c8-b225-64c6da0f25d3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_7837052e-580d-40c8-b225-64c6da0f25d3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_7837052e-580d-40c8-b225-64c6da0f25d3" xlink:to="loc_us-gaap_PlanNameDomain_7837052e-580d-40c8-b225-64c6da0f25d3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_c4251752-0d01-4d70-9fd4-4f2c8944b158" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_7837052e-580d-40c8-b225-64c6da0f25d3" xlink:to="loc_us-gaap_PlanNameDomain_c4251752-0d01-4d70-9fd4-4f2c8944b158" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_A2021EquityIncentiveAwardPlanMember_8bdb019e-505a-43a8-9b2a-d6c92ead4167" xlink:href="prct-20220630.xsd#prct_A2021EquityIncentiveAwardPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_c4251752-0d01-4d70-9fd4-4f2c8944b158" xlink:to="loc_prct_A2021EquityIncentiveAwardPlanMember_8bdb019e-505a-43a8-9b2a-d6c92ead4167" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_A2021EmployeeStockPurchasePlanMember_3741e338-c39c-4841-8d5c-9285baae3b9a" xlink:href="prct-20220630.xsd#prct_A2021EmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_c4251752-0d01-4d70-9fd4-4f2c8944b158" xlink:to="loc_prct_A2021EmployeeStockPurchasePlanMember_3741e338-c39c-4841-8d5c-9285baae3b9a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/StockBasedCompensationSummaryofStockOptionActivityDetails" xlink:type="simple" xlink:href="prct-20220630.xsd#StockBasedCompensationSummaryofStockOptionActivityDetails"/>
  <link:definitionLink xlink:role="http://www.procept-biorobotics.com/role/StockBasedCompensationSummaryofStockOptionActivityDetails" xlink:type="extended" id="ib302e6e2455048449d3a810d50063f22_StockBasedCompensationSummaryofStockOptionActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_93a106b9-acb4-4005-940d-73e6169d4626" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a2bfb901-6b5c-4e2d-a6e0-32ec9060c2ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_93a106b9-acb4-4005-940d-73e6169d4626" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a2bfb901-6b5c-4e2d-a6e0-32ec9060c2ae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8bd728d4-1301-4707-943d-0038460add73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a2bfb901-6b5c-4e2d-a6e0-32ec9060c2ae" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8bd728d4-1301-4707-943d-0038460add73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_ee894b73-86a2-48ce-b45a-24b3b6f299c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a2bfb901-6b5c-4e2d-a6e0-32ec9060c2ae" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_ee894b73-86a2-48ce-b45a-24b3b6f299c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3d2f604b-c8af-4e14-be81-e165967646d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a2bfb901-6b5c-4e2d-a6e0-32ec9060c2ae" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3d2f604b-c8af-4e14-be81-e165967646d1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_29b3c898-951c-4385-aaaf-5daf9f02ef36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a2bfb901-6b5c-4e2d-a6e0-32ec9060c2ae" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_29b3c898-951c-4385-aaaf-5daf9f02ef36" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_66a120a4-c4f8-464e-bb2b-f2cb0bd717b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_6968ab23-51e5-49f5-b681-e0f36fdd0d71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_93a106b9-acb4-4005-940d-73e6169d4626" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_6968ab23-51e5-49f5-b681-e0f36fdd0d71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_101c5ebd-753e-4943-b4cb-3a44f972e929" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_93a106b9-acb4-4005-940d-73e6169d4626" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_101c5ebd-753e-4943-b4cb-3a44f972e929" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_d92a5f18-58ba-4a3f-bcf1-48b86802d038" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_93a106b9-acb4-4005-940d-73e6169d4626" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_d92a5f18-58ba-4a3f-bcf1-48b86802d038" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_914a7b3e-4109-4c98-b770-580c5406789c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_d92a5f18-58ba-4a3f-bcf1-48b86802d038" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_914a7b3e-4109-4c98-b770-580c5406789c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_9e68d878-74fa-4195-b0b7-964128dcfc1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_d92a5f18-58ba-4a3f-bcf1-48b86802d038" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_9e68d878-74fa-4195-b0b7-964128dcfc1e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2eb402a0-9889-4739-abcb-9e35d3478dc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_d92a5f18-58ba-4a3f-bcf1-48b86802d038" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2eb402a0-9889-4739-abcb-9e35d3478dc1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_09d1e389-4b5a-46a8-b92d-6f3b72e7186e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_d92a5f18-58ba-4a3f-bcf1-48b86802d038" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_09d1e389-4b5a-46a8-b92d-6f3b72e7186e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_15349d83-14f7-410e-a4b2-b7b508d91ec0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_7151b17d-dd31-46ee-af22-73a97bd10a9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_93a106b9-acb4-4005-940d-73e6169d4626" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_7151b17d-dd31-46ee-af22-73a97bd10a9a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_572159e1-f5aa-4385-b775-857831ec0dd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_93a106b9-acb4-4005-940d-73e6169d4626" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_572159e1-f5aa-4385-b775-857831ec0dd0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_6041e859-ab05-48ee-9296-da0102cf0141" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_93a106b9-acb4-4005-940d-73e6169d4626" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_6041e859-ab05-48ee-9296-da0102cf0141" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_35c33622-babd-4bbb-85ba-1a963ec69307" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_6041e859-ab05-48ee-9296-da0102cf0141" xlink:to="loc_us-gaap_AwardTypeAxis_35c33622-babd-4bbb-85ba-1a963ec69307" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_35c33622-babd-4bbb-85ba-1a963ec69307_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_35c33622-babd-4bbb-85ba-1a963ec69307" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_35c33622-babd-4bbb-85ba-1a963ec69307_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1ae95c1c-fa05-4438-98e2-55e7772cc39c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_35c33622-babd-4bbb-85ba-1a963ec69307" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1ae95c1c-fa05-4438-98e2-55e7772cc39c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_6909c176-b784-4b63-b218-d71e1e3a1277" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1ae95c1c-fa05-4438-98e2-55e7772cc39c" xlink:to="loc_us-gaap_EmployeeStockOptionMember_6909c176-b784-4b63-b218-d71e1e3a1277" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/StockBasedCompensationFairValueAssumptionsDetails" xlink:type="simple" xlink:href="prct-20220630.xsd#StockBasedCompensationFairValueAssumptionsDetails"/>
  <link:definitionLink xlink:role="http://www.procept-biorobotics.com/role/StockBasedCompensationFairValueAssumptionsDetails" xlink:type="extended" id="i19cd9f13478347918dc43da78930b35a_StockBasedCompensationFairValueAssumptionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c60d3db9-4287-4f0c-97d5-1e8de69359f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_ad14293f-2c65-4a15-8539-5ec4b0fbd555" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c60d3db9-4287-4f0c-97d5-1e8de69359f8" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_ad14293f-2c65-4a15-8539-5ec4b0fbd555" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_0db64a83-a72e-40c6-97a4-f3d9071d1abd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c60d3db9-4287-4f0c-97d5-1e8de69359f8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_0db64a83-a72e-40c6-97a4-f3d9071d1abd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_ea2a4379-866e-4811-a3d7-7154fb1d6c85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c60d3db9-4287-4f0c-97d5-1e8de69359f8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_ea2a4379-866e-4811-a3d7-7154fb1d6c85" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_ac34bc8f-6972-4d29-8a52-aa1ac9ecfd77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c60d3db9-4287-4f0c-97d5-1e8de69359f8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_ac34bc8f-6972-4d29-8a52-aa1ac9ecfd77" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_b44f8d09-5e16-484d-8800-c5d54353d5c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c60d3db9-4287-4f0c-97d5-1e8de69359f8" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_b44f8d09-5e16-484d-8800-c5d54353d5c1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ebcb5951-9da0-4e63-8a1a-e0c757a31b22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c60d3db9-4287-4f0c-97d5-1e8de69359f8" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ebcb5951-9da0-4e63-8a1a-e0c757a31b22" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6d41f917-f152-4c4d-8cdc-f24dddbf368d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ebcb5951-9da0-4e63-8a1a-e0c757a31b22" xlink:to="loc_us-gaap_AwardTypeAxis_6d41f917-f152-4c4d-8cdc-f24dddbf368d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6d41f917-f152-4c4d-8cdc-f24dddbf368d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_6d41f917-f152-4c4d-8cdc-f24dddbf368d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6d41f917-f152-4c4d-8cdc-f24dddbf368d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_71b5ef75-a038-498a-b057-868c2393b58c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_6d41f917-f152-4c4d-8cdc-f24dddbf368d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_71b5ef75-a038-498a-b057-868c2393b58c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_a2e18cf5-f38b-4242-8213-c8aeecb3d63b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_71b5ef75-a038-498a-b057-868c2393b58c" xlink:to="loc_us-gaap_EmployeeStockOptionMember_a2e18cf5-f38b-4242-8213-c8aeecb3d63b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_4ed41c45-a2cb-4f94-a8aa-c1b27d0dc9d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ebcb5951-9da0-4e63-8a1a-e0c757a31b22" xlink:to="loc_us-gaap_PlanNameAxis_4ed41c45-a2cb-4f94-a8aa-c1b27d0dc9d7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_4ed41c45-a2cb-4f94-a8aa-c1b27d0dc9d7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_4ed41c45-a2cb-4f94-a8aa-c1b27d0dc9d7" xlink:to="loc_us-gaap_PlanNameDomain_4ed41c45-a2cb-4f94-a8aa-c1b27d0dc9d7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_d856cdb4-680b-43f6-a3e6-4d50858ea073" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_4ed41c45-a2cb-4f94-a8aa-c1b27d0dc9d7" xlink:to="loc_us-gaap_PlanNameDomain_d856cdb4-680b-43f6-a3e6-4d50858ea073" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_A2021EmployeeStockPurchasePlanMember_e6bf9cd0-7321-49ee-8533-9b47d26499c6" xlink:href="prct-20220630.xsd#prct_A2021EmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_d856cdb4-680b-43f6-a3e6-4d50858ea073" xlink:to="loc_prct_A2021EmployeeStockPurchasePlanMember_e6bf9cd0-7321-49ee-8533-9b47d26499c6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/StockBasedCompensationRestrictedStockUnitDetails" xlink:type="simple" xlink:href="prct-20220630.xsd#StockBasedCompensationRestrictedStockUnitDetails"/>
  <link:definitionLink xlink:role="http://www.procept-biorobotics.com/role/StockBasedCompensationRestrictedStockUnitDetails" xlink:type="extended" id="i1499f884ff2e48d1a777310d05ffd8ad_StockBasedCompensationRestrictedStockUnitDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6392276f-10a3-4373-b591-d7ef9015a256" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9b6631b2-dac8-41af-8f62-39ae708076df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6392276f-10a3-4373-b591-d7ef9015a256" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9b6631b2-dac8-41af-8f62-39ae708076df" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5c9d4fca-5fbe-4d68-bf0c-45fa5dc0c9a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9b6631b2-dac8-41af-8f62-39ae708076df" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5c9d4fca-5fbe-4d68-bf0c-45fa5dc0c9a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_6678f6e0-0b65-4b5a-a1f5-fbecaba83e0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9b6631b2-dac8-41af-8f62-39ae708076df" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_6678f6e0-0b65-4b5a-a1f5-fbecaba83e0a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_862cf5f9-a162-405d-a643-76387ea6525c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9b6631b2-dac8-41af-8f62-39ae708076df" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_862cf5f9-a162-405d-a643-76387ea6525c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1c445a6e-002e-418c-aaf7-690275bec195" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ac391d89-e1f8-4420-939c-69acce99c758" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6392276f-10a3-4373-b591-d7ef9015a256" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ac391d89-e1f8-4420-939c-69acce99c758" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b65c3eb0-a9c5-4753-b5e2-64764d8550af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ac391d89-e1f8-4420-939c-69acce99c758" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b65c3eb0-a9c5-4753-b5e2-64764d8550af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_33d08861-5ad0-40ed-869e-b27e163306de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ac391d89-e1f8-4420-939c-69acce99c758" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_33d08861-5ad0-40ed-869e-b27e163306de" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_dbfd814c-d99a-4a14-884e-3036183e11d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ac391d89-e1f8-4420-939c-69acce99c758" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_dbfd814c-d99a-4a14-884e-3036183e11d8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_70ecc610-3766-4056-9db2-d4731b0b9dac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_322b6828-2626-43bb-a947-dc97605bfdaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6392276f-10a3-4373-b591-d7ef9015a256" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_322b6828-2626-43bb-a947-dc97605bfdaf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_19edab67-8524-495b-9255-cc5fa7695512" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_322b6828-2626-43bb-a947-dc97605bfdaf" xlink:to="loc_us-gaap_AwardTypeAxis_19edab67-8524-495b-9255-cc5fa7695512" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_19edab67-8524-495b-9255-cc5fa7695512_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_19edab67-8524-495b-9255-cc5fa7695512" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_19edab67-8524-495b-9255-cc5fa7695512_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5af78e8a-5585-43d0-829a-db9534b347f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_19edab67-8524-495b-9255-cc5fa7695512" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5af78e8a-5585-43d0-829a-db9534b347f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_b8d670a9-12ff-4f6a-9836-a33b1c030c58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5af78e8a-5585-43d0-829a-db9534b347f6" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_b8d670a9-12ff-4f6a-9836-a33b1c030c58" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/StockBasedCompensationStockbasedCompensationDetails" xlink:type="simple" xlink:href="prct-20220630.xsd#StockBasedCompensationStockbasedCompensationDetails"/>
  <link:definitionLink xlink:role="http://www.procept-biorobotics.com/role/StockBasedCompensationStockbasedCompensationDetails" xlink:type="extended" id="i807a8644b1b841ebaf6d64ab72a15ddf_StockBasedCompensationStockbasedCompensationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_431e7e55-ae42-4569-a7a6-77063da67e73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_f35e513a-cccf-4d26-9b0f-e9547b9b5999" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_431e7e55-ae42-4569-a7a6-77063da67e73" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_f35e513a-cccf-4d26-9b0f-e9547b9b5999" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3c68a22b-79aa-4210-affc-ec46806a8005" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_431e7e55-ae42-4569-a7a6-77063da67e73" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3c68a22b-79aa-4210-affc-ec46806a8005" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_fe972de9-8236-4b79-b5e4-6934018401e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3c68a22b-79aa-4210-affc-ec46806a8005" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_fe972de9-8236-4b79-b5e4-6934018401e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_fe972de9-8236-4b79-b5e4-6934018401e2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_fe972de9-8236-4b79-b5e4-6934018401e2" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_fe972de9-8236-4b79-b5e4-6934018401e2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_982766bf-e02c-458d-a8a8-02416793bff7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_fe972de9-8236-4b79-b5e4-6934018401e2" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_982766bf-e02c-458d-a8a8-02416793bff7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_7b22c7e5-e42b-49fc-83d8-de5e49458eaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_982766bf-e02c-458d-a8a8-02416793bff7" xlink:to="loc_us-gaap_CostOfSalesMember_7b22c7e5-e42b-49fc-83d8-de5e49458eaa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_ac713c59-a99f-4b88-a7c6-dc289914d387" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_982766bf-e02c-458d-a8a8-02416793bff7" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_ac713c59-a99f-4b88-a7c6-dc289914d387" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_7e21d64a-aa47-408f-9f7a-f150a61e8853" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_982766bf-e02c-458d-a8a8-02416793bff7" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_7e21d64a-aa47-408f-9f7a-f150a61e8853" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/NetLossPerSharePotentiallyDilutiveSecuritiesDetails" xlink:type="simple" xlink:href="prct-20220630.xsd#NetLossPerSharePotentiallyDilutiveSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.procept-biorobotics.com/role/NetLossPerSharePotentiallyDilutiveSecuritiesDetails" xlink:type="extended" id="i2731383d20a84c489829367220e890d9_NetLossPerSharePotentiallyDilutiveSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_7e5be3a5-2dbb-4e5e-9a58-4c3758009462" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1b4e6652-e2e7-4da7-a051-84fbcfa99283" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_7e5be3a5-2dbb-4e5e-9a58-4c3758009462" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1b4e6652-e2e7-4da7-a051-84fbcfa99283" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_efb5206c-3883-484a-bd51-ae3fdaaa0e29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_7e5be3a5-2dbb-4e5e-9a58-4c3758009462" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_efb5206c-3883-484a-bd51-ae3fdaaa0e29" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_eb3b41f3-fc07-490d-85d3-2c727f8712b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_efb5206c-3883-484a-bd51-ae3fdaaa0e29" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_eb3b41f3-fc07-490d-85d3-2c727f8712b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_eb3b41f3-fc07-490d-85d3-2c727f8712b1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_eb3b41f3-fc07-490d-85d3-2c727f8712b1" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_eb3b41f3-fc07-490d-85d3-2c727f8712b1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a83ce520-7e37-4834-9980-c24f6a8831da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_eb3b41f3-fc07-490d-85d3-2c727f8712b1" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a83ce520-7e37-4834-9980-c24f6a8831da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableConvertiblePreferredStockMember_02c0fbc1-e656-45d8-bcd9-1bbd874de8ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a83ce520-7e37-4834-9980-c24f6a8831da" xlink:to="loc_us-gaap_RedeemableConvertiblePreferredStockMember_02c0fbc1-e656-45d8-bcd9-1bbd874de8ee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_RedeemableConvertiblePreferredStockWarrantsMember_5aab20e3-2cee-4468-a732-eef6bd6999c6" xlink:href="prct-20220630.xsd#prct_RedeemableConvertiblePreferredStockWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a83ce520-7e37-4834-9980-c24f6a8831da" xlink:to="loc_prct_RedeemableConvertiblePreferredStockWarrantsMember_5aab20e3-2cee-4468-a732-eef6bd6999c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_860987d7-9c06-4ac3-8f2e-fd4d8cdf04f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a83ce520-7e37-4834-9980-c24f6a8831da" xlink:to="loc_us-gaap_EmployeeStockOptionMember_860987d7-9c06-4ac3-8f2e-fd4d8cdf04f5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_16d5457f-3b41-4c8f-a387-385078d635b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a83ce520-7e37-4834-9980-c24f6a8831da" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_16d5457f-3b41-4c8f-a387-385078d635b6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_A2021EmployeeStockPurchasePlanMember_040327f7-20d7-4049-9403-4cb62b959472" xlink:href="prct-20220630.xsd#prct_A2021EmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a83ce520-7e37-4834-9980-c24f6a8831da" xlink:to="loc_prct_A2021EmployeeStockPurchasePlanMember_040327f7-20d7-4049-9403-4cb62b959472" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/RevenueDetails" xlink:type="simple" xlink:href="prct-20220630.xsd#RevenueDetails"/>
  <link:definitionLink xlink:role="http://www.procept-biorobotics.com/role/RevenueDetails" xlink:type="extended" id="ic8b4edfdbac14c898c2cf1511a117834_RevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_958d9bbf-a138-4417-a0c8-5ac1f36d1219" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d7726638-89c9-4617-b0ff-ec7b54591e44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_958d9bbf-a138-4417-a0c8-5ac1f36d1219" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d7726638-89c9-4617-b0ff-ec7b54591e44" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_a13a4068-c872-4760-8a40-ee407807c165" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_958d9bbf-a138-4417-a0c8-5ac1f36d1219" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_a13a4068-c872-4760-8a40-ee407807c165" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_c3309026-9fe8-4a62-9e99-d94f02b3b172" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_a13a4068-c872-4760-8a40-ee407807c165" xlink:to="loc_srt_ProductOrServiceAxis_c3309026-9fe8-4a62-9e99-d94f02b3b172" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c3309026-9fe8-4a62-9e99-d94f02b3b172_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_c3309026-9fe8-4a62-9e99-d94f02b3b172" xlink:to="loc_srt_ProductsAndServicesDomain_c3309026-9fe8-4a62-9e99-d94f02b3b172_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_cfe642e6-30ee-4574-ad3c-b7881c17bda7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_c3309026-9fe8-4a62-9e99-d94f02b3b172" xlink:to="loc_srt_ProductsAndServicesDomain_cfe642e6-30ee-4574-ad3c-b7881c17bda7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_SystemSalesAndRentalsMember_bb8d3a39-049f-4fbe-aba4-a8244d922952" xlink:href="prct-20220630.xsd#prct_SystemSalesAndRentalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_cfe642e6-30ee-4574-ad3c-b7881c17bda7" xlink:to="loc_prct_SystemSalesAndRentalsMember_bb8d3a39-049f-4fbe-aba4-a8244d922952" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_HandPiecesAndOtherConsumablesMember_3359452c-dc32-4f62-8c29-c8ea14562e02" xlink:href="prct-20220630.xsd#prct_HandPiecesAndOtherConsumablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_cfe642e6-30ee-4574-ad3c-b7881c17bda7" xlink:to="loc_prct_HandPiecesAndOtherConsumablesMember_3359452c-dc32-4f62-8c29-c8ea14562e02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_ServiceRevenueMember_19b38bc8-3298-476a-af4c-19647d81f1b2" xlink:href="prct-20220630.xsd#prct_ServiceRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_cfe642e6-30ee-4574-ad3c-b7881c17bda7" xlink:to="loc_prct_ServiceRevenueMember_19b38bc8-3298-476a-af4c-19647d81f1b2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_9f9d1c31-34c7-4fd7-9066-702e1d17281a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_a13a4068-c872-4760-8a40-ee407807c165" xlink:to="loc_srt_StatementGeographicalAxis_9f9d1c31-34c7-4fd7-9066-702e1d17281a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_9f9d1c31-34c7-4fd7-9066-702e1d17281a_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_9f9d1c31-34c7-4fd7-9066-702e1d17281a" xlink:to="loc_srt_SegmentGeographicalDomain_9f9d1c31-34c7-4fd7-9066-702e1d17281a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_67f0f99a-e8e7-4f49-b1b6-ad5abec71d8e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_9f9d1c31-34c7-4fd7-9066-702e1d17281a" xlink:to="loc_srt_SegmentGeographicalDomain_67f0f99a-e8e7-4f49-b1b6-ad5abec71d8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_930b3f82-df86-41e9-ab84-6db494747144" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_67f0f99a-e8e7-4f49-b1b6-ad5abec71d8e" xlink:to="loc_country_US_930b3f82-df86-41e9-ab84-6db494747144" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_OutsideTheUnitedStatesMember_8af62fae-262c-41c2-9e7a-3ed8e0ac9c49" xlink:href="prct-20220630.xsd#prct_OutsideTheUnitedStatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_67f0f99a-e8e7-4f49-b1b6-ad5abec71d8e" xlink:to="loc_prct_OutsideTheUnitedStatesMember_8af62fae-262c-41c2-9e7a-3ed8e0ac9c49" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/SegmentGeographicalandCustomerConcentrationDetails" xlink:type="simple" xlink:href="prct-20220630.xsd#SegmentGeographicalandCustomerConcentrationDetails"/>
  <link:definitionLink xlink:role="http://www.procept-biorobotics.com/role/SegmentGeographicalandCustomerConcentrationDetails" xlink:type="extended" id="ie75826586a944ce2931132faded952f7_SegmentGeographicalandCustomerConcentrationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_c47111ab-b5b5-4826-a494-e45053100225" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_b5135b51-edb1-46fc-bc16-8cff90bf24d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_c47111ab-b5b5-4826-a494-e45053100225" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_b5135b51-edb1-46fc-bc16-8cff90bf24d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_a527ee9e-5047-497d-8b1d-00fbcc1525b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_c47111ab-b5b5-4826-a494-e45053100225" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_a527ee9e-5047-497d-8b1d-00fbcc1525b2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_3abda6f3-0fa8-454a-8f0a-e9d68a5c13fa" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_a527ee9e-5047-497d-8b1d-00fbcc1525b2" xlink:to="loc_srt_MajorCustomersAxis_3abda6f3-0fa8-454a-8f0a-e9d68a5c13fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_3abda6f3-0fa8-454a-8f0a-e9d68a5c13fa_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_3abda6f3-0fa8-454a-8f0a-e9d68a5c13fa" xlink:to="loc_srt_NameOfMajorCustomerDomain_3abda6f3-0fa8-454a-8f0a-e9d68a5c13fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_98bf562f-f309-4779-86ee-270fe73352aa" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_3abda6f3-0fa8-454a-8f0a-e9d68a5c13fa" xlink:to="loc_srt_NameOfMajorCustomerDomain_98bf562f-f309-4779-86ee-270fe73352aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_Customer1Member_ad7b0008-7692-4895-aebd-133cd1c37adb" xlink:href="prct-20220630.xsd#prct_Customer1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_98bf562f-f309-4779-86ee-270fe73352aa" xlink:to="loc_prct_Customer1Member_ad7b0008-7692-4895-aebd-133cd1c37adb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_8e45b23c-e657-4b81-b697-2028910f0e36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_a527ee9e-5047-497d-8b1d-00fbcc1525b2" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_8e45b23c-e657-4b81-b697-2028910f0e36" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_8e45b23c-e657-4b81-b697-2028910f0e36_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_8e45b23c-e657-4b81-b697-2028910f0e36" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_8e45b23c-e657-4b81-b697-2028910f0e36_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_0a573617-e68a-40b9-a2a4-cd757228ec1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_8e45b23c-e657-4b81-b697-2028910f0e36" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_0a573617-e68a-40b9-a2a4-cd757228ec1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_5d421ed5-6aac-48bb-8bef-d08694d3225a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_0a573617-e68a-40b9-a2a4-cd757228ec1a" xlink:to="loc_us-gaap_AccountsReceivableMember_5d421ed5-6aac-48bb-8bef-d08694d3225a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_64ba95b3-4c6c-4371-bebe-bf24f12dc74d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_0a573617-e68a-40b9-a2a4-cd757228ec1a" xlink:to="loc_us-gaap_SalesRevenueNetMember_64ba95b3-4c6c-4371-bebe-bf24f12dc74d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_ac3d236c-dd1d-4ebc-b638-ba57eb0ad99c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_a527ee9e-5047-497d-8b1d-00fbcc1525b2" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_ac3d236c-dd1d-4ebc-b638-ba57eb0ad99c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_ac3d236c-dd1d-4ebc-b638-ba57eb0ad99c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_ac3d236c-dd1d-4ebc-b638-ba57eb0ad99c" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_ac3d236c-dd1d-4ebc-b638-ba57eb0ad99c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_8a3aed20-cbaf-46cd-9cf0-9d2a9b1f58bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_ac3d236c-dd1d-4ebc-b638-ba57eb0ad99c" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_8a3aed20-cbaf-46cd-9cf0-9d2a9b1f58bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_c657677f-51dc-4abf-bbfc-147efc65d209" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_8a3aed20-cbaf-46cd-9cf0-9d2a9b1f58bb" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_c657677f-51dc-4abf-bbfc-147efc65d209" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember_a988b996-ea26-473b-b884-e4c4a8a6f1d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_8a3aed20-cbaf-46cd-9cf0-9d2a9b1f58bb" xlink:to="loc_us-gaap_GeographicConcentrationRiskMember_a988b996-ea26-473b-b884-e4c4a8a6f1d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_355b97a2-6380-44bb-aeaa-d829cd98c45b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_a527ee9e-5047-497d-8b1d-00fbcc1525b2" xlink:to="loc_srt_StatementGeographicalAxis_355b97a2-6380-44bb-aeaa-d829cd98c45b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_355b97a2-6380-44bb-aeaa-d829cd98c45b_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_355b97a2-6380-44bb-aeaa-d829cd98c45b" xlink:to="loc_srt_SegmentGeographicalDomain_355b97a2-6380-44bb-aeaa-d829cd98c45b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_3aa995ea-937a-480b-b4a2-51fef0051c4e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_355b97a2-6380-44bb-aeaa-d829cd98c45b" xlink:to="loc_srt_SegmentGeographicalDomain_3aa995ea-937a-480b-b4a2-51fef0051c4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_1d6f1eca-341d-47b6-a70f-8ead07850e85" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_3aa995ea-937a-480b-b4a2-51fef0051c4e" xlink:to="loc_country_US_1d6f1eca-341d-47b6-a70f-8ead07850e85" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_OutsideTheUnitedStatesMember_0735c848-18bd-41dd-99fb-1c43c1dcbeb9" xlink:href="prct-20220630.xsd#prct_OutsideTheUnitedStatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_3aa995ea-937a-480b-b4a2-51fef0051c4e" xlink:to="loc_prct_OutsideTheUnitedStatesMember_0735c848-18bd-41dd-99fb-1c43c1dcbeb9" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="simple" xlink:href="prct-20220630.xsd#CommitmentsandContingenciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.procept-biorobotics.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="extended" id="i77b01d27b3fb4a5c9eb6282a7f96cd2e_CommitmentsandContingenciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_d81719db-e2ae-45fe-993b-97524c61a029" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_OperatingLeaseNumberOfBuildings_b998ada6-8148-4e58-b918-365bf4e1e109" xlink:href="prct-20220630.xsd#prct_OperatingLeaseNumberOfBuildings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_d81719db-e2ae-45fe-993b-97524c61a029" xlink:to="loc_prct_OperatingLeaseNumberOfBuildings_b998ada6-8148-4e58-b918-365bf4e1e109" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_OperatingLeaseNumberOfSquareFeet_7c41c9f1-068c-4549-93fb-947264fe07fe" xlink:href="prct-20220630.xsd#prct_OperatingLeaseNumberOfSquareFeet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_d81719db-e2ae-45fe-993b-97524c61a029" xlink:to="loc_prct_OperatingLeaseNumberOfSquareFeet_7c41c9f1-068c-4549-93fb-947264fe07fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_LesseeOperatingLeaseNumberOfRenewalOptions_e98403be-3da1-4d7f-b322-9d7be9748f97" xlink:href="prct-20220630.xsd#prct_LesseeOperatingLeaseNumberOfRenewalOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_d81719db-e2ae-45fe-993b-97524c61a029" xlink:to="loc_prct_LesseeOperatingLeaseNumberOfRenewalOptions_e98403be-3da1-4d7f-b322-9d7be9748f97" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_OperatingLeaseAnnualBaseRentYearOne_b28e276a-24bd-45dc-a2cb-af4d50528f66" xlink:href="prct-20220630.xsd#prct_OperatingLeaseAnnualBaseRentYearOne"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_d81719db-e2ae-45fe-993b-97524c61a029" xlink:to="loc_prct_OperatingLeaseAnnualBaseRentYearOne_b28e276a-24bd-45dc-a2cb-af4d50528f66" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_OperatingLeaseAnnualBaseRentYearTen_5ba87cb2-532a-4857-b75f-c23ad2782324" xlink:href="prct-20220630.xsd#prct_OperatingLeaseAnnualBaseRentYearTen"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_d81719db-e2ae-45fe-993b-97524c61a029" xlink:to="loc_prct_OperatingLeaseAnnualBaseRentYearTen_5ba87cb2-532a-4857-b75f-c23ad2782324" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_6e9d123f-f91e-43db-8b2f-e32c364d48e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_d81719db-e2ae-45fe-993b-97524c61a029" xlink:to="loc_us-gaap_OperatingLeaseLiability_6e9d123f-f91e-43db-8b2f-e32c364d48e3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_LesseeOperatingLeaseReceivableAllowanceForTenantImprovements_92bd8d7c-b527-4955-8f3b-f0e8d3a475b2" xlink:href="prct-20220630.xsd#prct_LesseeOperatingLeaseReceivableAllowanceForTenantImprovements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_d81719db-e2ae-45fe-993b-97524c61a029" xlink:to="loc_prct_LesseeOperatingLeaseReceivableAllowanceForTenantImprovements_92bd8d7c-b527-4955-8f3b-f0e8d3a475b2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable_e41f4ffb-15ec-4105-9b50-5007b48e0e30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_d81719db-e2ae-45fe-993b-97524c61a029" xlink:to="loc_us-gaap_OtherCommitmentsTable_e41f4ffb-15ec-4105-9b50-5007b48e0e30" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5fdec19c-b9c5-4691-af8f-132e6f898825" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_e41f4ffb-15ec-4105-9b50-5007b48e0e30" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5fdec19c-b9c5-4691-af8f-132e6f898825" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_5fdec19c-b9c5-4691-af8f-132e6f898825_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5fdec19c-b9c5-4691-af8f-132e6f898825" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_5fdec19c-b9c5-4691-af8f-132e6f898825_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_02ba8c8e-6fe9-4270-b377-30199776d662" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5fdec19c-b9c5-4691-af8f-132e6f898825" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_02ba8c8e-6fe9-4270-b377-30199776d662" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_ed53485d-511f-4b9b-a646-f56d6b82c38c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_02ba8c8e-6fe9-4270-b377-30199776d662" xlink:to="loc_us-gaap_BuildingMember_ed53485d-511f-4b9b-a646-f56d6b82c38c" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>prct-20220630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:311bf6b2-ae92-4a64-91ca-35c82a3f09ce,g:4b68a96a-367b-4d30-a7c4-4a5adc893ec2-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_prct_LoanFacilityMember_8ebe2cbf-64a1-4327-ae99-6f7582aef58b_terseLabel_en-US" xlink:label="lab_prct_LoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan Facility</link:label>
    <link:label id="lab_prct_LoanFacilityMember_label_en-US" xlink:label="lab_prct_LoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan Facility [Member]</link:label>
    <link:label id="lab_prct_LoanFacilityMember_documentation_en-US" xlink:label="lab_prct_LoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan Facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_LoanFacilityMember" xlink:href="prct-20220630.xsd#prct_LoanFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_LoanFacilityMember" xlink:to="lab_prct_LoanFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_9f6521dc-77d8-4bb1-9baf-dc9c2cc3ee69_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental cash flow information</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_8c05ec5a-07d4-4eda-a12b-8ac43dab9b8c_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcess_27c5efe7-f88b-41b2-bc5e-10d5c61c9f1d_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcess" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work-in-process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcess_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcess" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcess" xlink:to="lab_us-gaap_InventoryWorkInProcess" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_OperatingLeaseLiabilityAndLongTermDebtCurrent_532ef7fd-9e49-435f-ba76-04b1c5dc54d9_negatedTerseLabel_en-US" xlink:label="lab_prct_OperatingLeaseLiabilityAndLongTermDebtCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: current portion</link:label>
    <link:label id="lab_prct_OperatingLeaseLiabilityAndLongTermDebtCurrent_label_en-US" xlink:label="lab_prct_OperatingLeaseLiabilityAndLongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Liability and Long-Term Debt, Current</link:label>
    <link:label id="lab_prct_OperatingLeaseLiabilityAndLongTermDebtCurrent_documentation_en-US" xlink:label="lab_prct_OperatingLeaseLiabilityAndLongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Liability and Long-Term Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_OperatingLeaseLiabilityAndLongTermDebtCurrent" xlink:href="prct-20220630.xsd#prct_OperatingLeaseLiabilityAndLongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_OperatingLeaseLiabilityAndLongTermDebtCurrent" xlink:to="lab_prct_OperatingLeaseLiabilityAndLongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6435ecb3-994c-49f4-ad34-c49481b6c5d2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_27be8f82-af20-443f-9d6f-f24daff56bff_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_3ddaefdb-b884-47c1-9b08-551c59faa974_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_448a2e7d-e135-4ac4-b253-e43d917f36c0_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_LineOfCreditFacilityGainLossOnAmendmentOfDebtTerms_89765b2f-f737-4fd5-8814-4298f3a29db4_terseLabel_en-US" xlink:label="lab_prct_LineOfCreditFacilityGainLossOnAmendmentOfDebtTerms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on amendment of debt terms</link:label>
    <link:label id="lab_prct_LineOfCreditFacilityGainLossOnAmendmentOfDebtTerms_label_en-US" xlink:label="lab_prct_LineOfCreditFacilityGainLossOnAmendmentOfDebtTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Gain (Loss) on Amendment of Debt Terms</link:label>
    <link:label id="lab_prct_LineOfCreditFacilityGainLossOnAmendmentOfDebtTerms_documentation_en-US" xlink:label="lab_prct_LineOfCreditFacilityGainLossOnAmendmentOfDebtTerms" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Gain (Loss) on Amendment of Debt Terms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_LineOfCreditFacilityGainLossOnAmendmentOfDebtTerms" xlink:href="prct-20220630.xsd#prct_LineOfCreditFacilityGainLossOnAmendmentOfDebtTerms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_LineOfCreditFacilityGainLossOnAmendmentOfDebtTerms" xlink:to="lab_prct_LineOfCreditFacilityGainLossOnAmendmentOfDebtTerms" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_d85f6c54-1b15-4ab7-baae-4c59630b1329_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets, net</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_53ece7ef-6b0e-4a32-bda4-852cfbf7c789_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityRemainderOfFiscalYear_c01c87e8-d2f9-4ee2-b7cd-0930ef68e052_terseLabel_en-US" xlink:label="lab_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityRemainderOfFiscalYear_label_en-US" xlink:label="lab_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Liability and Long-Term Debt Maturity, Remainder of Fiscal year</link:label>
    <link:label id="lab_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityRemainderOfFiscalYear_documentation_en-US" xlink:label="lab_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Liability and Long-Term Debt Maturity, Remainder of Fiscal year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityRemainderOfFiscalYear" xlink:href="prct-20220630.xsd#prct_OperatingLeaseLiabilityAndLongTermDebtMaturityRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityRemainderOfFiscalYear" xlink:to="lab_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_84dae2af-a132-4633-9c09-3f36872ac8fe_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_184e6721-b55f-47cf-8fb1-af8e4b6a9230_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_1aff249e-0073-4f92-812a-5a6a45a40f07_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_ce1f7fd4-dd49-481d-ab70-e7df0072a6c8_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan facility derivative liability</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_580adc77-0019-41ea-a115-e4a37e77295a_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_e976da75-6c5a-493e-9bf5-3858bf4651c3_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_4b144d7c-3ff0-49f4-b88f-40596076f973_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in dollars per shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_InitialPublicOfferingAbstract_31021338-e4bf-4ae0-b292-d222ba712067_terseLabel_en-US" xlink:label="lab_prct_InitialPublicOfferingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Public Offering</link:label>
    <link:label id="lab_prct_InitialPublicOfferingAbstract_label_en-US" xlink:label="lab_prct_InitialPublicOfferingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Public Offering [Abstract]</link:label>
    <link:label id="lab_prct_InitialPublicOfferingAbstract_documentation_en-US" xlink:label="lab_prct_InitialPublicOfferingAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Public Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_InitialPublicOfferingAbstract" xlink:href="prct-20220630.xsd#prct_InitialPublicOfferingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_InitialPublicOfferingAbstract" xlink:to="lab_prct_InitialPublicOfferingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_LesseeOperatingLeaseNumberOfRenewalOptions_a8110bf9-a530-491d-865e-b139ad988bdc_terseLabel_en-US" xlink:label="lab_prct_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of renewal options</link:label>
    <link:label id="lab_prct_LesseeOperatingLeaseNumberOfRenewalOptions_label_en-US" xlink:label="lab_prct_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Number Of Renewal Options</link:label>
    <link:label id="lab_prct_LesseeOperatingLeaseNumberOfRenewalOptions_documentation_en-US" xlink:label="lab_prct_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Number Of Renewal Options</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:href="prct-20220630.xsd#prct_LesseeOperatingLeaseNumberOfRenewalOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:to="lab_prct_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_cdb66a4b-5407-4183-a4d6-5113d2845dc9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_08f1dccc-911e-4969-8674-cdbb722fc184_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at the beginning of the period (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_59a4e8c5-e906-4bce-8136-60d5433e697c_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at the end of the period (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_label_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesOutstanding" xlink:to="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_e7773a29-9764-450c-939a-ad17a4b83f1e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_94354d77-9520-44fa-8fdf-91ce3d06e74f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedSalaries_323a3319-9b87-4788-b42e-eb0e9997c639_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedSalaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedSalaries_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedSalaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Salaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedSalaries" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedSalaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedSalaries" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedSalaries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_ebda4936-a71e-4eb0-a4e0-a90763ff9fb3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected dividend rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_d09ffbdc-3c58-4377-94e4-f7a52529b5ae_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available for grant (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5601aaf1-3bbb-454a-baad-f83b8c7ba185_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (decrease) increase in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_09bac80f-6299-47d8-8918-536333554466_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2b097441-df10-4b8b-ab31-b185e51f217e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_55c5e93d-b97f-4925-9b82-9533d92ca98c_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_bf8c8550-2dd0-45e2-9206-7607ee3bdfee_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised in the period, intrinsic value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_526ae457-47bd-4261-8846-49a5decc0155_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_6ff5ec48-8089-44a3-a28a-538e1e218402_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaturitiesOfLongTermDebtAbstract_e6fb26d2-a2b6-45bb-8582-b1c75eeb6386_terseLabel_en-US" xlink:label="lab_us-gaap_MaturitiesOfLongTermDebtAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Repayments</link:label>
    <link:label id="lab_us-gaap_MaturitiesOfLongTermDebtAbstract_label_en-US" xlink:label="lab_us-gaap_MaturitiesOfLongTermDebtAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of Long-term Debt [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaturitiesOfLongTermDebtAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MaturitiesOfLongTermDebtAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaturitiesOfLongTermDebtAbstract" xlink:to="lab_us-gaap_MaturitiesOfLongTermDebtAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_ef4cb4f3-3bcc-4d16-97a3-2e2ff0721ba7_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueDomain" xlink:to="lab_us-gaap_ValuationTechniqueDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_93a67a2a-ac25-48da-a487-e67c447b998d_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive securities excluded from computation of earnings per share, amount (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_7fd873e5-4e72-4236-b911-679ba15cba54_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_LoanFacilityTrancheTwoMember_e83e9adc-c43a-499e-91dd-03e38527977d_terseLabel_en-US" xlink:label="lab_prct_LoanFacilityTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan Facility, Tranche Two</link:label>
    <link:label id="lab_prct_LoanFacilityTrancheTwoMember_label_en-US" xlink:label="lab_prct_LoanFacilityTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan Facility, Tranche Two [Member]</link:label>
    <link:label id="lab_prct_LoanFacilityTrancheTwoMember_documentation_en-US" xlink:label="lab_prct_LoanFacilityTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan Facility, Tranche Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_LoanFacilityTrancheTwoMember" xlink:href="prct-20220630.xsd#prct_LoanFacilityTrancheTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_LoanFacilityTrancheTwoMember" xlink:to="lab_prct_LoanFacilityTrancheTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_4b20531d-c9a4-489a-b986-c37b521152d1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Liabilities at Fair Value</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Liabilities at Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_e9931085-5513-4902-b577-87c22babc3cd_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_7fdd6ca7-f86c-426c-8be7-bf1fb0338f12_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingMember_384ec5ab-fdd9-45cd-a99a-b66b9cc14174_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building</link:label>
    <link:label id="lab_us-gaap_BuildingMember_label_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingMember" xlink:to="lab_us-gaap_BuildingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_952ec273-6bad-46dd-b97a-3993f93ec71f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awarded (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_fd233a6e-a59b-49d8-a156-d0a0bd4f0ae2_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment fee percentage</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInterestPayableNet_68827314-443a-4a15-8d4a-a77a09f2b7d2_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest expense</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInterestPayableNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Interest Payable, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInterestPayableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:to="lab_us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0e091c6f-d96d-4742-9cf8-d665ceb332ec_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_9fe154b9-1deb-4dd1-9a92-75c69695e277_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_4abb2d33-d5f4-44bd-8fd8-032897f91158_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_9336269c-f44e-4ebc-a2bc-bb286bf43b51_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c98dc56a-3401-4143-9299-29f7ffae7bcf_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_98e33f38-49dd-4fc2-b867-0632b7cacde0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_b50d4f2a-b95a-44c7-89b2-4ae5d17b654c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_bef22018-13ff-4e0f-9c5b-9615a238147a_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue by significant geographical locations outside the United States, percent</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_542a3662-a2da-48ed-95bb-47c554a9ce8d_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c483b229-ba3a-4ae3-950b-281914377c77_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at the beginning of the period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_123c692b-1d75-4824-b4b7-3ced1485b861_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at the end of the period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_8f124c66-62e7-4226-bbea-9b51bfe8b63a_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IPOMember_5b1d07f5-a0dd-447a-b82b-0839aecd9bb2_terseLabel_en-US" xlink:label="lab_us-gaap_IPOMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPO</link:label>
    <link:label id="lab_us-gaap_IPOMember_label_en-US" xlink:label="lab_us-gaap_IPOMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IPOMember" xlink:to="lab_us-gaap_IPOMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_A2021EmployeeStockPurchasePlanMember_396993e7-b561-4e79-86e9-e8b53a7cf5d3_terseLabel_en-US" xlink:label="lab_prct_A2021EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee stock purchase plan</link:label>
    <link:label id="lab_prct_A2021EmployeeStockPurchasePlanMember_label_en-US" xlink:label="lab_prct_A2021EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Employee Stock Purchase Plan [Member]</link:label>
    <link:label id="lab_prct_A2021EmployeeStockPurchasePlanMember_documentation_en-US" xlink:label="lab_prct_A2021EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_A2021EmployeeStockPurchasePlanMember" xlink:href="prct-20220630.xsd#prct_A2021EmployeeStockPurchasePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_A2021EmployeeStockPurchasePlanMember" xlink:to="lab_prct_A2021EmployeeStockPurchasePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_83b69215-33b5-41a0-9ea0-03671a15249e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_86abec4c-0843-4b37-945b-bddb21aeca00_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_TransferFromInventoryToPropertyAndEquipmentNet_e9375238-0e7e-4dfc-90f7-4ce111c94672_terseLabel_en-US" xlink:label="lab_prct_TransferFromInventoryToPropertyAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer of evaluation units from inventory to property and equipment, net</link:label>
    <link:label id="lab_prct_TransferFromInventoryToPropertyAndEquipmentNet_label_en-US" xlink:label="lab_prct_TransferFromInventoryToPropertyAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer From Inventory to Property and Equipment, Net</link:label>
    <link:label id="lab_prct_TransferFromInventoryToPropertyAndEquipmentNet_documentation_en-US" xlink:label="lab_prct_TransferFromInventoryToPropertyAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer From Inventory to Property and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_TransferFromInventoryToPropertyAndEquipmentNet" xlink:href="prct-20220630.xsd#prct_TransferFromInventoryToPropertyAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_TransferFromInventoryToPropertyAndEquipmentNet" xlink:to="lab_prct_TransferFromInventoryToPropertyAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmountAchievedExtendedInterestOnlyPeriod_ac5f8c01-7a93-4c52-b3d3-04e6fc03c0cb_terseLabel_en-US" xlink:label="lab_prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmountAchievedExtendedInterestOnlyPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant compliance, IPO capital raised in threshold amount achieved, extended interest only period (in months)</link:label>
    <link:label id="lab_prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmountAchievedExtendedInterestOnlyPeriod_label_en-US" xlink:label="lab_prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmountAchievedExtendedInterestOnlyPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant Compliance, Capital Raised in IPO Threshold Amount Achieved, Extended Interest Only Period</link:label>
    <link:label id="lab_prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmountAchievedExtendedInterestOnlyPeriod_documentation_en-US" xlink:label="lab_prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmountAchievedExtendedInterestOnlyPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant Compliance, Capital Raised in IPO Threshold Amount Achieved, Extended Interest Only Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmountAchievedExtendedInterestOnlyPeriod" xlink:href="prct-20220630.xsd#prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmountAchievedExtendedInterestOnlyPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmountAchievedExtendedInterestOnlyPeriod" xlink:to="lab_prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmountAchievedExtendedInterestOnlyPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_0a7da4d1-9958-4f89-8f0f-fe6dd66d8578_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesAndFairValueTextBlock_9d3681e1-0327-4fa7-a9c3-c7556604181f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesAndFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan Facility and Derivative Liability</link:label>
    <link:label id="lab_us-gaap_DerivativesAndFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesAndFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives and Fair Value [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesAndFairValueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesAndFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesAndFairValueTextBlock" xlink:to="lab_us-gaap_DerivativesAndFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_6bb36799-a225-470d-b9c5-5cb35ec7e69e_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of redeemable convertible preferred stock to common stock upon initial public offering</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_0648bae9-4da7-47d1-a465-80d055e85083_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_172a4a3b-f7ca-40e7-b609-dde637b1e0b1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_8419b31f-7cab-4494-bb4c-c75952be7882_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment included in accounts payable and other current liabilities</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_99e8b09f-1998-4e83-8b71-7248d1881842_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share, basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_a1650202-1398-49a0-bd05-b304a7bc52ca_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rent expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense" xlink:to="lab_us-gaap_OperatingLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_303008f4-5f77-455a-b7b1-a4722354b825_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_DebtInstrumentCovenantComplianceRevenueForecastForCommensuratePeriodPercent_297feaa7-1e99-4389-a586-15f3dd71201b_terseLabel_en-US" xlink:label="lab_prct_DebtInstrumentCovenantComplianceRevenueForecastForCommensuratePeriodPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant compliance, revenue forecast for commensurate period, percent</link:label>
    <link:label id="lab_prct_DebtInstrumentCovenantComplianceRevenueForecastForCommensuratePeriodPercent_label_en-US" xlink:label="lab_prct_DebtInstrumentCovenantComplianceRevenueForecastForCommensuratePeriodPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant Compliance, Revenue Forecast for Commensurate Period, Percent</link:label>
    <link:label id="lab_prct_DebtInstrumentCovenantComplianceRevenueForecastForCommensuratePeriodPercent_documentation_en-US" xlink:label="lab_prct_DebtInstrumentCovenantComplianceRevenueForecastForCommensuratePeriodPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant Compliance, Revenue Forecast for Commensurate Period, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_DebtInstrumentCovenantComplianceRevenueForecastForCommensuratePeriodPercent" xlink:href="prct-20220630.xsd#prct_DebtInstrumentCovenantComplianceRevenueForecastForCommensuratePeriodPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_DebtInstrumentCovenantComplianceRevenueForecastForCommensuratePeriodPercent" xlink:to="lab_prct_DebtInstrumentCovenantComplianceRevenueForecastForCommensuratePeriodPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2a1f53b7-566d-46c1-bb2d-26219f2de145_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5361d6d5-6250-495f-987d-1ab123f1a24a_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_d6ab2d6e-2c93-474d-8872-be9c7faba7cc_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_DebtInstrumentCovenantComplianceRevenueForecastAmountFirstTwoInstallmentsOnly_fad6cf28-93dc-4a8e-aad4-22083920e0ca_terseLabel_en-US" xlink:label="lab_prct_DebtInstrumentCovenantComplianceRevenueForecastAmountFirstTwoInstallmentsOnly" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant compliance, revenue forecast amount, first two installments only</link:label>
    <link:label id="lab_prct_DebtInstrumentCovenantComplianceRevenueForecastAmountFirstTwoInstallmentsOnly_label_en-US" xlink:label="lab_prct_DebtInstrumentCovenantComplianceRevenueForecastAmountFirstTwoInstallmentsOnly" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant Compliance, Revenue Forecast Amount, First Two Installments Only</link:label>
    <link:label id="lab_prct_DebtInstrumentCovenantComplianceRevenueForecastAmountFirstTwoInstallmentsOnly_documentation_en-US" xlink:label="lab_prct_DebtInstrumentCovenantComplianceRevenueForecastAmountFirstTwoInstallmentsOnly" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant Compliance, Revenue Forecast Amount, First Two Installments Only</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_DebtInstrumentCovenantComplianceRevenueForecastAmountFirstTwoInstallmentsOnly" xlink:href="prct-20220630.xsd#prct_DebtInstrumentCovenantComplianceRevenueForecastAmountFirstTwoInstallmentsOnly"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_DebtInstrumentCovenantComplianceRevenueForecastAmountFirstTwoInstallmentsOnly" xlink:to="lab_prct_DebtInstrumentCovenantComplianceRevenueForecastAmountFirstTwoInstallmentsOnly" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterials_ed3fff41-8a68-4972-b512-a70b5695dd08_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterials" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterials_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterials" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterials"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterials" xlink:to="lab_us-gaap_InventoryRawMaterials" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeographicConcentrationRiskMember_8e2d32c2-f48c-443e-9c8e-be45ffe3e362_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Concentration Risk</link:label>
    <link:label id="lab_us-gaap_GeographicConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_GeographicConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicConcentrationRiskMember" xlink:to="lab_us-gaap_GeographicConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_67752d67-77b8-439b-a264-a37dc26588de_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_A2021EquityIncentiveAwardPlanMember_7fb16971-6ba0-4c74-8102-bed0e714910c_terseLabel_en-US" xlink:label="lab_prct_A2021EquityIncentiveAwardPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Equity Incentive Award Plan</link:label>
    <link:label id="lab_prct_A2021EquityIncentiveAwardPlanMember_label_en-US" xlink:label="lab_prct_A2021EquityIncentiveAwardPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Equity Incentive Award Plan [Member]</link:label>
    <link:label id="lab_prct_A2021EquityIncentiveAwardPlanMember_documentation_en-US" xlink:label="lab_prct_A2021EquityIncentiveAwardPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Equity Incentive Award Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_A2021EquityIncentiveAwardPlanMember" xlink:href="prct-20220630.xsd#prct_A2021EquityIncentiveAwardPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_A2021EquityIncentiveAwardPlanMember" xlink:to="lab_prct_A2021EquityIncentiveAwardPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_OperatingLeaseNumberOfBuildings_74bd3b39-bc29-42d5-abeb-c31871eda61d_terseLabel_en-US" xlink:label="lab_prct_OperatingLeaseNumberOfBuildings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of buildings</link:label>
    <link:label id="lab_prct_OperatingLeaseNumberOfBuildings_label_en-US" xlink:label="lab_prct_OperatingLeaseNumberOfBuildings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Number of Buildings</link:label>
    <link:label id="lab_prct_OperatingLeaseNumberOfBuildings_documentation_en-US" xlink:label="lab_prct_OperatingLeaseNumberOfBuildings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Number of Buildings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_OperatingLeaseNumberOfBuildings" xlink:href="prct-20220630.xsd#prct_OperatingLeaseNumberOfBuildings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_OperatingLeaseNumberOfBuildings" xlink:to="lab_prct_OperatingLeaseNumberOfBuildings" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_HandPiecesAndOtherConsumablesMember_1dd9f63c-f86e-4c6a-9151-50191c61359e_terseLabel_en-US" xlink:label="lab_prct_HandPiecesAndOtherConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Handpieces and other consumables</link:label>
    <link:label id="lab_prct_HandPiecesAndOtherConsumablesMember_label_en-US" xlink:label="lab_prct_HandPiecesAndOtherConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hand Pieces and Other Consumables [Member]</link:label>
    <link:label id="lab_prct_HandPiecesAndOtherConsumablesMember_documentation_en-US" xlink:label="lab_prct_HandPiecesAndOtherConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hand Pieces and Other Consumables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_HandPiecesAndOtherConsumablesMember" xlink:href="prct-20220630.xsd#prct_HandPiecesAndOtherConsumablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_HandPiecesAndOtherConsumablesMember" xlink:to="lab_prct_HandPiecesAndOtherConsumablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_FiniteLivedIntangibleAssetExpectedAnnualAmortizationExpense_3dd08499-f0b0-4df3-9ddc-23bf9bf8651e_terseLabel_en-US" xlink:label="lab_prct_FiniteLivedIntangibleAssetExpectedAnnualAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected annual amortization expense</link:label>
    <link:label id="lab_prct_FiniteLivedIntangibleAssetExpectedAnnualAmortizationExpense_label_en-US" xlink:label="lab_prct_FiniteLivedIntangibleAssetExpectedAnnualAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Annual Amortization Expense</link:label>
    <link:label id="lab_prct_FiniteLivedIntangibleAssetExpectedAnnualAmortizationExpense_documentation_en-US" xlink:label="lab_prct_FiniteLivedIntangibleAssetExpectedAnnualAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Annual Amortization Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_FiniteLivedIntangibleAssetExpectedAnnualAmortizationExpense" xlink:href="prct-20220630.xsd#prct_FiniteLivedIntangibleAssetExpectedAnnualAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_FiniteLivedIntangibleAssetExpectedAnnualAmortizationExpense" xlink:to="lab_prct_FiniteLivedIntangibleAssetExpectedAnnualAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_e2d7bc1d-c0fe-47f2-bfe3-6a67f391b68b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward" xlink:to="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_dff2bfe8-373f-4a89-a696-d4128f712b5e_totalLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total minimum payments</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceFourInstallmentsDrawn_e8166d9a-facf-4e44-a5ae-4e628b9f75bc_terseLabel_en-US" xlink:label="lab_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceFourInstallmentsDrawn" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fee if all four installments are drawn</link:label>
    <link:label id="lab_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceFourInstallmentsDrawn_label_en-US" xlink:label="lab_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceFourInstallmentsDrawn" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Covenant Terms, Liquidity Occurrence, Four Installments Drawn</link:label>
    <link:label id="lab_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceFourInstallmentsDrawn_documentation_en-US" xlink:label="lab_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceFourInstallmentsDrawn" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Covenant Terms, Liquidity Occurrence, Four Installments Drawn</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceFourInstallmentsDrawn" xlink:href="prct-20220630.xsd#prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceFourInstallmentsDrawn"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceFourInstallmentsDrawn" xlink:to="lab_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceFourInstallmentsDrawn" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_96276fe0-14aa-44e5-9d0e-8f0ca60d56e5_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_fdb43190-929a-4010-98fd-0cce2fdbe510_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of future payments</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_LineOfCreditFacilityCovenantComplianceContingentTrailingSixTwelveMonthRevenueTarget_4f5f4126-242c-46c5-a6b3-5dc7a11ca7de_terseLabel_en-US" xlink:label="lab_prct_LineOfCreditFacilityCovenantComplianceContingentTrailingSixTwelveMonthRevenueTarget" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trailing six months revenue target</link:label>
    <link:label id="lab_prct_LineOfCreditFacilityCovenantComplianceContingentTrailingSixTwelveMonthRevenueTarget_label_en-US" xlink:label="lab_prct_LineOfCreditFacilityCovenantComplianceContingentTrailingSixTwelveMonthRevenueTarget" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Covenant Compliance, Contingent Trailing Six Twelve Month Revenue Target</link:label>
    <link:label id="lab_prct_LineOfCreditFacilityCovenantComplianceContingentTrailingSixTwelveMonthRevenueTarget_documentation_en-US" xlink:label="lab_prct_LineOfCreditFacilityCovenantComplianceContingentTrailingSixTwelveMonthRevenueTarget" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Covenant Compliance, Contingent Trailing Six Twelve Month Revenue Target</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_LineOfCreditFacilityCovenantComplianceContingentTrailingSixTwelveMonthRevenueTarget" xlink:href="prct-20220630.xsd#prct_LineOfCreditFacilityCovenantComplianceContingentTrailingSixTwelveMonthRevenueTarget"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_LineOfCreditFacilityCovenantComplianceContingentTrailingSixTwelveMonthRevenueTarget" xlink:to="lab_prct_LineOfCreditFacilityCovenantComplianceContingentTrailingSixTwelveMonthRevenueTarget" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_013ccc9c-09ee-4680-af3b-c8e012236bab_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6f88cb78-67ed-4cfd-b9c1-2c9c92a914d5_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_2ed34323-63ed-4bb8-b600-97c9973ff41c_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_2465188b-b29b-4327-ac47-9df271e5f9ab_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum Lease Payments</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_fa569319-d33a-4415-b123-51fc5e152916_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_OperatingLeaseAnnualBaseRentYearOne_4dc15cca-f8eb-40de-8bfd-c51ee68d54e6_terseLabel_en-US" xlink:label="lab_prct_OperatingLeaseAnnualBaseRentYearOne" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual base rent, year one</link:label>
    <link:label id="lab_prct_OperatingLeaseAnnualBaseRentYearOne_label_en-US" xlink:label="lab_prct_OperatingLeaseAnnualBaseRentYearOne" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Annual Base Rent, Year One</link:label>
    <link:label id="lab_prct_OperatingLeaseAnnualBaseRentYearOne_documentation_en-US" xlink:label="lab_prct_OperatingLeaseAnnualBaseRentYearOne" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Annual Base Rent, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_OperatingLeaseAnnualBaseRentYearOne" xlink:href="prct-20220630.xsd#prct_OperatingLeaseAnnualBaseRentYearOne"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_OperatingLeaseAnnualBaseRentYearOne" xlink:to="lab_prct_OperatingLeaseAnnualBaseRentYearOne" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_91fbe330-3c8c-4926-888b-38e6c313858a_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_8b24b411-feac-4b6a-b111-45af3ab50f9b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_1d2032e1-d5b7-4f83-838d-ec88343f86ad_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashEquivalentsAtCarryingValue_510bdd6c-0e62-4dc9-a1ea-2f2afc28fa7a_terseLabel_en-US" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9ddf2546-2fff-4acb-b3b3-bce424f3b93a_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_6102429d-2ee6-4ba5-811c-20b63f497e96_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_c528c2aa-22a3-4ce3-a3bf-6323c8332fb2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization</link:label>
    <link:label id="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Description and Basis of Presentation [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_4feb6cc0-0943-4de8-9af7-7c32f65ad787_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Diluted</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMeasurementInput_a4bf1ca9-1d6b-4765-bfc1-6ab5ed000c01_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flow discount</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMeasurementInput_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMeasurementInput" xlink:to="lab_us-gaap_LongTermDebtMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_6d2b7372-e5fb-4073-b04a-cbc6d3f1c5b3_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Loss Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_cf6a5cbb-583b-4779-80d6-7a4b686ab733_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_91c8c559-49e0-450e-ae52-5e67f4cb7308_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_3eee123c-6700-4f70-8573-0f09e016fddf_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance upon exercise of options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_SeriesERedeemableConvertiblePreferredStockWarrantsMember_432e2307-6981-4449-ac4d-352ea662909a_terseLabel_en-US" xlink:label="lab_prct_SeriesERedeemableConvertiblePreferredStockWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series E, Redeemable Convertible Preferred Stock Warrants</link:label>
    <link:label id="lab_prct_SeriesERedeemableConvertiblePreferredStockWarrantsMember_label_en-US" xlink:label="lab_prct_SeriesERedeemableConvertiblePreferredStockWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series E Redeemable Convertible Preferred Stock Warrants [Member]</link:label>
    <link:label id="lab_prct_SeriesERedeemableConvertiblePreferredStockWarrantsMember_documentation_en-US" xlink:label="lab_prct_SeriesERedeemableConvertiblePreferredStockWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series E Redeemable Convertible Preferred Stock Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_SeriesERedeemableConvertiblePreferredStockWarrantsMember" xlink:href="prct-20220630.xsd#prct_SeriesERedeemableConvertiblePreferredStockWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_SeriesERedeemableConvertiblePreferredStockWarrantsMember" xlink:to="lab_prct_SeriesERedeemableConvertiblePreferredStockWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_FairValueAdjustmentOfWarrantsAndGainLossOnDerivativeInstrumentsNetPretax_0c901e72-7747-4dc5-bcfe-c7f4f24213c0_terseLabel_en-US" xlink:label="lab_prct_FairValueAdjustmentOfWarrantsAndGainLossOnDerivativeInstrumentsNetPretax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of redeemable convertible preferred stock warrants and derivative liability</link:label>
    <link:label id="lab_prct_FairValueAdjustmentOfWarrantsAndGainLossOnDerivativeInstrumentsNetPretax_label_en-US" xlink:label="lab_prct_FairValueAdjustmentOfWarrantsAndGainLossOnDerivativeInstrumentsNetPretax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Adjustment of Warrants and Gain (Loss) on Derivative Instruments, Net, Pretax</link:label>
    <link:label id="lab_prct_FairValueAdjustmentOfWarrantsAndGainLossOnDerivativeInstrumentsNetPretax_documentation_en-US" xlink:label="lab_prct_FairValueAdjustmentOfWarrantsAndGainLossOnDerivativeInstrumentsNetPretax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Adjustment of Warrants and Gain (Loss) on Derivative Instruments, Net, Pretax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_FairValueAdjustmentOfWarrantsAndGainLossOnDerivativeInstrumentsNetPretax" xlink:href="prct-20220630.xsd#prct_FairValueAdjustmentOfWarrantsAndGainLossOnDerivativeInstrumentsNetPretax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_FairValueAdjustmentOfWarrantsAndGainLossOnDerivativeInstrumentsNetPretax" xlink:to="lab_prct_FairValueAdjustmentOfWarrantsAndGainLossOnDerivativeInstrumentsNetPretax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_7e008df6-60c3-4663-8b04-8d94b0dd12fd_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_fc647316-6a12-4a48-8b21-e68573c65fb7_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_TemporaryEquityStockIssuedDuringPeriodSharesWarrantExercises_7c7c79d9-54c7-4fe9-ab27-8968554fd19e_terseLabel_en-US" xlink:label="lab_prct_TemporaryEquityStockIssuedDuringPeriodSharesWarrantExercises" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance upon exercise of warrants (in shares)</link:label>
    <link:label id="lab_prct_TemporaryEquityStockIssuedDuringPeriodSharesWarrantExercises_label_en-US" xlink:label="lab_prct_TemporaryEquityStockIssuedDuringPeriodSharesWarrantExercises" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Shares, Warrant Exercises</link:label>
    <link:label id="lab_prct_TemporaryEquityStockIssuedDuringPeriodSharesWarrantExercises_documentation_en-US" xlink:label="lab_prct_TemporaryEquityStockIssuedDuringPeriodSharesWarrantExercises" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Shares, Warrant Exercises</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_TemporaryEquityStockIssuedDuringPeriodSharesWarrantExercises" xlink:href="prct-20220630.xsd#prct_TemporaryEquityStockIssuedDuringPeriodSharesWarrantExercises"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_TemporaryEquityStockIssuedDuringPeriodSharesWarrantExercises" xlink:to="lab_prct_TemporaryEquityStockIssuedDuringPeriodSharesWarrantExercises" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightLineItems_38817ecd-e0ea-4aeb-96bf-84475745bc27_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="lab_us-gaap_ClassOfWarrantOrRightLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_3b3da12a-5bf7-4cd4-b90d-a16dc021f3cb_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_f4fd5065-d93c-4385-aab9-14479131c651_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_d4ed7b99-468a-462c-a9cf-cf3f3ec21fda_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:to="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_b2513a58-f98e-450c-8df7-773dbf66a635_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding (in share)</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_LoanFacilityTrancheThreeMember_69c5ef83-6335-48f7-9cf5-3426359b91ff_terseLabel_en-US" xlink:label="lab_prct_LoanFacilityTrancheThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan Facility, Tranche Three</link:label>
    <link:label id="lab_prct_LoanFacilityTrancheThreeMember_label_en-US" xlink:label="lab_prct_LoanFacilityTrancheThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan Facility, Tranche Three [Member]</link:label>
    <link:label id="lab_prct_LoanFacilityTrancheThreeMember_documentation_en-US" xlink:label="lab_prct_LoanFacilityTrancheThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan Facility, Tranche Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_LoanFacilityTrancheThreeMember" xlink:href="prct-20220630.xsd#prct_LoanFacilityTrancheThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_LoanFacilityTrancheThreeMember" xlink:to="lab_prct_LoanFacilityTrancheThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_c7c385dc-9563-4091-ab38-5b36ad1e87ca_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_de679182-d2a2-41c9-bb78-dd4dd986acce_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock_83571632-d45d-464f-b14d-fd32e5e53346_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock Option Activity and Related Information</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightTable_ccfb8f68-13cd-4c27-a506-0c92d707a0ff_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Table]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightTable_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable" xlink:to="lab_us-gaap_ClassOfWarrantOrRightTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_f6735fed-31f9-4c52-ab91-b545301c0b58_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan Facility and Derivative Liability</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_402bb377-b841-4c56-9941-a249994a775c_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at the beginning of the period (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_064561f7-05fa-49a5-81c8-a90cbcd012f8_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at the end of the period (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_1fe7106c-4152-40b5-b631-cd95b79ed4bf_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_57f11d8b-66b1-48f6-a628-bb8020812790_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_67f6eff7-0797-4b54-86ed-76812f54881a_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityUnamortizedDebtDiscount_82a409b8-697e-44f6-9cb6-f48a386a98d4_negatedTerseLabel_en-US" xlink:label="lab_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityUnamortizedDebtDiscount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: amount representing interest/unamortized debt discount</link:label>
    <link:label id="lab_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityUnamortizedDebtDiscount_label_en-US" xlink:label="lab_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityUnamortizedDebtDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Liability and Long-Term Debt Maturity, Unamortized Debt Discount</link:label>
    <link:label id="lab_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityUnamortizedDebtDiscount_documentation_en-US" xlink:label="lab_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityUnamortizedDebtDiscount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Liability and Long-Term Debt Maturity, Unamortized Debt Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityUnamortizedDebtDiscount" xlink:href="prct-20220630.xsd#prct_OperatingLeaseLiabilityAndLongTermDebtMaturityUnamortizedDebtDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityUnamortizedDebtDiscount" xlink:to="lab_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityUnamortizedDebtDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_4c50f078-282a-4d21-9b21-d5c682522591_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of stock issuance costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Stock Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_44c8f4d5-5480-46c6-9338-980e8745d9e7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_c778fa56-401f-43ec-9bbd-ab55005db07c_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of future payments</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_97c7fd2f-dc42-463b-a8b6-75be187017b5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:to="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_89a95590-e9cb-4bd1-8483-c705d41ea6a0_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_0ab1b2b5-58d7-4920-850a-9291052006a9_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_75443f20-43d0-4204-b0f3-20b129dfe76a_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_5bcfc2a2-3783-44a6-a5e8-47e67438fb82_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average vesting period for unrecognized compensation cost</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_fede095b-a2db-4454-b40a-409a603d5b89_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_20f277e6-e614-47a8-8af1-685833411cf7_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, beginning of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_bb4e4691-3f10-4251-bd89-64a0c6d2ebf3_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, endof period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_DebtInstrumentInterestOnlyPeriod_c3062e47-4eb9-4026-a370-ae15768b8026_terseLabel_en-US" xlink:label="lab_prct_DebtInstrumentInterestOnlyPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest only period</link:label>
    <link:label id="lab_prct_DebtInstrumentInterestOnlyPeriod_label_en-US" xlink:label="lab_prct_DebtInstrumentInterestOnlyPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, Interest Only Period</link:label>
    <link:label id="lab_prct_DebtInstrumentInterestOnlyPeriod_documentation_en-US" xlink:label="lab_prct_DebtInstrumentInterestOnlyPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, Interest Only Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_DebtInstrumentInterestOnlyPeriod" xlink:href="prct-20220630.xsd#prct_DebtInstrumentInterestOnlyPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_DebtInstrumentInterestOnlyPeriod" xlink:to="lab_prct_DebtInstrumentInterestOnlyPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_48b80e36-612e-474c-881c-3bfba3844ee6_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceThreeInstallmentsDrawn_1f16a046-8302-448d-8795-b47f508cdd75_terseLabel_en-US" xlink:label="lab_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceThreeInstallmentsDrawn" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fee if first three installments drawn</link:label>
    <link:label id="lab_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceThreeInstallmentsDrawn_label_en-US" xlink:label="lab_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceThreeInstallmentsDrawn" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Covenant Terms, Liquidity Occurrence, Three Installments Drawn</link:label>
    <link:label id="lab_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceThreeInstallmentsDrawn_documentation_en-US" xlink:label="lab_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceThreeInstallmentsDrawn" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Covenant Terms, Liquidity Occurrence, Three Installments Drawn</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceThreeInstallmentsDrawn" xlink:href="prct-20220630.xsd#prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceThreeInstallmentsDrawn"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceThreeInstallmentsDrawn" xlink:to="lab_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceThreeInstallmentsDrawn" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_f5befa99-195d-4d76-a72e-cd211f96ca48_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_3a27fb8a-97c3-4644-a780-218f9adad82c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6028f0ac-d609-4a5b-9704-69449bd976ad_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_bbe4af50-18e9-4138-9962-153ce1bc5668_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityAbstract_3cf5a9fd-dd05-44d1-b9c6-740e9c7bd0c5_terseLabel_en-US" xlink:label="lab_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityAbstract_label_en-US" xlink:label="lab_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Liability and Long-Term Debt Maturity [Abstract]</link:label>
    <link:label id="lab_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityAbstract_documentation_en-US" xlink:label="lab_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Liability and Long-Term Debt Maturity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityAbstract" xlink:href="prct-20220630.xsd#prct_OperatingLeaseLiabilityAndLongTermDebtMaturityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityAbstract" xlink:to="lab_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_OperatingLeaseLiabilityAndLongTermDebt_3c59c78a-8a97-444c-bbe7-4fa58090b899_totalLabel_en-US" xlink:label="lab_prct_OperatingLeaseLiabilityAndLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of future payments</link:label>
    <link:label id="lab_prct_OperatingLeaseLiabilityAndLongTermDebt_label_en-US" xlink:label="lab_prct_OperatingLeaseLiabilityAndLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Liability and Long-Term Debt</link:label>
    <link:label id="lab_prct_OperatingLeaseLiabilityAndLongTermDebt_documentation_en-US" xlink:label="lab_prct_OperatingLeaseLiabilityAndLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Liability and Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_OperatingLeaseLiabilityAndLongTermDebt" xlink:href="prct-20220630.xsd#prct_OperatingLeaseLiabilityAndLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_OperatingLeaseLiabilityAndLongTermDebt" xlink:to="lab_prct_OperatingLeaseLiabilityAndLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_d73794d9-e773-4734-ae9f-bfa4deb48775_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning of the period</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_62edf16b-94d5-4b9d-9e2d-d131b468b9e5_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">End of the period</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_label_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis with Unobservable Inputs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" xlink:to="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_e51559e5-8eca-4e1a-bbe4-c9a58262eba2_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsTable_ce82fb3f-9849-4aad-9b6f-5524be173cc3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Table]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsTable_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsTable" xlink:to="lab_us-gaap_OtherCommitmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_5232d60d-358f-4d79-8ab5-2ab22bf024e0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosure of Asset and Liability Not Measured at Fair Value [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosure of Asset and Liability Not Measured at Fair Value [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable" xlink:to="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_LineOfCreditFacilityEarlyRepaymentFeeTwentyFourMonthsThruMaturityPercent_6497adcd-991b-41b9-b60f-d1b4d69cea52_terseLabel_en-US" xlink:label="lab_prct_LineOfCreditFacilityEarlyRepaymentFeeTwentyFourMonthsThruMaturityPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Early repayment fee, twenty four months thereafter, percent</link:label>
    <link:label id="lab_prct_LineOfCreditFacilityEarlyRepaymentFeeTwentyFourMonthsThruMaturityPercent_label_en-US" xlink:label="lab_prct_LineOfCreditFacilityEarlyRepaymentFeeTwentyFourMonthsThruMaturityPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Early Repayment Fee, Twenty Four Months Thru Maturity, Percent</link:label>
    <link:label id="lab_prct_LineOfCreditFacilityEarlyRepaymentFeeTwentyFourMonthsThruMaturityPercent_documentation_en-US" xlink:label="lab_prct_LineOfCreditFacilityEarlyRepaymentFeeTwentyFourMonthsThruMaturityPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Early Repayment Fee, Twenty Four Months Thru Maturity, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_LineOfCreditFacilityEarlyRepaymentFeeTwentyFourMonthsThruMaturityPercent" xlink:href="prct-20220630.xsd#prct_LineOfCreditFacilityEarlyRepaymentFeeTwentyFourMonthsThruMaturityPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_LineOfCreditFacilityEarlyRepaymentFeeTwentyFourMonthsThruMaturityPercent" xlink:to="lab_prct_LineOfCreditFacilityEarlyRepaymentFeeTwentyFourMonthsThruMaturityPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_fdb32041-bea9-4d16-b2b9-b87f60301456_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_324ad305-4a9c-4967-9525-0c84627b7644_terseLabel_en-US" xlink:label="lab_prct_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of preferred stock, net of issuance costs (in shares)</link:label>
    <link:label id="lab_prct_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_prct_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Shares, New Issues</link:label>
    <link:label id="lab_prct_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_documentation_en-US" xlink:label="lab_prct_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:href="prct-20220630.xsd#prct_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_prct_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_LineOfCreditFacilityNumberOfInstallments_170a360d-58ca-4fcc-94e7-48f43334e64c_terseLabel_en-US" xlink:label="lab_prct_LineOfCreditFacilityNumberOfInstallments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of installments</link:label>
    <link:label id="lab_prct_LineOfCreditFacilityNumberOfInstallments_label_en-US" xlink:label="lab_prct_LineOfCreditFacilityNumberOfInstallments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Number of Installments</link:label>
    <link:label id="lab_prct_LineOfCreditFacilityNumberOfInstallments_documentation_en-US" xlink:label="lab_prct_LineOfCreditFacilityNumberOfInstallments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Number of Installments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_LineOfCreditFacilityNumberOfInstallments" xlink:href="prct-20220630.xsd#prct_LineOfCreditFacilityNumberOfInstallments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_LineOfCreditFacilityNumberOfInstallments" xlink:to="lab_prct_LineOfCreditFacilityNumberOfInstallments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_e386081e-6b1a-4935-bcb5-ec6a1b6d9265_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Geographic Areas</link:label>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Geographic Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:to="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_b542c750-15d2-4f04-b009-9227ae5aa7bd_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_178dfd77-3309-4959-8483-df9ae5c5247b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: amount representing interest/unamortized debt discount</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_5bb71821-411c-46ac-b9a8-9994954bc37e_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]</link:label>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_label_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_52fa3ab5-23ea-4d46-8133-a8e22e9d6a85_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of stock, consideration received on transaction</link:label>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Cash_9a9869e6-1950-468e-b95b-ee4246452f5b_terseLabel_en-US" xlink:label="lab_us-gaap_Cash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_Cash_label_en-US" xlink:label="lab_us-gaap_Cash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Cash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Cash" xlink:to="lab_us-gaap_Cash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_4fd93927-4a03-4038-8588-9054896c1644_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings_42cbebfb-5b8c-40b5-9831-1362f0d3bd3a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_ccd02c5c-638a-44e8-8471-a6a89f7b2673_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at the beginning of the period</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_e66a33b0-1492-465d-a57f-ed814cf2b1f4_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at the end of the period</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Carrying Amount, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_48e1d4bc-93e7-48cd-91ab-b3770b25ba59_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_12195d5d-e350-4716-b0d3-270d5517e7a2_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_cb4a5139-7e30-4531-9eff-05a1b8cb1700_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_1ec81173-2ed2-4354-8bd7-db501ac2c9bd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_7cb24ed7-5e4e-41f8-9158-15a679e903dc_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_01411fe5-e226-4b53-8975-a0a5bdb55aff_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_4aee4ccb-ce68-42d6-ad36-54f9a115263d_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_de76b2a1-5fab-460d-9858-efbcfdbc2c81_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment, Geographical, and Customer Concentration</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_309d1f93-9346-4e46-82a4-eb9f7d6f29e4_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_fd2806bb-b2bd-42cc-bcd3-b8a35ccf8a3d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease &#8211; current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_e708f454-efc2-4270-bd64-7d71516d3b09_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_aad49c69-7f2e-497a-ba95-7ccb65ed5191_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of preferred stock, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1217d276-cb94-4691-b970-bed8b35865cf_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_41f760b8-d727-4210-9a5d-bdc06e3a9ce9_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_ed5a0c07-4ef3-4443-a721-febcf9431e48_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_1dcc3056-5ff4-48a6-bc7c-3cb4575f48ad_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_180f6ea6-5ad2-48c7-a3e8-0331efd6b775_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_1c80b52f-93af-4a38-8b39-e60e1cad8233_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_89a0d964-5944-4ef3-bb7e-42bda48e7968_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues_bf874df4-4c38-4c50-998c-47f27fc765fd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issued</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues_label_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues" xlink:to="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_InterestAndOtherIncomeExpense_77208c53-fa92-4c86-b0e4-93ce6b6c121a_terseLabel_en-US" xlink:label="lab_prct_InterestAndOtherIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and other income, net</link:label>
    <link:label id="lab_prct_InterestAndOtherIncomeExpense_label_en-US" xlink:label="lab_prct_InterestAndOtherIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest And Other Income (Expense)</link:label>
    <link:label id="lab_prct_InterestAndOtherIncomeExpense_documentation_en-US" xlink:label="lab_prct_InterestAndOtherIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest And Other Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_InterestAndOtherIncomeExpense" xlink:href="prct-20220630.xsd#prct_InterestAndOtherIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_InterestAndOtherIncomeExpense" xlink:to="lab_prct_InterestAndOtherIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_2fd76a43-eff5-4276-82b0-4c597c963a8a_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_DebtInstrumentPrincipalAndInterestPeriod_774cc77a-13dd-40f4-ae1d-e69352f4c62c_terseLabel_en-US" xlink:label="lab_prct_DebtInstrumentPrincipalAndInterestPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal and interest period (in months)</link:label>
    <link:label id="lab_prct_DebtInstrumentPrincipalAndInterestPeriod_label_en-US" xlink:label="lab_prct_DebtInstrumentPrincipalAndInterestPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, Principal and Interest Period</link:label>
    <link:label id="lab_prct_DebtInstrumentPrincipalAndInterestPeriod_documentation_en-US" xlink:label="lab_prct_DebtInstrumentPrincipalAndInterestPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, Principal and Interest Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_DebtInstrumentPrincipalAndInterestPeriod" xlink:href="prct-20220630.xsd#prct_DebtInstrumentPrincipalAndInterestPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_DebtInstrumentPrincipalAndInterestPeriod" xlink:to="lab_prct_DebtInstrumentPrincipalAndInterestPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_b51498fe-4ce8-48fa-bdc3-5847cdc32a8f_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_0c5c12a5-91ad-41d8-a3d2-336b92083948_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_4c4015af-622a-44b2-bfcc-440f57b177a2_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueAxis" xlink:to="lab_us-gaap_ValuationTechniqueAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceTwoInstallmentsDrawn_b86aa680-1dd6-41ca-8c9f-e47a854db23d_terseLabel_en-US" xlink:label="lab_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceTwoInstallmentsDrawn" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fee if first two installments drawn</link:label>
    <link:label id="lab_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceTwoInstallmentsDrawn_label_en-US" xlink:label="lab_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceTwoInstallmentsDrawn" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Covenant Terms, Liquidity Occurrence, Two Installments Drawn</link:label>
    <link:label id="lab_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceTwoInstallmentsDrawn_documentation_en-US" xlink:label="lab_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceTwoInstallmentsDrawn" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Covenant Terms, Liquidity Occurrence, Two Installments Drawn</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceTwoInstallmentsDrawn" xlink:href="prct-20220630.xsd#prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceTwoInstallmentsDrawn"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceTwoInstallmentsDrawn" xlink:to="lab_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceTwoInstallmentsDrawn" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_eb7761f2-7eac-4ddf-9d4c-e9c9f058aa51_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facility interest rate at period end (percent)</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Interest Rate at Period End</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:to="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_28238d87-98bb-43ad-ae23-03081e90285e_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_f1003e46-7832-4c1c-bf76-0e9e949e0339_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Revenue Reconciling Item [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Revenue Reconciling Item [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:to="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_ccd80656-caf3-4d3a-ba82-27bc148e8b37_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_a3b2b444-5b6e-43e1-9a61-56a01e9e13e0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d5826219-c721-4a0a-83b2-b74f9fea6344_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_13c95a6f-f28a-495c-b14f-92053bc2b1ea_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_6f35d47c-4079-48f9-91c2-3e12d431beae_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future minimum lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_391d5fa6-7a39-4c59-9c6b-51acc7dc2f12_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_1fc9db7c-eee4-4ed6-b149-2549e9afd0bb_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at the beginning of the period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_62f1644a-5dcd-41a2-8835-17c4cda28b51_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at the end of the period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_e618fb38-5e8c-4232-905c-406b8fa9e58c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_b8dd0ef3-0682-483c-a43e-7bcd2b5847ac_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_d56c86a0-f46b-40bc-a4b5-c1dac56d10a8_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_115b0f91-692f-47bc-a9cf-f4e102ad9a1a_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_778c1f96-9940-4c4d-a9ea-f182b5a7f621_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_d6c949a6-a75c-49af-89bc-9370cd9565fa_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_43d8c2bf-6d6a-4099-9480-c65059700ad1_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_3310492f-9d29-4ac8-8b65-ec38535e3e37_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease &#8211; non-current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_69e1c253-f273-4a21-aa76-dfba4647f847_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_c1cf74de-e744-4bc0-8c8b-599c77c6bc8f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_da95d533-0e24-4aee-a5d4-b73ccbacb436_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_0d28ded5-38db-4671-bc93-4c19042fc4de_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_e3b2a74a-1bda-48ff-ad9e-86de9ed0187f_negatedLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_fc965cf9-5df8-4b27-9b3d-0289a95e51ed_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_a40fa4ff-02f0-45fe-b48e-bf4ec5702d39_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued under employee stock purchase plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_20332597-612c-467a-9480-6acd6ec45a1a_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_LesseeOperatingLeaseReceivableAllowanceForTenantImprovements_c190ebfe-bd67-4a8e-855a-c5239bd5bead_terseLabel_en-US" xlink:label="lab_prct_LesseeOperatingLeaseReceivableAllowanceForTenantImprovements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable allowance for tenant improvements</link:label>
    <link:label id="lab_prct_LesseeOperatingLeaseReceivableAllowanceForTenantImprovements_label_en-US" xlink:label="lab_prct_LesseeOperatingLeaseReceivableAllowanceForTenantImprovements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Receivable Allowance for Tenant Improvements</link:label>
    <link:label id="lab_prct_LesseeOperatingLeaseReceivableAllowanceForTenantImprovements_documentation_en-US" xlink:label="lab_prct_LesseeOperatingLeaseReceivableAllowanceForTenantImprovements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Receivable Allowance for Tenant Improvements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_LesseeOperatingLeaseReceivableAllowanceForTenantImprovements" xlink:href="prct-20220630.xsd#prct_LesseeOperatingLeaseReceivableAllowanceForTenantImprovements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_LesseeOperatingLeaseReceivableAllowanceForTenantImprovements" xlink:to="lab_prct_LesseeOperatingLeaseReceivableAllowanceForTenantImprovements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2cc2d365-fec0-4c9e-8b5c-4b6590e4242b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember_33d4f3e2-8b00-4663-9d08-7e5b471d1851_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Technique, Discounted Cash Flow</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Technique, Discounted Cash Flow [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:to="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_3f75c154-39c2-401e-971f-89bf0b777526_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of cash, cash equivalents and restricted cash to balance sheets:</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_OperatingLeaseAnnualBaseRentYearTen_6ffc1aac-046c-49f0-80d0-79745f39414c_terseLabel_en-US" xlink:label="lab_prct_OperatingLeaseAnnualBaseRentYearTen" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual base rent, year ten</link:label>
    <link:label id="lab_prct_OperatingLeaseAnnualBaseRentYearTen_label_en-US" xlink:label="lab_prct_OperatingLeaseAnnualBaseRentYearTen" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Annual Base Rent, Year Ten</link:label>
    <link:label id="lab_prct_OperatingLeaseAnnualBaseRentYearTen_documentation_en-US" xlink:label="lab_prct_OperatingLeaseAnnualBaseRentYearTen" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Annual Base Rent, Year Ten</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_OperatingLeaseAnnualBaseRentYearTen" xlink:href="prct-20220630.xsd#prct_OperatingLeaseAnnualBaseRentYearTen"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_OperatingLeaseAnnualBaseRentYearTen" xlink:to="lab_prct_OperatingLeaseAnnualBaseRentYearTen" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock_ded44abe-2166-4e6b-b607-ad3ea0ff45c5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Outstanding Award, Activity, Excluding Option</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Outstanding Award, Activity, Excluding Option [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_5db73b46-4fa9-492d-a41f-4a612611bca2_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceOneInstallmentDrawn_5b8b52c0-c0f3-4ff6-8428-704f1ae29db0_terseLabel_en-US" xlink:label="lab_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceOneInstallmentDrawn" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fee on first installment drawn</link:label>
    <link:label id="lab_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceOneInstallmentDrawn_label_en-US" xlink:label="lab_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceOneInstallmentDrawn" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Covenant Terms, Liquidity Occurrence, One Installment Drawn</link:label>
    <link:label id="lab_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceOneInstallmentDrawn_documentation_en-US" xlink:label="lab_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceOneInstallmentDrawn" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Covenant Terms, Liquidity Occurrence, One Installment Drawn</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceOneInstallmentDrawn" xlink:href="prct-20220630.xsd#prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceOneInstallmentDrawn"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceOneInstallmentDrawn" xlink:to="lab_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceOneInstallmentDrawn" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_0b508680-fef0-49c9-a7eb-bde27d94a3dc_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of common stock from the exercise of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_ServiceRevenueMember_8d906a61-35fa-4068-9413-b84ad74b297c_terseLabel_en-US" xlink:label="lab_prct_ServiceRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service</link:label>
    <link:label id="lab_prct_ServiceRevenueMember_label_en-US" xlink:label="lab_prct_ServiceRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service Revenue [Member]</link:label>
    <link:label id="lab_prct_ServiceRevenueMember_documentation_en-US" xlink:label="lab_prct_ServiceRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_ServiceRevenueMember" xlink:href="prct-20220630.xsd#prct_ServiceRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_ServiceRevenueMember" xlink:to="lab_prct_ServiceRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_5cff5f28-8e2b-471e-9a03-5a9ece92fec4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_a38e850d-ef91-4b01-87b2-27e465e03751_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_f8dab969-7da1-4b0d-8bb7-facec49254a8_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_8e9d2f30-9afa-47a1-9c21-ccab4c90e670_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_7b3d4f1e-a539-4d55-b601-a587b9b9aeba_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_36af6112-1796-45cd-9d59-136c169e2102_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_1283a037-17a4-4589-b0ad-b6478706f02b_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_8256f71e-2821-4248-a8a4-063dc1be1cba_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_JobsActAccountingElectionPolicyTextBlock_4c857b3c-7fd1-4823-b996-d64425f41c09_terseLabel_en-US" xlink:label="lab_prct_JobsActAccountingElectionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Jobs Act Accounting Election</link:label>
    <link:label id="lab_prct_JobsActAccountingElectionPolicyTextBlock_label_en-US" xlink:label="lab_prct_JobsActAccountingElectionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Jobs Act Accounting Election [Policy Text Block]</link:label>
    <link:label id="lab_prct_JobsActAccountingElectionPolicyTextBlock_documentation_en-US" xlink:label="lab_prct_JobsActAccountingElectionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Jobs Act Accounting Election</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_JobsActAccountingElectionPolicyTextBlock" xlink:href="prct-20220630.xsd#prct_JobsActAccountingElectionPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_JobsActAccountingElectionPolicyTextBlock" xlink:to="lab_prct_JobsActAccountingElectionPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_51e8cdbd-047c-40b5-80a0-b30e183cca5b_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total minimum payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_27aee1e9-02b0-4a88-8d8a-93e9c026d6bf_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableMember_9fb87f9e-a858-4caf-a5cf-60681fdf1bf7_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableMember_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableMember" xlink:to="lab_us-gaap_AccountsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_36fae5b5-3f55-4f14-ba72-f748447996fb_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_8b4e745b-ffdd-4c53-8e3f-6db568f1392a_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_a43aff41-b55a-4e09-8755-545c6d6475aa_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_72c073f1-7b2c-4045-858b-65dd7c139f6b_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average shares used in computing net loss per share attributable to common shareholders</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_58cc7285-b7b5-4f31-b798-62128b1bb4e9_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_3a0cc91e-1142-4cc8-bf41-0f71cb8d65fd_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_8e437b4e-d281-49d8-b631-7d8f105e5c79_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_fc18af87-9047-4800-86d7-21dae8031e9b_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_5ce8c394-3421-408e-b18c-5ff2318cf90e_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_e129bbda-b0a7-4880-94e3-740ebdb00267_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average fair value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_d82a3136-f00a-41ab-8676-2b9f4ffd3012_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_RedeemableConvertiblePreferredStockWarrantsMember_66f77607-ed9e-4ab5-b24d-26282a91cf44_terseLabel_en-US" xlink:label="lab_prct_RedeemableConvertiblePreferredStockWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable convertible preferred stock warrants</link:label>
    <link:label id="lab_prct_RedeemableConvertiblePreferredStockWarrantsMember_label_en-US" xlink:label="lab_prct_RedeemableConvertiblePreferredStockWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Convertible Preferred Stock Warrants [Member]</link:label>
    <link:label id="lab_prct_RedeemableConvertiblePreferredStockWarrantsMember_documentation_en-US" xlink:label="lab_prct_RedeemableConvertiblePreferredStockWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Convertible Preferred Stock Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_RedeemableConvertiblePreferredStockWarrantsMember" xlink:href="prct-20220630.xsd#prct_RedeemableConvertiblePreferredStockWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_RedeemableConvertiblePreferredStockWarrantsMember" xlink:to="lab_prct_RedeemableConvertiblePreferredStockWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_465d70f9-84e3-416f-a8ac-ae3d1cce7f33_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_b89cd56a-7510-4fff-ae51-8a249770b7f6_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_a652b8f3-ab5d-4f40-94b4-d19a2eec5cba_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_c896cd5b-f6a3-4865-8009-2358721f758c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityPolicyTextBlock_088cc33d-d14d-4686-b06e-63ccec7c2b61_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Public Offering</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityPolicyTextBlock" xlink:to="lab_us-gaap_StockholdersEquityPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_fd9b455b-b1c5-4353-99c1-247cf6042dba_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_b338bb3c-28c7-41af-84da-7b604f6e0491_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashNoncurrent" xlink:to="lab_us-gaap_RestrictedCashNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_5bdea0df-fc6c-4169-9df3-ccc437b5aa91_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_LineOfCreditFacilityEarlyRepaymentFeeSecondTwelveMonthPeriodPercent_25b5415a-f8ae-46d3-8259-e09fb002b3e6_terseLabel_en-US" xlink:label="lab_prct_LineOfCreditFacilityEarlyRepaymentFeeSecondTwelveMonthPeriodPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Early repayment fee second twelve month period, percent</link:label>
    <link:label id="lab_prct_LineOfCreditFacilityEarlyRepaymentFeeSecondTwelveMonthPeriodPercent_label_en-US" xlink:label="lab_prct_LineOfCreditFacilityEarlyRepaymentFeeSecondTwelveMonthPeriodPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Early Repayment Fee Second Twelve Month Period, Percent</link:label>
    <link:label id="lab_prct_LineOfCreditFacilityEarlyRepaymentFeeSecondTwelveMonthPeriodPercent_documentation_en-US" xlink:label="lab_prct_LineOfCreditFacilityEarlyRepaymentFeeSecondTwelveMonthPeriodPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Early Repayment Fee Second Twelve Month Period, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_LineOfCreditFacilityEarlyRepaymentFeeSecondTwelveMonthPeriodPercent" xlink:href="prct-20220630.xsd#prct_LineOfCreditFacilityEarlyRepaymentFeeSecondTwelveMonthPeriodPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_LineOfCreditFacilityEarlyRepaymentFeeSecondTwelveMonthPeriodPercent" xlink:to="lab_prct_LineOfCreditFacilityEarlyRepaymentFeeSecondTwelveMonthPeriodPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_1f633a75-da65-4a4f-820a-5d5e47c807a9_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value Assumptions</link:label>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:to="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_b850fefb-166e-4c54-9946-ffc9db77cf46_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3b8d427b-09b2-459a-828b-78dcc898b1c0_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockLineItems_260d631d-52f2-4599-a244-1cdcbcb696ea_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_1ef3832b-74b1-4d83-b471-9275b1335a7b_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_873b9221-4ad3-4fde-a429-aa0faa8192fe_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems" xlink:to="lab_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_bdc36c8e-cbc1-41e3-80a7-902c06d453e2_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_5396bf8b-6ad8-491d-b9fd-fb41f3cf15c6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_6dccc7d7-a148-4d54-be9f-edfa078dc519_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityExTransitionPeriod_4af51bef-fcc3-4382-be78-6b0dcf32a5e2_terseLabel_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:label id="lab_dei_EntityExTransitionPeriod_label_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod" xlink:to="lab_dei_EntityExTransitionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_5339eeb5-3ada-4b5e-8015-dc59dd05a2a5_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_cd49649a-239e-4b83-85bd-8cdc89e9db0e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of common stock under employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_c1327352-857b-41e3-9760-3ac75a82ce17_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_c413aaa3-7579-434a-8059-d20e3764fe60_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_DebtInstrumentCovenantComplianceRevenueForecastAmountAllInstallmentsDrawn_716b5702-f6a3-44fa-8ec9-59d0e0d324c9_terseLabel_en-US" xlink:label="lab_prct_DebtInstrumentCovenantComplianceRevenueForecastAmountAllInstallmentsDrawn" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant compliance, revenue forecast amount, all installments</link:label>
    <link:label id="lab_prct_DebtInstrumentCovenantComplianceRevenueForecastAmountAllInstallmentsDrawn_label_en-US" xlink:label="lab_prct_DebtInstrumentCovenantComplianceRevenueForecastAmountAllInstallmentsDrawn" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant Compliance, Revenue Forecast Amount, All Installments Drawn</link:label>
    <link:label id="lab_prct_DebtInstrumentCovenantComplianceRevenueForecastAmountAllInstallmentsDrawn_documentation_en-US" xlink:label="lab_prct_DebtInstrumentCovenantComplianceRevenueForecastAmountAllInstallmentsDrawn" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant Compliance, Revenue Forecast Amount, All Installments Drawn</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_DebtInstrumentCovenantComplianceRevenueForecastAmountAllInstallmentsDrawn" xlink:href="prct-20220630.xsd#prct_DebtInstrumentCovenantComplianceRevenueForecastAmountAllInstallmentsDrawn"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_DebtInstrumentCovenantComplianceRevenueForecastAmountAllInstallmentsDrawn" xlink:to="lab_prct_DebtInstrumentCovenantComplianceRevenueForecastAmountAllInstallmentsDrawn" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_3444cc30-bc72-483e-a0c6-4678a7c60617_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_LineOfCreditFacilityFinalPaymentFeePercentage_148b3e1c-8d10-40f1-b0fe-2cb98bac9046_terseLabel_en-US" xlink:label="lab_prct_LineOfCreditFacilityFinalPaymentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Final payment fee, percentage</link:label>
    <link:label id="lab_prct_LineOfCreditFacilityFinalPaymentFeePercentage_label_en-US" xlink:label="lab_prct_LineOfCreditFacilityFinalPaymentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Final Payment Fee, Percentage</link:label>
    <link:label id="lab_prct_LineOfCreditFacilityFinalPaymentFeePercentage_documentation_en-US" xlink:label="lab_prct_LineOfCreditFacilityFinalPaymentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Final Payment Fee, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_LineOfCreditFacilityFinalPaymentFeePercentage" xlink:href="prct-20220630.xsd#prct_LineOfCreditFacilityFinalPaymentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_LineOfCreditFacilityFinalPaymentFeePercentage" xlink:to="lab_prct_LineOfCreditFacilityFinalPaymentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_92588d5a-345c-4a30-8e00-9de84a7882b4_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_5389217c-b302-42f7-8c5b-1970b2652986_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_78588abf-6bf5-4939-b695-7dc182614cac_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_ea60efe5-92cd-4e6f-9b1b-f3484a3274d4_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_0bafaef5-aac7-4db1-b279-ad2bcfadb0df_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_DeferredOfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction_5971296b-7bbe-4477-b67d-4c23662d4aa6_terseLabel_en-US" xlink:label="lab_prct_DeferredOfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred offering costs included in accounts payable and other current liabilities</link:label>
    <link:label id="lab_prct_DeferredOfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction_label_en-US" xlink:label="lab_prct_DeferredOfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Offering Costs Incurred During Noncash or Partial Noncash Transaction</link:label>
    <link:label id="lab_prct_DeferredOfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction_documentation_en-US" xlink:label="lab_prct_DeferredOfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Offering Costs Incurred During Noncash or Partial Noncash Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_DeferredOfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:href="prct-20220630.xsd#prct_DeferredOfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_DeferredOfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:to="lab_prct_DeferredOfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_DebtInstrumentContingentBorrowingExtendedPrincipalAndInterestPeriod_b4c3a623-f2d5-4ffc-ad86-80b90caadc23_terseLabel_en-US" xlink:label="lab_prct_DebtInstrumentContingentBorrowingExtendedPrincipalAndInterestPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended principal and interest period (in months)</link:label>
    <link:label id="lab_prct_DebtInstrumentContingentBorrowingExtendedPrincipalAndInterestPeriod_label_en-US" xlink:label="lab_prct_DebtInstrumentContingentBorrowingExtendedPrincipalAndInterestPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, Contingent Borrowing, Extended Principal and Interest Period</link:label>
    <link:label id="lab_prct_DebtInstrumentContingentBorrowingExtendedPrincipalAndInterestPeriod_documentation_en-US" xlink:label="lab_prct_DebtInstrumentContingentBorrowingExtendedPrincipalAndInterestPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, Contingent Borrowing, Extended Principal and Interest Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_DebtInstrumentContingentBorrowingExtendedPrincipalAndInterestPeriod" xlink:href="prct-20220630.xsd#prct_DebtInstrumentContingentBorrowingExtendedPrincipalAndInterestPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_DebtInstrumentContingentBorrowingExtendedPrincipalAndInterestPeriod" xlink:to="lab_prct_DebtInstrumentContingentBorrowingExtendedPrincipalAndInterestPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a67108e1-eacf-4ac4-8025-f9b982635644_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_a3296230-efd5-440e-ab39-2ccea6877236_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_e338f5f0-ee9e-45ba-9da0-0d58a9541c1e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_82a8fffb-312b-434e-995c-a011af8e2e83_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableConvertiblePreferredStockMember_fde74a51-d1c8-485f-8853-429546bc43ac_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable convertible preferred stock outstanding</link:label>
    <link:label id="lab_us-gaap_RedeemableConvertiblePreferredStockMember_label_en-US" xlink:label="lab_us-gaap_RedeemableConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Convertible Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableConvertiblePreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableConvertiblePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableConvertiblePreferredStockMember" xlink:to="lab_us-gaap_RedeemableConvertiblePreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityYearTwo_9bc0e17b-32ca-4e1e-9ae0-c074a06041bd_terseLabel_en-US" xlink:label="lab_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityYearTwo_label_en-US" xlink:label="lab_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Liability and Long-Term Debt Maturity, Year Two</link:label>
    <link:label id="lab_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityYearTwo_documentation_en-US" xlink:label="lab_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityYearTwo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Liability and Long-Term Debt Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityYearTwo" xlink:href="prct-20220630.xsd#prct_OperatingLeaseLiabilityAndLongTermDebtMaturityYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityYearTwo" xlink:to="lab_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_3db86790-10ad-4fb3-8262-0b053f2510d0_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_cd83e5a4-cebd-41fa-959a-3a5a1d6e2236_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2cfa59db-c7d4-45a7-9c3a-513b5d058cb4_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average common stock outstanding, basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_0b836829-4474-4ac2-9de9-3456b709de32_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share, diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_139a6049-b83f-4ac4-80be-fb4fa540b050_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityYearOne_97186081-5ba7-49d5-a416-f121dce09dd1_terseLabel_en-US" xlink:label="lab_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityYearOne" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityYearOne_label_en-US" xlink:label="lab_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityYearOne" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Liability and Long-Term Debt Maturity, Year One</link:label>
    <link:label id="lab_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityYearOne_documentation_en-US" xlink:label="lab_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityYearOne" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Liability and Long-Term Debt Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityYearOne" xlink:href="prct-20220630.xsd#prct_OperatingLeaseLiabilityAndLongTermDebtMaturityYearOne"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityYearOne" xlink:to="lab_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityYearOne" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock_64707cc0-740f-420b-af06-8e60734f01f6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_DebtInstrumentContingentBorrowingExtendedInterestOnlyPeriod_cbc06d22-f999-40bc-9d5b-682bc38e93b1_terseLabel_en-US" xlink:label="lab_prct_DebtInstrumentContingentBorrowingExtendedInterestOnlyPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended interest only period (in months)</link:label>
    <link:label id="lab_prct_DebtInstrumentContingentBorrowingExtendedInterestOnlyPeriod_label_en-US" xlink:label="lab_prct_DebtInstrumentContingentBorrowingExtendedInterestOnlyPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, Contingent Borrowing, Extended Interest Only Period</link:label>
    <link:label id="lab_prct_DebtInstrumentContingentBorrowingExtendedInterestOnlyPeriod_documentation_en-US" xlink:label="lab_prct_DebtInstrumentContingentBorrowingExtendedInterestOnlyPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, Contingent Borrowing, Extended Interest Only Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_DebtInstrumentContingentBorrowingExtendedInterestOnlyPeriod" xlink:href="prct-20220630.xsd#prct_DebtInstrumentContingentBorrowingExtendedInterestOnlyPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_DebtInstrumentContingentBorrowingExtendedInterestOnlyPeriod" xlink:to="lab_prct_DebtInstrumentContingentBorrowingExtendedInterestOnlyPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_198f10bd-738b-4c09-950a-76e30f3aaaa0_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenue_c96856a7-8f2e-40e4-ba33-8b6e781fe184_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfRevenue_label_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenue" xlink:to="lab_us-gaap_CostOfRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_8b1b4e14-8e49-4615-97d8-360a8077a3ae_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_340c979b-f715-415d-9fe8-8178c5f906a1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition_4382088e-57c5-4af8-bdcc-49a4e4e24245_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Other, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_DebtInstrumentCovenantComplianceRevenueForecastAmountFirstThreeInstallmentsOnly_53e53f6a-9ea6-4325-a3ac-0c8be85a89b4_terseLabel_en-US" xlink:label="lab_prct_DebtInstrumentCovenantComplianceRevenueForecastAmountFirstThreeInstallmentsOnly" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant compliance, revenue forecast amount, first three installments only</link:label>
    <link:label id="lab_prct_DebtInstrumentCovenantComplianceRevenueForecastAmountFirstThreeInstallmentsOnly_label_en-US" xlink:label="lab_prct_DebtInstrumentCovenantComplianceRevenueForecastAmountFirstThreeInstallmentsOnly" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant Compliance, Revenue Forecast Amount, First Three Installments Only</link:label>
    <link:label id="lab_prct_DebtInstrumentCovenantComplianceRevenueForecastAmountFirstThreeInstallmentsOnly_documentation_en-US" xlink:label="lab_prct_DebtInstrumentCovenantComplianceRevenueForecastAmountFirstThreeInstallmentsOnly" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant Compliance, Revenue Forecast Amount, First Three Installments Only</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_DebtInstrumentCovenantComplianceRevenueForecastAmountFirstThreeInstallmentsOnly" xlink:href="prct-20220630.xsd#prct_DebtInstrumentCovenantComplianceRevenueForecastAmountFirstThreeInstallmentsOnly"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_DebtInstrumentCovenantComplianceRevenueForecastAmountFirstThreeInstallmentsOnly" xlink:to="lab_prct_DebtInstrumentCovenantComplianceRevenueForecastAmountFirstThreeInstallmentsOnly" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_LoanFacilityTrancheOneMember_a486b8a1-5779-47a4-9c83-5a3b835cbb7f_terseLabel_en-US" xlink:label="lab_prct_LoanFacilityTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan Facility, Tranche One</link:label>
    <link:label id="lab_prct_LoanFacilityTrancheOneMember_label_en-US" xlink:label="lab_prct_LoanFacilityTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan Facility, Tranche One [Member]</link:label>
    <link:label id="lab_prct_LoanFacilityTrancheOneMember_documentation_en-US" xlink:label="lab_prct_LoanFacilityTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan Facility, Tranche One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_LoanFacilityTrancheOneMember" xlink:href="prct-20220630.xsd#prct_LoanFacilityTrancheOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_LoanFacilityTrancheOneMember" xlink:to="lab_prct_LoanFacilityTrancheOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesNoncurrent_0e75c24b-8492-43ec-97d2-73b7d7b43711_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan facility derivative liability</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:to="lab_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_54608ce2-67a8-443a-8533-ca954e912bc0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_63354dff-0dbb-4eb9-b916-c024460e067a_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_c26b987a-57c2-442d-b875-043a03dfaa96_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_OutsideTheUnitedStatesMember_14953b62-ef94-4f7b-be61-d0045f19f93d_terseLabel_en-US" xlink:label="lab_prct_OutsideTheUnitedStatesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outside of U.S.</link:label>
    <link:label id="lab_prct_OutsideTheUnitedStatesMember_label_en-US" xlink:label="lab_prct_OutsideTheUnitedStatesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outside the United States [Member]</link:label>
    <link:label id="lab_prct_OutsideTheUnitedStatesMember_documentation_en-US" xlink:label="lab_prct_OutsideTheUnitedStatesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outside the United States</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_OutsideTheUnitedStatesMember" xlink:href="prct-20220630.xsd#prct_OutsideTheUnitedStatesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_OutsideTheUnitedStatesMember" xlink:to="lab_prct_OutsideTheUnitedStatesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_0684aaac-a387-4935-b363-c1b01d4eb6c2_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_SystemSalesAndRentalsMember_4e1a486b-628b-4870-8741-7b391542a2a8_terseLabel_en-US" xlink:label="lab_prct_SystemSalesAndRentalsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">System sales and rentals</link:label>
    <link:label id="lab_prct_SystemSalesAndRentalsMember_label_en-US" xlink:label="lab_prct_SystemSalesAndRentalsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">System Sales and Rentals [Member]</link:label>
    <link:label id="lab_prct_SystemSalesAndRentalsMember_documentation_en-US" xlink:label="lab_prct_SystemSalesAndRentalsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">System Sales and Rentals</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_SystemSalesAndRentalsMember" xlink:href="prct-20220630.xsd#prct_SystemSalesAndRentalsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_SystemSalesAndRentalsMember" xlink:to="lab_prct_SystemSalesAndRentalsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedSalariesCurrent_ca26f966-30f5-47e3-a1ea-20531358107d_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedSalariesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation</link:label>
    <link:label id="lab_us-gaap_AccruedSalariesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedSalariesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Salaries, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalariesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedSalariesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedSalariesCurrent" xlink:to="lab_us-gaap_AccruedSalariesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_5d200ccd-89e6-49a6-8268-c26b67a475bf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLongTermLinesOfCredit_0b7c8625-ebcf-4a4d-aaea-faa59ca5e7a2_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from long-term lines of credit</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLongTermLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Long-term Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_cc230a0a-01e7-431e-a9f7-a510969cf086_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_932c89f2-c19b-437d-bb96-3d54cc717e4e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_dc470d24-f2a5-4912-884f-d08b2436ab02_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_46ee494c-86ee-403c-9f9c-0e6a9142b3f9_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Convertible Preferred Stock</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_6d1bacda-41a7-4c36-b39f-7f4ea3aca626_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_c8c5c997-a486-4314-8417-0cc07306b796_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to acquire intangible assets</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_b5d7c933-3f8a-4da4-8dd0-99f489a411b8_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_1e49b80b-c9a8-42dc-8b57-657cf24c1abe_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_3042dc08-8875-4b83-b0fa-a4fc218ae37c_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_effccb7a-7079-42a9-addc-43fedbb234bc_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain on cash equivalents</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_84e35051-838f-4abe-9b37-f2a0a542ea37_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_5970c1e0-f4a0-4226-8c71-0dde1f323350_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_d59c36bd-48c5-40b2-856d-562b199dd7c6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facility term (in years)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_4ebfd7e9-f706-4559-bc78-63ecae7a0295_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash investing and financing activities</link:label>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskDisclosureTextBlock_3c436de9-4839-4e9f-9881-f9062dd9a261_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment, Geographical, and Customer Concentration</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:to="lab_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_21a1feed-9b1f-4c5f-9d07-f474b1908699_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_092cf4ca-8580-4c2d-ae60-823a1386a38e_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_bfb66cc3-c0e5-4215-a0e0-17d1acef2d95_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity and Share-based Payments [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_9fe56a9b-75d2-41fd-834f-b7615c94f9b4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_3229bb15-dc48-4fca-b887-790323e1812a_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_53294d96-99a1-4687-bb31-7db14a928c84_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_707d92ae-aa48-4706-9425-3601caa70cf4_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of Series G preferred stock, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Preferred Stock and Preference Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_4825bae1-002f-4898-98a3-35915ccc35a8_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current borrowing amount</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Current Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_1f35bbdc-39a7-400d-a807-8ec50986d16d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_228c2d76-4d15-4ec4-a465-0764c10db8ff_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_21e6d950-895d-48b5-8204-e3cb201bab2c_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoods" xlink:to="lab_us-gaap_InventoryFinishedGoods" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_8f7dbbab-7d99-4c4f-a79f-01928cce9a9b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Line Items]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsLineItems" xlink:to="lab_us-gaap_OtherCommitmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_91ffc74a-3278-45e9-aa0a-8ff9ef7381d2_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at the beginning of the period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_5a79fb9c-0142-488e-afe3-1a9be7bf10ae_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at the end of the period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantMember_4d1549dd-1c56-49a1-94db-d08f9d4135e9_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Warrants</link:label>
    <link:label id="lab_us-gaap_WarrantMember_label_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember" xlink:to="lab_us-gaap_WarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_16dbbeb4-2a70-4319-8567-0693e17e91cf_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note payable &#8211; non-current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_70b553b6-a66d-417d-a933-1af72968f1cb_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_6f7a5d36-3e6a-4d8a-b27d-7ca51d114083_verboseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_735fe563-a6d6-4345-af51-a8a6f3b64f20_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_32dadd92-4b99-4f7a-ab7c-f6978a7eabe3_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Including Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_fd959a2e-0f2b-405c-9557-bc45891b932a_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_LineOfCreditFacilityCovenantComplianceContingentTrailingTwelveMonthRevenueTarget_3a79373c-fc39-440e-93d4-c191d4dfb24f_terseLabel_en-US" xlink:label="lab_prct_LineOfCreditFacilityCovenantComplianceContingentTrailingTwelveMonthRevenueTarget" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trailing twelve month revenue target</link:label>
    <link:label id="lab_prct_LineOfCreditFacilityCovenantComplianceContingentTrailingTwelveMonthRevenueTarget_label_en-US" xlink:label="lab_prct_LineOfCreditFacilityCovenantComplianceContingentTrailingTwelveMonthRevenueTarget" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Covenant Compliance, Contingent Trailing Twelve Month Revenue Target</link:label>
    <link:label id="lab_prct_LineOfCreditFacilityCovenantComplianceContingentTrailingTwelveMonthRevenueTarget_documentation_en-US" xlink:label="lab_prct_LineOfCreditFacilityCovenantComplianceContingentTrailingTwelveMonthRevenueTarget" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Covenant Compliance, Contingent Trailing Twelve Month Revenue Target</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_LineOfCreditFacilityCovenantComplianceContingentTrailingTwelveMonthRevenueTarget" xlink:href="prct-20220630.xsd#prct_LineOfCreditFacilityCovenantComplianceContingentTrailingTwelveMonthRevenueTarget"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_LineOfCreditFacilityCovenantComplianceContingentTrailingTwelveMonthRevenueTarget" xlink:to="lab_prct_LineOfCreditFacilityCovenantComplianceContingentTrailingTwelveMonthRevenueTarget" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_685940b7-8878-422b-990a-102b1236b126_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_42cdd891-5671-4b59-8627-17b2fd42042e_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible preferred stock, shares, number of shares issued upon conversion (in shares)</link:label>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_label_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock, Shares Issued upon Conversion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:to="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_OperatingLeaseNumberOfSquareFeet_5a1a41af-c472-408e-b351-69232278354b_terseLabel_en-US" xlink:label="lab_prct_OperatingLeaseNumberOfSquareFeet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of square feet</link:label>
    <link:label id="lab_prct_OperatingLeaseNumberOfSquareFeet_label_en-US" xlink:label="lab_prct_OperatingLeaseNumberOfSquareFeet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Number of Square Feet</link:label>
    <link:label id="lab_prct_OperatingLeaseNumberOfSquareFeet_documentation_en-US" xlink:label="lab_prct_OperatingLeaseNumberOfSquareFeet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Number of Square Feet</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_OperatingLeaseNumberOfSquareFeet" xlink:href="prct-20220630.xsd#prct_OperatingLeaseNumberOfSquareFeet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_OperatingLeaseNumberOfSquareFeet" xlink:to="lab_prct_OperatingLeaseNumberOfSquareFeet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_3d2bd67e-bffa-4acc-b498-bb8f8028525e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding and exercisable, aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_fd8fea96-40b4-43af-861e-d6a323b7652f_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:to="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f7cc8ba8-fd5b-4408-ba83-cc83e06d031c_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and restricted cash- Beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9bcf67d9-3fe9-4fc6-afd1-c289ba334606_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and restricted cash - End of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_511e50f5-d431-4d71-9f46-8c74723446e9_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash in balance sheets</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_1331d1a9-1d5e-45f4-9171-bebfbb2988b9_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S.</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_d44984ee-a21b-4d11-9cd1-6044f9cc3be1_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of stock, number of shares issued in transaction (in shares)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_3e1d0e68-cc12-4608-9f7c-5625f002e51e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_d335540f-a482-4dd5-bc68-ebe3e6271959_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_2c9bc97c-a0a0-4a54-a345-9ae375de2892_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR)</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_aba12c68-65a2-41a4-ad07-2a9fa1a01974_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_LoanFacilityTrancheFourMember_38fb27fd-63af-4de9-a76f-8ca054690684_terseLabel_en-US" xlink:label="lab_prct_LoanFacilityTrancheFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan Facility, Tranche Four</link:label>
    <link:label id="lab_prct_LoanFacilityTrancheFourMember_label_en-US" xlink:label="lab_prct_LoanFacilityTrancheFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan Facility, Tranche Four [Member]</link:label>
    <link:label id="lab_prct_LoanFacilityTrancheFourMember_documentation_en-US" xlink:label="lab_prct_LoanFacilityTrancheFourMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan Facility, Tranche Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_LoanFacilityTrancheFourMember" xlink:href="prct-20220630.xsd#prct_LoanFacilityTrancheFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_LoanFacilityTrancheFourMember" xlink:to="lab_prct_LoanFacilityTrancheFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_536a7dbd-33da-45a1-a704-8fc127b5fd5b_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance upon exercise of options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_cdee0946-ed96-4b89-90ed-9ae9aee9dcf7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_88bfdf1f-42f4-4355-892c-09e54d93c16c_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0692b848-e3bc-4993-b5c0-5cbf0fe2d56b_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average common stock outstanding, diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_afd6c9d8-b362-4636-8c6e-e0b0e2b0d70d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OverAllotmentOptionMember_6e3a2d6c-e6e1-4b18-a7db-e41b20ea2e41_terseLabel_en-US" xlink:label="lab_us-gaap_OverAllotmentOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Over-Allotment Option</link:label>
    <link:label id="lab_us-gaap_OverAllotmentOptionMember_label_en-US" xlink:label="lab_us-gaap_OverAllotmentOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Over-Allotment Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OverAllotmentOptionMember" xlink:to="lab_us-gaap_OverAllotmentOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityGross_fd264172-835e-46bc-baae-39fb52af6a21_totalLabel_en-US" xlink:label="lab_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total minimum payments</link:label>
    <link:label id="lab_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityGross_label_en-US" xlink:label="lab_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Liability and Long-Term Debt Maturity, Gross</link:label>
    <link:label id="lab_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityGross_documentation_en-US" xlink:label="lab_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Liability and Long-Term Debt Maturity, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityGross" xlink:href="prct-20220630.xsd#prct_OperatingLeaseLiabilityAndLongTermDebtMaturityGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityGross" xlink:to="lab_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_26ce34f8-eef4-4b87-aff2-3e61abbdaa19_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_6a6f2cb5-adf6-4718-89e9-c8d871ee6c6c_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Revenue from Segments to Consolidated [Table]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Revenue from Segments to Consolidated [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:to="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_0be4191f-4d58-411f-bc2b-aeea7b5f7058_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_f16719b5-b9d6-4346-9537-11dc2f94cb89_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_fdd09b8c-f193-42d0-b198-5ec83d620354_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_859d8610-b553-4900-b32b-9f8c83abe945_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d371fec6-102f-428e-832c-79ca51a5741a_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_4e7c7b69-1852-4d07-bd3a-7145d31817e6_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued under employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_a8aae006-c587-4724-b5cc-c1137e42a4e9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on cash equivalents</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9600c6c7-9b17-49f4-bd19-141c63811e6f_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_63150a46-6c5a-4b68-bda1-ee22468d219c_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_fa831fcf-68fe-4418-b353-4afa888b4f17_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected life (years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_7a3e0064-c6f0-4d24-8dbd-fe501e4ef9cc_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_31e69ff0-faad-4d45-a26b-9604b80be6c5_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_Customer1Member_a7bb52a4-7573-46c5-8f61-2f0301cd59d2_terseLabel_en-US" xlink:label="lab_prct_Customer1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer 1</link:label>
    <link:label id="lab_prct_Customer1Member_label_en-US" xlink:label="lab_prct_Customer1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer 1 [Member]</link:label>
    <link:label id="lab_prct_Customer1Member_documentation_en-US" xlink:label="lab_prct_Customer1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer 1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_Customer1Member" xlink:href="prct-20220630.xsd#prct_Customer1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_Customer1Member" xlink:to="lab_prct_Customer1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_a3ff5ce4-4a63-4f66-a6cf-784faed6df0a_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan facility, maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForUnderwritingExpense_033af388-ebcd-487e-b968-fa6a6fb0b0bc_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForUnderwritingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for underwriting discount and commissions</link:label>
    <link:label id="lab_us-gaap_PaymentsForUnderwritingExpense_label_en-US" xlink:label="lab_us-gaap_PaymentsForUnderwritingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Underwriting Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForUnderwritingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForUnderwritingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForUnderwritingExpense" xlink:to="lab_us-gaap_PaymentsForUnderwritingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_68d45d9a-b035-4573-aae7-00f491b8bdea_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding, aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_2ca425dd-e054-4ad8-99e4-dfef42a5fb7d_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmountAchievedExtendedPrincipalAndInterestPeriod_e57d1488-21b5-4ab4-9f68-46a6a2f77949_terseLabel_en-US" xlink:label="lab_prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmountAchievedExtendedPrincipalAndInterestPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant compliance, IPO capital raised in threshold amount achieved, extended principal and interest only period (in months)</link:label>
    <link:label id="lab_prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmountAchievedExtendedPrincipalAndInterestPeriod_label_en-US" xlink:label="lab_prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmountAchievedExtendedPrincipalAndInterestPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant Compliance, Capital Raised in IPO Threshold Amount Achieved, Extended Principal and Interest Period</link:label>
    <link:label id="lab_prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmountAchievedExtendedPrincipalAndInterestPeriod_documentation_en-US" xlink:label="lab_prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmountAchievedExtendedPrincipalAndInterestPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant Compliance, Capital Raised in IPO Threshold Amount Achieved, Extended Principal and Interest Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmountAchievedExtendedPrincipalAndInterestPeriod" xlink:href="prct-20220630.xsd#prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmountAchievedExtendedPrincipalAndInterestPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmountAchievedExtendedPrincipalAndInterestPeriod" xlink:to="lab_prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmountAchievedExtendedPrincipalAndInterestPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_b52879b2-f1a5-4ca4-842f-05ee38efe0b3_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_f2f83610-f77b-435c-b498-731279eb8ddb_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_5cce4ec7-201c-44a0-9597-3211bb8cec83_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_50212e94-1662-45f6-ad29-61424bd20c01_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_2990fa94-1b8d-4a11-9099-75ed987b55f4_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation cost</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_18dfc342-3775-47ad-86ee-8dd50d7cf923_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liability, loan facility</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Fair Value, Gross Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_NonCashLeaseAccretionExpense_f373a593-0984-4dda-ae96-ac1c014f4c7c_negatedTerseLabel_en-US" xlink:label="lab_prct_NonCashLeaseAccretionExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash lease adjustment</link:label>
    <link:label id="lab_prct_NonCashLeaseAccretionExpense_label_en-US" xlink:label="lab_prct_NonCashLeaseAccretionExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash Lease Accretion Expense</link:label>
    <link:label id="lab_prct_NonCashLeaseAccretionExpense_documentation_en-US" xlink:label="lab_prct_NonCashLeaseAccretionExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash Lease Accretion Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_NonCashLeaseAccretionExpense" xlink:href="prct-20220630.xsd#prct_NonCashLeaseAccretionExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_NonCashLeaseAccretionExpense" xlink:to="lab_prct_NonCashLeaseAccretionExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_91aaf2a9-22f9-47bb-8d74-a69c1322598d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: amount representing interest/unamortized debt discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_OperatingLeaseLiabilityAndLongTermDebtExcludingCurrentMaturities_57301882-685b-4253-91cf-5f347124367a_terseLabel_en-US" xlink:label="lab_prct_OperatingLeaseLiabilityAndLongTermDebtExcludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current portion</link:label>
    <link:label id="lab_prct_OperatingLeaseLiabilityAndLongTermDebtExcludingCurrentMaturities_label_en-US" xlink:label="lab_prct_OperatingLeaseLiabilityAndLongTermDebtExcludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Liability and Long-Term Debt, Excluding Current Maturities</link:label>
    <link:label id="lab_prct_OperatingLeaseLiabilityAndLongTermDebtExcludingCurrentMaturities_documentation_en-US" xlink:label="lab_prct_OperatingLeaseLiabilityAndLongTermDebtExcludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Liability and Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_OperatingLeaseLiabilityAndLongTermDebtExcludingCurrentMaturities" xlink:href="prct-20220630.xsd#prct_OperatingLeaseLiabilityAndLongTermDebtExcludingCurrentMaturities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_OperatingLeaseLiabilityAndLongTermDebtExcludingCurrentMaturities" xlink:to="lab_prct_OperatingLeaseLiabilityAndLongTermDebtExcludingCurrentMaturities" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmount_b94da5b4-783c-44b8-b586-ba3eb09a0154_terseLabel_en-US" xlink:label="lab_prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant compliance, IPO capital raised in threshold amount</link:label>
    <link:label id="lab_prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmount_label_en-US" xlink:label="lab_prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant Compliance, Capital Raised in IPO Threshold Amount</link:label>
    <link:label id="lab_prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmount_documentation_en-US" xlink:label="lab_prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant Compliance, Capital Raised in IPO Threshold Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmount" xlink:href="prct-20220630.xsd#prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmount" xlink:to="lab_prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_8302c821-2dbe-4789-b799-155c53f48e97_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3823f3ad-2acf-43d4-90bd-a116fe1ae9a5_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net loss to cash used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_f7c969c2-d54d-45c8-95f8-636e265b4369_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_prct_LineOfCreditFacilityEarlyRepaymentFeeFirstTwelveMonthPercent_75978a19-27fe-47d0-a28d-3e32e26dbaf3_terseLabel_en-US" xlink:label="lab_prct_LineOfCreditFacilityEarlyRepaymentFeeFirstTwelveMonthPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Early repayment fee first twelve month, percent</link:label>
    <link:label id="lab_prct_LineOfCreditFacilityEarlyRepaymentFeeFirstTwelveMonthPercent_label_en-US" xlink:label="lab_prct_LineOfCreditFacilityEarlyRepaymentFeeFirstTwelveMonthPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Early Repayment Fee First Twelve Month, Percent</link:label>
    <link:label id="lab_prct_LineOfCreditFacilityEarlyRepaymentFeeFirstTwelveMonthPercent_documentation_en-US" xlink:label="lab_prct_LineOfCreditFacilityEarlyRepaymentFeeFirstTwelveMonthPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Early Repayment Fee First Twelve Month, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prct_LineOfCreditFacilityEarlyRepaymentFeeFirstTwelveMonthPercent" xlink:href="prct-20220630.xsd#prct_LineOfCreditFacilityEarlyRepaymentFeeFirstTwelveMonthPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prct_LineOfCreditFacilityEarlyRepaymentFeeFirstTwelveMonthPercent" xlink:to="lab_prct_LineOfCreditFacilityEarlyRepaymentFeeFirstTwelveMonthPercent" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>prct-20220630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:311bf6b2-ae92-4a64-91ca-35c82a3f09ce,g:4b68a96a-367b-4d30-a7c4-4a5adc893ec2-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/Coverpage" xlink:type="simple" xlink:href="prct-20220630.xsd#Coverpage"/>
  <link:presentationLink xlink:role="http://www.procept-biorobotics.com/role/Coverpage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_8b064a6b-f131-4af3-886d-9876faedacdc" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_46f77c3b-3700-486b-84c3-b73a4b593f8a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8b064a6b-f131-4af3-886d-9876faedacdc" xlink:to="loc_dei_DocumentType_46f77c3b-3700-486b-84c3-b73a4b593f8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_95dc1907-54f9-4bad-ab32-a46baec0056c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8b064a6b-f131-4af3-886d-9876faedacdc" xlink:to="loc_dei_DocumentQuarterlyReport_95dc1907-54f9-4bad-ab32-a46baec0056c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_205621cb-df27-4fd9-b796-60ff2b7f30be" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8b064a6b-f131-4af3-886d-9876faedacdc" xlink:to="loc_dei_DocumentPeriodEndDate_205621cb-df27-4fd9-b796-60ff2b7f30be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_73bf1b07-fdf6-46f3-ae2c-fed24dcb743b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8b064a6b-f131-4af3-886d-9876faedacdc" xlink:to="loc_dei_DocumentTransitionReport_73bf1b07-fdf6-46f3-ae2c-fed24dcb743b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_024c10af-104b-4f56-9184-040e723757d0" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8b064a6b-f131-4af3-886d-9876faedacdc" xlink:to="loc_dei_EntityFileNumber_024c10af-104b-4f56-9184-040e723757d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_2456093b-3069-40bd-be29-2629405d6f16" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8b064a6b-f131-4af3-886d-9876faedacdc" xlink:to="loc_dei_EntityRegistrantName_2456093b-3069-40bd-be29-2629405d6f16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_158035cc-9161-425c-ad33-a173076e4fdf" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8b064a6b-f131-4af3-886d-9876faedacdc" xlink:to="loc_dei_EntityIncorporationStateCountryCode_158035cc-9161-425c-ad33-a173076e4fdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_621154e5-df0d-4703-9986-64733bdfc739" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8b064a6b-f131-4af3-886d-9876faedacdc" xlink:to="loc_dei_EntityTaxIdentificationNumber_621154e5-df0d-4703-9986-64733bdfc739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_0bc4659b-10c5-4fac-b6b3-df49219a6c87" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8b064a6b-f131-4af3-886d-9876faedacdc" xlink:to="loc_dei_EntityAddressAddressLine1_0bc4659b-10c5-4fac-b6b3-df49219a6c87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_b3a12093-cc9d-42a9-b9b2-90f592045d59" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8b064a6b-f131-4af3-886d-9876faedacdc" xlink:to="loc_dei_EntityAddressCityOrTown_b3a12093-cc9d-42a9-b9b2-90f592045d59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_5ef16cef-df90-4eb8-99a9-576b15d348d5" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8b064a6b-f131-4af3-886d-9876faedacdc" xlink:to="loc_dei_EntityAddressStateOrProvince_5ef16cef-df90-4eb8-99a9-576b15d348d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_afcd8d30-9334-4fe4-9c5a-bb388856b9a8" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8b064a6b-f131-4af3-886d-9876faedacdc" xlink:to="loc_dei_EntityAddressPostalZipCode_afcd8d30-9334-4fe4-9c5a-bb388856b9a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_e70f11be-8f93-411a-a713-f521925b0cf0" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8b064a6b-f131-4af3-886d-9876faedacdc" xlink:to="loc_dei_CityAreaCode_e70f11be-8f93-411a-a713-f521925b0cf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_1e3e5ca7-61d2-4268-afde-4ad0a37421a8" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8b064a6b-f131-4af3-886d-9876faedacdc" xlink:to="loc_dei_LocalPhoneNumber_1e3e5ca7-61d2-4268-afde-4ad0a37421a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_11ec263e-acb8-4c03-b41a-a617c28ef104" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8b064a6b-f131-4af3-886d-9876faedacdc" xlink:to="loc_dei_Security12bTitle_11ec263e-acb8-4c03-b41a-a617c28ef104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_f269635d-4f39-4fa8-bc7a-4640cd185e5c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8b064a6b-f131-4af3-886d-9876faedacdc" xlink:to="loc_dei_TradingSymbol_f269635d-4f39-4fa8-bc7a-4640cd185e5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_ff4999fb-c74a-4a4f-98ed-1810136a88a9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8b064a6b-f131-4af3-886d-9876faedacdc" xlink:to="loc_dei_SecurityExchangeName_ff4999fb-c74a-4a4f-98ed-1810136a88a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_7554f111-be31-4f56-bb7d-fbea558a8c30" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8b064a6b-f131-4af3-886d-9876faedacdc" xlink:to="loc_dei_EntityCurrentReportingStatus_7554f111-be31-4f56-bb7d-fbea558a8c30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_5a2a5d78-2c99-468a-b3bb-5534bbfdc0a3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8b064a6b-f131-4af3-886d-9876faedacdc" xlink:to="loc_dei_EntityInteractiveDataCurrent_5a2a5d78-2c99-468a-b3bb-5534bbfdc0a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_7618b14a-89d9-4c5a-a9cb-243a46eb770e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8b064a6b-f131-4af3-886d-9876faedacdc" xlink:to="loc_dei_EntityFilerCategory_7618b14a-89d9-4c5a-a9cb-243a46eb770e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_6891704b-d3bc-48e2-99ba-d24d343aae65" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8b064a6b-f131-4af3-886d-9876faedacdc" xlink:to="loc_dei_EntitySmallBusiness_6891704b-d3bc-48e2-99ba-d24d343aae65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_4db8835a-834a-4fd5-9ec3-5357d8d171f8" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8b064a6b-f131-4af3-886d-9876faedacdc" xlink:to="loc_dei_EntityEmergingGrowthCompany_4db8835a-834a-4fd5-9ec3-5357d8d171f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_b44f5d82-38a2-4459-aee5-63c303653d2b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8b064a6b-f131-4af3-886d-9876faedacdc" xlink:to="loc_dei_EntityExTransitionPeriod_b44f5d82-38a2-4459-aee5-63c303653d2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_3d0f86ba-ee2a-47e0-aec5-9f309d2426b9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8b064a6b-f131-4af3-886d-9876faedacdc" xlink:to="loc_dei_EntityShellCompany_3d0f86ba-ee2a-47e0-aec5-9f309d2426b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_225da40f-0d46-4869-a7b8-8c1d35d36b3e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8b064a6b-f131-4af3-886d-9876faedacdc" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_225da40f-0d46-4869-a7b8-8c1d35d36b3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_13eadcc1-a8d6-4df5-b43d-107b8b0416c7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8b064a6b-f131-4af3-886d-9876faedacdc" xlink:to="loc_dei_EntityCentralIndexKey_13eadcc1-a8d6-4df5-b43d-107b8b0416c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_7be39ea5-129a-46ba-ae08-a0e79d003ebf" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8b064a6b-f131-4af3-886d-9876faedacdc" xlink:to="loc_dei_CurrentFiscalYearEndDate_7be39ea5-129a-46ba-ae08-a0e79d003ebf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_b3dc5b35-48a0-4f10-b643-dc861a296b25" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8b064a6b-f131-4af3-886d-9876faedacdc" xlink:to="loc_dei_DocumentFiscalYearFocus_b3dc5b35-48a0-4f10-b643-dc861a296b25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_75e2f845-7144-49ef-9116-85b4222d53e0" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8b064a6b-f131-4af3-886d-9876faedacdc" xlink:to="loc_dei_AmendmentFlag_75e2f845-7144-49ef-9116-85b4222d53e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_81fae60a-c3f8-4ab0-abfc-3576cafd2249" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8b064a6b-f131-4af3-886d-9876faedacdc" xlink:to="loc_dei_DocumentFiscalPeriodFocus_81fae60a-c3f8-4ab0-abfc-3576cafd2249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="prct-20220630.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_0d444973-b834-4ff7-82ab-a39428a2557c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_41f12f1e-a98b-4396-b937-15512900fe02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0d444973-b834-4ff7-82ab-a39428a2557c" xlink:to="loc_us-gaap_AssetsAbstract_41f12f1e-a98b-4396-b937-15512900fe02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_fcfc7e8e-7a4a-4b10-a0b7-26cb29e1b277" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_41f12f1e-a98b-4396-b937-15512900fe02" xlink:to="loc_us-gaap_AssetsCurrentAbstract_fcfc7e8e-7a4a-4b10-a0b7-26cb29e1b277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3c333f00-c581-4975-9dbe-b689061ff171" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_fcfc7e8e-7a4a-4b10-a0b7-26cb29e1b277" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3c333f00-c581-4975-9dbe-b689061ff171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_f9361deb-fd7d-4784-9936-524f64c0ad29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_fcfc7e8e-7a4a-4b10-a0b7-26cb29e1b277" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_f9361deb-fd7d-4784-9936-524f64c0ad29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_8a1ec128-fb6c-4f4b-b054-8c4b2f76f3ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_fcfc7e8e-7a4a-4b10-a0b7-26cb29e1b277" xlink:to="loc_us-gaap_InventoryNet_8a1ec128-fb6c-4f4b-b054-8c4b2f76f3ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3ce3ddbb-5a98-454f-ad5e-f71ce2f9885f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_fcfc7e8e-7a4a-4b10-a0b7-26cb29e1b277" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3ce3ddbb-5a98-454f-ad5e-f71ce2f9885f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_95a3a044-1c0b-4f76-affa-4077c1158859" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_fcfc7e8e-7a4a-4b10-a0b7-26cb29e1b277" xlink:to="loc_us-gaap_AssetsCurrent_95a3a044-1c0b-4f76-affa-4077c1158859" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_e02ea29d-6fdb-49e5-8d6d-561cd11ae03a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_41f12f1e-a98b-4396-b937-15512900fe02" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_e02ea29d-6fdb-49e5-8d6d-561cd11ae03a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_fdecdde9-fa05-409b-a8c5-daa68fe20e58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_41f12f1e-a98b-4396-b937-15512900fe02" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_fdecdde9-fa05-409b-a8c5-daa68fe20e58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_f353453c-81a7-4ccc-846d-f0cb7ececb3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_41f12f1e-a98b-4396-b937-15512900fe02" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_f353453c-81a7-4ccc-846d-f0cb7ececb3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_2fefefb1-3eca-4728-a0b0-fd9baeb70c17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_41f12f1e-a98b-4396-b937-15512900fe02" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_2fefefb1-3eca-4728-a0b0-fd9baeb70c17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_63ae93f5-e1e4-4d26-b586-f839b838f066" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_41f12f1e-a98b-4396-b937-15512900fe02" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_63ae93f5-e1e4-4d26-b586-f839b838f066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_8d5f0f4c-020f-4979-9ecb-1d44cb37d8aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_41f12f1e-a98b-4396-b937-15512900fe02" xlink:to="loc_us-gaap_Assets_8d5f0f4c-020f-4979-9ecb-1d44cb37d8aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ac4a6338-9909-45e1-878c-bf32054954e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0d444973-b834-4ff7-82ab-a39428a2557c" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ac4a6338-9909-45e1-878c-bf32054954e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_d466fd1d-d900-403f-9421-d41fe6a9c80b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ac4a6338-9909-45e1-878c-bf32054954e2" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_d466fd1d-d900-403f-9421-d41fe6a9c80b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_36195651-acde-4564-9edb-3020e378bd14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d466fd1d-d900-403f-9421-d41fe6a9c80b" xlink:to="loc_us-gaap_AccountsPayableCurrent_36195651-acde-4564-9edb-3020e378bd14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalariesCurrent_4f74cd69-1696-443e-ac9f-f75408e94f21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedSalariesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d466fd1d-d900-403f-9421-d41fe6a9c80b" xlink:to="loc_us-gaap_AccruedSalariesCurrent_4f74cd69-1696-443e-ac9f-f75408e94f21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_cf5e5173-6550-4519-a492-c34ed8d890fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d466fd1d-d900-403f-9421-d41fe6a9c80b" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_cf5e5173-6550-4519-a492-c34ed8d890fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_fed5cf0c-f0be-41e8-8de3-99fbf484a3da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d466fd1d-d900-403f-9421-d41fe6a9c80b" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_fed5cf0c-f0be-41e8-8de3-99fbf484a3da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_3cd575c5-f883-42f4-a345-525f5050c37e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d466fd1d-d900-403f-9421-d41fe6a9c80b" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_3cd575c5-f883-42f4-a345-525f5050c37e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_6c091165-0208-4316-a262-60be16a32121" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d466fd1d-d900-403f-9421-d41fe6a9c80b" xlink:to="loc_us-gaap_LiabilitiesCurrent_6c091165-0208-4316-a262-60be16a32121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_b76e4307-5e75-46f7-b244-1fd44d8789e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ac4a6338-9909-45e1-878c-bf32054954e2" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_b76e4307-5e75-46f7-b244-1fd44d8789e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_369c3262-fb55-484f-b310-a4be4a8cc870" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ac4a6338-9909-45e1-878c-bf32054954e2" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_369c3262-fb55-484f-b310-a4be4a8cc870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent_34fbc056-683d-446d-bad2-df0f365695cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ac4a6338-9909-45e1-878c-bf32054954e2" xlink:to="loc_us-gaap_DerivativeLiabilitiesNoncurrent_34fbc056-683d-446d-bad2-df0f365695cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_5931f3e8-b719-4df6-b637-9d14c1c0b8bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ac4a6338-9909-45e1-878c-bf32054954e2" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_5931f3e8-b719-4df6-b637-9d14c1c0b8bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_21d2319f-aa95-4cf1-b39a-045316c64086" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ac4a6338-9909-45e1-878c-bf32054954e2" xlink:to="loc_us-gaap_Liabilities_21d2319f-aa95-4cf1-b39a-045316c64086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_adb1baa6-e98d-4c66-85f0-95ead92fbd7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ac4a6338-9909-45e1-878c-bf32054954e2" xlink:to="loc_us-gaap_CommitmentsAndContingencies_adb1baa6-e98d-4c66-85f0-95ead92fbd7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_91ef764e-fb9c-41ba-87fe-118d3b8e8863" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ac4a6338-9909-45e1-878c-bf32054954e2" xlink:to="loc_us-gaap_StockholdersEquityAbstract_91ef764e-fb9c-41ba-87fe-118d3b8e8863" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_e45373fe-5304-41a2-83a6-c28144b1ed4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_91ef764e-fb9c-41ba-87fe-118d3b8e8863" xlink:to="loc_us-gaap_PreferredStockValue_e45373fe-5304-41a2-83a6-c28144b1ed4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_79a0da67-50f4-4ad8-b546-502294a80bc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_91ef764e-fb9c-41ba-87fe-118d3b8e8863" xlink:to="loc_us-gaap_CommonStockValue_79a0da67-50f4-4ad8-b546-502294a80bc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_20fa9c51-a623-4c47-b06d-ba824a66e7fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_91ef764e-fb9c-41ba-87fe-118d3b8e8863" xlink:to="loc_us-gaap_AdditionalPaidInCapital_20fa9c51-a623-4c47-b06d-ba824a66e7fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_dc255fe9-9a41-4226-a944-82782563f77c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_91ef764e-fb9c-41ba-87fe-118d3b8e8863" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_dc255fe9-9a41-4226-a944-82782563f77c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_7ff8e05b-6980-47ec-bba6-6c49c8a1bb19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_91ef764e-fb9c-41ba-87fe-118d3b8e8863" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_7ff8e05b-6980-47ec-bba6-6c49c8a1bb19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_42add94d-e227-4c8c-9120-7bafce2ed162" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_91ef764e-fb9c-41ba-87fe-118d3b8e8863" xlink:to="loc_us-gaap_StockholdersEquity_42add94d-e227-4c8c-9120-7bafce2ed162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_dda981db-ccf1-4c85-be77-430b95b4627a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ac4a6338-9909-45e1-878c-bf32054954e2" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_dda981db-ccf1-4c85-be77-430b95b4627a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheetsParentheticals" xlink:type="simple" xlink:href="prct-20220630.xsd#CondensedConsolidatedBalanceSheetsParentheticals"/>
  <link:presentationLink xlink:role="http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheetsParentheticals" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_be2a6fc1-1cea-49fc-b5b7-05b286bc9e97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_50f0c246-9099-4140-9c7e-e18bd8b25a41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_be2a6fc1-1cea-49fc-b5b7-05b286bc9e97" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_50f0c246-9099-4140-9c7e-e18bd8b25a41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_839eed5f-e928-42f0-acf0-9c74942bdb43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_be2a6fc1-1cea-49fc-b5b7-05b286bc9e97" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_839eed5f-e928-42f0-acf0-9c74942bdb43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_20147a10-f6af-40e1-8e69-953af794a6d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_be2a6fc1-1cea-49fc-b5b7-05b286bc9e97" xlink:to="loc_us-gaap_PreferredStockSharesIssued_20147a10-f6af-40e1-8e69-953af794a6d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_7923eaa7-b1ce-4a9f-81e1-4759dd6d15a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_be2a6fc1-1cea-49fc-b5b7-05b286bc9e97" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_7923eaa7-b1ce-4a9f-81e1-4759dd6d15a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_2902d025-82a2-45a2-9e83-b112f761df32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_be2a6fc1-1cea-49fc-b5b7-05b286bc9e97" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_2902d025-82a2-45a2-9e83-b112f761df32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_9e7bbed6-ddd7-444e-8e4a-246624018da4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_be2a6fc1-1cea-49fc-b5b7-05b286bc9e97" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_9e7bbed6-ddd7-444e-8e4a-246624018da4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_13ba8fa6-960b-49fc-8e28-4384263c1440" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_be2a6fc1-1cea-49fc-b5b7-05b286bc9e97" xlink:to="loc_us-gaap_CommonStockSharesIssued_13ba8fa6-960b-49fc-8e28-4384263c1440" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_9bdc8579-0fd4-4365-95e7-477dcafcf421" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_be2a6fc1-1cea-49fc-b5b7-05b286bc9e97" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_9bdc8579-0fd4-4365-95e7-477dcafcf421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="simple" xlink:href="prct-20220630.xsd#CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_769de978-5522-4c02-abef-f9aa255fcc44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a3bbed44-5804-4f22-af1c-a2188d8bb865" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_769de978-5522-4c02-abef-f9aa255fcc44" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a3bbed44-5804-4f22-af1c-a2188d8bb865" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_8faca9c0-6383-400f-813a-4fce76153eda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_769de978-5522-4c02-abef-f9aa255fcc44" xlink:to="loc_us-gaap_CostOfRevenue_8faca9c0-6383-400f-813a-4fce76153eda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_4433271c-2bcf-49a3-8397-4df6ffa42ed8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_769de978-5522-4c02-abef-f9aa255fcc44" xlink:to="loc_us-gaap_GrossProfit_4433271c-2bcf-49a3-8397-4df6ffa42ed8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_8d22fcb6-f728-4e8b-8e94-ef52a1ab10c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_769de978-5522-4c02-abef-f9aa255fcc44" xlink:to="loc_us-gaap_OperatingExpensesAbstract_8d22fcb6-f728-4e8b-8e94-ef52a1ab10c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_6f0259d2-f00b-4ead-9d0e-2a53f6e0347c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_8d22fcb6-f728-4e8b-8e94-ef52a1ab10c1" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_6f0259d2-f00b-4ead-9d0e-2a53f6e0347c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_d5095b91-ee26-4f57-b193-791ba0be5ff9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_8d22fcb6-f728-4e8b-8e94-ef52a1ab10c1" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_d5095b91-ee26-4f57-b193-791ba0be5ff9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_59e87956-2692-4f76-80e0-8fb44ded6eda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_8d22fcb6-f728-4e8b-8e94-ef52a1ab10c1" xlink:to="loc_us-gaap_OperatingExpenses_59e87956-2692-4f76-80e0-8fb44ded6eda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_23caa7eb-c260-4087-9ded-dc5bb9941545" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_769de978-5522-4c02-abef-f9aa255fcc44" xlink:to="loc_us-gaap_OperatingIncomeLoss_23caa7eb-c260-4087-9ded-dc5bb9941545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_89acc4c3-fec0-4934-bac4-cb8d268b996a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_769de978-5522-4c02-abef-f9aa255fcc44" xlink:to="loc_us-gaap_InterestExpense_89acc4c3-fec0-4934-bac4-cb8d268b996a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_InterestAndOtherIncomeExpense_9438cd7b-a262-4c63-95e7-e52e20aa344f" xlink:href="prct-20220630.xsd#prct_InterestAndOtherIncomeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_769de978-5522-4c02-abef-f9aa255fcc44" xlink:to="loc_prct_InterestAndOtherIncomeExpense_9438cd7b-a262-4c63-95e7-e52e20aa344f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_73ac3bb6-9227-435b-aeac-5dcdce05de8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_769de978-5522-4c02-abef-f9aa255fcc44" xlink:to="loc_us-gaap_NetIncomeLoss_73ac3bb6-9227-435b-aeac-5dcdce05de8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_ea1bdaae-b049-444f-84fe-22d0e46d7914" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_769de978-5522-4c02-abef-f9aa255fcc44" xlink:to="loc_us-gaap_EarningsPerShareBasic_ea1bdaae-b049-444f-84fe-22d0e46d7914" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_4646ce04-917d-4a6f-be29-126c82e0d202" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_769de978-5522-4c02-abef-f9aa255fcc44" xlink:to="loc_us-gaap_EarningsPerShareDiluted_4646ce04-917d-4a6f-be29-126c82e0d202" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_e66ae7b8-ebd2-4f55-8cce-8511faea019a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_769de978-5522-4c02-abef-f9aa255fcc44" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_e66ae7b8-ebd2-4f55-8cce-8511faea019a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_84eef94f-f0d0-45a6-8066-a9f4b6f95f3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_e66ae7b8-ebd2-4f55-8cce-8511faea019a" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_84eef94f-f0d0-45a6-8066-a9f4b6f95f3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_75fa81e3-f106-4d02-b089-2db62c997f96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_e66ae7b8-ebd2-4f55-8cce-8511faea019a" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_75fa81e3-f106-4d02-b089-2db62c997f96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_5d10b247-9420-4752-9397-1e474e0abbbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_769de978-5522-4c02-abef-f9aa255fcc44" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_5d10b247-9420-4752-9397-1e474e0abbbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_991d24db-4c8f-4516-be81-9fd7b5ebc51e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_5d10b247-9420-4752-9397-1e474e0abbbf" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_991d24db-4c8f-4516-be81-9fd7b5ebc51e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_22de6ae1-7adf-463b-b6a1-26f293e1e2a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_5d10b247-9420-4752-9397-1e474e0abbbf" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_22de6ae1-7adf-463b-b6a1-26f293e1e2a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit" xlink:type="simple" xlink:href="prct-20220630.xsd#CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"/>
  <link:presentationLink xlink:role="http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_042130c3-79b5-4fe3-9a66-5177eadb9cbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_59e5a092-28d6-41f5-9bf6-29bab5bdf958" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_042130c3-79b5-4fe3-9a66-5177eadb9cbd" xlink:to="loc_us-gaap_StatementTable_59e5a092-28d6-41f5-9bf6-29bab5bdf958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_938011f9-015c-4ee7-94f7-7e5fc99dd526" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_59e5a092-28d6-41f5-9bf6-29bab5bdf958" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_938011f9-015c-4ee7-94f7-7e5fc99dd526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_445651ed-e618-4633-ace7-47d0f3fb2c55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_938011f9-015c-4ee7-94f7-7e5fc99dd526" xlink:to="loc_us-gaap_EquityComponentDomain_445651ed-e618-4633-ace7-47d0f3fb2c55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_67aee783-f544-4fda-8c74-9fa921211584" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_445651ed-e618-4633-ace7-47d0f3fb2c55" xlink:to="loc_us-gaap_CommonStockMember_67aee783-f544-4fda-8c74-9fa921211584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_a2eab1a0-f5c4-48cb-b0d9-b35fd81d0a00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_445651ed-e618-4633-ace7-47d0f3fb2c55" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_a2eab1a0-f5c4-48cb-b0d9-b35fd81d0a00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2c928d77-5564-4c7c-8ead-748716323535" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_445651ed-e618-4633-ace7-47d0f3fb2c55" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2c928d77-5564-4c7c-8ead-748716323535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_3a7dba85-823e-4625-a58e-d872a1613348" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_445651ed-e618-4633-ace7-47d0f3fb2c55" xlink:to="loc_us-gaap_RetainedEarningsMember_3a7dba85-823e-4625-a58e-d872a1613348" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_407e4304-27ee-4adc-9b30-32c1c0a3f455" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_59e5a092-28d6-41f5-9bf6-29bab5bdf958" xlink:to="loc_us-gaap_StatementLineItems_407e4304-27ee-4adc-9b30-32c1c0a3f455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_92dddc71-0360-4668-a7c3-394dec28b32d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_407e4304-27ee-4adc-9b30-32c1c0a3f455" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_92dddc71-0360-4668-a7c3-394dec28b32d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_d0c0ebe6-b2dd-44cd-b88c-afb7ed3b4584" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_92dddc71-0360-4668-a7c3-394dec28b32d" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_d0c0ebe6-b2dd-44cd-b88c-afb7ed3b4584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_66b39dc0-20e6-46b8-bf39-2d35d959636b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_92dddc71-0360-4668-a7c3-394dec28b32d" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_66b39dc0-20e6-46b8-bf39-2d35d959636b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_faa189db-bf92-44f7-8d17-c458723f5be2" xlink:href="prct-20220630.xsd#prct_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_92dddc71-0360-4668-a7c3-394dec28b32d" xlink:to="loc_prct_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_faa189db-bf92-44f7-8d17-c458723f5be2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_632f4a79-05e2-4d27-83e6-80960c291350" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_92dddc71-0360-4668-a7c3-394dec28b32d" xlink:to="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_632f4a79-05e2-4d27-83e6-80960c291350" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_3a7e27c6-a098-46bd-8192-0dec0ac16624" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_92dddc71-0360-4668-a7c3-394dec28b32d" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_3a7e27c6-a098-46bd-8192-0dec0ac16624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_c6a317ad-5a25-446f-a615-2b7b46c0bd48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_92dddc71-0360-4668-a7c3-394dec28b32d" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_c6a317ad-5a25-446f-a615-2b7b46c0bd48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_37154f0d-a23e-44fd-b253-afca999febb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_407e4304-27ee-4adc-9b30-32c1c0a3f455" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_37154f0d-a23e-44fd-b253-afca999febb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_5cd29bed-c54f-4b23-ac12-85e7468993ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_37154f0d-a23e-44fd-b253-afca999febb0" xlink:to="loc_us-gaap_SharesOutstanding_5cd29bed-c54f-4b23-ac12-85e7468993ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_68b9ef70-1f35-489c-b9d2-a28a9e6b6960" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_37154f0d-a23e-44fd-b253-afca999febb0" xlink:to="loc_us-gaap_StockholdersEquity_68b9ef70-1f35-489c-b9d2-a28a9e6b6960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2a9b4445-bb1f-4f20-a777-b057f3932236" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_37154f0d-a23e-44fd-b253-afca999febb0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2a9b4445-bb1f-4f20-a777-b057f3932236" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_463c7378-4d35-45b7-82dc-204936b4dff3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_37154f0d-a23e-44fd-b253-afca999febb0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_463c7378-4d35-45b7-82dc-204936b4dff3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_354a0e34-e276-48dc-9269-e2bc9d0dd485" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_37154f0d-a23e-44fd-b253-afca999febb0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_354a0e34-e276-48dc-9269-e2bc9d0dd485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_50d645a4-462f-47c8-bfd0-27fd3a2180d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_37154f0d-a23e-44fd-b253-afca999febb0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_50d645a4-462f-47c8-bfd0-27fd3a2180d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition_e0371510-508b-4f29-8e21-045522dad6bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_37154f0d-a23e-44fd-b253-afca999febb0" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition_e0371510-508b-4f29-8e21-045522dad6bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_d573cccb-6e88-4942-87b0-5ee9fe2cca1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_37154f0d-a23e-44fd-b253-afca999febb0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_d573cccb-6e88-4942-87b0-5ee9fe2cca1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e85d4675-2623-456e-8f23-531853329a21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_37154f0d-a23e-44fd-b253-afca999febb0" xlink:to="loc_us-gaap_NetIncomeLoss_e85d4675-2623-456e-8f23-531853329a21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_c2f171db-92ec-4c89-9205-17fd5d0b1760" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_37154f0d-a23e-44fd-b253-afca999febb0" xlink:to="loc_us-gaap_SharesOutstanding_c2f171db-92ec-4c89-9205-17fd5d0b1760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_de552706-885f-43f5-809e-f60b5779ffdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_37154f0d-a23e-44fd-b253-afca999febb0" xlink:to="loc_us-gaap_StockholdersEquity_de552706-885f-43f5-809e-f60b5779ffdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="prct-20220630.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_60fc1d99-15d3-4f8a-bf45-fa3ebb372334" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c3be7e6c-8545-4039-8bd0-41b676fcb59a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_60fc1d99-15d3-4f8a-bf45-fa3ebb372334" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c3be7e6c-8545-4039-8bd0-41b676fcb59a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_7404bb7e-e1b0-4727-8d68-7b4b93e7b62b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c3be7e6c-8545-4039-8bd0-41b676fcb59a" xlink:to="loc_us-gaap_NetIncomeLoss_7404bb7e-e1b0-4727-8d68-7b4b93e7b62b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6953990a-55a2-4a58-a3ee-949c64b439aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c3be7e6c-8545-4039-8bd0-41b676fcb59a" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6953990a-55a2-4a58-a3ee-949c64b439aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_509e12ac-0266-4a11-86e9-1d2b91f13ea6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6953990a-55a2-4a58-a3ee-949c64b439aa" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_509e12ac-0266-4a11-86e9-1d2b91f13ea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_a3a4c47c-f08f-4ec0-a65d-269d36655578" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6953990a-55a2-4a58-a3ee-949c64b439aa" xlink:to="loc_us-gaap_ShareBasedCompensation_a3a4c47c-f08f-4ec0-a65d-269d36655578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_FairValueAdjustmentOfWarrantsAndGainLossOnDerivativeInstrumentsNetPretax_d040a55a-9f2c-4b9f-992b-f8cb02e22591" xlink:href="prct-20220630.xsd#prct_FairValueAdjustmentOfWarrantsAndGainLossOnDerivativeInstrumentsNetPretax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6953990a-55a2-4a58-a3ee-949c64b439aa" xlink:to="loc_prct_FairValueAdjustmentOfWarrantsAndGainLossOnDerivativeInstrumentsNetPretax_d040a55a-9f2c-4b9f-992b-f8cb02e22591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_NonCashLeaseAccretionExpense_82fd27db-77b0-4cda-8030-6fe900c5102b" xlink:href="prct-20220630.xsd#prct_NonCashLeaseAccretionExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6953990a-55a2-4a58-a3ee-949c64b439aa" xlink:to="loc_prct_NonCashLeaseAccretionExpense_82fd27db-77b0-4cda-8030-6fe900c5102b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e187265e-8594-4c74-9cf0-3af991c67250" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6953990a-55a2-4a58-a3ee-949c64b439aa" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e187265e-8594-4c74-9cf0-3af991c67250" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_9ebfa6cc-72b4-4ba7-bac9-47c6332ec9ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e187265e-8594-4c74-9cf0-3af991c67250" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_9ebfa6cc-72b4-4ba7-bac9-47c6332ec9ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_f57a9dfc-4eee-4fbf-ae09-172fe7a31f67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e187265e-8594-4c74-9cf0-3af991c67250" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_f57a9dfc-4eee-4fbf-ae09-172fe7a31f67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_df2decbb-c2c4-4ed2-a6f2-dafc24a095a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e187265e-8594-4c74-9cf0-3af991c67250" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_df2decbb-c2c4-4ed2-a6f2-dafc24a095a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_f28b57f8-08d6-40ff-a7ad-54e6d373a518" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e187265e-8594-4c74-9cf0-3af991c67250" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_f28b57f8-08d6-40ff-a7ad-54e6d373a518" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_9bc7881d-484e-464c-b8b7-c764da360996" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e187265e-8594-4c74-9cf0-3af991c67250" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_9bc7881d-484e-464c-b8b7-c764da360996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedSalaries_51e51e61-12ba-4bf0-9820-a70710863363" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedSalaries"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e187265e-8594-4c74-9cf0-3af991c67250" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedSalaries_51e51e61-12ba-4bf0-9820-a70710863363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInterestPayableNet_e1832de4-5aa6-460a-bbc6-ec379af1f0f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInterestPayableNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e187265e-8594-4c74-9cf0-3af991c67250" xlink:to="loc_us-gaap_IncreaseDecreaseInInterestPayableNet_e1832de4-5aa6-460a-bbc6-ec379af1f0f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_3944ebcd-4859-4595-b3d5-5f0d113e61ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e187265e-8594-4c74-9cf0-3af991c67250" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_3944ebcd-4859-4595-b3d5-5f0d113e61ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_d91b0d5c-7abb-46c6-91ed-a12db29e2c45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e187265e-8594-4c74-9cf0-3af991c67250" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_d91b0d5c-7abb-46c6-91ed-a12db29e2c45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_974e7a96-44d6-4041-a280-98c6fad71f26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c3be7e6c-8545-4039-8bd0-41b676fcb59a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_974e7a96-44d6-4041-a280-98c6fad71f26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1fe7bd7d-2fe6-42b3-87c7-d97c72b6c2f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_60fc1d99-15d3-4f8a-bf45-fa3ebb372334" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1fe7bd7d-2fe6-42b3-87c7-d97c72b6c2f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_e8a54072-6ad4-4c99-9dfc-03ff7758e93e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1fe7bd7d-2fe6-42b3-87c7-d97c72b6c2f2" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_e8a54072-6ad4-4c99-9dfc-03ff7758e93e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_51a4034d-0e1f-479f-8ac9-58894d05a760" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1fe7bd7d-2fe6-42b3-87c7-d97c72b6c2f2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_51a4034d-0e1f-479f-8ac9-58894d05a760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0e96db3b-7afd-452c-999f-ef8522fe7b53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_60fc1d99-15d3-4f8a-bf45-fa3ebb372334" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0e96db3b-7afd-452c-999f-ef8522fe7b53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_d1107757-815f-4412-9499-20572befb8b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0e96db3b-7afd-452c-999f-ef8522fe7b53" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_d1107757-815f-4412-9499-20572befb8b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_02a38d5e-7a2a-4537-8999-838d37e2806e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0e96db3b-7afd-452c-999f-ef8522fe7b53" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_02a38d5e-7a2a-4537-8999-838d37e2806e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_1cdadf02-83b4-4a3a-9305-5d7c04b6fb4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0e96db3b-7afd-452c-999f-ef8522fe7b53" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_1cdadf02-83b4-4a3a-9305-5d7c04b6fb4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_be1ee522-6120-4f93-8afd-02aa4a6628e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0e96db3b-7afd-452c-999f-ef8522fe7b53" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_be1ee522-6120-4f93-8afd-02aa4a6628e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2cf0e41c-afad-4c4d-8903-7fcadd064728" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_60fc1d99-15d3-4f8a-bf45-fa3ebb372334" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2cf0e41c-afad-4c4d-8903-7fcadd064728" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a5210374-971a-42b2-ab37-cb33fa3364a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_60fc1d99-15d3-4f8a-bf45-fa3ebb372334" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a5210374-971a-42b2-ab37-cb33fa3364a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2d480d91-82f9-42e4-b649-5fdb26118f14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_60fc1d99-15d3-4f8a-bf45-fa3ebb372334" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2d480d91-82f9-42e4-b649-5fdb26118f14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_3506f182-c2e4-43e4-a4dc-c7c23c3d04ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_60fc1d99-15d3-4f8a-bf45-fa3ebb372334" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_3506f182-c2e4-43e4-a4dc-c7c23c3d04ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_57a38a69-32b6-42f6-a169-e0ee0a5a66cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_3506f182-c2e4-43e4-a4dc-c7c23c3d04ca" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_57a38a69-32b6-42f6-a169-e0ee0a5a66cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_3f4e7f11-3c28-471c-975b-af80ba0fc6ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_3506f182-c2e4-43e4-a4dc-c7c23c3d04ca" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_3f4e7f11-3c28-471c-975b-af80ba0fc6ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6ed9ebfa-8d02-4800-8cb5-59497564ea6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_3506f182-c2e4-43e4-a4dc-c7c23c3d04ca" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6ed9ebfa-8d02-4800-8cb5-59497564ea6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_6b8492b0-8330-414f-a049-97ad829dc46f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_60fc1d99-15d3-4f8a-bf45-fa3ebb372334" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_6b8492b0-8330-414f-a049-97ad829dc46f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_0b39cce8-78c9-49ae-8847-d82900908181" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_6b8492b0-8330-414f-a049-97ad829dc46f" xlink:to="loc_us-gaap_InterestPaidNet_0b39cce8-78c9-49ae-8847-d82900908181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_82c8d3ad-216b-4f9d-8dc9-c7d93dbe9154" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_6b8492b0-8330-414f-a049-97ad829dc46f" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_82c8d3ad-216b-4f9d-8dc9-c7d93dbe9154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_TransferFromInventoryToPropertyAndEquipmentNet_f37fa9fb-a9ed-467b-8f64-ef4f6740f81b" xlink:href="prct-20220630.xsd#prct_TransferFromInventoryToPropertyAndEquipmentNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_82c8d3ad-216b-4f9d-8dc9-c7d93dbe9154" xlink:to="loc_prct_TransferFromInventoryToPropertyAndEquipmentNet_f37fa9fb-a9ed-467b-8f64-ef4f6740f81b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_6487630a-01bf-4772-95ed-e994986bdd0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_82c8d3ad-216b-4f9d-8dc9-c7d93dbe9154" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_6487630a-01bf-4772-95ed-e994986bdd0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_DeferredOfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction_ef51d9ea-cc59-4ff5-be86-98100c3828ae" xlink:href="prct-20220630.xsd#prct_DeferredOfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_82c8d3ad-216b-4f9d-8dc9-c7d93dbe9154" xlink:to="loc_prct_DeferredOfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction_ef51d9ea-cc59-4ff5-be86-98100c3828ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/Organization" xlink:type="simple" xlink:href="prct-20220630.xsd#Organization"/>
  <link:presentationLink xlink:role="http://www.procept-biorobotics.com/role/Organization" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_a69c033e-30be-4ff3-852c-4c9a88e96c4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_4b98036b-d470-4204-8678-32b9518367bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a69c033e-30be-4ff3-852c-4c9a88e96c4e" xlink:to="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_4b98036b-d470-4204-8678-32b9518367bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/OrganizationDetails" xlink:type="simple" xlink:href="prct-20220630.xsd#OrganizationDetails"/>
  <link:presentationLink xlink:role="http://www.procept-biorobotics.com/role/OrganizationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_dd47b61e-ed27-4adb-a61a-2aa4635e561f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_97d3b636-96fc-4610-b6fb-0ca51afc0c49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_dd47b61e-ed27-4adb-a61a-2aa4635e561f" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_97d3b636-96fc-4610-b6fb-0ca51afc0c49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_2311e054-faed-4140-8993-56fb126797ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_97d3b636-96fc-4610-b6fb-0ca51afc0c49" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_2311e054-faed-4140-8993-56fb126797ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_ee100b44-ce04-43d8-83ad-9b9c96521e18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_2311e054-faed-4140-8993-56fb126797ca" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_ee100b44-ce04-43d8-83ad-9b9c96521e18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_7a52823b-e8f1-4ddf-ac77-b6ea27e41c47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_ee100b44-ce04-43d8-83ad-9b9c96521e18" xlink:to="loc_us-gaap_IPOMember_7a52823b-e8f1-4ddf-ac77-b6ea27e41c47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_a697868e-8268-4616-9cdd-6e7556d17431" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_97d3b636-96fc-4610-b6fb-0ca51afc0c49" xlink:to="loc_us-gaap_StatementClassOfStockAxis_a697868e-8268-4616-9cdd-6e7556d17431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_b113826f-d3a2-4662-87c2-74b53812d813" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_a697868e-8268-4616-9cdd-6e7556d17431" xlink:to="loc_us-gaap_ClassOfStockDomain_b113826f-d3a2-4662-87c2-74b53812d813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_692ae456-09f4-4358-a285-9826afc7b6d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_b113826f-d3a2-4662-87c2-74b53812d813" xlink:to="loc_us-gaap_CommonStockMember_692ae456-09f4-4358-a285-9826afc7b6d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_09831ab7-f6e7-4b1d-9846-6008e9303091" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_97d3b636-96fc-4610-b6fb-0ca51afc0c49" xlink:to="loc_us-gaap_SubsidiarySaleOfStockLineItems_09831ab7-f6e7-4b1d-9846-6008e9303091" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_31462219-20c2-45d7-83a7-30c626371ebe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_09831ab7-f6e7-4b1d-9846-6008e9303091" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_31462219-20c2-45d7-83a7-30c626371ebe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_60667959-741f-4f51-94be-66e4cdde5155" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_09831ab7-f6e7-4b1d-9846-6008e9303091" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_60667959-741f-4f51-94be-66e4cdde5155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_InitialPublicOfferingAbstract_a9bcd8a3-ece3-469a-93be-e91e4762333f" xlink:href="prct-20220630.xsd#prct_InitialPublicOfferingAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_09831ab7-f6e7-4b1d-9846-6008e9303091" xlink:to="loc_prct_InitialPublicOfferingAbstract_a9bcd8a3-ece3-469a-93be-e91e4762333f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_d38aea2d-9f95-4be2-bb81-0e9cae269095" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prct_InitialPublicOfferingAbstract_a9bcd8a3-ece3-469a-93be-e91e4762333f" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_d38aea2d-9f95-4be2-bb81-0e9cae269095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="prct-20220630.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.procept-biorobotics.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_3269aecc-0aea-4b7f-b108-3f964ec58108" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_8a473047-e392-448b-b3cc-4deb257bd575" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3269aecc-0aea-4b7f-b108-3f964ec58108" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_8a473047-e392-448b-b3cc-4deb257bd575" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="prct-20220630.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.procept-biorobotics.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_4fbf41f6-68a3-4efb-a585-54270bcdcb75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_a7410f03-7fef-4e96-ad36-0615168f4ee7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4fbf41f6-68a3-4efb-a585-54270bcdcb75" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_a7410f03-7fef-4e96-ad36-0615168f4ee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_5e08382a-112d-49f2-a5b7-c9a38ba16def" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4fbf41f6-68a3-4efb-a585-54270bcdcb75" xlink:to="loc_us-gaap_UseOfEstimates_5e08382a-112d-49f2-a5b7-c9a38ba16def" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityPolicyTextBlock_e246b7b7-2e61-49cd-bfc8-eeacf893e364" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4fbf41f6-68a3-4efb-a585-54270bcdcb75" xlink:to="loc_us-gaap_StockholdersEquityPolicyTextBlock_e246b7b7-2e61-49cd-bfc8-eeacf893e364" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_JobsActAccountingElectionPolicyTextBlock_1e7e7dc1-e1ac-4f1e-88b1-7118d73d80ed" xlink:href="prct-20220630.xsd#prct_JobsActAccountingElectionPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4fbf41f6-68a3-4efb-a585-54270bcdcb75" xlink:to="loc_prct_JobsActAccountingElectionPolicyTextBlock_1e7e7dc1-e1ac-4f1e-88b1-7118d73d80ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_fdbac5cc-238e-4d38-be33-380942e0905f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4fbf41f6-68a3-4efb-a585-54270bcdcb75" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_fdbac5cc-238e-4d38-be33-380942e0905f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="prct-20220630.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.procept-biorobotics.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_6b445d25-913b-4f07-9c36-f1b8ba6d92e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_6a559e27-d518-4ad3-bf55-16cd4d376502" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6b445d25-913b-4f07-9c36-f1b8ba6d92e8" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_6a559e27-d518-4ad3-bf55-16cd4d376502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_e9725fdf-e8fb-453d-b44d-97c7eb56f08b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_6a559e27-d518-4ad3-bf55-16cd4d376502" xlink:to="loc_us-gaap_StatementClassOfStockAxis_e9725fdf-e8fb-453d-b44d-97c7eb56f08b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_f1e7ca39-dbbf-443c-abcc-560c2eded199" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_e9725fdf-e8fb-453d-b44d-97c7eb56f08b" xlink:to="loc_us-gaap_ClassOfStockDomain_f1e7ca39-dbbf-443c-abcc-560c2eded199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_c2c65944-5a0d-48e3-9e4d-0b575cb5bcb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_f1e7ca39-dbbf-443c-abcc-560c2eded199" xlink:to="loc_us-gaap_CommonStockMember_c2c65944-5a0d-48e3-9e4d-0b575cb5bcb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_de574732-0c81-4ce7-9b91-4204f85d7963" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_6a559e27-d518-4ad3-bf55-16cd4d376502" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_de574732-0c81-4ce7-9b91-4204f85d7963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_753ae603-ae34-417f-bf97-c029abd8cd55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_de574732-0c81-4ce7-9b91-4204f85d7963" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_753ae603-ae34-417f-bf97-c029abd8cd55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_d437e7b2-9fea-47a5-b315-0c18c39b2c8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_753ae603-ae34-417f-bf97-c029abd8cd55" xlink:to="loc_us-gaap_IPOMember_d437e7b2-9fea-47a5-b315-0c18c39b2c8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember_4b603b75-05f4-4591-b88e-7df905907631" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_753ae603-ae34-417f-bf97-c029abd8cd55" xlink:to="loc_us-gaap_OverAllotmentOptionMember_4b603b75-05f4-4591-b88e-7df905907631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_aba0ef69-8458-4aee-bad4-d1c371c02190" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_6a559e27-d518-4ad3-bf55-16cd4d376502" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_aba0ef69-8458-4aee-bad4-d1c371c02190" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_35a30e83-6369-4282-9706-c261d62d308a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_aba0ef69-8458-4aee-bad4-d1c371c02190" xlink:to="loc_us-gaap_EquityComponentDomain_35a30e83-6369-4282-9706-c261d62d308a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_ce6ca11a-3137-4a5d-b121-208e4933b149" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_35a30e83-6369-4282-9706-c261d62d308a" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_ce6ca11a-3137-4a5d-b121-208e4933b149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_dac7746c-e020-4c77-9a76-1b2f75e53210" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_35a30e83-6369-4282-9706-c261d62d308a" xlink:to="loc_us-gaap_WarrantMember_dac7746c-e020-4c77-9a76-1b2f75e53210" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_6e204b95-ecb5-44d2-a416-c533ba14321e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_6a559e27-d518-4ad3-bf55-16cd4d376502" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_6e204b95-ecb5-44d2-a416-c533ba14321e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_a376a2c0-ff3c-420c-b239-fbca7193eb46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_6e204b95-ecb5-44d2-a416-c533ba14321e" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_a376a2c0-ff3c-420c-b239-fbca7193eb46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_SeriesERedeemableConvertiblePreferredStockWarrantsMember_b803db44-4074-450d-95b9-d309a8f3a9df" xlink:href="prct-20220630.xsd#prct_SeriesERedeemableConvertiblePreferredStockWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_a376a2c0-ff3c-420c-b239-fbca7193eb46" xlink:to="loc_prct_SeriesERedeemableConvertiblePreferredStockWarrantsMember_b803db44-4074-450d-95b9-d309a8f3a9df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_460fe6f5-b41e-4615-b995-a35f1d7c478c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_6a559e27-d518-4ad3-bf55-16cd4d376502" xlink:to="loc_us-gaap_SubsidiarySaleOfStockLineItems_460fe6f5-b41e-4615-b995-a35f1d7c478c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_d66e3489-6a22-4fe1-8fea-25e6700374b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_460fe6f5-b41e-4615-b995-a35f1d7c478c" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_d66e3489-6a22-4fe1-8fea-25e6700374b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_86fc4c55-b3e4-454b-81a5-f2b9bc3c0c72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_460fe6f5-b41e-4615-b995-a35f1d7c478c" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_86fc4c55-b3e4-454b-81a5-f2b9bc3c0c72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_4caa47ce-9ab0-49bf-8b5b-8e6957b89ed6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_460fe6f5-b41e-4615-b995-a35f1d7c478c" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_4caa47ce-9ab0-49bf-8b5b-8e6957b89ed6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForUnderwritingExpense_0eb7b004-234c-4f05-9f17-b8df2bdd0d1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForUnderwritingExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_460fe6f5-b41e-4615-b995-a35f1d7c478c" xlink:to="loc_us-gaap_PaymentsForUnderwritingExpense_0eb7b004-234c-4f05-9f17-b8df2bdd0d1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_72f5fc52-2e82-4e44-83d5-6ffe3fb27ef2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_460fe6f5-b41e-4615-b995-a35f1d7c478c" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_72f5fc52-2e82-4e44-83d5-6ffe3fb27ef2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_2e5e863e-d102-43de-8bbe-d5e5d89bfeb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_460fe6f5-b41e-4615-b995-a35f1d7c478c" xlink:to="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_2e5e863e-d102-43de-8bbe-d5e5d89bfeb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_a048f388-b541-4e33-801c-22f18b569ae8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_460fe6f5-b41e-4615-b995-a35f1d7c478c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_a048f388-b541-4e33-801c-22f18b569ae8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_TemporaryEquityStockIssuedDuringPeriodSharesWarrantExercises_d00b6cdc-45f8-49c7-8107-2cc9c081f3ed" xlink:href="prct-20220630.xsd#prct_TemporaryEquityStockIssuedDuringPeriodSharesWarrantExercises"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_460fe6f5-b41e-4615-b995-a35f1d7c478c" xlink:to="loc_prct_TemporaryEquityStockIssuedDuringPeriodSharesWarrantExercises_d00b6cdc-45f8-49c7-8107-2cc9c081f3ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="prct-20220630.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.procept-biorobotics.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_a0712cb2-485f-4cca-9623-c374b801057a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_7f90c168-a4d7-4911-b3f9-dc6ec030dea3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_a0712cb2-485f-4cca-9623-c374b801057a" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_7f90c168-a4d7-4911-b3f9-dc6ec030dea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="prct-20220630.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.procept-biorobotics.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_5296626a-b7ae-481b-ac39-7a76380b4bf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_9d292bb8-d69f-4c93-897b-26c84b27bd16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_5296626a-b7ae-481b-ac39-7a76380b4bf6" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_9d292bb8-d69f-4c93-897b-26c84b27bd16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_53da984b-16c3-418a-ba93-70cd52e07c8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_5296626a-b7ae-481b-ac39-7a76380b4bf6" xlink:to="loc_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_53da984b-16c3-418a-ba93-70cd52e07c8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="prct-20220630.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.procept-biorobotics.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_aa2d0110-1147-4c86-8c4e-2b4672d0adde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_0a896142-79a8-48c6-abe1-96fe1e878407" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_aa2d0110-1147-4c86-8c4e-2b4672d0adde" xlink:to="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_0a896142-79a8-48c6-abe1-96fe1e878407" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_395f35fe-64df-4d3e-9363-862ead7d5ad8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_0a896142-79a8-48c6-abe1-96fe1e878407" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_395f35fe-64df-4d3e-9363-862ead7d5ad8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d9ad6b18-cc43-42bf-b492-74810558b415" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_395f35fe-64df-4d3e-9363-862ead7d5ad8" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d9ad6b18-cc43-42bf-b492-74810558b415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_6f6a2153-d8c5-4fe9-8f80-975c8f9ed013" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d9ad6b18-cc43-42bf-b492-74810558b415" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_6f6a2153-d8c5-4fe9-8f80-975c8f9ed013" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_de36e115-cd3d-48f3-97e1-c3aa0fc2ec5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_0a896142-79a8-48c6-abe1-96fe1e878407" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_de36e115-cd3d-48f3-97e1-c3aa0fc2ec5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_807f1f1a-bf54-4d87-b62f-814d9263e209" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_de36e115-cd3d-48f3-97e1-c3aa0fc2ec5b" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_807f1f1a-bf54-4d87-b62f-814d9263e209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_ee70d7b2-f64a-4123-90a3-9dbae90f4797" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_807f1f1a-bf54-4d87-b62f-814d9263e209" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_ee70d7b2-f64a-4123-90a3-9dbae90f4797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_e325e786-d9e6-4eb9-b81f-f7d9f2ee38ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_0a896142-79a8-48c6-abe1-96fe1e878407" xlink:to="loc_us-gaap_ValuationTechniqueAxis_e325e786-d9e6-4eb9-b81f-f7d9f2ee38ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_5d95defa-5bf4-4cab-ad61-bbf922528913" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueAxis_e325e786-d9e6-4eb9-b81f-f7d9f2ee38ed" xlink:to="loc_us-gaap_ValuationTechniqueDomain_5d95defa-5bf4-4cab-ad61-bbf922528913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_62efad37-7cd8-46de-a59b-2819cb6fe27b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueDomain_5d95defa-5bf4-4cab-ad61-bbf922528913" xlink:to="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_62efad37-7cd8-46de-a59b-2819cb6fe27b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_59c233f4-a26c-4730-9216-93d74ca37cc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_0a896142-79a8-48c6-abe1-96fe1e878407" xlink:to="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_59c233f4-a26c-4730-9216-93d74ca37cc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMeasurementInput_4d65a22c-061d-4170-972a-9774eb591158" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMeasurementInput"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_59c233f4-a26c-4730-9216-93d74ca37cc6" xlink:to="loc_us-gaap_LongTermDebtMeasurementInput_4d65a22c-061d-4170-972a-9774eb591158" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/FairValueMeasurementsFairValueDetails" xlink:type="simple" xlink:href="prct-20220630.xsd#FairValueMeasurementsFairValueDetails"/>
  <link:presentationLink xlink:role="http://www.procept-biorobotics.com/role/FairValueMeasurementsFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_44c5abee-4103-49fe-9f7a-53bd9c62a827" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_fe780ce0-21ac-44a5-b8f0-56159ff6f802" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_44c5abee-4103-49fe-9f7a-53bd9c62a827" xlink:to="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_fe780ce0-21ac-44a5-b8f0-56159ff6f802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_db7668aa-0f67-4327-aafc-dabc996d32ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_fe780ce0-21ac-44a5-b8f0-56159ff6f802" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_db7668aa-0f67-4327-aafc-dabc996d32ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_df122141-2e3c-4fe1-9a79-3581f3b3d8fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_db7668aa-0f67-4327-aafc-dabc996d32ab" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_df122141-2e3c-4fe1-9a79-3581f3b3d8fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_4f5427ba-025d-4ede-bc3d-a7c3fb10945a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_df122141-2e3c-4fe1-9a79-3581f3b3d8fd" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_4f5427ba-025d-4ede-bc3d-a7c3fb10945a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_5b3079a2-4cfb-40e0-b2a3-41fc436d8ab9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_df122141-2e3c-4fe1-9a79-3581f3b3d8fd" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_5b3079a2-4cfb-40e0-b2a3-41fc436d8ab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_200a64b2-f573-4562-9dcd-51fd6ffa8dc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_df122141-2e3c-4fe1-9a79-3581f3b3d8fd" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_200a64b2-f573-4562-9dcd-51fd6ffa8dc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c6f49191-a3b8-4c7d-a908-b2a2487f64df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_fe780ce0-21ac-44a5-b8f0-56159ff6f802" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c6f49191-a3b8-4c7d-a908-b2a2487f64df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_dbdcd668-f295-4bbc-adfd-2d02aff725de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c6f49191-a3b8-4c7d-a908-b2a2487f64df" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_dbdcd668-f295-4bbc-adfd-2d02aff725de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_627a8255-3c6e-42d7-af36-8c368286b48a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_dbdcd668-f295-4bbc-adfd-2d02aff725de" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_627a8255-3c6e-42d7-af36-8c368286b48a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_aacf5721-930c-4fca-833a-28ec2f2a56bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_fe780ce0-21ac-44a5-b8f0-56159ff6f802" xlink:to="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_aacf5721-930c-4fca-833a-28ec2f2a56bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash_cd706965-b1e5-4d63-9673-9b3ae7a7cdcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Cash"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_aacf5721-930c-4fca-833a-28ec2f2a56bb" xlink:to="loc_us-gaap_Cash_cd706965-b1e5-4d63-9673-9b3ae7a7cdcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_49b45594-3eec-4fac-98cf-188c43034c4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_aacf5721-930c-4fca-833a-28ec2f2a56bb" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_49b45594-3eec-4fac-98cf-188c43034c4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2c42e753-c190-4ef1-8058-9032380957e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_aacf5721-930c-4fca-833a-28ec2f2a56bb" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2c42e753-c190-4ef1-8058-9032380957e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_eeb3ef66-2b9b-49ea-9df0-b5e3820fb672" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_aacf5721-930c-4fca-833a-28ec2f2a56bb" xlink:to="loc_us-gaap_DerivativeLiabilities_eeb3ef66-2b9b-49ea-9df0-b5e3820fb672" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/FairValueMeasurementsFairValueInputsLevel3FairValueMeasurementsRecurringDetails" xlink:type="simple" xlink:href="prct-20220630.xsd#FairValueMeasurementsFairValueInputsLevel3FairValueMeasurementsRecurringDetails"/>
  <link:presentationLink xlink:role="http://www.procept-biorobotics.com/role/FairValueMeasurementsFairValueInputsLevel3FairValueMeasurementsRecurringDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_090bc769-4d05-478a-87c9-62d4206184e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_736c7568-076a-4692-b47b-5ac4c1026d09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_090bc769-4d05-478a-87c9-62d4206184e3" xlink:to="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_736c7568-076a-4692-b47b-5ac4c1026d09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_097db3fe-69bb-464b-addf-643cdebccb4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_736c7568-076a-4692-b47b-5ac4c1026d09" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_097db3fe-69bb-464b-addf-643cdebccb4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_66e09fd1-f95b-473f-9225-c2ee3fd44d83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_097db3fe-69bb-464b-addf-643cdebccb4b" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_66e09fd1-f95b-473f-9225-c2ee3fd44d83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_6ffe426f-a479-469e-b7a3-af8593e8972a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_66e09fd1-f95b-473f-9225-c2ee3fd44d83" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_6ffe426f-a479-469e-b7a3-af8593e8972a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_637e30f1-3457-4580-b7a2-c2669cbcb01b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_736c7568-076a-4692-b47b-5ac4c1026d09" xlink:to="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_637e30f1-3457-4580-b7a2-c2669cbcb01b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_ee08393b-fb97-4cf9-b863-d1cedeb7b169" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_637e30f1-3457-4580-b7a2-c2669cbcb01b" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_ee08393b-fb97-4cf9-b863-d1cedeb7b169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_31e0cde2-fc65-4360-85b0-023debc24bf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_ee08393b-fb97-4cf9-b863-d1cedeb7b169" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_31e0cde2-fc65-4360-85b0-023debc24bf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues_bc8d157a-a95c-496c-8b4d-291c5161223a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_ee08393b-fb97-4cf9-b863-d1cedeb7b169" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues_bc8d157a-a95c-496c-8b4d-291c5161223a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings_3e939dc0-ea31-4570-a4ab-83728a1c7512" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_ee08393b-fb97-4cf9-b863-d1cedeb7b169" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings_3e939dc0-ea31-4570-a4ab-83728a1c7512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_b51f4c95-a4a7-47de-8982-ad9349bf720e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_ee08393b-fb97-4cf9-b863-d1cedeb7b169" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_b51f4c95-a4a7-47de-8982-ad9349bf720e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/Inventory" xlink:type="simple" xlink:href="prct-20220630.xsd#Inventory"/>
  <link:presentationLink xlink:role="http://www.procept-biorobotics.com/role/Inventory" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_09f4a3d9-2fd6-457a-922a-c4a7e0b82e44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_6d58871c-6e8a-4de2-a407-86df20ab8e0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_09f4a3d9-2fd6-457a-922a-c4a7e0b82e44" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_6d58871c-6e8a-4de2-a407-86df20ab8e0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/InventoryTables" xlink:type="simple" xlink:href="prct-20220630.xsd#InventoryTables"/>
  <link:presentationLink xlink:role="http://www.procept-biorobotics.com/role/InventoryTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_6d4daae1-2387-455a-b62d-1798c89cb164" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_dbf31e22-70f7-4204-afdd-f9f10db8eeda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_6d4daae1-2387-455a-b62d-1798c89cb164" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_dbf31e22-70f7-4204-afdd-f9f10db8eeda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/InventoryInventoryDetails" xlink:type="simple" xlink:href="prct-20220630.xsd#InventoryInventoryDetails"/>
  <link:presentationLink xlink:role="http://www.procept-biorobotics.com/role/InventoryInventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_8186cda3-4484-4b15-a4ac-e2f4a6001fbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials_3f814705-5b03-4aae-a09a-9543fc92f817" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterials"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_8186cda3-4484-4b15-a4ac-e2f4a6001fbe" xlink:to="loc_us-gaap_InventoryRawMaterials_3f814705-5b03-4aae-a09a-9543fc92f817" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess_1ae4325d-0b87-4739-861d-9eb702977b68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_8186cda3-4484-4b15-a4ac-e2f4a6001fbe" xlink:to="loc_us-gaap_InventoryWorkInProcess_1ae4325d-0b87-4739-861d-9eb702977b68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_19c6320c-efb7-4071-bcc7-ec79e9d855db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_8186cda3-4484-4b15-a4ac-e2f4a6001fbe" xlink:to="loc_us-gaap_InventoryFinishedGoods_19c6320c-efb7-4071-bcc7-ec79e9d855db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_4deba545-b021-437a-8ec5-e81c0ee4251d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_8186cda3-4484-4b15-a4ac-e2f4a6001fbe" xlink:to="loc_us-gaap_InventoryNet_4deba545-b021-437a-8ec5-e81c0ee4251d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/IntangibleAssets" xlink:type="simple" xlink:href="prct-20220630.xsd#IntangibleAssets"/>
  <link:presentationLink xlink:role="http://www.procept-biorobotics.com/role/IntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_54ca1db7-fc47-4f1d-8fa2-e0189e70a154" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_53695ff5-93b0-4ea2-8682-7ae0c43d1301" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_54ca1db7-fc47-4f1d-8fa2-e0189e70a154" xlink:to="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_53695ff5-93b0-4ea2-8682-7ae0c43d1301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/IntangibleAssetsDetails" xlink:type="simple" xlink:href="prct-20220630.xsd#IntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.procept-biorobotics.com/role/IntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_77e96494-5b5a-4bca-9ae9-3b6ee9c7cc57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_7043b616-a118-4706-af33-44520843052a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_77e96494-5b5a-4bca-9ae9-3b6ee9c7cc57" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_7043b616-a118-4706-af33-44520843052a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_3c04ca18-94df-4f86-9304-969cfad657c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_77e96494-5b5a-4bca-9ae9-3b6ee9c7cc57" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_3c04ca18-94df-4f86-9304-969cfad657c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_FiniteLivedIntangibleAssetExpectedAnnualAmortizationExpense_f13401a3-07ba-4d8f-a215-2f3f2e2cba51" xlink:href="prct-20220630.xsd#prct_FiniteLivedIntangibleAssetExpectedAnnualAmortizationExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_77e96494-5b5a-4bca-9ae9-3b6ee9c7cc57" xlink:to="loc_prct_FiniteLivedIntangibleAssetExpectedAnnualAmortizationExpense_f13401a3-07ba-4d8f-a215-2f3f2e2cba51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_6a07cc09-b768-4a7b-a20e-135985ad4497" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_77e96494-5b5a-4bca-9ae9-3b6ee9c7cc57" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_6a07cc09-b768-4a7b-a20e-135985ad4497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiability" xlink:type="simple" xlink:href="prct-20220630.xsd#LoanFacilityandDerivativeLiability"/>
  <link:presentationLink xlink:role="http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiability" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_470b97e3-a98c-4d14-964c-41273a7c5509" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_ff1c00c8-7036-4a01-8585-9e0a1c4b76f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_470b97e3-a98c-4d14-964c-41273a7c5509" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_ff1c00c8-7036-4a01-8585-9e0a1c4b76f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesAndFairValueTextBlock_ac3f6862-f6ed-40e3-8fa0-eeecb4de62d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesAndFairValueTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_470b97e3-a98c-4d14-964c-41273a7c5509" xlink:to="loc_us-gaap_DerivativesAndFairValueTextBlock_ac3f6862-f6ed-40e3-8fa0-eeecb4de62d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiabilityDetails" xlink:type="simple" xlink:href="prct-20220630.xsd#LoanFacilityandDerivativeLiabilityDetails"/>
  <link:presentationLink xlink:role="http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_9ca7be50-4644-46d3-a402-b739316b5305" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_afe178d2-908f-464a-8fe3-48672f58f339" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_9ca7be50-4644-46d3-a402-b739316b5305" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_afe178d2-908f-464a-8fe3-48672f58f339" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_062a56b4-3125-4de1-963a-f6545cf16bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_afe178d2-908f-464a-8fe3-48672f58f339" xlink:to="loc_us-gaap_DebtInstrumentAxis_062a56b4-3125-4de1-963a-f6545cf16bd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c27c2585-ec7e-4f79-9dac-10b4fbd28ba9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_062a56b4-3125-4de1-963a-f6545cf16bd0" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c27c2585-ec7e-4f79-9dac-10b4fbd28ba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_LoanFacilityMember_66d042c5-4f7f-4c13-b097-e7d2b646001f" xlink:href="prct-20220630.xsd#prct_LoanFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c27c2585-ec7e-4f79-9dac-10b4fbd28ba9" xlink:to="loc_prct_LoanFacilityMember_66d042c5-4f7f-4c13-b097-e7d2b646001f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_LoanFacilityTrancheOneMember_0b01461b-b661-42db-9375-2cdcec3b8fae" xlink:href="prct-20220630.xsd#prct_LoanFacilityTrancheOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prct_LoanFacilityMember_66d042c5-4f7f-4c13-b097-e7d2b646001f" xlink:to="loc_prct_LoanFacilityTrancheOneMember_0b01461b-b661-42db-9375-2cdcec3b8fae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_LoanFacilityTrancheTwoMember_5a5fe3b9-b5f4-4860-9b55-714f4a8773e7" xlink:href="prct-20220630.xsd#prct_LoanFacilityTrancheTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prct_LoanFacilityMember_66d042c5-4f7f-4c13-b097-e7d2b646001f" xlink:to="loc_prct_LoanFacilityTrancheTwoMember_5a5fe3b9-b5f4-4860-9b55-714f4a8773e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_LoanFacilityTrancheThreeMember_12c6efc8-8ecc-41ce-b834-53896f5bd3f3" xlink:href="prct-20220630.xsd#prct_LoanFacilityTrancheThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prct_LoanFacilityMember_66d042c5-4f7f-4c13-b097-e7d2b646001f" xlink:to="loc_prct_LoanFacilityTrancheThreeMember_12c6efc8-8ecc-41ce-b834-53896f5bd3f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_LoanFacilityTrancheFourMember_dc9e4deb-e609-4070-8989-731d2fbbd968" xlink:href="prct-20220630.xsd#prct_LoanFacilityTrancheFourMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prct_LoanFacilityMember_66d042c5-4f7f-4c13-b097-e7d2b646001f" xlink:to="loc_prct_LoanFacilityTrancheFourMember_dc9e4deb-e609-4070-8989-731d2fbbd968" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_b3a02581-f4cc-4d89-b102-671dfb29115d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_afe178d2-908f-464a-8fe3-48672f58f339" xlink:to="loc_us-gaap_CreditFacilityAxis_b3a02581-f4cc-4d89-b102-671dfb29115d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_fdacafcf-c98b-4359-a224-2237b4d02473" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_b3a02581-f4cc-4d89-b102-671dfb29115d" xlink:to="loc_us-gaap_CreditFacilityDomain_fdacafcf-c98b-4359-a224-2237b4d02473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_73d2d502-6d38-4add-bbe3-8a5b09751be5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_fdacafcf-c98b-4359-a224-2237b4d02473" xlink:to="loc_us-gaap_LineOfCreditMember_73d2d502-6d38-4add-bbe3-8a5b09751be5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_2954681d-fb41-4c86-b97d-f9c6c6a1da2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_afe178d2-908f-464a-8fe3-48672f58f339" xlink:to="loc_us-gaap_VariableRateAxis_2954681d-fb41-4c86-b97d-f9c6c6a1da2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_3353b57c-0ae1-4a89-aa1a-b7501fdf2ffd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_2954681d-fb41-4c86-b97d-f9c6c6a1da2c" xlink:to="loc_us-gaap_VariableRateDomain_3353b57c-0ae1-4a89-aa1a-b7501fdf2ffd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_86a8ca73-abbc-4067-9ef9-3a12abb345d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_3353b57c-0ae1-4a89-aa1a-b7501fdf2ffd" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_86a8ca73-abbc-4067-9ef9-3a12abb345d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_9ba3eaa6-d71b-486f-99fc-c9e662766a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_afe178d2-908f-464a-8fe3-48672f58f339" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_9ba3eaa6-d71b-486f-99fc-c9e662766a1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b4019566-99fb-488d-b8b5-b65edcedc263" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9ba3eaa6-d71b-486f-99fc-c9e662766a1f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b4019566-99fb-488d-b8b5-b65edcedc263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_96a6e80d-d9d4-4862-b682-d7e170139fc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b4019566-99fb-488d-b8b5-b65edcedc263" xlink:to="loc_us-gaap_LineOfCreditMember_96a6e80d-d9d4-4862-b682-d7e170139fc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_afe178d2-908f-464a-8fe3-48672f58f339" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_dd43303a-e3ab-4523-a233-488426393dac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_dd43303a-e3ab-4523-a233-488426393dac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_LineOfCreditFacilityNumberOfInstallments_1be7a390-d046-4bf4-84c4-91823ac95ffc" xlink:href="prct-20220630.xsd#prct_LineOfCreditFacilityNumberOfInstallments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_prct_LineOfCreditFacilityNumberOfInstallments_1be7a390-d046-4bf4-84c4-91823ac95ffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_2a193d91-2195-4690-b28d-43a6e03788f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_2a193d91-2195-4690-b28d-43a6e03788f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_61df8790-e5c0-4bfe-9a7c-60bc040ff7b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_61df8790-e5c0-4bfe-9a7c-60bc040ff7b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_LineOfCreditFacilityCovenantComplianceContingentTrailingSixTwelveMonthRevenueTarget_ea5e712a-30f2-4458-95f0-0d3f930d2e5e" xlink:href="prct-20220630.xsd#prct_LineOfCreditFacilityCovenantComplianceContingentTrailingSixTwelveMonthRevenueTarget"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_prct_LineOfCreditFacilityCovenantComplianceContingentTrailingSixTwelveMonthRevenueTarget_ea5e712a-30f2-4458-95f0-0d3f930d2e5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_2609a080-8833-40f3-84f0-365f8339a785" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_2609a080-8833-40f3-84f0-365f8339a785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_ec4da406-a010-4aeb-87ed-b2fd55ebfa41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_us-gaap_DebtInstrumentTerm_ec4da406-a010-4aeb-87ed-b2fd55ebfa41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_DebtInstrumentInterestOnlyPeriod_fdec8cae-c146-4cae-9467-cf7e6c5db488" xlink:href="prct-20220630.xsd#prct_DebtInstrumentInterestOnlyPeriod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_prct_DebtInstrumentInterestOnlyPeriod_fdec8cae-c146-4cae-9467-cf7e6c5db488" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_DebtInstrumentPrincipalAndInterestPeriod_c56a3c53-78eb-4c93-8037-8b7f3e74a273" xlink:href="prct-20220630.xsd#prct_DebtInstrumentPrincipalAndInterestPeriod"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_prct_DebtInstrumentPrincipalAndInterestPeriod_c56a3c53-78eb-4c93-8037-8b7f3e74a273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_DebtInstrumentContingentBorrowingExtendedInterestOnlyPeriod_05177679-71c2-45e5-a35a-b496782f181d" xlink:href="prct-20220630.xsd#prct_DebtInstrumentContingentBorrowingExtendedInterestOnlyPeriod"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_prct_DebtInstrumentContingentBorrowingExtendedInterestOnlyPeriod_05177679-71c2-45e5-a35a-b496782f181d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_DebtInstrumentContingentBorrowingExtendedPrincipalAndInterestPeriod_e70cbd89-eeef-44d2-9289-25b0051dbe3d" xlink:href="prct-20220630.xsd#prct_DebtInstrumentContingentBorrowingExtendedPrincipalAndInterestPeriod"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_prct_DebtInstrumentContingentBorrowingExtendedPrincipalAndInterestPeriod_e70cbd89-eeef-44d2-9289-25b0051dbe3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmount_bdcd135d-df6b-43d0-8e7c-a969c93c84cc" xlink:href="prct-20220630.xsd#prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmount"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmount_bdcd135d-df6b-43d0-8e7c-a969c93c84cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmountAchievedExtendedInterestOnlyPeriod_099d80d7-3108-4060-bfa9-8d3c53cef86c" xlink:href="prct-20220630.xsd#prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmountAchievedExtendedInterestOnlyPeriod"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmountAchievedExtendedInterestOnlyPeriod_099d80d7-3108-4060-bfa9-8d3c53cef86c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmountAchievedExtendedPrincipalAndInterestPeriod_7cca3b8b-a016-45fd-ad48-b1d2c889235d" xlink:href="prct-20220630.xsd#prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmountAchievedExtendedPrincipalAndInterestPeriod"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmountAchievedExtendedPrincipalAndInterestPeriod_7cca3b8b-a016-45fd-ad48-b1d2c889235d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_DebtInstrumentCovenantComplianceRevenueForecastForCommensuratePeriodPercent_a322c222-ca0a-4995-b425-a3d3c828223e" xlink:href="prct-20220630.xsd#prct_DebtInstrumentCovenantComplianceRevenueForecastForCommensuratePeriodPercent"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_prct_DebtInstrumentCovenantComplianceRevenueForecastForCommensuratePeriodPercent_a322c222-ca0a-4995-b425-a3d3c828223e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_DebtInstrumentCovenantComplianceRevenueForecastAmountFirstTwoInstallmentsOnly_d7a44f74-5ae3-41e4-a52a-8a7b5fa40eb2" xlink:href="prct-20220630.xsd#prct_DebtInstrumentCovenantComplianceRevenueForecastAmountFirstTwoInstallmentsOnly"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_prct_DebtInstrumentCovenantComplianceRevenueForecastAmountFirstTwoInstallmentsOnly_d7a44f74-5ae3-41e4-a52a-8a7b5fa40eb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_DebtInstrumentCovenantComplianceRevenueForecastAmountFirstThreeInstallmentsOnly_8d9b0546-7d7a-4f31-b4c9-18bd78024e06" xlink:href="prct-20220630.xsd#prct_DebtInstrumentCovenantComplianceRevenueForecastAmountFirstThreeInstallmentsOnly"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_prct_DebtInstrumentCovenantComplianceRevenueForecastAmountFirstThreeInstallmentsOnly_8d9b0546-7d7a-4f31-b4c9-18bd78024e06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_DebtInstrumentCovenantComplianceRevenueForecastAmountAllInstallmentsDrawn_3515466d-5536-4c20-93ca-d90c64444c92" xlink:href="prct-20220630.xsd#prct_DebtInstrumentCovenantComplianceRevenueForecastAmountAllInstallmentsDrawn"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_prct_DebtInstrumentCovenantComplianceRevenueForecastAmountAllInstallmentsDrawn_3515466d-5536-4c20-93ca-d90c64444c92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_LineOfCreditFacilityFinalPaymentFeePercentage_95862087-459c-41d6-8cdc-f4749c330114" xlink:href="prct-20220630.xsd#prct_LineOfCreditFacilityFinalPaymentFeePercentage"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_prct_LineOfCreditFacilityFinalPaymentFeePercentage_95862087-459c-41d6-8cdc-f4749c330114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_f40787f0-2788-4886-bb87-24c8a1042e99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_f40787f0-2788-4886-bb87-24c8a1042e99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_LineOfCreditFacilityEarlyRepaymentFeeFirstTwelveMonthPercent_d2eefb93-5f90-41c2-8cd9-469502c3b766" xlink:href="prct-20220630.xsd#prct_LineOfCreditFacilityEarlyRepaymentFeeFirstTwelveMonthPercent"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_prct_LineOfCreditFacilityEarlyRepaymentFeeFirstTwelveMonthPercent_d2eefb93-5f90-41c2-8cd9-469502c3b766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_LineOfCreditFacilityEarlyRepaymentFeeSecondTwelveMonthPeriodPercent_c6604748-0853-477f-83e2-011078c881bb" xlink:href="prct-20220630.xsd#prct_LineOfCreditFacilityEarlyRepaymentFeeSecondTwelveMonthPeriodPercent"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_prct_LineOfCreditFacilityEarlyRepaymentFeeSecondTwelveMonthPeriodPercent_c6604748-0853-477f-83e2-011078c881bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_LineOfCreditFacilityEarlyRepaymentFeeTwentyFourMonthsThruMaturityPercent_510e69d6-64be-4b48-ab28-39a4f52e6d19" xlink:href="prct-20220630.xsd#prct_LineOfCreditFacilityEarlyRepaymentFeeTwentyFourMonthsThruMaturityPercent"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_prct_LineOfCreditFacilityEarlyRepaymentFeeTwentyFourMonthsThruMaturityPercent_510e69d6-64be-4b48-ab28-39a4f52e6d19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_LineOfCreditFacilityCovenantComplianceContingentTrailingTwelveMonthRevenueTarget_a4a3e24b-eb84-48d8-b06c-b51093d22933" xlink:href="prct-20220630.xsd#prct_LineOfCreditFacilityCovenantComplianceContingentTrailingTwelveMonthRevenueTarget"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_prct_LineOfCreditFacilityCovenantComplianceContingentTrailingTwelveMonthRevenueTarget_a4a3e24b-eb84-48d8-b06c-b51093d22933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceOneInstallmentDrawn_a0f462df-44d8-4ab9-8019-877c1fb8f241" xlink:href="prct-20220630.xsd#prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceOneInstallmentDrawn"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceOneInstallmentDrawn_a0f462df-44d8-4ab9-8019-877c1fb8f241" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceTwoInstallmentsDrawn_c97bba57-3d29-4422-9443-3600e2a3dec7" xlink:href="prct-20220630.xsd#prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceTwoInstallmentsDrawn"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceTwoInstallmentsDrawn_c97bba57-3d29-4422-9443-3600e2a3dec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceThreeInstallmentsDrawn_5068ca09-05d5-495c-8c08-77381f557ca8" xlink:href="prct-20220630.xsd#prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceThreeInstallmentsDrawn"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceThreeInstallmentsDrawn_5068ca09-05d5-495c-8c08-77381f557ca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceFourInstallmentsDrawn_22d464c0-8ab4-4a3d-98fd-0961d3077403" xlink:href="prct-20220630.xsd#prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceFourInstallmentsDrawn"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceFourInstallmentsDrawn_22d464c0-8ab4-4a3d-98fd-0961d3077403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_LineOfCreditFacilityGainLossOnAmendmentOfDebtTerms_10eff209-deca-403c-87a9-655b20f38c94" xlink:href="prct-20220630.xsd#prct_LineOfCreditFacilityGainLossOnAmendmentOfDebtTerms"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_prct_LineOfCreditFacilityGainLossOnAmendmentOfDebtTerms_10eff209-deca-403c-87a9-655b20f38c94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_20e19ff0-fe20-41a7-b496-357bf86acdb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_dff0a4df-af81-456b-8d80-ac351615b5ed" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_20e19ff0-fe20-41a7-b496-357bf86acdb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/StockBasedCompensation" xlink:type="simple" xlink:href="prct-20220630.xsd#StockBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.procept-biorobotics.com/role/StockBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5d3e3e23-0694-4b4f-af64-368ed4f48268" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_598db0b0-3a30-4aed-aa25-2d0329994102" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5d3e3e23-0694-4b4f-af64-368ed4f48268" xlink:to="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_598db0b0-3a30-4aed-aa25-2d0329994102" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/StockBasedCompensationTables" xlink:type="simple" xlink:href="prct-20220630.xsd#StockBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.procept-biorobotics.com/role/StockBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_86443bf5-9981-4421-b2c0-0554bb366cbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock_fbf497b7-abdd-4006-9a4d-cbbe6a664ad8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_86443bf5-9981-4421-b2c0-0554bb366cbe" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock_fbf497b7-abdd-4006-9a4d-cbbe6a664ad8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_28e5de61-03d5-4397-90b1-38450f40f415" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_86443bf5-9981-4421-b2c0-0554bb366cbe" xlink:to="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_28e5de61-03d5-4397-90b1-38450f40f415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock_8d866599-825e-4987-95c7-284a5310dbd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_86443bf5-9981-4421-b2c0-0554bb366cbe" xlink:to="loc_us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock_8d866599-825e-4987-95c7-284a5310dbd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_ea67a039-c257-4a80-9b01-c92f379db076" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_86443bf5-9981-4421-b2c0-0554bb366cbe" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_ea67a039-c257-4a80-9b01-c92f379db076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/StockBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="prct-20220630.xsd#StockBasedCompensationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.procept-biorobotics.com/role/StockBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d4ee5e30-d6ca-4623-b306-4d3b7eb3dc92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_efd5597d-9535-47eb-a03f-8d0ded539d3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d4ee5e30-d6ca-4623-b306-4d3b7eb3dc92" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_efd5597d-9535-47eb-a03f-8d0ded539d3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_b1a23d84-086a-49e0-9f69-7f072b06581b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_efd5597d-9535-47eb-a03f-8d0ded539d3d" xlink:to="loc_us-gaap_AwardTypeAxis_b1a23d84-086a-49e0-9f69-7f072b06581b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_039d5350-5eef-4649-8ef3-86e76ee4a163" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_b1a23d84-086a-49e0-9f69-7f072b06581b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_039d5350-5eef-4649-8ef3-86e76ee4a163" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_2e539c46-1921-4898-aae5-79f2c313e438" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_039d5350-5eef-4649-8ef3-86e76ee4a163" xlink:to="loc_us-gaap_EmployeeStockOptionMember_2e539c46-1921-4898-aae5-79f2c313e438" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_18a67055-db8b-4830-9edd-e62f8320f96c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_039d5350-5eef-4649-8ef3-86e76ee4a163" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_18a67055-db8b-4830-9edd-e62f8320f96c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_7837052e-580d-40c8-b225-64c6da0f25d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_efd5597d-9535-47eb-a03f-8d0ded539d3d" xlink:to="loc_us-gaap_PlanNameAxis_7837052e-580d-40c8-b225-64c6da0f25d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_c4251752-0d01-4d70-9fd4-4f2c8944b158" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_7837052e-580d-40c8-b225-64c6da0f25d3" xlink:to="loc_us-gaap_PlanNameDomain_c4251752-0d01-4d70-9fd4-4f2c8944b158" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_A2021EquityIncentiveAwardPlanMember_8bdb019e-505a-43a8-9b2a-d6c92ead4167" xlink:href="prct-20220630.xsd#prct_A2021EquityIncentiveAwardPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_c4251752-0d01-4d70-9fd4-4f2c8944b158" xlink:to="loc_prct_A2021EquityIncentiveAwardPlanMember_8bdb019e-505a-43a8-9b2a-d6c92ead4167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_A2021EmployeeStockPurchasePlanMember_3741e338-c39c-4841-8d5c-9285baae3b9a" xlink:href="prct-20220630.xsd#prct_A2021EmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_c4251752-0d01-4d70-9fd4-4f2c8944b158" xlink:to="loc_prct_A2021EmployeeStockPurchasePlanMember_3741e338-c39c-4841-8d5c-9285baae3b9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_43576de2-4705-4d91-87a9-0d73e0485471" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_efd5597d-9535-47eb-a03f-8d0ded539d3d" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_43576de2-4705-4d91-87a9-0d73e0485471" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_1f426a45-5c39-4511-a11e-43aee02b3d3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_43576de2-4705-4d91-87a9-0d73e0485471" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_1f426a45-5c39-4511-a11e-43aee02b3d3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_bd1d9b86-281f-4990-adcc-a7011f8ff72b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_43576de2-4705-4d91-87a9-0d73e0485471" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_bd1d9b86-281f-4990-adcc-a7011f8ff72b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_28d50620-4d7a-4d50-a346-ceb69d8151a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_43576de2-4705-4d91-87a9-0d73e0485471" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_28d50620-4d7a-4d50-a346-ceb69d8151a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_02c402b9-0b03-47d2-8d1b-02ff039a43a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_43576de2-4705-4d91-87a9-0d73e0485471" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_02c402b9-0b03-47d2-8d1b-02ff039a43a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_13b39a7c-f512-42b6-a42e-7b3ad40f144c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_43576de2-4705-4d91-87a9-0d73e0485471" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_13b39a7c-f512-42b6-a42e-7b3ad40f144c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_fd7e7aaa-31ed-49c5-b5f1-a12d14570d94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_43576de2-4705-4d91-87a9-0d73e0485471" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_fd7e7aaa-31ed-49c5-b5f1-a12d14570d94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_0d7016cd-2172-4cc3-9841-9b8285384812" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_43576de2-4705-4d91-87a9-0d73e0485471" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_0d7016cd-2172-4cc3-9841-9b8285384812" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/StockBasedCompensationSummaryofStockOptionActivityDetails" xlink:type="simple" xlink:href="prct-20220630.xsd#StockBasedCompensationSummaryofStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://www.procept-biorobotics.com/role/StockBasedCompensationSummaryofStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a4d3fcb5-4c00-40de-a1a0-78e34a64aa16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_6041e859-ab05-48ee-9296-da0102cf0141" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a4d3fcb5-4c00-40de-a1a0-78e34a64aa16" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_6041e859-ab05-48ee-9296-da0102cf0141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_35c33622-babd-4bbb-85ba-1a963ec69307" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_6041e859-ab05-48ee-9296-da0102cf0141" xlink:to="loc_us-gaap_AwardTypeAxis_35c33622-babd-4bbb-85ba-1a963ec69307" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1ae95c1c-fa05-4438-98e2-55e7772cc39c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_35c33622-babd-4bbb-85ba-1a963ec69307" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1ae95c1c-fa05-4438-98e2-55e7772cc39c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_6909c176-b784-4b63-b218-d71e1e3a1277" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1ae95c1c-fa05-4438-98e2-55e7772cc39c" xlink:to="loc_us-gaap_EmployeeStockOptionMember_6909c176-b784-4b63-b218-d71e1e3a1277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_93a106b9-acb4-4005-940d-73e6169d4626" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_6041e859-ab05-48ee-9296-da0102cf0141" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_93a106b9-acb4-4005-940d-73e6169d4626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a2bfb901-6b5c-4e2d-a6e0-32ec9060c2ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_93a106b9-acb4-4005-940d-73e6169d4626" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a2bfb901-6b5c-4e2d-a6e0-32ec9060c2ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8bd728d4-1301-4707-943d-0038460add73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a2bfb901-6b5c-4e2d-a6e0-32ec9060c2ae" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8bd728d4-1301-4707-943d-0038460add73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_ee894b73-86a2-48ce-b45a-24b3b6f299c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a2bfb901-6b5c-4e2d-a6e0-32ec9060c2ae" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_ee894b73-86a2-48ce-b45a-24b3b6f299c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3d2f604b-c8af-4e14-be81-e165967646d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a2bfb901-6b5c-4e2d-a6e0-32ec9060c2ae" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3d2f604b-c8af-4e14-be81-e165967646d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_29b3c898-951c-4385-aaaf-5daf9f02ef36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a2bfb901-6b5c-4e2d-a6e0-32ec9060c2ae" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_29b3c898-951c-4385-aaaf-5daf9f02ef36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_66a120a4-c4f8-464e-bb2b-f2cb0bd717b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a2bfb901-6b5c-4e2d-a6e0-32ec9060c2ae" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_66a120a4-c4f8-464e-bb2b-f2cb0bd717b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_6968ab23-51e5-49f5-b681-e0f36fdd0d71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_93a106b9-acb4-4005-940d-73e6169d4626" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_6968ab23-51e5-49f5-b681-e0f36fdd0d71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_101c5ebd-753e-4943-b4cb-3a44f972e929" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_93a106b9-acb4-4005-940d-73e6169d4626" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_101c5ebd-753e-4943-b4cb-3a44f972e929" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_d92a5f18-58ba-4a3f-bcf1-48b86802d038" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_93a106b9-acb4-4005-940d-73e6169d4626" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_d92a5f18-58ba-4a3f-bcf1-48b86802d038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_914a7b3e-4109-4c98-b770-580c5406789c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_d92a5f18-58ba-4a3f-bcf1-48b86802d038" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_914a7b3e-4109-4c98-b770-580c5406789c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_9e68d878-74fa-4195-b0b7-964128dcfc1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_d92a5f18-58ba-4a3f-bcf1-48b86802d038" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_9e68d878-74fa-4195-b0b7-964128dcfc1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2eb402a0-9889-4739-abcb-9e35d3478dc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_d92a5f18-58ba-4a3f-bcf1-48b86802d038" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2eb402a0-9889-4739-abcb-9e35d3478dc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_09d1e389-4b5a-46a8-b92d-6f3b72e7186e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_d92a5f18-58ba-4a3f-bcf1-48b86802d038" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_09d1e389-4b5a-46a8-b92d-6f3b72e7186e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_15349d83-14f7-410e-a4b2-b7b508d91ec0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_d92a5f18-58ba-4a3f-bcf1-48b86802d038" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_15349d83-14f7-410e-a4b2-b7b508d91ec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_7151b17d-dd31-46ee-af22-73a97bd10a9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_93a106b9-acb4-4005-940d-73e6169d4626" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_7151b17d-dd31-46ee-af22-73a97bd10a9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_572159e1-f5aa-4385-b775-857831ec0dd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_93a106b9-acb4-4005-940d-73e6169d4626" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_572159e1-f5aa-4385-b775-857831ec0dd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/StockBasedCompensationFairValueAssumptionsDetails" xlink:type="simple" xlink:href="prct-20220630.xsd#StockBasedCompensationFairValueAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://www.procept-biorobotics.com/role/StockBasedCompensationFairValueAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1546037a-a9b1-4bc2-b721-3e8ceba5770c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ebcb5951-9da0-4e63-8a1a-e0c757a31b22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1546037a-a9b1-4bc2-b721-3e8ceba5770c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ebcb5951-9da0-4e63-8a1a-e0c757a31b22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6d41f917-f152-4c4d-8cdc-f24dddbf368d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ebcb5951-9da0-4e63-8a1a-e0c757a31b22" xlink:to="loc_us-gaap_AwardTypeAxis_6d41f917-f152-4c4d-8cdc-f24dddbf368d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_71b5ef75-a038-498a-b057-868c2393b58c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_6d41f917-f152-4c4d-8cdc-f24dddbf368d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_71b5ef75-a038-498a-b057-868c2393b58c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_a2e18cf5-f38b-4242-8213-c8aeecb3d63b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_71b5ef75-a038-498a-b057-868c2393b58c" xlink:to="loc_us-gaap_EmployeeStockOptionMember_a2e18cf5-f38b-4242-8213-c8aeecb3d63b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_4ed41c45-a2cb-4f94-a8aa-c1b27d0dc9d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ebcb5951-9da0-4e63-8a1a-e0c757a31b22" xlink:to="loc_us-gaap_PlanNameAxis_4ed41c45-a2cb-4f94-a8aa-c1b27d0dc9d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_d856cdb4-680b-43f6-a3e6-4d50858ea073" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_4ed41c45-a2cb-4f94-a8aa-c1b27d0dc9d7" xlink:to="loc_us-gaap_PlanNameDomain_d856cdb4-680b-43f6-a3e6-4d50858ea073" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_A2021EmployeeStockPurchasePlanMember_e6bf9cd0-7321-49ee-8533-9b47d26499c6" xlink:href="prct-20220630.xsd#prct_A2021EmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_d856cdb4-680b-43f6-a3e6-4d50858ea073" xlink:to="loc_prct_A2021EmployeeStockPurchasePlanMember_e6bf9cd0-7321-49ee-8533-9b47d26499c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c60d3db9-4287-4f0c-97d5-1e8de69359f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ebcb5951-9da0-4e63-8a1a-e0c757a31b22" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c60d3db9-4287-4f0c-97d5-1e8de69359f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_ad14293f-2c65-4a15-8539-5ec4b0fbd555" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c60d3db9-4287-4f0c-97d5-1e8de69359f8" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_ad14293f-2c65-4a15-8539-5ec4b0fbd555" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_0db64a83-a72e-40c6-97a4-f3d9071d1abd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c60d3db9-4287-4f0c-97d5-1e8de69359f8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_0db64a83-a72e-40c6-97a4-f3d9071d1abd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_ea2a4379-866e-4811-a3d7-7154fb1d6c85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c60d3db9-4287-4f0c-97d5-1e8de69359f8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_ea2a4379-866e-4811-a3d7-7154fb1d6c85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_ac34bc8f-6972-4d29-8a52-aa1ac9ecfd77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c60d3db9-4287-4f0c-97d5-1e8de69359f8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_ac34bc8f-6972-4d29-8a52-aa1ac9ecfd77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_b44f8d09-5e16-484d-8800-c5d54353d5c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c60d3db9-4287-4f0c-97d5-1e8de69359f8" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_b44f8d09-5e16-484d-8800-c5d54353d5c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/StockBasedCompensationRestrictedStockUnitDetails" xlink:type="simple" xlink:href="prct-20220630.xsd#StockBasedCompensationRestrictedStockUnitDetails"/>
  <link:presentationLink xlink:role="http://www.procept-biorobotics.com/role/StockBasedCompensationRestrictedStockUnitDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_bd6ca130-c864-4efa-9fe2-e3b95675b3b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_322b6828-2626-43bb-a947-dc97605bfdaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_bd6ca130-c864-4efa-9fe2-e3b95675b3b9" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_322b6828-2626-43bb-a947-dc97605bfdaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_19edab67-8524-495b-9255-cc5fa7695512" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_322b6828-2626-43bb-a947-dc97605bfdaf" xlink:to="loc_us-gaap_AwardTypeAxis_19edab67-8524-495b-9255-cc5fa7695512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5af78e8a-5585-43d0-829a-db9534b347f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_19edab67-8524-495b-9255-cc5fa7695512" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5af78e8a-5585-43d0-829a-db9534b347f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_b8d670a9-12ff-4f6a-9836-a33b1c030c58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5af78e8a-5585-43d0-829a-db9534b347f6" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_b8d670a9-12ff-4f6a-9836-a33b1c030c58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6392276f-10a3-4373-b591-d7ef9015a256" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_322b6828-2626-43bb-a947-dc97605bfdaf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6392276f-10a3-4373-b591-d7ef9015a256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9b6631b2-dac8-41af-8f62-39ae708076df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6392276f-10a3-4373-b591-d7ef9015a256" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9b6631b2-dac8-41af-8f62-39ae708076df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5c9d4fca-5fbe-4d68-bf0c-45fa5dc0c9a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9b6631b2-dac8-41af-8f62-39ae708076df" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5c9d4fca-5fbe-4d68-bf0c-45fa5dc0c9a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_6678f6e0-0b65-4b5a-a1f5-fbecaba83e0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9b6631b2-dac8-41af-8f62-39ae708076df" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_6678f6e0-0b65-4b5a-a1f5-fbecaba83e0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_862cf5f9-a162-405d-a643-76387ea6525c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9b6631b2-dac8-41af-8f62-39ae708076df" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_862cf5f9-a162-405d-a643-76387ea6525c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1c445a6e-002e-418c-aaf7-690275bec195" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9b6631b2-dac8-41af-8f62-39ae708076df" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1c445a6e-002e-418c-aaf7-690275bec195" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ac391d89-e1f8-4420-939c-69acce99c758" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6392276f-10a3-4373-b591-d7ef9015a256" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ac391d89-e1f8-4420-939c-69acce99c758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b65c3eb0-a9c5-4753-b5e2-64764d8550af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ac391d89-e1f8-4420-939c-69acce99c758" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b65c3eb0-a9c5-4753-b5e2-64764d8550af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_33d08861-5ad0-40ed-869e-b27e163306de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ac391d89-e1f8-4420-939c-69acce99c758" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_33d08861-5ad0-40ed-869e-b27e163306de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_dbfd814c-d99a-4a14-884e-3036183e11d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ac391d89-e1f8-4420-939c-69acce99c758" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_dbfd814c-d99a-4a14-884e-3036183e11d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_70ecc610-3766-4056-9db2-d4731b0b9dac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ac391d89-e1f8-4420-939c-69acce99c758" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_70ecc610-3766-4056-9db2-d4731b0b9dac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/StockBasedCompensationStockbasedCompensationDetails" xlink:type="simple" xlink:href="prct-20220630.xsd#StockBasedCompensationStockbasedCompensationDetails"/>
  <link:presentationLink xlink:role="http://www.procept-biorobotics.com/role/StockBasedCompensationStockbasedCompensationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_eb1dc25a-f51a-4b46-aa71-63002a9e2844" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3c68a22b-79aa-4210-affc-ec46806a8005" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_eb1dc25a-f51a-4b46-aa71-63002a9e2844" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3c68a22b-79aa-4210-affc-ec46806a8005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_fe972de9-8236-4b79-b5e4-6934018401e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3c68a22b-79aa-4210-affc-ec46806a8005" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_fe972de9-8236-4b79-b5e4-6934018401e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_982766bf-e02c-458d-a8a8-02416793bff7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_fe972de9-8236-4b79-b5e4-6934018401e2" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_982766bf-e02c-458d-a8a8-02416793bff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_7b22c7e5-e42b-49fc-83d8-de5e49458eaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_982766bf-e02c-458d-a8a8-02416793bff7" xlink:to="loc_us-gaap_CostOfSalesMember_7b22c7e5-e42b-49fc-83d8-de5e49458eaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_ac713c59-a99f-4b88-a7c6-dc289914d387" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_982766bf-e02c-458d-a8a8-02416793bff7" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_ac713c59-a99f-4b88-a7c6-dc289914d387" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_7e21d64a-aa47-408f-9f7a-f150a61e8853" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_982766bf-e02c-458d-a8a8-02416793bff7" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_7e21d64a-aa47-408f-9f7a-f150a61e8853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_431e7e55-ae42-4569-a7a6-77063da67e73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3c68a22b-79aa-4210-affc-ec46806a8005" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_431e7e55-ae42-4569-a7a6-77063da67e73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_f35e513a-cccf-4d26-9b0f-e9547b9b5999" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_431e7e55-ae42-4569-a7a6-77063da67e73" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_f35e513a-cccf-4d26-9b0f-e9547b9b5999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/NetLossPerShare" xlink:type="simple" xlink:href="prct-20220630.xsd#NetLossPerShare"/>
  <link:presentationLink xlink:role="http://www.procept-biorobotics.com/role/NetLossPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_24ea45f0-f0c8-435b-b04d-e5a7e2133314" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_3ee817d5-63fc-4c00-807d-6832d18710f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_24ea45f0-f0c8-435b-b04d-e5a7e2133314" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_3ee817d5-63fc-4c00-807d-6832d18710f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/NetLossPerShareTables" xlink:type="simple" xlink:href="prct-20220630.xsd#NetLossPerShareTables"/>
  <link:presentationLink xlink:role="http://www.procept-biorobotics.com/role/NetLossPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_9ff2a2a8-fc9a-4e19-9087-9cb06aa0bce9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock_e8567b7c-255e-4974-b41c-63720394f2bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_9ff2a2a8-fc9a-4e19-9087-9cb06aa0bce9" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock_e8567b7c-255e-4974-b41c-63720394f2bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_8db6dbed-890c-4077-b0ec-f043060ee6a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_9ff2a2a8-fc9a-4e19-9087-9cb06aa0bce9" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_8db6dbed-890c-4077-b0ec-f043060ee6a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_6672eee3-172c-442b-9687-dabfd1ebe13d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_9ff2a2a8-fc9a-4e19-9087-9cb06aa0bce9" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_6672eee3-172c-442b-9687-dabfd1ebe13d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/NetLossPerShareNarrativeDetails" xlink:type="simple" xlink:href="prct-20220630.xsd#NetLossPerShareNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.procept-biorobotics.com/role/NetLossPerShareNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_20c05d73-26b0-41e5-bca2-2d80a81691e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_bf6495f6-060a-4e6a-86b4-b143cbaa4e09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_20c05d73-26b0-41e5-bca2-2d80a81691e1" xlink:to="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_bf6495f6-060a-4e6a-86b4-b143cbaa4e09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/NetLossPerShareNetlosspershareDetails" xlink:type="simple" xlink:href="prct-20220630.xsd#NetLossPerShareNetlosspershareDetails"/>
  <link:presentationLink xlink:role="http://www.procept-biorobotics.com/role/NetLossPerShareNetlosspershareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_525d6e61-f94a-4218-8153-c7c9f99ec92d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_8bc3f48c-c838-46f5-a438-b8d747064f6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_525d6e61-f94a-4218-8153-c7c9f99ec92d" xlink:to="loc_us-gaap_NetIncomeLoss_8bc3f48c-c838-46f5-a438-b8d747064f6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3503dc5f-bd03-4fc9-98ce-00e496a409b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_525d6e61-f94a-4218-8153-c7c9f99ec92d" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3503dc5f-bd03-4fc9-98ce-00e496a409b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_27919eb8-1cca-4589-903f-6188d90f7ed7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_525d6e61-f94a-4218-8153-c7c9f99ec92d" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_27919eb8-1cca-4589-903f-6188d90f7ed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_fefcabcb-d8b9-4fa4-af2f-661036746a9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_525d6e61-f94a-4218-8153-c7c9f99ec92d" xlink:to="loc_us-gaap_EarningsPerShareBasic_fefcabcb-d8b9-4fa4-af2f-661036746a9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_39c55e75-0fb0-4514-bdf4-d85f76ddadd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_525d6e61-f94a-4218-8153-c7c9f99ec92d" xlink:to="loc_us-gaap_EarningsPerShareDiluted_39c55e75-0fb0-4514-bdf4-d85f76ddadd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/NetLossPerSharePotentiallyDilutiveSecuritiesDetails" xlink:type="simple" xlink:href="prct-20220630.xsd#NetLossPerSharePotentiallyDilutiveSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.procept-biorobotics.com/role/NetLossPerSharePotentiallyDilutiveSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_0fe265b2-2531-4502-8acc-4704ce7d0f93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_efb5206c-3883-484a-bd51-ae3fdaaa0e29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0fe265b2-2531-4502-8acc-4704ce7d0f93" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_efb5206c-3883-484a-bd51-ae3fdaaa0e29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_eb3b41f3-fc07-490d-85d3-2c727f8712b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_efb5206c-3883-484a-bd51-ae3fdaaa0e29" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_eb3b41f3-fc07-490d-85d3-2c727f8712b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a83ce520-7e37-4834-9980-c24f6a8831da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_eb3b41f3-fc07-490d-85d3-2c727f8712b1" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a83ce520-7e37-4834-9980-c24f6a8831da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableConvertiblePreferredStockMember_02c0fbc1-e656-45d8-bcd9-1bbd874de8ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a83ce520-7e37-4834-9980-c24f6a8831da" xlink:to="loc_us-gaap_RedeemableConvertiblePreferredStockMember_02c0fbc1-e656-45d8-bcd9-1bbd874de8ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_RedeemableConvertiblePreferredStockWarrantsMember_5aab20e3-2cee-4468-a732-eef6bd6999c6" xlink:href="prct-20220630.xsd#prct_RedeemableConvertiblePreferredStockWarrantsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a83ce520-7e37-4834-9980-c24f6a8831da" xlink:to="loc_prct_RedeemableConvertiblePreferredStockWarrantsMember_5aab20e3-2cee-4468-a732-eef6bd6999c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_860987d7-9c06-4ac3-8f2e-fd4d8cdf04f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a83ce520-7e37-4834-9980-c24f6a8831da" xlink:to="loc_us-gaap_EmployeeStockOptionMember_860987d7-9c06-4ac3-8f2e-fd4d8cdf04f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_16d5457f-3b41-4c8f-a387-385078d635b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a83ce520-7e37-4834-9980-c24f6a8831da" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_16d5457f-3b41-4c8f-a387-385078d635b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_A2021EmployeeStockPurchasePlanMember_040327f7-20d7-4049-9403-4cb62b959472" xlink:href="prct-20220630.xsd#prct_A2021EmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a83ce520-7e37-4834-9980-c24f6a8831da" xlink:to="loc_prct_A2021EmployeeStockPurchasePlanMember_040327f7-20d7-4049-9403-4cb62b959472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_7e5be3a5-2dbb-4e5e-9a58-4c3758009462" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_efb5206c-3883-484a-bd51-ae3fdaaa0e29" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_7e5be3a5-2dbb-4e5e-9a58-4c3758009462" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1b4e6652-e2e7-4da7-a051-84fbcfa99283" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_7e5be3a5-2dbb-4e5e-9a58-4c3758009462" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1b4e6652-e2e7-4da7-a051-84fbcfa99283" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/Revenue" xlink:type="simple" xlink:href="prct-20220630.xsd#Revenue"/>
  <link:presentationLink xlink:role="http://www.procept-biorobotics.com/role/Revenue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_d38b7809-7984-4369-9e8b-b1a5247578d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_a9e2ce55-956f-41f2-9f14-dc30ace42ab2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_d38b7809-7984-4369-9e8b-b1a5247578d4" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_a9e2ce55-956f-41f2-9f14-dc30ace42ab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/RevenueTables" xlink:type="simple" xlink:href="prct-20220630.xsd#RevenueTables"/>
  <link:presentationLink xlink:role="http://www.procept-biorobotics.com/role/RevenueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1e42dd9d-ab26-4d9f-a310-5bc98e367653" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_256a3b73-f33e-48b1-b129-6cc1351d5069" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1e42dd9d-ab26-4d9f-a310-5bc98e367653" xlink:to="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_256a3b73-f33e-48b1-b129-6cc1351d5069" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_6d3af787-e761-4b93-9f27-7ebf695a20e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1e42dd9d-ab26-4d9f-a310-5bc98e367653" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_6d3af787-e761-4b93-9f27-7ebf695a20e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/RevenueDetails" xlink:type="simple" xlink:href="prct-20220630.xsd#RevenueDetails"/>
  <link:presentationLink xlink:role="http://www.procept-biorobotics.com/role/RevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_217da4f3-4aab-4562-9797-b6dab4884730" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_a13a4068-c872-4760-8a40-ee407807c165" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_217da4f3-4aab-4562-9797-b6dab4884730" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_a13a4068-c872-4760-8a40-ee407807c165" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_c3309026-9fe8-4a62-9e99-d94f02b3b172" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_a13a4068-c872-4760-8a40-ee407807c165" xlink:to="loc_srt_ProductOrServiceAxis_c3309026-9fe8-4a62-9e99-d94f02b3b172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_cfe642e6-30ee-4574-ad3c-b7881c17bda7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_c3309026-9fe8-4a62-9e99-d94f02b3b172" xlink:to="loc_srt_ProductsAndServicesDomain_cfe642e6-30ee-4574-ad3c-b7881c17bda7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_SystemSalesAndRentalsMember_bb8d3a39-049f-4fbe-aba4-a8244d922952" xlink:href="prct-20220630.xsd#prct_SystemSalesAndRentalsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_cfe642e6-30ee-4574-ad3c-b7881c17bda7" xlink:to="loc_prct_SystemSalesAndRentalsMember_bb8d3a39-049f-4fbe-aba4-a8244d922952" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_HandPiecesAndOtherConsumablesMember_3359452c-dc32-4f62-8c29-c8ea14562e02" xlink:href="prct-20220630.xsd#prct_HandPiecesAndOtherConsumablesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_cfe642e6-30ee-4574-ad3c-b7881c17bda7" xlink:to="loc_prct_HandPiecesAndOtherConsumablesMember_3359452c-dc32-4f62-8c29-c8ea14562e02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_ServiceRevenueMember_19b38bc8-3298-476a-af4c-19647d81f1b2" xlink:href="prct-20220630.xsd#prct_ServiceRevenueMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_cfe642e6-30ee-4574-ad3c-b7881c17bda7" xlink:to="loc_prct_ServiceRevenueMember_19b38bc8-3298-476a-af4c-19647d81f1b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_9f9d1c31-34c7-4fd7-9066-702e1d17281a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_a13a4068-c872-4760-8a40-ee407807c165" xlink:to="loc_srt_StatementGeographicalAxis_9f9d1c31-34c7-4fd7-9066-702e1d17281a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_67f0f99a-e8e7-4f49-b1b6-ad5abec71d8e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_9f9d1c31-34c7-4fd7-9066-702e1d17281a" xlink:to="loc_srt_SegmentGeographicalDomain_67f0f99a-e8e7-4f49-b1b6-ad5abec71d8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_930b3f82-df86-41e9-ab84-6db494747144" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_67f0f99a-e8e7-4f49-b1b6-ad5abec71d8e" xlink:to="loc_country_US_930b3f82-df86-41e9-ab84-6db494747144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_OutsideTheUnitedStatesMember_8af62fae-262c-41c2-9e7a-3ed8e0ac9c49" xlink:href="prct-20220630.xsd#prct_OutsideTheUnitedStatesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_67f0f99a-e8e7-4f49-b1b6-ad5abec71d8e" xlink:to="loc_prct_OutsideTheUnitedStatesMember_8af62fae-262c-41c2-9e7a-3ed8e0ac9c49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_958d9bbf-a138-4417-a0c8-5ac1f36d1219" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_a13a4068-c872-4760-8a40-ee407807c165" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_958d9bbf-a138-4417-a0c8-5ac1f36d1219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d7726638-89c9-4617-b0ff-ec7b54591e44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_958d9bbf-a138-4417-a0c8-5ac1f36d1219" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d7726638-89c9-4617-b0ff-ec7b54591e44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/SegmentGeographicalandCustomerConcentration" xlink:type="simple" xlink:href="prct-20220630.xsd#SegmentGeographicalandCustomerConcentration"/>
  <link:presentationLink xlink:role="http://www.procept-biorobotics.com/role/SegmentGeographicalandCustomerConcentration" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_bb1c4051-981f-4b95-90e5-918916d46555" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskDisclosureTextBlock_3e82117c-854c-4d7a-be1f-d13e516ee47f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_bb1c4051-981f-4b95-90e5-918916d46555" xlink:to="loc_us-gaap_ConcentrationRiskDisclosureTextBlock_3e82117c-854c-4d7a-be1f-d13e516ee47f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_bc1c879f-bade-4528-a6d6-06f9709bb1f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_bb1c4051-981f-4b95-90e5-918916d46555" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_bc1c879f-bade-4528-a6d6-06f9709bb1f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/SegmentGeographicalandCustomerConcentrationTables" xlink:type="simple" xlink:href="prct-20220630.xsd#SegmentGeographicalandCustomerConcentrationTables"/>
  <link:presentationLink xlink:role="http://www.procept-biorobotics.com/role/SegmentGeographicalandCustomerConcentrationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_3ea8f185-38fe-47f8-bee4-a1d0c0b43ee7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_c956740f-4bd8-49c7-82c1-f0a95c815db9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_3ea8f185-38fe-47f8-bee4-a1d0c0b43ee7" xlink:to="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_c956740f-4bd8-49c7-82c1-f0a95c815db9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/SegmentGeographicalandCustomerConcentrationDetails" xlink:type="simple" xlink:href="prct-20220630.xsd#SegmentGeographicalandCustomerConcentrationDetails"/>
  <link:presentationLink xlink:role="http://www.procept-biorobotics.com/role/SegmentGeographicalandCustomerConcentrationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_3ae384c2-1718-4131-8b72-40ce4e24042a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_a527ee9e-5047-497d-8b1d-00fbcc1525b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_3ae384c2-1718-4131-8b72-40ce4e24042a" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_a527ee9e-5047-497d-8b1d-00fbcc1525b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_3abda6f3-0fa8-454a-8f0a-e9d68a5c13fa" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_a527ee9e-5047-497d-8b1d-00fbcc1525b2" xlink:to="loc_srt_MajorCustomersAxis_3abda6f3-0fa8-454a-8f0a-e9d68a5c13fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_98bf562f-f309-4779-86ee-270fe73352aa" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_3abda6f3-0fa8-454a-8f0a-e9d68a5c13fa" xlink:to="loc_srt_NameOfMajorCustomerDomain_98bf562f-f309-4779-86ee-270fe73352aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_Customer1Member_ad7b0008-7692-4895-aebd-133cd1c37adb" xlink:href="prct-20220630.xsd#prct_Customer1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_98bf562f-f309-4779-86ee-270fe73352aa" xlink:to="loc_prct_Customer1Member_ad7b0008-7692-4895-aebd-133cd1c37adb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_8e45b23c-e657-4b81-b697-2028910f0e36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_a527ee9e-5047-497d-8b1d-00fbcc1525b2" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_8e45b23c-e657-4b81-b697-2028910f0e36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_0a573617-e68a-40b9-a2a4-cd757228ec1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_8e45b23c-e657-4b81-b697-2028910f0e36" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_0a573617-e68a-40b9-a2a4-cd757228ec1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_5d421ed5-6aac-48bb-8bef-d08694d3225a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_0a573617-e68a-40b9-a2a4-cd757228ec1a" xlink:to="loc_us-gaap_AccountsReceivableMember_5d421ed5-6aac-48bb-8bef-d08694d3225a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_64ba95b3-4c6c-4371-bebe-bf24f12dc74d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_0a573617-e68a-40b9-a2a4-cd757228ec1a" xlink:to="loc_us-gaap_SalesRevenueNetMember_64ba95b3-4c6c-4371-bebe-bf24f12dc74d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_ac3d236c-dd1d-4ebc-b638-ba57eb0ad99c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_a527ee9e-5047-497d-8b1d-00fbcc1525b2" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_ac3d236c-dd1d-4ebc-b638-ba57eb0ad99c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_8a3aed20-cbaf-46cd-9cf0-9d2a9b1f58bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_ac3d236c-dd1d-4ebc-b638-ba57eb0ad99c" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_8a3aed20-cbaf-46cd-9cf0-9d2a9b1f58bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_c657677f-51dc-4abf-bbfc-147efc65d209" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_8a3aed20-cbaf-46cd-9cf0-9d2a9b1f58bb" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_c657677f-51dc-4abf-bbfc-147efc65d209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember_a988b996-ea26-473b-b884-e4c4a8a6f1d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_8a3aed20-cbaf-46cd-9cf0-9d2a9b1f58bb" xlink:to="loc_us-gaap_GeographicConcentrationRiskMember_a988b996-ea26-473b-b884-e4c4a8a6f1d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_355b97a2-6380-44bb-aeaa-d829cd98c45b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_a527ee9e-5047-497d-8b1d-00fbcc1525b2" xlink:to="loc_srt_StatementGeographicalAxis_355b97a2-6380-44bb-aeaa-d829cd98c45b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_3aa995ea-937a-480b-b4a2-51fef0051c4e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_355b97a2-6380-44bb-aeaa-d829cd98c45b" xlink:to="loc_srt_SegmentGeographicalDomain_3aa995ea-937a-480b-b4a2-51fef0051c4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_1d6f1eca-341d-47b6-a70f-8ead07850e85" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_3aa995ea-937a-480b-b4a2-51fef0051c4e" xlink:to="loc_country_US_1d6f1eca-341d-47b6-a70f-8ead07850e85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_OutsideTheUnitedStatesMember_0735c848-18bd-41dd-99fb-1c43c1dcbeb9" xlink:href="prct-20220630.xsd#prct_OutsideTheUnitedStatesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_3aa995ea-937a-480b-b4a2-51fef0051c4e" xlink:to="loc_prct_OutsideTheUnitedStatesMember_0735c848-18bd-41dd-99fb-1c43c1dcbeb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_c47111ab-b5b5-4826-a494-e45053100225" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_a527ee9e-5047-497d-8b1d-00fbcc1525b2" xlink:to="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_c47111ab-b5b5-4826-a494-e45053100225" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_b5135b51-edb1-46fc-bc16-8cff90bf24d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_c47111ab-b5b5-4826-a494-e45053100225" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_b5135b51-edb1-46fc-bc16-8cff90bf24d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="prct-20220630.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.procept-biorobotics.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c4c04663-d0cf-48f1-9135-6f91328673f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_67d563b3-b9fe-41ab-9d59-fd6579a10ea7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c4c04663-d0cf-48f1-9135-6f91328673f7" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_67d563b3-b9fe-41ab-9d59-fd6579a10ea7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_8b80c118-a81e-4397-899b-aab5aaec824d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c4c04663-d0cf-48f1-9135-6f91328673f7" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_8b80c118-a81e-4397-899b-aab5aaec824d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/CommitmentsandContingenciesTables" xlink:type="simple" xlink:href="prct-20220630.xsd#CommitmentsandContingenciesTables"/>
  <link:presentationLink xlink:role="http://www.procept-biorobotics.com/role/CommitmentsandContingenciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_153a9bf6-bc77-40e6-8732-4eda69d04813" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_c30208a7-e0aa-4596-9e6c-283d027b6dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_153a9bf6-bc77-40e6-8732-4eda69d04813" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_c30208a7-e0aa-4596-9e6c-283d027b6dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_37e3325c-b5c7-4aa8-8356-b08007d765de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_153a9bf6-bc77-40e6-8732-4eda69d04813" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_37e3325c-b5c7-4aa8-8356-b08007d765de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="simple" xlink:href="prct-20220630.xsd#CommitmentsandContingenciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.procept-biorobotics.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_89ef480f-ad1c-475f-8dcd-d73e3b973ed1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_c07a21ed-64c4-4755-b719-6f5c37a33a5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_89ef480f-ad1c-475f-8dcd-d73e3b973ed1" xlink:to="loc_us-gaap_OperatingLeaseExpense_c07a21ed-64c4-4755-b719-6f5c37a33a5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable_e41f4ffb-15ec-4105-9b50-5007b48e0e30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_89ef480f-ad1c-475f-8dcd-d73e3b973ed1" xlink:to="loc_us-gaap_OtherCommitmentsTable_e41f4ffb-15ec-4105-9b50-5007b48e0e30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5fdec19c-b9c5-4691-af8f-132e6f898825" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_e41f4ffb-15ec-4105-9b50-5007b48e0e30" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5fdec19c-b9c5-4691-af8f-132e6f898825" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_02ba8c8e-6fe9-4270-b377-30199776d662" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5fdec19c-b9c5-4691-af8f-132e6f898825" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_02ba8c8e-6fe9-4270-b377-30199776d662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_ed53485d-511f-4b9b-a646-f56d6b82c38c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_02ba8c8e-6fe9-4270-b377-30199776d662" xlink:to="loc_us-gaap_BuildingMember_ed53485d-511f-4b9b-a646-f56d6b82c38c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_d81719db-e2ae-45fe-993b-97524c61a029" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_e41f4ffb-15ec-4105-9b50-5007b48e0e30" xlink:to="loc_us-gaap_OtherCommitmentsLineItems_d81719db-e2ae-45fe-993b-97524c61a029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_OperatingLeaseNumberOfBuildings_b998ada6-8148-4e58-b918-365bf4e1e109" xlink:href="prct-20220630.xsd#prct_OperatingLeaseNumberOfBuildings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_d81719db-e2ae-45fe-993b-97524c61a029" xlink:to="loc_prct_OperatingLeaseNumberOfBuildings_b998ada6-8148-4e58-b918-365bf4e1e109" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_OperatingLeaseNumberOfSquareFeet_7c41c9f1-068c-4549-93fb-947264fe07fe" xlink:href="prct-20220630.xsd#prct_OperatingLeaseNumberOfSquareFeet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_d81719db-e2ae-45fe-993b-97524c61a029" xlink:to="loc_prct_OperatingLeaseNumberOfSquareFeet_7c41c9f1-068c-4549-93fb-947264fe07fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_LesseeOperatingLeaseNumberOfRenewalOptions_e98403be-3da1-4d7f-b322-9d7be9748f97" xlink:href="prct-20220630.xsd#prct_LesseeOperatingLeaseNumberOfRenewalOptions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_d81719db-e2ae-45fe-993b-97524c61a029" xlink:to="loc_prct_LesseeOperatingLeaseNumberOfRenewalOptions_e98403be-3da1-4d7f-b322-9d7be9748f97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_OperatingLeaseAnnualBaseRentYearOne_b28e276a-24bd-45dc-a2cb-af4d50528f66" xlink:href="prct-20220630.xsd#prct_OperatingLeaseAnnualBaseRentYearOne"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_d81719db-e2ae-45fe-993b-97524c61a029" xlink:to="loc_prct_OperatingLeaseAnnualBaseRentYearOne_b28e276a-24bd-45dc-a2cb-af4d50528f66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_OperatingLeaseAnnualBaseRentYearTen_5ba87cb2-532a-4857-b75f-c23ad2782324" xlink:href="prct-20220630.xsd#prct_OperatingLeaseAnnualBaseRentYearTen"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_d81719db-e2ae-45fe-993b-97524c61a029" xlink:to="loc_prct_OperatingLeaseAnnualBaseRentYearTen_5ba87cb2-532a-4857-b75f-c23ad2782324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_6e9d123f-f91e-43db-8b2f-e32c364d48e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_d81719db-e2ae-45fe-993b-97524c61a029" xlink:to="loc_us-gaap_OperatingLeaseLiability_6e9d123f-f91e-43db-8b2f-e32c364d48e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_LesseeOperatingLeaseReceivableAllowanceForTenantImprovements_92bd8d7c-b527-4955-8f3b-f0e8d3a475b2" xlink:href="prct-20220630.xsd#prct_LesseeOperatingLeaseReceivableAllowanceForTenantImprovements"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_d81719db-e2ae-45fe-993b-97524c61a029" xlink:to="loc_prct_LesseeOperatingLeaseReceivableAllowanceForTenantImprovements_92bd8d7c-b527-4955-8f3b-f0e8d3a475b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.procept-biorobotics.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsandLongTermDebtMaturitiesDetails" xlink:type="simple" xlink:href="prct-20220630.xsd#CommitmentsandContingenciesFutureMinimumLeasePaymentsandLongTermDebtMaturitiesDetails"/>
  <link:presentationLink xlink:role="http://www.procept-biorobotics.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsandLongTermDebtMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_76b8143d-9401-490d-832e-a850e16544f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_9c7ac7c7-0fdb-4992-82bf-3d31503922a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_76b8143d-9401-490d-832e-a850e16544f0" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_9c7ac7c7-0fdb-4992-82bf-3d31503922a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_48d16cd4-bf71-4491-898d-ff32bb9b9d70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_9c7ac7c7-0fdb-4992-82bf-3d31503922a0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_48d16cd4-bf71-4491-898d-ff32bb9b9d70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_2534e490-df30-489c-9686-91e5993cb442" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_9c7ac7c7-0fdb-4992-82bf-3d31503922a0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_2534e490-df30-489c-9686-91e5993cb442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_cdba5ff7-ec95-4f84-8ae0-6a1910d99b51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_9c7ac7c7-0fdb-4992-82bf-3d31503922a0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_cdba5ff7-ec95-4f84-8ae0-6a1910d99b51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5099f7fb-aeec-4bf1-ad90-7f6e98319443" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_9c7ac7c7-0fdb-4992-82bf-3d31503922a0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5099f7fb-aeec-4bf1-ad90-7f6e98319443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_7edb2866-5dcd-496c-9991-66b063e17967" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_9c7ac7c7-0fdb-4992-82bf-3d31503922a0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_7edb2866-5dcd-496c-9991-66b063e17967" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_cc1dc7e1-3ff5-4b44-984b-a362f8ca287c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_9c7ac7c7-0fdb-4992-82bf-3d31503922a0" xlink:to="loc_us-gaap_OperatingLeaseLiability_cc1dc7e1-3ff5-4b44-984b-a362f8ca287c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_8aa7e0a0-487e-4c98-b1a5-4933ef9d487d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_9c7ac7c7-0fdb-4992-82bf-3d31503922a0" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_8aa7e0a0-487e-4c98-b1a5-4933ef9d487d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_6eab77e8-ef8f-4154-b20e-943b77514d0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_9c7ac7c7-0fdb-4992-82bf-3d31503922a0" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_6eab77e8-ef8f-4154-b20e-943b77514d0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaturitiesOfLongTermDebtAbstract_768e657d-dcce-4651-94d4-f662376128b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MaturitiesOfLongTermDebtAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_76b8143d-9401-490d-832e-a850e16544f0" xlink:to="loc_us-gaap_MaturitiesOfLongTermDebtAbstract_768e657d-dcce-4651-94d4-f662376128b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_403465a0-28c4-4b39-ae27-7d60d0422efe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MaturitiesOfLongTermDebtAbstract_768e657d-dcce-4651-94d4-f662376128b4" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_403465a0-28c4-4b39-ae27-7d60d0422efe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_59aedbde-da95-4016-8f88-57cec1b0a6c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MaturitiesOfLongTermDebtAbstract_768e657d-dcce-4651-94d4-f662376128b4" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_59aedbde-da95-4016-8f88-57cec1b0a6c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_322d8e1a-96a9-4ffa-bc98-d88adefe0ae6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MaturitiesOfLongTermDebtAbstract_768e657d-dcce-4651-94d4-f662376128b4" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_322d8e1a-96a9-4ffa-bc98-d88adefe0ae6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_f82abd67-0ca4-4f49-8caa-21bb5723468c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MaturitiesOfLongTermDebtAbstract_768e657d-dcce-4651-94d4-f662376128b4" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_f82abd67-0ca4-4f49-8caa-21bb5723468c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_0792c584-5ab9-4ade-b384-7bd2c771f17a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MaturitiesOfLongTermDebtAbstract_768e657d-dcce-4651-94d4-f662376128b4" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_0792c584-5ab9-4ade-b384-7bd2c771f17a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_31268e4b-cde2-4348-aea9-3bd5c9280f35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MaturitiesOfLongTermDebtAbstract_768e657d-dcce-4651-94d4-f662376128b4" xlink:to="loc_us-gaap_LongTermDebt_31268e4b-cde2-4348-aea9-3bd5c9280f35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_478943d3-a7b0-483c-bc7f-ad3b930a3f99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MaturitiesOfLongTermDebtAbstract_768e657d-dcce-4651-94d4-f662376128b4" xlink:to="loc_us-gaap_LongTermDebtCurrent_478943d3-a7b0-483c-bc7f-ad3b930a3f99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_808bccbf-d9bc-4cdf-81fd-a38719e913af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MaturitiesOfLongTermDebtAbstract_768e657d-dcce-4651-94d4-f662376128b4" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_808bccbf-d9bc-4cdf-81fd-a38719e913af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityAbstract_9b2f661e-4224-4b20-a4c8-54380834e9b6" xlink:href="prct-20220630.xsd#prct_OperatingLeaseLiabilityAndLongTermDebtMaturityAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_76b8143d-9401-490d-832e-a850e16544f0" xlink:to="loc_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityAbstract_9b2f661e-4224-4b20-a4c8-54380834e9b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityRemainderOfFiscalYear_d14a322b-0bec-48e4-b729-38b39bd8c8d2" xlink:href="prct-20220630.xsd#prct_OperatingLeaseLiabilityAndLongTermDebtMaturityRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityAbstract_9b2f661e-4224-4b20-a4c8-54380834e9b6" xlink:to="loc_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityRemainderOfFiscalYear_d14a322b-0bec-48e4-b729-38b39bd8c8d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityYearOne_a95bc1c4-426a-4926-8e6d-1eae32123cd8" xlink:href="prct-20220630.xsd#prct_OperatingLeaseLiabilityAndLongTermDebtMaturityYearOne"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityAbstract_9b2f661e-4224-4b20-a4c8-54380834e9b6" xlink:to="loc_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityYearOne_a95bc1c4-426a-4926-8e6d-1eae32123cd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityYearTwo_54810dcc-1466-4e6e-b967-9d44c2dbcd09" xlink:href="prct-20220630.xsd#prct_OperatingLeaseLiabilityAndLongTermDebtMaturityYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityAbstract_9b2f661e-4224-4b20-a4c8-54380834e9b6" xlink:to="loc_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityYearTwo_54810dcc-1466-4e6e-b967-9d44c2dbcd09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityGross_4874b008-a262-487e-9e54-157be533cc5b" xlink:href="prct-20220630.xsd#prct_OperatingLeaseLiabilityAndLongTermDebtMaturityGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityAbstract_9b2f661e-4224-4b20-a4c8-54380834e9b6" xlink:to="loc_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityGross_4874b008-a262-487e-9e54-157be533cc5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityUnamortizedDebtDiscount_670af2d6-4878-435c-bf7a-062c9a765529" xlink:href="prct-20220630.xsd#prct_OperatingLeaseLiabilityAndLongTermDebtMaturityUnamortizedDebtDiscount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityAbstract_9b2f661e-4224-4b20-a4c8-54380834e9b6" xlink:to="loc_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityUnamortizedDebtDiscount_670af2d6-4878-435c-bf7a-062c9a765529" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_OperatingLeaseLiabilityAndLongTermDebt_551f6386-aec4-42e7-9214-c966fe5369ac" xlink:href="prct-20220630.xsd#prct_OperatingLeaseLiabilityAndLongTermDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityAbstract_9b2f661e-4224-4b20-a4c8-54380834e9b6" xlink:to="loc_prct_OperatingLeaseLiabilityAndLongTermDebt_551f6386-aec4-42e7-9214-c966fe5369ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_OperatingLeaseLiabilityAndLongTermDebtCurrent_554886fe-da75-4bff-a01b-967925c0dba1" xlink:href="prct-20220630.xsd#prct_OperatingLeaseLiabilityAndLongTermDebtCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityAbstract_9b2f661e-4224-4b20-a4c8-54380834e9b6" xlink:to="loc_prct_OperatingLeaseLiabilityAndLongTermDebtCurrent_554886fe-da75-4bff-a01b-967925c0dba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prct_OperatingLeaseLiabilityAndLongTermDebtExcludingCurrentMaturities_375420ae-702d-47ec-8136-649c438eee19" xlink:href="prct-20220630.xsd#prct_OperatingLeaseLiabilityAndLongTermDebtExcludingCurrentMaturities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityAbstract_9b2f661e-4224-4b20-a4c8-54380834e9b6" xlink:to="loc_prct_OperatingLeaseLiabilityAndLongTermDebtExcludingCurrentMaturities_375420ae-702d-47ec-8136-649c438eee19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140602535630656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover page - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jul. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40797<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">PROCEPT BioRobotics Corporation<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">26-0199180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">900 Island Drive<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Redwood City<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94065<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">232-7200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, $0.00001 par value per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PRCT<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding (in share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,592,286<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001588978<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140602535080176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 269,806<span></span>
</td>
<td class="nump">$ 304,320<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">10,894<span></span>
</td>
<td class="nump">4,464<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">13,777<span></span>
</td>
<td class="nump">13,147<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">3,860<span></span>
</td>
<td class="nump">4,242<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">298,337<span></span>
</td>
<td class="nump">326,173<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">3,814<span></span>
</td>
<td class="nump">777<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">4,397<span></span>
</td>
<td class="nump">5,045<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets, net</a></td>
<td class="nump">2,463<span></span>
</td>
<td class="nump">3,279<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">1,614<span></span>
</td>
<td class="nump">1,750<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">302<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">310,927<span></span>
</td>
<td class="nump">337,024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">3,342<span></span>
</td>
<td class="nump">2,029<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedSalariesCurrent', window );">Accrued compensation</a></td>
<td class="nump">6,906<span></span>
</td>
<td class="nump">6,475<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">1,863<span></span>
</td>
<td class="nump">1,025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease &#8211; current portion</a></td>
<td class="nump">2,258<span></span>
</td>
<td class="nump">2,105<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">4,264<span></span>
</td>
<td class="nump">4,608<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">18,633<span></span>
</td>
<td class="nump">16,242<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Note payable &#8211; non-current portion</a></td>
<td class="nump">50,507<span></span>
</td>
<td class="nump">50,004<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease &#8211; non-current portion</a></td>
<td class="nump">829<span></span>
</td>
<td class="nump">1,991<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesNoncurrent', window );">Loan facility derivative liability</a></td>
<td class="nump">1,570<span></span>
</td>
<td class="nump">1,496<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">200<span></span>
</td>
<td class="nump">200<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">71,739<span></span>
</td>
<td class="nump">69,933<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">537,046<span></span>
</td>
<td class="nump">528,666<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="nump">32<span></span>
</td>
<td class="num">(54)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(297,890)<span></span>
</td>
<td class="num">(261,521)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">239,188<span></span>
</td>
<td class="nump">267,091<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 310,927<span></span>
</td>
<td class="nump">$ 337,024<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalariesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalariesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetIncludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetIncludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140602535045424">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - Parentheticals - $ / shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, shares authorized (in shares)</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">300,000,000<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">44,538,000<span></span>
</td>
<td class="nump">43,676,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares, outstanding (in shares)</a></td>
<td class="nump">44,538,000<span></span>
</td>
<td class="nump">43,676,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140602535531728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 16,691<span></span>
</td>
<td class="nump">$ 8,476<span></span>
</td>
<td class="nump">$ 30,888<span></span>
</td>
<td class="nump">$ 15,668<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of sales</a></td>
<td class="nump">8,205<span></span>
</td>
<td class="nump">4,893<span></span>
</td>
<td class="nump">14,710<span></span>
</td>
<td class="nump">8,558<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">8,486<span></span>
</td>
<td class="nump">3,583<span></span>
</td>
<td class="nump">16,178<span></span>
</td>
<td class="nump">7,110<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">6,706<span></span>
</td>
<td class="nump">4,476<span></span>
</td>
<td class="nump">11,717<span></span>
</td>
<td class="nump">8,998<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">19,655<span></span>
</td>
<td class="nump">12,299<span></span>
</td>
<td class="nump">38,040<span></span>
</td>
<td class="nump">22,648<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">26,361<span></span>
</td>
<td class="nump">16,775<span></span>
</td>
<td class="nump">49,757<span></span>
</td>
<td class="nump">31,646<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(17,875)<span></span>
</td>
<td class="num">(13,192)<span></span>
</td>
<td class="num">(33,579)<span></span>
</td>
<td class="num">(24,536)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(1,441)<span></span>
</td>
<td class="num">(1,436)<span></span>
</td>
<td class="num">(2,862)<span></span>
</td>
<td class="num">(2,900)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prct_InterestAndOtherIncomeExpense', window );">Interest and other income, net</a></td>
<td class="nump">132<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="nump">72<span></span>
</td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (19,184)<span></span>
</td>
<td class="num">$ (14,580)<span></span>
</td>
<td class="num">$ (36,369)<span></span>
</td>
<td class="num">$ (27,402)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share, basic (in dollars per share)</a></td>
<td class="num">$ (0.43)<span></span>
</td>
<td class="num">$ (2.60)<span></span>
</td>
<td class="num">$ (0.82)<span></span>
</td>
<td class="num">$ (5.25)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share, diluted (in dollars per share)</a></td>
<td class="num">$ (0.43)<span></span>
</td>
<td class="num">$ (2.60)<span></span>
</td>
<td class="num">$ (0.82)<span></span>
</td>
<td class="num">$ (5.25)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Weighted-average shares used in computing net loss per share attributable to common shareholders</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">44,324,000<span></span>
</td>
<td class="nump">5,597,000<span></span>
</td>
<td class="nump">44,091,000<span></span>
</td>
<td class="nump">5,216,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">44,324,000<span></span>
</td>
<td class="nump">5,597,000<span></span>
</td>
<td class="nump">44,091,000<span></span>
</td>
<td class="nump">5,216,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive loss:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent', window );">Unrealized gain (loss) on cash equivalents</a></td>
<td class="nump">$ 85<span></span>
</td>
<td class="num">$ (9)<span></span>
</td>
<td class="nump">$ 87<span></span>
</td>
<td class="num">$ (25)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (19,099)<span></span>
</td>
<td class="num">$ (14,589)<span></span>
</td>
<td class="num">$ (36,282)<span></span>
</td>
<td class="num">$ (27,427)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prct_InterestAndOtherIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest And Other Income (Expense)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prct_InterestAndOtherIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prct_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140602530872832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at the beginning of the period (in shares) at Dec. 31, 2020</a></td>
<td class="nump">25,402<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at the beginning of the period at Dec. 31, 2020</a></td>
<td class="nump">$ 243,854<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at the end of the period (in shares) at Mar. 31, 2021</a></td>
<td class="nump">25,402<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at the end of the period at Mar. 31, 2021</a></td>
<td class="nump">$ 243,854<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at the beginning of the period (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,713<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning of the period at Dec. 31, 2020</a></td>
<td class="num">(182,894)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 18,788<span></span>
</td>
<td class="num">$ (14)<span></span>
</td>
<td class="num">$ (201,668)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance upon exercise of options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">504<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance upon exercise of options</a></td>
<td class="nump">1,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition', window );">Stock-based compensation expense</a></td>
<td class="nump">650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized gain on cash equivalents</a></td>
<td class="num">(16)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(12,822)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,822)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at the end of the period (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,217<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end of the period at Mar. 31, 2021</a></td>
<td class="num">$ (193,857)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">20,663<span></span>
</td>
<td class="num">(30)<span></span>
</td>
<td class="num">(214,490)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at the beginning of the period (in shares) at Dec. 31, 2020</a></td>
<td class="nump">25,402<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at the beginning of the period at Dec. 31, 2020</a></td>
<td class="nump">$ 243,854<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at the end of the period (in shares) at Jun. 30, 2021</a></td>
<td class="nump">29,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at the end of the period at Jun. 30, 2021</a></td>
<td class="nump">$ 328,564<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at the beginning of the period (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,713<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning of the period at Dec. 31, 2020</a></td>
<td class="num">(182,894)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">18,788<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="num">(201,668)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(27,402)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at the end of the period (in shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,792<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end of the period at Jun. 30, 2021</a></td>
<td class="num">$ (206,306)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">22,803<span></span>
</td>
<td class="num">(39)<span></span>
</td>
<td class="num">(229,070)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at the beginning of the period (in shares) at Mar. 31, 2021</a></td>
<td class="nump">25,402<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at the beginning of the period at Mar. 31, 2021</a></td>
<td class="nump">$ 243,854<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Redeemable Convertible Preferred Stock</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prct_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Issuance of preferred stock, net of issuance costs (in shares)</a></td>
<td class="nump">4,448<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues', window );">Issuance of preferred stock, net of issuance costs</a></td>
<td class="nump">$ 84,710<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at the end of the period (in shares) at Jun. 30, 2021</a></td>
<td class="nump">29,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at the end of the period at Jun. 30, 2021</a></td>
<td class="nump">$ 328,564<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at the beginning of the period (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,217<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning of the period at Mar. 31, 2021</a></td>
<td class="num">(193,857)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">20,663<span></span>
</td>
<td class="num">(30)<span></span>
</td>
<td class="num">(214,490)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance upon exercise of options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">575<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance upon exercise of options</a></td>
<td class="nump">1,415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition', window );">Stock-based compensation expense</a></td>
<td class="nump">725<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">725<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized gain on cash equivalents</a></td>
<td class="num">(9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(14,580)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,580)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at the end of the period (in shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,792<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end of the period at Jun. 30, 2021</a></td>
<td class="num">$ (206,306)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">22,803<span></span>
</td>
<td class="num">(39)<span></span>
</td>
<td class="num">(229,070)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at the beginning of the period (in shares) at Dec. 31, 2021</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at the beginning of the period at Dec. 31, 2021</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at the end of the period (in shares) at Mar. 31, 2022</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at the end of the period at Mar. 31, 2022</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at the beginning of the period (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,676<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning of the period at Dec. 31, 2021</a></td>
<td class="nump">267,091<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">528,666<span></span>
</td>
<td class="num">(54)<span></span>
</td>
<td class="num">(261,521)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance upon exercise of options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">401<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance upon exercise of options</a></td>
<td class="nump">1,291<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,291<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition', window );">Stock-based compensation expense</a></td>
<td class="nump">1,552<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,552<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized gain on cash equivalents</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(17,185)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17,185)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at the end of the period (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,077<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end of the period at Mar. 31, 2022</a></td>
<td class="nump">$ 252,750<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">531,509<span></span>
</td>
<td class="num">(53)<span></span>
</td>
<td class="num">(278,706)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at the beginning of the period (in shares) at Dec. 31, 2021</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at the beginning of the period at Dec. 31, 2021</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at the end of the period (in shares) at Jun. 30, 2022</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at the end of the period at Jun. 30, 2022</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at the beginning of the period (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,676<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning of the period at Dec. 31, 2021</a></td>
<td class="nump">267,091<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">528,666<span></span>
</td>
<td class="num">(54)<span></span>
</td>
<td class="num">(261,521)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(36,369)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at the end of the period (in shares) at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end of the period at Jun. 30, 2022</a></td>
<td class="nump">$ 239,188<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">537,046<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="num">(297,890)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at the beginning of the period (in shares) at Mar. 31, 2022</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at the beginning of the period at Mar. 31, 2022</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at the end of the period (in shares) at Jun. 30, 2022</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at the end of the period at Jun. 30, 2022</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at the beginning of the period (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,077<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning of the period at Mar. 31, 2022</a></td>
<td class="nump">252,750<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">531,509<span></span>
</td>
<td class="num">(53)<span></span>
</td>
<td class="num">(278,706)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance upon exercise of options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance upon exercise of options</a></td>
<td class="nump">1,572<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,572<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Shares issued under employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Shares issued under employee stock purchase plan</a></td>
<td class="nump">1,289<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,289<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition', window );">Stock-based compensation expense</a></td>
<td class="nump">2,676<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,676<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized gain on cash equivalents</a></td>
<td class="nump">85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(19,184)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19,184)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at the end of the period (in shares) at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end of the period at Jun. 30, 2022</a></td>
<td class="nump">$ 239,188<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 537,046<span></span>
</td>
<td class="nump">$ 32<span></span>
</td>
<td class="num">$ (297,890)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prct_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Stock Issued During Period, Shares, New Issues</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prct_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prct_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInTemporaryEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of new stock classified as temporary equity issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140602535460800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (36,369)<span></span>
</td>
<td class="num">$ (27,402)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1,475<span></span>
</td>
<td class="nump">1,765<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">4,228<span></span>
</td>
<td class="nump">1,375<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prct_FairValueAdjustmentOfWarrantsAndGainLossOnDerivativeInstrumentsNetPretax', window );">Change in fair value of redeemable convertible preferred stock warrants and derivative liability</a></td>
<td class="nump">74<span></span>
</td>
<td class="num">(43)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prct_NonCashLeaseAccretionExpense', window );">Non-cash lease adjustment</a></td>
<td class="num">(193)<span></span>
</td>
<td class="num">(158)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable, net</a></td>
<td class="num">(6,430)<span></span>
</td>
<td class="num">(3,591)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="num">(684)<span></span>
</td>
<td class="num">(2,761)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">471<span></span>
</td>
<td class="num">(1,412)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="num">(302)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">947<span></span>
</td>
<td class="nump">2,120<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedSalaries', window );">Accrued compensation</a></td>
<td class="nump">431<span></span>
</td>
<td class="num">(653)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInterestPayableNet', window );">Accrued interest expense</a></td>
<td class="nump">503<span></span>
</td>
<td class="nump">532<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="nump">838<span></span>
</td>
<td class="nump">431<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Other liabilities</a></td>
<td class="num">(346)<span></span>
</td>
<td class="nump">1,690<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(35,357)<span></span>
</td>
<td class="num">(28,107)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(273)<span></span>
</td>
<td class="num">(149)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(273)<span></span>
</td>
<td class="num">(149)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock', window );">Proceeds from issuance of Series G preferred stock, net of issuance costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">84,710<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock under employee stock purchase plan</a></td>
<td class="nump">1,289<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from issuance of common stock from the exercise of stock options</a></td>
<td class="nump">2,864<span></span>
</td>
<td class="nump">2,640<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">4,153<span></span>
</td>
<td class="nump">87,350<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net (decrease) increase in cash, cash equivalents and restricted cash</a></td>
<td class="num">(31,477)<span></span>
</td>
<td class="nump">59,094<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash- Beginning of period</a></td>
<td class="nump">305,097<span></span>
</td>
<td class="nump">100,907<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash - End of period</a></td>
<td class="nump">273,620<span></span>
</td>
<td class="nump">160,001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract', window );"><strong>Reconciliation of cash, cash equivalents and restricted cash to balance sheets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">269,806<span></span>
</td>
<td class="nump">159,224<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Restricted cash</a></td>
<td class="nump">3,814<span></span>
</td>
<td class="nump">777<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash in balance sheets</a></td>
<td class="nump">273,620<span></span>
</td>
<td class="nump">160,001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental cash flow information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="nump">2,369<span></span>
</td>
<td class="nump">2,369<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Non-cash investing and financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prct_TransferFromInventoryToPropertyAndEquipmentNet', window );">Transfer of evaluation units from inventory to property and equipment, net</a></td>
<td class="nump">53<span></span>
</td>
<td class="num">(439)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Property and equipment included in accounts payable and other current liabilities</a></td>
<td class="nump">566<span></span>
</td>
<td class="nump">226<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prct_DeferredOfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction', window );">Deferred offering costs included in accounts payable and other current liabilities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 856<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prct_DeferredOfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Offering Costs Incurred During Noncash or Partial Noncash Transaction</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prct_DeferredOfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prct_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prct_FairValueAdjustmentOfWarrantsAndGainLossOnDerivativeInstrumentsNetPretax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value Adjustment of Warrants and Gain (Loss) on Derivative Instruments, Net, Pretax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prct_FairValueAdjustmentOfWarrantsAndGainLossOnDerivativeInstrumentsNetPretax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prct_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prct_NonCashLeaseAccretionExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non-cash Lease Accretion Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prct_NonCashLeaseAccretionExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prct_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prct_TransferFromInventoryToPropertyAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Transfer From Inventory to Property and Equipment, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prct_TransferFromInventoryToPropertyAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prct_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedSalaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in accrued salaries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedSalaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123371682&amp;loc=d3e55415-109406<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInterestPayableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInterestPayableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140602537532528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">Organization</a></td>
<td class="text">Organization <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Description of Business </span></div><div style="margin-bottom:9pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PROCEPT BioRobotics Corporation (the &#8220;Company&#8221;) is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. BPH is the most common prostate disease and impacts approximately 40 million men in the United States. The AquaBeam Robotic System employs a single-use disposable handpiece to deliver the Company&#8217;s proprietary Aquablation therapy, which combines real-time, multi-dimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. The Company designed its AquaBeam Robotic System to enable consistent and reproducible BPH surgery outcomes. The Company received U.S. Food and Drug Administration clearance in December 2017 to market its AquaBeam Robotic System.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity</span></div><div style="margin-bottom:9pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, the Company had cash and cash equivalents of $269.8 million, and an accumulated deficit of $297.9 million. In September 2021, the Company completed its initial public offering (&#8220;IPO&#8221;) for net proceeds of approximately $172.4 million, after deducting underwriting discounts and commissions and offering expenses. Since its inception, the Company has financed its operations with a combination of debt and equity financing arrangements. The Company expects its cash and cash equivalents, revenue and available debt financing arrangements will be sufficient to fund its operations through at least the next twelve months from the issuance date of these financial statements. The Company has not achieved positive cash flow from operations to date and expects to continue incurring losses for the foreseeable future as it focuses on growing its business.</span></div>The COVID-19 pandemic and the resulting economic downturn are affecting business conditions in the industry in which the Company operates. In response to the pandemic, many state and local governments in the United States issued orders that temporarily precluded elective medical procedures in order to conserve scarce health system resources. The Company has taken necessary precautions to safeguard its employees, patients, customers, and other stakeholders from the COVID-19 pandemic, while maintaining business continuity to support its patients, customers and employees. The timing, extent and continuation of any increase in procedures, and any corresponding increase in sales of the Company&#8217;s products, and whether there could be a future decrease in the current level of procedures as a result of the COVID-19 pandemic or otherwise, remain uncertain and are subject to a variety of factors.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity.  Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140602624232608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation </span></div><div style="margin-bottom:9pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements have been presented in accordance with U.S. generally accepted accounting principles (&#8220;U.S. GAAP&#8221;) and pursuant to the rules and regulations of the United States Securities and Exchange Commission (&#8220;SEC&#8221;). These condensed consolidated financial statements include the accounts of the Company and its consolidated subsidiaries. All intercompany balances and transactions have been eliminated upon consolidation. The Company operates as one reportable segment.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unaudited Interim Financial Statements </span></div><div style="margin-bottom:9pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying balance sheet as of June&#160;30, 2022, the statements of operations and comprehensive loss for the three and six months ended June 30, 2022 and 2021, and cash flows for the six months ended June 30, 2022 and 2021, and the statements of redeemable convertible preferred stock and stockholders&#8217; equity (deficit) as of June&#160;30, 2022 and 2021, are unaudited. The financial data and other information disclosed in these notes to the financial statements related to June&#160;30, 2022, and the three and six months ended June 30, 2022 and 2021, are also unaudited. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying balance sheet as of December&#160;31, 2021 have been derived from the audited consolidated financial statements included in the Company&#8217;s Annual Report on Form 10-K (&#8220;Annual Report&#8221;) filed with the Securities and Exchange Commission.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited interim financial statements have been prepared on the same basis as the annual financial statements and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments, necessary to a fair statement of the Company&#8217;s financial position as of June&#160;30, 2022, and the results of its operations and cash flows for the three and six months ended June 30, 2022 and 2021. The results for the three and six months ended June 30, 2022, are not necessarily indicative of results to be expected for the year ending December&#160;31, 2022, or for any other interim period or for any future year and should be read in conjunction with the annual consolidated financial statements included in the Company&#8217;s Annual Report.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates </span></div><div style="margin-bottom:9pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts and disclosures reported in the condensed consolidated financial statements. Management uses significant judgment when making estimates related to its common stock valuation in periods before the Company&#8217;s IPO and related stock-based compensation expense, right-of-use lease asset, lease liability, and loan facility derivative liability, as well as certain accrued liabilities. Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results could differ from those estimates. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Initial Public Offering</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2021, the Company completed its IPO by issuing 6,556,000 shares of common stock, and the exercise of the underwriters option for 983,400 shares, at an offering price of $25.00 per share, for total net proceeds of approximately $172.4 million, after deducting underwriting discounts and commissions of $13.2 million and offering expenses of $2.9 million. Offering costs are capitalized, and consist of fees and expenses incurred in connection with the sale of common stock in its IPO, including legal, accounting, printing and other IPO-related costs. Upon completion of its IPO, these deferred offering costs were reclassified to stockholders&#8217; equity and recorded against the proceeds from the offering. In addition, all 29,912,264 shares of its then-outstanding redeemable convertible preferred stock automatically converted into 29,912,264 shares of common stock and it reclassified $329.5 million of redeemable convertible preferred stock to additional paid-in capital on its condensed consolidated balance sheet.  Also, upon the completion of the Company&#8217;s IPO, the Company&#8217;s 62,454 redeemable convertible preferred stock warrants were exercised and the remaining unexercised warrants expired.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">JOBS Act Accounting Election</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is an emerging growth company, as defined in the JOBS Act. Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act until such time as those standards apply to private companies. The Company has elected to avail itself of this exemption and, therefore, for new or revised accounting standards applicable to public companies, the Company will be subject to an extended transition period until those standards would otherwise apply to private companies.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2020-4, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (&#8220;ASU 2020-4&#8221;). The amendments in ASU 2020-4 provide optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. These amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. The expedients and exceptions provided do not apply to contract modifications made and hedging relationships entered into or evaluated after December 31, 2022, except for hedging relationships existing as of December 31, 2022, that an entity has elected certain optional expedients for and that are retained through the end of the hedging relationship. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These amendments are effective for all entities as of March 12, 2020 through December 31, 2022. The Company is currently evaluating the impact of the adoption of this ASU on its consolidated financial statements.</span></div><div style="margin-bottom:9pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments&#8212;Credit Losses (Topic 326) Measurement of Credit Losses on Financial Instruments (&#8220;ASU 2016-13&#8221;), which requires an entity to utilize a new impairment model known as the current expected credit loss (&#8220;CECL&#8221;) model to estimate its lifetime &#8220;expected credit loss&#8221; and record an allowance that, when deducted from the amortized cost basis of the financial assets and certain other instruments, including but not limited to available-for-sale debt securities. Credit losses relating to available-for-sale debt securities will be recorded through an allowance for credit losses rather than as a direct write-down to the security. ASU 2016-13 requires a cumulative effect adjustment to the balance sheet as of the beginning of the first reporting period in which the guidance is effective. In November 2019, the FASB issued ASU 2019-10, Financial Instruments&#8212;Credit Losses (Topic 326), Derivatives and Hedging (Topic 815) and Leases (Topic 842): Effective Dates, which defers the effective date of ASU 2016-13 to fiscal years beginning after December 15, 2022 for all entities except SEC reporting companies that are not smaller reporting companies. ASU 2016-13 will be effective for the Company beginning January 1, 2023. The Company is currently evaluating the impact of the adoption of this ASU on its consolidated financial statements.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Accounting Policies</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Property and Equipment </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation and amortization for property and equipment are determined using the straight-line method over the estimated useful lives of the respective assets, generally three to five years. As of June 30, 2022, the Company no longer reclassifies inventory used at customer sites for evaluation purposes to property and equipment due to change in customary business practices.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June 30, 2022, with the exception of the accounting policy above, there have been no material changes to the Company&#8217;s significant accounting policies as described in its 2021 Annual Report or the first quarter 2022 Quarterly Report that have had a material impact on the Company&#8217;s condensed consolidated financial statements and related notes.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140602537354208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements<div style="margin-bottom:9pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of assets and liabilities measured at fair value on a recurring basis (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.194%"><tr><td style="width:1.0%"/><td style="width:45.248%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.865%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.396%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.865%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.396%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.865%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.396%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.869%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,810&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,810&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265,996&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265,996&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash and cash equivalents</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269,806&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269,806&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 10pt;text-indent:-9pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loan facility derivative liability</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,570&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,570&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.194%"><tr><td style="width:1.0%"/><td style="width:45.248%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.865%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.396%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.865%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.396%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.865%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.396%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.869%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,621&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,621&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">290,699&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">290,699&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash and cash equivalents</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">304,320&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">304,320&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 10pt;text-indent:-9pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loan facility derivative liability</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,496&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,496&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents consist primarily of money market funds and treasury securities. </span></div><div style="margin-bottom:9pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no transfers in and out of Level 3 during the three and six months ended June 30, 2022 and year ended December&#160;31, 2021. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the loan facility derivative liability was determined using a discounted cash flow calculation discounted at 10%. </span></div><div style="margin-bottom:9pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth a summary of the changes in the estimated fair value of the Company&#8217;s loan facility derivative liability, classified as Level 3 (in thousands): </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.750%"><tr><td style="width:1.0%"/><td style="width:45.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.794%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,533&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,825&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,496&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,782&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of the period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,570&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,787&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,570&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,787&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140602620695136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventory<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventory</a></td>
<td class="text">Inventory<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory consists of the following (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,329&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,740&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,025&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">905&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,502&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,777&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,147&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140602530853344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Intangible Assets</a></td>
<td class="text">Intangible Assets <div style="margin-bottom:9pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2019, the Company entered into a license agreement with HydroCision, Inc. This agreement grants the Company an exclusive, perpetual, irrevocable, worldwide, fully paid-up license to develop, manufacture and commercialize products in the field of urology using the patented technology and know-how controlled by HydroCision as of the effective date and as well as new patented technology developed by HydroCision that cover certain activities and improvements that relate to the use of fluid jet technology in connection with the licensed products during the period commencing on the effective date and ending on the earlier of the date that the Company ceases to use HydroCision&#8217;s existing contract manufacturers and the third anniversary of the effective date. Also included is the right to utilize HydroCision&#8217;s contract manufacturers, if desired. The consideration paid was a one-time upfront payment of $2.5 million, as well as allowing HydroCision (a reciprocal license) to use any new patented technology and know-how developed by the Company relating to the HydroCision patented technology and know-how in the field of urology for HydroCision use outside the field of urology. HydroCision will pay for any patent maintenance fees on HydroCision&#8217;s licensed patents. As of June&#160;30, 2022 and December&#160;31, 2021, accumulated amortization was $0.9 million and $0.8 million, respectively, and the net carrying amount is expected to be amortized at a rate of $0.3 million per year until fully amortized.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense for intangible assets was $0.1 million and $0.1 million for the three and six months ended June 30, 2022 and 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140602535629744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loan Facility and Derivative Liability<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Loan Facility and Derivative Liability</a></td>
<td class="text">Loan Facility and Derivative LiabilityIn September 2019, the Company entered into a loan facility for up to $75.0 million available in four installments. The Company borrowed $25.0 million in September 2019. An additional $25.0 million was borrowed in March 2020. The third installment of $10.0 million was originally available for draw through March 31, 2021 contingent upon achieving $20.0 million in trailing six months revenue. In January 2021, the third installment was amended to be available for draw through June 30, 2021 contingent upon achieving $6.4 million trailing six months revenue. The remaining $15.0 million was originally available for draw through June 30, 2021 and is contingent upon achieving $25.0&#160;million in trailing six months revenue. In January 2021, this installment was amended to be available for draw through June 30, 2022. The facility bears an interest rate of the greater of (i) 9.37% and (ii) 7.17% plus 30 day LIBOR. The initial term of the facility is 60 months with interest-only payments each month for 24 months followed by 36 months amortization of principal and interest. In January 2021, the interest-only period was amended to 36 months followed by 24 months amortization (principal and interest) beginning October 1, 2022 since the amended trailing six months target revenue of $6.4 million was achieved, and accordingly, the current portion of the amount due was reclassified to non-current. Upon drawing the final $15.0 million tranche, the interest-only period was extended 12 months followed by 24 months amortization of principal and interest. Upon the completion of the Company raising over $50.0 million in its IPO in September 2021, interest-only payments were extended an additional 12 months followed by 12 months amortization of principal and interest. Substantially all assets of the Company are pledged as collateral. Commencing with the earlier of June 30, 2021 and the month following the funding of either the third or final installment, the Company is required to achieve revenues for the previous six months ended equal to the greater of (1) 70% of the forecast for the commensurate period, (2) $15.0 million if <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">neither third or final installments have been drawn, (3) $20.0 million if the third but not final installment has been drawn and (4) $25.0 million if both the third and final installments have been drawn.  </span></div><div style="margin-bottom:9pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The loan facility includes certain fees payable to the lender recorded as a loan discount that are accrued and amortized to interest expense during the loan term. A 6% final payment fee of each funded tranche is payable at the earlier of prepayment or loan maturity and a 0.25% facility fee paid at each funded tranche. A prepayment fee was originally payable if the loan is paid before maturity in the amount of 3% of loans outstanding if paid in full during first 12 months, 2% if loan is paid in full during second twelve months, or 1% if loan is paid in full thereafter before maturity. In January 2021, the prepayment fee was removed as part of the amendments. In addition, the Company would pay the lender&#8217;s loan initiation fees and a fee upon the earlier occurrence of a defined liquidity event, including but not limited to, a merger or sale of the Company&#8217;s assets or voting stock, or achieving a $200 million trailing twelve months revenue target, in each case, by September 2029</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success fees are calculated at the time of the liquidity event occurrence to be $1.0 million if only the first installment has been drawn, $2.0 million if the first two installments have been drawn, $2.4 million if the first three installments have been drawn, or $3.0 million if all four installments have been drawn, in each case, upon the occurrence of the defined liquidity event. As of June&#160;30, 2022, the Company has drawn on the first two installments. The Company determined that this obligation to pay success fees represents freestanding financial instruments. </span></div><div style="margin-bottom:9pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amendments in January 2021 were accounted for as a debt modification under ASC 470-50-40 as the changes in the debt terms are not considered substantial, and thus no gain or loss was recorded and a new effective interest rate was established based on the carrying value of the loan and the revised cash flows.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Company&#8217;s loan facility, the Company is obligated to pay a fee upon the earlier occurrence of a defined liquidity event, including but not limited to, a merger or sale of its assets or voting stock, or achieving a $200.0&#160;million trailing twelve months revenue target, in each case, by September 2029</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">. </span>The fee is calculated at the time of the liquidity event occurrence to be $1.0&#160;million if only the first installment has been drawn, $2.0 million if the first two installments have been drawn, $2.4 million if the first three installments have been drawn, or $3.0 million if all four installments have been drawn, in each case, upon the occurrence of the liquidity event. As of June&#160;30, 2022, the Company has drawn on the first two installments. The Company has determined this fee is a freestanding derivative instrument. The initial $1.4 million fair value of this loan facility derivative was recorded as a debt discount and liability on the date of issuance in connection with obtaining additional financing as applicable and will be revalued every reporting period until the earlier occurrence of a defined liquidity event or achieving a revenue target by September 2029 or termination of such fee arrangement.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesAndFairValueTextBlock', window );">Loan Facility and Derivative Liability</a></td>
<td class="text">Loan Facility and Derivative LiabilityIn September 2019, the Company entered into a loan facility for up to $75.0 million available in four installments. The Company borrowed $25.0 million in September 2019. An additional $25.0 million was borrowed in March 2020. The third installment of $10.0 million was originally available for draw through March 31, 2021 contingent upon achieving $20.0 million in trailing six months revenue. In January 2021, the third installment was amended to be available for draw through June 30, 2021 contingent upon achieving $6.4 million trailing six months revenue. The remaining $15.0 million was originally available for draw through June 30, 2021 and is contingent upon achieving $25.0&#160;million in trailing six months revenue. In January 2021, this installment was amended to be available for draw through June 30, 2022. The facility bears an interest rate of the greater of (i) 9.37% and (ii) 7.17% plus 30 day LIBOR. The initial term of the facility is 60 months with interest-only payments each month for 24 months followed by 36 months amortization of principal and interest. In January 2021, the interest-only period was amended to 36 months followed by 24 months amortization (principal and interest) beginning October 1, 2022 since the amended trailing six months target revenue of $6.4 million was achieved, and accordingly, the current portion of the amount due was reclassified to non-current. Upon drawing the final $15.0 million tranche, the interest-only period was extended 12 months followed by 24 months amortization of principal and interest. Upon the completion of the Company raising over $50.0 million in its IPO in September 2021, interest-only payments were extended an additional 12 months followed by 12 months amortization of principal and interest. Substantially all assets of the Company are pledged as collateral. Commencing with the earlier of June 30, 2021 and the month following the funding of either the third or final installment, the Company is required to achieve revenues for the previous six months ended equal to the greater of (1) 70% of the forecast for the commensurate period, (2) $15.0 million if <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">neither third or final installments have been drawn, (3) $20.0 million if the third but not final installment has been drawn and (4) $25.0 million if both the third and final installments have been drawn.  </span></div><div style="margin-bottom:9pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The loan facility includes certain fees payable to the lender recorded as a loan discount that are accrued and amortized to interest expense during the loan term. A 6% final payment fee of each funded tranche is payable at the earlier of prepayment or loan maturity and a 0.25% facility fee paid at each funded tranche. A prepayment fee was originally payable if the loan is paid before maturity in the amount of 3% of loans outstanding if paid in full during first 12 months, 2% if loan is paid in full during second twelve months, or 1% if loan is paid in full thereafter before maturity. In January 2021, the prepayment fee was removed as part of the amendments. In addition, the Company would pay the lender&#8217;s loan initiation fees and a fee upon the earlier occurrence of a defined liquidity event, including but not limited to, a merger or sale of the Company&#8217;s assets or voting stock, or achieving a $200 million trailing twelve months revenue target, in each case, by September 2029</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success fees are calculated at the time of the liquidity event occurrence to be $1.0 million if only the first installment has been drawn, $2.0 million if the first two installments have been drawn, $2.4 million if the first three installments have been drawn, or $3.0 million if all four installments have been drawn, in each case, upon the occurrence of the defined liquidity event. As of June&#160;30, 2022, the Company has drawn on the first two installments. The Company determined that this obligation to pay success fees represents freestanding financial instruments. </span></div><div style="margin-bottom:9pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amendments in January 2021 were accounted for as a debt modification under ASC 470-50-40 as the changes in the debt terms are not considered substantial, and thus no gain or loss was recorded and a new effective interest rate was established based on the carrying value of the loan and the revised cash flows.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Company&#8217;s loan facility, the Company is obligated to pay a fee upon the earlier occurrence of a defined liquidity event, including but not limited to, a merger or sale of its assets or voting stock, or achieving a $200.0&#160;million trailing twelve months revenue target, in each case, by September 2029</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">. </span>The fee is calculated at the time of the liquidity event occurrence to be $1.0&#160;million if only the first installment has been drawn, $2.0 million if the first two installments have been drawn, $2.4 million if the first three installments have been drawn, or $3.0 million if all four installments have been drawn, in each case, upon the occurrence of the liquidity event. As of June&#160;30, 2022, the Company has drawn on the first two installments. The Company has determined this fee is a freestanding derivative instrument. The initial $1.4 million fair value of this loan facility derivative was recorded as a debt discount and liability on the date of issuance in connection with obtaining additional financing as applicable and will be revalued every reporting period until the earlier occurrence of a defined liquidity event or achieving a revenue target by September 2029 or termination of such fee arrangement.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesAndFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivatives and fair value of assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -URI http://asc.fasb.org/topic&amp;trid=2155941<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesAndFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140602537515344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text">Stock-Based Compensation<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had 4.5&#160;million shares available for grant as of June 30, 2022 under the 2021 Equity Incentive Award Plan. The Company ceased making awards under the 2008 Stock Plan upon the effective date of the Company&#8217;s IPO.</span></div><div style="margin-bottom:9pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the Company&#8217;s stock option activity and related information are as follows (shares in thousands): </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding, beginning of period</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,365&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(802)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.09&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding, end of period</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,666&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,666&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,933&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022 and December&#160;31, 2021, the aggregate pre-tax intrinsic value of options outstanding and exercisable was $82.3 million and $64.3 million, respectively, and the aggregate pre-tax intrinsic value options outstanding were $147.1 million and $125.7 million, respectively. The aggregate pre-tax intrinsic value of options exercised was $21.7 million and $3.4 million during the six months ended June&#160;30, 2022 and 2021, respectively. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2022, there was a total of $11.4 million of unrecognized stock-based compensation expense related to stock options.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the options granted to employees or directors was estimated as of the grant date using the Black-Scholes model assuming the weighted-average assumptions listed in the following table: </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (years)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend rate </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.07&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.59&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.15&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.14&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Units</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the Company&#8217;s restricted stock unit (&#8220;RSU&#8221;) activity and related information are as follows (restricted stock units in thousands): </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding, beginning of period</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.78&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Awarded</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">538&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding, end of period</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">559&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2022, there was a total of $17.8 million of unrecognized stock-based compensation expense related to RSUs.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2022, there was approximately $0.7&#160;million of unrecognized cost related to employee stock purchases under the Employee Stock Purchase Plan (&#8220;ESPP&#8221;). This cost is expected to be recognized over a weighted average period of 0.5 years. As of June 30, 2022, a total of 0.8&#160;million shares were available for issuance under the ESPP.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the awards granted under the ESPP for the six months ended June 30, 2022 to employees was estimated as of the grant date using the Black-Scholes model assuming the weighted-average assumptions listed in the following table: </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.316%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.442%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (years)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend rate </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average fair value</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total stock-based compensation recognized, before taxes, are as follows (in thousands): </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.684%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,871&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">994&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,676&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">725&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,228&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,375&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140602537450960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss Per Share</a></td>
<td class="text">Net Loss Per Share<div style="margin-bottom:9pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the completion of the Company&#8217;s IPO in September 2021, all 29,912,264 shares of its then-outstanding redeemable convertible preferred stock automatically converted into 29,912,264 shares of common stock.</span></div><div style="margin-bottom:9pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss per share was determined as follows (in thousands): </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.684%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,184)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,580)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,369)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,402)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common stock outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,091&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share, basic and diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.43)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.60)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.82)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.25)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following potentially dilutive securities outstanding have been excluded from the computations of weighted-average shares outstanding because such securities have an antidilutive impact due to losses reported (in common stock equivalent shares, in thousands): </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of June 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable convertible preferred stock outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,850&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable convertible preferred stock warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,666&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,621&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">559&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,286&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,543&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140602537385392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue</a></td>
<td class="text">Revenue<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents revenue disaggregated by type and geography (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.684%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">System sales and rentals</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,770&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,330&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Handpieces and other consumables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,723&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,653&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,274&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">567&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">929&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total U.S. revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,806&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,560&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,366&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,813&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outside of U.S.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">System sales and rentals</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">869&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">973&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,610&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,244&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Handpieces and other consumables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">832&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">890&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,578&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,493&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total outside of U.S. revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,885&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,916&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,522&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,855&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,691&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,476&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,888&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,668&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140602540004304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment, Geographical, and Customer Concentration<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskDisclosureTextBlock', window );">Segment, Geographical, and Customer Concentration</a></td>
<td class="text">Segment, Geographical, and Customer Concentration<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates as a single operating segment. The Company&#8217;s chief operating decision maker, its Chief Executive Officer, reviews financial information on an aggregate basis for the purposes of allocating resources and evaluating financial performance. The Company&#8217;s long-lived assets are primarily based in the United States.</span></div><div style="margin-bottom:9pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No customers accounted for more than 10% of revenue during the three and six months ended June 30, 2022 and 2021.</span></div><div style="margin-bottom:9pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No customers accounted for more than 10% of accounts receivable at June&#160;30, 2022. One customer accounted for 11% of accounts receivable at  December&#160;31, 2021.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s revenue by geographical location is as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outside the United States</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment, Geographical, and Customer Concentration</a></td>
<td class="text">Segment, Geographical, and Customer Concentration<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates as a single operating segment. The Company&#8217;s chief operating decision maker, its Chief Executive Officer, reviews financial information on an aggregate basis for the purposes of allocating resources and evaluating financial performance. The Company&#8217;s long-lived assets are primarily based in the United States.</span></div><div style="margin-bottom:9pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No customers accounted for more than 10% of revenue during the three and six months ended June 30, 2022 and 2021.</span></div><div style="margin-bottom:9pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No customers accounted for more than 10% of accounts receivable at June&#160;30, 2022. One customer accounted for 11% of accounts receivable at  December&#160;31, 2021.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s revenue by geographical location is as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outside the United States</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140602540002464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Guarantees and Indemnifications  </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the Company enters into agreements that contain a variety of representations and provide for general indemnification. The Company&#8217;s exposure under these agreements is unknown because it involves claims that may be made against the Company in the future. To date, the Company has not paid any claims or been required to defend any action related to its indemnification obligations. As of June&#160;30, 2022 and December&#160;31, 2021, the Company does not have any material indemnification claims that were probable or reasonably possible and consequently has not recorded related liabilities. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Facility Lease </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2013, the Company entered into a lease agreement for its current facility located in Redwood City, California. In 2018, the Company expanded the lease space and extended the lease agreement through October 2023. The lease agreement provides for an escalation of rent payments each year and the Company records rent expense on a straight-line basis over the term of the lease.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rent expense recognized under the lease, including additional rent charges for utilities, parking, maintenance, and real estate taxes, was $0.7&#160;million for both the three months ended June 30, 2022 and 2021, respectively, and $1.4&#160;million and $1.3&#160;million for the  six months ended June 30, 2022 and 2021, respectively.</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.666%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of June&#160;30, 2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Minimum Lease Payments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Debt Repayments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,238&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,238&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,092&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,592&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total minimum payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,330&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,330&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amount representing interest/unamortized debt discount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(243)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">507&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of future payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,087&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,507&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,594&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,258)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,258)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current portion</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">829&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,507&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,336&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022 and December&#160;31, 2021, the Company&#8217;s security deposit is in the form of, and recorded as, restricted cash. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, the Company entered into a lease for two existing buildings, comprising approximately 158,221 square feet of space, located in San Jose, California.  The lease commenced in July 2022, and will continue for 122 months following thereafter, with two five year options to extend the term of the lease. The Lease provides for annual base rent of $4.3 million for the first year, which increases on a yearly basis up to $5.5 million for the tenth year, for an aggregate of $49.2 million. Under the terms of the lease, the Company will receive an allowance of up to $7.9 million from the landlord to be applied to the Company&#8217;s construction of tenant improvements following the landlord&#8217;s delivery of the two buildings to the Company.  The Company is currently assessing the accounting impact of the lease on its consolidated financial statements.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Guarantees and Indemnifications  </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the Company enters into agreements that contain a variety of representations and provide for general indemnification. The Company&#8217;s exposure under these agreements is unknown because it involves claims that may be made against the Company in the future. To date, the Company has not paid any claims or been required to defend any action related to its indemnification obligations. As of June&#160;30, 2022 and December&#160;31, 2021, the Company does not have any material indemnification claims that were probable or reasonably possible and consequently has not recorded related liabilities. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Facility Lease </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2013, the Company entered into a lease agreement for its current facility located in Redwood City, California. In 2018, the Company expanded the lease space and extended the lease agreement through October 2023. The lease agreement provides for an escalation of rent payments each year and the Company records rent expense on a straight-line basis over the term of the lease.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rent expense recognized under the lease, including additional rent charges for utilities, parking, maintenance, and real estate taxes, was $0.7&#160;million for both the three months ended June 30, 2022 and 2021, respectively, and $1.4&#160;million and $1.3&#160;million for the  six months ended June 30, 2022 and 2021, respectively.</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.666%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of June&#160;30, 2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Minimum Lease Payments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Debt Repayments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,238&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,238&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,092&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,592&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total minimum payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,330&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,330&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amount representing interest/unamortized debt discount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(243)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">507&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of future payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,087&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,507&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,594&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,258)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,258)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current portion</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">829&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,507&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,336&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022 and December&#160;31, 2021, the Company&#8217;s security deposit is in the form of, and recorded as, restricted cash. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, the Company entered into a lease for two existing buildings, comprising approximately 158,221 square feet of space, located in San Jose, California.  The lease commenced in July 2022, and will continue for 122 months following thereafter, with two five year options to extend the term of the lease. The Lease provides for annual base rent of $4.3 million for the first year, which increases on a yearly basis up to $5.5 million for the tenth year, for an aggregate of $49.2 million. Under the terms of the lease, the Company will receive an allowance of up to $7.9 million from the landlord to be applied to the Company&#8217;s construction of tenant improvements following the landlord&#8217;s delivery of the two buildings to the Company.  The Company is currently assessing the accounting impact of the lease on its consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140602535089344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation </span></div><div style="margin-bottom:9pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements have been presented in accordance with U.S. generally accepted accounting principles (&#8220;U.S. GAAP&#8221;) and pursuant to the rules and regulations of the United States Securities and Exchange Commission (&#8220;SEC&#8221;). These condensed consolidated financial statements include the accounts of the Company and its consolidated subsidiaries. All intercompany balances and transactions have been eliminated upon consolidation. The Company operates as one reportable segment.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text">Use of Estimates The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts and disclosures reported in the condensed consolidated financial statements. Management uses significant judgment when making estimates related to its common stock valuation in periods before the Company&#8217;s IPO and related stock-based compensation expense, right-of-use lease asset, lease liability, and loan facility derivative liability, as well as certain accrued liabilities. Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results could differ from those estimates.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityPolicyTextBlock', window );">Initial Public Offering</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Initial Public Offering</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2021, the Company completed its IPO by issuing 6,556,000 shares of common stock, and the exercise of the underwriters option for 983,400 shares, at an offering price of $25.00 per share, for total net proceeds of approximately $172.4 million, after deducting underwriting discounts and commissions of $13.2 million and offering expenses of $2.9 million. Offering costs are capitalized, and consist of fees and expenses incurred in connection with the sale of common stock in its IPO, including legal, accounting, printing and other IPO-related costs. Upon completion of its IPO, these deferred offering costs were reclassified to stockholders&#8217; equity and recorded against the proceeds from the offering. In addition, all 29,912,264 shares of its then-outstanding redeemable convertible preferred stock automatically converted into 29,912,264 shares of common stock and it reclassified $329.5 million of redeemable convertible preferred stock to additional paid-in capital on its condensed consolidated balance sheet.  Also, upon the completion of the Company&#8217;s IPO, the Company&#8217;s 62,454 redeemable convertible preferred stock warrants were exercised and the remaining unexercised warrants expired.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prct_JobsActAccountingElectionPolicyTextBlock', window );">Jobs Act Accounting Election</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">JOBS Act Accounting Election</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is an emerging growth company, as defined in the JOBS Act. Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act until such time as those standards apply to private companies. The Company has elected to avail itself of this exemption and, therefore, for new or revised accounting standards applicable to public companies, the Company will be subject to an extended transition period until those standards would otherwise apply to private companies.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2020-4, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (&#8220;ASU 2020-4&#8221;). The amendments in ASU 2020-4 provide optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. These amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. The expedients and exceptions provided do not apply to contract modifications made and hedging relationships entered into or evaluated after December 31, 2022, except for hedging relationships existing as of December 31, 2022, that an entity has elected certain optional expedients for and that are retained through the end of the hedging relationship. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These amendments are effective for all entities as of March 12, 2020 through December 31, 2022. The Company is currently evaluating the impact of the adoption of this ASU on its consolidated financial statements.</span></div><div style="margin-bottom:9pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments&#8212;Credit Losses (Topic 326) Measurement of Credit Losses on Financial Instruments (&#8220;ASU 2016-13&#8221;), which requires an entity to utilize a new impairment model known as the current expected credit loss (&#8220;CECL&#8221;) model to estimate its lifetime &#8220;expected credit loss&#8221; and record an allowance that, when deducted from the amortized cost basis of the financial assets and certain other instruments, including but not limited to available-for-sale debt securities. Credit losses relating to available-for-sale debt securities will be recorded through an allowance for credit losses rather than as a direct write-down to the security. ASU 2016-13 requires a cumulative effect adjustment to the balance sheet as of the beginning of the first reporting period in which the guidance is effective. In November 2019, the FASB issued ASU 2019-10, Financial Instruments&#8212;Credit Losses (Topic 326), Derivatives and Hedging (Topic 815) and Leases (Topic 842): Effective Dates, which defers the effective date of ASU 2016-13 to fiscal years beginning after December 15, 2022 for all entities except SEC reporting companies that are not smaller reporting companies. ASU 2016-13 will be effective for the Company beginning January 1, 2023. The Company is currently evaluating the impact of the adoption of this ASU on its consolidated financial statements.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Accounting Policies</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Property and Equipment </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation and amortization for property and equipment are determined using the straight-line method over the estimated useful lives of the respective assets, generally three to five years. As of June 30, 2022, the Company no longer reclassifies inventory used at customer sites for evaluation purposes to property and equipment due to change in customary business practices.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June 30, 2022, with the exception of the accounting policy above, there have been no material changes to the Company&#8217;s significant accounting policies as described in its 2021 Annual Report or the first quarter 2022 Quarterly Report that have had a material impact on the Company&#8217;s condensed consolidated financial statements and related notes.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prct_JobsActAccountingElectionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Jobs Act Accounting Election</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prct_JobsActAccountingElectionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prct_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its capital stock transactions, including dividends and accumulated other comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21459-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140602539996560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of assets and liabilities measured at fair value on a recurring basis (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.194%"><tr><td style="width:1.0%"/><td style="width:45.248%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.865%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.396%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.865%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.396%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.865%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.396%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.869%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,810&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,810&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265,996&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265,996&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash and cash equivalents</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269,806&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269,806&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 10pt;text-indent:-9pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loan facility derivative liability</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,570&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,570&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.194%"><tr><td style="width:1.0%"/><td style="width:45.248%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.865%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.396%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.865%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.396%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.865%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.396%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.869%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,621&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,621&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">290,699&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">290,699&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash and cash equivalents</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">304,320&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">304,320&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 10pt;text-indent:-9pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loan facility derivative liability</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,496&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,496&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock', window );">Schedule of Derivative Liabilities at Fair Value</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth a summary of the changes in the estimated fair value of the Company&#8217;s loan facility derivative liability, classified as Level 3 (in thousands): </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.750%"><tr><td style="width:1.0%"/><td style="width:45.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.794%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,533&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,825&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,496&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,782&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of the period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,570&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,787&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,570&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,787&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative liabilities at fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140602535599120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventory (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventory</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory consists of the following (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,329&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,740&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,025&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">905&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,502&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,777&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,147&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140602535028592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock', window );">Schedule of Stock Option Activity and Related Information</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the Company&#8217;s stock option activity and related information are as follows (shares in thousands): </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding, beginning of period</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,365&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(802)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.09&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding, end of period</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,666&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,666&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,933&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock', window );">Schedule of Fair Value Assumptions</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the options granted to employees or directors was estimated as of the grant date using the Black-Scholes model assuming the weighted-average assumptions listed in the following table: </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (years)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend rate </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.07&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.59&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.15&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.14&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the awards granted under the ESPP for the six months ended June 30, 2022 to employees was estimated as of the grant date using the Black-Scholes model assuming the weighted-average assumptions listed in the following table: </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.316%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.442%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (years)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend rate </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average fair value</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock', window );">Share-based Payment Arrangement, Outstanding Award, Activity, Excluding Option</a></td>
<td class="text">A summary of the Company&#8217;s restricted stock unit (&#8220;RSU&#8221;) activity and related information are as follows (restricted stock units in thousands): <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding, beginning of period</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.78&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Awarded</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">538&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding, end of period</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">559&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Share-based Payment Arrangement, Expensed and Capitalized, Amount</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total stock-based compensation recognized, before taxes, are as follows (in thousands): </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.684%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,871&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">994&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,676&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">725&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,228&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,375&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of activity for outstanding award under share-based payment arrangement excluding share and unit options and nonvested award.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding and exercisable options that are fully vested and expected to vest. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140602537151216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock', window );">Schedule of Earnings Per Share, Basic</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss per share was determined as follows (in thousands): </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.684%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,184)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,580)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,369)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,402)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common stock outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,091&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share, basic and diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.43)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.60)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.82)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.25)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock', window );">Schedule of Earnings Per Share, Diluted</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss per share was determined as follows (in thousands): </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.684%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,184)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,580)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,369)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,402)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common stock outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,091&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share, basic and diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.43)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.60)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.82)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.25)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following potentially dilutive securities outstanding have been excluded from the computations of weighted-average shares outstanding because such securities have an antidilutive impact due to losses reported (in common stock equivalent shares, in thousands): </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of June 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable convertible preferred stock outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,850&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable convertible preferred stock warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,666&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,621&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">559&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,286&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,543&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the effect of income (loss) on basic earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1278-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the effect of income (loss) on an entity's diluted earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1278-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140602537404592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock', window );">Revenue from External Customers by Geographic Areas</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents revenue disaggregated by type and geography (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.684%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">System sales and rentals</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,770&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,330&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Handpieces and other consumables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,723&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,653&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,274&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">567&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">929&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total U.S. revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,806&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,560&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,366&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,813&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outside of U.S.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">System sales and rentals</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">869&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">973&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,610&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,244&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Handpieces and other consumables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">832&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">890&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,578&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,493&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total outside of U.S. revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,885&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,916&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,522&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,855&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,691&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,476&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,888&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,668&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s revenue by geographical location is as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outside the United States</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock', window );">Revenue from External Customers by Products and Services</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents revenue disaggregated by type and geography (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.684%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">System sales and rentals</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,770&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,330&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Handpieces and other consumables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,723&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,653&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,274&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">567&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">929&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total U.S. revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,806&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,560&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,366&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,813&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outside of U.S.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">System sales and rentals</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">869&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">973&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,610&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,244&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Handpieces and other consumables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">832&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">890&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,578&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,493&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total outside of U.S. revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,885&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,916&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,522&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,855&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,691&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,476&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,888&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,668&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph a<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140602539984912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment, Geographical, and Customer Concentration (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock', window );">Revenue from External Customers by Geographic Areas</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents revenue disaggregated by type and geography (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.684%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">System sales and rentals</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,770&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,330&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Handpieces and other consumables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,723&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,653&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,274&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">567&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">929&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total U.S. revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,806&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,560&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,366&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,813&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outside of U.S.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">System sales and rentals</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">869&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">973&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,610&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,244&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Handpieces and other consumables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">832&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">890&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,578&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,493&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total outside of U.S. revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,885&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,916&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,522&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,855&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,691&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,476&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,888&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,668&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s revenue by geographical location is as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outside the United States</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph a<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140602537526928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Future minimum lease payments</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.666%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of June&#160;30, 2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Minimum Lease Payments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Debt Repayments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,238&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,238&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,092&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,592&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total minimum payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,330&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,330&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amount representing interest/unamortized debt discount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(243)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">507&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of future payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,087&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,507&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,594&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,258)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,258)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current portion</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">829&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,507&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,336&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Maturities of Long-term Debt</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.666%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of June&#160;30, 2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Minimum Lease Payments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Debt Repayments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,238&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,238&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,092&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,592&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total minimum payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,330&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,330&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amount representing interest/unamortized debt discount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(243)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">507&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of future payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,087&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,507&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,594&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,258)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,258)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current portion</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">829&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,507&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,336&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140602535485424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 269,806<span></span>
</td>
<td class="nump">$ 304,320<span></span>
</td>
<td class="nump">$ 159,224<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 297,890<span></span>
</td>
<td class="nump">$ 261,521<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prct_InitialPublicOfferingAbstract', window );"><strong>Initial Public Offering</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Sale of stock, consideration received on transaction</a></td>
<td class="nump">$ 172,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prct_InitialPublicOfferingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Initial Public Offering</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prct_InitialPublicOfferingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prct_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140602535434112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Narrative (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Share price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 25.00<span></span>
</td>
<td class="nump">$ 25.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForUnderwritingExpense', window );">Payments for underwriting discount and commissions | $</a></td>
<td class="nump">$ 13.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payments of stock issuance costs | $</a></td>
<td class="nump">$ 2.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Convertible preferred stock, shares, number of shares issued upon conversion (in shares) | shares</a></td>
<td class="nump">29,912,264<span></span>
</td>
<td class="nump">29,912,264<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-in Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversion of redeemable convertible preferred stock to common stock upon initial public offering | $</a></td>
<td class="nump">$ 329.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Common Stock Warrants | Series E, Redeemable Convertible Preferred Stock Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prct_TemporaryEquityStockIssuedDuringPeriodSharesWarrantExercises', window );">Issuance upon exercise of warrants (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,454<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock | IPO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock, number of shares issued in transaction (in shares) | shares</a></td>
<td class="nump">6,556,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Sale of stock, consideration received on transaction | $</a></td>
<td class="nump">$ 172.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock | Over-Allotment Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock, number of shares issued in transaction (in shares) | shares</a></td>
<td class="nump">983,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prct_TemporaryEquityStockIssuedDuringPeriodSharesWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Stock Issued During Period, Shares, Warrant Exercises</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prct_TemporaryEquityStockIssuedDuringPeriodSharesWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prct_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for each share of convertible preferred stock that is converted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21506-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForUnderwritingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash paid for expenses incurred during underwriting activities (the process to review insurance applications, evaluate risks, accept or reject applications, and determine the premiums to be charged) for insurance companies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForUnderwritingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=prct_SeriesERedeemableConvertiblePreferredStockWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=prct_SeriesERedeemableConvertiblePreferredStockWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140602537622432">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Narrative (Details)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Fair Value, Measurements, Recurring | Valuation Technique, Discounted Cash Flow</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems', window );"><strong>Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMeasurementInput', window );">Cash flow discount</a></td>
<td class="nump">0.10<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140602530650688">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Fair Value (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems', window );"><strong>Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 269,806<span></span>
</td>
<td class="nump">$ 304,320<span></span>
</td>
<td class="nump">$ 159,224<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems', window );"><strong>Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="nump">3,810<span></span>
</td>
<td class="nump">13,621<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="nump">265,996<span></span>
</td>
<td class="nump">290,699<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">269,806<span></span>
</td>
<td class="nump">304,320<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Loan facility derivative liability</a></td>
<td class="nump">1,570<span></span>
</td>
<td class="nump">1,496<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Fair Value, Measurements, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems', window );"><strong>Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="nump">3,810<span></span>
</td>
<td class="nump">13,621<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="nump">265,996<span></span>
</td>
<td class="nump">290,699<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">269,806<span></span>
</td>
<td class="nump">304,320<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Loan facility derivative liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Fair Value, Measurements, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems', window );"><strong>Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Loan facility derivative liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Fair Value, Measurements, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems', window );"><strong>Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Loan facility derivative liability</a></td>
<td class="nump">$ 1,570<span></span>
</td>
<td class="nump">$ 1,496<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631418-115840<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631419-115840<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140602535740432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Fair Value, Inputs, Level 3 - Fair Value, Measurements, Recurring (Details) - Fair Value, Measurements, Recurring - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward', window );"><strong>Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs', window );">Beginning of the period</a></td>
<td class="nump">$ 1,533<span></span>
</td>
<td class="nump">$ 1,825<span></span>
</td>
<td class="nump">$ 1,496<span></span>
</td>
<td class="nump">$ 1,782<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues', window );">Issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings', window );">Change in fair value</a></td>
<td class="nump">37<span></span>
</td>
<td class="num">(38)<span></span>
</td>
<td class="nump">74<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs', window );">End of the period</a></td>
<td class="nump">$ 1,570<span></span>
</td>
<td class="nump">$ 1,787<span></span>
</td>
<td class="nump">$ 1,570<span></span>
</td>
<td class="nump">$ 1,787<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from derivative asset (liability) after deduction of derivative liability (asset), measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of issuances of financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset), measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as derivative asset (liability) after deduction of derivative liability (asset), measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140602535155520">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventory - Inventory (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Raw materials</a></td>
<td class="nump">$ 5,329<span></span>
</td>
<td class="nump">$ 6,740<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcess', window );">Work-in-process</a></td>
<td class="nump">1,025<span></span>
</td>
<td class="nump">905<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished goods</a></td>
<td class="nump">7,423<span></span>
</td>
<td class="nump">5,502<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventory</a></td>
<td class="nump">$ 13,777<span></span>
</td>
<td class="nump">$ 13,147<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140602535130000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Payments to acquire intangible assets</a></td>
<td class="nump">$ 2.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prct_FiniteLivedIntangibleAssetExpectedAnnualAmortizationExpense', window );">Expected annual amortization expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prct_FiniteLivedIntangibleAssetExpectedAnnualAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived Intangible Asset, Expected Annual Amortization Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prct_FiniteLivedIntangibleAssetExpectedAnnualAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prct_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140602530863088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loan Facility and Derivative Liability (Details)<br></strong></div></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($) </div>
<div>installment</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prct_LineOfCreditFacilityGainLossOnAmendmentOfDebtTerms', window );">Gain (loss) on amendment of debt terms</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prct_LoanFacilityMember', window );">Loan Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prct_LineOfCreditFacilityCovenantComplianceContingentTrailingTwelveMonthRevenueTarget', window );">Trailing twelve month revenue target</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceOneInstallmentDrawn', window );">Fee on first installment drawn</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceTwoInstallmentsDrawn', window );">Fee if first two installments drawn</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceThreeInstallmentsDrawn', window );">Fee if first three installments drawn</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceFourInstallmentsDrawn', window );">Fee if all four installments are drawn</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liability, loan facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prct_LoanFacilityMember', window );">Loan Facility | Line of Credit | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Loan facility, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prct_LineOfCreditFacilityNumberOfInstallments', window );">Number of installments | installment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmount', window );">Covenant compliance, IPO capital raised in threshold amount</a></td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmountAchievedExtendedInterestOnlyPeriod', window );">Covenant compliance, IPO capital raised in threshold amount achieved, extended interest only period (in months)</a></td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmountAchievedExtendedPrincipalAndInterestPeriod', window );">Covenant compliance, IPO capital raised in threshold amount achieved, extended principal and interest only period (in months)</a></td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prct_DebtInstrumentCovenantComplianceRevenueForecastForCommensuratePeriodPercent', window );">Covenant compliance, revenue forecast for commensurate period, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prct_DebtInstrumentCovenantComplianceRevenueForecastAmountFirstTwoInstallmentsOnly', window );">Covenant compliance, revenue forecast amount, first two installments only</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prct_DebtInstrumentCovenantComplianceRevenueForecastAmountFirstThreeInstallmentsOnly', window );">Covenant compliance, revenue forecast amount, first three installments only</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prct_DebtInstrumentCovenantComplianceRevenueForecastAmountAllInstallmentsDrawn', window );">Covenant compliance, revenue forecast amount, all installments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prct_LineOfCreditFacilityFinalPaymentFeePercentage', window );">Final payment fee, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prct_LineOfCreditFacilityEarlyRepaymentFeeFirstTwelveMonthPercent', window );">Early repayment fee first twelve month, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prct_LineOfCreditFacilityEarlyRepaymentFeeSecondTwelveMonthPeriodPercent', window );">Early repayment fee second twelve month period, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prct_LineOfCreditFacilityEarlyRepaymentFeeTwentyFourMonthsThruMaturityPercent', window );">Early repayment fee, twenty four months thereafter, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prct_LineOfCreditFacilityCovenantComplianceContingentTrailingTwelveMonthRevenueTarget', window );">Trailing twelve month revenue target</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceOneInstallmentDrawn', window );">Fee on first installment drawn</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceTwoInstallmentsDrawn', window );">Fee if first two installments drawn</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceThreeInstallmentsDrawn', window );">Fee if first three installments drawn</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceFourInstallmentsDrawn', window );">Fee if all four installments are drawn</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prct_LoanFacilityTrancheOneMember', window );">Loan Facility, Tranche One | Line of Credit | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLongTermLinesOfCredit', window );">Proceeds from long-term lines of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prct_LoanFacilityTrancheTwoMember', window );">Loan Facility, Tranche Two | Line of Credit | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLongTermLinesOfCredit', window );">Proceeds from long-term lines of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd', window );">Facility interest rate at period end (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.37%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Facility term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">60 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prct_DebtInstrumentInterestOnlyPeriod', window );">Interest only period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">24 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prct_DebtInstrumentPrincipalAndInterestPeriod', window );">Principal and interest period (in months)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prct_LoanFacilityTrancheTwoMember', window );">Loan Facility, Tranche Two | Line of Credit | London Interbank Offered Rate (LIBOR) | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd', window );">Facility interest rate at period end (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.17%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prct_LoanFacilityTrancheThreeMember', window );">Loan Facility, Tranche Three | Line of Credit | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity', window );">Current borrowing amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prct_LineOfCreditFacilityCovenantComplianceContingentTrailingSixTwelveMonthRevenueTarget', window );">Trailing six months revenue target</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prct_DebtInstrumentInterestOnlyPeriod', window );">Interest only period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prct_DebtInstrumentPrincipalAndInterestPeriod', window );">Principal and interest period (in months)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">24 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prct_LoanFacilityTrancheFourMember', window );">Loan Facility, Tranche Four | Line of Credit | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity', window );">Current borrowing amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prct_LineOfCreditFacilityCovenantComplianceContingentTrailingSixTwelveMonthRevenueTarget', window );">Trailing six months revenue target</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prct_DebtInstrumentContingentBorrowingExtendedInterestOnlyPeriod', window );">Extended interest only period (in months)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prct_DebtInstrumentContingentBorrowingExtendedPrincipalAndInterestPeriod', window );">Extended principal and interest period (in months)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">24 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prct_DebtInstrumentContingentBorrowingExtendedInterestOnlyPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt instrument, Contingent Borrowing, Extended Interest Only Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prct_DebtInstrumentContingentBorrowingExtendedInterestOnlyPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prct_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prct_DebtInstrumentContingentBorrowingExtendedPrincipalAndInterestPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt instrument, Contingent Borrowing, Extended Principal and Interest Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prct_DebtInstrumentContingentBorrowingExtendedPrincipalAndInterestPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prct_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant Compliance, Capital Raised in IPO Threshold Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prct_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmountAchievedExtendedInterestOnlyPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant Compliance, Capital Raised in IPO Threshold Amount Achieved, Extended Interest Only Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmountAchievedExtendedInterestOnlyPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prct_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmountAchievedExtendedPrincipalAndInterestPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant Compliance, Capital Raised in IPO Threshold Amount Achieved, Extended Principal and Interest Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmountAchievedExtendedPrincipalAndInterestPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prct_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prct_DebtInstrumentCovenantComplianceRevenueForecastAmountAllInstallmentsDrawn">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant Compliance, Revenue Forecast Amount, All Installments Drawn</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prct_DebtInstrumentCovenantComplianceRevenueForecastAmountAllInstallmentsDrawn</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prct_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prct_DebtInstrumentCovenantComplianceRevenueForecastAmountFirstThreeInstallmentsOnly">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant Compliance, Revenue Forecast Amount, First Three Installments Only</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prct_DebtInstrumentCovenantComplianceRevenueForecastAmountFirstThreeInstallmentsOnly</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prct_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prct_DebtInstrumentCovenantComplianceRevenueForecastAmountFirstTwoInstallmentsOnly">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant Compliance, Revenue Forecast Amount, First Two Installments Only</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prct_DebtInstrumentCovenantComplianceRevenueForecastAmountFirstTwoInstallmentsOnly</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prct_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prct_DebtInstrumentCovenantComplianceRevenueForecastForCommensuratePeriodPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant Compliance, Revenue Forecast for Commensurate Period, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prct_DebtInstrumentCovenantComplianceRevenueForecastForCommensuratePeriodPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prct_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prct_DebtInstrumentInterestOnlyPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt instrument, Interest Only Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prct_DebtInstrumentInterestOnlyPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prct_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prct_DebtInstrumentPrincipalAndInterestPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt instrument, Principal and Interest Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prct_DebtInstrumentPrincipalAndInterestPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prct_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prct_LineOfCreditFacilityCovenantComplianceContingentTrailingSixTwelveMonthRevenueTarget">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Covenant Compliance, Contingent Trailing Six Twelve Month Revenue Target</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prct_LineOfCreditFacilityCovenantComplianceContingentTrailingSixTwelveMonthRevenueTarget</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prct_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prct_LineOfCreditFacilityCovenantComplianceContingentTrailingTwelveMonthRevenueTarget">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Covenant Compliance, Contingent Trailing Twelve Month Revenue Target</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prct_LineOfCreditFacilityCovenantComplianceContingentTrailingTwelveMonthRevenueTarget</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prct_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceFourInstallmentsDrawn">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Covenant Terms, Liquidity Occurrence, Four Installments Drawn</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceFourInstallmentsDrawn</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prct_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceOneInstallmentDrawn">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Covenant Terms, Liquidity Occurrence, One Installment Drawn</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceOneInstallmentDrawn</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prct_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceThreeInstallmentsDrawn">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Covenant Terms, Liquidity Occurrence, Three Installments Drawn</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceThreeInstallmentsDrawn</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prct_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceTwoInstallmentsDrawn">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Covenant Terms, Liquidity Occurrence, Two Installments Drawn</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceTwoInstallmentsDrawn</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prct_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prct_LineOfCreditFacilityEarlyRepaymentFeeFirstTwelveMonthPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Early Repayment Fee First Twelve Month, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prct_LineOfCreditFacilityEarlyRepaymentFeeFirstTwelveMonthPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prct_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prct_LineOfCreditFacilityEarlyRepaymentFeeSecondTwelveMonthPeriodPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Early Repayment Fee Second Twelve Month Period, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prct_LineOfCreditFacilityEarlyRepaymentFeeSecondTwelveMonthPeriodPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prct_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prct_LineOfCreditFacilityEarlyRepaymentFeeTwentyFourMonthsThruMaturityPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Early Repayment Fee, Twenty Four Months Thru Maturity, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prct_LineOfCreditFacilityEarlyRepaymentFeeTwentyFourMonthsThruMaturityPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prct_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prct_LineOfCreditFacilityFinalPaymentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Final Payment Fee, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prct_LineOfCreditFacilityFinalPaymentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prct_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prct_LineOfCreditFacilityGainLossOnAmendmentOfDebtTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Gain (Loss) on Amendment of Debt Terms</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prct_LineOfCreditFacilityGainLossOnAmendmentOfDebtTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prct_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prct_LineOfCreditFacilityNumberOfInstallments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Number of Installments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prct_LineOfCreditFacilityNumberOfInstallments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prct_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective interest rate at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLongTermLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLongTermLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prct_LoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prct_LoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prct_LoanFacilityTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prct_LoanFacilityTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prct_LoanFacilityTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prct_LoanFacilityTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prct_LoanFacilityTrancheThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prct_LoanFacilityTrancheThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prct_LoanFacilityTrancheFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prct_LoanFacilityTrancheFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140602530527888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Narrative (Details) - USD ($)<br> $ in Thousands, shares in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Unrecognized stock-based compensation expense</a></td>
<td class="nump">$ 2,676<span></span>
</td>
<td class="nump">$ 725<span></span>
</td>
<td class="nump">$ 1,375<span></span>
</td>
<td class="nump">$ 4,228<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=prct_A2021EmployeeStockPurchasePlanMember', window );">Employee stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for grant (in shares)</a></td>
<td class="nump">0.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost</a></td>
<td class="nump">$ 700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Average vesting period for unrecognized compensation cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Common stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Options outstanding and exercisable, aggregate intrinsic value</a></td>
<td class="nump">82,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 82,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 64,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Options outstanding, aggregate intrinsic value</a></td>
<td class="nump">$ 147,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">147,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 125,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Options exercised in the period, intrinsic value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,700<span></span>
</td>
<td class="nump">$ 3,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Unrecognized stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Common stock options | 2021 Equity Incentive Award Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for grant (in shares)</a></td>
<td class="nump">4.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Unrecognized stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=prct_A2021EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=prct_A2021EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=prct_A2021EquityIncentiveAwardPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=prct_A2021EquityIncentiveAwardPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140602535240176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Summary of Stock Option Activity (Details) - Common stock options - $ / shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Balance at the beginning of the period (in shares)</a></td>
<td class="nump">6,365,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">254,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(802,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited (in shares)</a></td>
<td class="num">(151,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Balance at the end of the period (in shares)</a></td>
<td class="nump">5,666,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested and expected to vest (in shares)</a></td>
<td class="nump">5,666,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable (in shares)</a></td>
<td class="nump">2,933,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Balance at the beginning of the period (in dollars per share)</a></td>
<td class="nump">$ 5.34<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share)</a></td>
<td class="nump">35.58<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share)</a></td>
<td class="nump">3.57<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited (in dollars per share)</a></td>
<td class="nump">7.09<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Balance at the end of the period (in dollars per share)</a></td>
<td class="nump">6.90<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Vested and expected to vest (in dollars per share)</a></td>
<td class="nump">6.90<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Exercisable (in dollars per share)</a></td>
<td class="nump">$ 4.63<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140602530285296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Fair Value Assumptions (Details) - Common stock options - $ / shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life (years)</a></td>
<td class="text">5 years 9 months 18 days<span></span>
</td>
<td class="text">6 years<span></span>
</td>
<td class="text">5 years 10 months 24 days<span></span>
</td>
<td class="text">6 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">56.00%<span></span>
</td>
<td class="nump">52.00%<span></span>
</td>
<td class="nump">55.00%<span></span>
</td>
<td class="nump">49.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">2.90%<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Weighted-average fair value (in dollars per share)</a></td>
<td class="nump">$ 20.07<span></span>
</td>
<td class="nump">$ 3.59<span></span>
</td>
<td class="nump">$ 19.15<span></span>
</td>
<td class="nump">$ 3.14<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life (years)</a></td>
<td class="text">9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">57.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">1.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Weighted-average fair value (in dollars per share)</a></td>
<td class="nump">$ 12.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of options vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=prct_A2021EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=prct_A2021EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140602535260112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Restricted Stock Unit (Details) - Restricted stock units<br> shares in Thousands</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Restricted Stock Units</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding, beginning of period (in shares) | shares</a></td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Award (in shares) | shares</a></td>
<td class="nump">538<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding, end of period (in shares) | shares</a></td>
<td class="nump">559<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding, beginning of period (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 34.78<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Awarded (in dollars per share) | $ / shares</a></td>
<td class="nump">34.14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per shares) | $ / shares</a></td>
<td class="nump">31.76<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding, endof period (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 34.22<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140602534991776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Stock-based Compensation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation</a></td>
<td class="nump">$ 2,676<span></span>
</td>
<td class="nump">$ 725<span></span>
</td>
<td class="nump">$ 1,375<span></span>
</td>
<td class="nump">$ 4,228<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation</a></td>
<td class="nump">252<span></span>
</td>
<td class="nump">51<span></span>
</td>
<td class="nump">74<span></span>
</td>
<td class="nump">375<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation</a></td>
<td class="nump">553<span></span>
</td>
<td class="nump">155<span></span>
</td>
<td class="nump">307<span></span>
</td>
<td class="nump">853<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Sales, general and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation</a></td>
<td class="nump">$ 1,871<span></span>
</td>
<td class="nump">$ 519<span></span>
</td>
<td class="nump">$ 994<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140602537598416">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Net Loss Per Share - Narrative (Details)<br></strong></div></th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Convertible preferred stock, shares, number of shares issued upon conversion (in shares)</a></td>
<td class="nump">29,912,264<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for each share of convertible preferred stock that is converted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21506-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140602535425248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share - Net loss per share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (19,184)<span></span>
</td>
<td class="num">$ (17,185)<span></span>
</td>
<td class="num">$ (14,580)<span></span>
</td>
<td class="num">$ (12,822)<span></span>
</td>
<td class="num">$ (36,369)<span></span>
</td>
<td class="num">$ (27,402)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average common stock outstanding, basic (in shares)</a></td>
<td class="nump">44,324,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,597,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,091,000<span></span>
</td>
<td class="nump">5,216,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average common stock outstanding, diluted (in shares)</a></td>
<td class="nump">44,324,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,597,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,091,000<span></span>
</td>
<td class="nump">5,216,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share, basic (in dollars per share)</a></td>
<td class="num">$ (0.43)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2.60)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.82)<span></span>
</td>
<td class="num">$ (5.25)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share, diluted (in dollars per share)</a></td>
<td class="num">$ (0.43)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2.60)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.82)<span></span>
</td>
<td class="num">$ (5.25)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140602530511808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share - Potentially Dilutive Securities (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share, amount (in shares)</a></td>
<td class="nump">6,286<span></span>
</td>
<td class="nump">36,543<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RedeemableConvertiblePreferredStockMember', window );">Redeemable convertible preferred stock outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share, amount (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">29,850<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=prct_RedeemableConvertiblePreferredStockWarrantsMember', window );">Redeemable convertible preferred stock warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share, amount (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Common stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share, amount (in shares)</a></td>
<td class="nump">5,666<span></span>
</td>
<td class="nump">6,621<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share, amount (in shares)</a></td>
<td class="nump">559<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=prct_A2021EmployeeStockPurchasePlanMember', window );">Employee stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share, amount (in shares)</a></td>
<td class="nump">61<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RedeemableConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RedeemableConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=prct_RedeemableConvertiblePreferredStockWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=prct_RedeemableConvertiblePreferredStockWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=prct_A2021EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=prct_A2021EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140602532107232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 16,691<span></span>
</td>
<td class="nump">$ 8,476<span></span>
</td>
<td class="nump">$ 30,888<span></span>
</td>
<td class="nump">$ 15,668<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">14,806<span></span>
</td>
<td class="nump">6,560<span></span>
</td>
<td class="nump">27,366<span></span>
</td>
<td class="nump">12,813<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=prct_OutsideTheUnitedStatesMember', window );">Outside of U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">1,885<span></span>
</td>
<td class="nump">1,916<span></span>
</td>
<td class="nump">3,522<span></span>
</td>
<td class="nump">2,855<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=prct_SystemSalesAndRentalsMember', window );">System sales and rentals | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">8,516<span></span>
</td>
<td class="nump">4,770<span></span>
</td>
<td class="nump">16,270<span></span>
</td>
<td class="nump">9,330<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=prct_SystemSalesAndRentalsMember', window );">System sales and rentals | Outside of U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">869<span></span>
</td>
<td class="nump">973<span></span>
</td>
<td class="nump">1,610<span></span>
</td>
<td class="nump">1,244<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=prct_HandPiecesAndOtherConsumablesMember', window );">Handpieces and other consumables | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">5,723<span></span>
</td>
<td class="nump">1,653<span></span>
</td>
<td class="nump">10,167<span></span>
</td>
<td class="nump">3,274<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=prct_HandPiecesAndOtherConsumablesMember', window );">Handpieces and other consumables | Outside of U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">832<span></span>
</td>
<td class="nump">890<span></span>
</td>
<td class="nump">1,578<span></span>
</td>
<td class="nump">1,493<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=prct_ServiceRevenueMember', window );">Service | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">567<span></span>
</td>
<td class="nump">137<span></span>
</td>
<td class="nump">929<span></span>
</td>
<td class="nump">209<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=prct_ServiceRevenueMember', window );">Service | Outside of U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 184<span></span>
</td>
<td class="nump">$ 53<span></span>
</td>
<td class="nump">$ 334<span></span>
</td>
<td class="nump">$ 118<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=prct_OutsideTheUnitedStatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=prct_OutsideTheUnitedStatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=prct_SystemSalesAndRentalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=prct_SystemSalesAndRentalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=prct_HandPiecesAndOtherConsumablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=prct_HandPiecesAndOtherConsumablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=prct_ServiceRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=prct_ServiceRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140602535214016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment, Geographical, and Customer Concentration (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark | Geographic Concentration Risk | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Revenue by significant geographical locations outside the United States, percent</a></td>
<td class="nump">89.00%<span></span>
</td>
<td class="nump">77.00%<span></span>
</td>
<td class="nump">89.00%<span></span>
</td>
<td class="nump">82.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark | Geographic Concentration Risk | Outside of U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Revenue by significant geographical locations outside the United States, percent</a></td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=prct_Customer1Member', window );">Customer 1 | Accounts Receivable | Customer Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Revenue by significant geographical locations outside the United States, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingRevenueReconcilingItemLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=prct_OutsideTheUnitedStatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=prct_OutsideTheUnitedStatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=prct_Customer1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=prct_Customer1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140602535576688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>renewalOption </div>
<div>ft&#178; </div>
<div>building</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Rent expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700<span></span>
</td>
<td class="nump">$ 700<span></span>
</td>
<td class="nump">$ 1,400<span></span>
</td>
<td class="nump">$ 1,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease, liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,087<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,087<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Building</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prct_OperatingLeaseNumberOfBuildings', window );">Number of buildings | building</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prct_OperatingLeaseNumberOfSquareFeet', window );">Number of square feet | ft&#178;</a></td>
<td class="nump">158,221<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prct_LesseeOperatingLeaseNumberOfRenewalOptions', window );">Number of renewal options | renewalOption</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prct_OperatingLeaseAnnualBaseRentYearOne', window );">Annual base rent, year one</a></td>
<td class="nump">$ 4,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prct_OperatingLeaseAnnualBaseRentYearTen', window );">Annual base rent, year ten</a></td>
<td class="nump">5,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease, liability</a></td>
<td class="nump">49,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prct_LesseeOperatingLeaseReceivableAllowanceForTenantImprovements', window );">Receivable allowance for tenant improvements</a></td>
<td class="nump">$ 7,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prct_LesseeOperatingLeaseNumberOfRenewalOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Number Of Renewal Options</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prct_LesseeOperatingLeaseNumberOfRenewalOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prct_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prct_LesseeOperatingLeaseReceivableAllowanceForTenantImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Receivable Allowance for Tenant Improvements</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prct_LesseeOperatingLeaseReceivableAllowanceForTenantImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prct_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prct_OperatingLeaseAnnualBaseRentYearOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease Annual Base Rent, Year One</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prct_OperatingLeaseAnnualBaseRentYearOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prct_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prct_OperatingLeaseAnnualBaseRentYearTen">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease Annual Base Rent, Year Ten</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prct_OperatingLeaseAnnualBaseRentYearTen</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prct_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prct_OperatingLeaseNumberOfBuildings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Number of Buildings</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prct_OperatingLeaseNumberOfBuildings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prct_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prct_OperatingLeaseNumberOfSquareFeet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Number of Square Feet</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prct_OperatingLeaseNumberOfSquareFeet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prct_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140602530268592">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Future Minimum Lease Payments and Long-Term Debt Maturities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Minimum Lease Payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2022</a></td>
<td class="nump">$ 1,238<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">2,092<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total minimum payments</a></td>
<td class="nump">3,330<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: amount representing interest/unamortized debt discount</a></td>
<td class="num">(243)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of future payments</a></td>
<td class="nump">3,087<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Less: current portion</a></td>
<td class="num">(2,258)<span></span>
</td>
<td class="num">$ (2,105)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Non-current portion</a></td>
<td class="nump">829<span></span>
</td>
<td class="nump">1,991<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MaturitiesOfLongTermDebtAbstract', window );"><strong>Debt Repayments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear', window );">2022</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2023</a></td>
<td class="nump">12,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2024</a></td>
<td class="nump">37,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total minimum payments</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet', window );">Less: amount representing interest/unamortized debt discount</a></td>
<td class="nump">507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Present value of future payments</a></td>
<td class="nump">50,507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less: current portion</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-current portion</a></td>
<td class="nump">50,507<span></span>
</td>
<td class="nump">$ 50,004<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityAbstract', window );"><strong>Total</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityRemainderOfFiscalYear', window );">2022</a></td>
<td class="nump">1,238<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityYearOne', window );">2023</a></td>
<td class="nump">14,592<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityYearTwo', window );">2024</a></td>
<td class="nump">37,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityGross', window );">Total minimum payments</a></td>
<td class="nump">53,330<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityUnamortizedDebtDiscount', window );">Less: amount representing interest/unamortized debt discount</a></td>
<td class="nump">264<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prct_OperatingLeaseLiabilityAndLongTermDebt', window );">Present value of future payments</a></td>
<td class="nump">53,594<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prct_OperatingLeaseLiabilityAndLongTermDebtCurrent', window );">Less: current portion</a></td>
<td class="num">(2,258)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_prct_OperatingLeaseLiabilityAndLongTermDebtExcludingCurrentMaturities', window );">Non-current portion</a></td>
<td class="nump">$ 51,336<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prct_OperatingLeaseLiabilityAndLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease Liability and Long-Term Debt</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prct_OperatingLeaseLiabilityAndLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prct_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prct_OperatingLeaseLiabilityAndLongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease Liability and Long-Term Debt, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prct_OperatingLeaseLiabilityAndLongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prct_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prct_OperatingLeaseLiabilityAndLongTermDebtExcludingCurrentMaturities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease Liability and Long-Term Debt, Excluding Current Maturities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prct_OperatingLeaseLiabilityAndLongTermDebtExcludingCurrentMaturities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prct_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease Liability and Long-Term Debt Maturity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prct_OperatingLeaseLiabilityAndLongTermDebtMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prct_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease Liability and Long-Term Debt Maturity, Gross</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prct_OperatingLeaseLiabilityAndLongTermDebtMaturityGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prct_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease Liability and Long-Term Debt Maturity, Remainder of Fiscal year</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prct_OperatingLeaseLiabilityAndLongTermDebtMaturityRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prct_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityUnamortizedDebtDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease Liability and Long-Term Debt Maturity, Unamortized Debt Discount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prct_OperatingLeaseLiabilityAndLongTermDebtMaturityUnamortizedDebtDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prct_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityYearOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease Liability and Long-Term Debt Maturity, Year One</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prct_OperatingLeaseLiabilityAndLongTermDebtMaturityYearOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prct_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prct_OperatingLeaseLiabilityAndLongTermDebtMaturityYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease Liability and Long-Term Debt Maturity, Year Two</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prct_OperatingLeaseLiabilityAndLongTermDebtMaturityYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prct_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount (premium).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28567-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MaturitiesOfLongTermDebtAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MaturitiesOfLongTermDebtAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>prct-20220630_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2021"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:prct="http://www.procept-biorobotics.com/20220630"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="prct-20220630.xsd" xlink:type="simple"/>
    <context id="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i5244b61f062c425cb72b630f1ffc25d3_I20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
        </entity>
        <period>
            <instant>2022-07-31</instant>
        </period>
    </context>
    <context id="i6225d555eeba47689e5b7d633c1f277f_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i96161312b8e749cc9c7f6f759945011c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9640280ee02a463885b62fb60246cfec_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4eeb8d5fbaa443cfb4b403f6bf784110_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i9585d1c54a684663894a7893b7489c39_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2247db1a4a2640a299b416b33a688b7c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1defffe1f1964d89826a5865f9c988a5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4f83ee6a840d4fcf9011375d58625785_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i01886b412db145e0a0a2fe5ced6a37b3_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4e567fde435a43809f3e7db528da3c7d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i5536a0a58c9e43a89b71f9c8d5fde9db_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib49ef5b808cc4ce58c5c2146e6a4a872_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="idbe9cd2e7c184e5f9f1b6182c72c33bc_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4a5f8472ee434d169dea6396cc0d2243_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic8e0d0a6ea974a85bc5c95e8ea39af53_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5d726aec89c84cdfacf0dd37b1b7db33_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie3c71862037247eaab3a9d37ea5de5f9_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if3fc05616d7449288a6f5900e51f12cd_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if60434966ba04e68bb10f89d746d9c71_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="id69d7c117e41411bb58321abe66da977_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i8e81cc1babd944fca585586deb7d643a_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i627bfed199d449d8b9f34ce309b5b446_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i24963d2b7ff64b7ea5ae30aef83c1ab2_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i2b4d8b1368e44cf78783a263b8dad765_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i4a939982b2f54db8a27e8f371521eb89_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="icbfd320e5dd848119b7bdb3871172b7a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i14cbbd3f6b274b5b9fb32f03421ac7b6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i282fabdbdaff4996a0ac69a7bc75b9b8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if5288075d3e6407caf4a41af1e03bf62_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic1f38e11fe9a410499fe555213ca38f8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i28c750db7e8b493c961a7d62d4a754ad_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i7fe5f544032b4ef4a2f76f6a6f973e06_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i5ee47d851f3042aaaf707d3b82004294_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iea9c042e07264772b04308a25e550340_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i7b181e472b094adbad522e89a97c3965_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i94b26e0dbca84b9b8524e15573d9bf33_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="iac576b608667443aad04c57beda563ac_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i9bc468ed15de4a9d97e08aa2fbe09c34_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ied0b777dba264312b4d74af5c79a0cb3_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i6966f0a91417487ba500b6d3df3fcc46_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i8722cf471d0a4e458baade237a5960c6_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i727054a48db344dc84054f19179656ea_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i38e5e80513f848e596aad02407f696f7_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia737ca5e401d4e1898b0e48e1bb51d05_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0a06654ca8fc49a0aaed81f85663e69f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ic2228949c5a34355af819610f5c3e6c7_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i67e7f282b71d4074a19bfe3304779fce_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i9dfc04e8f5654c70a7bd05c9b50882c4_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i8591f6f61272452cb59c7b8fd943a9f0_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i054a395a39bb4b049e783cf126b64e4c_D20210901-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i76637c8aeec140d2b14464b0d2e859c4_D20210901-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie390a471379b4ab1bcab0d1678411d3a_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ic71fc6b5bde14a3db707e62f0fc13d18_D20210901-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia464c84a1d294b1a90b1144fd82c6978_D20210901-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i50623cf37fe345b787005f8045a73bbf_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">prct:SeriesERedeemableConvertiblePreferredStockWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i271be39716a24ae3a1220dde2c194490_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i0624c3f7a1a24f1cbf5381ed78fa8773_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i28d56366abcb4c1ba6762562d89f11be_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i03e5fbb904174fc6a95ec0686a05e446_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ib662e1ac7c4f4fc09ed63ee4ad3d6920_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i06c709bf479e43c389950311b1d0360b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i71decfbc977f40ac8eb9c51a9d97ccbe_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idbcba339097743d39f83b2c7a95fa80c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2ec894abcc4c490b980330e1351b89bd_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i9261f6f74d684c688cfaeac2f36b5a12_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id9d53416940548b886aec19be0a44a4e_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic1c2312756cd4f6e99858bfda9b5b1dc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id4a5962583214d618c2bce6e91e2bc49_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i49866073e1f44cf1b38b071917bc10c4_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0b5a6a38e4a04bd580825d3c7c3c7b97_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i56ff5a0cd9ad480ca54975bb361ad2e2_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ida5e5f1bb1d542c9b2cd7ccf481a8af2_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ie19c67cd74ed40aabeb9098c4f2fb478_D20190301-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
        </entity>
        <period>
            <startDate>2019-03-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i1e254378ff134e9681a4249bcc83e5fc_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prct:LoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i10156edb55894acbb210fec9c3468287_D20190901-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prct:LoanFacilityTrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i0b01acac5e6143eaba1f435139069823_D20200301-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prct:LoanFacilityTrancheTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ib4b1440f6de14019a797df774eb5f464_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prct:LoanFacilityTrancheThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i3c2a33ef0d514076961c5e1590bfa66c_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prct:LoanFacilityTrancheThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i6777b1709ddc4642b6a8f38a6e6be39d_D20210101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prct:LoanFacilityTrancheThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="i33d2d97450ea42cea69aeef3e9ea7937_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prct:LoanFacilityTrancheFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia16ecc55dbd348ecaaaaaa7c92629f98_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prct:LoanFacilityTrancheFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9256f6c0b3ab484d973170c275d30dd6_I20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prct:LoanFacilityTrancheTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="ia2530161d85e4792bd363ce72e96e9b9_I20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prct:LoanFacilityTrancheTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="i861bb40fd82c4a378c9527bee4405c32_D20210101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prct:LoanFacilityTrancheTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="ia47c0681a1b8412cb1f3e5eb400ad5fc_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prct:LoanFacilityTrancheFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i3bba515e9a0d4545bb068c2fe7296bf1_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prct:LoanFacilityTrancheFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="if00ac5ae82404ee98272aabd9c6a9606_D20210901-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prct:LoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i683101ff096c40c2a24cbd6236452190_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prct:LoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ib1c06405d72a4f48a81ffc14a560fce7_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prct:LoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="id06260efb84542fcbe48470c87f30c7c_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prct:LoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i19e8bd64054f475ea78f283d6415e474_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie2afc20bf0a74c8497a36a93f40390d4_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prct:LoanFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i68b9bf6c49b34ddb9f9cdf4df2a9cde7_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prct:LoanFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ifa96468d217b44f29426837ed43cb27e_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">prct:A2021EquityIncentiveAwardPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i98ec9d7c3e23460eb44d3b79a24f38f8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i73c3f9942c10418c97d1df582f8b37c7_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i1f17d9fd3b0f45df96c50d9c3c83002b_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i7eabbab66fc246509ee375373f59a3c8_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i00f54e9cbe804bb38c30969068ff45d3_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i5734f87cb59c4ab99ff5087249c3e6bc_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i48c0e4524ffe4c1fa1c1d659ea30bc91_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i97a15a5737b34117975db805d85bb267_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ic60a1a1821b14d1d8d6ac4fff874549d_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i17afe0c0dcba45159077ed56cad20253_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">prct:A2021EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ib8d4c78e6b0f482fae70548a9459a7f1_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">prct:A2021EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i9c8e42000a7c49b7b20f5345c42d7b26_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">prct:A2021EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i277b8f845b9c4fe49bd226a094fd599c_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ibfcaafa17e4746279efe3c570e6f9fbb_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie094c47c8e41442d8f48b3161b3255d9_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3846b5796b46497498e5a63b411da5f9_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i164ec0a968a3490c8e5ca191f4a7e36b_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ie06546dec3a04d87b10442e18708fbee_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i028690643f5b41a3bf4ab56e7150dcfd_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i30ea9dc52b724da0aac81e7933fd37f3_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i90bfc90968d64d2f95bb4f0aab2fabef_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i0f12acefea06470fbd1ff183c033427c_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if0f804f4efc44311ad8c409d09969458_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i7eaf117796f144da98cb336ef5d2a3c6_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i16c6e66d4ce6495b8d9d4fb2a81130ec_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ia13da9ea227f4e738ed2a4ade74a841d_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="idaefefa698af4a6bb691e2fb7f0a6944_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">prct:RedeemableConvertiblePreferredStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i140935dcf8204cbf959d52cbd44911ae_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">prct:RedeemableConvertiblePreferredStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i01badfb698334a429a1be2da49cd7a91_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i1372789c7d3948d3b8aca78f2d9b92dd_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i124d9db5d45e4effa8c6d68140756087_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i10a1fb79429d4c70978ced6bf017f60f_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i49e74c53b47042178251b4824d6b4122_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">prct:A2021EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i34fe12d789d3432680d4d84cc2fdfe4f_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">prct:A2021EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iae550cb350ab4aa093330a1aa67fbb59_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prct:SystemSalesAndRentalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="icc3548f9c5af4248b89810935e741c81_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prct:SystemSalesAndRentalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i354124ad73aa4d359530dedf6cc892ff_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prct:SystemSalesAndRentalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i034be609d4174ca28c7931f45c17137f_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prct:SystemSalesAndRentalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i93f054b306ba42db85eac45b5398e920_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prct:HandPiecesAndOtherConsumablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i1a3ab372268f4d07ac5a6cef9de6d000_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prct:HandPiecesAndOtherConsumablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib0f3737d0aba4fb9a4cb003b37c4a03c_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prct:HandPiecesAndOtherConsumablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i34e859a6c83448509ff840a825f98408_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prct:HandPiecesAndOtherConsumablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ifa95f8ea20be433eafa6a8ca0854a1ab_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prct:ServiceRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i103aeef9defe4b0387c733d075b32506_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prct:ServiceRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i7323a463430b427eade72651460a0dda_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prct:ServiceRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i4c8cc8b31066433d9ab97e1244ff31b5_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prct:ServiceRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i56197f81b18f4fdd9144c91fbf486356_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i84cfac7405214cd68837a7cd08d45162_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iebbce8d97e394404821074c8c3cbf98b_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i1b6d991467f646b192fb0bf7523d7fe3_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie0697cd6105f4abf9c831356c1473b25_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prct:SystemSalesAndRentalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prct:OutsideTheUnitedStatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i837cadc9f10943b7b8afdee6a7838bae_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prct:SystemSalesAndRentalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prct:OutsideTheUnitedStatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1d7b2d1422fa47d7b08d486dff9d320a_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prct:SystemSalesAndRentalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prct:OutsideTheUnitedStatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ibb609047c8a640abaa29cd36b1d98737_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prct:SystemSalesAndRentalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prct:OutsideTheUnitedStatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i841d3dd4b3a54b2f94fa7066f3cea1e5_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prct:HandPiecesAndOtherConsumablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prct:OutsideTheUnitedStatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ie9832ef4d4be47168e465fd04aaf5f66_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prct:HandPiecesAndOtherConsumablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prct:OutsideTheUnitedStatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="idc2c8df366d747ccaf7c4700fcfa6b6b_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prct:HandPiecesAndOtherConsumablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prct:OutsideTheUnitedStatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i9d3b3cc27d31469897df4789948762e2_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prct:HandPiecesAndOtherConsumablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prct:OutsideTheUnitedStatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib25e541235774f03a985292fa15ef08c_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prct:ServiceRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prct:OutsideTheUnitedStatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="id619c937117e495295cff348cd8098f9_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prct:ServiceRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prct:OutsideTheUnitedStatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic8b4017be8a44b8c871ccec3eb53803d_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prct:ServiceRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prct:OutsideTheUnitedStatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i4ffaf08378e1423a947bf449998d53e6_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prct:ServiceRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prct:OutsideTheUnitedStatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2b75e831ee944df685fe171431077c73_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prct:OutsideTheUnitedStatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="if9f1dced786449a0ba9d25bcd7dda9de_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prct:OutsideTheUnitedStatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if17ffbed1df54f99a2e086997e1e3fec_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prct:OutsideTheUnitedStatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i7b6405459f5948bfb4f2a67be3632426_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prct:OutsideTheUnitedStatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4b602262223d4640893e5dd50f271572_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">prct:Customer1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i126dea3f4e7745c5ae15e412fd7a688c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">prct:Customer1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4fcecdc96c7946a6917102a9bc187595_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i06b7903ecea34c54885ee96df8bd17f7_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i24596b41408a4ffea6e70203801645e4_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i178c15123386454db3b2a62f93f77161_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i969ef2b7ba3b4291a15d9307f31bf736_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prct:OutsideTheUnitedStatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="id766d70acd42417684ab4d19ff0aaba3_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prct:OutsideTheUnitedStatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie317f3d85145457ebb62b991028c5dbc_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prct:OutsideTheUnitedStatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i74d4cb137b6049418262544587636450_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">prct:OutsideTheUnitedStatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id73017efcdff4610924f905608444615_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic8e9593d6af940928b18f5797d0ae114_D20211231-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001588978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-31</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="installment">
        <measure>prct:installment</measure>
    </unit>
    <unit id="building">
        <measure>prct:building</measure>
    </unit>
    <unit id="sqft">
        <measure>utr:sqft</measure>
    </unit>
    <unit id="renewaloption">
        <measure>prct:renewalOption</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80L2ZyYWc6NjI0MzlmZjQ2YTQ2NDNlZjhlMzNmMTczOWY2YzQ1YzIvdGFibGU6YTIwMjNmYWU4OGZjNGRkZGI4MDE3MDJhNDczODk0ODIvdGFibGVyYW5nZTphMjAyM2ZhZTg4ZmM0ZGRkYjgwMTcwMmE0NzM4OTQ4Ml8wLTEtMS0xLTcwMjY1_ef4fff61-9406-4b10-882f-d86b167c4745">0001588978</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80L2ZyYWc6NjI0MzlmZjQ2YTQ2NDNlZjhlMzNmMTczOWY2YzQ1YzIvdGFibGU6YTIwMjNmYWU4OGZjNGRkZGI4MDE3MDJhNDczODk0ODIvdGFibGVyYW5nZTphMjAyM2ZhZTg4ZmM0ZGRkYjgwMTcwMmE0NzM4OTQ4Ml8xLTEtMS0xLTcwMjY1_398de845-af58-4ca2-be8e-02e176392ea3">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80L2ZyYWc6NjI0MzlmZjQ2YTQ2NDNlZjhlMzNmMTczOWY2YzQ1YzIvdGFibGU6YTIwMjNmYWU4OGZjNGRkZGI4MDE3MDJhNDczODk0ODIvdGFibGVyYW5nZTphMjAyM2ZhZTg4ZmM0ZGRkYjgwMTcwMmE0NzM4OTQ4Ml8yLTEtMS0xLTcwMjY1_47ca55f7-d5cf-4f05-87b5-5659eea77779">2022</dei:DocumentFiscalYearFocus>
    <dei:AmendmentFlag
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80L2ZyYWc6NjI0MzlmZjQ2YTQ2NDNlZjhlMzNmMTczOWY2YzQ1YzIvdGFibGU6YTIwMjNmYWU4OGZjNGRkZGI4MDE3MDJhNDczODk0ODIvdGFibGVyYW5nZTphMjAyM2ZhZTg4ZmM0ZGRkYjgwMTcwMmE0NzM4OTQ4Ml8zLTEtMS0xLTcwMjY1_8a931e70-434f-4f2a-bd41-9f71c594f40b">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80L2ZyYWc6NjI0MzlmZjQ2YTQ2NDNlZjhlMzNmMTczOWY2YzQ1YzIvdGFibGU6YTIwMjNmYWU4OGZjNGRkZGI4MDE3MDJhNDczODk0ODIvdGFibGVyYW5nZTphMjAyM2ZhZTg4ZmM0ZGRkYjgwMTcwMmE0NzM4OTQ4Ml80LTEtMS0xLTcwMjY1_5c305ce1-5efc-46ff-883b-1957cd385970">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentType
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xL2ZyYWc6NjFiMmFlN2VmZGY0NDU1ODkxMDNkMzFkNzVhOGFmYjcvdGV4dHJlZ2lvbjo2MWIyYWU3ZWZkZjQ0NTU4OTEwM2QzMWQ3NWE4YWZiN18xOTc5_3af53476-37aa-4913-8a42-3837ac41e1b4">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xL2ZyYWc6NjFiMmFlN2VmZGY0NDU1ODkxMDNkMzFkNzVhOGFmYjcvdGFibGU6ZmJjMGNmYmExMWY4NDA0YTk5NjlkNDkyNjhiN2I3ZjcvdGFibGVyYW5nZTpmYmMwY2ZiYTExZjg0MDRhOTk2OWQ0OTI2OGI3YjdmN18wLTAtMS0xLTcwMjY1_05e0e3b4-3164-4669-b211-fa419fccccfb">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xL2ZyYWc6NjFiMmFlN2VmZGY0NDU1ODkxMDNkMzFkNzVhOGFmYjcvdGV4dHJlZ2lvbjo2MWIyYWU3ZWZkZjQ0NTU4OTEwM2QzMWQ3NWE4YWZiN18xMzQ_5d6f64e3-a322-4bdf-83fb-9d4086ee2940">2022-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xL2ZyYWc6NjFiMmFlN2VmZGY0NDU1ODkxMDNkMzFkNzVhOGFmYjcvdGFibGU6MjYwNTRjZjYzODc0NGNhYTkxNmQzOGQ2NDZjYjBmNTYvdGFibGVyYW5nZToyNjA1NGNmNjM4NzQ0Y2FhOTE2ZDM4ZDY0NmNiMGY1Nl8wLTAtMS0xLTcwMjY1_98c773b9-d664-4520-ba43-97eb696c353e">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xL2ZyYWc6NjFiMmFlN2VmZGY0NDU1ODkxMDNkMzFkNzVhOGFmYjcvdGV4dHJlZ2lvbjo2MWIyYWU3ZWZkZjQ0NTU4OTEwM2QzMWQ3NWE4YWZiN18xOTcy_9a9e1c69-ecc6-4233-afe1-1fbd5b4a3646">001-40797</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xL2ZyYWc6NjFiMmFlN2VmZGY0NDU1ODkxMDNkMzFkNzVhOGFmYjcvdGV4dHJlZ2lvbjo2MWIyYWU3ZWZkZjQ0NTU4OTEwM2QzMWQ3NWE4YWZiN18xOTcz_032477f4-dc3a-421e-882d-312dfd9b156c">PROCEPT BioRobotics Corporation</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xL2ZyYWc6NjFiMmFlN2VmZGY0NDU1ODkxMDNkMzFkNzVhOGFmYjcvdGFibGU6Y2Q4M2YyNzEyZDc5NGEyMDk4OGM1ZDkwZWMzYjMwYTIvdGFibGVyYW5nZTpjZDgzZjI3MTJkNzk0YTIwOTg4YzVkOTBlYzNiMzBhMl8wLTAtMS0xLTcwMjY1_607f3639-224a-4da3-9bca-ce6e1200faba">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xL2ZyYWc6NjFiMmFlN2VmZGY0NDU1ODkxMDNkMzFkNzVhOGFmYjcvdGFibGU6Y2Q4M2YyNzEyZDc5NGEyMDk4OGM1ZDkwZWMzYjMwYTIvdGFibGVyYW5nZTpjZDgzZjI3MTJkNzk0YTIwOTg4YzVkOTBlYzNiMzBhMl8wLTMtMS0xLTcwMjY1_4c6e58aa-65cd-4a95-af64-268e3c5e9d27">26-0199180</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xL2ZyYWc6NjFiMmFlN2VmZGY0NDU1ODkxMDNkMzFkNzVhOGFmYjcvdGFibGU6Y2Q4M2YyNzEyZDc5NGEyMDk4OGM1ZDkwZWMzYjMwYTIvdGFibGVyYW5nZTpjZDgzZjI3MTJkNzk0YTIwOTg4YzVkOTBlYzNiMzBhMl8zLTAtMS0xLTcwMjY1_338bffcf-8b54-43d3-9142-9e8cebec83e8">900 Island Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xL2ZyYWc6NjFiMmFlN2VmZGY0NDU1ODkxMDNkMzFkNzVhOGFmYjcvdGFibGU6Y2Q4M2YyNzEyZDc5NGEyMDk4OGM1ZDkwZWMzYjMwYTIvdGFibGVyYW5nZTpjZDgzZjI3MTJkNzk0YTIwOTg4YzVkOTBlYzNiMzBhMl8zLTEtMS0xLTcwMjY1_d79444cb-74bd-49a6-b72a-d9500dda7cab">Redwood City</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xL2ZyYWc6NjFiMmFlN2VmZGY0NDU1ODkxMDNkMzFkNzVhOGFmYjcvdGFibGU6Y2Q4M2YyNzEyZDc5NGEyMDk4OGM1ZDkwZWMzYjMwYTIvdGFibGVyYW5nZTpjZDgzZjI3MTJkNzk0YTIwOTg4YzVkOTBlYzNiMzBhMl8zLTItMS0xLTcwMjY1_8616a1ac-d669-4536-94c5-ff9fd262e048">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xL2ZyYWc6NjFiMmFlN2VmZGY0NDU1ODkxMDNkMzFkNzVhOGFmYjcvdGFibGU6Y2Q4M2YyNzEyZDc5NGEyMDk4OGM1ZDkwZWMzYjMwYTIvdGFibGVyYW5nZTpjZDgzZjI3MTJkNzk0YTIwOTg4YzVkOTBlYzNiMzBhMl8zLTMtMS0xLTcwMjY1_469cc424-383b-48b6-b0b2-2deaec2fa2f2">94065</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xL2ZyYWc6NjFiMmFlN2VmZGY0NDU1ODkxMDNkMzFkNzVhOGFmYjcvdGV4dHJlZ2lvbjo2MWIyYWU3ZWZkZjQ0NTU4OTEwM2QzMWQ3NWE4YWZiN18xOTgx_ff0f9ce7-c4ae-4d6e-960c-c437a19ee099">650</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xL2ZyYWc6NjFiMmFlN2VmZGY0NDU1ODkxMDNkMzFkNzVhOGFmYjcvdGV4dHJlZ2lvbjo2MWIyYWU3ZWZkZjQ0NTU4OTEwM2QzMWQ3NWE4YWZiN18xOTc1_40bbb563-a622-49b4-b7d1-709d7f9e27f3">232-7200</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xL2ZyYWc6NjFiMmFlN2VmZGY0NDU1ODkxMDNkMzFkNzVhOGFmYjcvdGFibGU6Yzc5NmQzNGE0MDE1NDg3MWE2YjI5NWZkODJlNTM3YzEvdGFibGVyYW5nZTpjNzk2ZDM0YTQwMTU0ODcxYTZiMjk1ZmQ4MmU1MzdjMV8xLTAtMS0xLTcwMjY1_b4d88d57-dda7-494a-a609-0d6e6af6059d">Common stock, $0.00001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xL2ZyYWc6NjFiMmFlN2VmZGY0NDU1ODkxMDNkMzFkNzVhOGFmYjcvdGFibGU6Yzc5NmQzNGE0MDE1NDg3MWE2YjI5NWZkODJlNTM3YzEvdGFibGVyYW5nZTpjNzk2ZDM0YTQwMTU0ODcxYTZiMjk1ZmQ4MmU1MzdjMV8xLTEtMS0xLTcwMjY1_b321cdd8-b9c9-481f-a10d-35936f9bf54c">PRCT</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xL2ZyYWc6NjFiMmFlN2VmZGY0NDU1ODkxMDNkMzFkNzVhOGFmYjcvdGFibGU6Yzc5NmQzNGE0MDE1NDg3MWE2YjI5NWZkODJlNTM3YzEvdGFibGVyYW5nZTpjNzk2ZDM0YTQwMTU0ODcxYTZiMjk1ZmQ4MmU1MzdjMV8xLTItMS0xLTcwMjY1_8da5c1f1-346d-4b6c-8b6c-f1e4f27d0556">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xL2ZyYWc6NjFiMmFlN2VmZGY0NDU1ODkxMDNkMzFkNzVhOGFmYjcvdGV4dHJlZ2lvbjo2MWIyYWU3ZWZkZjQ0NTU4OTEwM2QzMWQ3NWE4YWZiN18xOTgy_fe07d2ba-375b-4a58-b5e6-146bcb1bc2cc">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xL2ZyYWc6NjFiMmFlN2VmZGY0NDU1ODkxMDNkMzFkNzVhOGFmYjcvdGV4dHJlZ2lvbjo2MWIyYWU3ZWZkZjQ0NTU4OTEwM2QzMWQ3NWE4YWZiN18xOTc2_6acdede3-31bf-46c2-8b11-38022f123ffd">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xL2ZyYWc6NjFiMmFlN2VmZGY0NDU1ODkxMDNkMzFkNzVhOGFmYjcvdGFibGU6Mjk2YTBkZDU1NzZhNDE4NDg0NzIxZjU5NTFmOWZiZjQvdGFibGVyYW5nZToyOTZhMGRkNTU3NmE0MTg0ODQ3MjFmNTk1MWY5ZmJmNF8xLTAtMS0xLTcwMjY1_5cab031a-ea61-4f72-a9ee-0c85eba3db6d">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xL2ZyYWc6NjFiMmFlN2VmZGY0NDU1ODkxMDNkMzFkNzVhOGFmYjcvdGFibGU6Mjk2YTBkZDU1NzZhNDE4NDg0NzIxZjU5NTFmOWZiZjQvdGFibGVyYW5nZToyOTZhMGRkNTU3NmE0MTg0ODQ3MjFmNTk1MWY5ZmJmNF8xLTMtMS0xLTcwMjY1_d2b46026-a152-404d-9681-4b62c3ebd064">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xL2ZyYWc6NjFiMmFlN2VmZGY0NDU1ODkxMDNkMzFkNzVhOGFmYjcvdGFibGU6Mjk2YTBkZDU1NzZhNDE4NDg0NzIxZjU5NTFmOWZiZjQvdGFibGVyYW5nZToyOTZhMGRkNTU3NmE0MTg0ODQ3MjFmNTk1MWY5ZmJmNF8yLTMtMS0xLTcwMjY1_efc6ae47-d4cd-4b1a-8b48-7067a419ce5c">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xL2ZyYWc6NjFiMmFlN2VmZGY0NDU1ODkxMDNkMzFkNzVhOGFmYjcvdGV4dHJlZ2lvbjo2MWIyYWU3ZWZkZjQ0NTU4OTEwM2QzMWQ3NWE4YWZiN18xOTc3_4ea4b270-e485-4738-b9d8-8241113736f8">false</dei:EntityExTransitionPeriod>
    <dei:EntityShellCompany
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xL2ZyYWc6NjFiMmFlN2VmZGY0NDU1ODkxMDNkMzFkNzVhOGFmYjcvdGV4dHJlZ2lvbjo2MWIyYWU3ZWZkZjQ0NTU4OTEwM2QzMWQ3NWE4YWZiN18xOTc4_1a70f48b-92f4-4f36-85d0-28fbe3b1b686">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i5244b61f062c425cb72b630f1ffc25d3_I20220731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xL2ZyYWc6NjFiMmFlN2VmZGY0NDU1ODkxMDNkMzFkNzVhOGFmYjcvdGV4dHJlZ2lvbjo2MWIyYWU3ZWZkZjQ0NTU4OTEwM2QzMWQ3NWE4YWZiN18xOTM2_8486343d-73cc-4daa-b9f4-f39b4e1c7450"
      unitRef="shares">44592286</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNS0xLTEtMS03MDI2NQ_9296c4e4-8b8a-4f02-99ca-34b488c2721b"
      unitRef="usd">269806000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNS0zLTEtMS03MDI2NQ_c182f508-e1ae-483a-8797-8f5ccab68eaf"
      unitRef="usd">304320000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNi0xLTEtMS03MDI2NQ_f6b8da85-66e0-4ea2-a4c3-d65b5cc3b9dd"
      unitRef="usd">10894000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNi0zLTEtMS03MDI2NQ_5f457925-c24c-42b4-a710-a6520e18eccc"
      unitRef="usd">4464000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNy0xLTEtMS03MDI2NQ_413311c2-85e0-46d4-a95a-050bf364a151"
      unitRef="usd">13777000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNy0zLTEtMS03MDI2NQ_170e6b21-c5c6-49f3-9549-fd546e4b03a9"
      unitRef="usd">13147000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfOC0xLTEtMS03MDI2NQ_021bd6c2-f792-4800-b550-07257b89fbfc"
      unitRef="usd">3860000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfOC0zLTEtMS03MDI2NQ_20a6493e-7a2e-499c-bef4-8edabdb16617"
      unitRef="usd">4242000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfOS0xLTEtMS03MDI2NQ_fde3c172-d34e-4e00-a897-7d3f2fdd9ba0"
      unitRef="usd">298337000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfOS0zLTEtMS03MDI2NQ_7d8715dd-7571-40c9-949a-fbbdec331a02"
      unitRef="usd">326173000</us-gaap:AssetsCurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMTAtMS0xLTEtNzAyNjU_50366c0d-fa2e-4943-b929-f84d7552e6e8"
      unitRef="usd">3814000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMTAtMy0xLTEtNzAyNjU_f6219d35-ae11-46a2-ace9-d7b4c342820f"
      unitRef="usd">777000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMTEtMS0xLTEtNzAyNjU_fa13d38d-8803-4892-912d-9acedd692399"
      unitRef="usd">4397000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMTEtMy0xLTEtNzAyNjU_2b18e6eb-14c1-4a13-abb0-e5b97ac77b8c"
      unitRef="usd">5045000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMTItMS0xLTEtNzAyNjU_c7ac8f8b-bb17-45e9-96d7-fd4b46aa3dbd"
      unitRef="usd">2463000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMTItMy0xLTEtNzAyNjU_2e51967a-7a7c-4477-ac2d-f0518a851ba6"
      unitRef="usd">3279000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMTMtMS0xLTEtNzAyNjU_b774b6e5-ec2a-45fe-b290-20d31f006cca"
      unitRef="usd">1614000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMTMtMy0xLTEtNzAyNjU_65801247-407c-40f8-b668-0686b5ac0fd8"
      unitRef="usd">1750000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMTQtMS0xLTEtNzM3MTk_8a8769f3-8b43-4ba9-9a47-59a92c64e2ee"
      unitRef="usd">302000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMTQtMy0xLTEtNzM3MTc_32dbde0b-fea6-48dc-aa19-b222dfa784cf"
      unitRef="usd">0</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMTUtMS0xLTEtNzAyNjU_37916014-cbe9-4a8b-9675-eebefc159c57"
      unitRef="usd">310927000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMTUtMy0xLTEtNzAyNjU_58b28615-8f1f-4297-ac56-34d493ebf6db"
      unitRef="usd">337024000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMTgtMS0xLTEtNzAyNjU_7606a82e-2a22-4d14-b452-ba898fe6d5be"
      unitRef="usd">3342000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMTgtMy0xLTEtNzAyNjU_770fc02b-56d5-40b0-8c8e-868df6fb2af3"
      unitRef="usd">2029000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedSalariesCurrent
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMTktMS0xLTEtNzAyNjU_8bd42c68-d431-42d8-8b18-890557a560d2"
      unitRef="usd">6906000</us-gaap:AccruedSalariesCurrent>
    <us-gaap:AccruedSalariesCurrent
      contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMTktMy0xLTEtNzAyNjU_1f32e072-1266-460b-b5e1-e18edcb745d7"
      unitRef="usd">6475000</us-gaap:AccruedSalariesCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMjAtMS0xLTEtNzAyNjU_efc9de71-6310-41bf-b5f3-5683e2f8690a"
      unitRef="usd">1863000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMjAtMy0xLTEtNzAyNjU_a51507ea-623d-4f5a-8a4d-c942a3fcb560"
      unitRef="usd">1025000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMjItMS0xLTEtNzAyNjU_8da7a16c-d19a-45bd-9876-0bc27229eac0"
      unitRef="usd">2258000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMjItMy0xLTEtNzAyNjU_a5eb1e3f-b70b-4e93-8d27-b968f191b5b3"
      unitRef="usd">2105000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMjQtMS0xLTEtNzAyNjU_03b46e8d-9b81-41c3-8887-8ee3e6d0776c"
      unitRef="usd">4264000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMjQtMy0xLTEtNzAyNjU_c55bc481-6846-4a3c-8bf3-7733e45d604f"
      unitRef="usd">4608000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMjUtMS0xLTEtNzAyNjU_85785637-3505-4c0c-86b7-87fbe4f7c384"
      unitRef="usd">18633000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMjUtMy0xLTEtNzAyNjU_94dc9740-1168-4885-8f48-aae601c6a0e8"
      unitRef="usd">16242000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMjYtMS0xLTEtNzAyNjU_5b9579fc-e7e7-4029-bf4f-530fa1c92240"
      unitRef="usd">50507000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMjYtMy0xLTEtNzAyNjU_2238d332-1cb7-4e8e-a72a-4d5895481563"
      unitRef="usd">50004000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMjctMS0xLTEtNzAyNjU_fa1fc968-e683-4352-a7f7-06ee6f435128"
      unitRef="usd">829000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMjctMy0xLTEtNzAyNjU_6afc5e6d-f883-4480-b458-933b4c38bf20"
      unitRef="usd">1991000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMjgtMS0xLTEtNzAyNjU_4d1d861f-eadc-4529-b303-3c787cc1b4b0"
      unitRef="usd">1570000</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMjgtMy0xLTEtNzAyNjU_f1cb828b-5b3d-4a0a-be3d-c607e308ae86"
      unitRef="usd">1496000</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMzAtMS0xLTEtNzAyNjU_a3d01ecb-9887-4ffd-811e-b853a7199192"
      unitRef="usd">200000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMzAtMy0xLTEtNzAyNjU_1ed37ae3-bb6b-437b-a232-3d64d6f92476"
      unitRef="usd">200000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMzEtMS0xLTEtNzAyNjU_fe1cf0ad-58ad-47dd-981e-af56763ffce5"
      unitRef="usd">71739000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMzEtMy0xLTEtNzAyNjU_d88cb429-8d7c-456c-b253-32344aa4d964"
      unitRef="usd">69933000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMzItMS0xLTEtNzAyNjU_b8ff2f79-40a9-48d7-9f99-c8f826f302b0"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMzItMy0xLTEtNzAyNjU_d0c269df-d35b-4853-bf4a-127026e94e0f"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMzgtMC0xLTEtNzAyNjUvdGV4dHJlZ2lvbjo3NTlkYTdjYzg4NGI0MTQ2YTc4M2VmNzJhNDIyZWMwOF8yMQ_72efb2df-7534-4046-81c9-6621b10b8a7a"
      unitRef="usdPerShare">0.00001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMzgtMC0xLTEtNzAyNjUvdGV4dHJlZ2lvbjo3NTlkYTdjYzg4NGI0MTQ2YTc4M2VmNzJhNDIyZWMwOF8yMQ_b26c848d-cfc2-4d97-8c0d-84e83c2830b1"
      unitRef="usdPerShare">0.00001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMzktMC0xLTEtNzAyNjUvdGV4dHJlZ2lvbjozNTU3NzE1ZTVjMjI0N2IwOTExZGUxYmEwMTdhYjI3Nl8yMw_23a774f3-262a-49be-8f31-97e5a7f933e2"
      unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfMzktMC0xLTEtNzAyNjUvdGV4dHJlZ2lvbjozNTU3NzE1ZTVjMjI0N2IwOTExZGUxYmEwMTdhYjI3Nl8yMw_42a38fc6-5bf5-4d07-992c-89f894d9c78f"
      unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNDAtMC0xLTEtNzAyNjUvdGV4dHJlZ2lvbjpkNDE2ODhkNmJhMGE0OTQxOTBiYjgwZjE2MDgyZDUxNl8zNQ_3c007f0a-6136-4bed-9958-12520ca669f5"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNDAtMC0xLTEtNzAyNjUvdGV4dHJlZ2lvbjpkNDE2ODhkNmJhMGE0OTQxOTBiYjgwZjE2MDgyZDUxNl8zNQ_6b69a422-fa46-4ca7-9d97-68b301babbc1"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNDAtMC0xLTEtNzAyNjUvdGV4dHJlZ2lvbjpkNDE2ODhkNmJhMGE0OTQxOTBiYjgwZjE2MDgyZDUxNl8zNQ_bdd275b6-0e4f-4ec1-852c-fc5a7be0c30f"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNDAtMC0xLTEtNzAyNjUvdGV4dHJlZ2lvbjpkNDE2ODhkNmJhMGE0OTQxOTBiYjgwZjE2MDgyZDUxNl8zNQ_fbb4dee5-1039-4508-93b8-a70e039b8f2d"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNDAtMS0xLTEtNzAyNjU_da56874a-8947-48ad-b2a2-965f272900e7"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNDAtMy0xLTEtNzAyNjU_4c879951-aa2d-4248-ab10-5ebaaee95e2a"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNDEtMC0xLTEtNzAyNjUvdGV4dHJlZ2lvbjozYjRiZDNhOWZkOTk0YWMzODUxYzY3OTFkNTU2ZWQ5M18xOA_47caacac-6050-4fcd-9dce-14ad23034392"
      unitRef="usdPerShare">0.00001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNDEtMC0xLTEtNzAyNjUvdGV4dHJlZ2lvbjozYjRiZDNhOWZkOTk0YWMzODUxYzY3OTFkNTU2ZWQ5M18xOA_5f3c6f7b-cf9e-41fb-b515-28e25b1158a3"
      unitRef="usdPerShare">0.00001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNDItMC0xLTEtNzAyNjUvdGV4dHJlZ2lvbjozYjBjOWZkOWZhYzM0MjNiYTY5MTRkMGNhNWUyYjc5YV8yMw_01d221fe-9f60-494e-b3c1-aed245e5de0e"
      unitRef="shares">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNDItMC0xLTEtNzAyNjUvdGV4dHJlZ2lvbjozYjBjOWZkOWZhYzM0MjNiYTY5MTRkMGNhNWUyYjc5YV8yMw_c5f3f683-828e-410e-8b36-02c36d8468f7"
      unitRef="shares">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNDMtMC0xLTEtNzAyNjUvdGV4dHJlZ2lvbjoyNWNkOWM0OTI3NTA0MGM3ODk5MDQyODhkYzBmMWYzM18zNQ_ba7363c0-0f27-488e-8729-7bdfc0737916"
      unitRef="shares">44538000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNDMtMC0xLTEtNzAyNjUvdGV4dHJlZ2lvbjoyNWNkOWM0OTI3NTA0MGM3ODk5MDQyODhkYzBmMWYzM18zNQ_db3fa824-d7ee-4e3a-b836-d673b36a84f4"
      unitRef="shares">44538000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNDMtMC0xLTEtNzAyNjUvdGV4dHJlZ2lvbjoyNWNkOWM0OTI3NTA0MGM3ODk5MDQyODhkYzBmMWYzM180Mg_16708785-a482-4b7e-951b-28d3c7a64524"
      unitRef="shares">43676000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNDMtMC0xLTEtNzAyNjUvdGV4dHJlZ2lvbjoyNWNkOWM0OTI3NTA0MGM3ODk5MDQyODhkYzBmMWYzM180Mg_719d2b25-e946-4323-92b7-62d9081fc433"
      unitRef="shares">43676000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNDMtMS0xLTEtNzAyNjU_a1a6461f-408f-4d7f-9d67-a5d9d6d79d4c"
      unitRef="usd">0</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNDMtMy0xLTEtNzAyNjU_abae91aa-d6da-443f-a7c2-5a59176bd715"
      unitRef="usd">0</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNDQtMS0xLTEtNzAyNjU_abe2bca7-229e-449c-bfcd-e9e4ed25bc7d"
      unitRef="usd">537046000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNDQtMy0xLTEtNzAyNjU_fb96cd37-190e-47b5-aedf-0d163583fe02"
      unitRef="usd">528666000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNDUtMS0xLTEtNzAyNjU_b393c640-ef43-4af8-912c-98c2029d1b59"
      unitRef="usd">32000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNDUtMy0xLTEtNzAyNjU_cb3e5deb-1efe-4d74-9215-accebbcf890d"
      unitRef="usd">-54000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNDYtMS0xLTEtNzAyNjU_664252a8-0861-4f26-9ef8-2af1d3348d29"
      unitRef="usd">-297890000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNDYtMy0xLTEtNzAyNjU_7361e6be-8513-4ee0-9b48-adcff11411b9"
      unitRef="usd">-261521000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNDctMS0xLTEtNzAyNjU_7ea5009b-c02d-405d-9c79-5db7dc62144b"
      unitRef="usd">239188000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNDctMy0xLTEtNzAyNjU_bf317005-5830-4d7f-976a-f3ba7596f970"
      unitRef="usd">267091000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNDgtMS0xLTEtNzAyNjU_173895dc-f9a7-4d3a-9112-ac325e444f2d"
      unitRef="usd">310927000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8xOS9mcmFnOmQzODQ0OWY1ZjczYjQ4ZTZhYzUzMjQ0MDg3YjkyNjc1L3RhYmxlOjQ2ZGVmNjgwMTFiYjQyOWE4YTYyODFlZDVjMTkxZjVkL3RhYmxlcmFuZ2U6NDZkZWY2ODAxMWJiNDI5YThhNjI4MWVkNWMxOTFmNWRfNDgtMy0xLTEtNzAyNjU_19c3b112-2828-4ef7-b6fa-1f8a03d17a36"
      unitRef="usd">337024000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMy0xLTEtMS03MDI2NQ_38d02606-f4ca-4ff5-aa9d-49f7ccbd2429"
      unitRef="usd">16691000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMy0zLTEtMS03MDI2NQ_83aa9075-bd45-4c60-ba0a-4ba2baaad9ba"
      unitRef="usd">8476000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMy01LTEtMS03MDI2NQ_7a7665da-b0bd-4c61-888b-c4a237456f90"
      unitRef="usd">30888000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMy03LTEtMS03MDI2NQ_3ffdeec1-d38e-4217-8174-87adacfb3afb"
      unitRef="usd">15668000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfNC0xLTEtMS03MDI2NQ_4326534f-b06b-466e-a8bc-c3e171d4cafe"
      unitRef="usd">8205000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfNC0zLTEtMS03MDI2NQ_fb148d27-81e8-4161-99e5-913c2bd06e0a"
      unitRef="usd">4893000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfNC01LTEtMS03MDI2NQ_b045ad61-2f75-42b0-b4b0-d3d7482086cb"
      unitRef="usd">14710000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfNC03LTEtMS03MDI2NQ_dee37060-b457-4943-b525-ba2e86ae39cd"
      unitRef="usd">8558000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfNS0xLTEtMS03MDI2NQ_cf4a511a-3cbb-471b-bc8f-689dd10bfe5a"
      unitRef="usd">8486000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfNS0zLTEtMS03MDI2NQ_41edc136-a24c-4020-8c29-e8f1a05bdf79"
      unitRef="usd">3583000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfNS01LTEtMS03MDI2NQ_ae2af8c4-759b-4f32-9965-1954b63a2cf0"
      unitRef="usd">16178000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfNS03LTEtMS03MDI2NQ_b7bb89e0-28bb-48ac-97b1-11397a327543"
      unitRef="usd">7110000</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfNy0xLTEtMS03MDI2NQ_0cc23686-dcd4-408c-b1d0-34e8f4742a8c"
      unitRef="usd">6706000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfNy0zLTEtMS03MDI2NQ_b0269cb8-e055-4fd5-aceb-1328593484b5"
      unitRef="usd">4476000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfNy01LTEtMS03MDI2NQ_aec87159-c10a-46ad-8d79-96280351a8f5"
      unitRef="usd">11717000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfNy03LTEtMS03MDI2NQ_de05e74d-ab42-4d7f-87f7-0ff0596c2692"
      unitRef="usd">8998000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfOC0xLTEtMS03MDI2NQ_0e97e354-3227-4ce9-8ac0-2416282c2f08"
      unitRef="usd">19655000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfOC0zLTEtMS03MDI2NQ_488582b5-ca80-4e11-97f6-c4418337c449"
      unitRef="usd">12299000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfOC01LTEtMS03MDI2NQ_6c4a377e-fae6-4fda-a638-7bdf152d89f4"
      unitRef="usd">38040000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfOC03LTEtMS03MDI2NQ_139d2bd8-5a15-482f-8a6c-5a955a473136"
      unitRef="usd">22648000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfOS0xLTEtMS03MDI2NQ_0f692937-716c-45ff-bbc3-993c67d539c6"
      unitRef="usd">26361000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfOS0zLTEtMS03MDI2NQ_c1f6d9f7-c3f5-455d-86c7-ee32e5d6d2b9"
      unitRef="usd">16775000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfOS01LTEtMS03MDI2NQ_182122dc-c432-4c9f-b28b-e9ab5c46e607"
      unitRef="usd">49757000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfOS03LTEtMS03MDI2NQ_4bcde7ed-fd5b-44b7-a37d-b0b3b1f3e501"
      unitRef="usd">31646000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTAtMS0xLTEtNzAyNjU_89591113-f57e-4fa9-b24a-480959ee41cc"
      unitRef="usd">-17875000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTAtMy0xLTEtNzAyNjU_e737395b-6826-42be-bf54-eaaa2b338cfa"
      unitRef="usd">-13192000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTAtNS0xLTEtNzAyNjU_086e633d-8e1a-4090-a096-7805f81a359d"
      unitRef="usd">-33579000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTAtNy0xLTEtNzAyNjU_30ac1419-7195-46e9-bde4-738a74cf89d2"
      unitRef="usd">-24536000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTEtMS0xLTEtNzAyNjU_19b49b68-3afa-418f-809b-998545d4413e"
      unitRef="usd">1441000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTEtMy0xLTEtNzAyNjU_91263a00-811d-45fc-96d0-773999996db7"
      unitRef="usd">1436000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTEtNS0xLTEtNzAyNjU_428c6db9-e750-4b69-91c4-5fbc06d86c98"
      unitRef="usd">2862000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTEtNy0xLTEtNzAyNjU_eac76267-605f-4fc2-a35c-9ba227211b72"
      unitRef="usd">2900000</us-gaap:InterestExpense>
    <prct:InterestAndOtherIncomeExpense
      contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTItMS0xLTEtNzAyNjU_c96e35db-6a58-4718-9e84-2629de014f20"
      unitRef="usd">132000</prct:InterestAndOtherIncomeExpense>
    <prct:InterestAndOtherIncomeExpense
      contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTItMy0xLTEtNzAyNjU_349c3211-a61a-444f-9b12-58b09cbf316c"
      unitRef="usd">48000</prct:InterestAndOtherIncomeExpense>
    <prct:InterestAndOtherIncomeExpense
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTItNS0xLTEtNzAyNjU_b611c75c-c69c-4212-beff-957d73237378"
      unitRef="usd">72000</prct:InterestAndOtherIncomeExpense>
    <prct:InterestAndOtherIncomeExpense
      contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTItNy0xLTEtNzAyNjU_51445451-b0f8-43f6-9137-20154b3358be"
      unitRef="usd">34000</prct:InterestAndOtherIncomeExpense>
    <us-gaap:NetIncomeLoss
      contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTMtMS0xLTEtNzAyNjU_91d90ed2-fc99-4f47-8a40-b45c1fc16cf2"
      unitRef="usd">-19184000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i4eeb8d5fbaa443cfb4b403f6bf784110_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTMtMS0xLTEtNzAyNjU_e78c383b-eeb7-4cad-854f-9704ee3c0144"
      unitRef="usd">-19184000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTMtMy0xLTEtNzAyNjU_ffe67fac-e0e9-43f6-ac6f-d999dd0b9b21"
      unitRef="usd">-14580000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTMtNS0xLTEtNzAyNjU_81839024-b6fd-4fbf-a9c7-59a0ee237f7c"
      unitRef="usd">-36369000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTMtNy0xLTEtNzAyNjU_76597fa9-f7e1-4198-9844-82dc4325e151"
      unitRef="usd">-27402000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTQtMS0xLTEtNzAyNjU_a66ef6ea-5f36-4dba-8fca-8caf1d6a3155"
      unitRef="usdPerShare">-0.43</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTQtMS0xLTEtNzAyNjU_e3f896e7-cc04-48db-85f4-a38a78e7caea"
      unitRef="usdPerShare">-0.43</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTQtMy0xLTEtNzAyNjU_8199ac9f-19ae-4c99-8ebf-6f7c4f00162e"
      unitRef="usdPerShare">-2.60</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTQtMy0xLTEtNzAyNjU_972260d4-4ee1-48cd-bd02-04cf91767c60"
      unitRef="usdPerShare">-2.60</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTQtNS0xLTEtNzAyNjU_45a2bb4d-1575-4a16-9b59-ff61c5f7206d"
      unitRef="usdPerShare">-0.82</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTQtNS0xLTEtNzAyNjU_8e87b738-7f24-476f-b586-d16883f38e51"
      unitRef="usdPerShare">-0.82</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTQtNy0xLTEtNzAyNjU_45792bbf-c4f9-4460-a8a2-ab6354b498b5"
      unitRef="usdPerShare">-5.25</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTQtNy0xLTEtNzAyNjU_5017b47b-d6b4-44e3-8c83-cc7e589de302"
      unitRef="usdPerShare">-5.25</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTctMS0xLTEtNzAyNjU_65f36532-fa22-441b-a78e-be19a1f1cb7a"
      unitRef="shares">44324000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTctMS0xLTEtNzAyNjU_b12930c7-8fb3-42a7-a478-b07082351f3d"
      unitRef="shares">44324000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTctMy0xLTEtNzAyNjU_2caf95eb-bf27-45b3-9325-19432e3642f5"
      unitRef="shares">5597000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTctMy0xLTEtNzAyNjU_8606a51f-480a-4f62-87a3-64072fc20934"
      unitRef="shares">5597000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTctNS0xLTEtNzAyNjU_12c40465-6fa1-4805-bb0e-09cdafb643ce"
      unitRef="shares">44091000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTctNS0xLTEtNzAyNjU_76734d8a-db16-4bfd-8258-053b769bb979"
      unitRef="shares">44091000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTctNy0xLTEtNzAyNjU_47f3cacd-b344-4608-acfd-d6ed519a2c32"
      unitRef="shares">5216000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTctNy0xLTEtNzAyNjU_67d7feb5-abc3-492c-ad2b-8ef4074114cf"
      unitRef="shares">5216000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTktMS0xLTEtNzAyNjU_f0142852-1395-44fa-a538-e595d323a780"
      unitRef="usd">85000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTktMy0xLTEtNzAyNjU_39546480-9a97-4602-b40d-fa4f618e465a"
      unitRef="usd">-9000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTktNS0xLTEtNzAyNjU_bbfa17f7-13a9-4ad8-9c24-7dea077cfcff"
      unitRef="usd">87000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMTktNy0xLTEtNzAyNjU_3dcb7826-fcf3-41e2-8ade-2c4c2a00e123"
      unitRef="usd">-25000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMjAtMS0xLTEtNzAyNjU_cc94ce8e-b77b-4121-a72d-65de0286e25d"
      unitRef="usd">-19099000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMjAtMy0xLTEtNzAyNjU_cb978065-59d5-4f77-a2e8-b155ba453333"
      unitRef="usd">-14589000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMjAtNS0xLTEtNzAyNjU_f871bc66-0b81-44e9-8b7d-90ca0740af31"
      unitRef="usd">-36282000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yMi9mcmFnOjQwODNiN2EzNTdkMDQ5MTU5YmQxZDY3M2Q4M2IzMTQxL3RhYmxlOjM1YWE4YWI0OGEwMDQ1OTZiMDU2Njk5ZDNkM2MzZmUzL3RhYmxlcmFuZ2U6MzVhYThhYjQ4YTAwNDU5NmIwNTY2OTlkM2QzYzNmZTNfMjAtNy0xLTEtNzAyNjU_d797ed9f-c1c9-4b1a-bc6e-7bf9c27a004d"
      unitRef="usd">-27427000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMi0xLTEtMS03MDI2NQ_5ea86bd5-b4ea-4f04-924b-3a433e3a9de3"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMi0zLTEtMS03MDI2NQ_af06cebf-a711-4cd3-a732-c14e764c6cce"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="i9585d1c54a684663894a7893b7489c39_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMi02LTEtMS03MDI2NQ_2d852064-77ca-4cda-bb43-a278a1f280dd"
      unitRef="shares">43676000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i9585d1c54a684663894a7893b7489c39_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMi04LTEtMS03MDI2NQ_ef58509d-c103-464d-9fac-ea02b30bfa60"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2247db1a4a2640a299b416b33a688b7c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMi0xMC0xLTEtNzAyNjU_78f147eb-9bcb-4df7-9e3d-d9cbf1f177c8"
      unitRef="usd">528666000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1defffe1f1964d89826a5865f9c988a5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMi0xMi0xLTEtNzAyNjU_e2c81c9b-5fb9-4785-9285-c97f9be5b826"
      unitRef="usd">-54000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4f83ee6a840d4fcf9011375d58625785_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMi0xNC0xLTEtNzAyNjU_3e200035-c1dd-4d3d-b7b0-062ba19d983f"
      unitRef="usd">-261521000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMi0xNi0xLTEtNzAyNjU_998dc614-367a-4c79-9655-d8324f29ebc3"
      unitRef="usd">267091000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i01886b412db145e0a0a2fe5ced6a37b3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMy02LTEtMS03MDI2NQ_b2245320-cf0c-4bb2-bcac-46aea4a9e107"
      unitRef="shares">401000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i4e567fde435a43809f3e7db528da3c7d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMy0xMC0xLTEtNzAyNjU_b148999f-dbd8-460c-9752-7d0f22d0846f"
      unitRef="usd">1291000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i5536a0a58c9e43a89b71f9c8d5fde9db_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMy0xNi0xLTEtNzAyNjU_f6082ef4-e05f-41fb-9f8e-3510eb52490b"
      unitRef="usd">1291000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition
      contextRef="i4e567fde435a43809f3e7db528da3c7d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfNC0xMC0xLTEtNzAyNjU_a8135c1e-67da-40e9-8ed7-b46cc81b517b"
      unitRef="usd">1552000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition
      contextRef="i5536a0a58c9e43a89b71f9c8d5fde9db_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfNC0xNi0xLTEtNzAyNjU_c4c31b69-8337-4356-ae5e-9f6abd23b7fa"
      unitRef="usd">1552000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ib49ef5b808cc4ce58c5c2146e6a4a872_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfNS0xMi0xLTEtNzAyNjU_45b7aa5d-e8f1-4b39-87bc-63e26a23eb68"
      unitRef="usd">1000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i5536a0a58c9e43a89b71f9c8d5fde9db_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfNS0xNi0xLTEtNzAyNjU_2d6d7655-8441-458e-a6e0-d5e89214e1cf"
      unitRef="usd">1000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="idbe9cd2e7c184e5f9f1b6182c72c33bc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfNi0xNC0xLTEtNzAyNjU_89a1829e-04e0-451a-ac32-dd27a0ca5664"
      unitRef="usd">-17185000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5536a0a58c9e43a89b71f9c8d5fde9db_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfNi0xNi0xLTEtNzAyNjU_d0331936-575e-4049-9474-f5a9e93b4fd9"
      unitRef="usd">-17185000</us-gaap:NetIncomeLoss>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i4a5f8472ee434d169dea6396cc0d2243_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMTYtMS0xLTEtNzAyNjU_1199769e-308a-4a96-ad9a-0974634ba19b"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i4a5f8472ee434d169dea6396cc0d2243_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMTYtMy0xLTEtNzAyNjU_fe8f1b90-2b5c-4de4-b8c0-237a88478ed7"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="ic8e0d0a6ea974a85bc5c95e8ea39af53_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMTYtNi0xLTEtNzAyNjU_e530b129-f1a8-4fb5-b323-ea0a246567aa"
      unitRef="shares">44077000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ic8e0d0a6ea974a85bc5c95e8ea39af53_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMTYtOC0xLTEtNzAyNjU_ce5fd89b-fdc2-49fb-8b97-ad8e0c8f38d0"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5d726aec89c84cdfacf0dd37b1b7db33_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMTYtMTAtMS0xLTcwMjY1_7623538b-419c-49f3-b12f-7034507257c3"
      unitRef="usd">531509000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie3c71862037247eaab3a9d37ea5de5f9_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMTYtMTItMS0xLTcwMjY1_b1af74e6-d58c-4cb9-8491-d56ec32a510c"
      unitRef="usd">-53000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if3fc05616d7449288a6f5900e51f12cd_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMTYtMTQtMS0xLTcwMjY1_e2fc3d5e-ea38-47a7-b606-e685fc17129e"
      unitRef="usd">-278706000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4a5f8472ee434d169dea6396cc0d2243_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMTYtMTYtMS0xLTcwMjY1_34b84b10-2f63-4571-9fb1-439ac8d6584c"
      unitRef="usd">252750000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="if60434966ba04e68bb10f89d746d9c71_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMTItNi0xLTEtNzA2MzI_974c47f7-c32d-44a9-9a43-78b6fe682a7b"
      unitRef="shares">400000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="id69d7c117e41411bb58321abe66da977_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMTItMTAtMS0xLTcwNjMy_66aa6a4f-e46b-416b-ac8a-6cc55b145981"
      unitRef="usd">1572000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMTItMTYtMS0xLTcwNjMy_6d7c7bf5-695d-47c1-b2b2-5cb728dad7ab"
      unitRef="usd">1572000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="if60434966ba04e68bb10f89d746d9c71_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMTMtNi0xLTEtNzQ3MzA_4dab4047-ac74-42ab-a375-b347bbd640e8"
      unitRef="shares">61000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="id69d7c117e41411bb58321abe66da977_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMTMtMTAtMS0xLTc0NzMw_e6695b0f-044a-4a9b-8987-006ed1d65ab3"
      unitRef="usd">1289000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMTMtMTYtMS0xLTc0NzMw_4968ba88-1383-4e6c-90d1-d7ac4e8a6123"
      unitRef="usd">1289000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition
      contextRef="id69d7c117e41411bb58321abe66da977_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMTMtMTAtMS0xLTcwNjMy_9a6ad399-90c4-40d5-941f-f8223d36fa8d"
      unitRef="usd">2676000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition
      contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMTMtMTYtMS0xLTcwNjMy_da8c8c5a-19d5-490d-97ed-48f1a3b5a828"
      unitRef="usd">2676000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i8e81cc1babd944fca585586deb7d643a_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMTctMTItMS0xLTcwMjY1_dadb3e43-065c-4c62-95ba-aac674b9e050"
      unitRef="usd">85000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMTctMTYtMS0xLTcwMjY1_47f8dc22-01b3-4344-9af9-aebf3d803c53"
      unitRef="usd">85000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="i4eeb8d5fbaa443cfb4b403f6bf784110_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMTgtMTQtMS0xLTcwMjY1_9576bcd6-5111-4c95-9c35-5f96b4b295cd"
      unitRef="usd">-19184000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMTgtMTYtMS0xLTcwMjY1_43085164-18a0-4339-b6e6-0a4fc642dd13"
      unitRef="usd">-19184000</us-gaap:NetIncomeLoss>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMTktMS0xLTEtNzAyNjU_c81ec783-565a-4a91-99a4-c86577ed92a5"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMTktMy0xLTEtNzAyNjU_cbdabefc-4c2d-4afe-a1e4-27cbbabc1711"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="i627bfed199d449d8b9f34ce309b5b446_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMTktNi0xLTEtNzAyNjU_b5daaff5-f8a0-4ac4-9b76-d261bd30feba"
      unitRef="shares">44538000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i627bfed199d449d8b9f34ce309b5b446_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMTktOC0xLTEtNzAyNjU_657c33b8-4f0c-42d0-94a3-890354d0e108"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i24963d2b7ff64b7ea5ae30aef83c1ab2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMTktMTAtMS0xLTcwMjY1_026d9e7a-cb98-41e5-9dd6-cf1e771ea362"
      unitRef="usd">537046000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2b4d8b1368e44cf78783a263b8dad765_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMTktMTItMS0xLTcwMjY1_1e8d2bd2-fc2e-4104-a1f5-489f8fdf2cb4"
      unitRef="usd">32000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4a939982b2f54db8a27e8f371521eb89_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMTktMTQtMS0xLTcwMjY1_08d186da-d6ab-40aa-93e5-4b2e855f94e2"
      unitRef="usd">-297890000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOjg5NTk5NjA2MmY0OTQ3ZWZhZmI4NTgxOWY0MTQ2ZTMzL3RhYmxlcmFuZ2U6ODk1OTk2MDYyZjQ5NDdlZmFmYjg1ODE5ZjQxNDZlMzNfMTktMTYtMS0xLTcwMjY1_62d9c745-be13-4794-9421-2af1ab1b06c9"
      unitRef="usd">239188000</us-gaap:StockholdersEquity>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="icbfd320e5dd848119b7bdb3871172b7a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMi0xLTEtMS03MDY0MQ_18c08f87-af14-41a6-8bfa-780a751adfd9"
      unitRef="shares">25402000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="icbfd320e5dd848119b7bdb3871172b7a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMi0zLTEtMS03MDY0MQ_3de8be86-cec3-433d-bd0f-eeb0fc70e5cd"
      unitRef="usd">243854000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="i14cbbd3f6b274b5b9fb32f03421ac7b6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMi02LTEtMS03MDY0MQ_8297824c-3612-465f-ac53-68c28a57f572"
      unitRef="shares">4713000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i14cbbd3f6b274b5b9fb32f03421ac7b6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMi04LTEtMS03MDY0MQ_6b3b2394-35ab-4402-8b92-3ba31a0bba20"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i282fabdbdaff4996a0ac69a7bc75b9b8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMi0xMC0xLTEtNzA2NDE_5cf5a0c6-73c6-4cf7-80cf-19832e8865fc"
      unitRef="usd">18788000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if5288075d3e6407caf4a41af1e03bf62_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMi0xMi0xLTEtNzA2NDE_76e24612-ae6e-4a62-96de-2f4f9ea4abaf"
      unitRef="usd">-14000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic1f38e11fe9a410499fe555213ca38f8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMi0xNC0xLTEtNzA2NDE_194733be-28c8-46f6-b4df-17a81ab22469"
      unitRef="usd">-201668000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="icbfd320e5dd848119b7bdb3871172b7a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMi0xNi0xLTEtNzA2NDE_22b62c96-ccff-4ba9-959c-77e68d9b89d8"
      unitRef="usd">-182894000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i28c750db7e8b493c961a7d62d4a754ad_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMy02LTEtMS03MDY0MQ_21d57cb8-dc5e-411b-babc-b681e4c13fdd"
      unitRef="shares">504000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i28c750db7e8b493c961a7d62d4a754ad_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMy02LTEtMS03MDY0MQ_e7feec4c-489e-4d80-9048-18ae3bb0e00f"
      unitRef="shares">504000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i7fe5f544032b4ef4a2f76f6a6f973e06_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMy0xMC0xLTEtNzA2NDE_0de7cc78-555f-4294-aa3c-0c608c7f7daa"
      unitRef="usd">1225000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i7fe5f544032b4ef4a2f76f6a6f973e06_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMy0xMC0xLTEtNzA2NDE_a20a176c-cc16-4586-8dfe-b7fc1c460fb5"
      unitRef="usd">1225000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i5ee47d851f3042aaaf707d3b82004294_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMy0xNi0xLTEtNzA2NDE_146e532c-8a12-4a70-ab2e-1ceafb89023d"
      unitRef="usd">1225000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i5ee47d851f3042aaaf707d3b82004294_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMy0xNi0xLTEtNzA2NDE_31d3f15b-6434-4060-986f-19fdc54c90d7"
      unitRef="usd">1225000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition
      contextRef="i7fe5f544032b4ef4a2f76f6a6f973e06_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfNC0xMC0xLTEtNzA2NDE_2d7efedb-f749-4cc2-a1e2-0da9b179a77b"
      unitRef="usd">650000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition
      contextRef="i7fe5f544032b4ef4a2f76f6a6f973e06_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfNC0xMC0xLTEtNzA2NDE_403e4cd4-0ba0-4fdc-b1bf-76fe0a87a638"
      unitRef="usd">650000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition
      contextRef="i5ee47d851f3042aaaf707d3b82004294_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfNC0xNi0xLTEtNzA2NDE_07b7aac0-6e42-4fc7-8df7-5d5069fd058d"
      unitRef="usd">650000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition
      contextRef="i5ee47d851f3042aaaf707d3b82004294_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfNC0xNi0xLTEtNzA2NDE_15eaa27d-eac8-431a-927d-9fad5f148108"
      unitRef="usd">650000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="iea9c042e07264772b04308a25e550340_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfNS0xMi0xLTEtNzA2NDE_1b17c774-79fa-42a6-a1b2-096b8bceb2ae"
      unitRef="usd">-16000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="iea9c042e07264772b04308a25e550340_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfNS0xMi0xLTEtNzA2NDE_a2e2db64-6552-4ee0-8430-695c5926786b"
      unitRef="usd">-16000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i5ee47d851f3042aaaf707d3b82004294_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfNS0xNi0xLTEtNzA2NDE_074b3406-f636-4f55-ad79-0cda8c4fb39a"
      unitRef="usd">-16000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i5ee47d851f3042aaaf707d3b82004294_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfNS0xNi0xLTEtNzA2NDE_380ef97d-7aa9-49ab-be61-a110d29aa8d9"
      unitRef="usd">-16000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="i7b181e472b094adbad522e89a97c3965_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfNi0xNC0xLTEtNzA2NDE_00e294bd-11f5-42a7-8c94-b5355b2b3d4c"
      unitRef="usd">-12822000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i7b181e472b094adbad522e89a97c3965_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfNi0xNC0xLTEtNzA2NDE_c02ba51e-dac8-471d-9a8f-c15ce6cda549"
      unitRef="usd">-12822000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5ee47d851f3042aaaf707d3b82004294_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfNi0xNi0xLTEtNzA2NDE_cb9dc1e5-2329-436b-8c1f-e59bb80d669a"
      unitRef="usd">-12822000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5ee47d851f3042aaaf707d3b82004294_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfNi0xNi0xLTEtNzA2NDE_f4a4e2f1-1946-4c33-8206-3d5f9e8b0594"
      unitRef="usd">-12822000</us-gaap:NetIncomeLoss>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i94b26e0dbca84b9b8524e15573d9bf33_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMTEtMS0xLTEtNzA2NDE_0744c57f-6780-4d1d-9169-c53cc6ca3c62"
      unitRef="shares">25402000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i94b26e0dbca84b9b8524e15573d9bf33_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMTEtMy0xLTEtNzA2NDE_93052095-76b5-446d-9502-3201e3345963"
      unitRef="usd">243854000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="iac576b608667443aad04c57beda563ac_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMTEtNi0xLTEtNzA2NDE_1f3a2704-8e64-4db4-be11-3b36bca7b458"
      unitRef="shares">5217000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="iac576b608667443aad04c57beda563ac_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMTEtOC0xLTEtNzA2NDE_2242fa93-6a2d-4733-8530-dd931406816d"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9bc468ed15de4a9d97e08aa2fbe09c34_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMTEtMTAtMS0xLTcwNjQx_2cd069bd-ead1-4632-ae60-5cc7a59fc1d2"
      unitRef="usd">20663000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ied0b777dba264312b4d74af5c79a0cb3_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMTEtMTItMS0xLTcwNjQx_1a601ea7-60e8-42e7-9556-4987b51bc04c"
      unitRef="usd">-30000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6966f0a91417487ba500b6d3df3fcc46_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMTEtMTQtMS0xLTcwNjQx_ab91de7c-b82f-40f5-a808-0c54327044f3"
      unitRef="usd">-214490000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i94b26e0dbca84b9b8524e15573d9bf33_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMTEtMTYtMS0xLTcwNjQx_504dfb3e-032f-4417-b6aa-ef6748295a86"
      unitRef="usd">-193857000</us-gaap:StockholdersEquity>
    <prct:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMTItMS0xLTEtNzA5ODQ_b9424985-08d2-4526-9b7d-77a4257c26bc"
      unitRef="shares">4448000</prct:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues
      contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMTItMy0xLTEtNzA5ODQ_ea75dcb9-f852-4c15-8f5e-ba60dfd77fea"
      unitRef="usd">84710000</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i8722cf471d0a4e458baade237a5960c6_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMTItNi0xLTEtNzA2NDE_5b095172-fe01-4c02-abb7-5c9edbc2efae"
      unitRef="shares">575000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i727054a48db344dc84054f19179656ea_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMTItMTAtMS0xLTcwNjQx_237b9a17-de09-4861-aa9f-2e0ad4235267"
      unitRef="usd">1415000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMTItMTYtMS0xLTcwNjQx_de612158-558c-4f50-928e-c45c904d21a2"
      unitRef="usd">1415000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition
      contextRef="i727054a48db344dc84054f19179656ea_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMTMtMTAtMS0xLTcwNjQx_b027704f-6376-49ff-b632-792f91eec4b5"
      unitRef="usd">725000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition
      contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMTMtMTYtMS0xLTcwNjQx_260c4ac5-bae0-4733-afbd-d00b416503a0"
      unitRef="usd">725000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i38e5e80513f848e596aad02407f696f7_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMTQtMTItMS0xLTcwNjQx_ad2e211d-885f-474d-86e4-05efba42aa1f"
      unitRef="usd">-9000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMTQtMTYtMS0xLTcwNjQx_4405eb56-f77f-4660-8f93-f6c1eb653aff"
      unitRef="usd">-9000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="ia737ca5e401d4e1898b0e48e1bb51d05_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMTUtMTQtMS0xLTcwNjQx_04719ff5-8d96-4472-9f1d-39a375799bc5"
      unitRef="usd">-14580000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMTUtMTYtMS0xLTcwNjQx_c1b7be8a-8d8b-4340-8a6f-600edec4d3e5"
      unitRef="usd">-14580000</us-gaap:NetIncomeLoss>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i0a06654ca8fc49a0aaed81f85663e69f_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMTYtMS0xLTEtNzA2NDE_9ef395d3-e3b2-4325-a8e1-ac5689d83823"
      unitRef="shares">29850000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i0a06654ca8fc49a0aaed81f85663e69f_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMTYtMy0xLTEtNzA2NDE_d8f5a1b8-e2dc-4a20-a2dd-cc6fb52c7459"
      unitRef="usd">328564000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="ic2228949c5a34355af819610f5c3e6c7_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMTYtNi0xLTEtNzA2NDE_96eae6a0-4368-42fd-989e-b582f89c6dbd"
      unitRef="shares">5792000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ic2228949c5a34355af819610f5c3e6c7_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMTYtOC0xLTEtNzA2NDE_85c87891-015c-4a03-ac78-2df9e9f9bdcd"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i67e7f282b71d4074a19bfe3304779fce_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMTYtMTAtMS0xLTcwNjQx_98a215f4-bfc9-4960-b25c-3e21c80faf75"
      unitRef="usd">22803000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9dfc04e8f5654c70a7bd05c9b50882c4_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMTYtMTItMS0xLTcwNjQx_c6634834-7f92-4311-bde4-3b7724777da5"
      unitRef="usd">-39000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8591f6f61272452cb59c7b8fd943a9f0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMTYtMTQtMS0xLTcwNjQx_e0f28684-0629-4946-b49c-3eba5cb4fd23"
      unitRef="usd">-229070000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0a06654ca8fc49a0aaed81f85663e69f_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yNS9mcmFnOjk0ZjM5NGQ5NjdjMzQyZWJhOGZlYTUxZmFjZjZmNmU1L3RhYmxlOmNhZTdiYjgyODkxOTQ1Mzc4MWZiYjQwYWU2MmNiODU2L3RhYmxlcmFuZ2U6Y2FlN2JiODI4OTE5NDUzNzgxZmJiNDBhZTYyY2I4NTZfMTYtMTYtMS0xLTcwNjQx_f5f67fa2-ecca-4306-af46-bfcc4390e6fa"
      unitRef="usd">-206306000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfNC0xLTEtMS03MDI2NQ_e3fa9342-9e50-45b8-b617-4e0b4dbe40a8"
      unitRef="usd">-36369000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfNC0zLTEtMS03MDI2NQ_8b25b6da-f3a8-4d4a-b7b6-94097822d5d5"
      unitRef="usd">-27402000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfNi0xLTEtMS03MDI2NQ_95c39d9c-d262-4717-bb83-befdb997267d"
      unitRef="usd">1475000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfNi0zLTEtMS03MDI2NQ_f8927ca8-ebf4-42e6-b332-b65faa6a8594"
      unitRef="usd">1765000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfNy0xLTEtMS03MDI2NQ_d246b2d8-fb26-4086-bd19-18f59723b69b"
      unitRef="usd">4228000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfNy0zLTEtMS03MDI2NQ_6c5426f3-2bb1-4a42-a588-29c7e6e2fb5d"
      unitRef="usd">1375000</us-gaap:ShareBasedCompensation>
    <prct:FairValueAdjustmentOfWarrantsAndGainLossOnDerivativeInstrumentsNetPretax
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfOC0xLTEtMS03MDI2NQ_360cdad2-941d-4d1e-93f4-770cb25cc4bb"
      unitRef="usd">74000</prct:FairValueAdjustmentOfWarrantsAndGainLossOnDerivativeInstrumentsNetPretax>
    <prct:FairValueAdjustmentOfWarrantsAndGainLossOnDerivativeInstrumentsNetPretax
      contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfOC0zLTEtMS03MDI2NQ_d81b514c-c54a-4044-bf83-c07e80855417"
      unitRef="usd">-43000</prct:FairValueAdjustmentOfWarrantsAndGainLossOnDerivativeInstrumentsNetPretax>
    <prct:NonCashLeaseAccretionExpense
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfOS0xLTEtMS03MDI2NQ_2743975e-73bc-4ce5-9097-ef9d38a5b415"
      unitRef="usd">193000</prct:NonCashLeaseAccretionExpense>
    <prct:NonCashLeaseAccretionExpense
      contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfOS0zLTEtMS03MDI2NQ_7af64c14-165d-4b6f-915f-6dc059f3b0b7"
      unitRef="usd">158000</prct:NonCashLeaseAccretionExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMTQtMS0xLTEtNzAyNjU_a1894560-d55b-4c60-8ba9-ec8d75679a89"
      unitRef="usd">6430000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMTQtMy0xLTEtNzAyNjU_fc98d0fc-ee1a-409a-a7e2-2656261f35e6"
      unitRef="usd">3591000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMTUtMS0xLTEtNzAyNjU_414d3831-1899-400e-80e8-e8ea867acce9"
      unitRef="usd">684000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMTUtMy0xLTEtNzAyNjU_56d1ab28-3695-429a-8c82-e6d9e71c1165"
      unitRef="usd">2761000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMTYtMS0xLTEtNzAyNjU_328b3274-47b4-4ae4-9237-7c2901f2181e"
      unitRef="usd">-471000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMTYtMy0xLTEtNzAyNjU_f10150ef-89fd-44c0-9391-5001c80e84af"
      unitRef="usd">1412000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMTctMS0xLTEtNzM3MzI_b933b67c-aba9-40f3-8201-36c4318b64cd"
      unitRef="usd">302000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMTctMy0xLTEtNzM3MjY_37315116-39c8-4615-a3a5-6e1f36301add"
      unitRef="usd">0</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMTctMS0xLTEtNzAyNjU_03ff3de6-2ca4-419d-b2c8-a2803c9818b0"
      unitRef="usd">947000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMTctMy0xLTEtNzAyNjU_adafcf09-0ea5-47f8-a93e-3b30f9cc67cd"
      unitRef="usd">2120000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedSalaries
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMTgtMS0xLTEtNzAyNjU_e734e683-8079-4d15-bd0d-5a52702b93a7"
      unitRef="usd">431000</us-gaap:IncreaseDecreaseInAccruedSalaries>
    <us-gaap:IncreaseDecreaseInAccruedSalaries
      contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMTgtMy0xLTEtNzAyNjU_baf0d167-3172-4d2d-87cf-f6f0ede10cdf"
      unitRef="usd">-653000</us-gaap:IncreaseDecreaseInAccruedSalaries>
    <us-gaap:IncreaseDecreaseInInterestPayableNet
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMTktMS0xLTEtNzAyNjU_84829479-3748-4cf9-8e4e-096873f7a1d5"
      unitRef="usd">503000</us-gaap:IncreaseDecreaseInInterestPayableNet>
    <us-gaap:IncreaseDecreaseInInterestPayableNet
      contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMTktMy0xLTEtNzAyNjU_96a64f4a-2cb2-4412-8123-a5411b16935d"
      unitRef="usd">532000</us-gaap:IncreaseDecreaseInInterestPayableNet>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMjAtMS0xLTEtNzAyNjU_3b991b17-734c-401f-96ac-938c08fe447e"
      unitRef="usd">838000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMjAtMy0xLTEtNzAyNjU_cba222ce-efa2-4036-8c22-119b54749acd"
      unitRef="usd">431000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMjItMS0xLTEtNzAyNjU_56fe7261-e65c-4079-a626-afbdf57a9ceb"
      unitRef="usd">-346000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMjItMy0xLTEtNzAyNjU_0892fc03-ab66-403d-b655-3031230451f0"
      unitRef="usd">1690000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMjMtMS0xLTEtNzAyNjU_a9cd7df8-5893-4410-9430-0a2a5268b314"
      unitRef="usd">-35357000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMjMtMy0xLTEtNzAyNjU_b3fb231a-959e-4200-8547-05b234c88c15"
      unitRef="usd">-28107000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMjgtMS0xLTEtNzAyNjU_4c36f5e3-7a59-4a6d-bcd6-673b1c1ef193"
      unitRef="usd">273000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMjgtMy0xLTEtNzAyNjU_9de83458-1944-4169-bac7-bbe9207ad1ad"
      unitRef="usd">149000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMjktMS0xLTEtNzAyNjU_58d77fb4-0b94-4fd4-99ca-c8d9c489784e"
      unitRef="usd">-273000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMjktMy0xLTEtNzAyNjU_38a1cc63-cd8a-4eed-b053-d1fe6bc90450"
      unitRef="usd">-149000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMzItMS0xLTEtNzQ5ODU_fff480c6-56a8-4072-854b-b1ae434da25c"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
    <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
      contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMzEtMy0xLTEtNzM3MDk_0f027edf-5290-4a5c-a77e-6b068c7e8ecc"
      unitRef="usd">84710000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMzMtMS0xLTEtNzQ4ODc_96a8d5b0-54bc-4641-bdf3-d363e97dbd6c"
      unitRef="usd">1289000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMzMtMy0xLTEtNzQ4ODA_6b16f21c-eb06-4634-89a3-d6d891aba926"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMzEtMS0xLTEtNzAyNjU_e915e2cf-986c-4f33-aca2-f9cfebee09b6"
      unitRef="usd">2864000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMzEtMy0xLTEtNzAyNjU_bb1480f9-b5b9-4aa4-9381-a600af77e938"
      unitRef="usd">2640000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMzctMS0xLTEtNzAyNjU_df6ddb4b-1d37-404e-a37a-4d5b1c7e69b8"
      unitRef="usd">4153000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMzctMy0xLTEtNzAyNjU_42e02fbc-6a17-41df-98c7-deb100b59ff8"
      unitRef="usd">87350000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMzgtMS0xLTEtNzAyNjU_e366cd3a-39b2-4bf8-98ac-3863300c85e9"
      unitRef="usd">-31477000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfMzgtMy0xLTEtNzAyNjU_a89bd3af-3040-4877-b94b-031eac1172d1"
      unitRef="usd">59094000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfNDAtMS0xLTEtNzAyNjU_3ebfe7f7-034a-4702-8a34-e9dfc5624df2"
      unitRef="usd">305097000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="icbfd320e5dd848119b7bdb3871172b7a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfNDAtMy0xLTEtNzAyNjU_dd4fb9d9-7e68-40f3-914b-08f167bdefdc"
      unitRef="usd">100907000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfNDEtMS0xLTEtNzAyNjU_0d866545-3688-4cb2-a2c7-5049f54dc13f"
      unitRef="usd">273620000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i0a06654ca8fc49a0aaed81f85663e69f_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfNDEtMy0xLTEtNzAyNjU_949882b0-28b7-4f6c-9f47-6decd2acf400"
      unitRef="usd">160001000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfNDMtMS0xLTEtNzAyNjU_5599f259-af1e-47b1-88f9-c617296f724d"
      unitRef="usd">269806000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i0a06654ca8fc49a0aaed81f85663e69f_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfNDMtMy0xLTEtNzAyNjU_8b61e354-8e4c-439b-abfe-35c02f1d8388"
      unitRef="usd">159224000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfNDQtMS0xLTEtNzAyNjU_5f91fb71-3b44-496b-a44e-f42c8a311b84"
      unitRef="usd">3814000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="i0a06654ca8fc49a0aaed81f85663e69f_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfNDQtMy0xLTEtNzAyNjU_9aeebbb9-6f80-4811-b14d-d87391f6116f"
      unitRef="usd">777000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfNDUtMS0xLTEtNzAyNjU_339a16b3-0549-40ac-b87d-98aed89669e9"
      unitRef="usd">273620000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i0a06654ca8fc49a0aaed81f85663e69f_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfNDUtMy0xLTEtNzAyNjU_f679b267-d71e-41d5-a7d3-b2c1eb934cf2"
      unitRef="usd">160001000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfNDctMS0xLTEtNzAyNjU_b1649e05-ff30-4fbf-b019-d2b77cd0e52c"
      unitRef="usd">2369000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfNDctMy0xLTEtNzAyNjU_0ed3fe72-10ca-4eca-8f68-e0722cb3401d"
      unitRef="usd">2369000</us-gaap:InterestPaidNet>
    <prct:TransferFromInventoryToPropertyAndEquipmentNet
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfNTAtMS0xLTEtNzAyNjU_57baead7-e1c1-402f-a573-3edf007d031a"
      unitRef="usd">53000</prct:TransferFromInventoryToPropertyAndEquipmentNet>
    <prct:TransferFromInventoryToPropertyAndEquipmentNet
      contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfNTAtMy0xLTEtNzAyNjU_89480da0-f5c8-49f0-b25e-5f286c5649da"
      unitRef="usd">-439000</prct:TransferFromInventoryToPropertyAndEquipmentNet>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfNTEtMS0xLTEtNzAyNjU_8ec3f19a-1290-4c37-98e2-29ed68dd1b1c"
      unitRef="usd">566000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfNTEtMy0xLTEtNzAyNjU_242b64e9-83d2-4fa4-9b1d-8a57805f14be"
      unitRef="usd">226000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <prct:DeferredOfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfNTItMS0xLTEtNzA4NTg_10b3114f-a9c9-4509-b707-61145a9f5aac"
      unitRef="usd">0</prct:DeferredOfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction>
    <prct:DeferredOfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfNTItMS0xLTEtNzA4NTg_21cf0104-6a60-487e-9f45-572b90e3290e"
      unitRef="usd">0</prct:DeferredOfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction>
    <prct:DeferredOfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction
      contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8yOC9mcmFnOmU3ODdlYjc2ZDk4YjRlOWJhYmVjMmI2ODAwODc5YTQ3L3RhYmxlOmM0MDUzOGQyY2VhNjQ3MzU5NjczNzJkNDYwNmM2NGE1L3RhYmxlcmFuZ2U6YzQwNTM4ZDJjZWE2NDczNTk2NzM3MmQ0NjA2YzY0YTVfNTItMy0xLTEtNzA4NTc_6767a99d-e2ce-4d93-8e45-c0d6f7e93d3a"
      unitRef="usd">856000</prct:DeferredOfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8zNC9mcmFnOjYzZDBjYjE3MDdhNjRjMTdiYWZlYTY1ZjEwYTZmZDEzL3RleHRyZWdpb246NjNkMGNiMTcwN2E2NGMxN2JhZmVhNjVmMTBhNmZkMTNfMjg3Mg_ba7234aa-3a88-49b2-8af9-311905dd7fc6">Organization &lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Description of Business &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:24.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;PROCEPT BioRobotics Corporation (the &#x201c;Company&#x201d;) is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. BPH is the most common prostate disease and impacts approximately 40 million men in the United States. The AquaBeam Robotic System employs a single-use disposable handpiece to deliver the Company&#x2019;s proprietary Aquablation therapy, which combines real-time, multi-dimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. The Company designed its AquaBeam Robotic System to enable consistent and reproducible BPH surgery outcomes. The Company received U.S. Food and Drug Administration clearance in December 2017 to market its AquaBeam Robotic System.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Liquidity&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:24.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2022, the Company had cash and cash equivalents of $269.8 million, and an accumulated deficit of $297.9 million. In September 2021, the Company completed its initial public offering (&#x201c;IPO&#x201d;) for net proceeds of approximately $172.4 million, after deducting underwriting discounts and commissions and offering expenses. Since its inception, the Company has financed its operations with a combination of debt and equity financing arrangements. The Company expects its cash and cash equivalents, revenue and available debt financing arrangements will be sufficient to fund its operations through at least the next twelve months from the issuance date of these financial statements. The Company has not achieved positive cash flow from operations to date and expects to continue incurring losses for the foreseeable future as it focuses on growing its business.&lt;/span&gt;&lt;/div&gt;The COVID-19 pandemic and the resulting economic downturn are affecting business conditions in the industry in which the Company operates. In response to the pandemic, many state and local governments in the United States issued orders that temporarily precluded elective medical procedures in order to conserve scarce health system resources. The Company has taken necessary precautions to safeguard its employees, patients, customers, and other stakeholders from the COVID-19 pandemic, while maintaining business continuity to support its patients, customers and employees. The timing, extent and continuation of any increase in procedures, and any corresponding increase in sales of the Company&#x2019;s products, and whether there could be a future decrease in the current level of procedures as a result of the COVID-19 pandemic or otherwise, remain uncertain and are subject to a variety of factors.</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8zNC9mcmFnOjYzZDBjYjE3MDdhNjRjMTdiYWZlYTY1ZjEwYTZmZDEzL3RleHRyZWdpb246NjNkMGNiMTcwN2E2NGMxN2JhZmVhNjVmMTBhNmZkMTNfMTE2OA_2143e067-60af-41d6-8f13-d839b7d15029"
      unitRef="usd">269800000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8zNC9mcmFnOjYzZDBjYjE3MDdhNjRjMTdiYWZlYTY1ZjEwYTZmZDEzL3RleHRyZWdpb246NjNkMGNiMTcwN2E2NGMxN2JhZmVhNjVmMTBhNmZkMTNfMTIyMw_002bd278-8b43-4557-a8ae-e02bef148a2b"
      unitRef="usd">-297900000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="i054a395a39bb4b049e783cf126b64e4c_D20210901-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8zNC9mcmFnOjYzZDBjYjE3MDdhNjRjMTdiYWZlYTY1ZjEwYTZmZDEzL3RleHRyZWdpb246NjNkMGNiMTcwN2E2NGMxN2JhZmVhNjVmMTBhNmZkMTNfMTM1OQ_5433d853-6eba-4d52-b193-c933dccaaaaa"
      unitRef="usd">172400000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8zNy9mcmFnOjk0ZWQ0ZDVhNWYzZDRhMmFiOTNjY2ViMzc3YzViZWE1L3RleHRyZWdpb246OTRlZDRkNWE1ZjNkNGEyYWI5M2NjZWIzNzdjNWJlYTVfMzc0ODY_b790bfe9-3d9f-4860-883d-a3182955df03">Summary of Significant Accounting Policies &lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:24.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements have been presented in accordance with U.S. generally accepted accounting principles (&#x201c;U.S. GAAP&#x201d;) and pursuant to the rules and regulations of the United States Securities and Exchange Commission (&#x201c;SEC&#x201d;). These condensed consolidated financial statements include the accounts of the Company and its consolidated subsidiaries. All intercompany balances and transactions have been eliminated upon consolidation. The Company operates as one reportable segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Unaudited Interim Financial Statements &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:24.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying balance sheet as of June&#160;30, 2022, the statements of operations and comprehensive loss for the three and six months ended June 30, 2022 and 2021, and cash flows for the six months ended June 30, 2022 and 2021, and the statements of redeemable convertible preferred stock and stockholders&#x2019; equity (deficit) as of June&#160;30, 2022 and 2021, are unaudited. The financial data and other information disclosed in these notes to the financial statements related to June&#160;30, 2022, and the three and six months ended June 30, 2022 and 2021, are also unaudited. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying balance sheet as of December&#160;31, 2021 have been derived from the audited consolidated financial statements included in the Company&#x2019;s Annual Report on Form 10-K (&#x201c;Annual Report&#x201d;) filed with the Securities and Exchange Commission.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited interim financial statements have been prepared on the same basis as the annual financial statements and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments, necessary to a fair statement of the Company&#x2019;s financial position as of June&#160;30, 2022, and the results of its operations and cash flows for the three and six months ended June 30, 2022 and 2021. The results for the three and six months ended June 30, 2022, are not necessarily indicative of results to be expected for the year ending December&#160;31, 2022, or for any other interim period or for any future year and should be read in conjunction with the annual consolidated financial statements included in the Company&#x2019;s Annual Report.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:24.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts and disclosures reported in the condensed consolidated financial statements. Management uses significant judgment when making estimates related to its common stock valuation in periods before the Company&#x2019;s IPO and related stock-based compensation expense, right-of-use lease asset, lease liability, and loan facility derivative liability, as well as certain accrued liabilities. Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results could differ from those estimates. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Initial Public Offering&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2021, the Company completed its IPO by issuing 6,556,000 shares of common stock, and the exercise of the underwriters option for 983,400 shares, at an offering price of $25.00 per share, for total net proceeds of approximately $172.4 million, after deducting underwriting discounts and commissions of $13.2 million and offering expenses of $2.9 million. Offering costs are capitalized, and consist of fees and expenses incurred in connection with the sale of common stock in its IPO, including legal, accounting, printing and other IPO-related costs. Upon completion of its IPO, these deferred offering costs were reclassified to stockholders&#x2019; equity and recorded against the proceeds from the offering. In addition, all 29,912,264 shares of its then-outstanding redeemable convertible preferred stock automatically converted into 29,912,264 shares of common stock and it reclassified $329.5 million of redeemable convertible preferred stock to additional paid-in capital on its condensed consolidated balance sheet.  Also, upon the completion of the Company&#x2019;s IPO, the Company&#x2019;s 62,454 redeemable convertible preferred stock warrants were exercised and the remaining unexercised warrants expired.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;JOBS Act Accounting Election&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is an emerging growth company, as defined in the JOBS Act. Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act until such time as those standards apply to private companies. The Company has elected to avail itself of this exemption and, therefore, for new or revised accounting standards applicable to public companies, the Company will be subject to an extended transition period until those standards would otherwise apply to private companies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:24.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) No. 2020-4, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (&#x201c;ASU 2020-4&#x201d;). The amendments in ASU 2020-4 provide optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. These amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. The expedients and exceptions provided do not apply to contract modifications made and hedging relationships entered into or evaluated after December 31, 2022, except for hedging relationships existing as of December 31, 2022, that an entity has elected certain optional expedients for and that are retained through the end of the hedging relationship. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These amendments are effective for all entities as of March 12, 2020 through December 31, 2022. The Company is currently evaluating the impact of the adoption of this ASU on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:24.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments&#x2014;Credit Losses (Topic 326) Measurement of Credit Losses on Financial Instruments (&#x201c;ASU 2016-13&#x201d;), which requires an entity to utilize a new impairment model known as the current expected credit loss (&#x201c;CECL&#x201d;) model to estimate its lifetime &#x201c;expected credit loss&#x201d; and record an allowance that, when deducted from the amortized cost basis of the financial assets and certain other instruments, including but not limited to available-for-sale debt securities. Credit losses relating to available-for-sale debt securities will be recorded through an allowance for credit losses rather than as a direct write-down to the security. ASU 2016-13 requires a cumulative effect adjustment to the balance sheet as of the beginning of the first reporting period in which the guidance is effective. In November 2019, the FASB issued ASU 2019-10, Financial Instruments&#x2014;Credit Losses (Topic 326), Derivatives and Hedging (Topic 815) and Leases (Topic 842): Effective Dates, which defers the effective date of ASU 2016-13 to fiscal years beginning after December 15, 2022 for all entities except SEC reporting companies that are not smaller reporting companies. ASU 2016-13 will be effective for the Company beginning January 1, 2023. The Company is currently evaluating the impact of the adoption of this ASU on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Significant Accounting Policies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Property and Equipment &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation and amortization for property and equipment are determined using the straight-line method over the estimated useful lives of the respective assets, generally three to five years. As of June 30, 2022, the Company no longer reclassifies inventory used at customer sites for evaluation purposes to property and equipment due to change in customary business practices.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended June 30, 2022, with the exception of the accounting policy above, there have been no material changes to the Company&#x2019;s significant accounting policies as described in its 2021 Annual Report or the first quarter 2022 Quarterly Report that have had a material impact on the Company&#x2019;s condensed consolidated financial statements and related notes.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8zNy9mcmFnOjk0ZWQ0ZDVhNWYzZDRhMmFiOTNjY2ViMzc3YzViZWE1L3RleHRyZWdpb246OTRlZDRkNWE1ZjNkNGEyYWI5M2NjZWIzNzdjNWJlYTVfMzc0ODI_bfaaa8db-4070-4348-8f01-8d08779d4752">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:24.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements have been presented in accordance with U.S. generally accepted accounting principles (&#x201c;U.S. GAAP&#x201d;) and pursuant to the rules and regulations of the United States Securities and Exchange Commission (&#x201c;SEC&#x201d;). These condensed consolidated financial statements include the accounts of the Company and its consolidated subsidiaries. All intercompany balances and transactions have been eliminated upon consolidation. The Company operates as one reportable segment.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8zNy9mcmFnOjk0ZWQ0ZDVhNWYzZDRhMmFiOTNjY2ViMzc3YzViZWE1L3RleHRyZWdpb246OTRlZDRkNWE1ZjNkNGEyYWI5M2NjZWIzNzdjNWJlYTVfMzc0OTQ_2ac0738f-5a3a-46fa-9961-1fa9a847899b">Use of Estimates The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts and disclosures reported in the condensed consolidated financial statements. Management uses significant judgment when making estimates related to its common stock valuation in periods before the Company&#x2019;s IPO and related stock-based compensation expense, right-of-use lease asset, lease liability, and loan facility derivative liability, as well as certain accrued liabilities. Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results could differ from those estimates.</us-gaap:UseOfEstimates>
    <us-gaap:StockholdersEquityPolicyTextBlock
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8zNy9mcmFnOjk0ZWQ0ZDVhNWYzZDRhMmFiOTNjY2ViMzc3YzViZWE1L3RleHRyZWdpb246OTRlZDRkNWE1ZjNkNGEyYWI5M2NjZWIzNzdjNWJlYTVfMzc1MDE_a69562dc-4d85-4716-b8f1-05a003c89612">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Initial Public Offering&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2021, the Company completed its IPO by issuing 6,556,000 shares of common stock, and the exercise of the underwriters option for 983,400 shares, at an offering price of $25.00 per share, for total net proceeds of approximately $172.4 million, after deducting underwriting discounts and commissions of $13.2 million and offering expenses of $2.9 million. Offering costs are capitalized, and consist of fees and expenses incurred in connection with the sale of common stock in its IPO, including legal, accounting, printing and other IPO-related costs. Upon completion of its IPO, these deferred offering costs were reclassified to stockholders&#x2019; equity and recorded against the proceeds from the offering. In addition, all 29,912,264 shares of its then-outstanding redeemable convertible preferred stock automatically converted into 29,912,264 shares of common stock and it reclassified $329.5 million of redeemable convertible preferred stock to additional paid-in capital on its condensed consolidated balance sheet.  Also, upon the completion of the Company&#x2019;s IPO, the Company&#x2019;s 62,454 redeemable convertible preferred stock warrants were exercised and the remaining unexercised warrants expired.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityPolicyTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="i054a395a39bb4b049e783cf126b64e4c_D20210901-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8zNy9mcmFnOjk0ZWQ0ZDVhNWYzZDRhMmFiOTNjY2ViMzc3YzViZWE1L3RleHRyZWdpb246OTRlZDRkNWE1ZjNkNGEyYWI5M2NjZWIzNzdjNWJlYTVfMTU3Mw_9e825ae8-1641-4b07-9ba6-0c80afaddb53"
      unitRef="shares">6556000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="i76637c8aeec140d2b14464b0d2e859c4_D20210901-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8zNy9mcmFnOjk0ZWQ0ZDVhNWYzZDRhMmFiOTNjY2ViMzc3YzViZWE1L3RleHRyZWdpb246OTRlZDRkNWE1ZjNkNGEyYWI5M2NjZWIzNzdjNWJlYTVfMTY0OA_05d1ccc8-61ea-4829-a509-e8fe46d7913b"
      unitRef="shares">983400</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="ie390a471379b4ab1bcab0d1678411d3a_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8zNy9mcmFnOjk0ZWQ0ZDVhNWYzZDRhMmFiOTNjY2ViMzc3YzViZWE1L3RleHRyZWdpb246OTRlZDRkNWE1ZjNkNGEyYWI5M2NjZWIzNzdjNWJlYTVfMTY4Mw_d8535c2f-a2b0-4136-a49f-ed3b0a719d53"
      unitRef="usdPerShare">25.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="i054a395a39bb4b049e783cf126b64e4c_D20210901-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8zNy9mcmFnOjk0ZWQ0ZDVhNWYzZDRhMmFiOTNjY2ViMzc3YzViZWE1L3RleHRyZWdpb246OTRlZDRkNWE1ZjNkNGEyYWI5M2NjZWIzNzdjNWJlYTVfMTczNw_5433d853-6eba-4d52-b193-c933dccaaaaa"
      unitRef="usd">172400000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:PaymentsForUnderwritingExpense
      contextRef="ic71fc6b5bde14a3db707e62f0fc13d18_D20210901-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8zNy9mcmFnOjk0ZWQ0ZDVhNWYzZDRhMmFiOTNjY2ViMzc3YzViZWE1L3RleHRyZWdpb246OTRlZDRkNWE1ZjNkNGEyYWI5M2NjZWIzNzdjNWJlYTVfMTc5OQ_14ec219d-5708-4b6b-a762-bbd04a668c43"
      unitRef="usd">13200000</us-gaap:PaymentsForUnderwritingExpense>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="ic71fc6b5bde14a3db707e62f0fc13d18_D20210901-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8zNy9mcmFnOjk0ZWQ0ZDVhNWYzZDRhMmFiOTNjY2ViMzc3YzViZWE1L3RleHRyZWdpb246OTRlZDRkNWE1ZjNkNGEyYWI5M2NjZWIzNzdjNWJlYTVfMTgyNw_ee73f0a1-ba57-4f1b-9892-d09dba1716f4"
      unitRef="usd">2900000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="ie390a471379b4ab1bcab0d1678411d3a_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8zNy9mcmFnOjk0ZWQ0ZDVhNWYzZDRhMmFiOTNjY2ViMzc3YzViZWE1L3RleHRyZWdpb246OTRlZDRkNWE1ZjNkNGEyYWI5M2NjZWIzNzdjNWJlYTVfMjE5OA_a7746372-f170-45be-ba83-74b088b7a390"
      unitRef="shares">29912264</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="ie390a471379b4ab1bcab0d1678411d3a_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8zNy9mcmFnOjk0ZWQ0ZDVhNWYzZDRhMmFiOTNjY2ViMzc3YzViZWE1L3RleHRyZWdpb246OTRlZDRkNWE1ZjNkNGEyYWI5M2NjZWIzNzdjNWJlYTVfMjE5OA_be4c7d6f-0ed7-40a7-8a6e-b14a791ecf67"
      unitRef="shares">29912264</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="ie390a471379b4ab1bcab0d1678411d3a_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8zNy9mcmFnOjk0ZWQ0ZDVhNWYzZDRhMmFiOTNjY2ViMzc3YzViZWE1L3RleHRyZWdpb246OTRlZDRkNWE1ZjNkNGEyYWI5M2NjZWIzNzdjNWJlYTVfMjMwMA_a7746372-f170-45be-ba83-74b088b7a390"
      unitRef="shares">29912264</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="ie390a471379b4ab1bcab0d1678411d3a_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8zNy9mcmFnOjk0ZWQ0ZDVhNWYzZDRhMmFiOTNjY2ViMzc3YzViZWE1L3RleHRyZWdpb246OTRlZDRkNWE1ZjNkNGEyYWI5M2NjZWIzNzdjNWJlYTVfMjMwMA_be4c7d6f-0ed7-40a7-8a6e-b14a791ecf67"
      unitRef="shares">29912264</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="ia464c84a1d294b1a90b1144fd82c6978_D20210901-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8zNy9mcmFnOjk0ZWQ0ZDVhNWYzZDRhMmFiOTNjY2ViMzc3YzViZWE1L3RleHRyZWdpb246OTRlZDRkNWE1ZjNkNGEyYWI5M2NjZWIzNzdjNWJlYTVfMjM0Ng_6a50ec45-4e8f-493a-89be-fa30606e809b"
      unitRef="usd">329500000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <prct:TemporaryEquityStockIssuedDuringPeriodSharesWarrantExercises
      contextRef="i50623cf37fe345b787005f8045a73bbf_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8zNy9mcmFnOjk0ZWQ0ZDVhNWYzZDRhMmFiOTNjY2ViMzc3YzViZWE1L3RleHRyZWdpb246OTRlZDRkNWE1ZjNkNGEyYWI5M2NjZWIzNzdjNWJlYTVfMjc0ODc3OTE0NDk4OA_5b21fa2c-a0d1-495a-810e-c40f9d7b8b1b"
      unitRef="shares">62454</prct:TemporaryEquityStockIssuedDuringPeriodSharesWarrantExercises>
    <prct:JobsActAccountingElectionPolicyTextBlock
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8zNy9mcmFnOjk0ZWQ0ZDVhNWYzZDRhMmFiOTNjY2ViMzc3YzViZWE1L3RleHRyZWdpb246OTRlZDRkNWE1ZjNkNGEyYWI5M2NjZWIzNzdjNWJlYTVfMjE5OTAyMzM2MjY4OA_990a9101-08f0-40df-82c3-236045a87508">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;JOBS Act Accounting Election&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is an emerging growth company, as defined in the JOBS Act. Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act until such time as those standards apply to private companies. The Company has elected to avail itself of this exemption and, therefore, for new or revised accounting standards applicable to public companies, the Company will be subject to an extended transition period until those standards would otherwise apply to private companies.&lt;/span&gt;&lt;/div&gt;</prct:JobsActAccountingElectionPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8zNy9mcmFnOjk0ZWQ0ZDVhNWYzZDRhMmFiOTNjY2ViMzc3YzViZWE1L3RleHRyZWdpb246OTRlZDRkNWE1ZjNkNGEyYWI5M2NjZWIzNzdjNWJlYTVfMzc1MDI_688f6fb9-ce01-4ca4-a874-17ac9a56facd">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:24.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) No. 2020-4, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (&#x201c;ASU 2020-4&#x201d;). The amendments in ASU 2020-4 provide optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. These amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. The expedients and exceptions provided do not apply to contract modifications made and hedging relationships entered into or evaluated after December 31, 2022, except for hedging relationships existing as of December 31, 2022, that an entity has elected certain optional expedients for and that are retained through the end of the hedging relationship. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These amendments are effective for all entities as of March 12, 2020 through December 31, 2022. The Company is currently evaluating the impact of the adoption of this ASU on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:24.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments&#x2014;Credit Losses (Topic 326) Measurement of Credit Losses on Financial Instruments (&#x201c;ASU 2016-13&#x201d;), which requires an entity to utilize a new impairment model known as the current expected credit loss (&#x201c;CECL&#x201d;) model to estimate its lifetime &#x201c;expected credit loss&#x201d; and record an allowance that, when deducted from the amortized cost basis of the financial assets and certain other instruments, including but not limited to available-for-sale debt securities. Credit losses relating to available-for-sale debt securities will be recorded through an allowance for credit losses rather than as a direct write-down to the security. ASU 2016-13 requires a cumulative effect adjustment to the balance sheet as of the beginning of the first reporting period in which the guidance is effective. In November 2019, the FASB issued ASU 2019-10, Financial Instruments&#x2014;Credit Losses (Topic 326), Derivatives and Hedging (Topic 815) and Leases (Topic 842): Effective Dates, which defers the effective date of ASU 2016-13 to fiscal years beginning after December 15, 2022 for all entities except SEC reporting companies that are not smaller reporting companies. ASU 2016-13 will be effective for the Company beginning January 1, 2023. The Company is currently evaluating the impact of the adoption of this ASU on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Significant Accounting Policies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Property and Equipment &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation and amortization for property and equipment are determined using the straight-line method over the estimated useful lives of the respective assets, generally three to five years. As of June 30, 2022, the Company no longer reclassifies inventory used at customer sites for evaluation purposes to property and equipment due to change in customary business practices.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended June 30, 2022, with the exception of the accounting policy above, there have been no material changes to the Company&#x2019;s significant accounting policies as described in its 2021 Annual Report or the first quarter 2022 Quarterly Report that have had a material impact on the Company&#x2019;s condensed consolidated financial statements and related notes.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV8zNy9mcmFnOjk0ZWQ0ZDVhNWYzZDRhMmFiOTNjY2ViMzc3YzViZWE1L3RleHRyZWdpb246OTRlZDRkNWE1ZjNkNGEyYWI5M2NjZWIzNzdjNWJlYTVfMzc0ODE_01abfb44-b275-4bd5-8f12-019810cba2b1"
      xsi:nil="true"/>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90ZXh0cmVnaW9uOjFmYTI3OTlkMjlmNzQ4NTViNjdlNzZlNzMwMTYyMDVhXzg3OTYwOTMwMjYxMTM_e0af470b-81bd-45a2-b0b3-af899f995f51">Fair Value Measurements&lt;div style="margin-bottom:9pt;text-indent:24.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of assets and liabilities measured at fair value on a recurring basis (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.194%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.248%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.865%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.865%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.865%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.869%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265,996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265,996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 10pt;text-indent:-9pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loan facility derivative liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.194%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.248%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.865%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.865%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.865%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.869%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;290,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;290,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;304,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;304,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 10pt;text-indent:-9pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loan facility derivative liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents consist primarily of money market funds and treasury securities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:24.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no transfers in and out of Level 3 during the three and six months ended June 30, 2022 and year ended December&#160;31, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the loan facility derivative liability was determined using a discounted cash flow calculation discounted at 10%. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:24.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth a summary of the changes in the estimated fair value of the Company&#x2019;s loan facility derivative liability, classified as Level 3 (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.750%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.392%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.392%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.392%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.794%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90ZXh0cmVnaW9uOjFmYTI3OTlkMjlmNzQ4NTViNjdlNzZlNzMwMTYyMDVhXzg3OTYwOTMwMjYxMTQ_c743ea38-767a-40a7-a6b1-0b3fa5e2aa53">&lt;div style="margin-bottom:9pt;text-indent:24.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of assets and liabilities measured at fair value on a recurring basis (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.194%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.248%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.865%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.865%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.865%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.869%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265,996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265,996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 10pt;text-indent:-9pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loan facility derivative liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.194%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.248%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.865%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.865%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.865%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.869%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;290,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;290,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;304,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;304,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 10pt;text-indent:-9pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loan facility derivative liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:Cash
      contextRef="i271be39716a24ae3a1220dde2c194490_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTo1YzFmNTE4ZTRlZDY0Y2MyOGFjOTAxMTAwOTJjMjM1Zi90YWJsZXJhbmdlOjVjMWY1MThlNGVkNjRjYzI4YWM5MDExMDA5MmMyMzVmXzQtMS0xLTEtNzEyMTc_7a81d56e-b26b-4b80-9e2c-e1d6520b53c3"
      unitRef="usd">3810000</us-gaap:Cash>
    <us-gaap:Cash
      contextRef="i0624c3f7a1a24f1cbf5381ed78fa8773_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTo1YzFmNTE4ZTRlZDY0Y2MyOGFjOTAxMTAwOTJjMjM1Zi90YWJsZXJhbmdlOjVjMWY1MThlNGVkNjRjYzI4YWM5MDExMDA5MmMyMzVmXzQtMy0xLTEtNzEyMTc_2adb6a2e-6936-4cdc-a421-1a1b96a445c9"
      unitRef="usd">0</us-gaap:Cash>
    <us-gaap:Cash
      contextRef="i28d56366abcb4c1ba6762562d89f11be_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTo1YzFmNTE4ZTRlZDY0Y2MyOGFjOTAxMTAwOTJjMjM1Zi90YWJsZXJhbmdlOjVjMWY1MThlNGVkNjRjYzI4YWM5MDExMDA5MmMyMzVmXzQtNS0xLTEtNzEyMTc_db2a1493-7493-4b52-9d42-3d4d551555e7"
      unitRef="usd">0</us-gaap:Cash>
    <us-gaap:Cash
      contextRef="i03e5fbb904174fc6a95ec0686a05e446_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTo1YzFmNTE4ZTRlZDY0Y2MyOGFjOTAxMTAwOTJjMjM1Zi90YWJsZXJhbmdlOjVjMWY1MThlNGVkNjRjYzI4YWM5MDExMDA5MmMyMzVmXzQtNy0xLTEtNzEyMTc_90ca7df3-63fb-4c4b-b410-8d4c3d881e93"
      unitRef="usd">3810000</us-gaap:Cash>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="i271be39716a24ae3a1220dde2c194490_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTo1YzFmNTE4ZTRlZDY0Y2MyOGFjOTAxMTAwOTJjMjM1Zi90YWJsZXJhbmdlOjVjMWY1MThlNGVkNjRjYzI4YWM5MDExMDA5MmMyMzVmXzUtMS0xLTEtNzEyMTc_ca268236-cf05-4aaf-98da-def5573707d5"
      unitRef="usd">265996000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="i0624c3f7a1a24f1cbf5381ed78fa8773_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTo1YzFmNTE4ZTRlZDY0Y2MyOGFjOTAxMTAwOTJjMjM1Zi90YWJsZXJhbmdlOjVjMWY1MThlNGVkNjRjYzI4YWM5MDExMDA5MmMyMzVmXzUtMy0xLTEtNzEyMTc_03aa4919-7468-49a3-b185-0a4c8e330ec5"
      unitRef="usd">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="i28d56366abcb4c1ba6762562d89f11be_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTo1YzFmNTE4ZTRlZDY0Y2MyOGFjOTAxMTAwOTJjMjM1Zi90YWJsZXJhbmdlOjVjMWY1MThlNGVkNjRjYzI4YWM5MDExMDA5MmMyMzVmXzUtNS0xLTEtNzEyMTc_9d8fc30f-213c-4c51-ac4e-b1b2fee846e1"
      unitRef="usd">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="i03e5fbb904174fc6a95ec0686a05e446_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTo1YzFmNTE4ZTRlZDY0Y2MyOGFjOTAxMTAwOTJjMjM1Zi90YWJsZXJhbmdlOjVjMWY1MThlNGVkNjRjYzI4YWM5MDExMDA5MmMyMzVmXzUtNy0xLTEtNzEyMTc_122d9278-4c4f-431f-b48f-1cc4b0a10035"
      unitRef="usd">265996000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i271be39716a24ae3a1220dde2c194490_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTo1YzFmNTE4ZTRlZDY0Y2MyOGFjOTAxMTAwOTJjMjM1Zi90YWJsZXJhbmdlOjVjMWY1MThlNGVkNjRjYzI4YWM5MDExMDA5MmMyMzVmXzYtMS0xLTEtNzEyMTc_61c0ed0f-7f7a-42e6-9908-1d55f268b939"
      unitRef="usd">269806000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i0624c3f7a1a24f1cbf5381ed78fa8773_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTo1YzFmNTE4ZTRlZDY0Y2MyOGFjOTAxMTAwOTJjMjM1Zi90YWJsZXJhbmdlOjVjMWY1MThlNGVkNjRjYzI4YWM5MDExMDA5MmMyMzVmXzYtMy0xLTEtNzEyMTc_16cd84e5-fd8e-4adf-93cf-a68e042b8fd1"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i28d56366abcb4c1ba6762562d89f11be_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTo1YzFmNTE4ZTRlZDY0Y2MyOGFjOTAxMTAwOTJjMjM1Zi90YWJsZXJhbmdlOjVjMWY1MThlNGVkNjRjYzI4YWM5MDExMDA5MmMyMzVmXzYtNS0xLTEtNzEyMTc_27dcf86f-00db-4e34-84b9-78cf6163557d"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i03e5fbb904174fc6a95ec0686a05e446_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTo1YzFmNTE4ZTRlZDY0Y2MyOGFjOTAxMTAwOTJjMjM1Zi90YWJsZXJhbmdlOjVjMWY1MThlNGVkNjRjYzI4YWM5MDExMDA5MmMyMzVmXzYtNy0xLTEtNzEyMTc_61a45146-d69e-4720-a115-fa13e22eb859"
      unitRef="usd">269806000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:DerivativeLiabilities
      contextRef="i271be39716a24ae3a1220dde2c194490_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTo1YzFmNTE4ZTRlZDY0Y2MyOGFjOTAxMTAwOTJjMjM1Zi90YWJsZXJhbmdlOjVjMWY1MThlNGVkNjRjYzI4YWM5MDExMDA5MmMyMzVmXzktMS0xLTEtNzEyMTc_89dce56c-2e58-4729-858a-3e4d889a95cc"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i0624c3f7a1a24f1cbf5381ed78fa8773_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTo1YzFmNTE4ZTRlZDY0Y2MyOGFjOTAxMTAwOTJjMjM1Zi90YWJsZXJhbmdlOjVjMWY1MThlNGVkNjRjYzI4YWM5MDExMDA5MmMyMzVmXzktMy0xLTEtNzEyMTc_16597bf5-445c-45c8-9a04-371062e7672e"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i28d56366abcb4c1ba6762562d89f11be_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTo1YzFmNTE4ZTRlZDY0Y2MyOGFjOTAxMTAwOTJjMjM1Zi90YWJsZXJhbmdlOjVjMWY1MThlNGVkNjRjYzI4YWM5MDExMDA5MmMyMzVmXzktNS0xLTEtNzEyMTc_edf87591-751b-4528-bbf0-3d9676c2a04c"
      unitRef="usd">1570000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i03e5fbb904174fc6a95ec0686a05e446_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTo1YzFmNTE4ZTRlZDY0Y2MyOGFjOTAxMTAwOTJjMjM1Zi90YWJsZXJhbmdlOjVjMWY1MThlNGVkNjRjYzI4YWM5MDExMDA5MmMyMzVmXzktNy0xLTEtNzEyMTc_824eb70d-4c91-48f2-8828-e6bf00a9b493"
      unitRef="usd">1570000</us-gaap:DerivativeLiabilities>
    <us-gaap:Cash
      contextRef="ib662e1ac7c4f4fc09ed63ee4ad3d6920_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTowNWRiMTkyMzEyMDA0NjNlYTAxNjQ2ZWVhMDlkMGI0OS90YWJsZXJhbmdlOjA1ZGIxOTIzMTIwMDQ2M2VhMDE2NDZlZWEwOWQwYjQ5XzQtMS0xLTEtNzIzNzE_4e483dc2-ca92-4b2a-9dc1-79b6c7a211b8"
      unitRef="usd">13621000</us-gaap:Cash>
    <us-gaap:Cash
      contextRef="i06c709bf479e43c389950311b1d0360b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTowNWRiMTkyMzEyMDA0NjNlYTAxNjQ2ZWVhMDlkMGI0OS90YWJsZXJhbmdlOjA1ZGIxOTIzMTIwMDQ2M2VhMDE2NDZlZWEwOWQwYjQ5XzQtMy0xLTEtNzIzNzE_25234404-99a3-48e4-a4fc-17682c873cd3"
      unitRef="usd">0</us-gaap:Cash>
    <us-gaap:Cash
      contextRef="i71decfbc977f40ac8eb9c51a9d97ccbe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTowNWRiMTkyMzEyMDA0NjNlYTAxNjQ2ZWVhMDlkMGI0OS90YWJsZXJhbmdlOjA1ZGIxOTIzMTIwMDQ2M2VhMDE2NDZlZWEwOWQwYjQ5XzQtNS0xLTEtNzIzNzE_63cce9cd-9cce-4544-91cf-3837a767a477"
      unitRef="usd">0</us-gaap:Cash>
    <us-gaap:Cash
      contextRef="idbcba339097743d39f83b2c7a95fa80c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTowNWRiMTkyMzEyMDA0NjNlYTAxNjQ2ZWVhMDlkMGI0OS90YWJsZXJhbmdlOjA1ZGIxOTIzMTIwMDQ2M2VhMDE2NDZlZWEwOWQwYjQ5XzQtNy0xLTEtNzIzNzE_38ae79e0-a369-403e-bfdf-5779cb391a91"
      unitRef="usd">13621000</us-gaap:Cash>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="ib662e1ac7c4f4fc09ed63ee4ad3d6920_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTowNWRiMTkyMzEyMDA0NjNlYTAxNjQ2ZWVhMDlkMGI0OS90YWJsZXJhbmdlOjA1ZGIxOTIzMTIwMDQ2M2VhMDE2NDZlZWEwOWQwYjQ5XzUtMS0xLTEtNzIzNzE_04c73706-c349-497d-a68b-b62251dc6ded"
      unitRef="usd">290699000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="i06c709bf479e43c389950311b1d0360b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTowNWRiMTkyMzEyMDA0NjNlYTAxNjQ2ZWVhMDlkMGI0OS90YWJsZXJhbmdlOjA1ZGIxOTIzMTIwMDQ2M2VhMDE2NDZlZWEwOWQwYjQ5XzUtMy0xLTEtNzIzNzE_b1551b9d-c71f-4a99-b991-2f9eb1be822b"
      unitRef="usd">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="i71decfbc977f40ac8eb9c51a9d97ccbe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTowNWRiMTkyMzEyMDA0NjNlYTAxNjQ2ZWVhMDlkMGI0OS90YWJsZXJhbmdlOjA1ZGIxOTIzMTIwMDQ2M2VhMDE2NDZlZWEwOWQwYjQ5XzUtNS0xLTEtNzIzNzE_0fbe7d98-5e0d-4533-b3fd-e86548549777"
      unitRef="usd">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="idbcba339097743d39f83b2c7a95fa80c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTowNWRiMTkyMzEyMDA0NjNlYTAxNjQ2ZWVhMDlkMGI0OS90YWJsZXJhbmdlOjA1ZGIxOTIzMTIwMDQ2M2VhMDE2NDZlZWEwOWQwYjQ5XzUtNy0xLTEtNzIzNzE_e78a57f6-9f51-4c77-a4fe-64b0d0058bfe"
      unitRef="usd">290699000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ib662e1ac7c4f4fc09ed63ee4ad3d6920_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTowNWRiMTkyMzEyMDA0NjNlYTAxNjQ2ZWVhMDlkMGI0OS90YWJsZXJhbmdlOjA1ZGIxOTIzMTIwMDQ2M2VhMDE2NDZlZWEwOWQwYjQ5XzYtMS0xLTEtNzIzNzE_bc7685a8-39e5-4667-b055-43c8e0772507"
      unitRef="usd">304320000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i06c709bf479e43c389950311b1d0360b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTowNWRiMTkyMzEyMDA0NjNlYTAxNjQ2ZWVhMDlkMGI0OS90YWJsZXJhbmdlOjA1ZGIxOTIzMTIwMDQ2M2VhMDE2NDZlZWEwOWQwYjQ5XzYtMy0xLTEtNzIzNzE_71aaf50a-a4bd-45ae-99b9-dc71b4dbd5d8"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i71decfbc977f40ac8eb9c51a9d97ccbe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTowNWRiMTkyMzEyMDA0NjNlYTAxNjQ2ZWVhMDlkMGI0OS90YWJsZXJhbmdlOjA1ZGIxOTIzMTIwMDQ2M2VhMDE2NDZlZWEwOWQwYjQ5XzYtNS0xLTEtNzIzNzE_90777a4a-7bf9-4cb9-9c84-9d97ba4bbf50"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="idbcba339097743d39f83b2c7a95fa80c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTowNWRiMTkyMzEyMDA0NjNlYTAxNjQ2ZWVhMDlkMGI0OS90YWJsZXJhbmdlOjA1ZGIxOTIzMTIwMDQ2M2VhMDE2NDZlZWEwOWQwYjQ5XzYtNy0xLTEtNzIzNzE_9ea27873-7671-4160-ac56-32d3d9d7c19a"
      unitRef="usd">304320000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:DerivativeLiabilities
      contextRef="ib662e1ac7c4f4fc09ed63ee4ad3d6920_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTowNWRiMTkyMzEyMDA0NjNlYTAxNjQ2ZWVhMDlkMGI0OS90YWJsZXJhbmdlOjA1ZGIxOTIzMTIwMDQ2M2VhMDE2NDZlZWEwOWQwYjQ5XzktMS0xLTEtNzIzNzU_c685fcff-44b8-49bf-9e60-ee4654eb498c"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i06c709bf479e43c389950311b1d0360b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTowNWRiMTkyMzEyMDA0NjNlYTAxNjQ2ZWVhMDlkMGI0OS90YWJsZXJhbmdlOjA1ZGIxOTIzMTIwMDQ2M2VhMDE2NDZlZWEwOWQwYjQ5XzktMy0xLTEtNzIzNzU_0b35ff25-be43-441a-a804-a35389ffb2bc"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i71decfbc977f40ac8eb9c51a9d97ccbe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTowNWRiMTkyMzEyMDA0NjNlYTAxNjQ2ZWVhMDlkMGI0OS90YWJsZXJhbmdlOjA1ZGIxOTIzMTIwMDQ2M2VhMDE2NDZlZWEwOWQwYjQ5XzktNS0xLTEtNzIzNzU_f806dc1d-06dd-4966-82fa-46124bce5530"
      unitRef="usd">1496000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="idbcba339097743d39f83b2c7a95fa80c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTowNWRiMTkyMzEyMDA0NjNlYTAxNjQ2ZWVhMDlkMGI0OS90YWJsZXJhbmdlOjA1ZGIxOTIzMTIwMDQ2M2VhMDE2NDZlZWEwOWQwYjQ5XzktNy0xLTEtNzIzNzU_643dfae6-be92-46b6-be3b-c274c2983525"
      unitRef="usd">1496000</us-gaap:DerivativeLiabilities>
    <us-gaap:LongTermDebtMeasurementInput
      contextRef="i2ec894abcc4c490b980330e1351b89bd_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90ZXh0cmVnaW9uOjFmYTI3OTlkMjlmNzQ4NTViNjdlNzZlNzMwMTYyMDVhXzI3NDg3NzkwNzE1MTU_0b7a0e65-d0a7-40df-b6be-5ac1530904e8"
      unitRef="number">0.10</us-gaap:LongTermDebtMeasurementInput>
    <us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90ZXh0cmVnaW9uOjFmYTI3OTlkMjlmNzQ4NTViNjdlNzZlNzMwMTYyMDVhXzg3OTYwOTMwMjYxMTU_6fc69fa5-8731-42ab-b18d-73e8c2ebdb29">&lt;div style="margin-bottom:9pt;text-indent:24.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth a summary of the changes in the estimated fair value of the Company&#x2019;s loan facility derivative liability, classified as Level 3 (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.750%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.392%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.392%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.392%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.794%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="i9261f6f74d684c688cfaeac2f36b5a12_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTpkYTZhODdhM2Q4ODM0NWEyOTMyM2ZlNTU2NzI2MGU0Yi90YWJsZXJhbmdlOmRhNmE4N2EzZDg4MzQ1YTI5MzIzZmU1NTY3MjYwZTRiXzMtMS0xLTEtNzEyMjc_dcaafdb3-34b8-4bac-84f5-902ab1d65ad7"
      unitRef="usd">1533000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="id9d53416940548b886aec19be0a44a4e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTpkYTZhODdhM2Q4ODM0NWEyOTMyM2ZlNTU2NzI2MGU0Yi90YWJsZXJhbmdlOmRhNmE4N2EzZDg4MzQ1YTI5MzIzZmU1NTY3MjYwZTRiXzMtMy0xLTEtNzEyMjc_78650459-7d77-4212-94c4-895f6a1c335a"
      unitRef="usd">1825000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="idbcba339097743d39f83b2c7a95fa80c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTpkYTZhODdhM2Q4ODM0NWEyOTMyM2ZlNTU2NzI2MGU0Yi90YWJsZXJhbmdlOmRhNmE4N2EzZDg4MzQ1YTI5MzIzZmU1NTY3MjYwZTRiXzMtNS0xLTEtNzIzMTU_5fa6ce1d-473d-4c2e-9031-3c8469f7287a"
      unitRef="usd">1496000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="ic1c2312756cd4f6e99858bfda9b5b1dc_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTpkYTZhODdhM2Q4ODM0NWEyOTMyM2ZlNTU2NzI2MGU0Yi90YWJsZXJhbmdlOmRhNmE4N2EzZDg4MzQ1YTI5MzIzZmU1NTY3MjYwZTRiXzMtNy0xLTEtNzIzMTU_83f4cbc2-e3b4-45c9-a3cb-bd6329118a51"
      unitRef="usd">1782000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues
      contextRef="id4a5962583214d618c2bce6e91e2bc49_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTpkYTZhODdhM2Q4ODM0NWEyOTMyM2ZlNTU2NzI2MGU0Yi90YWJsZXJhbmdlOmRhNmE4N2EzZDg4MzQ1YTI5MzIzZmU1NTY3MjYwZTRiXzQtMS0xLTEtNzEyMjc_5cc8d423-34ad-4516-a8c2-4ea1f4a6ce33"
      unitRef="usd">0</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues
      contextRef="i49866073e1f44cf1b38b071917bc10c4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTpkYTZhODdhM2Q4ODM0NWEyOTMyM2ZlNTU2NzI2MGU0Yi90YWJsZXJhbmdlOmRhNmE4N2EzZDg4MzQ1YTI5MzIzZmU1NTY3MjYwZTRiXzQtMy0xLTEtNzEyMjc_ba29d121-f5cc-4127-a60f-33c3ececd268"
      unitRef="usd">0</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues
      contextRef="i0b5a6a38e4a04bd580825d3c7c3c7b97_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTpkYTZhODdhM2Q4ODM0NWEyOTMyM2ZlNTU2NzI2MGU0Yi90YWJsZXJhbmdlOmRhNmE4N2EzZDg4MzQ1YTI5MzIzZmU1NTY3MjYwZTRiXzQtNS0xLTEtNzIzMTU_4609fc61-8346-47d4-991f-d62a70bb3072"
      unitRef="usd">0</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues
      contextRef="i56ff5a0cd9ad480ca54975bb361ad2e2_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTpkYTZhODdhM2Q4ODM0NWEyOTMyM2ZlNTU2NzI2MGU0Yi90YWJsZXJhbmdlOmRhNmE4N2EzZDg4MzQ1YTI5MzIzZmU1NTY3MjYwZTRiXzQtNy0xLTEtNzIzMTU_d44abcaa-3603-4df3-87f8-c1d2533b69af"
      unitRef="usd">0</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
      contextRef="id4a5962583214d618c2bce6e91e2bc49_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTpkYTZhODdhM2Q4ODM0NWEyOTMyM2ZlNTU2NzI2MGU0Yi90YWJsZXJhbmdlOmRhNmE4N2EzZDg4MzQ1YTI5MzIzZmU1NTY3MjYwZTRiXzUtMS0xLTEtNzEyMjc_d7195ddf-7463-4f46-8c41-8f85f7ae2e4c"
      unitRef="usd">-37000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
      contextRef="i49866073e1f44cf1b38b071917bc10c4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTpkYTZhODdhM2Q4ODM0NWEyOTMyM2ZlNTU2NzI2MGU0Yi90YWJsZXJhbmdlOmRhNmE4N2EzZDg4MzQ1YTI5MzIzZmU1NTY3MjYwZTRiXzUtMy0xLTEtNzEyMjc_cbf28e71-e17a-4f17-aa18-986d641d7c42"
      unitRef="usd">38000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
      contextRef="i0b5a6a38e4a04bd580825d3c7c3c7b97_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTpkYTZhODdhM2Q4ODM0NWEyOTMyM2ZlNTU2NzI2MGU0Yi90YWJsZXJhbmdlOmRhNmE4N2EzZDg4MzQ1YTI5MzIzZmU1NTY3MjYwZTRiXzUtNS0xLTEtNzIzMTU_93acfead-d1e5-4f79-9606-620f2619e8ef"
      unitRef="usd">-74000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
      contextRef="i56ff5a0cd9ad480ca54975bb361ad2e2_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTpkYTZhODdhM2Q4ODM0NWEyOTMyM2ZlNTU2NzI2MGU0Yi90YWJsZXJhbmdlOmRhNmE4N2EzZDg4MzQ1YTI5MzIzZmU1NTY3MjYwZTRiXzUtNy0xLTEtNzIzMTU_1b0400b0-226a-443d-a9e0-81ba28a65568"
      unitRef="usd">-5000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="i03e5fbb904174fc6a95ec0686a05e446_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTpkYTZhODdhM2Q4ODM0NWEyOTMyM2ZlNTU2NzI2MGU0Yi90YWJsZXJhbmdlOmRhNmE4N2EzZDg4MzQ1YTI5MzIzZmU1NTY3MjYwZTRiXzctMS0xLTEtNzEyMjc_ed306ab1-1b27-4056-82b6-f352d9db6ce5"
      unitRef="usd">1570000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="ida5e5f1bb1d542c9b2cd7ccf481a8af2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTpkYTZhODdhM2Q4ODM0NWEyOTMyM2ZlNTU2NzI2MGU0Yi90YWJsZXJhbmdlOmRhNmE4N2EzZDg4MzQ1YTI5MzIzZmU1NTY3MjYwZTRiXzctMy0xLTEtNzEyMjc_7295ab86-b9b1-419c-9ee1-43fadf7fbe69"
      unitRef="usd">1787000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="i03e5fbb904174fc6a95ec0686a05e446_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTpkYTZhODdhM2Q4ODM0NWEyOTMyM2ZlNTU2NzI2MGU0Yi90YWJsZXJhbmdlOmRhNmE4N2EzZDg4MzQ1YTI5MzIzZmU1NTY3MjYwZTRiXzctNS0xLTEtNzIzMTU_d6958737-b6cf-4b05-a5e9-cfeb0ac00f2c"
      unitRef="usd">1570000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="ida5e5f1bb1d542c9b2cd7ccf481a8af2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NTIvZnJhZzoxZmEyNzk5ZDI5Zjc0ODU1YjY3ZTc2ZTczMDE2MjA1YS90YWJsZTpkYTZhODdhM2Q4ODM0NWEyOTMyM2ZlNTU2NzI2MGU0Yi90YWJsZXJhbmdlOmRhNmE4N2EzZDg4MzQ1YTI5MzIzZmU1NTY3MjYwZTRiXzctNy0xLTEtNzIzMTU_6cbdb289-2613-49b9-bf43-394ba40e0436"
      unitRef="usd">1787000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80MC9mcmFnOjZjNTZlY2ZjNDFiZDQ1MTdhMzU0ZDA4NjhiZjIwMmY4L3RleHRyZWdpb246NmM1NmVjZmM0MWJkNDUxN2EzNTRkMDg2OGJmMjAyZjhfNDI0_55959934-567a-48bc-aa11-0ba72fd26509">Inventory&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory consists of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventory&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80MC9mcmFnOjZjNTZlY2ZjNDFiZDQ1MTdhMzU0ZDA4NjhiZjIwMmY4L3RleHRyZWdpb246NmM1NmVjZmM0MWJkNDUxN2EzNTRkMDg2OGJmMjAyZjhfNDI1_c7d231eb-a392-4ce9-827e-cf013b35a65e">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory consists of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventory&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterials
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80MC9mcmFnOjZjNTZlY2ZjNDFiZDQ1MTdhMzU0ZDA4NjhiZjIwMmY4L3RhYmxlOjJlNWJkMWM1ZWY0ODQ3Mjk5MWU1MGVhNzBlZjg1ZGVjL3RhYmxlcmFuZ2U6MmU1YmQxYzVlZjQ4NDcyOTkxZTUwZWE3MGVmODVkZWNfMy0xLTEtMS03MDI2NQ_a0949e74-f3dc-436d-8a89-b529622a385f"
      unitRef="usd">5329000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryRawMaterials
      contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80MC9mcmFnOjZjNTZlY2ZjNDFiZDQ1MTdhMzU0ZDA4NjhiZjIwMmY4L3RhYmxlOjJlNWJkMWM1ZWY0ODQ3Mjk5MWU1MGVhNzBlZjg1ZGVjL3RhYmxlcmFuZ2U6MmU1YmQxYzVlZjQ4NDcyOTkxZTUwZWE3MGVmODVkZWNfMy0zLTEtMS03MDI2NQ_d35f9561-b94c-47f3-b24f-82cbc2242dc0"
      unitRef="usd">6740000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryWorkInProcess
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80MC9mcmFnOjZjNTZlY2ZjNDFiZDQ1MTdhMzU0ZDA4NjhiZjIwMmY4L3RhYmxlOjJlNWJkMWM1ZWY0ODQ3Mjk5MWU1MGVhNzBlZjg1ZGVjL3RhYmxlcmFuZ2U6MmU1YmQxYzVlZjQ4NDcyOTkxZTUwZWE3MGVmODVkZWNfNC0xLTEtMS03MDI2NQ_4a992dc7-8bd0-4266-812a-62460c37954c"
      unitRef="usd">1025000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryWorkInProcess
      contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80MC9mcmFnOjZjNTZlY2ZjNDFiZDQ1MTdhMzU0ZDA4NjhiZjIwMmY4L3RhYmxlOjJlNWJkMWM1ZWY0ODQ3Mjk5MWU1MGVhNzBlZjg1ZGVjL3RhYmxlcmFuZ2U6MmU1YmQxYzVlZjQ4NDcyOTkxZTUwZWE3MGVmODVkZWNfNC0zLTEtMS03MDI2NQ_26c15947-faf9-466c-afff-9c0fe702319e"
      unitRef="usd">905000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryFinishedGoods
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80MC9mcmFnOjZjNTZlY2ZjNDFiZDQ1MTdhMzU0ZDA4NjhiZjIwMmY4L3RhYmxlOjJlNWJkMWM1ZWY0ODQ3Mjk5MWU1MGVhNzBlZjg1ZGVjL3RhYmxlcmFuZ2U6MmU1YmQxYzVlZjQ4NDcyOTkxZTUwZWE3MGVmODVkZWNfNS0xLTEtMS03MDI2NQ_a2148859-aeeb-4237-957d-a70dd36e772c"
      unitRef="usd">7423000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods
      contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80MC9mcmFnOjZjNTZlY2ZjNDFiZDQ1MTdhMzU0ZDA4NjhiZjIwMmY4L3RhYmxlOjJlNWJkMWM1ZWY0ODQ3Mjk5MWU1MGVhNzBlZjg1ZGVjL3RhYmxlcmFuZ2U6MmU1YmQxYzVlZjQ4NDcyOTkxZTUwZWE3MGVmODVkZWNfNS0zLTEtMS03MDI2NQ_db1eb403-f4a0-441e-aa76-5f5655dc2375"
      unitRef="usd">5502000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryNet
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80MC9mcmFnOjZjNTZlY2ZjNDFiZDQ1MTdhMzU0ZDA4NjhiZjIwMmY4L3RhYmxlOjJlNWJkMWM1ZWY0ODQ3Mjk5MWU1MGVhNzBlZjg1ZGVjL3RhYmxlcmFuZ2U6MmU1YmQxYzVlZjQ4NDcyOTkxZTUwZWE3MGVmODVkZWNfNi0xLTEtMS03MDI2NQ_bc127c17-2f1d-4a34-8a0b-31a15c875271"
      unitRef="usd">13777000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80MC9mcmFnOjZjNTZlY2ZjNDFiZDQ1MTdhMzU0ZDA4NjhiZjIwMmY4L3RhYmxlOjJlNWJkMWM1ZWY0ODQ3Mjk5MWU1MGVhNzBlZjg1ZGVjL3RhYmxlcmFuZ2U6MmU1YmQxYzVlZjQ4NDcyOTkxZTUwZWE3MGVmODVkZWNfNi0zLTEtMS03MDI2NQ_25384c2a-9fb3-4959-a912-9d56c16c5a10"
      unitRef="usd">13147000</us-gaap:InventoryNet>
    <us-gaap:IntangibleAssetsDisclosureTextBlock
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80My9mcmFnOjYzZTE5MDliYTU0OTQzOWE5OTc1YTE1ZmQ1YjU1ZGM4L3RleHRyZWdpb246NjNlMTkwOWJhNTQ5NDM5YTk5NzVhMTVmZDViNTVkYzhfMTU0OA_2fa5aa88-44c0-4cb3-8cae-4ceb851dda17">Intangible Assets &lt;div style="margin-bottom:9pt;text-indent:24.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2019, the Company entered into a license agreement with HydroCision, Inc. This agreement grants the Company an exclusive, perpetual, irrevocable, worldwide, fully paid-up license to develop, manufacture and commercialize products in the field of urology using the patented technology and know-how controlled by HydroCision as of the effective date and as well as new patented technology developed by HydroCision that cover certain activities and improvements that relate to the use of fluid jet technology in connection with the licensed products during the period commencing on the effective date and ending on the earlier of the date that the Company ceases to use HydroCision&#x2019;s existing contract manufacturers and the third anniversary of the effective date. Also included is the right to utilize HydroCision&#x2019;s contract manufacturers, if desired. The consideration paid was a one-time upfront payment of $2.5 million, as well as allowing HydroCision (a reciprocal license) to use any new patented technology and know-how developed by the Company relating to the HydroCision patented technology and know-how in the field of urology for HydroCision use outside the field of urology. HydroCision will pay for any patent maintenance fees on HydroCision&#x2019;s licensed patents. As of June&#160;30, 2022 and December&#160;31, 2021, accumulated amortization was $0.9 million and $0.8 million, respectively, and the net carrying amount is expected to be amortized at a rate of $0.3 million per year until fully amortized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense for intangible assets was $0.1 million and $0.1 million for the three and six months ended June 30, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="ie19c67cd74ed40aabeb9098c4f2fb478_D20190301-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80My9mcmFnOjYzZTE5MDliYTU0OTQzOWE5OTc1YTE1ZmQ1YjU1ZGM4L3RleHRyZWdpb246NjNlMTkwOWJhNTQ5NDM5YTk5NzVhMTVmZDViNTVkYzhfOTQz_b2fb0e85-0a50-41e3-bd01-4fe9cf0b930f"
      unitRef="usd">2500000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80My9mcmFnOjYzZTE5MDliYTU0OTQzOWE5OTc1YTE1ZmQ1YjU1ZGM4L3RleHRyZWdpb246NjNlMTkwOWJhNTQ5NDM5YTk5NzVhMTVmZDViNTVkYzhfMTM0NA_0c50c5b2-449e-4135-bc2e-a979d231b691"
      unitRef="usd">900000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80My9mcmFnOjYzZTE5MDliYTU0OTQzOWE5OTc1YTE1ZmQ1YjU1ZGM4L3RleHRyZWdpb246NjNlMTkwOWJhNTQ5NDM5YTk5NzVhMTVmZDViNTVkYzhfMTM1MQ_2246c6d5-b4e3-4e6a-9ca5-d6921ac691d6"
      unitRef="usd">800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <prct:FiniteLivedIntangibleAssetExpectedAnnualAmortizationExpense
      contextRef="i96161312b8e749cc9c7f6f759945011c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80My9mcmFnOjYzZTE5MDliYTU0OTQzOWE5OTc1YTE1ZmQ1YjU1ZGM4L3RleHRyZWdpb246NjNlMTkwOWJhNTQ5NDM5YTk5NzVhMTVmZDViNTVkYzhfMTQzOA_f74d799f-1fb9-43c0-8974-14cc380c3f70"
      unitRef="usd">300000</prct:FiniteLivedIntangibleAssetExpectedAnnualAmortizationExpense>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80My9mcmFnOjYzZTE5MDliYTU0OTQzOWE5OTc1YTE1ZmQ1YjU1ZGM4L3RleHRyZWdpb246NjNlMTkwOWJhNTQ5NDM5YTk5NzVhMTVmZDViNTVkYzhfOTM0NTg0ODgzNzY2Mw_8056540d-d1c4-4316-9826-5b8bf626c111"
      unitRef="usd">100000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80My9mcmFnOjYzZTE5MDliYTU0OTQzOWE5OTc1YTE1ZmQ1YjU1ZGM4L3RleHRyZWdpb246NjNlMTkwOWJhNTQ5NDM5YTk5NzVhMTVmZDViNTVkYzhfOTM0NTg0ODgzNzY2Mw_8fef072b-1977-4685-aba8-e2006c3083b6"
      unitRef="usd">100000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80My9mcmFnOjYzZTE5MDliYTU0OTQzOWE5OTc1YTE1ZmQ1YjU1ZGM4L3RleHRyZWdpb246NjNlMTkwOWJhNTQ5NDM5YTk5NzVhMTVmZDViNTVkYzhfOTM0NTg0ODgzNzY5Ng_0cb44966-db8b-40f1-8787-5d04c993f957"
      unitRef="usd">100000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80My9mcmFnOjYzZTE5MDliYTU0OTQzOWE5OTc1YTE1ZmQ1YjU1ZGM4L3RleHRyZWdpb246NjNlMTkwOWJhNTQ5NDM5YTk5NzVhMTVmZDViNTVkYzhfOTM0NTg0ODgzNzY5Ng_1d316f01-87d9-4f68-b757-e569b818f5d4"
      unitRef="usd">100000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfNDAwOA_12393036-695d-4904-946f-8d3d094e3dc0">Loan Facility and Derivative LiabilityIn September 2019, the Company entered into a loan facility for up to $75.0 million available in four installments. The Company borrowed $25.0 million in September 2019. An additional $25.0 million was borrowed in March 2020. The third installment of $10.0 million was originally available for draw through March 31, 2021 contingent upon achieving $20.0 million in trailing six months revenue. In January 2021, the third installment was amended to be available for draw through June 30, 2021 contingent upon achieving $6.4 million trailing six months revenue. The remaining $15.0 million was originally available for draw through June 30, 2021 and is contingent upon achieving $25.0&#160;million in trailing six months revenue. In January 2021, this installment was amended to be available for draw through June 30, 2022. The facility bears an interest rate of the greater of (i) 9.37% and (ii) 7.17% plus 30 day LIBOR. The initial term of the facility is 60 months with interest-only payments each month for 24 months followed by 36 months amortization of principal and interest. In January 2021, the interest-only period was amended to 36 months followed by 24 months amortization (principal and interest) beginning October 1, 2022 since the amended trailing six months target revenue of $6.4 million was achieved, and accordingly, the current portion of the amount due was reclassified to non-current. Upon drawing the final $15.0 million tranche, the interest-only period was extended 12 months followed by 24 months amortization of principal and interest. Upon the completion of the Company raising over $50.0 million in its IPO in September 2021, interest-only payments were extended an additional 12 months followed by 12 months amortization of principal and interest. Substantially all assets of the Company are pledged as collateral. Commencing with the earlier of June 30, 2021 and the month following the funding of either the third or final installment, the Company is required to achieve revenues for the previous six months ended equal to the greater of (1) 70% of the forecast for the commensurate period, (2) $15.0 million if &lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;neither third or final installments have been drawn, (3) $20.0 million if the third but not final installment has been drawn and (4) $25.0 million if both the third and final installments have been drawn.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:24.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The loan facility includes certain fees payable to the lender recorded as a loan discount that are accrued and amortized to interest expense during the loan term. A 6% final payment fee of each funded tranche is payable at the earlier of prepayment or loan maturity and a 0.25% facility fee paid at each funded tranche. A prepayment fee was originally payable if the loan is paid before maturity in the amount of 3% of loans outstanding if paid in full during first 12 months, 2% if loan is paid in full during second twelve months, or 1% if loan is paid in full thereafter before maturity. In January 2021, the prepayment fee was removed as part of the amendments. In addition, the Company would pay the lender&#x2019;s loan initiation fees and a fee upon the earlier occurrence of a defined liquidity event, including but not limited to, a merger or sale of the Company&#x2019;s assets or voting stock, or achieving a $200 million trailing twelve months revenue target, in each case, by September 2029&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The success fees are calculated at the time of the liquidity event occurrence to be $1.0 million if only the first installment has been drawn, $2.0 million if the first two installments have been drawn, $2.4 million if the first three installments have been drawn, or $3.0 million if all four installments have been drawn, in each case, upon the occurrence of the defined liquidity event. As of June&#160;30, 2022, the Company has drawn on the first two installments. The Company determined that this obligation to pay success fees represents freestanding financial instruments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:24.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amendments in January 2021 were accounted for as a debt modification under ASC 470-50-40 as the changes in the debt terms are not considered substantial, and thus no gain or loss was recorded and a new effective interest rate was established based on the carrying value of the loan and the revised cash flows.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the Company&#x2019;s loan facility, the Company is obligated to pay a fee upon the earlier occurrence of a defined liquidity event, including but not limited to, a merger or sale of its assets or voting stock, or achieving a $200.0&#160;million trailing twelve months revenue target, in each case, by September 2029&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;. &lt;/span&gt;The fee is calculated at the time of the liquidity event occurrence to be $1.0&#160;million if only the first installment has been drawn, $2.0 million if the first two installments have been drawn, $2.4 million if the first three installments have been drawn, or $3.0 million if all four installments have been drawn, in each case, upon the occurrence of the liquidity event. As of June&#160;30, 2022, the Company has drawn on the first two installments. The Company has determined this fee is a freestanding derivative instrument. The initial $1.4 million fair value of this loan facility derivative was recorded as a debt discount and liability on the date of issuance in connection with obtaining additional financing as applicable and will be revalued every reporting period until the earlier occurrence of a defined liquidity event or achieving a revenue target by September 2029 or termination of such fee arrangement.</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DerivativesAndFairValueTextBlock
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfNjU5NzA2OTc3MjM5OQ_cbf4eeda-c9dc-478d-a680-d538a266ad87">Loan Facility and Derivative LiabilityIn September 2019, the Company entered into a loan facility for up to $75.0 million available in four installments. The Company borrowed $25.0 million in September 2019. An additional $25.0 million was borrowed in March 2020. The third installment of $10.0 million was originally available for draw through March 31, 2021 contingent upon achieving $20.0 million in trailing six months revenue. In January 2021, the third installment was amended to be available for draw through June 30, 2021 contingent upon achieving $6.4 million trailing six months revenue. The remaining $15.0 million was originally available for draw through June 30, 2021 and is contingent upon achieving $25.0&#160;million in trailing six months revenue. In January 2021, this installment was amended to be available for draw through June 30, 2022. The facility bears an interest rate of the greater of (i) 9.37% and (ii) 7.17% plus 30 day LIBOR. The initial term of the facility is 60 months with interest-only payments each month for 24 months followed by 36 months amortization of principal and interest. In January 2021, the interest-only period was amended to 36 months followed by 24 months amortization (principal and interest) beginning October 1, 2022 since the amended trailing six months target revenue of $6.4 million was achieved, and accordingly, the current portion of the amount due was reclassified to non-current. Upon drawing the final $15.0 million tranche, the interest-only period was extended 12 months followed by 24 months amortization of principal and interest. Upon the completion of the Company raising over $50.0 million in its IPO in September 2021, interest-only payments were extended an additional 12 months followed by 12 months amortization of principal and interest. Substantially all assets of the Company are pledged as collateral. Commencing with the earlier of June 30, 2021 and the month following the funding of either the third or final installment, the Company is required to achieve revenues for the previous six months ended equal to the greater of (1) 70% of the forecast for the commensurate period, (2) $15.0 million if &lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;neither third or final installments have been drawn, (3) $20.0 million if the third but not final installment has been drawn and (4) $25.0 million if both the third and final installments have been drawn.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:24.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The loan facility includes certain fees payable to the lender recorded as a loan discount that are accrued and amortized to interest expense during the loan term. A 6% final payment fee of each funded tranche is payable at the earlier of prepayment or loan maturity and a 0.25% facility fee paid at each funded tranche. A prepayment fee was originally payable if the loan is paid before maturity in the amount of 3% of loans outstanding if paid in full during first 12 months, 2% if loan is paid in full during second twelve months, or 1% if loan is paid in full thereafter before maturity. In January 2021, the prepayment fee was removed as part of the amendments. In addition, the Company would pay the lender&#x2019;s loan initiation fees and a fee upon the earlier occurrence of a defined liquidity event, including but not limited to, a merger or sale of the Company&#x2019;s assets or voting stock, or achieving a $200 million trailing twelve months revenue target, in each case, by September 2029&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The success fees are calculated at the time of the liquidity event occurrence to be $1.0 million if only the first installment has been drawn, $2.0 million if the first two installments have been drawn, $2.4 million if the first three installments have been drawn, or $3.0 million if all four installments have been drawn, in each case, upon the occurrence of the defined liquidity event. As of June&#160;30, 2022, the Company has drawn on the first two installments. The Company determined that this obligation to pay success fees represents freestanding financial instruments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:24.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amendments in January 2021 were accounted for as a debt modification under ASC 470-50-40 as the changes in the debt terms are not considered substantial, and thus no gain or loss was recorded and a new effective interest rate was established based on the carrying value of the loan and the revised cash flows.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the Company&#x2019;s loan facility, the Company is obligated to pay a fee upon the earlier occurrence of a defined liquidity event, including but not limited to, a merger or sale of its assets or voting stock, or achieving a $200.0&#160;million trailing twelve months revenue target, in each case, by September 2029&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;. &lt;/span&gt;The fee is calculated at the time of the liquidity event occurrence to be $1.0&#160;million if only the first installment has been drawn, $2.0 million if the first two installments have been drawn, $2.4 million if the first three installments have been drawn, or $3.0 million if all four installments have been drawn, in each case, upon the occurrence of the liquidity event. As of June&#160;30, 2022, the Company has drawn on the first two installments. The Company has determined this fee is a freestanding derivative instrument. The initial $1.4 million fair value of this loan facility derivative was recorded as a debt discount and liability on the date of issuance in connection with obtaining additional financing as applicable and will be revalued every reporting period until the earlier occurrence of a defined liquidity event or achieving a revenue target by September 2029 or termination of such fee arrangement.</us-gaap:DerivativesAndFairValueTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i1e254378ff134e9681a4249bcc83e5fc_I20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfOTM_6bb78aa4-2dcc-45bd-882e-c783e4c3bfd0"
      unitRef="usd">75000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <prct:LineOfCreditFacilityNumberOfInstallments
      contextRef="i1e254378ff134e9681a4249bcc83e5fc_I20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfMTA5_fbf30033-3218-472e-a0e1-00a3003fa218"
      unitRef="installment">4</prct:LineOfCreditFacilityNumberOfInstallments>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="i10156edb55894acbb210fec9c3468287_D20190901-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfMTQ3_dfc6b2df-3c5a-4727-a567-a0c8e114772e"
      unitRef="usd">25000000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="i0b01acac5e6143eaba1f435139069823_D20200301-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfMTgz_41e54911-702e-494e-a072-460b4d205320"
      unitRef="usd">25000000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
      contextRef="ib4b1440f6de14019a797df774eb5f464_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfMjM5_2fc9d59b-4942-4c3b-8291-a259b8369b04"
      unitRef="usd">10000000</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <prct:LineOfCreditFacilityCovenantComplianceContingentTrailingSixTwelveMonthRevenueTarget
      contextRef="i3c2a33ef0d514076961c5e1590bfa66c_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfMzI1_40c29f20-9b05-456a-9e0b-a350ed2789bb"
      unitRef="usd">20000000</prct:LineOfCreditFacilityCovenantComplianceContingentTrailingSixTwelveMonthRevenueTarget>
    <prct:LineOfCreditFacilityCovenantComplianceContingentTrailingSixTwelveMonthRevenueTarget
      contextRef="i6777b1709ddc4642b6a8f38a6e6be39d_D20210101-20210131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfNDgz_1a347504-e99a-4dac-9e60-278806c4eafb"
      unitRef="usd">6400000</prct:LineOfCreditFacilityCovenantComplianceContingentTrailingSixTwelveMonthRevenueTarget>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
      contextRef="i33d2d97450ea42cea69aeef3e9ea7937_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfNTI4_b6f0f067-83dd-46ec-a55c-24c496137151"
      unitRef="usd">15000000</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <prct:LineOfCreditFacilityCovenantComplianceContingentTrailingSixTwelveMonthRevenueTarget
      contextRef="ia16ecc55dbd348ecaaaaaa7c92629f98_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfNjIw_05bff03a-d723-4f09-beb6-6cbc45913d1e"
      unitRef="usd">25000000</prct:LineOfCreditFacilityCovenantComplianceContingentTrailingSixTwelveMonthRevenueTarget>
    <us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd
      contextRef="i9256f6c0b3ab484d973170c275d30dd6_I20210131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfNzg3_725f1028-ab4b-4381-8d91-d77e53c74ba3"
      unitRef="number">0.0937</us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
    <us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd
      contextRef="ia2530161d85e4792bd363ce72e96e9b9_I20210131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfNjU5NzA2OTc3MjM5Mw_ac900af3-5ea9-4b38-9161-b3cef8ac25ca"
      unitRef="number">0.0717</us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
    <us-gaap:DebtInstrumentTerm
      contextRef="i861bb40fd82c4a378c9527bee4405c32_D20210101-20210131"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfNDAwOQ_d84fba94-c867-4754-ae89-2a7dde6ba83f">P60M</us-gaap:DebtInstrumentTerm>
    <prct:DebtInstrumentInterestOnlyPeriod
      contextRef="i861bb40fd82c4a378c9527bee4405c32_D20210101-20210131"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfNDAxMA_f4ac91f5-51d5-4ed0-ad39-f3a8d4e56741">P24M</prct:DebtInstrumentInterestOnlyPeriod>
    <prct:DebtInstrumentPrincipalAndInterestPeriod
      contextRef="i861bb40fd82c4a378c9527bee4405c32_D20210101-20210131"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfNDAxNA_9a86baa3-b670-4bd0-82a2-fa8215cf424b">P36M</prct:DebtInstrumentPrincipalAndInterestPeriod>
    <prct:DebtInstrumentInterestOnlyPeriod
      contextRef="i6777b1709ddc4642b6a8f38a6e6be39d_D20210101-20210131"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfNDAxNQ_02d0093d-67c4-4c7d-9438-bbfcb7d179ee">P36M</prct:DebtInstrumentInterestOnlyPeriod>
    <prct:DebtInstrumentPrincipalAndInterestPeriod
      contextRef="i6777b1709ddc4642b6a8f38a6e6be39d_D20210101-20210131"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfNDAxNg_a9229fed-2799-4792-a72b-5c9a0582d85b">P24M</prct:DebtInstrumentPrincipalAndInterestPeriod>
    <prct:LineOfCreditFacilityCovenantComplianceContingentTrailingSixTwelveMonthRevenueTarget
      contextRef="i6777b1709ddc4642b6a8f38a6e6be39d_D20210101-20210131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfMTIxMg_d268d0ea-488e-4f3d-84a0-b22290abf70f"
      unitRef="usd">6400000</prct:LineOfCreditFacilityCovenantComplianceContingentTrailingSixTwelveMonthRevenueTarget>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
      contextRef="ia47c0681a1b8412cb1f3e5eb400ad5fc_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfMTM0MA_a5bc32c1-9048-43cc-b92e-8608bff06f04"
      unitRef="usd">15000000</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <prct:DebtInstrumentContingentBorrowingExtendedInterestOnlyPeriod
      contextRef="i3bba515e9a0d4545bb068c2fe7296bf1_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfNDAxMQ_ef8f93c4-1194-404f-8121-da60b486ebef">P12M</prct:DebtInstrumentContingentBorrowingExtendedInterestOnlyPeriod>
    <prct:DebtInstrumentContingentBorrowingExtendedPrincipalAndInterestPeriod
      contextRef="i3bba515e9a0d4545bb068c2fe7296bf1_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfNDAxMg_33775792-359e-471d-a526-60d2fa8a554a">P24M</prct:DebtInstrumentContingentBorrowingExtendedPrincipalAndInterestPeriod>
    <prct:DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmount
      contextRef="if00ac5ae82404ee98272aabd9c6a9606_D20210901-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfMTUwNQ_19923278-9ff0-4238-a496-2bddbfa0455c"
      unitRef="usd">50000000</prct:DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmount>
    <prct:DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmountAchievedExtendedInterestOnlyPeriod
      contextRef="if00ac5ae82404ee98272aabd9c6a9606_D20210901-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfNDAwNQ_b4cccc6e-4b21-4754-b3d0-2351cbfd517d">P12M</prct:DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmountAchievedExtendedInterestOnlyPeriod>
    <prct:DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmountAchievedExtendedPrincipalAndInterestPeriod
      contextRef="if00ac5ae82404ee98272aabd9c6a9606_D20210901-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfNDAwNg_49a59d95-e62c-447d-8bce-5ab15c32c4cf">P12M</prct:DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmountAchievedExtendedPrincipalAndInterestPeriod>
    <prct:DebtInstrumentCovenantComplianceRevenueForecastForCommensuratePeriodPercent
      contextRef="i683101ff096c40c2a24cbd6236452190_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfMTk1Ng_918e0328-7703-45b7-ad44-db916ce18e5f"
      unitRef="number">0.70</prct:DebtInstrumentCovenantComplianceRevenueForecastForCommensuratePeriodPercent>
    <prct:DebtInstrumentCovenantComplianceRevenueForecastAmountFirstTwoInstallmentsOnly
      contextRef="i683101ff096c40c2a24cbd6236452190_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfMjAwOA_7e079d51-e970-42d0-80a9-39d9fbf03a6e"
      unitRef="usd">15000000</prct:DebtInstrumentCovenantComplianceRevenueForecastAmountFirstTwoInstallmentsOnly>
    <prct:DebtInstrumentCovenantComplianceRevenueForecastAmountFirstThreeInstallmentsOnly
      contextRef="i683101ff096c40c2a24cbd6236452190_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfMjA3MQ_49045d63-9ba1-465a-93e1-032637cd4c29"
      unitRef="usd">20000000</prct:DebtInstrumentCovenantComplianceRevenueForecastAmountFirstThreeInstallmentsOnly>
    <prct:DebtInstrumentCovenantComplianceRevenueForecastAmountAllInstallmentsDrawn
      contextRef="i683101ff096c40c2a24cbd6236452190_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfMjEzNg_26c4cf16-9105-4f4e-b19e-af396538ca49"
      unitRef="usd">25000000</prct:DebtInstrumentCovenantComplianceRevenueForecastAmountAllInstallmentsDrawn>
    <prct:LineOfCreditFacilityFinalPaymentFeePercentage
      contextRef="ib1c06405d72a4f48a81ffc14a560fce7_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfMjM2NA_87d0906b-2816-4835-a39d-ffab936fefd7"
      unitRef="number">0.06</prct:LineOfCreditFacilityFinalPaymentFeePercentage>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="id06260efb84542fcbe48470c87f30c7c_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfMjQ3MQ_9b1380e7-6ffe-43b1-8358-d331e85bac70"
      unitRef="number">0.0025</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <prct:LineOfCreditFacilityEarlyRepaymentFeeFirstTwelveMonthPercent
      contextRef="ib1c06405d72a4f48a81ffc14a560fce7_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfMjYwOQ_d28c193b-d0a3-44db-bcf8-0a21867ab9bb"
      unitRef="number">0.03</prct:LineOfCreditFacilityEarlyRepaymentFeeFirstTwelveMonthPercent>
    <prct:LineOfCreditFacilityEarlyRepaymentFeeSecondTwelveMonthPeriodPercent
      contextRef="ib1c06405d72a4f48a81ffc14a560fce7_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfMjY3Mw_9693eb04-e308-405a-bbd1-bd6f6bc10819"
      unitRef="number">0.02</prct:LineOfCreditFacilityEarlyRepaymentFeeSecondTwelveMonthPeriodPercent>
    <prct:LineOfCreditFacilityEarlyRepaymentFeeTwentyFourMonthsThruMaturityPercent
      contextRef="ib1c06405d72a4f48a81ffc14a560fce7_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfMjcyOA_8fe4aa38-745f-484f-89c3-c9f2f46e6703"
      unitRef="number">0.01</prct:LineOfCreditFacilityEarlyRepaymentFeeTwentyFourMonthsThruMaturityPercent>
    <prct:LineOfCreditFacilityCovenantComplianceContingentTrailingTwelveMonthRevenueTarget
      contextRef="id06260efb84542fcbe48470c87f30c7c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfMzA5OQ_76cefc1d-e696-4a2a-914f-d1b8e6eeb121"
      unitRef="usd">200000000</prct:LineOfCreditFacilityCovenantComplianceContingentTrailingTwelveMonthRevenueTarget>
    <prct:LineOfCreditFacilityCovenantTermsLiquidityOccurrenceOneInstallmentDrawn
      contextRef="ib1c06405d72a4f48a81ffc14a560fce7_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfMzI1NA_5e96bd46-144d-4932-aec7-e32b0ea593d2"
      unitRef="usd">1000000</prct:LineOfCreditFacilityCovenantTermsLiquidityOccurrenceOneInstallmentDrawn>
    <prct:LineOfCreditFacilityCovenantTermsLiquidityOccurrenceTwoInstallmentsDrawn
      contextRef="ib1c06405d72a4f48a81ffc14a560fce7_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfMzMwMw_31bf5def-018e-49b1-8b03-ee577e5b3243"
      unitRef="usd">2000000</prct:LineOfCreditFacilityCovenantTermsLiquidityOccurrenceTwoInstallmentsDrawn>
    <prct:LineOfCreditFacilityCovenantTermsLiquidityOccurrenceThreeInstallmentsDrawn
      contextRef="ib1c06405d72a4f48a81ffc14a560fce7_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfMzM1Mw_ad694229-3d2f-43ba-a5ca-d94f5e901144"
      unitRef="usd">2400000</prct:LineOfCreditFacilityCovenantTermsLiquidityOccurrenceThreeInstallmentsDrawn>
    <prct:LineOfCreditFacilityCovenantTermsLiquidityOccurrenceFourInstallmentsDrawn
      contextRef="ib1c06405d72a4f48a81ffc14a560fce7_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfMzQwOA_35b64f86-2784-4bcb-aefa-ca15551a116d"
      unitRef="usd">3000000</prct:LineOfCreditFacilityCovenantTermsLiquidityOccurrenceFourInstallmentsDrawn>
    <prct:LineOfCreditFacilityGainLossOnAmendmentOfDebtTerms
      contextRef="i19e8bd64054f475ea78f283d6415e474_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfMzg2MA_bb66c231-6a03-471f-978c-5ced04519851"
      unitRef="usd">0</prct:LineOfCreditFacilityGainLossOnAmendmentOfDebtTerms>
    <prct:LineOfCreditFacilityCovenantComplianceContingentTrailingTwelveMonthRevenueTarget
      contextRef="ie2afc20bf0a74c8497a36a93f40390d4_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfMjc0ODc3OTA3MzczNA_904dcc18-8cbf-4cc1-8ba9-0430013a97b4"
      unitRef="usd">200000000</prct:LineOfCreditFacilityCovenantComplianceContingentTrailingTwelveMonthRevenueTarget>
    <prct:LineOfCreditFacilityCovenantTermsLiquidityOccurrenceOneInstallmentDrawn
      contextRef="i68b9bf6c49b34ddb9f9cdf4df2a9cde7_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfMjc0ODc3OTA3Mzg4NA_e6a9150c-1d23-4b9b-824c-3f5bf673ee30"
      unitRef="usd">1000000</prct:LineOfCreditFacilityCovenantTermsLiquidityOccurrenceOneInstallmentDrawn>
    <prct:LineOfCreditFacilityCovenantTermsLiquidityOccurrenceTwoInstallmentsDrawn
      contextRef="i68b9bf6c49b34ddb9f9cdf4df2a9cde7_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfMjc0ODc3OTA3MzkzNA_f127809d-f540-4a74-885f-1054dcf680a6"
      unitRef="usd">2000000</prct:LineOfCreditFacilityCovenantTermsLiquidityOccurrenceTwoInstallmentsDrawn>
    <prct:LineOfCreditFacilityCovenantTermsLiquidityOccurrenceThreeInstallmentsDrawn
      contextRef="i68b9bf6c49b34ddb9f9cdf4df2a9cde7_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfMjc0ODc3OTA3Mzk4NQ_eb09fbb2-2f0a-45d8-8f82-c9a924355d65"
      unitRef="usd">2400000</prct:LineOfCreditFacilityCovenantTermsLiquidityOccurrenceThreeInstallmentsDrawn>
    <prct:LineOfCreditFacilityCovenantTermsLiquidityOccurrenceFourInstallmentsDrawn
      contextRef="i68b9bf6c49b34ddb9f9cdf4df2a9cde7_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfMjc0ODc3OTA3NDA0MQ_aebe9f25-fa48-437b-8cc1-7f7f43271688"
      unitRef="usd">3000000</prct:LineOfCreditFacilityCovenantTermsLiquidityOccurrenceFourInstallmentsDrawn>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i68b9bf6c49b34ddb9f9cdf4df2a9cde7_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80Ni9mcmFnOmY5NzNiNTI1NjQ4ODQyNTFhYjQ5NzUzNjU3YWZhNWZiL3RleHRyZWdpb246Zjk3M2I1MjU2NDg4NDI1MWFiNDk3NTM2NTdhZmE1ZmJfMjc0ODc3OTA3NDI5MA_6b638070-44e5-4f1d-8798-5af42b73e56f"
      unitRef="usd">1400000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RleHRyZWdpb246YmIwZTNiYzI1ODYxNDUxOTliMWM1ZWZiN2U2YWM3YjNfNDk4_8d40bc61-e66f-4649-a066-6844c5fb5231">Stock-Based Compensation&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had 4.5&#160;million shares available for grant as of June 30, 2022 under the 2021 Equity Incentive Award Plan. The Company ceased making awards under the 2008 Stock Plan upon the effective date of the Company&#x2019;s IPO.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:24.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the Company&#x2019;s stock option activity and related information are as follows (shares in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(802)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(151)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and expected to vest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2022 and December&#160;31, 2021, the aggregate pre-tax intrinsic value of options outstanding and exercisable was $82.3 million and $64.3 million, respectively, and the aggregate pre-tax intrinsic value options outstanding were $147.1 million and $125.7 million, respectively. The aggregate pre-tax intrinsic value of options exercised was $21.7 million and $3.4 million during the six months ended June&#160;30, 2022 and 2021, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June 30, 2022, there was a total of $11.4 million of unrecognized stock-based compensation expense related to stock options.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the options granted to employees or directors was estimated as of the grant date using the Black-Scholes model assuming the weighted-average assumptions listed in the following table: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend rate &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Stock Units&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the Company&#x2019;s restricted stock unit (&#x201c;RSU&#x201d;) activity and related information are as follows (restricted stock units in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Awarded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June 30, 2022, there was a total of $17.8 million of unrecognized stock-based compensation expense related to RSUs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June 30, 2022, there was approximately $0.7&#160;million of unrecognized cost related to employee stock purchases under the Employee Stock Purchase Plan (&#x201c;ESPP&#x201d;). This cost is expected to be recognized over a weighted average period of 0.5 years. As of June 30, 2022, a total of 0.8&#160;million shares were available for issuance under the ESPP.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the awards granted under the ESPP for the six months ended June 30, 2022 to employees was estimated as of the grant date using the Black-Scholes model assuming the weighted-average assumptions listed in the following table: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.316%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.442%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend rate &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total stock-based compensation recognized, before taxes, are as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.684%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="ifa96468d217b44f29426837ed43cb27e_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RleHRyZWdpb246YmIwZTNiYzI1ODYxNDUxOTliMWM1ZWZiN2U2YWM3YjNfMjc0ODc3OTA4MTUxMg_4b788c39-2e71-416a-8fed-e10f996e5791"
      unitRef="shares">4500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RleHRyZWdpb246YmIwZTNiYzI1ODYxNDUxOTliMWM1ZWZiN2U2YWM3YjNfODc5NjA5MzAyODI4Ng_f16bf758-b403-4bfe-8bf2-a0f984b8e1f4">&lt;div style="margin-bottom:9pt;text-indent:24.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the Company&#x2019;s stock option activity and related information are as follows (shares in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(802)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(151)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and expected to vest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i98ec9d7c3e23460eb44d3b79a24f38f8_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjJiY2E4MjE2MGFmZDRlZmRhNTIwMzFkMjdhMGFlODdiL3RhYmxlcmFuZ2U6MmJjYTgyMTYwYWZkNGVmZGE1MjAzMWQyN2EwYWU4N2JfNC0xLTEtMS03MTQ4Ng_20095078-ab91-4cfb-b5c5-05112718bb23"
      unitRef="shares">6365000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i98ec9d7c3e23460eb44d3b79a24f38f8_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjJiY2E4MjE2MGFmZDRlZmRhNTIwMzFkMjdhMGFlODdiL3RhYmxlcmFuZ2U6MmJjYTgyMTYwYWZkNGVmZGE1MjAzMWQyN2EwYWU4N2JfNC0zLTEtMS03MTQ4Ng_9c89d86f-b907-49e2-831e-186adbb2348b"
      unitRef="usdPerShare">5.34</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i73c3f9942c10418c97d1df582f8b37c7_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjJiY2E4MjE2MGFmZDRlZmRhNTIwMzFkMjdhMGFlODdiL3RhYmxlcmFuZ2U6MmJjYTgyMTYwYWZkNGVmZGE1MjAzMWQyN2EwYWU4N2JfNS0xLTEtMS03MTQ4Ng_1f35fefb-3294-4316-9f75-b81ac7b7ccd7"
      unitRef="shares">254000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i73c3f9942c10418c97d1df582f8b37c7_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjJiY2E4MjE2MGFmZDRlZmRhNTIwMzFkMjdhMGFlODdiL3RhYmxlcmFuZ2U6MmJjYTgyMTYwYWZkNGVmZGE1MjAzMWQyN2EwYWU4N2JfNS0zLTEtMS03MTQ4Ng_8c1c5d0d-1669-48b6-9e7e-fb4da5e4604b"
      unitRef="usdPerShare">35.58</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i73c3f9942c10418c97d1df582f8b37c7_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjJiY2E4MjE2MGFmZDRlZmRhNTIwMzFkMjdhMGFlODdiL3RhYmxlcmFuZ2U6MmJjYTgyMTYwYWZkNGVmZGE1MjAzMWQyN2EwYWU4N2JfNi0xLTEtMS03MTQ4Ng_c0669320-04e3-4a75-b95b-5aafa8c38cd6"
      unitRef="shares">802000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i73c3f9942c10418c97d1df582f8b37c7_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjJiY2E4MjE2MGFmZDRlZmRhNTIwMzFkMjdhMGFlODdiL3RhYmxlcmFuZ2U6MmJjYTgyMTYwYWZkNGVmZGE1MjAzMWQyN2EwYWU4N2JfNi0zLTEtMS03MTQ4Ng_551c0eae-b5a6-47d7-aa9e-d1e84f6b52cb"
      unitRef="usdPerShare">3.57</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i73c3f9942c10418c97d1df582f8b37c7_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjJiY2E4MjE2MGFmZDRlZmRhNTIwMzFkMjdhMGFlODdiL3RhYmxlcmFuZ2U6MmJjYTgyMTYwYWZkNGVmZGE1MjAzMWQyN2EwYWU4N2JfNy0xLTEtMS03MTQ4Ng_46c7d224-ba38-445e-bca7-5c779e88345a"
      unitRef="shares">151000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i73c3f9942c10418c97d1df582f8b37c7_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjJiY2E4MjE2MGFmZDRlZmRhNTIwMzFkMjdhMGFlODdiL3RhYmxlcmFuZ2U6MmJjYTgyMTYwYWZkNGVmZGE1MjAzMWQyN2EwYWU4N2JfNy0zLTEtMS03MTQ4Ng_a9c81159-b06a-4419-9f55-809d5570ee0e"
      unitRef="usdPerShare">7.09</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i1f17d9fd3b0f45df96c50d9c3c83002b_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjJiY2E4MjE2MGFmZDRlZmRhNTIwMzFkMjdhMGFlODdiL3RhYmxlcmFuZ2U6MmJjYTgyMTYwYWZkNGVmZGE1MjAzMWQyN2EwYWU4N2JfOC0xLTEtMS03MTQ4Ng_effdf7ea-8dd5-4ef1-9231-66a223c726c0"
      unitRef="shares">5666000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i1f17d9fd3b0f45df96c50d9c3c83002b_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjJiY2E4MjE2MGFmZDRlZmRhNTIwMzFkMjdhMGFlODdiL3RhYmxlcmFuZ2U6MmJjYTgyMTYwYWZkNGVmZGE1MjAzMWQyN2EwYWU4N2JfOC0zLTEtMS03MTQ4Ng_adf664c0-e211-41ed-85db-526d8debeec1"
      unitRef="usdPerShare">6.90</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="i1f17d9fd3b0f45df96c50d9c3c83002b_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjJiY2E4MjE2MGFmZDRlZmRhNTIwMzFkMjdhMGFlODdiL3RhYmxlcmFuZ2U6MmJjYTgyMTYwYWZkNGVmZGE1MjAzMWQyN2EwYWU4N2JfOS0xLTEtMS03MTQ4Ng_26c212d3-b2b4-4a3d-bf96-d77b3c4c5029"
      unitRef="shares">5666000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="i1f17d9fd3b0f45df96c50d9c3c83002b_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjJiY2E4MjE2MGFmZDRlZmRhNTIwMzFkMjdhMGFlODdiL3RhYmxlcmFuZ2U6MmJjYTgyMTYwYWZkNGVmZGE1MjAzMWQyN2EwYWU4N2JfOS0zLTEtMS03MTQ4Ng_7d5049a6-8624-4008-ba9d-161f92de2bec"
      unitRef="usdPerShare">6.90</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i1f17d9fd3b0f45df96c50d9c3c83002b_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjJiY2E4MjE2MGFmZDRlZmRhNTIwMzFkMjdhMGFlODdiL3RhYmxlcmFuZ2U6MmJjYTgyMTYwYWZkNGVmZGE1MjAzMWQyN2EwYWU4N2JfMTAtMS0xLTEtNzE0ODY_cbd37ea6-b91c-4a07-ac70-d47817993d8f"
      unitRef="shares">2933000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
      contextRef="i1f17d9fd3b0f45df96c50d9c3c83002b_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjJiY2E4MjE2MGFmZDRlZmRhNTIwMzFkMjdhMGFlODdiL3RhYmxlcmFuZ2U6MmJjYTgyMTYwYWZkNGVmZGE1MjAzMWQyN2EwYWU4N2JfMTAtMy0xLTEtNzE0ODY_0d137cf2-5fb8-465f-98a0-b7520b712230"
      unitRef="usdPerShare">4.63</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
      contextRef="i1f17d9fd3b0f45df96c50d9c3c83002b_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RleHRyZWdpb246YmIwZTNiYzI1ODYxNDUxOTliMWM1ZWZiN2U2YWM3YjNfMjc0ODc3OTA3MDY5OQ_2ad4d252-6b45-4cad-aa84-e31306184684"
      unitRef="usd">82300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
      contextRef="i98ec9d7c3e23460eb44d3b79a24f38f8_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RleHRyZWdpb246YmIwZTNiYzI1ODYxNDUxOTliMWM1ZWZiN2U2YWM3YjNfMjc0ODc3OTA3MDcwNw_1c2444ce-19c5-47a6-9a95-b7b1bee04be5"
      unitRef="usd">64300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="i1f17d9fd3b0f45df96c50d9c3c83002b_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RleHRyZWdpb246YmIwZTNiYzI1ODYxNDUxOTliMWM1ZWZiN2U2YWM3YjNfMjc0ODc3OTA3MDc1NQ_fe11a9f5-877e-4eb5-a222-aeda3999d194"
      unitRef="usd">147100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="i98ec9d7c3e23460eb44d3b79a24f38f8_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RleHRyZWdpb246YmIwZTNiYzI1ODYxNDUxOTliMWM1ZWZiN2U2YWM3YjNfMjc0ODc3OTA3MDc2Mw_6e912663-0b92-4432-8282-d7f64f1665b1"
      unitRef="usd">125700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i73c3f9942c10418c97d1df582f8b37c7_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RleHRyZWdpb246YmIwZTNiYzI1ODYxNDUxOTliMWM1ZWZiN2U2YWM3YjNfMjc0ODc3OTA3MDg0NQ_00ef5f3a-f30e-486f-a4ac-97ef208dfd5f"
      unitRef="usd">21700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i7eabbab66fc246509ee375373f59a3c8_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RleHRyZWdpb246YmIwZTNiYzI1ODYxNDUxOTliMWM1ZWZiN2U2YWM3YjNfMjc0ODc3OTA3MDg1Mw_ad0c3ad0-c9cb-4aaf-bb44-67dd959eea1e"
      unitRef="usd">3400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i73c3f9942c10418c97d1df582f8b37c7_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RleHRyZWdpb246YmIwZTNiYzI1ODYxNDUxOTliMWM1ZWZiN2U2YWM3YjNfOTM0NTg0ODg0MzA0Ng_e16d7be5-2157-486c-8960-4d4610132162"
      unitRef="usd">11400000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RleHRyZWdpb246YmIwZTNiYzI1ODYxNDUxOTliMWM1ZWZiN2U2YWM3YjNfNjU5NzA2OTc3ODg4OA_2c4734e6-3283-4c29-a3b6-afdc01a3cfe1">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the options granted to employees or directors was estimated as of the grant date using the Black-Scholes model assuming the weighted-average assumptions listed in the following table: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend rate &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the awards granted under the ESPP for the six months ended June 30, 2022 to employees was estimated as of the grant date using the Black-Scholes model assuming the weighted-average assumptions listed in the following table: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.316%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.442%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend rate &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i00f54e9cbe804bb38c30969068ff45d3_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOmM3NGM4MzYxNDQ2NDQ0ZjZhZTJjMzY2ODVjNjRiZjViL3RhYmxlcmFuZ2U6Yzc0YzgzNjE0NDY0NDRmNmFlMmMzNjY4NWM2NGJmNWJfMy0xLTEtMS03MjY5MA_5dbe2cc6-982b-496b-b863-146aab0c62bf">P5Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i5734f87cb59c4ab99ff5087249c3e6bc_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOmM3NGM4MzYxNDQ2NDQ0ZjZhZTJjMzY2ODVjNjRiZjViL3RhYmxlcmFuZ2U6Yzc0YzgzNjE0NDY0NDRmNmFlMmMzNjY4NWM2NGJmNWJfMy0zLTEtMS03MjY5MA_9795ab42-2f22-4669-9945-c9bd71c60147">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i73c3f9942c10418c97d1df582f8b37c7_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOmM3NGM4MzYxNDQ2NDQ0ZjZhZTJjMzY2ODVjNjRiZjViL3RhYmxlcmFuZ2U6Yzc0YzgzNjE0NDY0NDRmNmFlMmMzNjY4NWM2NGJmNWJfMy01LTEtMS03Mjc3NQ_bc69e36e-3309-4e3a-abc6-847037b5067f">P5Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i7eabbab66fc246509ee375373f59a3c8_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOmM3NGM4MzYxNDQ2NDQ0ZjZhZTJjMzY2ODVjNjRiZjViL3RhYmxlcmFuZ2U6Yzc0YzgzNjE0NDY0NDRmNmFlMmMzNjY4NWM2NGJmNWJfMy03LTEtMS03Mjc3NQ_050f5688-0db2-4b26-9e62-d56fd1eaf442">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i00f54e9cbe804bb38c30969068ff45d3_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOmM3NGM4MzYxNDQ2NDQ0ZjZhZTJjMzY2ODVjNjRiZjViL3RhYmxlcmFuZ2U6Yzc0YzgzNjE0NDY0NDRmNmFlMmMzNjY4NWM2NGJmNWJfNC0xLTEtMS03MjY5MA_378299c6-8b33-4c36-ad2e-33b3037021fc"
      unitRef="number">0.56</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i5734f87cb59c4ab99ff5087249c3e6bc_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOmM3NGM4MzYxNDQ2NDQ0ZjZhZTJjMzY2ODVjNjRiZjViL3RhYmxlcmFuZ2U6Yzc0YzgzNjE0NDY0NDRmNmFlMmMzNjY4NWM2NGJmNWJfNC0zLTEtMS03MjY5MA_bb0ca9a1-95b2-4e1f-87d2-2f9d8ea2a656"
      unitRef="number">0.52</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i73c3f9942c10418c97d1df582f8b37c7_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOmM3NGM4MzYxNDQ2NDQ0ZjZhZTJjMzY2ODVjNjRiZjViL3RhYmxlcmFuZ2U6Yzc0YzgzNjE0NDY0NDRmNmFlMmMzNjY4NWM2NGJmNWJfNC01LTEtMS03Mjc3NQ_769e793b-34f2-4e8b-9713-1ab29bfaefad"
      unitRef="number">0.55</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i7eabbab66fc246509ee375373f59a3c8_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOmM3NGM4MzYxNDQ2NDQ0ZjZhZTJjMzY2ODVjNjRiZjViL3RhYmxlcmFuZ2U6Yzc0YzgzNjE0NDY0NDRmNmFlMmMzNjY4NWM2NGJmNWJfNC03LTEtMS03Mjc3NQ_2d7b410d-7043-4a7c-8faf-b596b804070b"
      unitRef="number">0.49</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i00f54e9cbe804bb38c30969068ff45d3_D20220401-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOmM3NGM4MzYxNDQ2NDQ0ZjZhZTJjMzY2ODVjNjRiZjViL3RhYmxlcmFuZ2U6Yzc0YzgzNjE0NDY0NDRmNmFlMmMzNjY4NWM2NGJmNWJfNS0xLTEtMS03MjY5MA_8334b2bc-f17c-4244-ad6e-5675a5b76721"
      unitRef="number">0.029</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i5734f87cb59c4ab99ff5087249c3e6bc_D20210401-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOmM3NGM4MzYxNDQ2NDQ0ZjZhZTJjMzY2ODVjNjRiZjViL3RhYmxlcmFuZ2U6Yzc0YzgzNjE0NDY0NDRmNmFlMmMzNjY4NWM2NGJmNWJfNS0zLTEtMS03MjY5MA_f2c412b7-0d58-443a-9f28-2115f2e2c17f"
      unitRef="number">0.011</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i73c3f9942c10418c97d1df582f8b37c7_D20220101-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOmM3NGM4MzYxNDQ2NDQ0ZjZhZTJjMzY2ODVjNjRiZjViL3RhYmxlcmFuZ2U6Yzc0YzgzNjE0NDY0NDRmNmFlMmMzNjY4NWM2NGJmNWJfNS01LTEtMS03Mjc3NQ_088f382d-d31a-45af-9b12-892ccfb97e36"
      unitRef="number">0.025</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i7eabbab66fc246509ee375373f59a3c8_D20210101-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOmM3NGM4MzYxNDQ2NDQ0ZjZhZTJjMzY2ODVjNjRiZjViL3RhYmxlcmFuZ2U6Yzc0YzgzNjE0NDY0NDRmNmFlMmMzNjY4NWM2NGJmNWJfNS03LTEtMS03Mjc3NQ_bb679333-671d-4284-81cf-fa771f826f6a"
      unitRef="number">0.011</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i00f54e9cbe804bb38c30969068ff45d3_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOmM3NGM4MzYxNDQ2NDQ0ZjZhZTJjMzY2ODVjNjRiZjViL3RhYmxlcmFuZ2U6Yzc0YzgzNjE0NDY0NDRmNmFlMmMzNjY4NWM2NGJmNWJfNi0xLTEtMS03MjY5MA_d2b79c1b-3659-43e9-b2cf-f3698ed24c09"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i5734f87cb59c4ab99ff5087249c3e6bc_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOmM3NGM4MzYxNDQ2NDQ0ZjZhZTJjMzY2ODVjNjRiZjViL3RhYmxlcmFuZ2U6Yzc0YzgzNjE0NDY0NDRmNmFlMmMzNjY4NWM2NGJmNWJfNi0zLTEtMS03MjY5MA_9067e8da-ce20-48c0-a3e2-27cb530671ce"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i73c3f9942c10418c97d1df582f8b37c7_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOmM3NGM4MzYxNDQ2NDQ0ZjZhZTJjMzY2ODVjNjRiZjViL3RhYmxlcmFuZ2U6Yzc0YzgzNjE0NDY0NDRmNmFlMmMzNjY4NWM2NGJmNWJfNi01LTEtMS03Mjc3NQ_fdfb1875-a22e-48ee-84f2-1117806ee773"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i7eabbab66fc246509ee375373f59a3c8_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOmM3NGM4MzYxNDQ2NDQ0ZjZhZTJjMzY2ODVjNjRiZjViL3RhYmxlcmFuZ2U6Yzc0YzgzNjE0NDY0NDRmNmFlMmMzNjY4NWM2NGJmNWJfNi03LTEtMS03Mjc3NQ_c8e4f863-9fc4-482e-b186-d26ff26d145f"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="i00f54e9cbe804bb38c30969068ff45d3_D20220401-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOmM3NGM4MzYxNDQ2NDQ0ZjZhZTJjMzY2ODVjNjRiZjViL3RhYmxlcmFuZ2U6Yzc0YzgzNjE0NDY0NDRmNmFlMmMzNjY4NWM2NGJmNWJfNy0xLTEtMS03MjY5MA_af46e522-30e8-4f2f-9552-08462537fb86"
      unitRef="usdPerShare">20.07</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="i5734f87cb59c4ab99ff5087249c3e6bc_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOmM3NGM4MzYxNDQ2NDQ0ZjZhZTJjMzY2ODVjNjRiZjViL3RhYmxlcmFuZ2U6Yzc0YzgzNjE0NDY0NDRmNmFlMmMzNjY4NWM2NGJmNWJfNy0zLTEtMS03MjY5MA_ba4ffb24-a73c-45fc-b597-8b5a725e4475"
      unitRef="usdPerShare">3.59</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="i73c3f9942c10418c97d1df582f8b37c7_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOmM3NGM4MzYxNDQ2NDQ0ZjZhZTJjMzY2ODVjNjRiZjViL3RhYmxlcmFuZ2U6Yzc0YzgzNjE0NDY0NDRmNmFlMmMzNjY4NWM2NGJmNWJfNy01LTEtMS03Mjc3NQ_12f1de09-ae01-4105-a449-97769610871e"
      unitRef="usdPerShare">19.15</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="i7eabbab66fc246509ee375373f59a3c8_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOmM3NGM4MzYxNDQ2NDQ0ZjZhZTJjMzY2ODVjNjRiZjViL3RhYmxlcmFuZ2U6Yzc0YzgzNjE0NDY0NDRmNmFlMmMzNjY4NWM2NGJmNWJfNy03LTEtMS03Mjc3NQ_17a1d241-c93c-480f-ab6e-0c8ff2628e3b"
      unitRef="usdPerShare">3.14</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfOtherShareBasedCompensationActivityTableTextBlock
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RleHRyZWdpb246YmIwZTNiYzI1ODYxNDUxOTliMWM1ZWZiN2U2YWM3YjNfODc5NjA5MzAyODI4Nw_b2b51fc6-331d-481b-ba20-48f8b7b5fa8a">A summary of the Company&#x2019;s restricted stock unit (&#x201c;RSU&#x201d;) activity and related information are as follows (restricted stock units in thousands): &lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Awarded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfOtherShareBasedCompensationActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i48c0e4524ffe4c1fa1c1d659ea30bc91_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjIwNDFiYjU3MWE3NjQyOWY5ZGI1YTcwYmNhZDJkNzliL3RhYmxlcmFuZ2U6MjA0MWJiNTcxYTc2NDI5ZjlkYjVhNzBiY2FkMmQ3OWJfNC0xLTEtMS03MTQ4Ng_027838ea-90cf-4482-82eb-71c516f75f58"
      unitRef="shares">35000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i48c0e4524ffe4c1fa1c1d659ea30bc91_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjIwNDFiYjU3MWE3NjQyOWY5ZGI1YTcwYmNhZDJkNzliL3RhYmxlcmFuZ2U6MjA0MWJiNTcxYTc2NDI5ZjlkYjVhNzBiY2FkMmQ3OWJfNC0zLTEtMS03MTQ4Ng_39c577f7-0ae0-4d40-8392-3cdd465feae4"
      unitRef="usdPerShare">34.78</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i97a15a5737b34117975db805d85bb267_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjIwNDFiYjU3MWE3NjQyOWY5ZGI1YTcwYmNhZDJkNzliL3RhYmxlcmFuZ2U6MjA0MWJiNTcxYTc2NDI5ZjlkYjVhNzBiY2FkMmQ3OWJfNS0xLTEtMS03MTQ4Ng_6db1be7d-488b-41ec-91ca-bd8da6a47cf3"
      unitRef="shares">538000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i97a15a5737b34117975db805d85bb267_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjIwNDFiYjU3MWE3NjQyOWY5ZGI1YTcwYmNhZDJkNzliL3RhYmxlcmFuZ2U6MjA0MWJiNTcxYTc2NDI5ZjlkYjVhNzBiY2FkMmQ3OWJfNS0zLTEtMS03MTQ4Ng_328fe883-d577-4c41-8e79-2b720144977f"
      unitRef="usdPerShare">34.14</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i97a15a5737b34117975db805d85bb267_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjIwNDFiYjU3MWE3NjQyOWY5ZGI1YTcwYmNhZDJkNzliL3RhYmxlcmFuZ2U6MjA0MWJiNTcxYTc2NDI5ZjlkYjVhNzBiY2FkMmQ3OWJfNy0xLTEtMS03MTQ4Ng_2b9253fd-90a3-4f72-8164-4eb0968c2166"
      unitRef="shares">14000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i97a15a5737b34117975db805d85bb267_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjIwNDFiYjU3MWE3NjQyOWY5ZGI1YTcwYmNhZDJkNzliL3RhYmxlcmFuZ2U6MjA0MWJiNTcxYTc2NDI5ZjlkYjVhNzBiY2FkMmQ3OWJfNy0zLTEtMS03MTQ4Ng_7419c8ba-ad35-4514-9595-0591371f28c7"
      unitRef="usdPerShare">31.76</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ic60a1a1821b14d1d8d6ac4fff874549d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjIwNDFiYjU3MWE3NjQyOWY5ZGI1YTcwYmNhZDJkNzliL3RhYmxlcmFuZ2U6MjA0MWJiNTcxYTc2NDI5ZjlkYjVhNzBiY2FkMmQ3OWJfOC0xLTEtMS03MTQ4Ng_1f1adfcf-bce1-4649-bfa7-73fd7669cab8"
      unitRef="shares">559000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ic60a1a1821b14d1d8d6ac4fff874549d_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjIwNDFiYjU3MWE3NjQyOWY5ZGI1YTcwYmNhZDJkNzliL3RhYmxlcmFuZ2U6MjA0MWJiNTcxYTc2NDI5ZjlkYjVhNzBiY2FkMmQ3OWJfOC0zLTEtMS03MTQ4Ng_1af444fb-fb44-4fd9-9c0b-43d24ce4865e"
      unitRef="usdPerShare">34.22</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i97a15a5737b34117975db805d85bb267_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RleHRyZWdpb246YmIwZTNiYzI1ODYxNDUxOTliMWM1ZWZiN2U2YWM3YjNfOTM0NTg0ODg0MzA1MQ_82f3c188-3a32-4e6e-9add-376e1e4eaf75"
      unitRef="usd">17800000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i17afe0c0dcba45159077ed56cad20253_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RleHRyZWdpb246YmIwZTNiYzI1ODYxNDUxOTliMWM1ZWZiN2U2YWM3YjNfMjc0ODc3OTA4MTc5NA_c0f42acd-d9a6-46e6-a492-ff064da9e3a4"
      unitRef="usd">700000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="ib8d4c78e6b0f482fae70548a9459a7f1_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RleHRyZWdpb246YmIwZTNiYzI1ODYxNDUxOTliMWM1ZWZiN2U2YWM3YjNfNjU5NzA2OTc3OTA0Mg_246d5e83-fda5-4422-8e4e-9fc197e202ce">P0Y6M</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i17afe0c0dcba45159077ed56cad20253_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RleHRyZWdpb246YmIwZTNiYzI1ODYxNDUxOTliMWM1ZWZiN2U2YWM3YjNfMjc0ODc3OTA4MTgxOA_8300f0a6-2d90-4918-b66e-426602d57748"
      unitRef="shares">800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i9c8e42000a7c49b7b20f5345c42d7b26_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOmRhZGU5MzY2YzM0NTQxNjJhN2I2Njk0MjE3ODBiZGU4L3RhYmxlcmFuZ2U6ZGFkZTkzNjZjMzQ1NDE2MmE3YjY2OTQyMTc4MGJkZThfMy0xLTEtMS03Mjc5Nw_fcc57f93-ab92-485f-876f-615b13547645">P0Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i9c8e42000a7c49b7b20f5345c42d7b26_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOmRhZGU5MzY2YzM0NTQxNjJhN2I2Njk0MjE3ODBiZGU4L3RhYmxlcmFuZ2U6ZGFkZTkzNjZjMzQ1NDE2MmE3YjY2OTQyMTc4MGJkZThfNC0xLTEtMS03Mjc5Nw_e045e20d-3ff6-4e2c-87c5-a458cfbf480d"
      unitRef="number">0.57</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i9c8e42000a7c49b7b20f5345c42d7b26_D20220401-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOmRhZGU5MzY2YzM0NTQxNjJhN2I2Njk0MjE3ODBiZGU4L3RhYmxlcmFuZ2U6ZGFkZTkzNjZjMzQ1NDE2MmE3YjY2OTQyMTc4MGJkZThfNS0xLTEtMS03Mjc5Nw_b54f8f5b-6f45-4eab-8eb5-76ff680a8405"
      unitRef="number">0.018</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i9c8e42000a7c49b7b20f5345c42d7b26_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOmRhZGU5MzY2YzM0NTQxNjJhN2I2Njk0MjE3ODBiZGU4L3RhYmxlcmFuZ2U6ZGFkZTkzNjZjMzQ1NDE2MmE3YjY2OTQyMTc4MGJkZThfNi0xLTEtMS03Mjc5Nw_f5d0a174-6472-4741-bda8-c139bfaee749"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="i9c8e42000a7c49b7b20f5345c42d7b26_D20220401-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOmRhZGU5MzY2YzM0NTQxNjJhN2I2Njk0MjE3ODBiZGU4L3RhYmxlcmFuZ2U6ZGFkZTkzNjZjMzQ1NDE2MmE3YjY2OTQyMTc4MGJkZThfNy0xLTEtMS03Mjc5Nw_14c9fcd7-41aa-4f5f-b15d-58880c94ab28"
      unitRef="usdPerShare">12.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RleHRyZWdpb246YmIwZTNiYzI1ODYxNDUxOTliMWM1ZWZiN2U2YWM3YjNfODc5NjA5MzAyODI4OA_028b0cb6-474c-4718-a338-9d7e89ab5352">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total stock-based compensation recognized, before taxes, are as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.684%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i277b8f845b9c4fe49bd226a094fd599c_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjIxNWI5ZWFlODZiMjQ5Mzc4N2M4YmJmMTJlMTAwNDU3L3RhYmxlcmFuZ2U6MjE1YjllYWU4NmIyNDkzNzg3YzhiYmYxMmUxMDA0NTdfMy0xLTEtMS03MTUwNA_063077c7-44cc-4d72-be6d-ad0de5ed9ff2"
      unitRef="usd">252000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ibfcaafa17e4746279efe3c570e6f9fbb_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjIxNWI5ZWFlODZiMjQ5Mzc4N2M4YmJmMTJlMTAwNDU3L3RhYmxlcmFuZ2U6MjE1YjllYWU4NmIyNDkzNzg3YzhiYmYxMmUxMDA0NTdfMy0zLTEtMS03MTUwNA_28f04b9d-7686-4bbe-a686-36a3e594dbad"
      unitRef="usd">51000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie094c47c8e41442d8f48b3161b3255d9_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjIxNWI5ZWFlODZiMjQ5Mzc4N2M4YmJmMTJlMTAwNDU3L3RhYmxlcmFuZ2U6MjE1YjllYWU4NmIyNDkzNzg3YzhiYmYxMmUxMDA0NTdfMy01LTEtMS03MjgzNA_a2979434-3856-498f-aa8a-72d4c9b2e7e2"
      unitRef="usd">375000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i3846b5796b46497498e5a63b411da5f9_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjIxNWI5ZWFlODZiMjQ5Mzc4N2M4YmJmMTJlMTAwNDU3L3RhYmxlcmFuZ2U6MjE1YjllYWU4NmIyNDkzNzg3YzhiYmYxMmUxMDA0NTdfMy03LTEtMS03MjgzNA_b9c36c60-c109-46fb-b163-9cd233b08012"
      unitRef="usd">74000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i164ec0a968a3490c8e5ca191f4a7e36b_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjIxNWI5ZWFlODZiMjQ5Mzc4N2M4YmJmMTJlMTAwNDU3L3RhYmxlcmFuZ2U6MjE1YjllYWU4NmIyNDkzNzg3YzhiYmYxMmUxMDA0NTdfNC0xLTEtMS03MTUwNA_bb399525-3a02-4d99-a5c2-d0d703df9efb"
      unitRef="usd">553000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie06546dec3a04d87b10442e18708fbee_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjIxNWI5ZWFlODZiMjQ5Mzc4N2M4YmJmMTJlMTAwNDU3L3RhYmxlcmFuZ2U6MjE1YjllYWU4NmIyNDkzNzg3YzhiYmYxMmUxMDA0NTdfNC0zLTEtMS03MTUwNA_a3b8f734-7f9b-45ed-8502-e104307eb569"
      unitRef="usd">155000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i028690643f5b41a3bf4ab56e7150dcfd_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjIxNWI5ZWFlODZiMjQ5Mzc4N2M4YmJmMTJlMTAwNDU3L3RhYmxlcmFuZ2U6MjE1YjllYWU4NmIyNDkzNzg3YzhiYmYxMmUxMDA0NTdfNC01LTEtMS03MjgzNA_c6c9c399-3a9f-4217-ac05-1cc57307c204"
      unitRef="usd">853000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i30ea9dc52b724da0aac81e7933fd37f3_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjIxNWI5ZWFlODZiMjQ5Mzc4N2M4YmJmMTJlMTAwNDU3L3RhYmxlcmFuZ2U6MjE1YjllYWU4NmIyNDkzNzg3YzhiYmYxMmUxMDA0NTdfNC03LTEtMS03MjgzNA_20a833f5-6d3f-4f67-8105-6ff3195e028e"
      unitRef="usd">307000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i90bfc90968d64d2f95bb4f0aab2fabef_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjIxNWI5ZWFlODZiMjQ5Mzc4N2M4YmJmMTJlMTAwNDU3L3RhYmxlcmFuZ2U6MjE1YjllYWU4NmIyNDkzNzg3YzhiYmYxMmUxMDA0NTdfNS0xLTEtMS03MTUwNA_94a82d2e-f2f1-451f-82ef-1c30abfd4191"
      unitRef="usd">1871000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i0f12acefea06470fbd1ff183c033427c_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjIxNWI5ZWFlODZiMjQ5Mzc4N2M4YmJmMTJlMTAwNDU3L3RhYmxlcmFuZ2U6MjE1YjllYWU4NmIyNDkzNzg3YzhiYmYxMmUxMDA0NTdfNS0zLTEtMS03MTUwNA_2fcf2d7f-a40d-48ae-b2fa-14760655ce41"
      unitRef="usd">519000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="if0f804f4efc44311ad8c409d09969458_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjIxNWI5ZWFlODZiMjQ5Mzc4N2M4YmJmMTJlMTAwNDU3L3RhYmxlcmFuZ2U6MjE1YjllYWU4NmIyNDkzNzg3YzhiYmYxMmUxMDA0NTdfNS01LTEtMS03MjgzNA_d14dfd60-90ac-467a-b1b4-0a4e762730d2"
      unitRef="usd">3000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i7eaf117796f144da98cb336ef5d2a3c6_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjIxNWI5ZWFlODZiMjQ5Mzc4N2M4YmJmMTJlMTAwNDU3L3RhYmxlcmFuZ2U6MjE1YjllYWU4NmIyNDkzNzg3YzhiYmYxMmUxMDA0NTdfNS03LTEtMS03MjgzNA_2c58c580-bee2-4043-8d2d-1ed3da7bf273"
      unitRef="usd">994000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjIxNWI5ZWFlODZiMjQ5Mzc4N2M4YmJmMTJlMTAwNDU3L3RhYmxlcmFuZ2U6MjE1YjllYWU4NmIyNDkzNzg3YzhiYmYxMmUxMDA0NTdfNi0xLTEtMS03MTUwNA_f8e6ecc5-c2ee-4a42-a411-b72d4fea9c29"
      unitRef="usd">2676000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjIxNWI5ZWFlODZiMjQ5Mzc4N2M4YmJmMTJlMTAwNDU3L3RhYmxlcmFuZ2U6MjE1YjllYWU4NmIyNDkzNzg3YzhiYmYxMmUxMDA0NTdfNi0zLTEtMS03MTUwNA_e342561e-6ca7-422a-afd6-6798f4cbe8d2"
      unitRef="usd">725000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjIxNWI5ZWFlODZiMjQ5Mzc4N2M4YmJmMTJlMTAwNDU3L3RhYmxlcmFuZ2U6MjE1YjllYWU4NmIyNDkzNzg3YzhiYmYxMmUxMDA0NTdfNi01LTEtMS03MjgzNA_52fad106-b10d-4f2e-8baf-393f13e3bd03"
      unitRef="usd">4228000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV80OS9mcmFnOmJiMGUzYmMyNTg2MTQ1MTk5YjFjNWVmYjdlNmFjN2IzL3RhYmxlOjIxNWI5ZWFlODZiMjQ5Mzc4N2M4YmJmMTJlMTAwNDU3L3RhYmxlcmFuZ2U6MjE1YjllYWU4NmIyNDkzNzg3YzhiYmYxMmUxMDA0NTdfNi03LTEtMS03MjgzNA_984f85e8-ca99-4d12-9253-c35626dda568"
      unitRef="usd">1375000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RleHRyZWdpb246MDZiY2U3MTkzN2QxNDI0YTkxMDlhYzZjYmEyZjQxMWVfNDYz_e2944664-c2b8-4a89-b8be-3070e8172afe">Net Loss Per Share&lt;div style="margin-bottom:9pt;text-indent:24.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon the completion of the Company&#x2019;s IPO in September 2021, all 29,912,264 shares of its then-outstanding redeemable convertible preferred stock automatically converted into 29,912,264 shares of common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:24.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net loss per share was determined as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.684%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,184)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,580)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36,369)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27,402)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average common stock outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss per share, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.82)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:24.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following potentially dilutive securities outstanding have been excluded from the computations of weighted-average shares outstanding because such securities have an antidilutive impact due to losses reported (in common stock equivalent shares, in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable convertible preferred stock outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable convertible preferred stock warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee stock purchase plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="ie390a471379b4ab1bcab0d1678411d3a_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RleHRyZWdpb246MDZiY2U3MTkzN2QxNDI0YTkxMDlhYzZjYmEyZjQxMWVfMjc0ODc3OTA3MDQ3OQ_a7746372-f170-45be-ba83-74b088b7a390"
      unitRef="shares">29912264</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="ie390a471379b4ab1bcab0d1678411d3a_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RleHRyZWdpb246MDZiY2U3MTkzN2QxNDI0YTkxMDlhYzZjYmEyZjQxMWVfMjc0ODc3OTA3MDQ3OQ_be4c7d6f-0ed7-40a7-8a6e-b14a791ecf67"
      unitRef="shares">29912264</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="ie390a471379b4ab1bcab0d1678411d3a_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RleHRyZWdpb246MDZiY2U3MTkzN2QxNDI0YTkxMDlhYzZjYmEyZjQxMWVfMjc0ODc3OTA3MDU4Mg_a7746372-f170-45be-ba83-74b088b7a390"
      unitRef="shares">29912264</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="ie390a471379b4ab1bcab0d1678411d3a_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RleHRyZWdpb246MDZiY2U3MTkzN2QxNDI0YTkxMDlhYzZjYmEyZjQxMWVfMjc0ODc3OTA3MDU4Mg_be4c7d6f-0ed7-40a7-8a6e-b14a791ecf67"
      unitRef="shares">29912264</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RleHRyZWdpb246MDZiY2U3MTkzN2QxNDI0YTkxMDlhYzZjYmEyZjQxMWVfODc5NjA5MzAyMzczNw_195039ee-c4e5-48af-b4de-1d9393aca24b">&lt;div style="margin-bottom:9pt;text-indent:24.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net loss per share was determined as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.684%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,184)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,580)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36,369)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27,402)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average common stock outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss per share, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.82)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicByCommonClassTextBlock
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RleHRyZWdpb246MDZiY2U3MTkzN2QxNDI0YTkxMDlhYzZjYmEyZjQxMWVfODc5NjA5MzAyMzczNw_b10c1c8b-18ef-486d-a2ca-cb76aa3e3768">&lt;div style="margin-bottom:9pt;text-indent:24.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net loss per share was determined as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.684%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,184)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,580)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36,369)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27,402)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average common stock outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss per share, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.82)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicByCommonClassTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjhiNzE4NjA2ZDA1NTQyMTU4ZDQzZjM1M2ZkMWI1NzFiL3RhYmxlcmFuZ2U6OGI3MTg2MDZkMDU1NDIxNThkNDNmMzUzZmQxYjU3MWJfMy0xLTEtMS03MTUzNw_871817a3-a850-42a3-93cb-d2e4d18c2d8f"
      unitRef="usd">-19184000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjhiNzE4NjA2ZDA1NTQyMTU4ZDQzZjM1M2ZkMWI1NzFiL3RhYmxlcmFuZ2U6OGI3MTg2MDZkMDU1NDIxNThkNDNmMzUzZmQxYjU3MWJfMy0zLTEtMS03MTUzNw_f042ced7-6f09-4c88-8f56-19072f9830d7"
      unitRef="usd">-14580000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjhiNzE4NjA2ZDA1NTQyMTU4ZDQzZjM1M2ZkMWI1NzFiL3RhYmxlcmFuZ2U6OGI3MTg2MDZkMDU1NDIxNThkNDNmMzUzZmQxYjU3MWJfMy01LTEtMS03MzAxNA_3912ccdf-349d-4e63-aea3-6a2e13f852cd"
      unitRef="usd">-36369000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjhiNzE4NjA2ZDA1NTQyMTU4ZDQzZjM1M2ZkMWI1NzFiL3RhYmxlcmFuZ2U6OGI3MTg2MDZkMDU1NDIxNThkNDNmMzUzZmQxYjU3MWJfMy03LTEtMS03MzAxNA_f7c0bfd8-31ba-457e-b7d8-9de45d41d020"
      unitRef="usd">-27402000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjhiNzE4NjA2ZDA1NTQyMTU4ZDQzZjM1M2ZkMWI1NzFiL3RhYmxlcmFuZ2U6OGI3MTg2MDZkMDU1NDIxNThkNDNmMzUzZmQxYjU3MWJfNC0xLTEtMS03MTUzNw_c1fe3667-a14c-405c-88ff-65cea064158b"
      unitRef="shares">44324000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjhiNzE4NjA2ZDA1NTQyMTU4ZDQzZjM1M2ZkMWI1NzFiL3RhYmxlcmFuZ2U6OGI3MTg2MDZkMDU1NDIxNThkNDNmMzUzZmQxYjU3MWJfNC0xLTEtMS03MTUzNw_d8b58e26-feaa-4fab-9596-dd85a7a8131b"
      unitRef="shares">44324000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjhiNzE4NjA2ZDA1NTQyMTU4ZDQzZjM1M2ZkMWI1NzFiL3RhYmxlcmFuZ2U6OGI3MTg2MDZkMDU1NDIxNThkNDNmMzUzZmQxYjU3MWJfNC0zLTEtMS03MTUzNw_80c7b1e4-f080-4fb8-87c5-3c7fb24e5db7"
      unitRef="shares">5597000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjhiNzE4NjA2ZDA1NTQyMTU4ZDQzZjM1M2ZkMWI1NzFiL3RhYmxlcmFuZ2U6OGI3MTg2MDZkMDU1NDIxNThkNDNmMzUzZmQxYjU3MWJfNC0zLTEtMS03MTUzNw_c19dd207-19d0-40a2-9e99-c961b67dfc6d"
      unitRef="shares">5597000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjhiNzE4NjA2ZDA1NTQyMTU4ZDQzZjM1M2ZkMWI1NzFiL3RhYmxlcmFuZ2U6OGI3MTg2MDZkMDU1NDIxNThkNDNmMzUzZmQxYjU3MWJfNC01LTEtMS03MzExNg_49191a23-6772-46a3-9b2f-c9a0f9f061fc"
      unitRef="shares">44091000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjhiNzE4NjA2ZDA1NTQyMTU4ZDQzZjM1M2ZkMWI1NzFiL3RhYmxlcmFuZ2U6OGI3MTg2MDZkMDU1NDIxNThkNDNmMzUzZmQxYjU3MWJfNC01LTEtMS03MzExNg_b17c71a7-f774-495d-91a9-4ab6682ce8c8"
      unitRef="shares">44091000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjhiNzE4NjA2ZDA1NTQyMTU4ZDQzZjM1M2ZkMWI1NzFiL3RhYmxlcmFuZ2U6OGI3MTg2MDZkMDU1NDIxNThkNDNmMzUzZmQxYjU3MWJfNC03LTEtMS03MzExNg_024de2bf-30cd-46ba-8e80-a70020f0850c"
      unitRef="shares">5216000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjhiNzE4NjA2ZDA1NTQyMTU4ZDQzZjM1M2ZkMWI1NzFiL3RhYmxlcmFuZ2U6OGI3MTg2MDZkMDU1NDIxNThkNDNmMzUzZmQxYjU3MWJfNC03LTEtMS03MzExNg_176704e1-b4d3-4e18-a760-2d516b48f3c8"
      unitRef="shares">5216000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjhiNzE4NjA2ZDA1NTQyMTU4ZDQzZjM1M2ZkMWI1NzFiL3RhYmxlcmFuZ2U6OGI3MTg2MDZkMDU1NDIxNThkNDNmMzUzZmQxYjU3MWJfNS0xLTEtMS03MTUzNw_21edf69d-0ab2-4d60-b9b5-f1c8c81380bc"
      unitRef="usdPerShare">-0.43</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjhiNzE4NjA2ZDA1NTQyMTU4ZDQzZjM1M2ZkMWI1NzFiL3RhYmxlcmFuZ2U6OGI3MTg2MDZkMDU1NDIxNThkNDNmMzUzZmQxYjU3MWJfNS0xLTEtMS03MTUzNw_237c89ea-bfe8-4d95-ab26-48f21728efa0"
      unitRef="usdPerShare">-0.43</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjhiNzE4NjA2ZDA1NTQyMTU4ZDQzZjM1M2ZkMWI1NzFiL3RhYmxlcmFuZ2U6OGI3MTg2MDZkMDU1NDIxNThkNDNmMzUzZmQxYjU3MWJfNS0zLTEtMS03MTUzNw_2fcae088-bc43-46bc-9d1e-fcf22ba2cfe9"
      unitRef="usdPerShare">-2.60</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjhiNzE4NjA2ZDA1NTQyMTU4ZDQzZjM1M2ZkMWI1NzFiL3RhYmxlcmFuZ2U6OGI3MTg2MDZkMDU1NDIxNThkNDNmMzUzZmQxYjU3MWJfNS0zLTEtMS03MTUzNw_6edc0d90-f8ff-4c18-8cb2-4a0ab2c98c1e"
      unitRef="usdPerShare">-2.60</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjhiNzE4NjA2ZDA1NTQyMTU4ZDQzZjM1M2ZkMWI1NzFiL3RhYmxlcmFuZ2U6OGI3MTg2MDZkMDU1NDIxNThkNDNmMzUzZmQxYjU3MWJfNS01LTEtMS03MzAyMQ_0d2a47e5-0d6c-457e-b938-54d1bba7af8c"
      unitRef="usdPerShare">-0.82</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjhiNzE4NjA2ZDA1NTQyMTU4ZDQzZjM1M2ZkMWI1NzFiL3RhYmxlcmFuZ2U6OGI3MTg2MDZkMDU1NDIxNThkNDNmMzUzZmQxYjU3MWJfNS01LTEtMS03MzAyMQ_e1efac9e-6c8b-4370-a80f-375513b5e5e6"
      unitRef="usdPerShare">-0.82</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjhiNzE4NjA2ZDA1NTQyMTU4ZDQzZjM1M2ZkMWI1NzFiL3RhYmxlcmFuZ2U6OGI3MTg2MDZkMDU1NDIxNThkNDNmMzUzZmQxYjU3MWJfNS03LTEtMS03MzAyMQ_252c63d4-b601-4b3c-a79f-9dea85a01181"
      unitRef="usdPerShare">-5.25</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjhiNzE4NjA2ZDA1NTQyMTU4ZDQzZjM1M2ZkMWI1NzFiL3RhYmxlcmFuZ2U6OGI3MTg2MDZkMDU1NDIxNThkNDNmMzUzZmQxYjU3MWJfNS03LTEtMS03MzAyMQ_25de0304-ac87-4cb3-aa09-ec214339b92c"
      unitRef="usdPerShare">-5.25</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RleHRyZWdpb246MDZiY2U3MTkzN2QxNDI0YTkxMDlhYzZjYmEyZjQxMWVfODc5NjA5MzAyMzczOA_e56a6957-7615-4f2c-8078-e83445cbd2f2">&lt;div style="margin-bottom:9pt;text-indent:24.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following potentially dilutive securities outstanding have been excluded from the computations of weighted-average shares outstanding because such securities have an antidilutive impact due to losses reported (in common stock equivalent shares, in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable convertible preferred stock outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable convertible preferred stock warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee stock purchase plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i16c6e66d4ce6495b8d9d4fb2a81130ec_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjAwM2NmYTA1Y2JiNjQzMWFiMmM5YTVhZGEwODYwMGIyL3RhYmxlcmFuZ2U6MDAzY2ZhMDVjYmI2NDMxYWIyYzlhNWFkYTA4NjAwYjJfMy0xLTEtMS03MTUzNw_e81361b7-ef5c-4735-b6a7-9f294f2d56dd"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ia13da9ea227f4e738ed2a4ade74a841d_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjAwM2NmYTA1Y2JiNjQzMWFiMmM5YTVhZGEwODYwMGIyL3RhYmxlcmFuZ2U6MDAzY2ZhMDVjYmI2NDMxYWIyYzlhNWFkYTA4NjAwYjJfMy0zLTEtMS03MTUzNw_bf93d8a9-094b-4c41-99ea-eae32a7df0e2"
      unitRef="shares">29850000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="idaefefa698af4a6bb691e2fb7f0a6944_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjAwM2NmYTA1Y2JiNjQzMWFiMmM5YTVhZGEwODYwMGIyL3RhYmxlcmFuZ2U6MDAzY2ZhMDVjYmI2NDMxYWIyYzlhNWFkYTA4NjAwYjJfNC0xLTEtMS03MTUzNw_24841bb5-5df8-43d6-a4b5-1be6584c2032"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i140935dcf8204cbf959d52cbd44911ae_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjAwM2NmYTA1Y2JiNjQzMWFiMmM5YTVhZGEwODYwMGIyL3RhYmxlcmFuZ2U6MDAzY2ZhMDVjYmI2NDMxYWIyYzlhNWFkYTA4NjAwYjJfNC0zLTEtMS03MTUzNw_c41ed12c-0a3e-4c2e-9f24-fcb965968203"
      unitRef="shares">72000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i01badfb698334a429a1be2da49cd7a91_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjAwM2NmYTA1Y2JiNjQzMWFiMmM5YTVhZGEwODYwMGIyL3RhYmxlcmFuZ2U6MDAzY2ZhMDVjYmI2NDMxYWIyYzlhNWFkYTA4NjAwYjJfNi0xLTEtMS03MTUzNw_43e9fe6e-980c-4e97-a0af-e32a29447554"
      unitRef="shares">5666000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i1372789c7d3948d3b8aca78f2d9b92dd_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjAwM2NmYTA1Y2JiNjQzMWFiMmM5YTVhZGEwODYwMGIyL3RhYmxlcmFuZ2U6MDAzY2ZhMDVjYmI2NDMxYWIyYzlhNWFkYTA4NjAwYjJfNi0zLTEtMS03MTUzNw_20c60216-d89e-448e-92d3-70a6e2ab4bca"
      unitRef="shares">6621000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i124d9db5d45e4effa8c6d68140756087_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjAwM2NmYTA1Y2JiNjQzMWFiMmM5YTVhZGEwODYwMGIyL3RhYmxlcmFuZ2U6MDAzY2ZhMDVjYmI2NDMxYWIyYzlhNWFkYTA4NjAwYjJfNy0xLTEtMS03MTUzNw_5304ae3b-df1b-482e-b93f-d5051087bf69"
      unitRef="shares">559000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i10a1fb79429d4c70978ced6bf017f60f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjAwM2NmYTA1Y2JiNjQzMWFiMmM5YTVhZGEwODYwMGIyL3RhYmxlcmFuZ2U6MDAzY2ZhMDVjYmI2NDMxYWIyYzlhNWFkYTA4NjAwYjJfNy0zLTEtMS03MTUzNw_e51128ef-ab4b-4014-a5c3-4b739e02d859"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i49e74c53b47042178251b4824d6b4122_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjAwM2NmYTA1Y2JiNjQzMWFiMmM5YTVhZGEwODYwMGIyL3RhYmxlcmFuZ2U6MDAzY2ZhMDVjYmI2NDMxYWIyYzlhNWFkYTA4NjAwYjJfOC0xLTEtMS03MTUzNw_b5875f7b-5fce-4752-af0e-80a3e84465fa"
      unitRef="shares">61000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i34fe12d789d3432680d4d84cc2fdfe4f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjAwM2NmYTA1Y2JiNjQzMWFiMmM5YTVhZGEwODYwMGIyL3RhYmxlcmFuZ2U6MDAzY2ZhMDVjYmI2NDMxYWIyYzlhNWFkYTA4NjAwYjJfOC0zLTEtMS03MTUzNw_5b0c6d0e-ab25-4c14-841d-659b95006567"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjAwM2NmYTA1Y2JiNjQzMWFiMmM5YTVhZGEwODYwMGIyL3RhYmxlcmFuZ2U6MDAzY2ZhMDVjYmI2NDMxYWIyYzlhNWFkYTA4NjAwYjJfOS0xLTEtMS03MTUzNw_61f07685-d5af-4969-b7d2-cf1c91978575"
      unitRef="shares">6286000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81Mi9mcmFnOjA2YmNlNzE5MzdkMTQyNGE5MTA5YWM2Y2JhMmY0MTFlL3RhYmxlOjAwM2NmYTA1Y2JiNjQzMWFiMmM5YTVhZGEwODYwMGIyL3RhYmxlcmFuZ2U6MDAzY2ZhMDVjYmI2NDMxYWIyYzlhNWFkYTA4NjAwYjJfOS0zLTEtMS03MTUzNw_0d2e9cf8-53c0-42f5-a48a-123d686c9ca3"
      unitRef="shares">36543000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RleHRyZWdpb246MTY0MzE4NWVmNjI4NDI1N2E1N2I1MDEwYjA5YWIwZDBfNzQzMA_06b3d1d7-8b42-4efa-93d2-0cb7577516a6">Revenue&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents revenue disaggregated by type and geography (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.684%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;System sales and rentals&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Handpieces and other consumables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total U.S. revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outside of U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;System sales and rentals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Handpieces and other consumables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total outside of U.S. revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RleHRyZWdpb246MTY0MzE4NWVmNjI4NDI1N2E1N2I1MDEwYjA5YWIwZDBfODc5NjA5MzAzNzEwOQ_20ffde5f-4f40-4480-bf54-b502fa3ff063">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents revenue disaggregated by type and geography (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.684%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;System sales and rentals&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Handpieces and other consumables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total U.S. revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outside of U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;System sales and rentals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Handpieces and other consumables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total outside of U.S. revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock>
    <us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RleHRyZWdpb246MTY0MzE4NWVmNjI4NDI1N2E1N2I1MDEwYjA5YWIwZDBfODc5NjA5MzAzNzEwOQ_eb67f7d1-5804-4cd2-864e-80435f85cb85">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents revenue disaggregated by type and geography (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.684%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;System sales and rentals&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Handpieces and other consumables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total U.S. revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outside of U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;System sales and rentals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Handpieces and other consumables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total outside of U.S. revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s revenue by geographical location is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outside the United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iae550cb350ab4aa093330a1aa67fbb59_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfNC0xLTEtMS03MTU1Ng_50e1377f-092c-4d5a-a1e3-511a76a87a23"
      unitRef="usd">8516000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icc3548f9c5af4248b89810935e741c81_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfNC0zLTEtMS03MTU1Ng_50ae5ac7-93d5-457f-883e-63b390a5e4ad"
      unitRef="usd">4770000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i354124ad73aa4d359530dedf6cc892ff_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfMy01LTEtMS03NDk5Ng_46b661a6-f321-42cf-b403-080856933da6"
      unitRef="usd">16270000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i034be609d4174ca28c7931f45c17137f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfMy03LTEtMS03NDk5Ng_41f61bd0-fe3b-417b-ba7b-126c5d459559"
      unitRef="usd">9330000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i93f054b306ba42db85eac45b5398e920_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfNS0xLTEtMS03MTU1Ng_77681a72-1345-4218-93b5-9564e9ab07e7"
      unitRef="usd">5723000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1a3ab372268f4d07ac5a6cef9de6d000_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfNS0zLTEtMS03MTU1Ng_a0fa790e-dd7a-40ff-8ebd-b23281f4be2d"
      unitRef="usd">1653000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib0f3737d0aba4fb9a4cb003b37c4a03c_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfNC01LTEtMS03NDk5Ng_6e0b562a-f474-4fb3-92cc-65901796c70b"
      unitRef="usd">10167000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i34e859a6c83448509ff840a825f98408_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfNC03LTEtMS03NDk5Ng_475c9f9f-3d0f-4a2c-9184-c82454247c7e"
      unitRef="usd">3274000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifa95f8ea20be433eafa6a8ca0854a1ab_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfNi0xLTEtMS03MTU1Ng_61df5fe5-7d51-4058-9da6-a883678e3f86"
      unitRef="usd">567000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i103aeef9defe4b0387c733d075b32506_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfNi0zLTEtMS03MTU1Ng_27b4336a-cec7-400f-ba85-eb56aeeef1f2"
      unitRef="usd">137000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7323a463430b427eade72651460a0dda_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfNS01LTEtMS03NDk5Ng_23e3b52e-2c4f-4340-80de-952d0b416621"
      unitRef="usd">929000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4c8cc8b31066433d9ab97e1244ff31b5_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfNS03LTEtMS03NDk5Ng_742fe878-1212-47c8-bbe4-752967848abb"
      unitRef="usd">209000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i56197f81b18f4fdd9144c91fbf486356_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfNy0xLTEtMS03MTU1Ng_6ab92ad5-aef6-4563-ac2b-421724ca056c"
      unitRef="usd">14806000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i84cfac7405214cd68837a7cd08d45162_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfNy0zLTEtMS03MTU1Ng_a29d3f9b-8748-4129-9825-5183ff1802b4"
      unitRef="usd">6560000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iebbce8d97e394404821074c8c3cbf98b_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfNi01LTEtMS03NDk5Ng_fd6439e7-4fd6-48c9-af7c-8f04f4c7cb52"
      unitRef="usd">27366000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1b6d991467f646b192fb0bf7523d7fe3_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfNi03LTEtMS03NDk5Ng_a72ca281-70ff-4ddd-adad-b754b0515674"
      unitRef="usd">12813000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie0697cd6105f4abf9c831356c1473b25_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfOS0xLTEtMS03MTU1Ng_80819347-04f8-4e54-9d58-3bd8281285f9"
      unitRef="usd">869000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i837cadc9f10943b7b8afdee6a7838bae_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfOS0zLTEtMS03MTU1Ng_199f2eb2-a694-4cfb-8437-9d9daf579b7f"
      unitRef="usd">973000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1d7b2d1422fa47d7b08d486dff9d320a_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfOC01LTEtMS03NDk5Ng_98a7091e-a4e0-4e5b-8d1b-e75a6f03bd9f"
      unitRef="usd">1610000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibb609047c8a640abaa29cd36b1d98737_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfOC03LTEtMS03NDk5Ng_22df346a-9633-42bc-a3cf-4659d617bfb8"
      unitRef="usd">1244000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i841d3dd4b3a54b2f94fa7066f3cea1e5_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfMTAtMS0xLTEtNzE1NTY_9b2ba30d-6b10-45dc-aabb-d7ae0a958fcc"
      unitRef="usd">832000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie9832ef4d4be47168e465fd04aaf5f66_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfMTAtMy0xLTEtNzE1NTY_f4f5b33b-1757-4ea5-8c1c-1845c4066957"
      unitRef="usd">890000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idc2c8df366d747ccaf7c4700fcfa6b6b_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfOS01LTEtMS03NDk5Ng_366acf76-71a2-44dd-9da2-33ae22cb18fa"
      unitRef="usd">1578000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9d3b3cc27d31469897df4789948762e2_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfOS03LTEtMS03NDk5Ng_f376a8ff-ad6b-41d4-9f41-7443688135c4"
      unitRef="usd">1493000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib25e541235774f03a985292fa15ef08c_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfMTEtMS0xLTEtNzE1NTY_ba927a83-1462-44c4-9fdd-c91826d08e86"
      unitRef="usd">184000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id619c937117e495295cff348cd8098f9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfMTEtMy0xLTEtNzE1NTY_f8d667e3-777b-47a9-95ce-43222bfc4273"
      unitRef="usd">53000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic8b4017be8a44b8c871ccec3eb53803d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfMTAtNS0xLTEtNzQ5OTY_88a823f7-dac5-4bcc-a520-d2979d46d2d3"
      unitRef="usd">334000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4ffaf08378e1423a947bf449998d53e6_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfMTAtNy0xLTEtNzQ5OTY_186ff9ae-06ff-40b7-a734-668338b5647c"
      unitRef="usd">118000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2b75e831ee944df685fe171431077c73_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfMTItMS0xLTEtNzE1NTY_d3d76978-6385-47e0-8bb1-d9878f6f5ab6"
      unitRef="usd">1885000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if9f1dced786449a0ba9d25bcd7dda9de_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfMTItMy0xLTEtNzE1NTY_10114ea5-b5a5-428b-bf34-77f7df452185"
      unitRef="usd">1916000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if17ffbed1df54f99a2e086997e1e3fec_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfMTEtNS0xLTEtNzQ5OTY_d27588f4-e584-48f6-92d7-b015c13b80bc"
      unitRef="usd">3522000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7b6405459f5948bfb4f2a67be3632426_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfMTEtNy0xLTEtNzQ5OTY_8d3b13b3-bab3-40a4-8be9-8daabffd45d4"
      unitRef="usd">2855000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfMTMtMS0xLTEtNzE1NTY_feb07ba1-b9ab-4cc0-aca3-33807d7f3608"
      unitRef="usd">16691000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfMTMtMy0xLTEtNzE1NTY_d832e31f-9dff-47ee-b759-0635d4bccf66"
      unitRef="usd">8476000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfMTItNS0xLTEtNzQ5OTY_89b4bb48-b0e2-4804-b2b8-eafc49b082bd"
      unitRef="usd">30888000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81NS9mcmFnOjE2NDMxODVlZjYyODQyNTdhNTdiNTAxMGIwOWFiMGQwL3RhYmxlOjg5MDU3NjBjNDEwNTRjZmU4OWU4ZTE0YTcyZjNjMjJmL3RhYmxlcmFuZ2U6ODkwNTc2MGM0MTA1NGNmZTg5ZThlMTRhNzJmM2MyMmZfMTItNy0xLTEtNzQ5OTY_77ccd770-978a-4f6d-8b7e-1278e1f22f2d"
      unitRef="usd">15668000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskDisclosureTextBlock
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81OC9mcmFnOmFhZjdhMjRkZGE3MDRlZmI5YmI3YWExMzQ5M2QwZDkyL3RleHRyZWdpb246YWFmN2EyNGRkYTcwNGVmYjliYjdhYTEzNDkzZDBkOTJfMjg0Ng_452600b5-0100-4f68-99a8-d45813610e07">Segment, Geographical, and Customer Concentration&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates as a single operating segment. The Company&#x2019;s chief operating decision maker, its Chief Executive Officer, reviews financial information on an aggregate basis for the purposes of allocating resources and evaluating financial performance. The Company&#x2019;s long-lived assets are primarily based in the United States.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:24.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No customers accounted for more than 10% of revenue during the three and six months ended June 30, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:24.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No customers accounted for more than 10% of accounts receivable at June&#160;30, 2022. One customer accounted for 11% of accounts receivable at  December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s revenue by geographical location is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outside the United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ConcentrationRiskDisclosureTextBlock>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81OC9mcmFnOmFhZjdhMjRkZGE3MDRlZmI5YmI3YWExMzQ5M2QwZDkyL3RleHRyZWdpb246YWFmN2EyNGRkYTcwNGVmYjliYjdhYTEzNDkzZDBkOTJfNjU5NzA2OTc3MzUyNQ_86c4f378-6222-4343-8a2a-d7505b542d4b">Segment, Geographical, and Customer Concentration&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates as a single operating segment. The Company&#x2019;s chief operating decision maker, its Chief Executive Officer, reviews financial information on an aggregate basis for the purposes of allocating resources and evaluating financial performance. The Company&#x2019;s long-lived assets are primarily based in the United States.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:24.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No customers accounted for more than 10% of revenue during the three and six months ended June 30, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:24.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No customers accounted for more than 10% of accounts receivable at June&#160;30, 2022. One customer accounted for 11% of accounts receivable at  December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s revenue by geographical location is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outside the United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i4b602262223d4640893e5dd50f271572_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81OC9mcmFnOmFhZjdhMjRkZGE3MDRlZmI5YmI3YWExMzQ5M2QwZDkyL3RleHRyZWdpb246YWFmN2EyNGRkYTcwNGVmYjliYjdhYTEzNDkzZDBkOTJfNjU5NzA2OTc3MzE5Ng_d3b376e8-bbf1-48ec-a994-e07de44a2c3b"
      unitRef="number">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i126dea3f4e7745c5ae15e412fd7a688c_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81OC9mcmFnOmFhZjdhMjRkZGE3MDRlZmI5YmI3YWExMzQ5M2QwZDkyL3RleHRyZWdpb246YWFmN2EyNGRkYTcwNGVmYjliYjdhYTEzNDkzZDBkOTJfMjc0ODc3OTA3MjU2Mg_33254af5-3a85-4b11-9e58-b7a7518d611f"
      unitRef="number">0.11</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i4fcecdc96c7946a6917102a9bc187595_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81OC9mcmFnOmFhZjdhMjRkZGE3MDRlZmI5YmI3YWExMzQ5M2QwZDkyL3RhYmxlOjYyMTI2NDk4OGMzMjQwMTM4NWVhZWYwY2UzYTQwNTU0L3RhYmxlcmFuZ2U6NjIxMjY0OTg4YzMyNDAxMzg1ZWFlZjBjZTNhNDA1NTRfMy0xLTEtMS03NDk3MA_a0820456-a431-455b-8e58-4dfb0edd88e2"
      unitRef="number">0.89</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i06b7903ecea34c54885ee96df8bd17f7_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81OC9mcmFnOmFhZjdhMjRkZGE3MDRlZmI5YmI3YWExMzQ5M2QwZDkyL3RhYmxlOjYyMTI2NDk4OGMzMjQwMTM4NWVhZWYwY2UzYTQwNTU0L3RhYmxlcmFuZ2U6NjIxMjY0OTg4YzMyNDAxMzg1ZWFlZjBjZTNhNDA1NTRfMy0zLTEtMS03NDk3MA_a649853b-a083-4eb6-87e4-500fc9cab9bd"
      unitRef="number">0.77</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i24596b41408a4ffea6e70203801645e4_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81OC9mcmFnOmFhZjdhMjRkZGE3MDRlZmI5YmI3YWExMzQ5M2QwZDkyL3RhYmxlOjYyMTI2NDk4OGMzMjQwMTM4NWVhZWYwY2UzYTQwNTU0L3RhYmxlcmFuZ2U6NjIxMjY0OTg4YzMyNDAxMzg1ZWFlZjBjZTNhNDA1NTRfMy01LTEtMS03NDk3MA_0e9ce6c2-faa1-4c32-82ff-c8e4d18150d1"
      unitRef="number">0.89</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i178c15123386454db3b2a62f93f77161_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81OC9mcmFnOmFhZjdhMjRkZGE3MDRlZmI5YmI3YWExMzQ5M2QwZDkyL3RhYmxlOjYyMTI2NDk4OGMzMjQwMTM4NWVhZWYwY2UzYTQwNTU0L3RhYmxlcmFuZ2U6NjIxMjY0OTg4YzMyNDAxMzg1ZWFlZjBjZTNhNDA1NTRfMy03LTEtMS03NDk3MA_a154b315-8612-4397-be36-bde3a45895d6"
      unitRef="number">0.82</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i969ef2b7ba3b4291a15d9307f31bf736_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81OC9mcmFnOmFhZjdhMjRkZGE3MDRlZmI5YmI3YWExMzQ5M2QwZDkyL3RhYmxlOjYyMTI2NDk4OGMzMjQwMTM4NWVhZWYwY2UzYTQwNTU0L3RhYmxlcmFuZ2U6NjIxMjY0OTg4YzMyNDAxMzg1ZWFlZjBjZTNhNDA1NTRfNC0xLTEtMS03NDk3MA_485abdff-c08e-4d7b-a525-3388be0d2d2b"
      unitRef="number">0.11</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="id766d70acd42417684ab4d19ff0aaba3_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81OC9mcmFnOmFhZjdhMjRkZGE3MDRlZmI5YmI3YWExMzQ5M2QwZDkyL3RhYmxlOjYyMTI2NDk4OGMzMjQwMTM4NWVhZWYwY2UzYTQwNTU0L3RhYmxlcmFuZ2U6NjIxMjY0OTg4YzMyNDAxMzg1ZWFlZjBjZTNhNDA1NTRfNC0zLTEtMS03NDk3MA_d3eca336-401e-4b23-b459-c609f3d4fe61"
      unitRef="number">0.23</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ie317f3d85145457ebb62b991028c5dbc_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81OC9mcmFnOmFhZjdhMjRkZGE3MDRlZmI5YmI3YWExMzQ5M2QwZDkyL3RhYmxlOjYyMTI2NDk4OGMzMjQwMTM4NWVhZWYwY2UzYTQwNTU0L3RhYmxlcmFuZ2U6NjIxMjY0OTg4YzMyNDAxMzg1ZWFlZjBjZTNhNDA1NTRfNC01LTEtMS03NDk3MA_88b13906-e64d-4c42-aca5-9f2aaf8abd6e"
      unitRef="number">0.11</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i74d4cb137b6049418262544587636450_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV81OC9mcmFnOmFhZjdhMjRkZGE3MDRlZmI5YmI3YWExMzQ5M2QwZDkyL3RhYmxlOjYyMTI2NDk4OGMzMjQwMTM4NWVhZWYwY2UzYTQwNTU0L3RhYmxlcmFuZ2U6NjIxMjY0OTg4YzMyNDAxMzg1ZWFlZjBjZTNhNDA1NTRfNC03LTEtMS03NDk3MA_9aa36a9f-5be4-4dd9-b911-444e0c116f27"
      unitRef="number">0.18</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90ZXh0cmVnaW9uOmY3NzA3NzM4ZGNjMDQzNWJiNzAxMjdmMGE3ZWZjYjEzXzg3OTYwOTMwMjYxNzE_5d5f8b1a-bf7d-4b3b-bb5a-7d1227a334f1">Commitments and Contingencies&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Guarantees and Indemnifications  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the normal course of business, the Company enters into agreements that contain a variety of representations and provide for general indemnification. The Company&#x2019;s exposure under these agreements is unknown because it involves claims that may be made against the Company in the future. To date, the Company has not paid any claims or been required to defend any action related to its indemnification obligations. As of June&#160;30, 2022 and December&#160;31, 2021, the Company does not have any material indemnification claims that were probable or reasonably possible and consequently has not recorded related liabilities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Facility Lease &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2013, the Company entered into a lease agreement for its current facility located in Redwood City, California. In 2018, the Company expanded the lease space and extended the lease agreement through October 2023. The lease agreement provides for an escalation of rent payments each year and the Company records rent expense on a straight-line basis over the term of the lease.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Rent expense recognized under the lease, including additional rent charges for utilities, parking, maintenance, and real estate taxes, was $0.7&#160;million for both the three months ended June 30, 2022 and 2021, respectively, and $1.4&#160;million and $1.3&#160;million for the  six months ended June 30, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.666%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of June&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Minimum Lease Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Debt Repayments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total minimum payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amount representing interest/unamortized debt discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(243)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of future payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,258)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,258)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current portion&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2022 and December&#160;31, 2021, the Company&#x2019;s security deposit is in the form of, and recorded as, restricted cash. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2021, the Company entered into a lease for two existing buildings, comprising approximately 158,221 square feet of space, located in San Jose, California.  The lease commenced in July 2022, and will continue for 122 months following thereafter, with two five year options to extend the term of the lease. The Lease provides for annual base rent of $4.3 million for the first year, which increases on a yearly basis up to $5.5 million for the tenth year, for an aggregate of $49.2 million. Under the terms of the lease, the Company will receive an allowance of up to $7.9 million from the landlord to be applied to the Company&#x2019;s construction of tenant improvements following the landlord&#x2019;s delivery of the two buildings to the Company.  The Company is currently assessing the accounting impact of the lease on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90ZXh0cmVnaW9uOmY3NzA3NzM4ZGNjMDQzNWJiNzAxMjdmMGE3ZWZjYjEzXzg3OTYwOTMwMjYxNzE_6357a1a0-0a00-4c54-8164-3167ae8be832">Commitments and Contingencies&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Guarantees and Indemnifications  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the normal course of business, the Company enters into agreements that contain a variety of representations and provide for general indemnification. The Company&#x2019;s exposure under these agreements is unknown because it involves claims that may be made against the Company in the future. To date, the Company has not paid any claims or been required to defend any action related to its indemnification obligations. As of June&#160;30, 2022 and December&#160;31, 2021, the Company does not have any material indemnification claims that were probable or reasonably possible and consequently has not recorded related liabilities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Facility Lease &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2013, the Company entered into a lease agreement for its current facility located in Redwood City, California. In 2018, the Company expanded the lease space and extended the lease agreement through October 2023. The lease agreement provides for an escalation of rent payments each year and the Company records rent expense on a straight-line basis over the term of the lease.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Rent expense recognized under the lease, including additional rent charges for utilities, parking, maintenance, and real estate taxes, was $0.7&#160;million for both the three months ended June 30, 2022 and 2021, respectively, and $1.4&#160;million and $1.3&#160;million for the  six months ended June 30, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.666%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of June&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Minimum Lease Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Debt Repayments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total minimum payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amount representing interest/unamortized debt discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(243)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of future payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,258)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,258)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current portion&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2022 and December&#160;31, 2021, the Company&#x2019;s security deposit is in the form of, and recorded as, restricted cash. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2021, the Company entered into a lease for two existing buildings, comprising approximately 158,221 square feet of space, located in San Jose, California.  The lease commenced in July 2022, and will continue for 122 months following thereafter, with two five year options to extend the term of the lease. The Lease provides for annual base rent of $4.3 million for the first year, which increases on a yearly basis up to $5.5 million for the tenth year, for an aggregate of $49.2 million. Under the terms of the lease, the Company will receive an allowance of up to $7.9 million from the landlord to be applied to the Company&#x2019;s construction of tenant improvements following the landlord&#x2019;s delivery of the two buildings to the Company.  The Company is currently assessing the accounting impact of the lease on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:OperatingLeaseExpense
      contextRef="ia7f49cd919b04e2c8cb7889c5352bac8_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90ZXh0cmVnaW9uOmY3NzA3NzM4ZGNjMDQzNWJiNzAxMjdmMGE3ZWZjYjEzXzk4OTU2MDQ2NTQ2NjI_0fe96ed4-27dd-4bb7-8454-4eea1a34a7a9"
      unitRef="usd">700000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i9640280ee02a463885b62fb60246cfec_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90ZXh0cmVnaW9uOmY3NzA3NzM4ZGNjMDQzNWJiNzAxMjdmMGE3ZWZjYjEzXzk4OTU2MDQ2NTQ2NjI_b6e24881-64e7-4f6a-b898-529a2df44b9a"
      unitRef="usd">700000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90ZXh0cmVnaW9uOmY3NzA3NzM4ZGNjMDQzNWJiNzAxMjdmMGE3ZWZjYjEzXzk4OTU2MDQ2NTQ2NzA_0c7e2246-0d9c-4854-a4c4-5fe191f34bec"
      unitRef="usd">1400000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i78068bd85b89418bad73a8f597e8a8ba_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90ZXh0cmVnaW9uOmY3NzA3NzM4ZGNjMDQzNWJiNzAxMjdmMGE3ZWZjYjEzXzk4OTU2MDQ2NTQ2Nzg_ab197ae3-c528-405b-ab7d-1c30bfa5ca6e"
      unitRef="usd">1300000</us-gaap:OperatingLeaseExpense>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90ZXh0cmVnaW9uOmY3NzA3NzM4ZGNjMDQzNWJiNzAxMjdmMGE3ZWZjYjEzXzg3OTYwOTMwMjYxNzI_866dff97-bb0b-41bd-b846-d0c381616000">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.666%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of June&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Minimum Lease Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Debt Repayments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total minimum payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amount representing interest/unamortized debt discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(243)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of future payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,258)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,258)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current portion&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90ZXh0cmVnaW9uOmY3NzA3NzM4ZGNjMDQzNWJiNzAxMjdmMGE3ZWZjYjEzXzg3OTYwOTMwMjYxNzI_acb6d04a-28e2-4259-bedb-049e0ef2df0c">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.666%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of June&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Minimum Lease Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Debt Repayments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total minimum payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amount representing interest/unamortized debt discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(243)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of future payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,258)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,258)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current portion&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90YWJsZToyODQ0NjgzZDUwNzc0MjJmODI1MDdjNzk5MjFjYmNiOS90YWJsZXJhbmdlOjI4NDQ2ODNkNTA3NzQyMmY4MjUwN2M3OTkyMWNiY2I5XzEtMS0xLTEtNzE2MDY_1980a0ea-410f-4d85-a001-e3c43c2c3020"
      unitRef="usd">1238000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90YWJsZToyODQ0NjgzZDUwNzc0MjJmODI1MDdjNzk5MjFjYmNiOS90YWJsZXJhbmdlOjI4NDQ2ODNkNTA3NzQyMmY4MjUwN2M3OTkyMWNiY2I5XzEtMy0xLTEtNzE2MDY_c1d26a3c-1a93-4803-a3da-3998cdf2040c"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear>
    <prct:OperatingLeaseLiabilityAndLongTermDebtMaturityRemainderOfFiscalYear
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90YWJsZToyODQ0NjgzZDUwNzc0MjJmODI1MDdjNzk5MjFjYmNiOS90YWJsZXJhbmdlOjI4NDQ2ODNkNTA3NzQyMmY4MjUwN2M3OTkyMWNiY2I5XzEtNS0xLTEtNzE2MDY_eefcba78-463c-4af4-b2aa-f8a076425837"
      unitRef="usd">1238000</prct:OperatingLeaseLiabilityAndLongTermDebtMaturityRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90YWJsZToyODQ0NjgzZDUwNzc0MjJmODI1MDdjNzk5MjFjYmNiOS90YWJsZXJhbmdlOjI4NDQ2ODNkNTA3NzQyMmY4MjUwN2M3OTkyMWNiY2I5XzItMS0xLTEtNzE2MDY_d7a9cbc7-4362-4287-a5a1-30a01562a407"
      unitRef="usd">2092000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90YWJsZToyODQ0NjgzZDUwNzc0MjJmODI1MDdjNzk5MjFjYmNiOS90YWJsZXJhbmdlOjI4NDQ2ODNkNTA3NzQyMmY4MjUwN2M3OTkyMWNiY2I5XzItMy0xLTEtNzE2MDY_2ad4c098-e67c-43d0-bc56-2ebfc5442c04"
      unitRef="usd">12500000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <prct:OperatingLeaseLiabilityAndLongTermDebtMaturityYearOne
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90YWJsZToyODQ0NjgzZDUwNzc0MjJmODI1MDdjNzk5MjFjYmNiOS90YWJsZXJhbmdlOjI4NDQ2ODNkNTA3NzQyMmY4MjUwN2M3OTkyMWNiY2I5XzItNS0xLTEtNzE2MDY_ee745ff7-7266-4e6f-beca-4729350d439f"
      unitRef="usd">14592000</prct:OperatingLeaseLiabilityAndLongTermDebtMaturityYearOne>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90YWJsZToyODQ0NjgzZDUwNzc0MjJmODI1MDdjNzk5MjFjYmNiOS90YWJsZXJhbmdlOjI4NDQ2ODNkNTA3NzQyMmY4MjUwN2M3OTkyMWNiY2I5XzMtMS0xLTEtNzE2MDY_670073d3-bd67-4d22-b16c-3859785ff359"
      unitRef="usd">0</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90YWJsZToyODQ0NjgzZDUwNzc0MjJmODI1MDdjNzk5MjFjYmNiOS90YWJsZXJhbmdlOjI4NDQ2ODNkNTA3NzQyMmY4MjUwN2M3OTkyMWNiY2I5XzMtMy0xLTEtNzE2MDY_dc07ce02-c114-4ac4-8149-1b2024d83115"
      unitRef="usd">37500000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <prct:OperatingLeaseLiabilityAndLongTermDebtMaturityYearTwo
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90YWJsZToyODQ0NjgzZDUwNzc0MjJmODI1MDdjNzk5MjFjYmNiOS90YWJsZXJhbmdlOjI4NDQ2ODNkNTA3NzQyMmY4MjUwN2M3OTkyMWNiY2I5XzMtNS0xLTEtNzE2MDY_253e293e-bf0b-45ff-a03a-e6d10ce4022d"
      unitRef="usd">37500000</prct:OperatingLeaseLiabilityAndLongTermDebtMaturityYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90YWJsZToyODQ0NjgzZDUwNzc0MjJmODI1MDdjNzk5MjFjYmNiOS90YWJsZXJhbmdlOjI4NDQ2ODNkNTA3NzQyMmY4MjUwN2M3OTkyMWNiY2I5XzYtMS0xLTEtNzE2MDY_67520135-a542-4c42-a682-ba7e1c0d7f57"
      unitRef="usd">3330000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90YWJsZToyODQ0NjgzZDUwNzc0MjJmODI1MDdjNzk5MjFjYmNiOS90YWJsZXJhbmdlOjI4NDQ2ODNkNTA3NzQyMmY4MjUwN2M3OTkyMWNiY2I5XzYtMy0xLTEtNzE2MDY_3410fab4-0deb-4b7d-ab0b-11c5b0cf30f9"
      unitRef="usd">50000000</us-gaap:DebtInstrumentCarryingAmount>
    <prct:OperatingLeaseLiabilityAndLongTermDebtMaturityGross
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90YWJsZToyODQ0NjgzZDUwNzc0MjJmODI1MDdjNzk5MjFjYmNiOS90YWJsZXJhbmdlOjI4NDQ2ODNkNTA3NzQyMmY4MjUwN2M3OTkyMWNiY2I5XzYtNS0xLTEtNzE2MDY_b79c93ff-d897-4140-b8b8-8e05e6ef1258"
      unitRef="usd">53330000</prct:OperatingLeaseLiabilityAndLongTermDebtMaturityGross>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90YWJsZToyODQ0NjgzZDUwNzc0MjJmODI1MDdjNzk5MjFjYmNiOS90YWJsZXJhbmdlOjI4NDQ2ODNkNTA3NzQyMmY4MjUwN2M3OTkyMWNiY2I5XzctMS0xLTEtNzE2MDY_340a9414-6d0c-4189-8817-0aea20869deb"
      unitRef="usd">243000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90YWJsZToyODQ0NjgzZDUwNzc0MjJmODI1MDdjNzk5MjFjYmNiOS90YWJsZXJhbmdlOjI4NDQ2ODNkNTA3NzQyMmY4MjUwN2M3OTkyMWNiY2I5XzctMy0xLTEtNzE2MDY_eeb3ec72-8e0a-41ec-8f1e-ebcc289565f5"
      unitRef="usd">507000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <prct:OperatingLeaseLiabilityAndLongTermDebtMaturityUnamortizedDebtDiscount
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90YWJsZToyODQ0NjgzZDUwNzc0MjJmODI1MDdjNzk5MjFjYmNiOS90YWJsZXJhbmdlOjI4NDQ2ODNkNTA3NzQyMmY4MjUwN2M3OTkyMWNiY2I5XzctNS0xLTEtNzE2MDY_f1294319-905e-430c-a46c-656108fbf809"
      unitRef="usd">-264000</prct:OperatingLeaseLiabilityAndLongTermDebtMaturityUnamortizedDebtDiscount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90YWJsZToyODQ0NjgzZDUwNzc0MjJmODI1MDdjNzk5MjFjYmNiOS90YWJsZXJhbmdlOjI4NDQ2ODNkNTA3NzQyMmY4MjUwN2M3OTkyMWNiY2I5XzgtMS0xLTEtNzE2MDY_b3b5008a-6fed-4a0b-afff-61b032bd994e"
      unitRef="usd">3087000</us-gaap:OperatingLeaseLiability>
    <us-gaap:LongTermDebt
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90YWJsZToyODQ0NjgzZDUwNzc0MjJmODI1MDdjNzk5MjFjYmNiOS90YWJsZXJhbmdlOjI4NDQ2ODNkNTA3NzQyMmY4MjUwN2M3OTkyMWNiY2I5XzgtMy0xLTEtNzE2MDY_9f6c92be-47c3-4d15-b4ed-245ad96bc963"
      unitRef="usd">50507000</us-gaap:LongTermDebt>
    <prct:OperatingLeaseLiabilityAndLongTermDebt
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90YWJsZToyODQ0NjgzZDUwNzc0MjJmODI1MDdjNzk5MjFjYmNiOS90YWJsZXJhbmdlOjI4NDQ2ODNkNTA3NzQyMmY4MjUwN2M3OTkyMWNiY2I5XzgtNS0xLTEtNzE2MDY_95d183dc-8c96-4298-87c3-e86fd04b1cbd"
      unitRef="usd">53594000</prct:OperatingLeaseLiabilityAndLongTermDebt>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90YWJsZToyODQ0NjgzZDUwNzc0MjJmODI1MDdjNzk5MjFjYmNiOS90YWJsZXJhbmdlOjI4NDQ2ODNkNTA3NzQyMmY4MjUwN2M3OTkyMWNiY2I5XzktMS0xLTEtNzE2MDY_0eb72c57-85c6-49f5-bb2a-2e1c9ba7351f"
      unitRef="usd">2258000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90YWJsZToyODQ0NjgzZDUwNzc0MjJmODI1MDdjNzk5MjFjYmNiOS90YWJsZXJhbmdlOjI4NDQ2ODNkNTA3NzQyMmY4MjUwN2M3OTkyMWNiY2I5XzktMy0xLTEtNzE2MDY_72c2e2f3-ba22-461b-963b-31929a2e2bc1"
      unitRef="usd">0</us-gaap:LongTermDebtCurrent>
    <prct:OperatingLeaseLiabilityAndLongTermDebtCurrent
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90YWJsZToyODQ0NjgzZDUwNzc0MjJmODI1MDdjNzk5MjFjYmNiOS90YWJsZXJhbmdlOjI4NDQ2ODNkNTA3NzQyMmY4MjUwN2M3OTkyMWNiY2I5XzktNS0xLTEtNzE2MDY_2b1cd728-3ee8-434e-a143-edb2f41b490a"
      unitRef="usd">2258000</prct:OperatingLeaseLiabilityAndLongTermDebtCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90YWJsZToyODQ0NjgzZDUwNzc0MjJmODI1MDdjNzk5MjFjYmNiOS90YWJsZXJhbmdlOjI4NDQ2ODNkNTA3NzQyMmY4MjUwN2M3OTkyMWNiY2I5XzEwLTEtMS0xLTcxNjA2_d3cb8f26-f320-48df-b8c2-7ba3566eeafb"
      unitRef="usd">829000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90YWJsZToyODQ0NjgzZDUwNzc0MjJmODI1MDdjNzk5MjFjYmNiOS90YWJsZXJhbmdlOjI4NDQ2ODNkNTA3NzQyMmY4MjUwN2M3OTkyMWNiY2I5XzEwLTMtMS0xLTcxNjA2_b6a724ef-c2f5-40dc-875a-30a8a7b03afe"
      unitRef="usd">50507000</us-gaap:LongTermDebtNoncurrent>
    <prct:OperatingLeaseLiabilityAndLongTermDebtExcludingCurrentMaturities
      contextRef="i6225d555eeba47689e5b7d633c1f277f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90YWJsZToyODQ0NjgzZDUwNzc0MjJmODI1MDdjNzk5MjFjYmNiOS90YWJsZXJhbmdlOjI4NDQ2ODNkNTA3NzQyMmY4MjUwN2M3OTkyMWNiY2I5XzEwLTUtMS0xLTcxNjA2_2a60854a-5174-44f2-87e1-10227399fcc3"
      unitRef="usd">51336000</prct:OperatingLeaseLiabilityAndLongTermDebtExcludingCurrentMaturities>
    <prct:OperatingLeaseNumberOfBuildings
      contextRef="id73017efcdff4610924f905608444615_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90ZXh0cmVnaW9uOmY3NzA3NzM4ZGNjMDQzNWJiNzAxMjdmMGE3ZWZjYjEzXzkzNDU4NDg4NDEwMjc_5f0bc918-6756-435c-92f4-8877bdb37878"
      unitRef="building">2</prct:OperatingLeaseNumberOfBuildings>
    <prct:OperatingLeaseNumberOfSquareFeet
      contextRef="id73017efcdff4610924f905608444615_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90ZXh0cmVnaW9uOmY3NzA3NzM4ZGNjMDQzNWJiNzAxMjdmMGE3ZWZjYjEzXzkzNDU4NDg4NDEwNzY_6ff2c060-8134-408b-8d75-702260d7b3c2"
      unitRef="sqft">158221</prct:OperatingLeaseNumberOfSquareFeet>
    <prct:LesseeOperatingLeaseNumberOfRenewalOptions
      contextRef="ic8e9593d6af940928b18f5797d0ae114_D20211231-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90ZXh0cmVnaW9uOmY3NzA3NzM4ZGNjMDQzNWJiNzAxMjdmMGE3ZWZjYjEzXzkzNDU4NDg4NDEyMzA_102a04b5-44b4-4c84-b0fb-edbbebc27820"
      unitRef="renewaloption">2</prct:LesseeOperatingLeaseNumberOfRenewalOptions>
    <prct:OperatingLeaseAnnualBaseRentYearOne
      contextRef="id73017efcdff4610924f905608444615_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90ZXh0cmVnaW9uOmY3NzA3NzM4ZGNjMDQzNWJiNzAxMjdmMGE3ZWZjYjEzXzkzNDU4NDg4NDEzMjc_ade2578b-bf20-4c3b-836a-f8cf1c87f777"
      unitRef="usd">4300000</prct:OperatingLeaseAnnualBaseRentYearOne>
    <prct:OperatingLeaseAnnualBaseRentYearTen
      contextRef="id73017efcdff4610924f905608444615_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90ZXh0cmVnaW9uOmY3NzA3NzM4ZGNjMDQzNWJiNzAxMjdmMGE3ZWZjYjEzXzkzNDU4NDg4NDEzODk_29fda2d3-a81c-4af5-9eb9-642206cc35f6"
      unitRef="usd">5500000</prct:OperatingLeaseAnnualBaseRentYearTen>
    <us-gaap:OperatingLeaseLiability
      contextRef="id73017efcdff4610924f905608444615_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90ZXh0cmVnaW9uOmY3NzA3NzM4ZGNjMDQzNWJiNzAxMjdmMGE3ZWZjYjEzXzkzNDU4NDg4NDE0MzE_87b7ff9d-da96-49f3-a0ea-965aff5544ef"
      unitRef="usd">49200000</us-gaap:OperatingLeaseLiability>
    <prct:LesseeOperatingLeaseReceivableAllowanceForTenantImprovements
      contextRef="id73017efcdff4610924f905608444615_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90ZXh0cmVnaW9uOmY3NzA3NzM4ZGNjMDQzNWJiNzAxMjdmMGE3ZWZjYjEzXzkzNDU4NDg4NDE1MTM_5474f1d9-9d7c-4855-807f-c0e25b8ed905"
      unitRef="usd">7900000</prct:LesseeOperatingLeaseReceivableAllowanceForTenantImprovements>
    <prct:OperatingLeaseNumberOfBuildings
      contextRef="id73017efcdff4610924f905608444615_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJiMmRmNDU2YWZmZjQzNTViYWU4N2FmOWQxMjQwNjI1L3NlYzpiYjJkZjQ1NmFmZmY0MzU1YmFlODdhZjlkMTI0MDYyNV82NjcvZnJhZzpmNzcwNzczOGRjYzA0MzViYjcwMTI3ZjBhN2VmY2IxMy90ZXh0cmVnaW9uOmY3NzA3NzM4ZGNjMDQzNWJiNzAxMjdmMGE3ZWZjYjEzXzkzNDU4NDg4NDE2NDM_32eceadd-013e-4f58-9d90-dddb36169a94"
      unitRef="building">2</prct:OperatingLeaseNumberOfBuildings>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>57
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M 4_DQ\;YC>3;[.1UR:7D47:Y8=1G0KT WZ\XE\<;]0/%X?WX/U!+ P04
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M@$S:"KS FU=IJYCG+11I-)K8SM#;0B _%[U);/&H1G7832&8)' !^D" R$V
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M%[DY9<*)1^7:5,4CN32<"9@JHI=Y3M7O&^!R/79\YVGACBTR8Q?<>%30!<S
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M%^@9RDKT(>5[H:#B=BK5)/50T_5Q0O?-A$C/A%STEI<R%6BI)I8 ]HMA^V#
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MY 52+7--18K8EWUVH+E^@0RF"=LOG4RM#6"NS*<JR(_Y; 'YZ=ML2">PR;#
MGEOU"/(DD ISS*?#.8A3*LSB"^#<@%A;+(13*HR$!NWIV8>#@E7;^HN-4(MM
M7\KFI7![M?TJ]*K^%F)<O\<W<PQ<7^";9?/-IW/??()Z2ZMM5@J4LXT:RKD.
M5>NHFJ\ZS8GDN_JSQ8I+R8OZ,&54;<0:H.YO.)>G$SU ^VUM]@]02P,$%
M  @ G8 %52+EK\\D#0  29   !@   !X;"]W;W)K<VAE971S+W-H965T-2YX
M;6S%G5USX[89A?\*1\VTV9DH(L%/I;9GLA(PV4[3[NPF[46G%UP)MC@KB0I)
MV9O^^I*R5A ^#!+VL7*SEK3 >2$< B0>O*2N'LKJ<[WBO/&^;-;;^GJT:IK=
M#Y-)O5CQ35Y_7^[XMOV?V[+:Y$W[MKJ;U+N*Y\M#I<UZ0GP_F6SR8CNZN3I\
M]KZZN2KWS;K8\O>55^\WF[SZ_2U?EP_7HV#T]8,/Q=VJZ3Z8W%SM\CO^D3>_
M[MY7[;O)2659;/BV+LJM5_';Z]&/P0\L(UV%0XE_%?RA/GOM=5_E4UE^[MZ\
M6UZ/_*Y%?,T732>1MW_N^8ROUYU2VX[?CJ*C4\RNXOGKK^KL\.7;+_,IK_FL
M7/^[6#:KZU$V\I;\-M^OFP_EPT_\^(7B3F]1KNO#O][#L:P_\A;[NBDWQ\IM
M"S;%]O%O_N78$6<5@O")"N18@0RM$!XKA$H%DCY1(3I6B)0*X5,5XF.%6(WP
MU)=.CA620]\_=M:AI^=YD]]<5>6#5W6E6[7NQ<&N0^VV@XMM=V1];*KV?XNV
M7G,S*[?+]CCA2Z]]59?K8IDW[9N/3?NG/8":VBMOO0]\R=L#^M.:=Z7N>=44
MW>OW[4' J^I0O%Q\]O+M\=6J7"]Y5?_%H[_MB^9W[]LYORT61?/&&WN_?IQ[
MWW[SQJM7><5KK]AZOZS*?=W6K;_SOI'>7TV:]AMV[9PLCM_F[>.W(4]\FU_*
M)E\;JLWLU6;E9M,>Y8>V&VK/[;5_7"Z+;I3D:^]]7BS'[5>8Y;O"W!+:H[58
M[#?[]<&#?S8K7K4=OFFGC%4WEN^Y]_>R-G4+&ZYZM$(6F;1'S>G0(:=#AQQ4
MHR=4W^;K?+O@7MYX;4N]3_RNV&Z+[5UWQ'0?['A5E$OOV[8_'LU^TQ6=\\7W
M7AA\YQ&?^":''X/&AZ#=O'A_0^+()U>3^W-#K4WKIN,?ZEV^X->CMO-J7MWS
MT<V?_Q0D_E]-_B+%*%*,@<0D?\.3OR'"WR&>/@9*SCV-PBR.%%.M[7$U%2E&
MD6(,)":9&IU,C5Q,Y>V4;1VN/^?5R=K 9&TT:+A:&^7J+%*,(L482$QR-CXY
M&[_,V2%NQL,&JK4EKG8BQ2A2C('$)#N3DYW)'W%VM09U[)]9HHW]* U"^5B9
M(R-2I!@#B4GVIB=[TTN=7%/-A7&0D6RJ#MI4&]N^8I5>(LC2+)-+4;W4.%!B
M,4,9X@=)(K2D7LM.O98=*H9/]-J[[:)=/M>\6U$\OGK3K1B,BX[_?"C7:Z]=
M?C[DU?*_IH[+D&,!*39'BE&D& .)2>Y/3^Y/K6/F75WO#X-FOVM7:_P+KQ9%
M>RRT(Z;<=0NP^GPV-!ENE7<U?*H-N]A7AL$<&9 BQ1A(3/(Q\ 5T\%_FI''I
M[VL]'A 2*[.</;+K0!P4DT)C,I2:[,T9$ JLWAPFTW%'ZY;>HMSL^+;.#Q"0
M?^E><Z,U@=9-2>RKSECC.CLS("2%AF0H-=D8@5L".V_Y==N>\=;%_UI?[O)V
MHFLM6>3URN/M^>X^7W>PSNB-#E3&0:)Z ^4I4#4ZY LP5$C9&X%* CLK^0=O
MO+69S;T]5I7;3S*BKI'M(9P]@/(/J!KK[Q'9!@$W@@O3#7L\UTN&0(<E,0E2
MY:(!&I-"U1A*3?97(([@ HPCT"''.)B&69RJ U(OJ*Z8CD4D_.4G2:B>A_1B
MX]!7IS!#(1)$T=1_8E@(E!#\(2PAT-?_)O9G;YSSO ;E"5 UAE*3;19((;@8
M4PCT!;P1!-I;Y.PM4HU"U1A*3?96@(_ NK)V/K/];;]M'?8MLV"F#]YIIE^T
M0[D&5(U"U1A*3398L(W #C>&G-KZ39UJPS8D69QHPQ;)$N90-0I58R@U>8=<
M@ YB!QVOM4>.! XSHD,. \>'QJ10-892DUT6R(38D0GPQ$MTK&&F^<>"MHM3
M@Y:)YQM#JD#?5,A&],E9%@FY(-,G2/0P@ZK-H6H4JL90:O)!(/@)>3X_(09:
M0%)#2A"4GT#5*%2-H=1DLP1E(5C*TGO98H_G/&@-E"6=$G5RA%(6J!I#J<G^
M"LI"7DY9^CTU4!;B)Z&OHF=#0>U$9J L)/-5RF(H-@ZGZHG,1%G(U$^?H"Q$
M4!;R&I2E%U>1893%WCCGV0]*6:!J#*4FVRPH"T%1EGYK!U(6>XN<O852%J@:
M0ZG)W@K*0NSY)<,2W8U60I-)H&ISJ!J%JC&4FFRXH"YD8$I).WAW)Y?KSN7O
MO&U[4=I^7GPMLRCKIC?'A.AY(5$49>J(A@(8J!J%JC&4FIS"+@!,.##39+#!
MQOQU7YNHLR@-5%AJ;XMS CL4N$#5&$I-=E4 E] )N+Q\!1+J>,-$P^W-<C88
MJ4:A:@RE)ALLH%#H=&_1\Y8@QQB]--S>%F=7H90'JL90:K*K9S<40>XH<ETA
MV:.Z7GN%.FXR)&E 8U*H&D.IR2X+/!0ZX:&7+)!"'>684S6.!6T0P:!E2M4P
MA=12-4R%;*D:H6 O87Q!&AXB;X>90=7F4#4*56,H-?D@$"0IM).D%R>ZV_6=
M?=<)5)S&ZO""$B.H&D.IR78*8A3:B=&SLMU#_;:>( K4;'=[9.<A.20FA<9D
M*#79&T%\0GM>S7.RW4,]=2;5[D.PQW5V9D!("@W)4&JR,8+,A'8R\\QL]U#'
M+^.I:@T4OD#5Z(#V,U1$^09R@50B.U*Q[=5&>BK).(CB3%U(VT,XWQ .)250
M-=;?([(-@H%$%V8@]GBN%PV13E0,N[#0F!2JQE!JLK\"@4070""1CD#,N["&
M@NH"*C(\F<6P"VLHIN_"F@K9=F$CP1BBUV ,YWE9YH[4J8 VIT'S3Z!J%*K&
M4&JRQ6>/,$$!AGY;>[G!S-X89UNA:2=0-892DVT5Z"-Z8=J)A0L2H[EZJH=F
M+A1I0-4H5(VAU&1S!=*(G))C>N_<,AN:](]6:!H,5(U"U1A*33940(T(D@;C
M?)Y%PH59I .-*$S21+VR@6;$0-482DVV6?"1R.F^HQ>=:PUW'"6I/PW4(9SU
M7XKJ4C')DB11KT7U<F,UNXJ9"I$DB$GPQ+6H8!C1]((P/X(^O@2J-H>J4:@:
M0ZG)3V43N"1^X;-.^F"^7=_5]]APLX^O#,$Y-"2%JC&4FFRGP"ZQ';L\"^;'
MACMQB#;QV2.[#LE!,2DT)D.IR=X(9!+;D<ES8'ZLDX@@CM7L:GM@9VN&Q*30
MF RE)ELCL$QLQS+/Q/FQCEVT40/%+E UVM]\A@HH^R)82FQG*3:8'YNR+](@
M4[>Z["&<'8 2$J@:Z^\1V8:S9[=>F'W8XSE?-.@D)8K\5$V*@@:E4#6&4I,-
M%OPCO@#_B'7^06*2:FFJAG+J"BHVY'2$0>Q/U9.07FX<A^H<9BA$TBP]VV60
MNTU0AO@/H0RQS@6T/H1F5D#5*%2-H=1DBP5AB"]&&.)><C"S-\;95NB=-5 U
MAE*3;17L(W[A\TPLV]/FR4_/C-#,A3(-J!J%JC&4FOQH<L$T$J?'FO3N31L-
M3?2;:E1#[<UP-12J1J%J#*4F&RJH1@)Y@HGK>=8>U?4J--&)AHGF0X-2J!I#
MJ<DV"T"20'ZR9Y"UAFP0$\U/^A-+#%)&FF\HI]-\4R$;S4\$PDC""]+\!'K3
M"E1M#E6C4#6&4I,/ L%+DN?SDL1 !\(D3-3\4WL(9[.@O 2JQE!JLEF"JB18
MJM)_R0*E*HF)JL1AIDZ/4*H"56,H-=G@L]_(>3E5Z3?50%7":: ^)VUF**>=
MR4Q4)?4C[4RFEPN)>B(S095IFCUUCUDBH$KR&E"EETXE_5#%WC#GF0\*5:!J
M#*4F6RR@2H*"*OVV]D,5>V.<;85"%:@:0ZG)M@JHDEP8JB3]4,7>)&=SH5 %
MJL90:O(/@@FHDEX JJ3]4,7>#%=#H6H4JL90:K*A JJDKP%5>B=D>U37B]#4
M %4,6WO0H!2JQE!JLLT"JJ0HJ-)OK>G'CPT;?&D_5#%(&3?X#.7T#3Y3(=L&
M7RJ@2GI)J))"H0I4;0Y5HU UAE*3#P(!55([5'EQBJ1=W]EWG>-$OC:^H-@%
MJL90:K*= KND=NSRK!3)5(<A09RJ>7CVR,Y#<DA,"HW)4&JR-X*8I'9B\O$P
MB Z/O.-+;[]M)UB/;W;K\G?.'Q^+Y^WVU6+53<F[]KS6._*@3QI)=>:1J+G)
MT(@4JL90:K*Y9[\I; <[KN8:#34\ X1D*L*V-\1Y' Z)2:$Q&4I-MDH FA3_
MW)'4> .->B>W/;"S-4-B4FA,AE*3K1&0)7V5)X^D.DK1,F7MD9V]@;*4 >UG
MJ(CRCW\+0I(]_\DCF>DY&],@4Q_V: _A:@%4C4+56'^/R#8(KI&]WI-'C,M>
M>SS7BXC,1#3T;35H4 I58R@UV6!!-#+LHT?,INJ,PKBM9BBGKK4,18S;:H9R
MVK::H8QY6VU2KSAOYGF3WUSM\CO^<U[=%>U2=,UOVYK^]]V%?%7<K4YOFG)W
M/6J-^U0V3;DYO%SQO+T&ZPJT_W];ELW7-Y-6_Z&L/A]BW/P?4$L#!!0    (
M )V !55PGODNM0<  !@C   8    >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL
MK5IM;^.X$?XKA'LH[H#U6B3U8J>)@8VWU^X!=PTV=^UG1J)C=6711U+)IK^^
M0TF6;&G$)("_)+(\'#W#>7EF:%T_*_W-[*2TY/N^*,W-;&?MX6JQ,.E.[H7Y
MJ ZRA&^V2N^%A8_Z<6$.6HJL7K0O%BP(XL5>Y.5L?5W?N]/K:U79(B_EG2:F
MVN^%?KF5A7J^F='9\<;7_'%GW8W%^OH@'N6]M'\<[C1\6G1:LGPO2Y.KDFBY
MO9E]HE>;L%Y02_P[E\_FY)HX4QZ4^N8^?,EN9H%#) N96J="P+\GN9%%X30!
MCC];I;/NF6[AZ?51^\^U\6#,@S!RHXK_Y)G=W<R6,Y+)K:@*^U4]_U.V!D5.
M7ZH*4_\ESZUL,"-I9:S:MXL!P3XOF__B>[L1)PM #[Z M0O8<$$XL8"W"WAM
M:(.L-NNSL&)]K=4ST4X:M+F+>F_JU6!-7CHWWEL-W^:PSJXWJLS *3(C<&54
MD6?"PH=["__ 6]80M24;87;D9_"X(7/RQ_UG\N,//Y$?2%Z2WW>J,J+,S/7"
M AJG<Y&V3[YMGLPFGAR37U5I=X;\'1!DY^L78$5G"CN:<LN\"G^IRH^$!Q\(
M"QA#\&S>OIQZX/!N9WFMCT_MK-NT;;UI6ZWV!#)/"YN7CTWHYC:7Y@K;MD9M
MB*MU:7UE#B*5-S/(6R/UDYRM__H7&@=_PVR^D+*S'0B['0A]VM>_014JE$%C
MHUD9URM=J7E:SWG,X]7UXND4/B+&DC!@G=@9L*@#%GE=\RG[+V16$]Y6035*
M59GFA21EB]C=39W_*I<9$.=O=EYT2>==2-G9'L7='L5>YWV6H#3-15-LRXR(
MO=(V_U]] [.\41>=N(J&233P)R*4Q!'NS:1#FGB1WEN5?IN[6IZ15.V!X$R#
M6GYWUQ(#FXQPA(PM!V#'0I0G$V"7'=BE%^QF)\I'Z4)J*W)-GD1125=BM<PD
M$/0#!"$$XY.$K7;7X(.MU/ E,<Y*\BRT%BYLG4<RJ?,GX6B0%+EXR(O<OF#&
M+D=V).' U+'(/.2XI:O.TI4_^U4YKW.HD. :(KJ<PR"NQL^G*SX B0E%2QPE
M#7H"#/QUNO:(&62Y,;+=Y>/63F5\J_Y"*7\I;>>;<=(-4*_3/J6IJEQ\0>Y+
M""Z(P0^N*J*&T[$_XI ' Z]A8CQ:T0F_L1XJ\T+] EE26J71D&_7GF-;#J,>
MDV))/ 6M9W[JI=7UG98'D6?' M3$D;([J:&E@VPN;1M@*'0^KDT)'2(?"\UI
M2"=XD?:,3?V4_:\:I =<B#CSA(Y;=&.I8 )93]G4RW9]9![$BPM+%%TT>NXJ
M3(;@QD*,LBE\/5U2/U\"/ET-& C%.*; D(_<.Q::Q]%$0:8]45(_4QXQYJ65
M4#VLCR'IF/VB8%B1,2$^%80]15(_1WX^<IZ6D.(5#F_,6$L^)'!$Z'2OS^'U
MO$;]Q-;DR DMH/@0LN)A/ 0XEJ+Q:B(664]IS,L2=>/]:ON*H6[U#FHUCX8Y
MA,FQ)0V2">0]_S#ZKJ$IAR)OWM)W,R^OO9>%+Z7M?!=Z:F-^:KNK=+H3CCB@
M,SQHYSW[4I.(_+/*#U--%$/I;)BSF!0-5Q.>ZSF/^3EO%'.8ZU#4")4AJ%'"
MFT+=\QT+WQ5OV[P4, J^(=Z\//KN>+N0MO-=Z+F5^;GU3JM4RNR8<\94L GU
M6'(/(P:$X3^&@TC=%#J!3CA5!F\9V)AOARTB(K*$GF>J#O:<S/R</&T7L/0>
M)L1FJ*I*F*2(W!\*]2)E>_/0YB Y% (E<H;,LFPY/,! I*;,ZFF<^6G\C6;5
MWP)7 <M+G>:FEFB^4@?7GN#N&E,Z6\;#SAF3BL,IRWKF9W[F[XH(%+VG/(-H
M>WA!<Q)%CK ]C4:%!&D<$AY-0>^[ O;*N O0?\QDJMVT^Q-4O^;*54)GT8?&
M+E>_8>:7QQ'>=6$Z3]V1J_L>-0OK)&B8C#AY+!>M@E6(&\;[9H+[FXD-BOX#
M!G].;N5C7I;.5XZYH'BH#+.)C_L''D3!:F@3(D>#8#759_"^S^#^.?<=1I&Y
M.Z%^Q9[QC L4%K-AH4/DH(@'P41/RON.@3,OCWUMCS#;\SI7"MX<=.ZP\T$4
M=0VI?TB8.);V]BSO/I>^D+;S_3HYF_=W*S7ON[T8;A!J^;CW8/%J&0R[>42.
M1BO&IE*P[U*X?RK_^GJ5X..1FR_IL&PC4DDRE4Q]^\#][0.>3&BH034\#S74
M%F1"1[-I+.?-IKYOX+$WF^ZKPZ&H?_X218/;M8@ OOG9=&*RY]YFY-T)<B%M
MYUO0]QC<WV-\.1X1N(,LU%JD QC_?O.:U#FZOD_@2Z^#NK/EDR$#HNVMG0+W
M=B'O]M2%M)WO1=]X<'_C\;L6I8'>W!5]Z7Y/:"B@*G-[,D37)Z6NTN/CY.0A
M+T>ZBF%+A<C,0S[AY+!O/$)_XW&'(G6=55%ES8PI!H>"R$'K*^<TX;C#B.)A
M84>$&(LG[.M[D-#?@W3'7&H+%RYJZQGJT@;2T4^HPSJ*B"RCH7F+DW<,]E(_
MUJ]>&%+#:WZC[^YVKW=\JE]J&-R_I5>;YB6-7DWSSLBO0D/W:$@AMZ R^)C
MANOF-8SF@U6'^DV&!V6MVM>7.RE@>',"\/U6*7O\X![0O0RS_C]02P,$%
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M1%=UQEA7VK:_ZK[C8<_@=/*(P:PSF"7<;:"$\D9%=7GNW8:\[(8W>4BI)FN
MTU:*<A<]OFK8Q<N/?J6L_J:$HO-QA$=Y/\XZZWEK/7O$^I@^.!O+0#_;G//O
M[<= TL.9[>#,9T\Z_*6Q(SJ<#&DVF<V>\'?8IW>8_!T^XN\JRUQCH[8K6CBC
M,\V!_KA:ANC1#G\^E'#K[^AA?S(B;T*M,KX88 8"^S4/+E\\FQY/SIY >]2C
M/7K*^W\6X_];TPV'S.LZ/;N"YDW [A!H<?OQ^N?%)YIK=^N6+NHLT+7SM?.M
MW<M8,KUX=CJ;3<ZN754KNTVKZ=E/I ,I3*]?Z4P9\COSK-U&A4._<DXR:_E:
MV4Q8K^&6;:1,>:;E%@.SAA#4\@DUL*&5%0PF!6<:@1!(6VJ\,VZU'='[N#,)
M0_2];0H4K@'UI&Q.F&X32"!??6W4G%5%759TMPV1JR&V=6@X'Y*N(#0'JT;G
MLOHQ%0K)!HEX0B:" Q,'&V.V6*Q5$)PM--D-<_;;(28VEA('>Z.&NT2$T! A
MDZGWEFSURE+M78A*(I7;FGUMX%$-">'FBW<C^2,<2SH5-@JQE>NMF'(=& *4
M,M?@/(M@H<;G>V",#)!'$R V1@H)X90$Q-EGX$)=[L1)&-&GQ^DBKFKCMJG.
MP&WX0'A W-H%M31,)6+7FC.FZ% 8 T)\BK'7*].3LR"@:Z\Y0NA3L*5I^PM[
MO:J%M%)GI:2XE,:$OBMS$"'WJ#($51_TT@]"I6R ,R20%N2-_H9\$KN5-!>(
MM#9M4 T$4TFV?7L*6R5V'A2>F3;XZ/_"8=<CDFH#YHK%2C8#G\9?KMP:L3$\
M?0&B#J'AEL$N89 04%J8:E3C,5I!%MM$8(8&UW@'U"D6PWG>9%J^2?V[IB*<
MG^!F5ZY=, _F07E.GT=W(WKK7(OXQC<KNLJE64794EJ98>6E[:4+;F!7+5&J
MV61Z(FAP '\!"4]@'M&O^BL&14<4, @-T&;NM7FX7W6T18X)#V5"DQX8MJ /
M>2;;Y[/CUZ/377,.TSZ9S"QK4.Y4,!RET.?8[GY],GJ]VPT1L'3'==RE,)M^
M'UT$R*3R23Z[*:R;)00?[@KV,H,O.U5[O_C8*YK4WH('%"%CSA/4[R?J^?1D
M-CK: UZ@?X 5-4N3W>#@\QNOTP*#DHZ;MNED?-$P2=)DW2/A>URI@M3V3J<"
M)=09)[7^D=A A;9)OM(^W,;: H=.=KH14CNESWG9MI94 +5KK26L\NB'%<O$
M_-!6 DC$1 (\6L8ANF_-MFGU1ZV5-JFC4\"'HP"B,1 _='4AQ96N1_,5C?U7
M,K'TKEDA<B0T+L1/6+!\CX<-F[4H8KIH%-Y5Z9N,8FKO7"83B>,EM*H#@OJG
MD7T@6:'4.G"4E9IEEJ!M.IU *>,"U]0VRCXZUX9)O'9DX1V&&75O9,2RQJ?:
M&A=0V594$!2_0,6)J**1@XN4\-P=ENF46.&6(*;"R+([IT</W2;&>]>\BJ$3
MU^GX2RW7WOCZM_U]^:J])OZSO;UL?X#@:21FN(#I9'3R:D"^O<"VB^CJ=&F$
M)$!1TR-$%+TN&_"]<"[N%A*@_R_B\F]02P,$%     @ G8 %59@7&Y"O#0
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MG4&FIF89SCUR@$']C-[BXX=P$GPY(#<9Y":'V \?Q4'H?F%O[;]%F2([&6M
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MF%IL;$5A\1UZZV%!O\5QU(Y;NPGR9T+$8<4MR_KG*'!X]/UY"#>R>X3^.>X
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M0%4_*:H'(PO[8V JC9&9'2XXP[XC 7P_D](T#[1 ^Z?HZE]02P,$%     @
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MFW[1/V7_B?<?!)^YW@ERJ,8MJ<:3TRP W3^R_<:JUC]L&V5I7OAE1=\EJ)T
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MIB=MEPW]FU :!SH_"*'/&W/!\K?;_@=02P,$%     @ G8 %52G68>J+ P
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MSI"+T/T5NT<S N$LK(+.AP?DC>]GN,ESP;W0X-:W+.1",<4%DR!4.[0\@A\
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M3L!L!XTG*&(T*0B QS/$MQ/!QB;:E'*#==+'T@A.Y0P^N?1E1)E6WY?@?"_
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M2R=3;W 7"95KD 5+:RJ8U,G'0C8FJ@!^M^P9">U*^%)5QM9REBOAU(),&>Y
M[%%$[-%.J-W!>;#]RM6ZH-.V@?7')+ 10%PEK<<M'OY8>&@1E35=/_0@2F"#
M$[XT&F@&U9:H3;2#L%;(STJHJ $%0#K4L\K[OU[*6LCY'!7'1[WP0:=UF79I
M;EQ#0KV+?9K4/Y9M0_&QTZAQ$.9ZM/U7DW'$Q'H)$$!;RJI.7ZMR%@Q+/.B*
M GY#C4D_BY7,&^]'* 5(:),Y8 G^47W$4D*,7[QRXOKF4T@X+Y.E[%&!)"L*
M- W.BU/W]%DEPE*!W#/S/:@M<H65Y#Q5)^%+KN5,YPA&PH)S(TLQERG_A$)K
M]4I2!=]8Y\0:!9W^3Q5 ZVG'-M"A7<4YU/,9:>C8_,XOT'*I88"%%W-6&*E'
MQ$5ZX.$*J6@:K(,C[):(6\JZ7*N5]^V,DD@Z4W(2-8BM]6'6-FT*Q)*R-_'$
MI1S:!Z:%]5*G2T%XY"<SYF9\;</8QA9PFJ&[\A*EM0_TD**G6 R[U$-NPP7G
M:=W N/9 T%%.H 18K9A;0X<:UP/WKJ0_CDE_O#-EK\&\!-^;9H:2*C[18=!V
M6^[_E"!Q78+/446*&:Q )S!.-MB5<)@K3K3:(W;V($#R#>T]3HZ.CI/1:"3<
M4EKOO'Y&>!22.'4/\M6>?N@[1W2-(J(L=C$2.%"G)P?)892'_8 &T5)0%M4M
M91G/)D=#+ /*_-*$=]>FAH4E^O#*FE2IS(>SPK=[#@F*YK/QB\GP$'U@GN-0
MG#"'#LB-K$FY@$;-Z LQ3L<_::QO+/?9^& X:05YG+=ZAH3URR;#TW;5L/-[
M:AR)M83 2D-O_;?*DG .&G97T^:Y"AP9):(D-M9ZXL/",K3F3+[D62=S]3@.
MM#:$+PDUE53(U4+F2:][2+A]8,O9',Y5;-IK&8J5'HH[7P\9&:%L1/$U%WDT
M]8JU-)OVKI6EC$USY!@8UR<[Z[@T.1SO CD**A[U0Z!'ZH*HS5F G9Q/VQC@
MD'@JGC0D2,LLT[6/+[AM<IJ<CB?)Y/BP!U32&/O*/3 !$0J[!"HKC&Q$.G#N
M"H2HZ3-J9+#'^U,V&"I I2GW86$EQP3F;#UM(QR^9=GTP[.#R>GP*,()6[Y3
M%YS86@OP5U)G>P0-#RJBWM <;2N/H0\2//Q0G^1,XKL=7U/[$7ZB@B5;'QQ/
MDL.CP^\U80T.EF4+CY8KLL@>5M%L[+.S>QIW(3?0:&2[Z/9%I-L7.UGRO9DY
MXOG^]'85QM]MG/L-:9\NID])VV@@-26Y0'6U"UJS@-9(Y]"M<HU&0D%X;'=:
MR<C%6!O;WY(G!%&_CA8'HG*)S,J(=K&FQ-@/[K1JY7W>J<I9(2V2C @_=-5(
M3-5-#:I$X\Q-04!(-)EDH.MJ4)!1#JE/">6QDPIB1O9 4L6-B>KTW&ROE]C+
M=Q">+N1*0C)0K?*Y/U83!I1O* @TC$G+C9<O#-]C(VF#A"9\DDJ^3$:--JOB
M&EE*/0H<\A=WJH;C=U\KFLW]1,$9&=K X(W'#EAS!\$TNZ;BN,,A.[!]$K%]
MLA.-MRI%H'# .84>:O8'=FM*?$Y#8T^)%Y=?^^ _N7I;7GRG)M\2353^45I@
M")W)R,?@76SI>]NFT:<7!O_%^?/=^?0BCKWZJ].Z;7<5,6+<=SZ]B]O^,$,^
M?N\P@5- 7-S7WM+R6\7-YF]_F@I@.3D\>?Y2O//]MNSSYA4/-%P(MDO TLZN
M6YYM2+^>.D&%C6D:TQ$ %V>Q;A65QY7&X.Q;J]"19SH&5]W3U0%W,I0?##PZ
MD"<W !!LS=<VP/U290M?&L.EP%)7+NDU"!OSLQ_=J+0\"!M-I>E86&^JGL=!
M(^4&4$MN@PJJ0/Z*H&>63PE3^KSX:;5XR.CT^7!]\>F6&$&6?O$C5<E;+=T@
MS;D-),00?&8JE8WO9+<:Z"/SM+]#:# Y&('3NZ1OC1.%R7@:]>L+F?DI:JO%
M@BZ+;-MZP"+EIU!B.>YLWR+7N+<_&/N;OB0HPX%_0N8]VD_N AFR6T3XH:VD
MTZE-ZS-T&]QMT&.L<5$/,Y]5M)8<O;2F62Q#4<G:Q-FFWS:44-O R*/IED\!
M0;-R.ES+S .1H#/C)(DG?F7=\'%IYH:;^2HXES0B[326I+'T^8K:)CWV43YV
M_=>W+B5 =>_1WD"%\7%@.I!7)"W(\D0T/MX;'R0]NKA&3VP;EL+]U^35)0"!
M_O*#<30Q!'8ZF!P_%Q\Q5#=6M15[<^$&"?6D/J(A5J#EH20,W?&VIP,%\-B@
MZF&N$9(K,+E+6SX;$%>Y^%R:=>D[ ]5ZN<N]U"N70[FHP>75Y8=(S%X(CFDG
M;G9UKN>*.XZP99N\(*(W7I#>P(Q9<S],^$S\#9"?#"EJ[: A"V+GO\,X%&X9
M @:ZT/8N$6)&,-7HSK']86S6U$P'=.O8;W2H(=D#HO=XL,O4K!8NWK\.VPCF
M/H(^30B=W[,[MC%QPFIS8L,9E$[IYC'2,^Q2<O0D"-)2&\0#_5Y&00W]83CL
M82AZV.F!!5$O^+)YU28PTNBOQM5%K\G<F%)",O/O"MS 8T'TOG5UN!KDZP+?
M?,'U'J2T9M%H?Z-.36-+&9Q]?YA5>PLR/MV>@?1D;SSZR>Q+P#7M%9Q'QN^!
MWMH&8GSD+^<_*-G;>W(X05]Q%?GM+5TNM8G'D[;/H(X!N9>!4_I.AS/GJ&-0
M^4%)ZWK>>U0HQD>>![_FT5 XIE>7/2=WPT5D=<*Q*["5*^M7"S?!T()PD[_[
MW7:GZ7M9-O2JS3/UP?^)J;_UE@\]+) 7;B^N /6*T;SQLXH_D\-8>D:W740I
M=)L+SL.4XI.#>@6%F1F*M!-.2T+A9<3;78_9G]73AV<*X2^X"C>N=1B]M>/+
M9NK=J3=;(I&0(#XR+>'2#C5O<K#62L6\1&97(92>!9/>2RM0C%(>C'C.4 0>
M>"^7O_:%Y.; 51IP3[E@/,5+$VIZ5[#" !&-"_[C][UT+:CI6GK>=40\C36V
M,I19/&-M]4C6L';AE18UJ2R14#<C]U!D*FK3=$I(?MO8UF7>LL*_I/6#X".+
MXB5=; <C(GMO\ A&#W1#O5)AD.V]E2KI#0HWS7G0T;4T^?@.IO]6X['\T!5E
MRJ$'G_E[!4(_70"+\[)LXA@B0C)Z;OV"]*O]1?%$_--_05##4B8 UG4I$8U.
MTS;]RJV*_L@KI_[[$M#,$Y/Q?N]M/MV%\-\L\(U]6?L7^_'7^&<1Y_ZO ;KE
M_F\JT#6"?=!6J#FVCH8OC@;^-4S[I385_VW S-3 "7]<*O3LEA;@^=Q S?"%
M#HA_+'+V/U!+ P04    " "=@ 55  H+Y;X#   S"@  &0   'AL+W=O<FMS
M:&5E=',O<VAE970Q.2YX;6RE5MMNVS@0_96!NB@2P(ANOB:V@=C9HETD0)!D
MNP^+?:"EL464$EV2BI._WR%UL9W83H&^B*0X<^;,D(?D>"/5#YTA&GC)1:$G
M7F;,^M+W=9)ASO2%7&-!,TNI<F9HJ%:^7BMDJ7/*A1\%0=_/&2^\Z=C]NU?3
ML2R-X 7>*]!EGC/U.D,A-Q,O])H?#WR5&?O#GX[7;(6/:/Y>WRL:^2U*RG,L
M-)<%*%Q.O.OP<M:S]L[@.\>-WNF#S60AY0\[^)9.O, 20H&)L0B,FF><HQ 6
MB&C\K#&]-J1UW.TWZ%]<[I3+@FF<2_$/3TTV\88>I+ADI3 /<O,5ZWP<P40*
M[;ZPJ6P'/0^24AN9U\[$(.=%U;*7N@X[#L/@B$-4.T2.=Q7(L;QAADW'2FY
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M*BHQRXUU5HI;>IZ5UJ51%()/'65,8TCU>VZ$.+#&@G"567*64D7DYA_9/*G
M=\:)3^(IUH[G>3"94'WO=Q+IY,2$'5(E, J-G" 8FZKC& 6[P#(\>./D*-?V
M):=(*@6V?NZTN^UC<5:_D1[)ZY?F.R8)]U2P<46LGIO0KXRL7V_U0HO2OI@6
M0M/[RTXW].!%:0CH?"6$WB_,!>T3>OH74$L#!!0    ( )V !55O[(B5XP,
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M#B[H@Z;:$:K=&%F[L64M#0U!;EG0U(G*'J#W&TGUVFVL@WZ.G7\#4$L#!!0
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MKVCU5-]#-A.E\$#I.CP+^''+9Q#Y+H1^&)[!BR87(XL7O>#B1HH.;I"KQ%+
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MIEDV@M-5:%!S[:C=A>F*_B_0> 7:7VCM-H)WT/VQ3'\ 4$L#!!0    ( )V
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M3G3MLYLH7ML.-.=*]S,[7.D_#@@3H/<7G*O7B6EJPS\L_PU02P,$%     @
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M;4Z-K&4H7P45P*BP7\Y)&=]<'"4$4"ZBE N2YI6T;;D<>S],M?=S+IWN;JT
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MO(+Z?<J87-_D#JH#>./_ %!+ P04    " "=@ 55>^/=.HL#  #D#   &0
M 'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6RUEVN/VC@4AO^*E:ZJ5NKD2D*8
M0J1AVNYNI>Z..MKVLTD.Q)K$3FT#TW^_MA,2*"1DI-TO$%_.>9]C.R]FOF?\
M2>0 $CV7!14+*Y>RNG4<D>908F&S"J@:63->8JF:?..(B@/.3%!9.+[K1DZ)
M";62N>E[X,F<;65!*#QP)+9EB?G/)11LO[ \Z]#QE6QRJ3N<9%[A#3R"_*=Z
MX*KEM%DR4@(5A%'$8;VP[KS;I1?K #/C&X&].'I&NI058T^Z\6>VL%Q-! 6D
M4J? ZFL']U 4.I/B^-$DM5I-'7C\?,C^R12OBEEA ?>L^$XRF2^LV$(9K/&V
MD%_9_@]H"@IUOI05PGRB?3/7M5"Z%9*53; B* FMO_%SLQ!' 2K/Y0"_"? -
M=RUD*#]@B9,Y9WO$]6R533^84DVT@B-4[\JCY&J4J#B9/$J6/MTL55T9NF>E
MVFR!S7+=H,=ZHQ!;(S,+_5V9D3N]D$3^1&\^@,2D$&_59!5;JC%A)C(S4:CN
MWY"#1(XYB+DC%:X6==(&;5FC^3UH$?K"J,P%^D@SR$[C'55F6ZM_J'7I#R;\
MO*4V"MQWR'=]?R!?T*Y=8/(%/?G^VI8KX&9]>DNL,TPN9]"OW*VH< H+2[U3
M O@.K.3U*R]RWP_P35J^R5#V9(D+3%- 6"*9 UK!AE!*Z$83ZXX*.&$9>D-H
MLT=O+U50:X1&0[_CNR0*HM!UW;FSNP 7MG#A(-SO'%,)5]7#,W4_G/2*1ZUX
M-"C^\1EX2L1U^>A,_B9V_5[]::L_'=17AK(&,J+\Z;F^%WJ]^G&K'[_D9 #-
M7G8FXC.L,(JB7JQ9BS4;Q/H&0J\)5CCP7"G?5@W)T$YU7R.:O8S(<SM_=,<<
M%;PJX!I#D^GDL,Z"H!_BR*2]0:?Y;GY<U&K<[8"K'TMT.,#H@9,4+L)X_X/S
M>'Y'[/]7WI.QHL!<Z*YZ=2\O;JT7'^^P'4QZ5K:S<&_0@4]L:"1(G5!O=DL2
MA'88]Z!T;NT-V_6I*8V$F5R L<-I#TMGSMZP.Y\:U$B6\)QE:KNS'I;.J[UA
MLQYE5B,1HW/$R.XC[-S<&[;S:[XU$F[Z$KC.ZKUAK__5P$;"Q&>OV\2.@E]@
MG*.+9PE\8Z[7 J5L2V5]!VU[VRO\77UQ[:;7]_\OF"N+$*B M0IU[:DZ3;R^
M4M<-R2ISC5TQJ2[%YC%7?T. ZPEJ?,V8/#2T0/O')OD74$L#!!0    ( )V
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M_K@&$@'7 NK]DC&Y'V@#5?MZ]A-02P,$%     @ G8 %56P<=/8- P  U D
M !D   !X;"]W;W)K<VAE971S+W-H965T,S<N>&ULM99;;]HP%(#_BI5-4RL5
M<H$ [2 2M*NV2=6J=FV?37(@5A,[LQWHI/WX^1("+8'15GN)+SF7[YSCVW#)
M^*-( 21ZRC,J1DXJ97'FNB).(<>BS0J@ZL^,\1Q+->1S5Q0<<&*4\LP-/*_G
MYIA0)QJ:N6L>#5DI,T+AFB-1YCGFOR>0L>7(\9W5Q V9IU)/N-&PP'.X!7E7
M7',U<FLK"<F!"L(HXC ;.6/_;.('6L%(W!-8BHT^TJ%,&7O4@V_)R/$T$600
M2VT"JV8!YY!EVI+B^%49=6J?6G&SO[)^:8)7P4RQ@'.6/9!$IB-GX* $9KC,
MY U;?H4JH%#;BUDFS!<M*UG/07$I),LK9460$VI;_%0E8D.A$^Q0""H%DPC7
M.C*4%UCB:,C9$G$MK:SIC@G5:"LX0G55;B57?XG2D]&M9/%C:Z+B2M YRU6Q
M!3;I:J$;$)*36*H_1@K=42+1T05(3#)Q_%Q"&(E220@D4LQ!($+1SY25 M-$
M#%VI8+5+-Z[ )A8LV '60U>,RE2@+S2!Y+F^JX*L(PU6D4Z"O0:_E[2-.MX)
M"KP@0!^1N^*TS1X/G3J7'>.AL\-#8\(:0[=VNLUV]$8\$P6.8>2HG2: +\")
M/GWP>][G/93=FK*[SWKTHY1"JIH0.C]!4Y@32E47L1DJ@!.6H"-5.)N38_2G
M,3LV".LF-&[TYE]$G7#H+AK0PAHMW(LV7F)^N/]PRW_8&30#]&J WEX M=%G
M0'0!#X7H;4&T_&XS1+^&Z!]>(*#)&TK3WTY->-I,-:BI!GL7]X,YWR!IC1?
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MC,9P[EGUN*TZ@J[+M]4+%?!2*YL)P3%AT@'&EY2*?4<&:/[#$/P#4$L#!!0
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M]Z:2#"BBB&?;:AG )\8#:_NX^,K$)$,L2BA#PF (VYGQ*&'HW[/"H"=>._E
M:0$H+82BR;4A76W(C>2A 4.5")(6@-)"*)I<HLZ]8:W_T$J$.5BPGMU?_'-%
ME.6Z_9V"(@H[I!\6*L)\TS3.:$3G@K#>!FDTXH)]A!Y^]5R$I 6@M!"*)I>I
M\W+8OI5<@/H]4%H 2@NA:'*).L^'M:Y%*Q?.4"X<OZ\6PR#?-?MB,0S"#AYH
MA2**6-89K>B,$]8[IP]"'W8Q739*D?,M+= RS]@^C5Y*_=#L*[3DJV<A)"T
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M<SK(<SRO84/+^^5N4SR^SGOP==[#=KD/D92[3?*+6/;J4NQI7O\&;P4'*/:
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M-:Y( P  SA0   T   !X;"]S='EL97,N>&ULW5A=;]HP%/TK4;I.K30U0-I
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M<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ G8 %55&NC?O4 P  (QX
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M82I'@2I'H2I'P2I'X2I' 2M'(:M (:M (:M (:M (:M (:M (:M (:M (:M
M(:M (:M$(:M$(:M$(:M$(:M$(:M$(:M$(:M$(:M$(:M$(6N"0M8$A:P)"ED3
M%+(F*&1-_I.L[UJO_OHW3[O&M2J;HS_K_J7-/P%02P$"% ,4    " "=@ 55
M!T%-8H$   "Q    $               @ $     9&]C4')O<',O87!P+GAM
M;%!+ 0(4 Q0    ( )V !55+1' 5[P   "L"   1              "  :\
M  !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( )V !5697)PC$ 8  )PG
M   3              "  <T!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#
M%     @ G8 %54>,SY/Q!0  R!\  !@              ("!#@@  'AL+W=O
M<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( )V !55'EN1-#@8  ($:
M   8              " @34.  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q0
M2P$"% ,4    " "=@ 55_WHJ0/H"  !C"@  &               @(%Y%
M>&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @ G8 %51_9(=/\
M!0  9QL  !@              ("!J1<  'AL+W=O<FMS:&5E=',O<VAE970T
M+GAM;%!+ 0(4 Q0    ( )V !54BY:_/) T  $F0   8              "
M@=L=  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"% ,4    " "=@ 55
M<)[Y+K4'   8(P  &               @($U*P  >&PO=V]R:W-H965T<R]S
M:&5E=#8N>&UL4$L! A0#%     @ G8 %5=CARMNU!0  40P  !@
M     ("!(#,  'AL+W=O<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    (
M )V !568%QN0KPT  &\F   8              " @0LY  !X;"]W;W)K<VAE
M971S+W-H965T."YX;6Q02P$"% ,4    " "=@ 55KL9SNQ($  "O"@  &
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M970Q,RYX;6Q02P$"% ,4    " "=@ 55)<N_[NP#  #U"   &0
M    @($,8@  >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    (
M )V !55[!J<3*0,  /D&   9              " @2]F  !X;"]W;W)K<VAE
M971S+W-H965T,34N>&UL4$L! A0#%     @ G8 %52G68>J+ P  8 P  !D
M             ("!CVD  'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"
M% ,4    " "=@ 55R@E;H=4&  !)&P  &0              @(%1;0  >&PO
M=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    ( )V !54MUI2">0P
M #@B   9              " @5UT  !X;"]W;W)K<VAE971S+W-H965T,3@N
M>&UL4$L! A0#%     @ G8 %50 *"^6^ P  ,PH  !D              ("!
M#8$  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4    " "=@ 55
MB=K*AH@"  !R!0  &0              @($"A0  >&PO=V]R:W-H965T<R]S
M:&5E=#(P+GAM;%!+ 0(4 Q0    ( )V !56D)^_M= 4  $X/   9
M      " @<&'  !X;"]W;W)K<VAE971S+W-H965T,C$N>&UL4$L! A0#%
M  @ G8 %56_LB)7C P  TPH  !D              ("!;(T  'AL+W=O<FMS
M:&5E=',O<VAE970R,BYX;6Q02P$"% ,4    " "=@ 55Y?W#D;,#   ""P
M&0              @(&&D0  >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+
M 0(4 Q0    ( )V !5704$D@G0,   8(   9              " @7"5  !X
M;"]W;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#%     @ G8 %588[+&T8
M P  O0@  !D              ("!1)D  'AL+W=O<FMS:&5E=',O<VAE970R
M-2YX;6Q02P$"% ,4    " "=@ 55&,43*UH#  !=#0  &0
M@(&3G   >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    ( )V
M!55@6!77Y 0  $,6   9              " @22@  !X;"]W;W)K<VAE971S
M+W-H965T,C<N>&UL4$L! A0#%     @ G8 %553*A!Y2 @  , 4  !D
M         ("!/Z4  'AL+W=O<FMS:&5E=',O<VAE970R."YX;6Q02P$"% ,4
M    " "=@ 55(.81LL$$  "1(   &0              @('(IP  >&PO=V]R
M:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    ( )V !57X\/RU7@,  "@+
M   9              " @<"L  !X;"]W;W)K<VAE971S+W-H965T,S N>&UL
M4$L! A0#%     @ G8 %5;'22]>) @  SP8  !D              ("!5;
M 'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"% ,4    " "=@ 55LI@\
M-& #  #I#P  &0              @($5LP  >&PO=V]R:W-H965T<R]S:&5E
M=#,R+GAM;%!+ 0(4 Q0    ( )V !5571U(+H@P  !VC   9
M  " @:RV  !X;"]W;W)K<VAE971S+W-H965T,S,N>&UL4$L! A0#%     @
MG8 %59IQ0SR9!0  C"<  !D              ("!A<,  'AL+W=O<FMS:&5E
M=',O<VAE970S-"YX;6Q02P$"% ,4    " "=@ 55>^/=.HL#  #D#   &0
M            @(%5R0  >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4
M Q0    ( )V !56;6O4?3@0  ,H6   9              " @1?-  !X;"]W
M;W)K<VAE971S+W-H965T,S8N>&UL4$L! A0#%     @ G8 %56P<=/8- P
MU D  !D              ("!G-$  'AL+W=O<FMS:&5E=',O<VAE970S-RYX
M;6Q02P$"% ,4    " "=@ 55'/@7=,8#  !:%   &0              @('@
MU   >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4 Q0    ( )V !56!
MY8,>) (  %T$   9              " @=W8  !X;"]W;W)K<VAE971S+W-H
M965T,SDN>&UL4$L! A0#%     @ G8 %5=!?D2') P  ;1   !D
M     ("!.-L  'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( )V !57T8F,YB@0  "T9   9              "
M@?OQ  !X;"]W;W)K<VAE971S+W-H965T-#4N>&UL4$L! A0#%     @ G8 %
M56^7-:Y( P  SA0   T              ( !O/8  'AL+W-T>6QE<RYX;6Q0
M2P$"% ,4    " "=@ 55EXJ[',     3 @  "P              @ $O^@
M7W)E;',O+G)E;'-02P$"% ,4    " "=@ 554:Z-^]0#   C'@  #P
M        @ $8^P  >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ G8 %5;@V
MQ-RI 0  +AL  !H              ( !&?\  'AL+U]R96QS+W=O<FMB;V]K
M+GAM;"YR96QS4$L! A0#%     @ G8 %55/9*RFR 0  4QL  !,
M     ( !^@ ! %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     #4 -0!J#@
&W0(!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>176</ContextCount>
  <ElementCount>266</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>45</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>8</UnitCount>
  <MyReports>
    <Report instance="prct-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.procept-biorobotics.com/role/Coverpage</Role>
      <ShortName>Cover page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="prct-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="prct-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - Condensed Consolidated Balance Sheets - Parentheticals</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheetsParentheticals</Role>
      <ShortName>Condensed Consolidated Balance Sheets - Parentheticals</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="prct-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss</Role>
      <ShortName>Condensed Consolidated Statements of Operations and Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="prct-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit</Role>
      <ShortName>Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="prct-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - Condensed Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="prct-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Organization</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.procept-biorobotics.com/role/Organization</Role>
      <ShortName>Organization</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="prct-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2103102 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.procept-biorobotics.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="prct-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2106103 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.procept-biorobotics.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="prct-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2111104 - Disclosure - Inventory</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.procept-biorobotics.com/role/Inventory</Role>
      <ShortName>Inventory</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="prct-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2114105 - Disclosure - Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.procept-biorobotics.com/role/IntangibleAssets</Role>
      <ShortName>Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="prct-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2116106 - Disclosure - Loan Facility and Derivative Liability</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiability</Role>
      <ShortName>Loan Facility and Derivative Liability</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="prct-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2118107 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.procept-biorobotics.com/role/StockBasedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="prct-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2125108 - Disclosure - Net Loss Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.procept-biorobotics.com/role/NetLossPerShare</Role>
      <ShortName>Net Loss Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="prct-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2130109 - Disclosure - Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.procept-biorobotics.com/role/Revenue</Role>
      <ShortName>Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="prct-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2133110 - Disclosure - Segment, Geographical, and Customer Concentration</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.procept-biorobotics.com/role/SegmentGeographicalandCustomerConcentration</Role>
      <ShortName>Segment, Geographical, and Customer Concentration</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="prct-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2136111 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.procept-biorobotics.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="prct-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2204201 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.procept-biorobotics.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.procept-biorobotics.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="prct-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2307301 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.procept-biorobotics.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.procept-biorobotics.com/role/FairValueMeasurements</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="prct-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2312302 - Disclosure - Inventory (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.procept-biorobotics.com/role/InventoryTables</Role>
      <ShortName>Inventory (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.procept-biorobotics.com/role/Inventory</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="prct-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2319303 - Disclosure - Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.procept-biorobotics.com/role/StockBasedCompensationTables</Role>
      <ShortName>Stock-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.procept-biorobotics.com/role/StockBasedCompensation</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="prct-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2326304 - Disclosure - Net Loss Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.procept-biorobotics.com/role/NetLossPerShareTables</Role>
      <ShortName>Net Loss Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.procept-biorobotics.com/role/NetLossPerShare</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="prct-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2331305 - Disclosure - Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.procept-biorobotics.com/role/RevenueTables</Role>
      <ShortName>Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.procept-biorobotics.com/role/Revenue</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="prct-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2334306 - Disclosure - Segment, Geographical, and Customer Concentration (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.procept-biorobotics.com/role/SegmentGeographicalandCustomerConcentrationTables</Role>
      <ShortName>Segment, Geographical, and Customer Concentration (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.procept-biorobotics.com/role/SegmentGeographicalandCustomerConcentration</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="prct-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2337307 - Disclosure - Commitments and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.procept-biorobotics.com/role/CommitmentsandContingenciesTables</Role>
      <ShortName>Commitments and Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.procept-biorobotics.com/role/CommitmentsandContingencies</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="prct-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2402401 - Disclosure - Organization (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.procept-biorobotics.com/role/OrganizationDetails</Role>
      <ShortName>Organization (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.procept-biorobotics.com/role/Organization</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="prct-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2405402 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.procept-biorobotics.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="prct-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2408403 - Disclosure - Fair Value Measurements - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.procept-biorobotics.com/role/FairValueMeasurementsNarrativeDetails</Role>
      <ShortName>Fair Value Measurements - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="prct-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2409404 - Disclosure - Fair Value Measurements - Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.procept-biorobotics.com/role/FairValueMeasurementsFairValueDetails</Role>
      <ShortName>Fair Value Measurements - Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="prct-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2410405 - Disclosure - Fair Value Measurements - Fair Value, Inputs, Level 3 - Fair Value, Measurements, Recurring (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.procept-biorobotics.com/role/FairValueMeasurementsFairValueInputsLevel3FairValueMeasurementsRecurringDetails</Role>
      <ShortName>Fair Value Measurements - Fair Value, Inputs, Level 3 - Fair Value, Measurements, Recurring (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="prct-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2413406 - Disclosure - Inventory - Inventory (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.procept-biorobotics.com/role/InventoryInventoryDetails</Role>
      <ShortName>Inventory - Inventory (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="prct-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2415407 - Disclosure - Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.procept-biorobotics.com/role/IntangibleAssetsDetails</Role>
      <ShortName>Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.procept-biorobotics.com/role/IntangibleAssets</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="prct-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2417408 - Disclosure - Loan Facility and Derivative Liability (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiabilityDetails</Role>
      <ShortName>Loan Facility and Derivative Liability (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiability</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="prct-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2420409 - Disclosure - Stock-Based Compensation - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.procept-biorobotics.com/role/StockBasedCompensationNarrativeDetails</Role>
      <ShortName>Stock-Based Compensation - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="prct-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2421410 - Disclosure - Stock-Based Compensation - Summary of Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.procept-biorobotics.com/role/StockBasedCompensationSummaryofStockOptionActivityDetails</Role>
      <ShortName>Stock-Based Compensation - Summary of Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="prct-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2422411 - Disclosure - Stock-Based Compensation - Fair Value Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.procept-biorobotics.com/role/StockBasedCompensationFairValueAssumptionsDetails</Role>
      <ShortName>Stock-Based Compensation - Fair Value Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="prct-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2423412 - Disclosure - Stock-Based Compensation - Restricted Stock Unit (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.procept-biorobotics.com/role/StockBasedCompensationRestrictedStockUnitDetails</Role>
      <ShortName>Stock-Based Compensation - Restricted Stock Unit (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="prct-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2424413 - Disclosure - Stock-Based Compensation - Stock-based Compensation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.procept-biorobotics.com/role/StockBasedCompensationStockbasedCompensationDetails</Role>
      <ShortName>Stock-Based Compensation - Stock-based Compensation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="prct-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2427414 - Disclosure - Net Loss Per Share - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.procept-biorobotics.com/role/NetLossPerShareNarrativeDetails</Role>
      <ShortName>Net Loss Per Share - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="prct-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2428415 - Disclosure - Net Loss Per Share - Net loss per share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.procept-biorobotics.com/role/NetLossPerShareNetlosspershareDetails</Role>
      <ShortName>Net Loss Per Share - Net loss per share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="prct-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2429416 - Disclosure - Net Loss Per Share - Potentially Dilutive Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.procept-biorobotics.com/role/NetLossPerSharePotentiallyDilutiveSecuritiesDetails</Role>
      <ShortName>Net Loss Per Share - Potentially Dilutive Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="prct-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2432417 - Disclosure - Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.procept-biorobotics.com/role/RevenueDetails</Role>
      <ShortName>Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.procept-biorobotics.com/role/RevenueTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="prct-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2435418 - Disclosure - Segment, Geographical, and Customer Concentration (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.procept-biorobotics.com/role/SegmentGeographicalandCustomerConcentrationDetails</Role>
      <ShortName>Segment, Geographical, and Customer Concentration (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.procept-biorobotics.com/role/SegmentGeographicalandCustomerConcentrationTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="prct-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2438419 - Disclosure - Commitments and Contingencies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.procept-biorobotics.com/role/CommitmentsandContingenciesNarrativeDetails</Role>
      <ShortName>Commitments and Contingencies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="prct-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2439420 - Disclosure - Commitments and Contingencies - Future Minimum Lease Payments and Long-Term Debt Maturities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.procept-biorobotics.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsandLongTermDebtMaturitiesDetails</Role>
      <ShortName>Commitments and Contingencies - Future Minimum Lease Payments and Long-Term Debt Maturities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="prct-20220630.htm">prct-20220630.htm</File>
    <File>ex311soxcertificationrzadn.htm</File>
    <File>ex312soxcertificationkwate.htm</File>
    <File>ex321soxcertificationrzadn.htm</File>
    <File>ex322soxcertificationkwate.htm</File>
    <File>prct-20220630.xsd</File>
    <File>prct-20220630_cal.xml</File>
    <File>prct-20220630_def.xml</File>
    <File>prct-20220630_lab.xml</File>
    <File>prct-20220630_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="588">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="30">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>62
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "prct-20220630.htm": {
   "axisCustom": 0,
   "axisStandard": 21,
   "contextCount": 176,
   "dts": {
    "calculationLink": {
     "local": [
      "prct-20220630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "prct-20220630_def.xml"
     ]
    },
    "inline": {
     "local": [
      "prct-20220630.htm"
     ]
    },
    "labelLink": {
     "local": [
      "prct-20220630_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "prct-20220630_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "prct-20220630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 410,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 5,
    "total": 5
   },
   "keyCustom": 46,
   "keyStandard": 220,
   "memberCustom": 14,
   "memberStandard": 26,
   "nsprefix": "prct",
   "nsuri": "http://www.procept-biorobotics.com/20220630",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover page",
     "role": "http://www.procept-biorobotics.com/role/Coverpage",
     "shortName": "Cover page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2111104 - Disclosure - Inventory",
     "role": "http://www.procept-biorobotics.com/role/Inventory",
     "shortName": "Inventory",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2114105 - Disclosure - Intangible Assets",
     "role": "http://www.procept-biorobotics.com/role/IntangibleAssets",
     "shortName": "Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2116106 - Disclosure - Loan Facility and Derivative Liability",
     "role": "http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiability",
     "shortName": "Loan Facility and Derivative Liability",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2118107 - Disclosure - Stock-Based Compensation",
     "role": "http://www.procept-biorobotics.com/role/StockBasedCompensation",
     "shortName": "Stock-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2125108 - Disclosure - Net Loss Per Share",
     "role": "http://www.procept-biorobotics.com/role/NetLossPerShare",
     "shortName": "Net Loss Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2130109 - Disclosure - Revenue",
     "role": "http://www.procept-biorobotics.com/role/Revenue",
     "shortName": "Revenue",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2133110 - Disclosure - Segment, Geographical, and Customer Concentration",
     "role": "http://www.procept-biorobotics.com/role/SegmentGeographicalandCustomerConcentration",
     "shortName": "Segment, Geographical, and Customer Concentration",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2136111 - Disclosure - Commitments and Contingencies",
     "role": "http://www.procept-biorobotics.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2204201 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "role": "http://www.procept-biorobotics.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2307301 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://www.procept-biorobotics.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "i6225d555eeba47689e5b7d633c1f277f_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Condensed Consolidated Balance Sheets",
     "role": "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "i6225d555eeba47689e5b7d633c1f277f_I20220630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2312302 - Disclosure - Inventory (Tables)",
     "role": "http://www.procept-biorobotics.com/role/InventoryTables",
     "shortName": "Inventory (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2319303 - Disclosure - Stock-Based Compensation (Tables)",
     "role": "http://www.procept-biorobotics.com/role/StockBasedCompensationTables",
     "shortName": "Stock-Based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicByCommonClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2326304 - Disclosure - Net Loss Per Share (Tables)",
     "role": "http://www.procept-biorobotics.com/role/NetLossPerShareTables",
     "shortName": "Net Loss Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicByCommonClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2331305 - Disclosure - Revenue (Tables)",
     "role": "http://www.procept-biorobotics.com/role/RevenueTables",
     "shortName": "Revenue (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2334306 - Disclosure - Segment, Geographical, and Customer Concentration (Tables)",
     "role": "http://www.procept-biorobotics.com/role/SegmentGeographicalandCustomerConcentrationTables",
     "shortName": "Segment, Geographical, and Customer Concentration (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2337307 - Disclosure - Commitments and Contingencies (Tables)",
     "role": "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesTables",
     "shortName": "Commitments and Contingencies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "i6225d555eeba47689e5b7d633c1f277f_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2402401 - Disclosure - Organization (Details)",
     "role": "http://www.procept-biorobotics.com/role/OrganizationDetails",
     "shortName": "Organization (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:StockholdersEquityPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "ie390a471379b4ab1bcab0d1678411d3a_I20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SaleOfStockPricePerShare",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405402 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)",
     "role": "http://www.procept-biorobotics.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Summary of Significant Accounting Policies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:StockholdersEquityPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "ic71fc6b5bde14a3db707e62f0fc13d18_D20210901-20210930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:PaymentsForUnderwritingExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "i2ec894abcc4c490b980330e1351b89bd_I20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMeasurementInput",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408403 - Disclosure - Fair Value Measurements - Narrative (Details)",
     "role": "http://www.procept-biorobotics.com/role/FairValueMeasurementsNarrativeDetails",
     "shortName": "Fair Value Measurements - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "i2ec894abcc4c490b980330e1351b89bd_I20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMeasurementInput",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "i6225d555eeba47689e5b7d633c1f277f_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409404 - Disclosure - Fair Value Measurements - Fair Value (Details)",
     "role": "http://www.procept-biorobotics.com/role/FairValueMeasurementsFairValueDetails",
     "shortName": "Fair Value Measurements - Fair Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "i03e5fbb904174fc6a95ec0686a05e446_I20220630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:Cash",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "i6225d555eeba47689e5b7d633c1f277f_I20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - Condensed Consolidated Balance Sheets - Parentheticals",
     "role": "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheetsParentheticals",
     "shortName": "Condensed Consolidated Balance Sheets - Parentheticals",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "i6225d555eeba47689e5b7d633c1f277f_I20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "i9261f6f74d684c688cfaeac2f36b5a12_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410405 - Disclosure - Fair Value Measurements - Fair Value, Inputs, Level 3 - Fair Value, Measurements, Recurring (Details)",
     "role": "http://www.procept-biorobotics.com/role/FairValueMeasurementsFairValueInputsLevel3FairValueMeasurementsRecurringDetails",
     "shortName": "Fair Value Measurements - Fair Value, Inputs, Level 3 - Fair Value, Measurements, Recurring (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "i9261f6f74d684c688cfaeac2f36b5a12_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "i6225d555eeba47689e5b7d633c1f277f_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterials",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413406 - Disclosure - Inventory - Inventory (Details)",
     "role": "http://www.procept-biorobotics.com/role/InventoryInventoryDetails",
     "shortName": "Inventory - Inventory (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "i6225d555eeba47689e5b7d633c1f277f_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterials",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "ie19c67cd74ed40aabeb9098c4f2fb478_D20190301-20190331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415407 - Disclosure - Intangible Assets (Details)",
     "role": "http://www.procept-biorobotics.com/role/IntangibleAssetsDetails",
     "shortName": "Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "ie19c67cd74ed40aabeb9098c4f2fb478_D20190301-20190331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "i19e8bd64054f475ea78f283d6415e474_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "prct:LineOfCreditFacilityGainLossOnAmendmentOfDebtTerms",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417408 - Disclosure - Loan Facility and Derivative Liability (Details)",
     "role": "http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiabilityDetails",
     "shortName": "Loan Facility and Derivative Liability (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "i19e8bd64054f475ea78f283d6415e474_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "prct:LineOfCreditFacilityGainLossOnAmendmentOfDebtTerms",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "i9640280ee02a463885b62fb60246cfec_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420409 - Disclosure - Stock-Based Compensation - Narrative (Details)",
     "role": "http://www.procept-biorobotics.com/role/StockBasedCompensationNarrativeDetails",
     "shortName": "Stock-Based Compensation - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "ib8d4c78e6b0f482fae70548a9459a7f1_D20220101-20220630",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "i98ec9d7c3e23460eb44d3b79a24f38f8_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421410 - Disclosure - Stock-Based Compensation - Summary of Stock Option Activity (Details)",
     "role": "http://www.procept-biorobotics.com/role/StockBasedCompensationSummaryofStockOptionActivityDetails",
     "shortName": "Stock-Based Compensation - Summary of Stock Option Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "i98ec9d7c3e23460eb44d3b79a24f38f8_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "i00f54e9cbe804bb38c30969068ff45d3_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422411 - Disclosure - Stock-Based Compensation - Fair Value Assumptions (Details)",
     "role": "http://www.procept-biorobotics.com/role/StockBasedCompensationFairValueAssumptionsDetails",
     "shortName": "Stock-Based Compensation - Fair Value Assumptions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "i00f54e9cbe804bb38c30969068ff45d3_D20220401-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "i48c0e4524ffe4c1fa1c1d659ea30bc91_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423412 - Disclosure - Stock-Based Compensation - Restricted Stock Unit (Details)",
     "role": "http://www.procept-biorobotics.com/role/StockBasedCompensationRestrictedStockUnitDetails",
     "shortName": "Stock-Based Compensation - Restricted Stock Unit (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "i48c0e4524ffe4c1fa1c1d659ea30bc91_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "i9640280ee02a463885b62fb60246cfec_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424413 - Disclosure - Stock-Based Compensation - Stock-based Compensation (Details)",
     "role": "http://www.procept-biorobotics.com/role/StockBasedCompensationStockbasedCompensationDetails",
     "shortName": "Stock-Based Compensation - Stock-based Compensation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "i277b8f845b9c4fe49bd226a094fd599c_D20220401-20220630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion",
       "span",
       "div",
       "us-gaap:StockholdersEquityPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "ie390a471379b4ab1bcab0d1678411d3a_I20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427414 - Disclosure - Net Loss Per Share - Narrative (Details)",
     "role": "http://www.procept-biorobotics.com/role/NetLossPerShareNarrativeDetails",
     "shortName": "Net Loss Per Share - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "i9640280ee02a463885b62fb60246cfec_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss",
     "role": "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
     "shortName": "Condensed Consolidated Statements of Operations and Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "i9640280ee02a463885b62fb60246cfec_D20220401-20220630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostOfRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicByCommonClassTextBlock",
       "us-gaap:ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "i9640280ee02a463885b62fb60246cfec_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428415 - Disclosure - Net Loss Per Share - Net loss per share (Details)",
     "role": "http://www.procept-biorobotics.com/role/NetLossPerShareNetlosspershareDetails",
     "shortName": "Net Loss Per Share - Net loss per share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429416 - Disclosure - Net Loss Per Share - Potentially Dilutive Securities (Details)",
     "role": "http://www.procept-biorobotics.com/role/NetLossPerSharePotentiallyDilutiveSecuritiesDetails",
     "shortName": "Net Loss Per Share - Potentially Dilutive Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "i9640280ee02a463885b62fb60246cfec_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432417 - Disclosure - Revenue (Details)",
     "role": "http://www.procept-biorobotics.com/role/RevenueDetails",
     "shortName": "Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "i56197f81b18f4fdd9144c91fbf486356_D20220401-20220630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "i4fcecdc96c7946a6917102a9bc187595_D20220401-20220630",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2435418 - Disclosure - Segment, Geographical, and Customer Concentration (Details)",
     "role": "http://www.procept-biorobotics.com/role/SegmentGeographicalandCustomerConcentrationDetails",
     "shortName": "Segment, Geographical, and Customer Concentration (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "i4fcecdc96c7946a6917102a9bc187595_D20220401-20220630",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:OperatingLeaseExpense",
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "i9640280ee02a463885b62fb60246cfec_D20220401-20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438419 - Disclosure - Commitments and Contingencies - Narrative (Details)",
     "role": "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesNarrativeDetails",
     "shortName": "Commitments and Contingencies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:OperatingLeaseExpense",
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "i9640280ee02a463885b62fb60246cfec_D20220401-20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "i6225d555eeba47689e5b7d633c1f277f_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439420 - Disclosure - Commitments and Contingencies - Future Minimum Lease Payments and Long-Term Debt Maturities (Details)",
     "role": "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsandLongTermDebtMaturitiesDetails",
     "shortName": "Commitments and Contingencies - Future Minimum Lease Payments and Long-Term Debt Maturities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "i6225d555eeba47689e5b7d633c1f277f_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "icbfd320e5dd848119b7bdb3871172b7a_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquitySharesOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit)",
     "role": "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit",
     "shortName": "Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "i28c750db7e8b493c961a7d62d4a754ad_D20210101-20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicByCommonClassTextBlock",
       "us-gaap:ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - Condensed Consolidated Statements of Cash Flows",
     "role": "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows",
     "shortName": "Condensed Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Organization",
     "role": "http://www.procept-biorobotics.com/role/Organization",
     "shortName": "Organization",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2103102 - Disclosure - Summary of Significant Accounting Policies",
     "role": "http://www.procept-biorobotics.com/role/SummaryofSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2106103 - Disclosure - Fair Value Measurements",
     "role": "http://www.procept-biorobotics.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "prct-20220630.htm",
      "contextRef": "icb21163ddcda4df6ad69fa5f9dc1853f_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 45,
   "tag": {
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "U.S."
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.procept-biorobotics.com/role/RevenueDetails",
      "http://www.procept-biorobotics.com/role/SegmentGeographicalandCustomerConcentrationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.procept-biorobotics.com/role/Coverpage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.procept-biorobotics.com/role/Coverpage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.procept-biorobotics.com/role/Coverpage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.procept-biorobotics.com/role/Coverpage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.procept-biorobotics.com/role/Coverpage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.procept-biorobotics.com/role/Coverpage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.procept-biorobotics.com/role/Coverpage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.procept-biorobotics.com/role/Coverpage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.procept-biorobotics.com/role/Coverpage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.procept-biorobotics.com/role/Coverpage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.procept-biorobotics.com/role/Coverpage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.procept-biorobotics.com/role/Coverpage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.procept-biorobotics.com/role/Coverpage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.procept-biorobotics.com/role/Coverpage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding (in share)"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.procept-biorobotics.com/role/Coverpage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.procept-biorobotics.com/role/Coverpage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.procept-biorobotics.com/role/Coverpage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.procept-biorobotics.com/role/Coverpage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.procept-biorobotics.com/role/Coverpage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.procept-biorobotics.com/role/Coverpage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.procept-biorobotics.com/role/Coverpage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.procept-biorobotics.com/role/Coverpage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.procept-biorobotics.com/role/Coverpage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.procept-biorobotics.com/role/Coverpage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.procept-biorobotics.com/role/Coverpage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.procept-biorobotics.com/role/Coverpage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.procept-biorobotics.com/role/Coverpage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.procept-biorobotics.com/role/Coverpage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.procept-biorobotics.com/role/Coverpage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.procept-biorobotics.com/role/Coverpage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "prct_A2021EmployeeStockPurchasePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2021 Employee Stock Purchase Plan",
        "label": "2021 Employee Stock Purchase Plan [Member]",
        "terseLabel": "Employee stock purchase plan"
       }
      }
     },
     "localname": "A2021EmployeeStockPurchasePlanMember",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/NetLossPerSharePotentiallyDilutiveSecuritiesDetails",
      "http://www.procept-biorobotics.com/role/StockBasedCompensationFairValueAssumptionsDetails",
      "http://www.procept-biorobotics.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prct_A2021EquityIncentiveAwardPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2021 Equity Incentive Award Plan",
        "label": "2021 Equity Incentive Award Plan [Member]",
        "terseLabel": "2021 Equity Incentive Award Plan"
       }
      }
     },
     "localname": "A2021EquityIncentiveAwardPlanMember",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prct_Customer1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer 1",
        "label": "Customer 1 [Member]",
        "terseLabel": "Customer 1"
       }
      }
     },
     "localname": "Customer1Member",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/SegmentGeographicalandCustomerConcentrationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prct_DebtInstrumentContingentBorrowingExtendedInterestOnlyPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument, Contingent Borrowing, Extended Interest Only Period",
        "label": "Debt instrument, Contingent Borrowing, Extended Interest Only Period",
        "terseLabel": "Extended interest only period (in months)"
       }
      }
     },
     "localname": "DebtInstrumentContingentBorrowingExtendedInterestOnlyPeriod",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiabilityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "prct_DebtInstrumentContingentBorrowingExtendedPrincipalAndInterestPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument, Contingent Borrowing, Extended Principal and Interest Period",
        "label": "Debt instrument, Contingent Borrowing, Extended Principal and Interest Period",
        "terseLabel": "Extended principal and interest period (in months)"
       }
      }
     },
     "localname": "DebtInstrumentContingentBorrowingExtendedPrincipalAndInterestPeriod",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiabilityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant Compliance, Capital Raised in IPO Threshold Amount",
        "label": "Debt Instrument, Covenant Compliance, Capital Raised in IPO Threshold Amount",
        "terseLabel": "Covenant compliance, IPO capital raised in threshold amount"
       }
      }
     },
     "localname": "DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmount",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmountAchievedExtendedInterestOnlyPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant Compliance, Capital Raised in IPO Threshold Amount Achieved, Extended Interest Only Period",
        "label": "Debt Instrument, Covenant Compliance, Capital Raised in IPO Threshold Amount Achieved, Extended Interest Only Period",
        "terseLabel": "Covenant compliance, IPO capital raised in threshold amount achieved, extended interest only period (in months)"
       }
      }
     },
     "localname": "DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmountAchievedExtendedInterestOnlyPeriod",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiabilityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "prct_DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmountAchievedExtendedPrincipalAndInterestPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant Compliance, Capital Raised in IPO Threshold Amount Achieved, Extended Principal and Interest Period",
        "label": "Debt Instrument, Covenant Compliance, Capital Raised in IPO Threshold Amount Achieved, Extended Principal and Interest Period",
        "terseLabel": "Covenant compliance, IPO capital raised in threshold amount achieved, extended principal and interest only period (in months)"
       }
      }
     },
     "localname": "DebtInstrumentCovenantComplianceCapitalRaisedInIPOThresholdAmountAchievedExtendedPrincipalAndInterestPeriod",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiabilityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "prct_DebtInstrumentCovenantComplianceRevenueForecastAmountAllInstallmentsDrawn": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant Compliance, Revenue Forecast Amount, All Installments Drawn",
        "label": "Debt Instrument, Covenant Compliance, Revenue Forecast Amount, All Installments Drawn",
        "terseLabel": "Covenant compliance, revenue forecast amount, all installments"
       }
      }
     },
     "localname": "DebtInstrumentCovenantComplianceRevenueForecastAmountAllInstallmentsDrawn",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prct_DebtInstrumentCovenantComplianceRevenueForecastAmountFirstThreeInstallmentsOnly": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant Compliance, Revenue Forecast Amount, First Three Installments Only",
        "label": "Debt Instrument, Covenant Compliance, Revenue Forecast Amount, First Three Installments Only",
        "terseLabel": "Covenant compliance, revenue forecast amount, first three installments only"
       }
      }
     },
     "localname": "DebtInstrumentCovenantComplianceRevenueForecastAmountFirstThreeInstallmentsOnly",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prct_DebtInstrumentCovenantComplianceRevenueForecastAmountFirstTwoInstallmentsOnly": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant Compliance, Revenue Forecast Amount, First Two Installments Only",
        "label": "Debt Instrument, Covenant Compliance, Revenue Forecast Amount, First Two Installments Only",
        "terseLabel": "Covenant compliance, revenue forecast amount, first two installments only"
       }
      }
     },
     "localname": "DebtInstrumentCovenantComplianceRevenueForecastAmountFirstTwoInstallmentsOnly",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prct_DebtInstrumentCovenantComplianceRevenueForecastForCommensuratePeriodPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant Compliance, Revenue Forecast for Commensurate Period, Percent",
        "label": "Debt Instrument, Covenant Compliance, Revenue Forecast for Commensurate Period, Percent",
        "terseLabel": "Covenant compliance, revenue forecast for commensurate period, percent"
       }
      }
     },
     "localname": "DebtInstrumentCovenantComplianceRevenueForecastForCommensuratePeriodPercent",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiabilityDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "prct_DebtInstrumentInterestOnlyPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument, Interest Only Period",
        "label": "Debt instrument, Interest Only Period",
        "terseLabel": "Interest only period"
       }
      }
     },
     "localname": "DebtInstrumentInterestOnlyPeriod",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiabilityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "prct_DebtInstrumentPrincipalAndInterestPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument, Principal and Interest Period",
        "label": "Debt instrument, Principal and Interest Period",
        "terseLabel": "Principal and interest period (in months)"
       }
      }
     },
     "localname": "DebtInstrumentPrincipalAndInterestPeriod",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiabilityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "prct_DeferredOfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Offering Costs Incurred During Noncash or Partial Noncash Transaction",
        "label": "Deferred Offering Costs Incurred During Noncash or Partial Noncash Transaction",
        "terseLabel": "Deferred offering costs included in accounts payable and other current liabilities"
       }
      }
     },
     "localname": "DeferredOfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prct_FairValueAdjustmentOfWarrantsAndGainLossOnDerivativeInstrumentsNetPretax": {
     "auth_ref": [],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value Adjustment of Warrants and Gain (Loss) on Derivative Instruments, Net, Pretax",
        "label": "Fair Value Adjustment of Warrants and Gain (Loss) on Derivative Instruments, Net, Pretax",
        "terseLabel": "Change in fair value of redeemable convertible preferred stock warrants and derivative liability"
       }
      }
     },
     "localname": "FairValueAdjustmentOfWarrantsAndGainLossOnDerivativeInstrumentsNetPretax",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prct_FiniteLivedIntangibleAssetExpectedAnnualAmortizationExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived Intangible Asset, Expected Annual Amortization Expense",
        "label": "Finite-Lived Intangible Asset, Expected Annual Amortization Expense",
        "terseLabel": "Expected annual amortization expense"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetExpectedAnnualAmortizationExpense",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/IntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prct_HandPiecesAndOtherConsumablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hand Pieces and Other Consumables",
        "label": "Hand Pieces and Other Consumables [Member]",
        "terseLabel": "Handpieces and other consumables"
       }
      }
     },
     "localname": "HandPiecesAndOtherConsumablesMember",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prct_InitialPublicOfferingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Initial Public Offering",
        "label": "Initial Public Offering [Abstract]",
        "terseLabel": "Initial Public Offering"
       }
      }
     },
     "localname": "InitialPublicOfferingAbstract",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/OrganizationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "prct_InterestAndOtherIncomeExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 3.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest And Other Income (Expense)",
        "label": "Interest And Other Income (Expense)",
        "terseLabel": "Interest and other income, net"
       }
      }
     },
     "localname": "InterestAndOtherIncomeExpense",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prct_JobsActAccountingElectionPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Jobs Act Accounting Election",
        "label": "Jobs Act Accounting Election [Policy Text Block]",
        "terseLabel": "Jobs Act Accounting Election"
       }
      }
     },
     "localname": "JobsActAccountingElectionPolicyTextBlock",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "prct_LesseeOperatingLeaseNumberOfRenewalOptions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Number Of Renewal Options",
        "label": "Lessee, Operating Lease, Number Of Renewal Options",
        "terseLabel": "Number of renewal options"
       }
      }
     },
     "localname": "LesseeOperatingLeaseNumberOfRenewalOptions",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prct_LesseeOperatingLeaseReceivableAllowanceForTenantImprovements": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Receivable Allowance for Tenant Improvements",
        "label": "Lessee, Operating Lease, Receivable Allowance for Tenant Improvements",
        "terseLabel": "Receivable allowance for tenant improvements"
       }
      }
     },
     "localname": "LesseeOperatingLeaseReceivableAllowanceForTenantImprovements",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prct_LineOfCreditFacilityCovenantComplianceContingentTrailingSixTwelveMonthRevenueTarget": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line of Credit Facility, Covenant Compliance, Contingent Trailing Six Twelve Month Revenue Target",
        "label": "Line of Credit Facility, Covenant Compliance, Contingent Trailing Six Twelve Month Revenue Target",
        "terseLabel": "Trailing six months revenue target"
       }
      }
     },
     "localname": "LineOfCreditFacilityCovenantComplianceContingentTrailingSixTwelveMonthRevenueTarget",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prct_LineOfCreditFacilityCovenantComplianceContingentTrailingTwelveMonthRevenueTarget": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line of Credit Facility, Covenant Compliance, Contingent Trailing Twelve Month Revenue Target",
        "label": "Line of Credit Facility, Covenant Compliance, Contingent Trailing Twelve Month Revenue Target",
        "terseLabel": "Trailing twelve month revenue target"
       }
      }
     },
     "localname": "LineOfCreditFacilityCovenantComplianceContingentTrailingTwelveMonthRevenueTarget",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceFourInstallmentsDrawn": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line of Credit Facility, Covenant Terms, Liquidity Occurrence, Four Installments Drawn",
        "label": "Line of Credit Facility, Covenant Terms, Liquidity Occurrence, Four Installments Drawn",
        "terseLabel": "Fee if all four installments are drawn"
       }
      }
     },
     "localname": "LineOfCreditFacilityCovenantTermsLiquidityOccurrenceFourInstallmentsDrawn",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceOneInstallmentDrawn": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line of Credit Facility, Covenant Terms, Liquidity Occurrence, One Installment Drawn",
        "label": "Line of Credit Facility, Covenant Terms, Liquidity Occurrence, One Installment Drawn",
        "terseLabel": "Fee on first installment drawn"
       }
      }
     },
     "localname": "LineOfCreditFacilityCovenantTermsLiquidityOccurrenceOneInstallmentDrawn",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceThreeInstallmentsDrawn": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line of Credit Facility, Covenant Terms, Liquidity Occurrence, Three Installments Drawn",
        "label": "Line of Credit Facility, Covenant Terms, Liquidity Occurrence, Three Installments Drawn",
        "terseLabel": "Fee if first three installments drawn"
       }
      }
     },
     "localname": "LineOfCreditFacilityCovenantTermsLiquidityOccurrenceThreeInstallmentsDrawn",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prct_LineOfCreditFacilityCovenantTermsLiquidityOccurrenceTwoInstallmentsDrawn": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line of Credit Facility, Covenant Terms, Liquidity Occurrence, Two Installments Drawn",
        "label": "Line of Credit Facility, Covenant Terms, Liquidity Occurrence, Two Installments Drawn",
        "terseLabel": "Fee if first two installments drawn"
       }
      }
     },
     "localname": "LineOfCreditFacilityCovenantTermsLiquidityOccurrenceTwoInstallmentsDrawn",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prct_LineOfCreditFacilityEarlyRepaymentFeeFirstTwelveMonthPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line of Credit Facility, Early Repayment Fee First Twelve Month, Percent",
        "label": "Line of Credit Facility, Early Repayment Fee First Twelve Month, Percent",
        "terseLabel": "Early repayment fee first twelve month, percent"
       }
      }
     },
     "localname": "LineOfCreditFacilityEarlyRepaymentFeeFirstTwelveMonthPercent",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiabilityDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "prct_LineOfCreditFacilityEarlyRepaymentFeeSecondTwelveMonthPeriodPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line of Credit Facility, Early Repayment Fee Second Twelve Month Period, Percent",
        "label": "Line of Credit Facility, Early Repayment Fee Second Twelve Month Period, Percent",
        "terseLabel": "Early repayment fee second twelve month period, percent"
       }
      }
     },
     "localname": "LineOfCreditFacilityEarlyRepaymentFeeSecondTwelveMonthPeriodPercent",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiabilityDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "prct_LineOfCreditFacilityEarlyRepaymentFeeTwentyFourMonthsThruMaturityPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line of Credit Facility, Early Repayment Fee, Twenty Four Months Thru Maturity, Percent",
        "label": "Line of Credit Facility, Early Repayment Fee, Twenty Four Months Thru Maturity, Percent",
        "terseLabel": "Early repayment fee, twenty four months thereafter, percent"
       }
      }
     },
     "localname": "LineOfCreditFacilityEarlyRepaymentFeeTwentyFourMonthsThruMaturityPercent",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiabilityDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "prct_LineOfCreditFacilityFinalPaymentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line of Credit Facility, Final Payment Fee, Percentage",
        "label": "Line of Credit Facility, Final Payment Fee, Percentage",
        "terseLabel": "Final payment fee, percentage"
       }
      }
     },
     "localname": "LineOfCreditFacilityFinalPaymentFeePercentage",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiabilityDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "prct_LineOfCreditFacilityGainLossOnAmendmentOfDebtTerms": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line of Credit Facility, Gain (Loss) on Amendment of Debt Terms",
        "label": "Line of Credit Facility, Gain (Loss) on Amendment of Debt Terms",
        "terseLabel": "Gain (loss) on amendment of debt terms"
       }
      }
     },
     "localname": "LineOfCreditFacilityGainLossOnAmendmentOfDebtTerms",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prct_LineOfCreditFacilityNumberOfInstallments": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line of Credit Facility, Number of Installments",
        "label": "Line of Credit Facility, Number of Installments",
        "terseLabel": "Number of installments"
       }
      }
     },
     "localname": "LineOfCreditFacilityNumberOfInstallments",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiabilityDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prct_LoanFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loan Facility",
        "label": "Loan Facility [Member]",
        "terseLabel": "Loan Facility"
       }
      }
     },
     "localname": "LoanFacilityMember",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiabilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prct_LoanFacilityTrancheFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loan Facility, Tranche Four",
        "label": "Loan Facility, Tranche Four [Member]",
        "terseLabel": "Loan Facility, Tranche Four"
       }
      }
     },
     "localname": "LoanFacilityTrancheFourMember",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiabilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prct_LoanFacilityTrancheOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loan Facility, Tranche One",
        "label": "Loan Facility, Tranche One [Member]",
        "terseLabel": "Loan Facility, Tranche One"
       }
      }
     },
     "localname": "LoanFacilityTrancheOneMember",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiabilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prct_LoanFacilityTrancheThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loan Facility, Tranche Three",
        "label": "Loan Facility, Tranche Three [Member]",
        "terseLabel": "Loan Facility, Tranche Three"
       }
      }
     },
     "localname": "LoanFacilityTrancheThreeMember",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiabilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prct_LoanFacilityTrancheTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loan Facility, Tranche Two",
        "label": "Loan Facility, Tranche Two [Member]",
        "terseLabel": "Loan Facility, Tranche Two"
       }
      }
     },
     "localname": "LoanFacilityTrancheTwoMember",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiabilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prct_NonCashLeaseAccretionExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-cash Lease Accretion Expense",
        "label": "Non-cash Lease Accretion Expense",
        "negatedTerseLabel": "Non-cash lease adjustment"
       }
      }
     },
     "localname": "NonCashLeaseAccretionExpense",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prct_OperatingLeaseAnnualBaseRentYearOne": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease Annual Base Rent, Year One",
        "label": "Operating Lease Annual Base Rent, Year One",
        "terseLabel": "Annual base rent, year one"
       }
      }
     },
     "localname": "OperatingLeaseAnnualBaseRentYearOne",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prct_OperatingLeaseAnnualBaseRentYearTen": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease Annual Base Rent, Year Ten",
        "label": "Operating Lease Annual Base Rent, Year Ten",
        "terseLabel": "Annual base rent, year ten"
       }
      }
     },
     "localname": "OperatingLeaseAnnualBaseRentYearTen",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prct_OperatingLeaseLiabilityAndLongTermDebt": {
     "auth_ref": [],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsandLongTermDebtMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease Liability and Long-Term Debt",
        "label": "Operating Lease Liability and Long-Term Debt",
        "totalLabel": "Present value of future payments"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityAndLongTermDebt",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsandLongTermDebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prct_OperatingLeaseLiabilityAndLongTermDebtCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsandLongTermDebtMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "prct_OperatingLeaseLiabilityAndLongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease Liability and Long-Term Debt, Current",
        "label": "Operating Lease Liability and Long-Term Debt, Current",
        "negatedTerseLabel": "Less: current portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityAndLongTermDebtCurrent",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsandLongTermDebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prct_OperatingLeaseLiabilityAndLongTermDebtExcludingCurrentMaturities": {
     "auth_ref": [],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsandLongTermDebtMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "prct_OperatingLeaseLiabilityAndLongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease Liability and Long-Term Debt, Excluding Current Maturities",
        "label": "Operating Lease Liability and Long-Term Debt, Excluding Current Maturities",
        "terseLabel": "Non-current portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityAndLongTermDebtExcludingCurrentMaturities",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsandLongTermDebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prct_OperatingLeaseLiabilityAndLongTermDebtMaturityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease Liability and Long-Term Debt Maturity",
        "label": "Operating Lease Liability and Long-Term Debt Maturity [Abstract]",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityAndLongTermDebtMaturityAbstract",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsandLongTermDebtMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "prct_OperatingLeaseLiabilityAndLongTermDebtMaturityGross": {
     "auth_ref": [],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsandLongTermDebtMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease Liability and Long-Term Debt Maturity, Gross",
        "label": "Operating Lease Liability and Long-Term Debt Maturity, Gross",
        "totalLabel": "Total minimum payments"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityAndLongTermDebtMaturityGross",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsandLongTermDebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prct_OperatingLeaseLiabilityAndLongTermDebtMaturityRemainderOfFiscalYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsandLongTermDebtMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "prct_OperatingLeaseLiabilityAndLongTermDebtMaturityGross",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease Liability and Long-Term Debt Maturity, Remainder of Fiscal year",
        "label": "Operating Lease Liability and Long-Term Debt Maturity, Remainder of Fiscal year",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityAndLongTermDebtMaturityRemainderOfFiscalYear",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsandLongTermDebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prct_OperatingLeaseLiabilityAndLongTermDebtMaturityUnamortizedDebtDiscount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease Liability and Long-Term Debt Maturity, Unamortized Debt Discount",
        "label": "Operating Lease Liability and Long-Term Debt Maturity, Unamortized Debt Discount",
        "negatedTerseLabel": "Less: amount representing interest/unamortized debt discount"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityAndLongTermDebtMaturityUnamortizedDebtDiscount",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsandLongTermDebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prct_OperatingLeaseLiabilityAndLongTermDebtMaturityYearOne": {
     "auth_ref": [],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsandLongTermDebtMaturitiesDetails": {
       "order": 3.0,
       "parentTag": "prct_OperatingLeaseLiabilityAndLongTermDebtMaturityGross",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease Liability and Long-Term Debt Maturity, Year One",
        "label": "Operating Lease Liability and Long-Term Debt Maturity, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityAndLongTermDebtMaturityYearOne",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsandLongTermDebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prct_OperatingLeaseLiabilityAndLongTermDebtMaturityYearTwo": {
     "auth_ref": [],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsandLongTermDebtMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "prct_OperatingLeaseLiabilityAndLongTermDebtMaturityGross",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease Liability and Long-Term Debt Maturity, Year Two",
        "label": "Operating Lease Liability and Long-Term Debt Maturity, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityAndLongTermDebtMaturityYearTwo",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsandLongTermDebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "prct_OperatingLeaseNumberOfBuildings": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Number of Buildings",
        "label": "Operating Lease, Number of Buildings",
        "terseLabel": "Number of buildings"
       }
      }
     },
     "localname": "OperatingLeaseNumberOfBuildings",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prct_OperatingLeaseNumberOfSquareFeet": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Number of Square Feet",
        "label": "Operating Lease, Number of Square Feet",
        "terseLabel": "Number of square feet"
       }
      }
     },
     "localname": "OperatingLeaseNumberOfSquareFeet",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "prct_OutsideTheUnitedStatesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outside the United States",
        "label": "Outside the United States [Member]",
        "terseLabel": "Outside of U.S."
       }
      }
     },
     "localname": "OutsideTheUnitedStatesMember",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/RevenueDetails",
      "http://www.procept-biorobotics.com/role/SegmentGeographicalandCustomerConcentrationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prct_RedeemableConvertiblePreferredStockWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeemable Convertible Preferred Stock Warrants",
        "label": "Redeemable Convertible Preferred Stock Warrants [Member]",
        "terseLabel": "Redeemable convertible preferred stock warrants"
       }
      }
     },
     "localname": "RedeemableConvertiblePreferredStockWarrantsMember",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/NetLossPerSharePotentiallyDilutiveSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prct_SeriesERedeemableConvertiblePreferredStockWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series E Redeemable Convertible Preferred Stock Warrants",
        "label": "Series E Redeemable Convertible Preferred Stock Warrants [Member]",
        "terseLabel": "Series E, Redeemable Convertible Preferred Stock Warrants"
       }
      }
     },
     "localname": "SeriesERedeemableConvertiblePreferredStockWarrantsMember",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prct_ServiceRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Service Revenue",
        "label": "Service Revenue [Member]",
        "terseLabel": "Service"
       }
      }
     },
     "localname": "ServiceRevenueMember",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prct_SystemSalesAndRentalsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "System Sales and Rentals",
        "label": "System Sales and Rentals [Member]",
        "terseLabel": "System sales and rentals"
       }
      }
     },
     "localname": "SystemSalesAndRentalsMember",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "prct_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Stock Issued During Period, Shares, New Issues",
        "label": "Temporary Equity, Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Issuance of preferred stock, net of issuance costs (in shares)"
       }
      }
     },
     "localname": "TemporaryEquityStockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "prct_TemporaryEquityStockIssuedDuringPeriodSharesWarrantExercises": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Stock Issued During Period, Shares, Warrant Exercises",
        "label": "Temporary Equity, Stock Issued During Period, Shares, Warrant Exercises",
        "terseLabel": "Issuance upon exercise of warrants (in shares)"
       }
      }
     },
     "localname": "TemporaryEquityStockIssuedDuringPeriodSharesWarrantExercises",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "prct_TransferFromInventoryToPropertyAndEquipmentNet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transfer From Inventory to Property and Equipment, Net",
        "label": "Transfer From Inventory to Property and Equipment, Net",
        "terseLabel": "Transfer of evaluation units from inventory to property and equipment, net"
       }
      }
     },
     "localname": "TransferFromInventoryToPropertyAndEquipmentNet",
     "nsuri": "http://www.procept-biorobotics.com/20220630",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r175",
      "r266",
      "r271",
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/SegmentGeographicalandCustomerConcentrationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r175",
      "r266",
      "r271",
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/SegmentGeographicalandCustomerConcentrationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r170",
      "r266",
      "r269",
      "r379",
      "r401",
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/RevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r170",
      "r266",
      "r269",
      "r379",
      "r401",
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r171",
      "r172",
      "r266",
      "r270",
      "r403",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/RevenueDetails",
      "http://www.procept-biorobotics.com/role/SegmentGeographicalandCustomerConcentrationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r171",
      "r172",
      "r266",
      "r270",
      "r403",
      "r414",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/RevenueDetails",
      "http://www.procept-biorobotics.com/role/SegmentGeographicalandCustomerConcentrationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r39",
      "r372"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/SegmentGeographicalandCustomerConcentrationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r5",
      "r24",
      "r177",
      "r178"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedSalariesCurrent": {
     "auth_ref": [
      "r10",
      "r11",
      "r43"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Salaries, Current",
        "terseLabel": "Accrued compensation"
       }
      }
     },
     "localname": "AccruedSalariesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r27",
      "r62",
      "r63",
      "r64",
      "r393",
      "r409",
      "r410"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r61",
      "r64",
      "r70",
      "r71",
      "r72",
      "r105",
      "r106",
      "r107",
      "r327",
      "r405",
      "r406",
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r25",
      "r315",
      "r372"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r105",
      "r106",
      "r107",
      "r312",
      "r313",
      "r314",
      "r331"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit",
      "http://www.procept-biorobotics.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement, classified as other.",
        "label": "APIC, Share-based Payment Arrangement, Other, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r286",
      "r308",
      "r317"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Total stock-based compensation",
        "verboseLabel": "Unrecognized stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.procept-biorobotics.com/role/StockBasedCompensationStockbasedCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r90",
      "r183",
      "r185"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization expense"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/IntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive securities excluded from computation of earnings per share, amount (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/NetLossPerSharePotentiallyDilutiveSecuritiesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/NetLossPerSharePotentiallyDilutiveSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/NetLossPerSharePotentiallyDilutiveSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/NetLossPerSharePotentiallyDilutiveSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r102",
      "r156",
      "r160",
      "r166",
      "r180",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r324",
      "r328",
      "r350",
      "r370",
      "r372",
      "r380",
      "r391"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r6",
      "r7",
      "r53",
      "r102",
      "r180",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r324",
      "r328",
      "r350",
      "r370",
      "r372"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r287",
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/StockBasedCompensationFairValueAssumptionsDetails",
      "http://www.procept-biorobotics.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.procept-biorobotics.com/role/StockBasedCompensationRestrictedStockUnitDetails",
      "http://www.procept-biorobotics.com/role/StockBasedCompensationSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BuildingMember": {
     "auth_ref": [
      "r187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.",
        "label": "Building [Member]",
        "terseLabel": "Building"
       }
      }
     },
     "localname": "BuildingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": {
     "auth_ref": [
      "r2",
      "r104",
      "r148"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the business description and basis of presentation concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity.  Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Business Description and Basis of Presentation [Text Block]",
        "terseLabel": "Organization"
       }
      }
     },
     "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/Organization"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r94",
      "r95",
      "r96"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Property and equipment included in accounts payable and other current liabilities"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Cash": {
     "auth_ref": [
      "r36",
      "r372",
      "r412",
      "r413"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "Cash",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/FairValueMeasurementsFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r3",
      "r36",
      "r92"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.procept-biorobotics.com/role/FairValueMeasurementsFairValueDetails",
      "http://www.procept-biorobotics.com/role/OrganizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r85",
      "r92",
      "r97"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents, and restricted cash - End of period",
        "periodStartLabel": "Cash, cash equivalents, and restricted cash- Beginning of period",
        "totalLabel": "Cash, cash equivalents and restricted cash in balance sheets"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]",
        "terseLabel": "Reconciliation of cash, cash equivalents and restricted cash to balance sheets:"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r85",
      "r351"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net (decrease) increase in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r36"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash equivalents"
       }
      }
     },
     "localname": "CashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/FairValueMeasurementsFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]",
        "terseLabel": "Non-cash investing and financing activities"
       }
      }
     },
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r100",
      "r102",
      "r120",
      "r121",
      "r122",
      "r124",
      "r126",
      "r134",
      "r135",
      "r136",
      "r180",
      "r198",
      "r202",
      "r203",
      "r204",
      "r207",
      "r208",
      "r244",
      "r245",
      "r246",
      "r247",
      "r350",
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/OrganizationDetails",
      "http://www.procept-biorobotics.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "auth_ref": [
      "r253",
      "r285"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of warrant or right issued.",
        "label": "Class of Warrant or Right [Axis]",
        "terseLabel": "Class of Warrant or Right [Axis]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.",
        "label": "Class of Warrant or Right [Domain]",
        "terseLabel": "Class of Warrant or Right [Domain]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfWarrantOrRightLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Warrant or Right [Line Items]",
        "terseLabel": "Class of Warrant or Right [Line Items]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.procept-biorobotics.com/role/StockBasedCompensationSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightTable": {
     "auth_ref": [
      "r253",
      "r285"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.",
        "label": "Class of Warrant or Right [Table]",
        "terseLabel": "Class of Warrant or Right [Table]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.procept-biorobotics.com/role/StockBasedCompensationSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r47",
      "r194",
      "r384",
      "r397"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r191",
      "r192",
      "r193",
      "r195",
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r105",
      "r106",
      "r331"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit",
      "http://www.procept-biorobotics.com/role/OrganizationDetails",
      "http://www.procept-biorobotics.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheetsParentheticals"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheetsParentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheetsParentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r23",
      "r249"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, shares, outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheetsParentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r23",
      "r372"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r66",
      "r68",
      "r69",
      "r75",
      "r386",
      "r399"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r143",
      "r144",
      "r175",
      "r348",
      "r349",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/SegmentGeographicalandCustomerConcentrationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r143",
      "r144",
      "r175",
      "r348",
      "r349",
      "r411",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/SegmentGeographicalandCustomerConcentrationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r143",
      "r144",
      "r175",
      "r348",
      "r349",
      "r411",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/SegmentGeographicalandCustomerConcentrationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskDisclosureTextBlock": {
     "auth_ref": [
      "r148"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.",
        "label": "Concentration Risk Disclosure [Text Block]",
        "terseLabel": "Segment, Geographical, and Customer Concentration"
       }
      }
     },
     "localname": "ConcentrationRiskDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/SegmentGeographicalandCustomerConcentration"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r143",
      "r144",
      "r175",
      "r348",
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Revenue by significant geographical locations outside the United States, percent"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/SegmentGeographicalandCustomerConcentrationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r143",
      "r144",
      "r175",
      "r348",
      "r349",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/SegmentGeographicalandCustomerConcentrationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r255",
      "r256",
      "r267"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion": {
     "auth_ref": [
      "r21",
      "r22",
      "r248",
      "r250",
      "r251"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued for each share of convertible preferred stock that is converted.",
        "label": "Convertible Preferred Stock, Shares Issued upon Conversion",
        "terseLabel": "Convertible preferred stock, shares, number of shares issued upon conversion (in shares)"
       }
      }
     },
     "localname": "ConvertiblePreferredStockSharesIssuedUponConversion",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/NetLossPerShareNarrativeDetails",
      "http://www.procept-biorobotics.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CostOfRevenue": {
     "auth_ref": [
      "r78",
      "r102",
      "r180",
      "r198",
      "r199",
      "r200",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r350"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Cost of Revenue",
        "terseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/StockBasedCompensationStockbasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiabilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r141",
      "r175"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/SegmentGeographicalandCustomerConcentrationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r99",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r226",
      "r233",
      "r234",
      "r235",
      "r242"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Loan Facility and Derivative Liability"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiability"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r17",
      "r18",
      "r19",
      "r101",
      "r103",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r216",
      "r222",
      "r223",
      "r224",
      "r225",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r238",
      "r239",
      "r240",
      "r241",
      "r363",
      "r381",
      "r382",
      "r390"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r19",
      "r236",
      "r382",
      "r390"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsandLongTermDebtMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "totalLabel": "Total minimum payments"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsandLongTermDebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r45",
      "r101",
      "r103",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r216",
      "r222",
      "r223",
      "r224",
      "r225",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r238",
      "r239",
      "r240",
      "r241",
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiabilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Facility term (in years)"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiabilityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet": {
     "auth_ref": [
      "r222",
      "r359",
      "r360",
      "r361",
      "r362",
      "r364"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount (premium).",
        "label": "Debt Instrument, Unamortized Discount (Premium), Net",
        "terseLabel": "Less: amount representing interest/unamortized debt discount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountPremiumNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsandLongTermDebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r90",
      "r155"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "auth_ref": [
      "r54",
      "r57",
      "r58",
      "r330",
      "r376"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Fair Value, Gross Liability",
        "terseLabel": "Derivative liability, loan facility"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilities": {
     "auth_ref": [
      "r55",
      "r56",
      "r57",
      "r347"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability",
        "terseLabel": "Loan facility derivative liability"
       }
      }
     },
     "localname": "DerivativeLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/FairValueMeasurementsFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilitiesNoncurrent": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability, Noncurrent",
        "terseLabel": "Loan facility derivative liability"
       }
      }
     },
     "localname": "DerivativeLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativesAndFairValueTextBlock": {
     "auth_ref": [
      "r334",
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivatives and fair value of assets and liabilities.",
        "label": "Derivatives and Fair Value [Text Block]",
        "terseLabel": "Loan Facility and Derivative Liability"
       }
      }
     },
     "localname": "DerivativesAndFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiability"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/RevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r266",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/RevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": {
     "auth_ref": [
      "r287",
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of share-based payment arrangement.",
        "label": "Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]",
        "terseLabel": "Schedule of Fair Value Assumptions"
       }
      }
     },
     "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r76",
      "r110",
      "r111",
      "r112",
      "r113",
      "r114",
      "r118",
      "r120",
      "r124",
      "r125",
      "r126",
      "r130",
      "r131",
      "r332",
      "r333",
      "r387",
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Net loss per share, basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.procept-biorobotics.com/role/NetLossPerShareNetlosspershareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r76",
      "r110",
      "r111",
      "r112",
      "r113",
      "r114",
      "r120",
      "r124",
      "r125",
      "r126",
      "r130",
      "r131",
      "r332",
      "r333",
      "r387",
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Net loss per share, diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.procept-biorobotics.com/role/NetLossPerShareNetlosspershareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r127",
      "r128",
      "r129",
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Net Loss Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/NetLossPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r309"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation cost"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Average vesting period for unrecognized compensation cost"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Common stock options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/NetLossPerSharePotentiallyDilutiveSecuritiesDetails",
      "http://www.procept-biorobotics.com/role/StockBasedCompensationFairValueAssumptionsDetails",
      "http://www.procept-biorobotics.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.procept-biorobotics.com/role/StockBasedCompensationSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r70",
      "r71",
      "r72",
      "r105",
      "r106",
      "r107",
      "r109",
      "r115",
      "r117",
      "r133",
      "r181",
      "r249",
      "r252",
      "r312",
      "r313",
      "r314",
      "r320",
      "r321",
      "r331",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r405",
      "r406",
      "r407",
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit",
      "http://www.procept-biorobotics.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r224",
      "r238",
      "r239",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r336",
      "r373",
      "r374",
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/FairValueMeasurementsFairValueDetails",
      "http://www.procept-biorobotics.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r335",
      "r336",
      "r338",
      "r339",
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/FairValueMeasurementsFairValueDetails",
      "http://www.procept-biorobotics.com/role/FairValueMeasurementsFairValueInputsLevel3FairValueMeasurementsRecurringDetails",
      "http://www.procept-biorobotics.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]",
        "terseLabel": "Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]"
       }
      }
     },
     "localname": "FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/FairValueMeasurementsFairValueDetails",
      "http://www.procept-biorobotics.com/role/FairValueMeasurementsFairValueInputsLevel3FairValueMeasurementsRecurringDetails",
      "http://www.procept-biorobotics.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable": {
     "auth_ref": [
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about fair value of asset and liability not measured at fair value.",
        "label": "Fair Value Disclosure of Asset and Liability Not Measured at Fair Value [Table]",
        "terseLabel": "Fair Value Disclosure of Asset and Liability Not Measured at Fair Value [Table]"
       }
      }
     },
     "localname": "FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/FairValueMeasurementsFairValueDetails",
      "http://www.procept-biorobotics.com/role/FairValueMeasurementsFairValueInputsLevel3FairValueMeasurementsRecurringDetails",
      "http://www.procept-biorobotics.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r224",
      "r277",
      "r278",
      "r283",
      "r284",
      "r336",
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/FairValueMeasurementsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r224",
      "r238",
      "r239",
      "r277",
      "r278",
      "r283",
      "r284",
      "r336",
      "r374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/FairValueMeasurementsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r224",
      "r238",
      "r239",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r336",
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/FairValueMeasurementsFairValueDetails",
      "http://www.procept-biorobotics.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/FairValueMeasurementsFairValueDetails",
      "http://www.procept-biorobotics.com/role/FairValueMeasurementsFairValueInputsLevel3FairValueMeasurementsRecurringDetails",
      "http://www.procept-biorobotics.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r224",
      "r238",
      "r239",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r373",
      "r374",
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/FairValueMeasurementsFairValueDetails",
      "http://www.procept-biorobotics.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r342",
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value, Measurements, Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/FairValueMeasurementsFairValueDetails",
      "http://www.procept-biorobotics.com/role/FairValueMeasurementsFairValueInputsLevel3FairValueMeasurementsRecurringDetails",
      "http://www.procept-biorobotics.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]",
        "terseLabel": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/FairValueMeasurementsFairValueInputsLevel3FairValueMeasurementsRecurringDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings": {
     "auth_ref": [
      "r340",
      "r344"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from derivative asset (liability) after deduction of derivative liability (asset), measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Earnings",
        "negatedTerseLabel": "Change in fair value"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/FairValueMeasurementsFairValueInputsLevel3FairValueMeasurementsRecurringDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues": {
     "auth_ref": [
      "r341",
      "r344"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of issuances of financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset), measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Issues",
        "terseLabel": "Issued"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/FairValueMeasurementsFairValueInputsLevel3FairValueMeasurementsRecurringDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs": {
     "auth_ref": [
      "r335",
      "r344"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as derivative asset (liability) after deduction of derivative liability (asset), measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis with Unobservable Inputs",
        "periodEndLabel": "End of the period",
        "periodStartLabel": "Beginning of the period"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/FairValueMeasurementsFairValueInputsLevel3FairValueMeasurementsRecurringDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r184"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "terseLabel": "Accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/IntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeographicConcentrationRiskMember": {
     "auth_ref": [
      "r142",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that a specified dollar value on the balance sheet or income statement in the period from one or more specified geographic areas is to a corresponding consolidated, segment, or product line amount. Risk is the materially adverse effects of economic decline or antagonistic political actions resulting in loss of assets, sales volume, labor supply, or source of materials and supplies in a US state or a specified country, continent, or region such as EMEA (Europe, Middle East, Africa).",
        "label": "Geographic Concentration Risk [Member]",
        "terseLabel": "Geographic Concentration Risk"
       }
      }
     },
     "localname": "GeographicConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/SegmentGeographicalandCustomerConcentrationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r77",
      "r102",
      "r156",
      "r159",
      "r162",
      "r165",
      "r168",
      "r180",
      "r198",
      "r199",
      "r200",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r350"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IPOMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First sale of stock by a private company to the public.",
        "label": "IPO [Member]",
        "terseLabel": "IPO"
       }
      }
     },
     "localname": "IPOMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/OrganizationDetails",
      "http://www.procept-biorobotics.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r189",
      "r190"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/StockBasedCompensationStockbasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r190"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/StockBasedCompensationStockbasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedSalaries": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in accrued salaries.",
        "label": "Increase (Decrease) in Accrued Salaries",
        "terseLabel": "Accrued compensation"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedSalaries",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "auth_ref": [
      "r89",
      "r377"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInterestPayableNet": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity.",
        "label": "Increase (Decrease) in Interest Payable, Net",
        "terseLabel": "Accrued interest expense"
       }
      }
     },
     "localname": "IncreaseDecreaseInInterestPayableNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Inventory"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedTerseLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Liabilities",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Temporary Equity [Roll Forward]",
        "terseLabel": "Redeemable Convertible Preferred Stock"
       }
      }
     },
     "localname": "IncreaseDecreaseInTemporaryEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all or part of the information related to intangible assets.",
        "label": "Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Intangible Assets"
       }
      }
     },
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/IntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsNetIncludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.",
        "label": "Intangible Assets, Net (Including Goodwill)",
        "terseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetIncludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r73",
      "r154",
      "r358",
      "r361",
      "r388"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedTerseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r84",
      "r86",
      "r93"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/Inventory"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoods": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/InventoryInventoryDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.",
        "label": "Inventory, Finished Goods, Gross",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoods",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/InventoryInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r4",
      "r52",
      "r372"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.procept-biorobotics.com/role/InventoryInventoryDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventory",
        "totalLabel": "Total inventory"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.procept-biorobotics.com/role/InventoryInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterials": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/InventoryInventoryDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Raw Materials, Gross",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterials",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/InventoryInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcess": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/InventoryInventoryDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.",
        "label": "Inventory, Work in Process, Gross",
        "terseLabel": "Work-in-process"
       }
      }
     },
     "localname": "InventoryWorkInProcess",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/InventoryInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Future minimum lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r368"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsandLongTermDebtMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total minimum payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsandLongTermDebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r368"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsandLongTermDebtMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsandLongTermDebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r368"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsandLongTermDebtMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsandLongTermDebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r368"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsandLongTermDebtMaturitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsandLongTermDebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r368"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less: amount representing interest/unamortized debt discount"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsandLongTermDebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r42",
      "r102",
      "r161",
      "r180",
      "r198",
      "r199",
      "r200",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r325",
      "r328",
      "r329",
      "r350",
      "r370",
      "r371"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r30",
      "r102",
      "r180",
      "r350",
      "r372",
      "r383",
      "r395"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and Stockholders' Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r44",
      "r102",
      "r180",
      "r198",
      "r199",
      "r200",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r325",
      "r328",
      "r329",
      "r350",
      "r370",
      "r371",
      "r372"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.",
        "label": "Line of Credit Facility, Commitment Fee Percentage",
        "terseLabel": "Commitment fee percentage"
       }
      }
     },
     "localname": "LineOfCreditFacilityCommitmentFeePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiabilityDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity": {
     "auth_ref": [
      "r40"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Current Borrowing Capacity",
        "terseLabel": "Current borrowing amount"
       }
      }
     },
     "localname": "LineOfCreditFacilityCurrentBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The effective interest rate at the end of the reporting period.",
        "label": "Line of Credit Facility, Interest Rate at Period End",
        "terseLabel": "Facility interest rate at period end (percent)"
       }
      }
     },
     "localname": "LineOfCreditFacilityInterestRateAtPeriodEnd",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiabilityDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Line of Credit Facility [Line Items]",
        "terseLabel": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r40"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Loan facility, maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "auth_ref": [
      "r40",
      "r101"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Line of Credit Facility [Table]",
        "terseLabel": "Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "LineOfCreditFacilityTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiabilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "London Interbank Offered Rate (LIBOR)"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiabilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r19",
      "r223",
      "r237",
      "r238",
      "r239",
      "r382",
      "r392"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsandLongTermDebtMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "totalLabel": "Present value of future payments"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsandLongTermDebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsandLongTermDebtMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Current Maturities",
        "negatedTerseLabel": "Less: current portion"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsandLongTermDebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r103",
      "r196",
      "r228"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsandLongTermDebtMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsandLongTermDebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r103",
      "r196",
      "r228"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsandLongTermDebtMaturitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsandLongTermDebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsandLongTermDebtMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.",
        "label": "Long-Term Debt, Maturity, Remainder of Fiscal Year",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsandLongTermDebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMeasurementInput": {
     "auth_ref": [
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure long-term debt.",
        "label": "Long-term Debt, Measurement Input",
        "terseLabel": "Cash flow discount"
       }
      }
     },
     "localname": "LongTermDebtMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsandLongTermDebtMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      },
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Non-current portion",
        "verboseLabel": "Note payable \u2013 non-current portion"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsandLongTermDebtMaturitiesDetails",
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r45"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r45",
      "r197"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiabilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MaturitiesOfLongTermDebtAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maturities of Long-term Debt [Abstract]",
        "terseLabel": "Debt Repayments"
       }
      }
     },
     "localname": "MaturitiesOfLongTermDebtAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsandLongTermDebtMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r85",
      "r88",
      "r91"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r1",
      "r65",
      "r67",
      "r72",
      "r74",
      "r91",
      "r102",
      "r108",
      "r110",
      "r111",
      "r112",
      "r113",
      "r116",
      "r117",
      "r123",
      "r156",
      "r159",
      "r162",
      "r165",
      "r168",
      "r180",
      "r198",
      "r199",
      "r200",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r333",
      "r350",
      "r385",
      "r398"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss",
        "verboseLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit",
      "http://www.procept-biorobotics.com/role/NetLossPerShareNetlosspershareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r156",
      "r159",
      "r162",
      "r165",
      "r168"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Loss from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r367"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease, Expense",
        "terseLabel": "Rent expense"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]",
        "terseLabel": "Minimum Lease Payments"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsandLongTermDebtMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r366"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsandLongTermDebtMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Operating lease, liability",
        "totalLabel": "Present value of future payments"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsandLongTermDebtMaturitiesDetails",
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r366"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsandLongTermDebtMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      },
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "negatedTerseLabel": "Less: current portion",
        "terseLabel": "Operating lease \u2013 current portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsandLongTermDebtMaturitiesDetails",
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r366"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsandLongTermDebtMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      },
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Non-current portion",
        "verboseLabel": "Operating lease \u2013 non-current portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsandLongTermDebtMaturitiesDetails",
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r365"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets, net"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCommitmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Other Commitments [Line Items]",
        "terseLabel": "Other Commitments [Line Items]"
       }
      }
     },
     "localname": "OtherCommitmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherCommitmentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about obligations resulting from other commitments.",
        "label": "Other Commitments [Table]",
        "terseLabel": "Other Commitments [Table]"
       }
      }
     },
     "localname": "OtherCommitmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r322",
      "r323",
      "r326"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.",
        "label": "Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Unrealized gain (loss) on cash equivalents"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r59",
      "r60",
      "r62"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax",
        "terseLabel": "Unrealized gain on cash equivalents"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive loss:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r9",
      "r10",
      "r43",
      "r372"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OverAllotmentOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.",
        "label": "Over-Allotment Option [Member]",
        "terseLabel": "Over-Allotment Option"
       }
      }
     },
     "localname": "OverAllotmentOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForUnderwritingExpense": {
     "auth_ref": [
      "r87"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash paid for expenses incurred during underwriting activities (the process to review insurance applications, evaluate risks, accept or reject applications, and determine the premiums to be charged) for insurance companies.",
        "label": "Payments for Underwriting Expense",
        "terseLabel": "Payments for underwriting discount and commissions"
       }
      }
     },
     "localname": "PaymentsForUnderwritingExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "auth_ref": [
      "r83"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
        "label": "Payments of Stock Issuance Costs",
        "terseLabel": "Payments of stock issuance costs"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "auth_ref": [
      "r80"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.",
        "label": "Payments to Acquire Intangible Assets",
        "terseLabel": "Payments to acquire intangible assets"
       }
      }
     },
     "localname": "PaymentsToAcquireIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/IntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r287",
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/StockBasedCompensationFairValueAssumptionsDetails",
      "http://www.procept-biorobotics.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/StockBasedCompensationFairValueAssumptionsDetails",
      "http://www.procept-biorobotics.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r22",
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred Stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheetsParentheticals"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred Stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheetsParentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r22",
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred Stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheetsParentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred Stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheetsParentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r22",
      "r372"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r6",
      "r34",
      "r35"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Proceeds from issuance of common stock under employee stock purchase plan"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation.",
        "label": "Proceeds from Issuance of Preferred Stock and Preference Stock",
        "terseLabel": "Proceeds from issuance of Series G preferred stock, net of issuance costs"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfPreferredStockAndPreferenceStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLongTermLinesOfCredit": {
     "auth_ref": [
      "r82"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.",
        "label": "Proceeds from Long-term Lines of Credit",
        "terseLabel": "Proceeds from long-term lines of credit"
       }
      }
     },
     "localname": "ProceedsFromLongTermLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r81",
      "r311"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from issuance of common stock from the exercise of stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r37",
      "r188"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Long-Lived Tangible Asset [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r14",
      "r15",
      "r188",
      "r372",
      "r389",
      "r396"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r14",
      "r187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Long-Lived Tangible Asset [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable": {
     "auth_ref": [
      "r158",
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification, description, and amounts of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues.",
        "label": "Reconciliation of Revenue from Segments to Consolidated [Table]",
        "terseLabel": "Reconciliation of Revenue from Segments to Consolidated [Table]"
       }
      }
     },
     "localname": "ReconciliationOfRevenueFromSegmentsToConsolidatedTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/SegmentGeographicalandCustomerConcentrationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RedeemableConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of type or class of redeemable convertible preferred stock. Convertible redeemable preferred stock possess conversion and redemption features. The stock has redemption features that are outside the control of the issuer.",
        "label": "Redeemable Convertible Preferred Stock [Member]",
        "terseLabel": "Redeemable convertible preferred stock outstanding"
       }
      }
     },
     "localname": "RedeemableConvertiblePreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/NetLossPerSharePotentiallyDilutiveSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r319",
      "r378",
      "r427"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/StockBasedCompensationStockbasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r3",
      "r13",
      "r92",
      "r97"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash and Cash Equivalents, Current",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "auth_ref": [
      "r8",
      "r16",
      "r97",
      "r415"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Noncurrent",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted stock units"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/NetLossPerSharePotentiallyDilutiveSecuritiesDetails",
      "http://www.procept-biorobotics.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.procept-biorobotics.com/role/StockBasedCompensationRestrictedStockUnitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r26",
      "r252",
      "r315",
      "r372",
      "r394",
      "r408",
      "r410"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "negatedLabel": "Accumulated deficit",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.procept-biorobotics.com/role/OrganizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r105",
      "r106",
      "r107",
      "r109",
      "r115",
      "r117",
      "r181",
      "r312",
      "r313",
      "r314",
      "r320",
      "r321",
      "r331",
      "r405",
      "r407"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r152",
      "r153",
      "r158",
      "r163",
      "r164",
      "r170",
      "r171",
      "r175",
      "r265",
      "r266",
      "r379"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "verboseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.procept-biorobotics.com/role/RevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r268",
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/Revenue"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": {
     "auth_ref": [
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.",
        "label": "Revenue from External Customers by Geographic Areas [Table Text Block]",
        "terseLabel": "Revenue from External Customers by Geographic Areas"
       }
      }
     },
     "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/RevenueTables",
      "http://www.procept-biorobotics.com/role/SegmentGeographicalandCustomerConcentrationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received on stock transaction after deduction of issuance costs.",
        "label": "Sale of Stock, Consideration Received on Transaction",
        "terseLabel": "Sale of stock, consideration received on transaction"
       }
      }
     },
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/OrganizationDetails",
      "http://www.procept-biorobotics.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock [Domain]"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/OrganizationDetails",
      "http://www.procept-biorobotics.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "terseLabel": "Sale of stock, number of shares issued in transaction (in shares)"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Share price (in dollars per share)"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r143",
      "r175"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]",
        "terseLabel": "Revenue Benchmark"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/SegmentGeographicalandCustomerConcentrationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/NetLossPerSharePotentiallyDilutiveSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/NetLossPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of derivative liabilities at fair value.",
        "label": "Schedule of Derivative Liabilities at Fair Value [Table Text Block]",
        "terseLabel": "Schedule of Derivative Liabilities at Fair Value"
       }
      }
     },
     "localname": "ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock": {
     "auth_ref": [
      "r121",
      "r126",
      "r131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the effect of income (loss) on basic earnings per share.",
        "label": "Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table Text Block]",
        "terseLabel": "Schedule of Earnings Per Share, Basic"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicByCommonClassTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/NetLossPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock": {
     "auth_ref": [
      "r121",
      "r126",
      "r131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the effect of income (loss) on an entity's diluted earnings per share.",
        "label": "Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table Text Block]",
        "terseLabel": "Schedule of Earnings Per Share, Diluted"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/NetLossPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r286",
      "r307",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock": {
     "auth_ref": [
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.",
        "label": "Revenue from External Customers by Products and Services [Table Text Block]",
        "terseLabel": "Revenue from External Customers by Products and Services"
       }
      }
     },
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/RevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r335",
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r12",
      "r31",
      "r32",
      "r33"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of Inventory"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/InventoryTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r196"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-term Debt [Table Text Block]",
        "terseLabel": "Schedule of Maturities of Long-term Debt"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CommitmentsandContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock": {
     "auth_ref": [
      "r294"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of activity for outstanding award under share-based payment arrangement excluding share and unit options and nonvested award.",
        "label": "Share-based Payment Arrangement, Outstanding Award, Activity, Excluding Option [Table Text Block]",
        "terseLabel": "Share-based Payment Arrangement, Outstanding Award, Activity, Excluding Option"
       }
      }
     },
     "localname": "ScheduleOfOtherShareBasedCompensationActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r287",
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/StockBasedCompensationFairValueAssumptionsDetails",
      "http://www.procept-biorobotics.com/role/StockBasedCompensationRestrictedStockUnitDetails",
      "http://www.procept-biorobotics.com/role/StockBasedCompensationStockbasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r149",
      "r150",
      "r151",
      "r156",
      "r157",
      "r162",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r174",
      "r175",
      "r176"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment, Geographical, and Customer Concentration"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/SegmentGeographicalandCustomerConcentration"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingRevenueReconcilingItemLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting, Revenue Reconciling Item [Line Items]",
        "terseLabel": "Segment Reporting, Revenue Reconciling Item [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingRevenueReconcilingItemLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/SegmentGeographicalandCustomerConcentrationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "Sales, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/StockBasedCompensationStockbasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedTerseLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/StockBasedCompensationRestrictedStockUnitDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited (in dollars per shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/StockBasedCompensationRestrictedStockUnitDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Award (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/StockBasedCompensationRestrictedStockUnitDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Awarded (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/StockBasedCompensationRestrictedStockUnitDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r295"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Outstanding, end of period (in shares)",
        "periodStartLabel": "Outstanding, beginning of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/StockBasedCompensationRestrictedStockUnitDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Restricted Stock Units"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/StockBasedCompensationRestrictedStockUnitDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r295"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Outstanding, endof period (in dollars per share)",
        "periodStartLabel": "Outstanding, beginning of period (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/StockBasedCompensationRestrictedStockUnitDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted-Average Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/StockBasedCompensationRestrictedStockUnitDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r304"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Expected dividend rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/StockBasedCompensationFairValueAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/StockBasedCompensationFairValueAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/StockBasedCompensationFairValueAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangements"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/StockBasedCompensationFairValueAssumptionsDetails",
      "http://www.procept-biorobotics.com/role/StockBasedCompensationRestrictedStockUnitDetails",
      "http://www.procept-biorobotics.com/role/StockBasedCompensationStockbasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Shares available for grant (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Exercisable (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/StockBasedCompensationSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r298"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Options exercised in the period, intrinsic value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "negatedTerseLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/StockBasedCompensationSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/StockBasedCompensationSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r290",
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Balance at the end of the period (in shares)",
        "periodStartLabel": "Balance at the beginning of the period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/StockBasedCompensationSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Number of Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/StockBasedCompensationSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Balance at the end of the period (in dollars per share)",
        "periodStartLabel": "Balance at the beginning of the period (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/StockBasedCompensationSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/StockBasedCompensationSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue": {
     "auth_ref": [
      "r301"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value",
        "terseLabel": "Options outstanding and exercisable, aggregate intrinsic value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Exercisable (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/StockBasedCompensationSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [
      "r299"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Options outstanding, aggregate intrinsic value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock": {
     "auth_ref": [
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding and exercisable options that are fully vested and expected to vest. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Table Text Block]",
        "terseLabel": "Schedule of Stock Option Activity and Related Information"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "terseLabel": "Vested and expected to vest (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/StockBasedCompensationSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Vested and expected to vest (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/StockBasedCompensationSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r285",
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/StockBasedCompensationFairValueAssumptionsDetails",
      "http://www.procept-biorobotics.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.procept-biorobotics.com/role/StockBasedCompensationRestrictedStockUnitDetails",
      "http://www.procept-biorobotics.com/role/StockBasedCompensationSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/StockBasedCompensationSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/StockBasedCompensationSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/StockBasedCompensationSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r302",
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected life (years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/StockBasedCompensationFairValueAssumptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average grant-date fair value of options vested.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-average fair value (in dollars per share)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/StockBasedCompensationFairValueAssumptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r254",
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).",
        "label": "Shareholders' Equity and Share-based Payments [Text Block]",
        "verboseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "ShareholdersEquityAndShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/StockBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Balance at the end of the period (in shares)",
        "periodStartLabel": "Balance at the beginning of the period (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r98",
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r21",
      "r22",
      "r23",
      "r100",
      "r102",
      "r120",
      "r121",
      "r122",
      "r124",
      "r126",
      "r134",
      "r135",
      "r136",
      "r180",
      "r198",
      "r202",
      "r203",
      "r204",
      "r207",
      "r208",
      "r244",
      "r245",
      "r246",
      "r247",
      "r249",
      "r350",
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/OrganizationDetails",
      "http://www.procept-biorobotics.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r48",
      "r70",
      "r71",
      "r72",
      "r105",
      "r106",
      "r107",
      "r109",
      "r115",
      "r117",
      "r133",
      "r181",
      "r249",
      "r252",
      "r312",
      "r313",
      "r314",
      "r320",
      "r321",
      "r331",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r405",
      "r406",
      "r407",
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit",
      "http://www.procept-biorobotics.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r105",
      "r106",
      "r107",
      "r133",
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r22",
      "r23",
      "r249",
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Shares issued under employee stock purchase plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r22",
      "r23",
      "r249",
      "r252",
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedTerseLabel": "Exercised (in shares)",
        "verboseLabel": "Issuance upon exercise of options (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit",
      "http://www.procept-biorobotics.com/role/StockBasedCompensationSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r48",
      "r249",
      "r252"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.",
        "label": "Stock Issued During Period, Value, Conversion of Convertible Securities",
        "terseLabel": "Conversion of redeemable convertible preferred stock to common stock upon initial public offering"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r22",
      "r23",
      "r249",
      "r252"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Shares issued under employee stock purchase plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r48",
      "r249",
      "r252"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Issuance upon exercise of options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r23",
      "r28",
      "r29",
      "r102",
      "r179",
      "r180",
      "r350",
      "r372"
     ],
     "calculation": {
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Balance at the end of the period",
        "periodStartLabel": "Balance at the beginning of the period",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityPolicyTextBlock": {
     "auth_ref": [
      "r243"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its capital stock transactions, including dividends and accumulated other comprehensive income.",
        "label": "Stockholders' Equity, Policy [Policy Text Block]",
        "terseLabel": "Initial Public Offering"
       }
      }
     },
     "localname": "StockholdersEquityPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Different names of stock transactions and the different attributes of each transaction.",
        "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]",
        "terseLabel": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]"
       }
      }
     },
     "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/OrganizationDetails",
      "http://www.procept-biorobotics.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/OrganizationDetails",
      "http://www.procept-biorobotics.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Subsidiary, Sale of Stock [Line Items]",
        "terseLabel": "Subsidiary, Sale of Stock [Line Items]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/OrganizationDetails",
      "http://www.procept-biorobotics.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental cash flow information"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": {
     "auth_ref": [
      "r198",
      "r202",
      "r203",
      "r204",
      "r207",
      "r208"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Carrying Amount, Attributable to Parent",
        "periodEndLabel": "Balance at the end of the period",
        "periodStartLabel": "Balance at the beginning of the period"
       }
      }
     },
     "localname": "TemporaryEquityCarryingAmountAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquitySharesOutstanding": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Outstanding",
        "periodEndLabel": "Balance at the end of the period (in shares)",
        "periodStartLabel": "Balance at the beginning of the period (in shares)"
       }
      }
     },
     "localname": "TemporaryEquitySharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of new stock classified as temporary equity issued during the period.",
        "label": "Temporary Equity, Stock Issued During Period, Value, New Issues",
        "terseLabel": "Issuance of preferred stock, net of issuance costs"
       }
      }
     },
     "localname": "TemporaryEquityStockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r137",
      "r138",
      "r139",
      "r140",
      "r145",
      "r146",
      "r147"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationTechniqueAxis": {
     "auth_ref": [
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by valuation approach and technique.",
        "label": "Valuation Approach and Technique [Axis]",
        "terseLabel": "Valuation Approach and Technique [Axis]"
       }
      }
     },
     "localname": "ValuationTechniqueAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ValuationTechniqueDiscountedCashFlowMember": {
     "auth_ref": [
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation technique calculating present value of future cash flows.",
        "label": "Valuation Technique, Discounted Cash Flow [Member]",
        "terseLabel": "Valuation Technique, Discounted Cash Flow"
       }
      }
     },
     "localname": "ValuationTechniqueDiscountedCashFlowMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationTechniqueDomain": {
     "auth_ref": [
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation approach and technique.",
        "label": "Valuation Approach and Technique [Domain]",
        "terseLabel": "Valuation Approach and Technique [Domain]"
       }
      }
     },
     "localname": "ValuationTechniqueDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/LoanFacilityandDerivativeLiabilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]",
        "terseLabel": "Common Stock Warrants"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r119",
      "r126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "verboseLabel": "Weighted-average common stock outstanding, diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.procept-biorobotics.com/role/NetLossPerShareNetlosspershareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r118",
      "r126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Weighted-average common stock outstanding, basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.procept-biorobotics.com/role/NetLossPerShareNetlosspershareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]",
        "terseLabel": "Weighted-average shares used in computing net loss per share attributable to common shareholders"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.procept-biorobotics.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 8
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "a",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21459-112644"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "50",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "http://asc.fasb.org/topic&trid=2229140"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL7498357-110258"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "820",
   "URI": "http://asc.fasb.org/topic&trid=2155941"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28567-108399"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=123371682&loc=d3e55415-109406"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r428": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r429": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r431": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r432": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r433": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r434": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r435": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>63
<FILENAME>0001628280-22-021350-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-22-021350-xbrl.zip
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M)A@C])(U(V?K)_>_[RR)[:[8.IBK(HG+QT/7@UWN&#S[JB>/LN?(GZ<SD<S
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MDW3&T([%@BMES,!_,Y)B/X<YDPPMOVU9X<_:L"J<0L2DYO&J"EDN54XP!EK
M37H;F_8[97:C182*S&P5MT>78TR.X'+64"*G)&6J-KQ*V IZD870Y$@5Y00-
M:+0ZCTZ7C%"#42UA,0;RX$X"U9XU@W;]O2)LV\\) E'F3YPGF$P1ID5B@G<=
M4,G^RKED9O-4!B%59J)?WR68-A+\QB[=NT;U)OS7H2^A]0_J(8)ZT#&)\6,
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MO:+7#,N)7OF(%G^\&/SXQXM!T[;CSY;_\,77K-L[:X8_%WS1/6Z:LY?M3CO
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MO;?K;&-UC6ZL_GW06(7G5H_0YNKHF4_0%V_O[1P?;!RNG&V0O8.]G7VVU]I
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M'CC7,*RKMU9:V_0ZY4]._*WGTX^KH=UI%>V[FGVH>%QKXL7UT7^?[@P1A4)
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M?X1^XO"?B5!5,TM$ )3BC&+)'^.$!<RYI%[;.(RPF!9M=RU*>UP[K<9Q*:Q
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M :\:2C4"#F+44QT5M<1)@!_@^: 9*#LQ*[!CC*5"4J9/!IZ&8XYI9+5"E**
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M A)-7@%JIP(C,,%&IK5D:0GX 91QQXB'+^(YPOY9YJ"G]S>(3"6(%>,6_ U
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M@_VV=FI<KV*0K!.S\H(Q,M/-NL?!I3U.GQ7MK.AU,W=0>9,SO6S(\!*G:NQ
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M"N^;8?ZB?X=:_PP36PG23,*4H4M[#FYL"\;S=@W:6\.-U7VZ\7F-[!ZN\P9
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M]57JN3LLH-2/K-03#HQBDD19EBL4)$<A,6)D7'E,-OB4".&$N%*I)6D*.GU
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M=)J%F%<1E\>/T^]9*O/I5/"O07\X;!P/^NE^%3+G769F(4!I[I%\Q8TW%3,
MDN8&27M3<;Q/W I"+&+>Y3A>$8><UPE);4(@V*4HQLO)^ODL)X.V/W;L#]K^
M,-H^&?ES$G.(QR2RE'N4(1LC[:E!42=BL7 AJ;)^?U/H>T?^H.W+HNUSSQ:
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M](NK]'//3(#2/Z323R8AN/,AJAA0"L(ASIU"EJE05C1FCB06!28KJXPT)5^
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M 55W,@7 J?99/0V*2F#$G33($,^12,YC&;3T1N<HH*GE?=)_H+JU5-VY;SP
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MX"E%F#B&..,<&9L,LM$E%C1F7K":H?#SWGJ61;_1R6H"6\Q@30;8!%O,0 I
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M3:4UP!' T5,^VR\SX%$25&NL1&!1<JR\3=QR8A.)F+DDZ>UX-,S/F5_=!9@
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MR&A9[JU,P0ON#0YJ =RN.1WU7]#EO$IOD+/C@LW=X]@;5N5M&_&T?!V?62&
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MZ66&:1R340$I:PWBQCKDHB39#R0X4&.M+EM=U=:</^\-^ED+JMP[;,2'_0;
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MM'Y6\WGO'JST!#F;M2,_??<X]H:V4N1X6KZ.SVROX)/G[&%IY5FR"?;H@!0
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M5VXK:,Y;J;G@6?<+O!L8?KP!@U:_/PSE"E83AD5(>;\IY B[<=NRPF*%3E[
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M\0_S[AK[@.9-\<G TC)]0+6M\).P:4K' //.:UJHY!B*B#,2D>4J(N(<M]@
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M<OW:UM2'EOU\ W ]NZ"O;(CS69Z\\Y-,P<]3T<R/1TXJ$5V,B'.K$-<V(AW
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M>F.AD998(DEQI)+HH *87P6OE8.G"PI+<,?4H+#6H##EDR$6%$%L,:)4@I+
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M4"@LE?4 \DISHJSQ!3,J"ET$9>#/NPZ6JC?Z83::> #XB-/V>E!ZHE3(%J)
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M%; ?5TP@ THWBM%8S60,T1<O7LDYYEO)6:,V\D!KV;^0,B*3OZ',@4@AP^1
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ML_O=&(>RUC^P_4IT;;-=L[6?MMN,_=,A7])Q-_9R9F\X0WG:CKN=G[DJ)-/
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M[3D>F,6.![CJCYV.UPL]# !YPO/MT1C'&:[D9F%T)8P;X68&WWUN@)R#JQ>
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MN"MIJZ3\US ,=&B9%;)I0):Z0N.Q*@'LI10#=7E(S3D\9*C4(*B,M=BW+&W
MF .&4JGS'I:D:%4Y:L7Y]"9'6P*%$B*2M$<K05)]GG/V\JTNGU=ML/>V8*]]
M[,'>/0&NH4QA&[@*_U%Y)]WHE8;2W!6S4\XK+^EBEZE7NMPA1CG#5I=*=PJ
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M8%O 'M>3+6 ?%K#JD;;!4KO&SAHL'1ZV'\N3+6!;P![7DRU@6\ >UY,M8%O
M'M>3+6 ?$K!M0.))N\W;S1YT0.).&W6R].B*&.OA3<6^B+X9[^&I:6Z\30(1
M_(>7_?+Z'V4BC'[/W,5$^R.%R^G432Z;M7/?BR&:%^-I3%2W>[:]23/G.T^[
M.<BD5%I8Y^G T]H%R3TOJ"VE1+4H>']@;C5V]NZT).NIL;P746(4T[2$)8+<
M-,0W7\!IYB+#K;J7(O]Y&P ^J+GU)(K9/XDKD91+->S;'''CQ,[]%74]\&#U
M_1T,=,CQ>-N*M0.K_&YQ[3APS1J8PZV'S#X'7#NNA/4C2CP'C+/MMEO_@6>1
M3_;33W ?1]U*>W\271M.T[PPTM#(W?B>78N/M ^ Y9@CZU';9!]C+X#]W<_8
M' S:5@V'S"R'IC78SV#/]I(V']>PQQMZ5LT:?J.9T?,L#:/[-3MZBIW$+> 1
MHWN:E$^N@/1)W>S(M+;6GMJ+/8*+G9B]^SJ!GMS%'N'U6?:C>O">]FP]6G'S
M2>^L G#ZU^.;T@<&C#V9!H=Q^)\V":D_/TME2R@Z^VDT=QB'?U@4.O8UVJK&
M=HV'JFI\$G[]\Z61A"];AO),UGA6?K=/(A=NYD^I[7@@KD2<SF<B*>XWU_I(
M9T-8ECFR'C5,>XP#(O89S)I,CCRSYHG[36P@H&T'C[>9*(^>#=GZMAX%T!<B
MAC]>FL:E2$"/C$FXNL$L2J*\0+WR2MQ/OAYI,D)_;/:<-EGD8._'MLUA.]CC
MH'FW-3#[DS9=Y,!O:>O0WX&FB]B# Y>PG],"Q&JZY*5I4T>4\W]BCNX[R?S)
M!:*?U,WV+1#6P_9FG][-6F/3LJSV9H_5OKXOOST@^_J@A?[OF!\29NE,"?XT
M^:Z:BR?%/%[T^^9@-&G'T3^M6[4=<[#-V.KV5H_A5B=FS^FWEWJ,5]<?;7UO
M!V3='[1\KT9@2VO^.86@7]CF>/A8XZ:.,;RYUZN9]+:?>_A\KF:_[I ])NRW
M-[216Z.UBA]%:F*0.2VF(C.BQ$]GPC02<;]:RB,-8SYNL>XQAC#WF +@M'=S
MP#QZ:RG:AI8?/4>U;47P.)#^( HC3O,EU_*&(9AV"O@#@>:PZ?-%?VCVAUOX
MWY_.&/"6,%K"N,U],C*=WO:NK98P6L)XVH0Q-B?#+:()3X<NGKC#ZT5_B]C>
MKKU=6XUI>B#HT(JK:O67FMK;W$1S-G>S*$\3;*7Y>9H)0<ZLQ=DPAIH+8^#D
M#WH$1U;4I12+1Y9O&=FPL7F:1Y@Q\C(3,55@U+.C< :/]BT)H5[]%=<#.BJ+
M]5]9@NWR%(''QT6"K3UH0D?_][1J #!W+T7'RX3[M>.&L-F7;GSMWN0__-(\
M)1Q1!^G&T)!G?TW#?5;MYVY01H  "1QJO!>\70U;.1R@PK]VZ-FQC>9J-]L.
M/=LI+]ELB@N+N';L63OVK!U[=A#P;,>>;0VU=NQ9._:L'7OV1#,Q+V[R0LQX
MJ@79V1G".=XZ)/8,')5'Y'"<F/WQMCTA#R];KL6Y8\*Y@3ER^BW.M3CWF,E,
MYM#9-EGF\'#NB0=)A@_%%0Z.U)[?5+3_!)5Q'@E?*H^<E.RG25[.T-N]AT%I
M>Y[T-!CLIQ=WFU^Y10?#P=:*2GM)CWQ)CMG;9QIL>TF;M2I[J&3R6P7=\W'.
MB.PJ\O=0';O?B5F#/=:1M2K]1H0_:8=1'_@5#88M%1WX%=F3A_+1/H#X/$+C
ME%M'9IR[=<\6+(^3L;V_:LW-O8.[A,L!EZ]:0W,XV99U[A V^RQ];6FBI8G5
M4SF<T;9]2%N2>+:%/8]*%7N%R=BTK7OZ>X^AN.=Y>[<FVS9YW;%S:ZOZGK8B
MX=CRYMO-MA4)>TBP7"RU:^L1VGJ$MAZAK4<X'JBU]0AM/4);C_!40]YM/<(3
MS-.U1N9X?/PAXQ;IC@KI>N9@M&TSTA;I6J3[KN0EL]^[Y\BV \*Y)YYX,7RH
M >8'1VIM1<(SKTBP+'/DM"4)!WY+CCD:/E2TJ;VDG17W3$9M\_0#OR1KZX&Y
M;4E"6Y)P)U:9]H-5L;9:_:Z*P>T]3N5MKVBCE)I^:QL?^!79XX>ZHK8HH2U*
M..I4TSW.U.J9X_$];8\V [NEB:=($]; ' Y;FM@_31Q)+.GY5"4 9=CVMM'V
MMBSA2!3TXRE+>,1Y#AM-;X@2/Q-N+@+CQW'7-N!-<90FII%FQF3TDVD4J?&C
M->R.U"=&4&8 ,:.8"O@'&[G/.'%:+,\H,0'M<+8)_!V7&7<']UC%,BEFI>W3
M&M0;E?ND]?N][F35"_+HV^:;A,57GO761:RN\1F> 12[+J:P567*&-=N;LRS
M"+  ;M!PBR*+O)++4N!E<.OJ6#CZ1;\ .O./EM,=5G^IE\T-8#C1%6PBS-(9
M;>]+$A7P^T7A%O!Q"%"I08M+W06#3.1SX>-@F/B&?BOC H].+Y@"WHA,YI]=
MI7&)> @;!JR>&FF9&2?_*MU?A3L#Q(2_1;XA,]8HV B?Y[!4+#HEG!-S^-*<
M(#"MHI)\Q=5AQ#<@B#SB@3A1DI>9F_@"[@D(T;WD ^%S%?  -'.1Y6F2B!A_
MH7=6V7( _:^"3I-FEVX2_>WB6)N\:YP!F('^"T)X?GZ7IX*'BCP*Z&Z7[VCJ
M!H0 LQG\FD5@_P:B/HX.Z^U(KDDLWHWQ8T_#Z%N6OAU%NNOG#!W1S)K3-"_P
M.BXJY/@M2_/<>$]'.,PC;G0@OE2-2?:[_08S'XXE,]>9S/UYN;.:U6[-RX=-
M5CZRE<AQ[L&&EP7.\+ZL7&<M?@/&M[/THB$&\+>DG'G /.'[)=!_COIAT#T^
M1&,ZX>UI%PA''E@_W1^1'/NG!6FU.?+@N^V?-L>.YHL'FW]S!4Y<ZN#8!B40
M"1B33.-Z&OE3PXWC]!K>6.;X=#Z'=[!X"Z-O\.=YFA52%*+0@8LL0]<O>.LH
M$:?X/.)H3K_",3(!VTF#TJ<O$MIUC1,IZ>!U(.&O!0AY8)I_PQND>'>E=,T%
M4 RL#2?RB:>L$%ZP[,[$Y&$2PY:"Y9/(A9OA;<*IWX":%J?S&>S2>/MM+I(<
M7GV0I]S\3(%V)J'.].+?_M\8K.I7G_[-G<U?O:'?K%<_ZPS>7C J!CW)X7=C
M4S@[LBEL;3>PR[[:I67M0 Y-NKU=R"$)Y1K\3;X3E,1NQ&P>IS="=&C2(ZQ:
M/2XYB%I&5X;I9;FHG\W+.3(>(/3+E)D!\1-05^&G*X%HD%=ZN(X;\!*WXC3T
M1 +8;%R*!+@+\:-"^-,$4/@R MIOIU?>0H#VL)U>^5 ,^X*EG&G\1IC)J'H2
M )BBO,@(R8Z9=U?'8\*+F>&YS?/5?/SB-V(*)PW6/>HZ31.B8HJ3G?!NRZYM
ME.]U"#DZ]P9;Q^"=]L?W8+V+^P3CM[(CEKFR MWWLN6[_!6R\"^:>666$P->
M=:4-#X<!&[F6[A0\)+XF2L+,A<=+5"%I9P&ZDMA)I)@^/+?DRWH2:MH9<G.1
M5VK9$5)V=02)0(1NF,L/2(!(L41(=[O_JEG23\/)4T$(CW5.M0YG"5"T,.&=
MQ39'E'_!T,XA8D!=RQ')\R6B,!\:(:+@__LA\CP[")W!T W#T.D/!IXKQB,W
MG 26[?2&]N#/4?^'#;LT/2P(5\]<_SWZ5QF!EGI#)SUUYXA<!A@\P/K\K03^
M'K!^]9'.KS +&58_2!*^%:'_$"1P8U%((77V\9Q$JY@7@KQG+/;97Y*Y$4O]
MD:TK*(#Z%"[(\U)&"W)T>WP$\16E98Y.#UR:!?.-H6X:ON++ZY^Z( <](1*.
M1,"35R"IC7GL^M+@@8=!*1""JJ:0QB@RB#_/,Q&*##6&7/A <$4DA7D@O,((
MHP3VA%3H7@(%TF*'*4]OO:<3@@!R"HZVUOK2M:!XAN_F["V@'P30V!5H-1)R
M/]K#27=<7QCLW_7]<E:R/A2(,/*C@I^<C&K_,JM[/PYZFJF/D94"_DQ*$L=[
MXA06#%T_BH&LN\8?K-[ZK,W4NADL4*MORO,(_P7K5]"MAB4J1B;%E%R,^\+^
M,JE)P8V#7L8*W<S]"GIDZ>$^"@S?1( -><&(4H59&OH<8.!<6L&JC\-J#TO7
M> \[0F^>*14X/ B\%'8.I]$,[.I@L$%7QNU(H^07(<;A!_/2 R[":FUR@X?S
MXY*@%XM+L@Y\/RT3WF05<6,].(Z(GJXC4 <16%E9MZ&XQ,NCX\@8U\7;4^D6
M2#FH":\#-$W]K]@FA-I)X84Q)9/:JY$+ZJ.9"]+(E,"$ZV&+']Y@:N)N0>G%
M#^99&HH\9ZCD7)"15^#I&N?P+KY:^ \C3H8(FDG2)L0(!#P>X 9GN&_TLZ99
MKH'KY19$*W,+.IA"\+(_7"#CSA[IF/QTPRI9XO&WT(2-Y70'" MV)5TJ%25#
MY@L8Q.2#& KB@%!16DS2)\6XB%YH+Y8>)L 1=W[SJKVLA[VLW <VP^0>S8@5
MAQH7; ;B@<7Z_&PCNH\/ ).9B<Q''JJ;K^WU/?#U12 ,4#[R-7EE#M_,\SH-
M0_E^\=(NX]2#^SD]_Y^S-QUK8I!'808B1?F B6^R#%AZB+Q'R%"9>]=_%O.(
M5X'/0:23$Y.%!OHI,!\%-#>,&J&T;O'A,<C9K/@NL%?@Q3FS5Q4#)WHMLXQ<
M_95$]>$EF" 'XANHN%(.4$*#8&\O[H$O3K^<=2HER$_0E4C1:N_C,>ZC*18U
ME5UJS2D8H7X,=X4J34X<<HZQ-:"?]H(>X8+09,I3T#K0^"3C!B64BG-F M@9
M\+.I6X ""I(++-6LO9>]W M^LI#VLF@ %%HX2$M]B9'_M>3T.->&7*XH7- $
MT(D0B%"PF4TZ?X+Z/UT=Q: *$<>@WI7 #N&ZYB(K;@RJ*F@OZR$OZWHJ2 ._
M!DO,)^<'$%>4!1WT=-U(]U"$J6D5::&'3$O8:*_G@6FI$-DL7U0>*M/)QZ$5
M7LI^+].((U\DN2(RZ1O+,O2RL5>+Y->U(!$&9KGKQ5$^;>_P@>\0@)]="NFI
M0J+B:+Y.1V3Q2E_FE<ARH=Q<FLJ>O\)K;2_K82^+S%VD$G))5^D2)*2RQ%4I
ML^O#-6VBVFM[U":J[0:2OY(**UUR=1!G'KL)A8*D[R6^,3P11\ KF,5SC"O*
MZ>&U43@,H121'\U)MU8U:I1%=.5&,86_%N.5NC2A&(F'4:\08W7H5<! F!"\
M 15';<15J+"KE*G@6OBKF&9I>3E%R@,C&.QEJI7 5-'B6L175?Y7Y8VL KN!
M]$]QBCQM%$,^F)C.@56,_7$LE\L$IE&.PB^:T1<3M"_*V5QM0QIXE-:*QX'S
M76<IJK"X=2D[$\&Y8&418<Y\(\6U EU]?AE<[AIGM$W@[BK<C#$NC*_I ,P!
M)'EXPU',*C%!AZ*I]I$+\96^ OJSO@D9W\.OP%=!MM U:K$U%#<>*N<4=JV_
M"$83_*S%33&]#3WV"&&Y'/O_ZECWXMJX,1EYA/6#")@816%2=O]C\&^:Q@%(
M.5S*5!4%OBQ[K$/G\GW-;2^^V92Q1>TI/RUCLONNL-H.@[IL2YAR;:$\+!C2
MCV)QB0G.(HE0MTWK4*6*1:0);[IKO&D0 ^P\K*_;I'-'R56*V(JUB? 8(#QF
MYF217RAC1\-Y\G*#Q/<(UBOCN7C"KG$""M\"(:;-L"]#2JEWE!)!^\$(-=XR
MJY'T.:)<DN(=7X'B*(M2RFHW^OWH52+:NXD"8 4@C1K;<>4X)M<^8M4,P\>\
MJ'I[F<B87?5.(@@T/F!+\*G\NT+,%:^N$-\3BB"(#@,0KS>+N>>F%DG2DR:U
M?,JFWV";=+>#R?,Y2Q S1("QFN-+(3EK9O58$TYPH(PVTKE2PVVF<C 21TF$
M218@]V8NT'@YI_II^!<R7$P9&0VT3-\:2P&O0G8Y@("(XUI @!&54=G5C[;^
MS6AQ?RP>&]BY](WWY'"W>W:/^2?9U/HK07@16_K1ZNF[1/GB(LU$<%ETN'KC
M^'B0N=>5H.27]"W.@9:I*)>X>#F7^H+K3T$E0$3_T=9?5 !_H)(N+>LOJ^K_
MR;RDOP*582;,PJL.-"GT5C3#6P#9R<XH2A"OH;$YR!M9YTL0UZ&]@!"W )RJ
MSO_A)B4FH7%:6[$297";[HR3,UDMV10Y[+N08ZBER]^&&R N642N2+_GM*DR
MHQSQK7>]!%Y;9?<!I23I-?P#7 !.D-7?9]JJV((G7%(HV%##=-A,4PPOP<PH
MN.SV1?2S,>GV1S_1OE]$\.NH:\&O\QBD8+_7"4"4_'[VZ_FGA3=PU@_J%R4(
M2<H:3,0EIQS5\A[9DXGR#^4+6?1PE\EE;E::P&JA'VE\',4F\4#F@#[H.R@1
M5;Y42!>:I1A?!:)P?=6_ $5PGBJAKV\4;Y!]LH$(753-6%<@3:E6UI3'*6)#
M5T$/Y6@D4]E =Q<R2TX!AO*M\%NLM<>"'TDI1R<6= ]S]X;KP9K)>LQV$3Z@
M:]R63G@M,EE\W<Q PZA,#?SES:D"#1(7=+;*5JCN-3>&/87KM*A"H4Z: $>0
M6T>MN\IY$]5Y4&&%&P0C"FTALI%F6**+E;14?^LB;*(4TR%>&OVA?!$IC]>X
MBRAF4$VE^28J>BN G8(M5==#+_ $ (^C]LVKW6<5PRL+MH]0IY/9M)49AGF6
M#5Y&%,;0E%9&&H).S>F,F6'9.]@1IWNA#GN??72-+\CD9 JQ1&-<3E5(+R]V
M2Y+Q:EP@Q@:RC3E;4Q^H01"FLI;;N]'^*O&CHK :?RH_$[R/M!(X0'")2<1U
M7BF*J#A6JBO8KH)"9.P*+JAT30$6]::N<8I*,"ON%?[^"\0-LI>5U512(=?U
M:W6+Z@;5&^8RFWJY?@"^[!)BCWH_51278A@UKV^>]'/*+BVJ/2&0B5X62]2)
M^)-$<"BO.DI#.:PVGP)&7)); [8 EP94& K!TH]<LFX61R@/?/:@L&_6I:SC
M!+Y5V]W$.?4,6207I)0XFD7\ F#W!KEX,Z0 92UKUP-_O4K)XB#KRJPLOTH&
MNZBBK=31FNZ/)@D14 2L0L:SB6C60-^)E& "W27P3.S+Y&J7.74!.I:ZG(43
MZY!AP?VCI=,,G _I@9TN65XTZ'<*^$B)\RC>$Q/+J1M?K;]57*<-75Q+NJ^_
MZZSY+E6OW/YM5++[S9<C]2S9 ,O?;$*V0IPFPJP W!URC-Y#KS#DBJL!<><R
MP0(7TZ5J+0:;6?"MS_H6G_5XO<]ZBS*GX0_'Y>C>4\'5*;JBWX%P/,9B:N*I
M)-J)09,QDY<S+/#]F]I\9>QJ#^E\E:PDJ8:EP")'1 ^V*!Z @\K7*,JC'I,D
M\^>Y>*E^>*5&HD8);9N^]*JYW&"^W'P5X<H?UVC7[3'JR5[C\LUWCY<?]<"X
MVFR\_-93Z^U[+7O[9XYSOV_>N=G^ILNN:.CY?4-P]S!8]ZF.O+\ Q?8]ZUYO
M4;$E)JL4Y@V&;.\7Z-L,^SZ*ZT %J!UMOE-X6@^.Q8=(&9.G1AF-(>SMP/6=
MMI/&-A&DT;TH<PI+_:RBR^C:>;D)0[KW!)W#6^/HF,&]9^(LVAL'A93G=4EW
M5<KS/?W.G^@L@R.:2?"B/S#[@]'/WW/$/<\5:!'NJ!#.'IM6[Y 0[@G(E@WU
MFX.6+6=4M7^[;-EHA,CQSOA[88_ZFQ-&.X+QL:_'<B8'=#U/@&\]!9WX79VH
M_GU\ZWA''SFF-=AV#//AZ9%/_)+&(U#T[SE]K&5B6RM?C!2].[A99_)8W&RR
M49@1O4XOU!"@NA,S)<*X^=1<[JHG>\A1EJ'@>I]M160[%?%A07/8?.E%WS*=
MT18&X0Y!LV=]N26,EC#6PV0P,7L3YWY#WP^/. Y4T"]/S=PPZ6JRY][26Y9L
MH6"G!*@O'$TR:E?^266V'&%>U)O-!RHD*J(F VIZ@]H:!)AD_6-_H+=UEHW,
M(QY()6<J4.HN+AGC%"XL_^KK-2VR9$M7H*@[M-83E]-T0QP@-*Q?1@U_*>4Z
M#4-X!!-L 6L[M'-_BCFX_*W!XD2(56?#DL^5LR P8:S:O?S;XCS+>K-5BU^L
M^]4F-*PN=ES=\HTW>4OG3;4$EX;P,19 *%L$8TZR+T %I2)02F#'--@TN^D:
M'Q9AI=K0!\W+HZSH#I=G4W^,)-=/,(<W1'(NT=.E"FLKJK#'76MKJK!']Z8*
M^QY4T:\[=#]GJC!KDI"MJ<7<C>J)+ZLANF[=N7O#U6^;$I=./SSK80VU'67Y
M\Y(L!=#5T8MG*TZC%0$<9AP]?1"LQC>P$*G, )?D#**J#QOU:_M7&<E.]-_#
MSM;N"K>UFIUMNJUC1MV/=2Z147NPGQWN:BE5>L>9!?QMB*(%1,E2L+@"V21&
M?$.F+=&&1PZD<UDI>Q\DWFQ[X]$:;75I?U4#&YP_+; QLO&;/C>$*\56CC%1
M$PXV.^U]1_:,[3V;5;=7D& )M,L](T^U^F0:X*/JW7T]_G,TQ,,5RV&:S5AH
MR\)S8J$?TD(8EJ64(4"P )4(ZLA#O@.J[UO5!ZFQS$?0.(PSTSC#R;P6E[)%
MN?'?50WF)R'G?1KO8!^&U>O\-]80XF"I;(X-!W%0L,@$2]RJK<[]D6UPR,AV
M'H:=7]V8*/!BB@VN3O1&6,>'8G_@\.6 ZEBY(K%FB$MU2E7GJR"E+]0]Q^BK
MU(T2X.-)^.0$'[U1F D:.78@SXUJT*!"45".\[GPN8H;$"NGYB]5LZ<KT&)E
MWQ8UY4Y^VDZ*O;68<;*+8L;QN"UFW$@48=\Q''=P4DU-,CX"+_;5T*^WLMO<
M,7**]V[B,AUCTTYK](H&</@ES5:23@0WO@$U1]G+M?!!Z11IPTK1:LZU<51H
M^\/W/+W)X2K1I9K!U$7:9$-GT@('J&=!W1+D2_>BJ^;<8K<$:CJ&1>_U[<B6
M"[&R^7DYO>=)OKJ9H.J*D&/'-#7U2U372^#0V@FJVL^,I"GN0?5%"Z5[!9OV
M<B\8ZK,LZ_M-;9 704[.1 / QVD._%-.L-+>G(DF'$&<%VE&:(EK@7Z9R($[
M\ #R56S;P UJY%RKJGV<:B7)72#</.76;'55N1]E?CG+:?I2;LH35I?+=X7J
M"WT"NY+MK@!8"/R_RN!2ZFI>6A:R^5^6W>"'5VY<BAH\M&$-0LT6=K"Y +T<
M[AR1(2E8%>9#53T73UA'5!O$[G%!A*U"JEZ2N7Z%?$I^@MQ#VG5R^T%&:7G9
M.,X,A9OZ@B\;('K8IP[8(Z#/,3HMJ>TCB+$H! PB)UE-.SIGT^ F;?QE4L+6
M?F5 O3*V45?QD@.1^UGD28<A=LRH%[KKZTQDV&Y4$N&-<%7'DS?"YR89JJE9
MW<0*\(K0#"X3.WLP,G.;SEI]QJV<)$E)0T(7%>7_,GA;L@V<K0S==.$[:FZU
M0=V0>Z]6<-HW34Y[HG':=]6A3QM<]E--B.<5EZ4W6*]N/T.W;JHBOB'/U*YP
M\?YO5#.JQ@TUK KX+QDKMLG0U+AWDE;$(=?)J_:@=R#=W7/!F]TR#L,S=*OZ
M\(_S7R^02^GJP]M8]KG!*[V8@2 #9.5KPH]/>7"C<0'X7AZAA?L'"Q>WPGUJ
MD8XGDW/&U61*A;A S:HUCVQ3IJ#6-;Y4<DG]S316KT?-8>&EW"[4#=!# L\D
M<"@:+7G%O:_J:Z".*FX6Y.2 D8V80 .0G7IYT!E(3]4*3-^$@6O$+!VHT8Z;
MJU:UU:H@N&+J :>&RU;[K+L6"T0%V6XX%[)]L>H\10W@F/AEE[&0A-0,UJTZ
M/FUR/I*K; I6HD^$-'/MBGLLLPR7O;;8 ;6P9WGB1G\EA@GU:%;J!3;@8PE>
M]?1+UEP8]2ZF%GU@I$3D#[D2,3M_([!"KU(?5),;='5A QSUNEO 4WGQEM#H
MI)Z8:LJXSUTR1FN$2_NMVNG6(*%#\WW<=1FPM01^]AL"K#FI=?%*CG!HL")]
M;%3H*O+/)8?+*@XG#[R>_M^J\;%T>7_4[8[50%[L-6FL79B:-1EDP:J>89O@
M8_6F A5_-[@".>7*GHRR2Z/$P1PT[Z;*KK6^Q"#EFITIS4HU5U?/+[]0=A)?
M?@_2:<Z'(2PJJ_9CN#"&:N6O>G=K8RKB0(5RD=KBB(@>N$V,+2D!D1/L;*KW
MG)J!<4#.'-G**L;F;M7@2.RC*4W"7*#F!T2$NU6=WNHV:*R%5"UH&V^T&FW1
M-/$_PZEJ&&4E5U0],%R^A+0]5S::W]7Q1[W='?\(:?=\LW.J[H) #*SYD@9Y
M>9EAM]1JLDEEZ=$WIRYB[LI+,!HMXU$U%<C \3+J]((&]V;6N:CDRT:BDJXH
M-!-0FVD73I1="JU=*=X5$F>3[7PJ@10MV^O8FBVL\Z'*4THO\2EV+SG1>@EW
MFVKSAURJ9DT>2C<!!FD]"8%L(NP'7Q0XTT=F*&@S%RC Q.JDTW->>#]7T[G=
MS'/A$COGWV)Q4Y\@E?UH<?HU*@(\NY-@I>1_+;90+O,N!5XIC4\AGX6RBT@B
M*[G%[6U#-4XEKEK94F/.6LI6;/'>$86)=<@1A4_$N!H>PX;X/S[F<&?4RCZB
MH%4;2E#7VN_M(I0P<=I0PB9L@5"[WT6<QD 7-Q='=@I_B-7O;S1=[X1<J.]9
MI'Z*\J\'X>_8,A/F3$7W/J'TV/(4A\+_3M>-6>+4R^&D.ZYS+]?V=JV3^#"/
M0YMIXV99Q)U[_U6F^+E4H\ *1Y^SG%A;33) !QM^]X;9I.8I TTA5F.\R3%'
M,Q[810?,$L@MFJ$ QEM8'+T:QAB^Y8S+1I]]]E<L!8C188%.@]A-E/^BYO*@
M0:$# 3 Z5_Y(3A C;PIR\A!D0WJ,[O.SNB&XR0J>\I*Z'LZ5JM5'<BBQ;@;T
MCI:<-(GUN2ZU&TR%CY::_=*PJ,:<%!R(4%\21DVP(2G?'37<KEMTU^,/%F8E
MV%W[)[S YE2$AJXMC6?Q#8/WY*5"S)%92<JY&R6WH$MC<IEK3&_F&,'AB"JP
M>1E FJ=14H_UY9E6=7IL<_7%+<LY!^3>PL[);NU^CD )]XO;@H^U"B+B7%Q/
MY2""NU6/PW ];\F*3WD V)'R8'+.1#SRJFK#NY(G$SN; 09C%%B[=^S!'16E
MC$VS\?(EH9@3.MM%7EM(DLUA@C7J>6J8&UFHRLAA_P"UBM=<NNC\$]<B6#NS
MKG;O-/:#;U;4$G&;=6UT7"-BJGJ2DS,RH1GFN$4]\"X;FF? 17!$"!@B&0\^
MJTQ[ A(PDR(F@@,K5,Z'(^$@1W@='Y:<4^O]Y>J5.FV> ^[$S-3$ V5M<WM_
M]-LE<M94<X38AU2.7:'Y=OP6P6[Y&0M:.+#%0Q%6EM 4*Z-8YXFHUEU8UK)N
M6TQY0>2"U1"G/T23\>HWJX*M*U8D#:&0LQ4\'E(HORK-?W*V8VYJ3OD,L?+9
MYU-DD'#'*K15CS8&I %H266%24N>%%,:MG"4'0P;!2$ OR;&*0\+N#E6AGI"
M>IA6#(/YR$@",OQ?9:E0L#Y):7(06^NA!(&<ET#I+>2S!9E/01ORGI49*'CO
M2LP)K+5+C3U57D)BQ)C9\P9[G6?DA'?)JR0GD42^4,.5=4>33IVD-^%,R"6N
MWD6Q#7B8X7I\OK7/DLY#$S?1CY"JC"/>E^2_*2HO^LDYCX G4[*N)#.(]#&'
M38C=L":ESQ[1]*GJ(:$<D%*Q.F],BJUNB,:G #53HODM9\.;E#5&JV]QP7!H
M'*:Q\\UUO)_6ZG6<6L0\9 4N!(P+F#M 23_:+O>C\AT?A:\RVRH=RD72N<S<
M&8)XBK.(^+[)]5"DY*?7+Z*&_S$R[;?$3HAKG"5A3(SH^"ZTVKJ> RE/!E3J
MW2ABB^1$6BPIP3/'8)MF*E-34/+28JVD+XLNN QE+8%'U1862(_# (]%>ANZ
M)D>''"<@AZ#3I9*6+(V9^WY$]2I (CQ(]-R6[&J]$:-VE7/SJ,Y\I\$QJ[+[
MM#F"5/A+ ]@U%>MT&HG0>/M-^"6)O7.T\$0=S.;/Z_P_^;DITX5D$"Y8'7?#
M!>I< 15]TRK*",3&B^7(9VY8?;=C#5Z(G^EI:Q#(WU8'0W^67DY.D@K4CS(/
M!V<V9FQ";.))^56E-A-_J2T-\WL@Q@ #$$B.(T=W5KY9K4AQ0[#1E,HZ1T>.
M6=-RJ#&;.*-4]1C9:AMYNBWR9*V//#WW(-*6+/9W=$"IJ?.)\7:1*SQ%IGN&
M>9Z43BPS?Q37D&K/W>1L:DP;?2 IK/5W58.0W*S_'B<XHQ-]FEX#5XACN1<:
M%AI(^PQ+ZS =5>8D\D3%E<R"W#MJ5B2/N<]I-F>5/>']Q3>:TT#I.OB@'KXD
M\;(!"YN5E%85QLJRQNH0/C+'B+@JA,LK*%R%HRI5Y2T]IT$MJBIF>(XHY;NJ
M A!REM:70L4B@))AQ#HX\+ \0CBLVVIE&')>091)M?0(38_3VK _4YDQIWIF
M3"V\JBSPXR/)SX1 )"31EUR?F6-_&V8$W:J<A WE)%ROG&B9A.NGX=I:7K0R
M8BIS"LD7#2:]2NK&B*.O@G.ZE[Y@;G?.^SH3^L-;Q5:K9#24#'L7Z2UPXB/+
M;U%#(;'OX'[N8S4C_'CRZ;-Q=K8%ZA_H0<X__^?;3\;9AW?GG]Z??#X[_W!?
M_X35ZQ^\@\+J&K^+2V!>'[DIR5%*IS]$55B:EZ1/D<J2W-3^JY@..:\.>?_F
M*E9O>/BW>M+EN-4[+A ^OBM%QXN*9IMK"]/K:(DJ$J8*%2GDJ1F;D9242@YJ
MJ:R6QI".T((.Z#?_FJ0XUSL#I8-^U$,WG!5#S2["R.?@N2$K4Z?"C8NIS_D#
M 2C@&:6%D]T _^6OLM7!#E1U)M:>I)^WH?G7W?+JC%SL+ >_%=/-/*JF<9.6
M&+;%0(I*E\=$-!&6L9K]+DO'94N 57FZ)Z9*:=)QJ:Y(O:N85I7OZG4=:ZMX
M,6T_J/UK%V]/<;%F)2Z7_#-0\?HQYYI*=RC13II(?!(JWFON3=;LK@8?Q_=T
MQ2_ R+:H5$ Z[*T8:>JSHRG/8%77!+:U2B[NX0(6BH V6ENM*9#5W%I%0R%?
M5Y,[QWR5M,RQ-V,%'4H4D-??-7X5B!UYXZ]-4.*&EB&Y$HRF'A1==T_-B%5%
M>=="^VL@Q$P68$2SZG04.<;RL^^ZI[5W<X0QP,^4:M2X.]G#()KAA;A<[DJF
M5)5W*-LLZ)&;-51!32>9C7AD*P4<C4[^@BLE6%8$>\]6 5J/#*[?7^)"%1.J
M#>F+:H$JO1)=7OK7;/,1B_/7U3,@=?ENR;E9Q)'TFS)U2='LY\&HK/Q=&TL_
M[$>:%]KS\  )$>[N1/=85;U6152JXA+N0;5L"B+?Q<(D%)J<X:&MI+H?8,(O
M;E9;&(^JM2\I@)H#SI5(9+1$ZS>2J<\Q6:%Z"W:P^@[=;-\-Q>_6S6RL>]?J
MLBXX9R4TWOZKQ$2JBSIU'.'\A;%'JN='J,E]2)/[-Y>SK(-N9:B*/MZ(T"6D
M_C('VKP0203875_DL[NT@VX)J +S[^$3H+Y0 -%IA3G'>%D%^><CG_I+W__:
MQ@=_;8.N<4Z2\JRVCH[QPE925^O;K7R[_9WX=FWKL'V[ !Z_ R#'Q*R7>0F&
M3G;SZI#HC5//AUWC[;=IY$5;-4S=0X1N?7ESF,9@EG-:K3P)^FS8Z0"R.BRS
M),JG&.3%$BG,[@&MBZ)$C1IDO?@8XT&I>:\$M]?_00-S:MJE24*88>_.<_%2
M_?!*#=R)$CH6?6D!00;+H^^(BOGC&F^[/<9=.9-/OEE^W*6/%L8B\6?C[F1L
MK_VTU[7N^5E_<+]5;]OKR.DZ#["L97='EK/1LG>,/;QK1.NC#,X:WT7^A"B2
MXHT/:8V^ZR=#W3D-]*AA\(:*0.<-96-+6-PU#W/366++(GJ)^M/YGD:M];O6
M8: *<=@U$ C#AX& 9?_$^PN$G[)_Z"6YW? IV).[4NA+:?1J[QLTIB#70/<L
MBGG^\I=?KJ^ON[#/[F5Z]<M)YD\Q/^D7$5RZV2^!6[B_P#ZMP7@\&8WIQZ$]
MML<]V^I9XXG=_T6>JF]UT*B"&QQ_^]J=%G U)S/V9DN76D%"]12O$3M'%H(S
M^)7 )7IS*RWJD7':0DEBO%@O_XM4Z44&H+Z*V[!K)W,U?^.IK#==T W&&"-A
M#02=!O."8R*VC(G\O* ]WH_C+%@5 WI@9Y3Y"(_>7Z0>'G^T6_[8\L>:/]J;
M\<=?;V+W.C\:3FBWG' OG/! 9\.V&VXWW&ZXW7"[X7;#[8;;#;<;;C?<;OA)
M;/B8?"]6U_KW?W^^[A< PF&[7V[?H'2_B&]]R\K3;W[E,8;'LK_=(&'WR:G^
M=TZ;HW%Q;KRBQ\#',L/1O)0@JU4B.B]<K1*1?JLK$;7D/+TH$5]E3?H.I72>
MX'0:$3365UW<^SU[?0MWZMO9Z]E=W=73NCR># .R6P;T%!B0O<B OEZ[A;B3
M 2TW,6D94,N 'I$!V:T&]"08D/T@&I UIL:,I]V*55C]0>].?C+I#5M^\ESY
M2:O0/ E^\B *S7'PDR= AU;/ZIY]N#@,0MQ'8L(9)4<;__OKI]^-LX1GFQMO
M4K^D3E64>F"]DB7U\M- ?1JDLB#9G<]YZ@8]2)V<7&X%^,8M7$I.,#Q9S(G9
MX_2VPKWD/'),5P@"6;]>K5%O2[WOWJFT3PM=+T[_LT57Q(O/[K<T26<WH)L5
M(J&"Y M_*F9NA;\MQA#&G)[\WF+,&HPY=6._E%V;?X^2KSAYH<6?)OZ\>?NN
MQ9\U^/,&&_)%+?K<@CZ_G_S:HL\:]/G=]43<8LX:S/GXZ6V+.6LPYR-.*TB*
M5G*M1R#G"!PL#XI"I]1C]:-[N<(H>X=&V8M-;:]=))'_0A6XKY>KG^57.@A$
MZBS0:#70>8A> XLEC*N+G_]<^M_:"NZ#/<._/TC9PR;O?M6$B8,0>$=U"MA^
M#1%N?1N'PP7GOW-9__*_WU55\-7QUCVZ@V/?T>)XX^X=A](J>;-N#H?38\/9
M38^-8YL/?JAMAR_.?OMP\OG+I[<71SAM4'?E<^D7C0ZH1J+6,0!LJ6$-7@0_
M5V[^#3(:7"Z+XZ$(GZJR,IJC&I3QC4&.6=F4DMNPR[9V<G0#O!J]MIZ8NG'(
MHVOD+&=^0#;4+!/X%BWHEL4TS0 "P1%VA7R#%7HOC9/RLLP+YM<#;ARZ5?N6
MH^E1XO2[]N1^C4AN6Q96M8<[7W70'3W 7@D$F[4^V= ^VD4P?'C@9NOJMA\?
M/YV?OOWXV?CU[/S3^:_GG\].+XS3\T\?SS\UV\&OSTNP'BLQ81G &V1-6/UC
M39MH#W)H!WE<))="2(J5S3OE'))GC%C,+_DOH,?\[1K_YP9)NHJC[ 6PV_4?
M.CBHUA UC8_3[ION_@%[3.!#?VR$NBME'Z\9S=B"=!N0OIA7Z5*B@F3*D/QY
M$T6B%0S/3S#\%TX+-/[ &0?Y_LGM:8B&PX+I,4'N[?]\--?-X6TA>4]A4(]H
M0%'K^GY:)CSOX3G(AB=RD+71P'O[G \EE'' 48O!^JC%+UX:W,!_IL4L?OW_
M U!+ P04    " "=@ 55)4;*.J$.  #)FP  $0   '!R8W0M,C R,C V,S N
M>'-D[5UM<]I($OZ>7S''E]NK"@$!=FQ7G"W'+SE?.8:RG=N]3UN#-,!<Q(C,
MC(RY7W_3(PD)) 9)B(VR>"NU!FGZ9?KI;O6\:/CPZ\O41<^$"^JQ\X;UKMU
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MXRIG;=FAL1/3NH[<MZP#J*Z47D/0M+7-ZB6'GH_TY4\;YAIEU3;/%E^(5/5
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M__[MZ1_I&$\"3.?+59BG^H#E](?E^L6GBQ16:YG?BNOHQG?4G^#R;5!? BY
M\N_?+O.]G[X[.CH7Q["8X0LL1_7_/U\\^>B1I\,BX>D*XG0Q+.)B-4W+[]/B
MY'Y][_V'BWG&^1(S?;-<S*:Y:OSG,*N#^>,8<;6D(:T?L7IWBC_>6TY/3F=X
M^=KQ@.7'>Z=#6D'5/3.256#_V.)3[W\ G\(LG<W6LGI*/U]\=H77;QSX=H7T
M%^<RO 0R6Z2/WC2K&EP,EW\Y"Q%GZU<G9TMX%<+IY,%R21\]444DS86!0C(
MQ56$&+('#%HGJ;PSS'TLLSJN)0ULK>T2EG&M\HN/)=4+?A]GJ^7E*U6\'!B_
MT/P_/G[^N3!W'\4+7*Z&:2*)/0S+X]\7\W0V#&0!)H8'RXK7D O7H!)]YT1"
M,%)E(87C,6.7<=V$Z..17B'.@R$=+8:, UFX>T=OL-JC"V-W#B\,Z1-&?3S5
M+MYQ?WEV<K+^3)BN\.3R[ZOEVUOWJT4'P9]KF=#O2X/GP^(4A]6[YS1K5@_F
M^9?_/9N>5D_P.ZXFRAOCC2H@"G=DE%4 9^G'P@*+'"5ZWX?BGT.U#1W$UT.'
M9@IH1HGS03V\8*7G*H4D)*20R44;\L[!E@0"I>71:/+ENJ.9>[B]#9!?C])W
M%W$S+3^94_#R:AIG> Z&Z/9DGF9G-43\=;'(;Z:SV20*ZRAXXT0];D%I'B H
M&B-CVCE?HO0N=E'^-NBVX83Z>CC17"'-J/*,#!0)8?[J*5) ^J**\UGY<WF.
M<Z)$2=SX#"QKBMR93> *0RC9>F%S1J%]%XY\%M8VY-!?#SG:J: =*U;'.%Q0
M]4,0$STZ:PT-S8L,RMH"(1L'-B4O(Q/6\M2'#9O@;,,"\Q6Q8&^1-]/^TVF(
MT]ET-<4E!:[*&IXE&"\H<"VD'U\*@H\V!"5M+-YVT?D5$$W8?.7SKLI7HV-(
MHDT9/2C)$WAO#7 NK<PE2Q$[&;@;,8TI)=J5"1O)O;\&.GF]2V#OKB9LOFB?
MM &9%47G21IPBFF(QFEKH^->\P-XO@W0QI0C->-'4WVT,X2+^:N7.)P\PKBZ
M@B50D.:RRB!=IFB-2PDN"D9?DC%!^!Q#G]1Y,YXQY4^M"-% \CW<X656%WAB
M&%D!A2: $H@0)>'PD?&@0Q&BR-Y>\0[9\Z$RI6;:WT_BS33_"(?I:QKX:]SL
MN[!X$R)E;%)%BLZP#D\0.PO145AO.,,^AN 68&-*D%IQHJ4N>IH&%4,(Q%1(
ME)Z!4A2LN^@+I.10RY)8U.&+F(9F4=+[I2WCDV0Y ,FZ&F.2N#-(8\;((^H4
MN#C$XL!U7".-GW?AQY9ATBX*:38%'B[FJR&DU5_3U?'#L^5J<?(ATG^/+ E%
MP)0&:6(BZZT,I;$H093D"TW/@$ETH<HVZ$8:4+<@3'/EM%UAVC#::!1FS3)8
MRVMQ@><T6L;HN^!)HIG[J Z2D(]P<Z*U-6F@@G8;4RD-9YC_"+,P7!T?5\RY
MPL$&3B9-,$58BJC;J)9XR[S2G7:H-N(9:;#=@@T-%-"2#(NS^6KY/+P+<8:7
M6)Q34BHFH=@ZO)02N(P:!-; TG'N/>M%A@UX1AIE-R+#O@KH$6,_F.<_5HOT
M]_%B1M)=UNWTU;N)CMZY*!-XI@B5Y1&BD8%BGYRDIG'KT,=&W(9LWY%O&*N0
M+#E#OMK5A5+E18!8$KEN*VF2%I2E]'&/MXUN-''V_ARY/AGV5$.7;9E:8RG0
ME1K@(TWN1#$;\Q%D%$4K,M7>'GA;9C1Q<WL"["KXACG6R<ET50N'ZNAJ4$\Y
M(,Y3!>1CD2ER#TE5FVPMF7GA$5@JSC.-)76R")\!-=*@N3TS6BFF4WV7U8RB
MMXQ@G->@,"%$83/H&.JH0^:N9QEKHV6HRV#D!>&?OJ[QR.^XNAPBBHB%20I-
MH_>@=)#@=8D@O+16^AB,*UUCPDVHQN0:=V?$34'AWGIH6.?VFIZ]&-[5>DI/
M0PK"97#( @6GG!!8&X$GQ6.23EB;.]6S?4 Q)I_83O,[R[EA*3.>AFG^Y>UI
M/11 MO9*N<S[=8M$&4_F&GBL.P#."0A.&[*_9(F-4B*5/NO16X ;DT=LQXO6
M6FD7,(7E<77(]%_U\J_#;.VB5P_#,+PC%_U?87:&$R^$*&P]8$=#UY9!])J!
M3!)-UCY&V6>K9BMX8UIK:D>9]III1II-L2%2D);(JWF/H>9Y# (Z4JF*+%-D
MJ(7HPY#VBPD/<IY638?9<YJR3^8/P^ET%6832=/2AL! >TVI+&F/#+LS4 I#
MP;(E<]ZGE.$&0&.*G?9DQ"<!5 ,5M/2H!6D^GZ=$Y]..!ZL3UY$>GP1-NZ(A
M&&]!%N6E%(I&UX<+&\",*9)JS(-]1=^, R]P%:9SS+^$84ZV=TD1_ME)%3/F
M1UBF:;J:J*)TE)Y&QY"XF94"5TH HU R50KGRG2AQ.W8QA13-69(8\4T78A:
MS*_0UKN$R)(!PT(!)<E;>Y83"!JDU8)'7OH<(KJ.9$S14F,R["7TEGMREQ1<
M1_F$ZG3 8PK\IZ_QR3PM3O#I8EE/-CTK+\/;B<G18LH*+*6+H(0I0'D ?9%:
M):>S1]TG';\CT#'MXK6.-SJJ[!JO_GG_NOB>TL^]^AG\L:*OZU771;FHB:+?
MAKH">V6$=6P?P]VCV<$='GF(3@B[2J!1FX1?!_KDY\.BD".RU@F,9(UR]IRB
M5^)JC#Z#SU(XX4BJK$^$< 7$_GYM27/@!;[&>;6OQ;'$#*6;+DE03&0(B4(S
MI1D68YVE2=')J5V!<<=$"+I:IET5_JDOVU70#8/>]<,?TQ@WE<?]\O;B7&Y=
M\Z!_N5I&K8U&)P.P6NZ@I$D0-5,060D^1&F9Z]4WX\Y@QY0XM:)-;YVU#)"O
MN]CW[E5ZS-YJXKB.CCBN*,6SUH.7E/[;E*J;[Q4KWP2J21GGAL]_\#I,9W6+
MJ"R&99CA'YC.AO--V/P_I+6+)AAK#,\7PYJ>J]4PC6>K^E<O%\_#>JE1!VT3
M+P6*EI066Q4@8K; 8@C$F>!UZE@.VF]@8UKE:L79C?6E(^%&LPE^WKGA(G*>
M2.L2$XZ!+9D!!<D.HB179H).QJGDB^U3U_X1C#%9_%YDVEWN[0\-7^QW+2?:
M)\JUR9&9>LI?15L@NJ*!!^>42SF'TF=[X!,H#3J&(8FH;LT\(E\[6ZS;%%U\
M^L335(LR%D@F4F+(*46,R4;RY%&0/K&>KNH4_GP&UIALZ'[<V-!&K)$VVFV.
MX6Q6F]7@G 8Z(V /\LET/EVNAO69O/?8L' ,8FV$*8X/YR<T)20L@6>'+)8^
M=8G;X1N3I6Q+F0[ZZ>0S<Q'*,:')=ENB+U,,'/EQ2!2<:^VTE9TZBGS&9^[A
M#*Z,#"F3,<I*X-X5RG!L/9W.,Q2C3/&^=O'IW#/B;C'!H8SC[OJ_\0#DCE)O
MV6$-!UR^M\D!I8V:)JR@B523S0RQPI&R2&:T5\GT.8-P#<@=#5S?1:-V>M]'
MW'OKO*X0OT=P6>1T/K!+/"49QI/,D&7MWZ8P@ZN' G)A-C";M%'7TM1/EYUO
M?\R8-CSWUVUCL;8/\Z^,+VENBPZ*G*6K^09'LC$A$2ZNI=51,-FG,.)6R]XB
MC;$<)5><[&8.)&:LBV2&\C(7M4DTER3-M"^1QGSA->]]B7"C\]I)\,WX?75-
MMC >BY#U!)^C>:O7IR!\!EW=*&7K/&(?S=^X=S.2F+R1RG>5]6AV5VN=YN/9
MXDV?C=0/GW[H/=,;QM5H>[2>BZ 'D.)?3^G3?G[W)T%Y,G\\G8=YJML4B7*R
M\_-DW%LC%2)@2J:>KR[@.4N B)*2LARTZK.$M#W&!FW($V)>UMV;)\OE66WA
M_ZQ\7 1'_O_\!:S]_>LK$YX#R41K\,@L*$[AA,,H(.H0&-?*&-DG3]P-[\@2
MKA[\V]#>O+=B6_;"WX#U2FG5Q#M9.!>N=F''6E"'$#.CD)87RVV03L0^*=RM
MT,;D(;\HM7955Q<6K6$\.UT7WOSR%H<T)4E,=#0\L! A>5^(W#Z ]^3OC2_9
M)EMD*'VJ86Z%-K+L\= LVE]=+==#-XW^??!Y9?3:*1$"9Y",('RJ=L?5%(:B
ML#+H0M]WNK!E>XS[+Z6EH;8S>X3G_S^97QPK>W3A1S8>+YN0DQ E.@?(1:U_
MUARBDAYR%KP4(TVXON32;,5M%[RCRFP[$?#35;ONFFVSN/<X3(=U:?6' H1G
MY:\P#.'\8/^O83JON>"S^8<NE$_FR]6POE>M%M#2P%;A[819RY*+D7)%M=Z:
MJR=YO%S?]I&S8J$H?EO6U!315Q ZM&+=E]-DPWZSIP.FZ5J8]/T,UYJ:YP<G
MM0SF_]:O3X+6P2JNP-JZCA U!3Y6Z@JT4%@M.6*?C'$;=%]!D-':RC576L--
MJNOV]UJ3MXE5%%2A2U"2$!?[*%DS"&1K?2XL^$YUK;="&]-YGB_F+O=15U\6
M7>T.1^1F/B2G*(BN'72XC>!2C:FYP.0*5YKUN1?F5FAC.MSS)5FTL[IZU4VB
M4 $+<3AG/">R4Z4 RR;X2!E\MGVRY#O731[J!J$#L6-W-72T)^O@_T-OZRO=
MUEPJF)2I7?_K4!')UFDF*$<O6.N5 L8^L<X=0&[#(OMML:B7"MMD<[\OYE4(
MZQ[IU8.N [++DH+D*!3#H$&&0)1/:"@0<[52@?,L(O<&KU5LWY"A?>XIVU#"
M?2/)?EN1=[0RG^V%/N%.A:1-J(L.!-(27%^" $KWDN RL)#[[#;=$>@VU/+?
MNK5II\J.?+LL;;H(NVKKM)(C>H&UW-83,H<<7/8!:"(48TST4?0)>[9!M]4*
M)?O6J;6GUKKRZ;P)7QTSQ6:YR.(A$P(RJ9:<JH^2G&HTS*AZTWB?>K3/PMJ*
M0=_^(O>NBCI QOZA=>>D6"UE(E !Z[Z:10W.% M9*\)*$9OLU-IL&W1;,>F0
M=<Q?-G/?46WM#O\<AP%_#NMZJI,:U)TO:B94*28E(##-ZM:LK^?Y$+@O1<28
MG2U]V@MOQK,5:;ZQQ><&FCE88G]Y23)WDG$6 9W-M5,P T>.%")+7GLF++H^
MIV2VP[<5B]0W;WKV5EW37J[7VH6^H !MF*85YHMVHA^_<.6=SW&8+O*GP[OH
M%_'+VW0<YJ_P15CA+Z4@I;+)6V>4TV"$$23&6I,MD@?FHZN7;NOB^C6%/=PX
M#UC#$GF,TI./\DY2_,RC ^=R!&.3,T)%944?-[%K#<L7;L<P7KYO6$WN08+>
MA58U0%]>PY<P>!M2 4EFK2Z%!_ ED7V3E/HEDW+F!ZW#WH!Q3+4<7S])]R5!
M;Y)NJH4T$67,V=<.ZAH4"X;\;UU)C4G8I%4I9ER'!;YL <C73])]23".(&Q2
MNWM9HQ&T,F3\ W,0?)+@R0\@#^0!4J<NL?O ;M!3Y>,GW=+T7BJOHY02BBJ*
M4GO)P:5H0/BD')+4..]S?\4=@7XSP=*=>+FA1TLW[1[X'@P1C=6&). TX5,D
M$PB%1Y(%R]8%GHSN=#MS*[I]%6'/7G1KK\DO$65G%J/2WH(H-H%"'2$ZH0 +
M%S(H'U085Y2]PQ&A\&Y=2OQR\2"1H@:D9U(^M'KW?!;FM<]!5=^ZG]-$<U=H
M[K-J SB06<BUYW\ U,6HR(.-G9H;;H_Q:SBVL"_1/CDUU$>#ASK3_?ZRKO??
M/*JW"<QV.L)]\X<U/K&])>I&![0_NM!,Z2R\TXK\,5_?7T??$4M 1%=D$9%C
M.?3%<7N,Z*_%\'<]:$.R7BXG'%&C21:T9S0/"GF;B+%N%P6FE1?)JCZ1]V8\
M8PH==^; C;?C[2[Z]C<BO@AO?J/4=)B&&:6,S*&/)H*H :@*3D&]&QP,PRR]
MD4J)7ELN&^",*:!K3X*=!=^> X]K \!CS+\N%KGV:,(@4W+D [&V_JM'79$2
M$,^TSE%K[3IU^=F,9TP+1>U9L+OH#]?ZY?W5Q>':U<6/SU9G _Y&0S@Y.UG7
M=%Z&1/3.IXOYJY<XG#S"N"*B7W1NWB/$Z .D>4.9[M+:,[19U^%^J,"N.-Z7
M1#[8".3=NCO1Q"91<M*%^.Y<O:=:0)1$3F>90F^3,5S>IL-='[Y7G??=GO<"
M3\*4Y#L\*X^G2^+$?V,8)DRXS+RV4 RGP:="DS)P"46*B,:ALC)U&/Q&,&,(
MC@["HH]*QP^MQ39G#.Z&NH)\^68Q\5SR(BD<X*Q>DHTJ@4\^0JE7G5@OH[_>
M);0)VRX>/X:X:^S\VD537XI1S^8X24'8*)P RC0")1G<0S0N@&56%ZZ+%Z)T
M8A0]?@PQW-? J+MJZI",FH0LE506P282@3+%@:>?@17+8F897?(-*72 (5W>
M4\UM]%J(>G=>O5>WU+OS?%"@)3>\A)05SPU'=H>KWD?DQN^D_QWFP2[*."3_
MW]\==0'T0Y0^<;%6@V@!5F5*VQ1E@MY'BC)"\$YZ[9-I.3-N1O*5>>[>E&JD
MLH9M6^+J0Q.9RQVY!R>U=G]B$D^6RT*Y?R)$0B X%!J0>RMXO< H]#FJ\SE4
M^XYX<UK[ D\O,M_:!7)*V?%IF#V9_TZ9[<LW.'N-OU'>?+R<)"5<#)@@H$^U
M4*9 3!FA:*<DJTJ3??:;]X(]!KO>G''7%[ .I]AFL^\.D#=GCU$H)DW)@+)>
M2\6T@F 2&8Y0!.4!/KK8IWW)OLC'X!;&Q,C]U?LE2/ED?IET6ADC<L8()*OW
M>EL*EK+3Y,LH> HJ&*WZ;$3N@G8,N=^8R+>;&KL0;I*5BJ8:WJ0T45X9?;[M
MQ!V17FMOLNQ32=@BT=OT69=)1$ 1D@D%ZA!J,Q&:QB8*X"FED$IFB??ITC#2
M/&]O[7^.\+L(O0N??U_,TR46Z5C4,D-RFM?CKPE<0@O&:$;Y9?8B]3>1'_",
MR0-WX<".HF]_&<_'">'$45)G$R-3[I6IQ146HE,4>+K,,/.L,_:)V6X U&F<
MEU.0"86">U>G(,E>LD@CK=%U,98;[TT2?6C_>5QC,H$MF'+CC3W[:Z7WC+@R
M405G5K- ,]Y0U*-LH8#7HX=<TR\,FHQYG_3Z5FAC,I<'Y,N.NFGG2W&Y1+P!
MW&6QPJ,SG$1$JXI4@,[3V#%D6)\H#RD'ZWC@1?1I![LMPD-)XI.5C2AUBB4[
M<$'6P#Z3WC@%0H*"HZQ94H%]6<F,>;6J"_\^B5H.H=J#3\G+G+*>'/(D&RB2
M0CE*)#U0-$8RRIXS8T(.K$\=[QV!CLG"CXIVNRCRL&R[H;2&6RN51@AUX40%
MSZ'>8@<%0_0I2:'C%S1\.R^+'FIE:CP<W%^]6U:F7KQ>OT0"\M-W_P]02P,$
M%     @ G8 %5:__Z3PH/@  W<X" !4   !P<F-T+3(P,C(P-C,P7V1E9BYX
M;6SM?6ESFT>2YO?Y%5[OU\UVW4?']&S0LM6K"+6ID.3IF4^(.K(DK$% #8"2
MM;]^LT"0HHB#.-X"P&.B1^8!ON^3F4]5969E9?W[__[S8O##9QQ/^J/AWW[D
M?V$__H##-,K]X8>__?C[^Y?@?OS?__%O__;O_P/@OWY^^_J'7T;I\@*'TQ]>
MC#%,,?_PI3_]^,,_,T[^^*&,1Q<__',T_J/_.0#\Q^R/7HP^?1WW/WR<_B"8
M$'=_._ZKY#P6$P4$] )4, H\3P&D3DX$69A/^+\^_%5%XX(W]'-C(Z@L&02;
M%/V!#CDY+S&)V4,'_>$??ZW_Q##!'TBXX63V[=]^_#B=?OKK3S]]^?+E+W_&
M\> OH_&'GP1C\J?K3_\X__B?"Y__(F>?YM[[GV:_O?GHI+_L@_18_M-__>/U
MN_01+P+TAY-I&*9O+Z#7Y^G-']Y&HW^Z^B5]=-+_ZV3V]Z]'*4QGYKE7A!]6
M?J)^!]<?@_HCX (D_\N?D_SC?_S;#S]<:2Z,TW@TP+=8?IA_^?O;5XM(^\/I
M3[E_\=/\,S^%P8 0SYXP_?H)__;CI'_Q:8#7/_LXQK(2_;7(%92N</YG?=I/
M>V/Z2$#&Z3(BT$]Q6 G>(<9E3]\?\\VS(&,)EX-IAX@7G]TIWM%%Z'>IX(5'
M=X!V]B"XP(N(XRZA?O?<6SBO0=Y%6!_Y:3Q*^&D*L3\:C^)HVD^3OZ31Q4\S
MI"]&PTS28Z8O)J-!/]>I]MV4_JUS[V14WF)&FAKB .D3-'U/^_3E&X*-XW']
MY"C]$897__TX&F2:WW_]UV5_^O47+/W4WX!6G\:I2B@$,Y+-I&R.Z9;BB*']
M8;].>J_IVSFPJIE352'^.45Z7_[QAW[^VX]]996T683H;%9&2"^349+%D'T,
MBME><W15E]?:'(S2=V '=4$9W8R 08@XF/VT=SF!#R%\ZMT@(?7C*_IRTB/4
M2"(H$!:1UMV<P$=:AJ5(/#%:J976B^-G<CT>2YC$V0B:OX)&DN _X6 ZN?Y)
M91L'QN>+TO]<C>6**;M+]VJ8R'F9X"]X]=]7P_=X\6DT#N.O5TI\.QH,7H[&
M7\(X][S(.2=+R*1AH(QQU?.0(+W*Y'2X*$5N(O<V*+_7R+?1<S:^ULU\#MQQ
MDJR>7:<,F8X.9)(K3I!P/_XP&M,P^=N/;%_ZW$'V[F,8X^3\<EJ=O.HW]S)+
M#",:B 04E$H9HG,)0HD6LXQ*.]6$,O<A.SQ-VMEUU- HBZ3A'9/F11B/OQ*L
MLXO1Y7!Z-IV.^_%R6J?[]Z,W!'TX[1D3I<^)D;$)M3+102S2@\A29Z^]D28>
M@D7W0WTZM.K8;(L\$[ORK/IK"X.@>@>O)I-+S+]<C@GV&QSW1_EJ;/R&7V:_
MFO1*"-SY' EG#<%5L> RMY!H2%@ABXXH[G,.=W_](R3/@6RQR![9]=*V'/1_
MAL$E?L-LI"@J6 ],(V'.@C!+XKYCWK D/)>:'62YVP3M(Z3;P8RW2#C5W)>2
MP:*PR4!@WM7I-(/C-#08J8.%Q(T1I^!+'<(A2"9(;D,&'82FN<$4"(9K$-%&
M91*+6;E3= BZ"- 6 ]W;HT9:KE5A&8*06&=-\NV$EN3;I>"]+QACFQEH2Z"/
M,$SKSC -G.[%Z42G+'S$#(EP@8J"L"0NP&FTRCCO)2[) G:1Q3C%6*Q#XXVZ
MU'P+*BR(VC,N>BR6 2^2YE/G$T2?!8GK@D<3#:V C3):=[$\<C+LI_L.HZ3O
M$*WRQF>_//]4]3_Y]4\<I_X$<T\$'Y52&F+DQ-\BZ@ZDM1"9MA3?22&D:<>6
MK; ^ 3:ULUV#J&J=)[X<L#(R66E=W>FFX:$C>>6"%FK!E)<FJER*/"395D-]
MDESKR'(-XJFU@^/7BT^#T5>\0O[F<IP^DOK>#,)PTI-:!892 05;AN;CZA0*
MX^G;F'QFF4*+5KL[.P%^DK3KU(J+Y-,MY[F5J'N:9:-T4!3<"YJ<;:H)T\PH
M/"E9!L$=RPW=L&WA/DGB=6C!1=J9?6EWEO_OY60ZVS=_/SK+>6:/,'@3^OG5
M\$7XU)^&P6SHU-*G_&)T\0F'DUE%U?GT(XY?CX8?ICB^(#W3(_J?K\;26R3%
M3OI3?(?CS_V$5XIXBVGTX<K@/615TYR!9BY6I\*#PTHTBI^%R"&;V&9C^#CR
M/F[B/P .+8X<N^_(F6&OPHSQ8RVV^DPZ3J,+?#V:3,X^A_Z@)O5(O>_"@&1(
M-"-,^SCYIJO?<'I>WH<_>UE;F5**8-"1Z^,5Q?4VDEB(I'>14N!MTBI=2?"X
MV7T4.R_RU>W+5\+Q#7@/G<[*6 W""$FNMD%PA;[2DCLMI?"T]#0AW7<P'C=S
M=M?XHOE]]^G<) JW/$=R<S&!2L[35TP#)\]#9Q:Y;97"ZWH[:$F.+",M I89
M<$Z36R6+KKMR",6PJ*WUI>1RE/SD'O6$[^M,T],>=6!>@'"9XA1.DOE8# @?
M0]0Q%Z_;[&1]CZ/#H7NK +[Y)LP>RER66/_AJISYKVDP(M?F;S].QY?X[8>C
MX13_G/XZF+WP;S].\,-%!QM\-R+,=Q1I:1H-J_-U]F=_TO/2,<Z+)P-J&M6(
M%GRMA+"H2_(^9RU:I5K7P.J0+6N.)JQASP[F7L6<O=7>8(?F#J9?9HOA1J!Z
M=PY+=,J)I;"Z7/17'?E8PX3]S3=JI?N#$4.1^Z$Y9D##:V&(K/N)A%#9S(HL
M4:1&]>@'),1W9VJ.SX=M5-Z !P3G8G3EZ_YCYB+WC TDEI-0M%(4/N< +ED%
MO@0ON."\5:'U I3#1P$=F&C4I7X;%-JOR,/,P06!(?+ "%P]".HH*HTL>XA2
ME^QX9H&U\?W7PGH,1.A.[PUF@;.4+B\N!_6\U*JTQARH2)Y\)&M!:T- DTW@
M,&2PREENI)!:MEDA-H;X*,C2Q!X-:C[>XI1DQ?QK& \I8)_,4<E@<PR.8NM9
M=L0(#4$[\LR=%8$;+F6CJLKE>!X#)3K0],HJC'__Z8YB**;^HX,3M^?C#V'8
M_W^SE/XO%?]@\CV6S0[)+GM,M^=:[P5ZYRBJR(%+TCJ6(I5A(0B? B\H+-+Z
MG7)OV0/WC.XOXZ2?^V'\M2:4S\O,I?B6^V#>21ZBA6(JH2+/X)TR8!ASZ"63
MS+?)VZ['M;=[&B8?SX:Y_J<.J<_TBNJ*3Z_+I6>;J#W)B?B">\*8!"B=:[U]
ML"!9,L)(RS&VV2G9"-X1"I2[X\J"/]NY01KXN'?GREO+Z?PH=\\P8ZS7GA;*
M6?6:YA3(101C4*6<4?-&D>[]V!X57SHV18>^[^Q V:NJ6G+)+^.@G\Y+P5J?
M<18GTW&@WP8?4W9! B:4M+CZ %X2,O0<E35"2EGN6[SN?\VCL'?'VFQ1GOQ-
MU-H?HD]/G2W/;PD.>=7Y?/A^'(830EJ+"+)T 8,@R8O7I ,4$*.C 8VTTJ,P
MGOE&M7O;P#P<=;JV[]TD>C/CM#CV<#-\SL=7COX_</IQ1$']9YQ,$6\)\_/7
MQ0]??^QJZ\';+*.1!KPIB;3&&413(K 4- \EL:1\8\=M?RD.MNG7;J$ZFE%/
M9OMPF6YG26\A.4>F%91 L:OBBD$]6@2:1.*"UFZ;PN%BBZ-N&QZ-)"O9NH^Q
M6LR-W^#\%B[HRUOS]CP+L@G"IKN/]V,\TE9D-T9=O;1V:9'C< >1,Q:5@H1,
M@9+9U<"2IOGHDS=:<.2-BER.Q)G[=BN/19EM#-& *J_>G,\3H#9HX82,@*YP
M4#D7"*D>0S/D(5I4/"G;A!$W$(X0OW5LG[L'TG=2;H,\SLU>_(M!F$QNLSL8
M;YUQ"$Z8FDGGM(JFG('\/JU-YE;)1NG.59">79).C-4@\+^-9SXZ-D'4U 59
MQ'3DZJ?]C'8W2=R-QEN4NRPBBYQ+ E6@'JNJW8%J^7T28%74TG&1'6]S+/A0
M'-BTX*DU!;91]&$JG;P(J+0!YDM=([6KK1(T>$))DYV-)K=)O9Q I=.^]KF_
MS&D+Y:YT'5IM3+^[O+B@17!4WO4_#/NEG\)P>I92;;U4SV>.!OW4Q\EO85RS
MD)]QC[WK'=_4[?9V%^+>V0&W7B 3*3#.@C(VA\2M2$ER4:Q0PO5V?&?337)E
M6$%3-$3%:[$$IZ^\UQ"D+CQ;<F9=>H";Y+?#@<LZ^.B;V5&:JT/'K[[/G1N#
M4CD/)@@:Y04YN((!A$9C&9,TVD4;'6R!\N2VQ+9ASKIHNE/SM(BXOF%],[XZ
M73O#VG,4$*BD26R)-)UK%<'QH*&(Z&.2%!G8YK3Y#M%CI<CN:F^;D=M@6TZE
M$)1-"#Y$!LK' BYJ0HS&:QN=Q]SHB-%I[ID>EC@=&ZA!(/XF?)TU W@Y&O].
MKL3X2ST2/?SPZY_UW#_V&$8;63V^)U6BJ8^1LUBXA>@RT3UGEGF;;:;UN!X5
M7SHT08.>7M?HYB+7];%>\?1B-)E.>E8479(6(-#1RHA*@9-9@RD%:^VLQ=)F
M!5J'ZE&28V_U-^C!M?+"EMNNU.^?1L.K#];,1T^@1F<D0N9,U!PXTG17LZH:
M=78T^V%LLQ[M /91$:FUL0[<9NL;RO-R2[1O33UZ@2E7I',0M>(T.*0$QW@"
M(0JG%=;X@*W.WN\!^U%Q[G &[+#;UM:7&ORSYDN&T^O6B)->9BR:E&FQUJ4V
MCTF6 @1F0:3D$W.\2+S3,*N#>R;NHG@41#JL+1HTGNIT)] $K3T*2_-O/:H4
MLH18* [E)*#*TAK-&L7[CZ\L<:]I[5A&/9FRQ)7;4^BMT"676IP0:<S)3 I6
M&;Q-%FG.+LRUN<OI<=< ;$62C6L MC'68?9]-T'TQ&L MC+:_1O NVC\,%PH
M'&T*TD..L8!2,D&(*8&NU_5@QLQ]HYW@4Z\!Z)@"VRCZ(#4 222CO5*@ \N@
M'$KP2/+5;G Z11U3;%3]<9(U %O9Y]X:@&V4VV(S:V5Q;$9ME94"6'(4[M4S
M^#YZ^DHP59S.UIM&5P$\ZA,->[D.G1BK[;G!5<6VFR!\/M&PNU&W+T_?Q2+'
M.=%@M0QHF(10[QA0W)9Z3:6%Q(0/,;N46UT!_M!.-#2FS#:&:'JB(2MIT48!
MOA9^*!OJ[C_7)#9W2?HHDFO3S>*T3S1L99^5)QJV46X#E^3\,X[/!H/1K /X
MU3TW<V JDFS1$A)=ZR4U$3LZAV!S\4Q[9DVC$PTK(3TZ%G2C_";WZ*WK.1EB
M8%B,!Z=T]:H0(8:L(/,D+2?!N6]UE\LI=NX]&8>U,Z,UJ*18WG]L$U#/?7^W
M-M]&?5YWT?W!^OY*'21#)\%(0JB$H_6Q-LE/PO!L1);,M2F]>BA]?[OGPS8J
M;]'Q<VT[TH0F!<X#F4M:$E=GB)P,*)A#Y:6,O%%3D@?1!G8KTVW5!G8;O3?P
M3N<[VM>N<CWJJTP"9(+5UJ(4;P5K@$=1K$8M!6_C=WP'XS$8?7>]MMO^F&,Z
M'[_M?_@XG4UR!BF2CEX#IJA!J7IUL.(DHB;F!:X(6*,VBJL@/7DGLQMCM:C'
M7 9L/E0V@7:(G=5EX([C;'9DQDW(L8<-#C797'O$1/T@$H-29*I9O 112 \E
MIF"YEQA5H_+<0]/C'M?S\.S81O5=M]Q\A^,^3GY]BQGQHDZ0*ZN%Y]"O6UU'
MQV2N+4T4LS5)PS)X'3W0TNN#*S+XNU=WK2AUW!7!T79H][?AZ- &./B1[I>A
M/YX5^_X#P^1R/ OE.CG!O=F#NSVPO8,P=\YGF^!=#CYF)HPJ0D;-D1N;D7G'
M392]S5ZQW^Q_\XY?^I-:,TBO.9M,<'HVS*_[(?8'Y"O]-IK.$>2SZ<T?O+XI
MGM0^"2F+@B#(9596,O"B=J*0V:I$@R"E-JM$!^#W73WK#;CO<7SQ"\;I+3.]
M&GZZG/94-CH(D8!1 %(SX:08*P+]8Q5&[>M%,DT4LP[5X:?(0W/L[C+;F8T:
MQ/-+='->-M3.5>S"@O.&*P&69OAZ+XT!>@VO_:&0H[..EH)#C;[MH!^J]OO8
M_#NLC4^E*OQ&A)^_WGSY?_HX)F0?O[[&SSB8^<_2ZR)U03 J%Z!@&TFG1H(S
M D.V68?<9H[<#-^QTAL'YLPJQG9GNP:1ZU+_:!'O=79P [!-4QY;P3U.$J2%
MW5=1JYG1CLZT[$,VD3M(24D*^V*!J'SMTN4XT]I%Q=O4BYT P^[)HYP<P;:Q
M54MBS9S1R4P#\KH]6S%!<"TANZ1KGR$/KKCJGNKDBL?,&G4]7 /JB,%#]^9<
M19P];=$R2OCYZRTUO!SCORYQF+[.:R^EJ5>;0<JR5O(72>AHO4\R!%:2P*3;
MG+7; -R3]Z(ZL5J#ROEEH^L&X$VA]OT0#^XXW0%Y='>I&P-OL)1U89T#>4AW
MH3IF"R\\U+U51:NZJUW*10''5?;"2!2L3<G*T0BTN3=T-/YL8Y1#>=9O:]>/
MVLMAOOHB6I9K17@Q*H#B@G3  OV38T#/BK*^<8IK#;K3<(GV,NLF'O0^-FG@
M$55\LS9Z[S%]'/9)]JNSL%)HM,Y ]FA 8?00'2]0;/9%($IWM]=*1TQ9CN=I
M^CT=V*9!O?4BJNLS[QO@:NK?K$)V'*>F"^O=2X@]5-]@$5J)3V>OZ^M!QWKH
M)(4(%%]RB+%X(;1POE$(?EA*W..F')(1VVC\,$R@&;1V1,?9A<HO!Z,OURD!
M03"SM&!3KE<O9(2@?03AN$_1U)O&V\3;FV,\O&O2C5WO)TL71CF-^I=O2W7'
M]2\+#SY _<MZ8>[4OQ15F(\V!>:R,ARCE!3.,*UMYAC,BOJ7A5<<O_XEA%2T
MI;'J):LM>5, )V4@TF$2101M8N/,V_'J7^KXZZ5LF?%&0^2H*=@P% 882_]$
M&= &&HNI-%% ??O#K&?9AC,+9:/;ZKQ!_%4QU$KZSV$P.X$U?1'&XZ\4'L[D
M["D?E=9>@42LXH4$WJ4"W+FD)),JJ39QV'I<3Y,K'=FI1>TYH2--W -2)"70
M:@F)>T:.9N'@F';@F132,:\M-FH M0F\I\FI;JW68&?C%QP3LEHH>ZV3VD08
MR<O 8@S4RSE >0S@<V$0-84K@I5H&MV1LA3.TZ/._E9ID!G:/UM6* YF"1D(
M3C.H4K5EB2,!M.':EV**:]2*]TG58.Y#O,/:^('58.9HC7$A "O&@I+"0@@E
M00XQ>6^R%*%YZ<"CK,'<BC.[U6!N8[OC5\9M /:Y!K-[N^]7(K>#T8[/M,*%
MX(J#P'KTKE[2YX/U('5M\A]E=J5- 'H"#.NF!O. !-O"5@>JP>377<>*5L)&
M4H+0F8*8C!"3S!!LDB5RYI5NTW5G#:C3*#CHR)P;U&#N8HN6-9BWH(DY-!TE
ML[Y>R9QJ"VY&*WX408+B)2EIL@NQ<673(JBG1I-=;''@BF[!6#"JULQH2X"T
M$13GI@R:EVQ*"2ZGQG5,#["BNV.:[&*+EH6W:TK_DBG*<\\AR.AJ%R*:ZSQS
ME<Y".5OJX8CGBNXCQ62=6.U(%=V;0'RNZ.[$P#M4Y.YBG2-5=.=(4R9%"5"$
MUZ!B3!!RR2 R$Z$42XY:FW9D#[FBNS5_MC'*L2JZC;#!":U!)H.@1*;@LD@#
M+DGCA#-1->IF^G KNK<RZRX5W=O8Y,1JIV[[=^ME;59EM3V$0]9C[:F@.Y5;
M*04EDI#:DV=NC8]1<>X1 ]>*6^_N<?&W!W/\&B\C+4I6:#Y1VE*XX"BJM!1D
M)F&,3S%%QA]MC=?-$W_#Z;<-W!F*&PC7[S\?WACOYS#I3WX?CN($QY^KZSVS
M._UZ-$ST-[.*SK>CP>#E:/PEC',/D3GI9802O:W1>ZTG-K(V<,9<;[WGIG$2
MI:E\#W.S?QO>KUQU3H<W+?.".TCYS_[TXX*DDY[DR%)& 2496NJE8>!T9,"$
M)(&24+&<WDA8+LL167]"K.MP8'1 F99.?Q=*GWRO]=GEWI->3"YS;0,%2SJ!
M\B:!BXK\7\^3YH8+(1N'#,UD>QXDK5>/_2G5,E770,*_$PM>CR:35\,TN"3/
M_=7PUS >TE_35(%>^IP88)"<EG3+(*@0P4DK7.#):MZX6.V@\CX/K@,/KHZH
MU[+0L[MU-VI>5/*ZRD%&L!G!>2<@9"^5C\4*UC@#VLA5.T89K96&*& <,&L"
M*.,%1&4CZ)!4XDR8W+I!R%,HH^TDI#N(C4^PC'9E5I]YFZ.L+>M\C"27J@=<
M<P&C9*H>>(KJN?U66[;LL%F[C=6.M,>V"<3GS=I.#+S#9MLNUCD2D8Q!YDOF
M4+R.M85U@7KTGN9]1%FR4MDU[B?Y #=K6_-G&Z,<;;.V%%3"%/)QK:^3,%:'
M04(H3GN)KO;+?]ZLW=VL.VW6;F&3@V_6OAZ%X<N09JM[&.;%0W]?]]B&W?SA
MW6ZP[BC4G:U3&V4RLBA/\BB55! TKQ3TB6DOI$J]S5^SY\4E% ^<EQ?D=/6G
MU^_[%B/D4EBHO9>)3S50-Q2C9PH40I(U,::C;M1';2VLO2]K6?+P?X0_^Q>7
M%S^/QN/1%QI?+\(G^LWT:R]G)263 5 &&L):T. 24H)RC@:>]#*'=# 5K$)Y
M^-FO.]XL7-/2RCH=;OK-;N=:!O2WRZJV\_)J.)E2!#^;LWL\(LW)GD%FRH"J
MG8\<C7GPW D9DM>EI/NFNZW>^!CHT$[%#?RG-W7%P#QY28JYOF:H8I]<@^^)
MP(F,GH/@M6S+^'H<P650,I"/(*USI<UE /=">PQD:6.'!GL]RT1_01X=D7AQ
M<C,\%V<)(>K$*JFQGGE(8%A,3+%2R(LXV-*S"N5CHD\SZW2XB;%R7GPQ^HS#
M,)S6Z[ '_3!,];;(*2$F]._'Y"K2E^_Z?[[_@H//^ _ZU<>W2']14VSC#SCM
M8=!HN0@@61&@5.W1H@L#EF7QDF6!^EZGO!6XQT"RDS!<@_NEEXGT:CC%,4ZF
M;\,4SZ9O*'@9Y5^'N2<,\X&1HIRK3AHKDI9I@BJ-+O03&C^NS2JX!<C'P+76
MMEFDD=Z_45.<5I=N?%D]NKIP]S"I'!0S$!BG&38@26XQTX)=LM882U"\"5L6
ML3PF4NRIZ47;F[W6LN_A7+/S?#CX>L7-7LF87 H(B5??OG[EE;&0BD63=(X4
M[&VT,-WWIL=@Y.Y5NFAOVZ&]WXS[P]3_% 9GPWP-= XR:1-DTA*L(SZJY&E"
M(@\=7+1%HE5!6+F#W5>_\9':OR,5+_+ =<B#;R[/C:?]ZSQENH2_3'-KC?5@
M>2*71Z.&('6HEWP9ZT3ACN<=J+$5B$?*EG:&6"20/PR!U@P M"S%[#P@8B'?
M.0OP@KX5.C*2+4>4'1/IR4T_[0VS)*&W7V;WK@ +\5GXU)^&P=O0G]11\>K-
M^7LBQ^3C:)#/+FI#^EX]I,FESI +J4W)3&XUV@3!&T^S;'(J;9;RW1O*HV55
M6Z,LX=3.6>)NX)^ECWV*^_.ZV=A[4F6V%,\P1R&<84"NNR<%UT4^87'F0*R[
M'^PS+QL9=@ES=TY;MQ%PS;1O4ZKM$&(-1"DPT25#R,I!Y%DDY[R@X7L<!C_!
M=?M4#+V$T?NES^\3=)Y??3D:8PJ3*?V7?E?+R2['88I7$M"_B?ZX%Z0020@!
M*;  RGM-SJ^H;C"-32><$'*SM'F'H)X,(UL9:@GC=LZ3[R+(U7!ZV1]/IN^_
MC&[O=-=%H9=M4*I8!3I@[6B'"H(6 5RP49>@&$;1@G/K83U5UG5HK"6\VSFQ
MOJ\H1!Q<$,9E'YE6!BR)!:I(3H,H>> N9NN84,A,:^8M _;,O0X,MH1]7:;V
M-Q3F;#"X+<4OX_!EV".MD1 F@]:R)JP% PK8 F3/DE'T?\DWG/&607K:C-O;
M2$NXMM^VPC+MO.P/P^!-^#HKS4:<>P+A _:\=D8P5\^]^423<J[]K7*"HJSR
M24K&:<'?M=AAY6L?#6?:*7L)+W;>9EA;UD-^8G^ZB+4H9ITM#(1U]<)C9R!&
M@BY4<H$S)="W.7NZ!<C'0*/6MEG"H_UV&Y8!_36,!U_?XJ<;TL^=P)M"G>O8
M(PO$$KT$7>HE6'6OA$; [,"&9B+)VF-_Y^EF4Q2/@3:'-<62 M#N2\87D+^K
M;13R]]!OQ;')&$83IP/F-,43UA9P$@5-*9R&1W*.W[UF=!\NK0?SM"C5H6&6
M,&N_[86-!"#H0UJH1Y?C&?P)A0R7_PC3RS%]^%H*S1D:3TNT41%!19(G1.%
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M? K<FHC=Z@BCBR3 !WIG9L/ES*S)B*RT;Y:[:SLJ;BCPM+DM2VY*<J;GTU^
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MIL"X -N0@"U, 'L%V]?5N( 2F"M000.VL $E.&"IT0$U/%=@"Z KT$ $:HQ
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M?Q':&\ZD@,2T@,$ICV-,"9=N9=0/R!@;P:Q5! NCHQL_',+0CA;.1*9G-MB
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M<5-!-X8T80C&@J<T##E-[1(5^U)P;/-[HS)8Y-_ 4UG+:ET#:5EJ[&EMU'5
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MT55L/EZ^]?$^KS_>LE0<^-KPJHG4$FO+UX7E+),$_ Z\Q11XB>'L>4K<]"(
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MNF7$VL+3FNQZ\B'#Y;':VK.3HFI]4[>5O9X"\L6M>I,-^%K]=Q/.BPVG2I3
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M4Y.%E/$44B0S&"#M!RB1L#1U*L[>*FULG_U&66"TA7I=7>OK]NFW0VS' MZ
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M(<6[E]^U0)^7G^9+JKWFY?TU7\]_U*<'FU-QD>$D3V("N6$"1S2B$*<F5Z]
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MIMO^(-6<S]>S2"182)'!% L&45[$D'&2&F9=$J%$<>U>N.6[G!MR:A[$CH1
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M>,D)U-OR2$8B31"W"MSX%6MJAJ)3Q3C]K2Y7'7\[4*TZ@-;Z7 &M"ICOJ.3
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M>_&P;?$_Y/S^82W%M796Z;W\^FR<TQO5,&K=;'=V[V@UYS,N<"HSBB"73)N
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MTC'?+I'"$UJ]R16^QABPQ']9T>4GRNNT;]/KC#_(FZ5LR0(IPCG#--:[V()
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M)D$,IY!%BNJ-CN))C*E,"^Z4S>))L*F9KUV]P%8QT&G6I)'MZ&92R#KMS$%
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MZO'AQL\K[57[:*9H_QWNM>%W)379/]]?'MEJ,4N3A#"F'1_!$89(Z2T0P[B
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M=VIT[SC^U+82K9S##:0K_E%.$H81AC)E'")"4L@R'L&,,Q4IF8@L=_0K L[
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MB+3"@<5<Z3W:BZ2E,\=GN'FU/!*=Q&R%/C>]G#-T2W$$=A0V%*+M.V!T]GC
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MNJGRF\FL$#'"&"8QTUXX90@2E6.(<IK31!4%05:5<F,+/CFCU"IK#AU:;:^
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M@RC)4DABKF"F4E3$"4KSPJKNUHLT4S.(M0O0ULX\-0TD'/RFB^?&PAL=$_'
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M?-T.>V1ER-?D&;*OG?29+$!RXI!IF:()/CGV6 G+()#KZMZU#08>!MHA"ND
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M62@;[NNI<]'S[(8H!JI6.)2FHY<S#"K$X5O7/-)VB2G!)4LUU25JLNSKZ+A
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M7.HV<;5]J!V]+\TX1_C@BNP0K'?,%/+=4=AD@-R\&@Z(&1RG9<A(?"PD7KL
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M&C=?N/;.LTZ =Z\3TNRTMBEZ^7OZ'.:?\#W9]R]+05*"2(6AXG7(9" E)'(
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MZ=T@BBP"12)OB?_H!#Z4B'&C%.UA>%0E=;!I7F>AWE;=.@),8"0FYB%:0T=
ML)&X80A<:N]TR$HU&B;\.%WC1C^.MQD.J)TGX&B\683YJY V.6-AGN\VR=DK
M?6J+3QW:_=B5D8$\D3K=[1X DN$6O44)P;M$.Q*O)Z-*=?2TE8'.1MVH&<G]
M]!S>W>KZIUYYW:7PQ%AR8)DTM!B('J<=.>%(#GU2M$1*FZWJ 8+&]2,&P,+=
MIE6'"[Z#$^]J-:YH [\J ;[D)R19C#-U0#OF.@!"UO 0 T1,464T(K?I0_$C
MRL9U 9H@:D!5_"$.N -B:]M_^/&/NY;QMP=PZ1.90ZA9;86BZ@!I61,]!9E*
MTDMNHI:LC6O?YM0CY>#;\IPP/5U?R/JL:T$HR*W+ CPC7X.X#;1&:*$H9ZPH
MVA4IVQSO#Y+4Y<FW"Q[NC,\=1/A=G'UQ_7I.$CFMH;^SOD%FTZI2D79%;?J\
M&7HM ^VX6NE42#*9-5LG-VD9%S<#*?D>H^D B7>'F5_#"9ZW_TG")E$-/4P6
M017KP>>0@+.H2LS"Q=#.K[B/HO'WG4,T_2AP]A3[V-'.ZY;!14\GDYD225?*
M:3$E+B$R;P%M%M&H38+(5D',NY_=D_[W5=AB..GUI/R/RS!/G_'M',\989%Q
M97B$: ROXU@B>&DUB)03)AG)S/^AQ?O#IXP#B$%T]Q .#A)DAXCX^&UQ,7<Q
M:#I4HX>HBZIG*P,?M0;+55'!62O1[HN(RZ>,XT(? Q'[";)'1)!R+\#-13)8
MDJN)?S6DD!"BDPJT=-X4';,L<F],7#UGG$NMHZ!B3V%VB(M7B]/E.2<Y>:S9
MH8"&^9H]S&J%N <K>18EQNQOY_YO#XNKQXQSR70,5.PIR@Z<D9ONV<;(CC(P
M,J\X%%5AG8GXR,FQ-Y;G$H7G7#>:\W.'EG$#M&T<V ,EWAUFSHWR0A9X**E
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MWI;WF!:?YM/_Q'R6![?1R)4@,!@;F/20A+9UUE"=Q4SX3%X4:3WY2M8T1OS
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M&=!%+Q>KR<:FOEML+.JZ("A)R3RKPP<+.I).%0QZ#]FKPD24D6\_JCR.*?K
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M8V%T:6]N:W=A=&4N:'1M4$L! A0#%     @ G8 %591R#AR\!0  8A<  !X
M             ( !WA   &5X,S(Q<V]X8V5R=&EF:6-A=&EO;G)Z861N+FAT
M;5!+ 0(4 Q0    ( )V !57 Z'NTQ 4  -,7   >              "  =86
M  !E>#,R,G-O>&-E<G1I9FEC871I;VYK=V%T92YH=&U02P$"% ,4    " "=
M@ 55C3'*JIB0 0 "MQ, $0              @ '6'   <')C="TR,#(R,#8S
M,"YH=&U02P$"% ,4    " "=@ 55)4;*.J$.  #)FP  $0
M@ &=K0$ <')C="TR,#(R,#8S,"YX<V102P$"% ,4    " "=@ 559P&/%FD6
M  "QT   %0              @ %MO $ <')C="TR,#(R,#8S,%]C86PN>&UL
M4$L! A0#%     @ G8 %5:__Z3PH/@  W<X" !4              ( !"=,!
M '!R8W0M,C R,C V,S!?9&5F+GAM;%!+ 0(4 Q0    ( )V !55FE;0!=+\
M .@@"  5              "  601 @!P<F-T+3(P,C(P-C,P7VQA8BYX;6Q0
M2P$"% ,4    " "=@ 55Y!Q]<5]N  "%)P4 %0              @ $+T0(
K<')C="TR,#(R,#8S,%]P<F4N>&UL4$L%!@     *  H N@(  )T_ P    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
